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William Maxwell Cowan (1931-2002)
It is with great sadness that the world of biomedical research learned of the death of Dr.
William Maxwell Cowan on June 30, 2002. A long-time friend, course lecturer, symposium
speaker-organizer, and trustee (1988-1994), Dr. Cowan greatly enhanced our Laboratory
through his intelligence, teaching abilities, and the open fairness with which he judged sci-
ence and its participants.
He was born in Johannesburg, South Africa on September 27, 1931. After receiving
Bachelor's degrees from the University of Witwatersrand in 1951 and 1952 (with honors), he
attended Oxford University where, between 1956 and 1959, he received B.M., B.Ch., M.A.,
and D. Phil. degrees. During this early period at Oxford, his obvious skills led to a fellowship
at Pembroke College and an almost instant Demonstratorship in Anatomy. Max then com-
pleted his clinical training and embarked on an illustrious career in neurobiology. Among his
first studies were those that mapped an unusual group of connections in the brain between
the thalamus and the corpus striatum. It provided the foundation for a career that included
more than 200 published articles.
Max remained at Oxford until 1966, when he moved briefly to the University of Wisconsin
as an Associate Professor. In 1968, he joined the Washington University School of Medicine
in St. Louis, where he was appointed Professor and Chairman of the Department of
Anatomy. There Max was among the first to use electron microscopy to establish patterns of
synaptic connections between nerve cells. In doing so, he uncovered an "activity-depen-
dent" mechanism that prunes erroneous or excess connections.
From 1988 to 2000, Max served as Vice President and Chief Scientific Officer of the
Howard Hughes Medical Institute. During this interval, the Howard Hughes Medical Institute
successfully navigated a period of unprecedented expansion and is today a premier sup-
porter of biomedical research and education in the United States and throughout the world.
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He was a Foreign Associate of the U.S. National Academy of Sciences, a Fellow of the
Royal Society (London), and member of the American Academy of Arts and Sciences, the
American Philosophical Society, and the Society of Neuroscience (President 1977-1978) for
whose main journal he served as Editor-in-Chief between 1980 and 1987. Among his prizes
were the Karl Spencer Lashley Prize for Neurobiology and the Dana Foundation
Distinguished Achievement Award in Health.
Max's association with Cold Spring Harbor Laboratory began when I invited him in 1971
to give a lecture in the Laboratory's newly created summer neurobiology course, "Basic
Principles of Neurobiology." Liking the experience, he returned to Cold Spring Harbor the
next summer to give five lectures, living with his family in a cabin next to the Page Motel.
On the basis of these and subsequent summer lectures at Cold Spring Harbor Laboratory,
Dr. Cowan was invited to teach a five-week course at The Salk Institute in La Jolla, California.
This led him to a series of positions at The Salk Institute and at the University of California,
San Diego, between 1980 and 1986, culminating in a vice presidency at The Salk Institute.
He returned to Washington University as Provost in 1986. In this position, Max typically
enjoyed interacting with the students more than with the faculty, because in discussions with
the latter, he would "run out of synonyms for no."
As Chief Scientific Officer of the Howard Hughes Medical Institute, he was thought by
some recipients of its largesse as a micro-manager. In reality, his sense of fairness never let
him give out monies that he thought were more for the inflation of egos than for the doing of
important science. We frequently had supper together in Bethesda when I was at NIH as
Director of its Human Genome effort. Always a realist and in no way a cynic, Max worried
about the way the Decade of the Brain (1990-1999) had come about. When it was over, he
thought no one would remember it. Toward that end, he, Kay Jamison, and I persuaded
David Mahoney, the President of the Dana Foundation, to hold a meeting at our Banbury
Center in November 1992 to discuss funding for the Decade of the Brain. Out of it came the
Dana Alliance for Brain Initiatives. Over the last 10 years, it most imaginatively has taken up
the task of explaining to the general public how research will lead to the development of new
treatments and therapies for brain diseases.
Shortly after his retirement in 2000 from Hughes, Max found himself a victim of prostate
cancer and underwent surgery. Wicked complications arose and Max's next months were
not easy. Never a complainer, Max's exemplary fortitude was always there when I saw him
and his wife Margaret at their home in Rockville. Fortunately, his disease temporarily went
into seemingly complete remission allowing him to attend our November 2, 2001 com-
mencement where we bestowed upon him the degree of Doctor of Science honoris causa
from our School of Biological Sciences. At the ceremony, he spoke of his fondness for us
and his strong support for our research. Six months later, his cancer came back with a
vengeance that mercifully did not let him suffer long.
Max is sorely missed by all who had the good fortune to know him.
Jim Watson
President
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William L. Matheson (1924-2002)
A long-time resident of Mill Neck, New York, New York City, and Hobe Sound, Florida, Bill
Matheson was a gregarious, public-spirited attorney and businessman with a sharp wit and
an unfailing sense of humor. Behind his contagious humor was a seriousness of purpose that
led him and his wonderful wife of 25 years, Mardi, to become among the most devoted and
prolific supporters in the Laboratory's history.
Bill was born in Coeburn, Virginia, and spent his formative years in northern Georgia. He
was a graduate of Emory University and the University of Virginia Law School where he
earned his LL.B and J.D. degrees. During the war years, he served in the United States Navy
from 1942 to 1946. Bill's very successful professional career in New York began as an asso-
ciate attorney with Patterson, Belknap and Webb, and he was admitted to the New York
State Bar in 1951. He was later employed on Wall Street at Werthheim & Company before
returning to law practice at Webster, Sheffield and Chrystie. The combination of legal and
business skills served Bill well as he went on to become Chairman of Michigan Energy
Resources and its predecessor companies, a post he held from 1959 until its merger with
UtiliCorp in 1989.
Bill's penchant for hard work did not preclude time for family and leisure activities. He was
a lover of the outdoors and of animals. He owned and maintained a cattle farm for many
years in Ocala, Florida. Bill had a love for horseback riding and tried his hand at investing in
and training racehorses. He was an enthusiastic golfer with an enviable list of memberships
at many of the great courses in Florida and on Long Island.
Always generous with his time and resources, Bill had many civic and educational involve-
ments. Among those were the Police Athletic League in New York where he served as a
Trustee for 40 years and the Madison Square Boys Club where he was a board member from
1958 to 1976. He also served his alma mater as a member of the University of Virginia Law
School Alumni Council.
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Most fortunately for this institution, Cold Spring Harbor Laboratory began to capture Bill's
imagination during the decade of the 1990s and a wonderful partnership evolved. Increased
exposure to the Laboratory and its leadership sparked Bill's innate intellectual curiosity. His
interest and support resulted in his election to the Board of Trustees in 1996. Bill was an
engaged and active Trustee who served on the Audit Committee. He clearly enjoyed his asso-
ciation with Jim Watson, the scientists, and his colleagues on the board. He grasped the seri-
ousness of the Laboratory's mission, enjoyed learning about the science, and developed a
genuine interest in the neuroscience program. Bill understood philanthropy and knew how to
employ it to an institution's maximum advantage. His and Mardi's pattern of generosity to Cold
Spring Harbor Laboratory has been deliberately planned to give inspiration and support at
absolutely critical times in the Laboratory's development. In 1996, The Marjorie Anderson
Matheson and William Lyon Matheson Fund for Neuroscience was established to provide
ongoing support for young investigators in this rapidly growing area of the Laboratory's
research. The nature of the neuroscience program was such that many of these young inves-
tigators were doing important work not deemed mainstream enough by the government
agencies to be publicly fundable. The Matheson Fund provided the necessary shot in the arm.
Having done his part to ensure the success of the neuroscience program, Bill recognized
the formation of the Laboratory's innovative Ph.D. program, the Watson School of Biological
Sciences, as a seminal event in the institution's history. In 1998, Bill and Mardi announced
their intention to establish the Cold Spring Harbor Laboratory, Watson School of Biological
Sciences Founders Endowment in honor of George A. and Marjorie H. Anderson (Mardi's
parents). The importance of this lead gift to the permanent endowment of the new graduate
school cannot be overstated. In addition to providing funding for five Anderson Fellowships,
it gave all those associated with Cold Spring Harbor Laboratory-Trustees, faculty, and sup-
porters alike-the inspiration and the confidence to proceed with this unprecedented edu-
cational mission. The gift provided the cornerstone for former Board Chairman David Luke's
successful campaign to endow the school and its talented students.
As Bill's health began to decline in recent years, he and Mardi spent more time at their
beautiful home on the inland waterway in Hobe Sound, Florida. Fortunately, distance did not
diminish Bill's interest in the Laboratory. He encouraged our visits and kept himself current
on our plans and aspirations. He was particularly interested in the plans to expand our
research and academic facilities on the western elevation of the main campus. As his body
began to succumb to the too familiar ravages of cancer, his mind and his wit remained sharp
and, unbeknownst to us, he and Mardi were planning another major gift to the Laboratory
during the weeks and days before his death. This gift will give us the distinct pleasure of nam-
ing a new cancer research building (one of four new buildings planned for phase one of our
upper campus) after Bill and Mardi. Again, the timing and magnitude of this philanthropy
instill us with confidence and inspiration as we embark on the next critical stage of the
Laboratory's development.
Bill's final days were spent peacefully at his home in Hobe Sound with Mardi at his side.
To lose another wonderful friend and Trustee to cancer deeply saddens us. At the same time,
it is people like Bill Matheson who inspire us and increase our determination and resolve. As
Bill's quality of life declined at the end, Mardi tells us that his sense of humor never left him.
We will remember the ever-present twinkle in his eye and will always value his friendship. Bill
lived a full life and he did so with a keen sense of humor, dignity, and generosity.
Dill Ayres
Chief Operating Officer
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Much has been written about the extraordinary events that took place in Cambridge,
England, 50 years ago that changed biology forever. The discovery of the double-helical
structure of DNA ushered in an immediate future for understanding how genes are inherited,
how genetic information is read, and how mutations are fixed in our genome. 2003 will
appropriately celebrate the discovery and the stunning developments that have occurred
since, not only in biology and medicine, but also in fields unanticipated by Jim Watson and
Francis Crick when they proposed the double helix. DNA-based forensics is but one exam-
ple, having an impact in the law to such an extent that some states are now reviewing
whether capital punishment should be continued because of the possibility of irreversibly
condemning the innocent.
In all the writings and lore about the double-helix discovery, one of the little discussed
points that struck me was the freedom that both Jim and Francis had to pursue what they
felt was important, namely, the structure of DNA. Having completed graduate studies in the
United States, Jim Watson went to Copenhagen to continue to become a biochemist in the
hope that he might understand the gene, but he soon realized that biochemistry was not his
forte. Most importantly, after hearing Maurice Wilkins talk about his early structural studies
on DNA, Jim had the foresight that understanding DNA structure might help understand the
gene and therefore he decided to move to Cambridge, then, as now, a center of the field
now known as structural biology. Remarkably, although this decision was strongly support-
ed by his mentors, it was not favored by the U.S. funding agency that paid his stipend in
Copenhagen. If Jim had followed the suggestions of the funding agency, he would have
moved to Stockholm to work with the cell biologist Torbjorn Caspersson, almost certainly
ensuring that he would play no role in figuring out the double helix. Support from Salvador
Luria, his Ph.D. research mentor, and his new colleagues at Cambridge enabled him to make
this important move and essentially ignore funding considerations. Although supposedly
working on protein structure, Jim was intellectually free to think more about DNA than pro-
tein. Eventually, Luria's and later Max Delbruck's support facilitated funding for Jim to remain
in Cambridge. Thus, it helps to have supporters who can influence funding agencies.
Meeting Francis Crick at Cambridge is now the stuff of legend. Francis was pursuing his
thesis work on proteins, but he had the freedom and eventual support from his peers to go
after DNA when it was clear that building models was the best way to proceed. Individually,
they took a big gamble, particularly Jim Watson because failing meant having nothing to
show for a substantial amount of time, talk, and energy. However, Cambridge was an envi-
ronment where risky projects were the norm. At the same time, Fred Sanger was sequenc-
ing the first protein (insulin), and Max Perutz and John Kendrew were determining the first
three-dimensional structures of protein.
Fifty years ago at Cold Spring Harbor, Al Hershey and Martha Chase had just demon-
strated that DNA was the genetic material in phage, the viruses that infect bacteria.
Meanwhile, then-director Milislav Demerec yet again played an important role in the devel-
opment of Cold Spring Harbor Laboratory as a major research center. Immediately after the
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Second World War, the two laboratories at Cold Spring Harbor that were both directed by
Demerec proposed an expansion of the inadequate facilities, including the addition of a lec-
ture hall and new laboratory buildings and upgrading the grounds. The necessary funds
came in 1950 from the Carnegie Corporation and the Rockefeller Foundation. But the events
in Korea (some things never change) prevented starting the project until August 1951.
Vannevar Bush, then director of the Office of Scientific Research and Development that was
responsible for science during the Second World War, opened the new lecture hall in late
May 1953, just in time for the annual Symposium. (In 1945, in response to a request for rec-
ommendations from President Roosevelt, Bush issued a now-classic report ["Science: The
Endless Frontier"] in which he described the importance of biomedical research "for the War
Against Disease, for our National Security, and for the Public Welfare.")
Organized principally by Max DelbrOck, it was at the first Symposium in the new Bush
Lecture Hall in June of 1953, attended by a record 272 scientists, that Jim Watson present-
ed the double helix to a well-prepared audience. Delbruck had distributed copies of the
Nature paper prior to Jim's talk. A few weeks earlier, Bush, the engineer turned science
administrator, stated about biological research, "If I were a young man I am sure that that
would be a field I would plunge into. Every day it becomes more attractive; and it touches
the lives of all of us in countless ways." Perhaps he had been tipped off about the lecture
that was soon to be presented in the hall that now bears his name. He went on, "It is a priv-
ilege of you neighbors on Long Island to extend this opportunity to men of great intellect,
who can qualify, and who can thus bear the torch for all of the rest of us, in delving into some
of the mysteries of life." It is still a happy circumstance that men and women who work at or
visit Cold Spring Harbor receive most welcome support and encouragement from our neigh-
bors.
Bush was correct in noting that the field of biology was then at a pivotal time. The double
helix was the seed of a revolution that is still ongoing. Although life is no longer mysterious,
surprising discoveries continue, such as the recently discovered RNA interference (RNAi)
field that scientists at Cold Spring Harbor have helped understand. These new discoveries
come from investigator-initiated research that is generously supported by U.S. taxpayers via
grants and very importantly by philanthropic donations that provide the catalyst for new
ideas.
The modern scientific enterprise depends on appropriate peer review of grant applica-
tions, but there are warning signs that the quality of peer review and the mechanisms for dis-
tribution of funds need attention. The number of scientists has greatly increased and thus
competition for grants is keener now than it ever has been, even in the era when Congress
has most strongly supported National Institutes of Health (NIH) funding increases. But the
huge success of molecular biology and the wide availability of techniques provide challenges
to the Federal funding mechanism. Due to wide dissemination of kit-based techniques, it is
relatively easy for individual scientists to string together a series of standard molecular biol-
ogy methods and propose in a grant application to tackle what is effectively an incremental
problem, most likely a problem that many others are also pursuing. When these grant appli-
cations are reviewed, they receive enthusiastic support from a panel of peers because the
science can obviously be achieved. Grant applications that propose straightforward research
do relatively well compared to grant applications that contain really unique and innovative
ideas and experimental strategies with fewer preliminary results. Thus, the process of peer
review often stifles innovative science, in much the same way as Jim Watson would have
been stifled by taking the advice of his funding agency.
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Why does truly innovative science fair poorly in grant applications? One reason is that the
panel of scientists who collectively review grant proposals tends to make conservative deci-
sions, even though individual scientists in that group may be very receptive to innovative
ideas. Equally important is the sagging quality of peer reviewers. In the past year, I have read
many reviews of applications for grants from my colleagues at Cold Spring Harbor and a sur-
prising number defy explanation. In a couple of particularly egregious cases, two of our sci-
entists had separate grant applications in which they proposed research which led them to
discover that RNAi-based mechanisms are directly involved in the formation of heterochro-
matin, the part of the genome that is transcriptionally silent. Incredibly, both of the grant
applications not only failed to receive support, but in one case, the review suggested that the
whole approach was a waste of time and that the applicant could "improve" his chances of
being funded by working on other areas, which the review then went on to suggest. It was
obvious to me that the originally proposed science-and more importantly the scientists-
were innovative, on the cutting edge, and had a good probability of discovering important
new findings. Thus, I found funds from our budget to allow the research to continue. Later,
those same two scientists along with another Cold Spring Harbor colleague and others else-
where were cited by Science as having made the #1 "Breakthrough of the Year" in 2002. This
Letterman-like top ten list of scientific accomplishments contains what editors at Science
consider to be the key important advances in all fields of science made over the past year
or so.
All scientists can point to such anecdotes, but my reading of many grant reviews over the
past couple of years is that these are no longer isolated cases. What can be done to improve
peer review? First, it should be stated that investigator-initiated proposals and peer review of
them are the foundation of the success of American science, so the system should not rad-
ically change. But there are changes that I believe would greatly improve the current situa-
tion.
First among these is improving the quality of reviews. Reviewers who remain anonymous
to the applicant should nonetheless be held accountable for the comments that they write
into grant reviews. One of the principal roles of the chair of the review panel should be to
read the reviews of those grant applications that do not get funded and the response to
those reviews made by applicants when they resubmit the grant application. If the applicants
write a short, limited response to the reviews and only focus on the important issues, this will
not be a difficult task for a panel chair. Although the chair will find many of the applicant's
responses an overreaction to the panel's comments, the latter that fit into the egregious cat-
egory would allow the chair to counsel the reviewer on the appropriate way to review appli-
cations. If this mechanism were in place, reviewers who spend four years on a review panel
would receive some education about the concept of constructive criticism.
A second improvement could be the reintroduction of a limited number of awards that
fund truly outstanding scientists and not specific projects, much like the highly successful
mechanism of funding science at the Howard Hughes Medical Institute (HHMI). The NIH had
for some time an outstanding investigator awards program that allowed those individuals to
use the funds to pursue innovative ideas. A modified version of this mechanism within the
NIH structure would go a long way toward giving scientists with a proven record of the high-
est quality of research the confidence that they could remain innovative, without having to
receive HHMI support.
The idea of supporting people and not projects should also be extended to younger sci-
entists in the earlier stages of their careers. All too often, they must apply for research fund-
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ing for specific projects without the preliminary results that are now so important to obtain
an NIH grant. A new mechanism that encourages bright new investigators to be bold in their
initial research would greatly enhance NIH support of our best young scientists who are now
in danger of being demoralized by the existing peer review process. Cold Spring Harbor
Laboratory has for some years now had a highly successful CSHL Fellows program that
enables recent Ph.D. graduates to pursue independent research without any financial bur-
den. Most importantly, they have the freedom to do what they think is best. This program
has been very productive and all former Fellows are now leaders in their field of research (see
www.cshl.edu:80/public/fellows.html).
Finally, there needs to be a reassessment of the "Request for Application" (RFA) mecha-
nism that has grown so prominent within the NIH. Under current practice, staff within the
Institutes at NIH can initiate funding in a particular area of research by advertising an RFA
and soliciting grant applications in these areas. They often come with designated funds,
thereby limiting the pool of funds available for investigator-initiated ideas. The RFA mecha-
nism works very well when staff in an individual Institute organize a meeting of broad thinkers
in a particular field to advise on major new research directions that will be beneficial to sci-
ence. Good examples are large-scale research projects that the National Cancer Institute
(NCI) introduced under the leadership of Richard Klausner when he was Director of the NCI.
These projects, such as the mouse models for human cancer, the cancer genome anatomy
project, and the development of innovative imaging technologies, were introduced after
much thought and debate. They also challenged investigators to think of innovative ideas in
new areas of potentially high impact to controlling cancer.
Institute staff initiate RFAs within their portfolio of research funding, but unfortunately, my
reading of some of them is that they propose obvious, incremental science. For example,
some propose the use of RNAi to study a certain aspect of biology. This exciting new genet-
ic technique has raced around the scientific community and there is no need to encourage
its use. Those scientists who are thinking well ahead would have already submitted grant
applications using the new technology, leaving those who respond to the RFA to be scien-
tists who would have missed the boat if it had not been for an RFA. Such a mechanism, if
allowed to proliferate, will encourage only incremental science by those who cannot be inno-
vative on their own. I believe that there needs to be a reassessment of the whole process of
issuing RFAs.
In some ways, research has not changed since the days when Jim Watson and Francis
Crick proposed the structure that has become an icon for modern medical research. Today,
new investigators in the formative stages of their careers still have many of the best ideas.
The MRC-funded Cavendish laboratory and its highly successful successor, The Laboratory
of Molecular Biology (LMB), were arguably the most productive research centers in the
world, mainly because they supported the careers and visions of talented people, not spe-
cific research projects. Fred Sanger, who developed both protein sequencing and DNA
sequencing over long periods of time and received two Nobel Prizes for the accomplish-
ments, might not have survived if he had been subject to current NIH peer review. When
assuming the Directorship in 1968, Jim Watson in many ways modeled Cold Spring Harbor
Laboratory after the LMB. Although dependent on NIH grants, he made sure that we had
the necessary funds when peer reviewers turned down some applications that were,
nonetheless, worth funding. Such support, still common today, is the reason why Cold
Spring Harbor Laboratory remains a leader in the fields we choose to pursue.
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HIGHLIGHTS OF THE YEAR
Research
Cancer
In October, Masaaki Hamaguchi and Michael Wig ler published their discovery of a new tumor
suppressor gene that is missing from or inactive in 60% of the breast cancer specimens they
examined. The study is significant in part because it focused on sporadic (nonheritable) forms of
breast cancer. Sporadic disease accounts for greater than 90% of all breast and other cancers.
Masaaki used a gene discovery method pioneered by Michael
(called Representational Difference Analysis or RDA) for detecting
the differences between the DNA of normal cells and breast
tumors-differences that might contribute to tumor formation. This
analysis, combined with other methods, enabled Masaaki to pin-
point a candidate tumor suppressor gene located on human chro-
mosome 8. The gene was dubbed DBC2, for deleted in breast can-
cer. Subsequent analysis confirmed that the DBC2 gene was either
deleted, mutated, or silenced in many of the breast tumors or
breast cancer cell lines Masaaki examined.
Importantly, restoring DBC2 gene expression was sufficient to
restrain the growth of breast cancer cells that lack DBC2 expres-
sion. When expression of a mutated DBC2 gene was induced in a
breast cancer cell line, the cells continued to grow in an unre-
strained manner. However, when expression of a normal DBC2
gene was induced in the breast cancer cell line, the cells stopped
growing. From a clinical standpoint, Mike Wigler thinks it would be difficult to restore a normal
DBC2 gene to cancer cells that lack it, say, by gene therapy. Instead, he believes identifying
other proteins activated by the loss of DBC2 expression in cancer cells, and inhibiting those
proteins with new drugs, would be a promising therapeutic strategy.
By using genetically well-defined mouse models of cancer, Scott Lowe and his colleagues
continue to reveal important information about the role of the p53 tumor suppressor in pro-
grammed cell death ("apoptosis"), and how the alteration of specific downstream effectors in
the p53 pathway (e.g., BcI2, Caspase-9) can unleash tumor growth and metastasis. Scott has
developed powerful transgenic mouse models of lymphoma in which transplanted cells that are
genetically predisposed to forming tumors are also labeled through their expression of a fluo-
rescent protein. In this way, Scott and his colleagues can carry out whole-body fluorescence
imaging of the mice to follow tumor formation and progression.
This year, such a study by Scott showed that among the many functions of p53, its action
through BcI2 and Caspase-9 to trigger the destruction of precancerous cells is p53's principal
tumor-suppressing function. This finding removes some of the complexity previously believed
to underlie the role of p53 in suppressing tumor formation, and significantly improves the theo-
retical framework necessary for developing rational cancer therapies.
Masaaki Hamaguchi
Molecular Biology
By developing a method to correct defects in a complex process called RNA splicing, Adrian
Krainer and Senior Fellow Luca Cartegni have moved a step closer to developing treatments for
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a host of diseases as diverse as breast cancer, muscular dys-
trophy, and cystic fibrosis.
Mutations in DNA frequently cause errors in RNA splicing.
Improperly spliced messenger RNA molecules can lead to the
creation of altered proteins that fail to perform their duties prop-
erly, often resulting in disease. Many human diseases have been
linked to defects in RNA splicing. Adrian's laboratory investi-
gates this molecular editing process, which takes the informa-
tion coded in genes and ultimately makes it available for building
proteins. Adrian and Luca have devised a clever way to correct
RNA-splicing defects implicated in breast cancer and spinal
muscular atrophy (a neurodegenerative disease). In principle, the
technique could correct RNA-splicing defects associated with
any gene or disease.
For now, the method has been shown to work under the sim-
Adrian Krainer plest of conditions-in test tubes with small segments of RNA.
The next step is to adapt the technique for use in living cells. Adrian and Luca dubbed the
method ESSENCE (for Exon-Specific Splicing Enhancement by small Chimeric Effectors). They
are working to create ESSENCE designer splicing molecules that pass easily into cells and effi-
ciently home in on the desired RNA-splicing targets. If such molecules can be developed, they
may ultimately prove useful for treating a great diversity of human diseases.
RNA Interference
In the December 20 issue of the prestigious journal
Science, the research of Greg Hannon, Shiv Grewal, and
Rob Martienssen was recognized along with work from
other institutions as the "Breakthrough of the Year" for
2002 among all the sciences. Collectively, the Break-
through of the Year citation recognized the discovery that
through a multifaceted process called RNA interference
(RNAi), small RNA molecules can play a surprising variety
of key roles in cells: They can inhibit translation of mes-
senger RNA into protein, cause degradation of other mes-
senger RNAs, and even initiate complete silencing of gene
expression from the genome. The "Breakthrough of the
Year" citation specifically characterized the work of Greg,
Shiv, and Rob as "a crucial step" and as "the year's most
stunning revelations."
Greg's lab has made a series of important and exciting Applications of RNAi
discoveries concerning the properties and mechanisms of RNAi. Moreover, through detailed
examination of the families of proteins involved in RNAi, Greg and his colleagues have uncov-
ered a link between RNAi and the Fragile X syndrome, the most common developmental cause
of mental impairment in humans. Finally, Greg's lab has developed methods for using RNAi to
uncover genes that are involved in cancer.
Rob, Shiv, and their colleagues have revealed a previously undiscovered biological phenom-
enon, namely, that RNAi is required to establish specialized subregions within chromosomes in
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which genes are kept silent. This finding has profound implications for understanding how chro-
mosome structure is regulated, and how specific active versus silent regions of chromosomes
are determined and inherited. In addition, studies at Cold Spring Harbor Laboratory and else-
where have shown that defects in the establishment or maintenance of silent chromosome
architecture in the vicinity of tumor suppressor genes may contribute to cancer.
Neuroscience
Brain Imaging: By literally peering through a window into the brains of living mice, Karel
Svoboda and his colleagues have caught a groundbreaking glimpse of adult brain cells forming
new connections called synapses. Their study helps overturn a long-held tenet that the struc-
ture of the adult brain is largely fixed and sheds light on processes that underlie learning and
memory.
Karel's lab has provided clear evidence that the brain can alter its wiring pattern in response
to the outside world. Although the neuroscience community had begun to speculate that the
architecture of the adult neocortex might be more dynamic than previously believed, definitive
evidence was lacking, and neuroscience orthodoxy still held that brain architecture is relatively
stable, limiting learning and recovery from injury.
Karel and his colleagues have demonstrated that new synapses are formed in the adult brain
in response to new experience. Crucially, Karel has established that synapses form and dissolve
in the neocortex continuously, perhaps through a "random sampling" process, and that senso-
ry input stabilizes or makes permanent a subpopulation of particular synapses.
Receptor Trafficking: Evolution is an accidental tinkerer. It uses genes
and segments of genes that are lying around in a genome, changes
them at random or puts them together in myriad combinations, and
auditions the new genes for new roles in the lives of the cell.
Successful new genes are passed on efficiently to future generations.
Two gene products, Ras and Rap, have well-defined, antagonistic
growth-promoting and growth-inhibiting functions in nonneuronal cells
which, when altered, can lead to cancer. Demonstrating the happen-
stance of evolution, this year, Roberto Malinow and Linda Van Aelst
have discovered intriguing roles for Ras and Rap in cells of the ner-
vous system.
Synaptic plasticity, or the ability of connections between neurons to
be shaped by experience, is believed
to underlie several important aspects
of brain development, learning, and
memory. The most widely studied
examples of synaptic plasticity are long-term potentiation (LTP),
which strengthens the connections between neurons, and long-
term depression (LTD), which weakens the connections between
neurons.
Roberto's lab had previously shown that LTP results from the
delivery of neurotransmitter receptor proteins called AMPA
receptors to synapses. In new work, Roberto, Linda, and their
colleagues have shown that Ras mediates this addition of AMPA
receptors to synapses during LTP induction, whereas underLinda Van Aelst
Roberto Malinow
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conditions that induce LTD, Rap mediates the removal of AMPA receptors from synapses.
Moreover, Roberto and Linda established a differential effect of Ras and Rap on different types
of AMPA receptors. The resulting dynamics of AMPA receptor replacement at synapses is like-
ly to be a principal mechanism of learning and memory.
Learning and Memory: Tim Tully and Josh Dubnau together have
taken two distinct yet complementary approaches to identifying
genes that are involved in the formation of long-term memory in the
fruit fly Drosophila melanogaster. Evolution and experimental evi-
dence dictate that many of these genes are also involved in human
memory. By using DNA microarray analysis, Tim, Josh, and their
colleagues have identified 42 candidate memory genes. By using a
behavioral screen for fruit flies with defective memory, they have
identified 60 memory mutants. In his book Time, Love, Memory,
Pulitzer Prize-winning author Jonathan Weiner called such mutants
"Pavlov's Flies" (see below).
The separate approaches described above beautifully con-
verged on an overlapping set of genes, reinforcing the notion that
the genes are bona fide memory genes. Additional studies are
required to determine the precise neurological functions of all of the candidate memory genes
Tim and Josh have identified. Until then, the genes have been given names that correspond to
those that Russian psychologist Ivan Pavlov (1849-1936) gave his famed Pavlov's Dogs, e.g.,
Norka, Laska, Tungus, Chingis Khan, Trezor, John, Jack, etc. (Tim uncovered some 40 such
names during a 1992 visit to Pavlov's former residence in St. Petersburg, Russia.) Ultimately,
comprehensive knowledge of how these numerous gene products act and interact should pro-
vide a solid foundation for understanding the processes of learning and memory.
Drosophila Brain
Awards and Honors
Cold Spring Harbor Laboratory Assistant Professor Z. Josh Huang is one of 18 scientists in the
nation named a Scholar in 2002 by the Pew Scholars Program in the Biomedical Sciences. The
program, funded by the Pew Charitable Trusts, supports young inves-
tigators of outstanding promise in basic or clinical sciences relevant to
the advancement of human health.
Karen Zito, a postdoctoral fellow in Karel Svoboda's lab, is one of 17
researchers named a 2002 Burroughs Wellcome Fund Career Awardee
in the Biomedical Sciences. Each award provides a five-year, $500,000
grant to support advanced postdoctoral training as well as the first
years of faculty research.
Peter Gillespie, a postdoctoral fellow in Tatsuya Hirano's lab, has
received a three-year, $125,000 Postdoctoral Fellowship from the Jane
Coffin Childs Memorial Fund for Medical Research. The fund was
established in 1937 by the late Miss Alice S. Coffin and Mr. Starling W.
Childs as a gift in trust to Yale University to support wide-ranging scientific inquiry into the caus-
es and treatment of cancer.
Two Cold Spring Harbor Laboratory scientists received awards at the 93rd Annual Meeting
of the American Association for Cancer Research (AACR) held in San Francisco in April. Scott
Z. Josh Huang
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Lowe received a Sidney Kimmel Symposium for Cancer Research Scholars Award, and H.
Guido Wendel, a postdoc in Scott's lab, was awarded an AACR-Amgen Fellowship in
Translational Research. Scott and eight other early career scientists were selected for the
Kimmel Symposium Award based on their receipt of highly competitive research grants from
one of the following leading funders of cancer research: The Susan G. Komen Breast Cancer
Foundation; the Cancer Research Foundation of America; the Damon Runyon Cancer
Research Fund; the Leukemia & Lymphoma Society of America; the American Association for
Cancer Research; or the Sidney Kimmel Foundation for Cancer Research. Scott is a CSHL
Professor and Deputy Director of the CSHL Cancer Center. The AACR-Amgen Fellowship in
Translational Research awarded to Guido is intended to foster cancer research throughout the
world by scientists currently at the postdoctoral or clinical research fellow level.
DNA from the Beginning, a Web Site created by the multimedia group at the CSHL Dolan
DNA Learning Center, is a winner of Scientific American magazine's 2002 Science and
Technology Awards. Scientific American's editors reviewed thousands of sites and selected
DNA from the Beginning as one of 50 of the most valuable science and technology resources
for their readers. Other awards and commendations garnered by DNA from the Beginning
include "Ten Cool Sites" (Exploratorium, San Francisco), "Best of the Web" (Popular Science),
"Big Chalk Best" (bigchalk.com), "The Webby Awards" (2000 nominee), "Top Rated Site"
(Med Explorer), "Hotspot-Keysite" (New Scientist), "Selected Member" (Britannica Internet
Guide), "Seal of Approval" (Web Feet: The Internet Traveler's Desk Reference), and "Digital
Dozen" (The Eisenhower National Clearinghouse). DNA from the Beginning was made possible
by a grant from the Josiah Macy Jr., Foundation.
Thomson-ISI, the Institute for Scientific Information, is an agency that tracks the impact of
published research papers, mainly by counting the number of times a particular paper is cited
by other scientists in the field. In January 2003, ISI ranked Cold Spring Harbor Laboratory as
the number-one-cited institution in Molecular Biology and Genetics Papers for the past decade.
This honor and distinction underscores the laboratory's mission to spread the details of our
research to other scientists worldwide.
Cold Spring Harbor Laboratory President James D. Watson was again an award-winner, fol-
lowing the 2001 announcement that made him an Honorary Knight of the British Empire. This
year, Jim was honored with the Gairdner Foundation Award of Merit for his work and dedica-
tion to genomics science, together with Francis S. Collins, Director of the National Human
Genome Research Institute. The Gairdner Foundation, based in Toronto, is a nonprofit corpo-
ration devoted to the recognition of outstanding achievement in biomedical research worldwide.
This year's awards focused on achievements in the field of genomics science.
Symposium
The 67th Cold Spring Harbor Symposium on Quantitative Biology was held May 29 through
June 3, 2002. This year's Symposium, "The Cardiovascular System," was organized by David
Stewart and myself. The Symposium addressed many aspects of cardiovascular science
including normal heart and cardiovascular development and function, the failing heart, hyper-
tension, atherosclerosis, vascular biology, angiogenesis, and tumor angiogenesis. The
Symposium attracted 256 participants and featured 68 talks and 108 posters. Opening night
speakers included Richard Harvey, Mark C. Fishman, Jonathan G. Seidman, and Rakesh K.
Jain and the summary was presented by Christine Seidman. Richard Lifton delivered the annu-
al Dorcas Cummings Memorial lecture, "Salt and Blood Pressure: New Insights from Human
Genetic Studies" to a mixed audience of scientists and lay friends of the Laboratory.
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Laboratory Senior Management Restructured
For more than eight years, Dr. Winship Herr served as the Assistant Director of Cold Spring
Harbor Laboratory. During this period, the Laboratory's research program expanded consider-
ably and, with the establishment of the Watson School of Biological
Sciences in 1998, has become an accredited Ph.D. degree-granting
institution. Winship led the formation of the Watson School and,
along with his role as the Laboratory's Assistant Director, has been
the inaugural Dean of the School since 1998. The parallel expansion
of the Laboratory's research and academic programs has placed
ever-increasing responsibilities on the roles of the Assistant Director
and Dean. In August, Winship asked to step down as Assistant
Director, to devote his efforts to the ever-expanding Watson School
and his successful research program, to which I reluctantly agreed.
During the past eight years, Winship has done a remarkable job in
helping to both expand the Laboratory's research program and
develop the highly successful Watson School. I thank him for his
dedication and contributions as Assistant Director and am pleased
that he will continue to play a senior leadership role at Cold Spring
Harbor Laboratory as Dean of the Watson School of Biological
Sciences.
On August 1, 2002, Dr. Hollis Cline accepted the position of Associate Director for Research
at Cold Spring Harbor Laboratory. Holly assumed the position following a reorganization of the
research leadership of the Laboratory. As Associate
Director for Research, Holly will have an important role in
the future research directions of the Laboratory, as well as
budget management for the research program and imple-
menting the decisions made by the Laboratory adminis-
tration. Holly is the Charles Robertson Professor at Cold
Spring Harbor Laboratory and has made major contribu-
tions to the understanding of brain development and
function. She is an outstanding neuroscientist who has
already helped to expand the highly successful neuro-
science program at the Laboratory. Her broad knowledge
of neuroscience, coupled with an interest in cancer
research, made her an obvious choice to help lead the
Laboratory's research program.
Winship Herr
Governmental Achievements Holly Cline
New York Governor George Pataki, together with Nassau County's Senate Delegation of Dean
Skelos, Charles Fuschillo, Kemp Hannon, Michael Balboni, and Carl Marcel lino, made a
ground-breaking announcement at Cold Spring Harbor Laboratory on Tuesday, September 24,
2002, by creating a biotechnology corridor on Long Island, called "Biotech Island." This new ini-
tiative, linking several institutions on Long Island, will create jobs, industry, financial improve-
ments, educational opportunities, and a focus on research that will rival the rest of the nation,
including Silicon Valley. With a $48 million investment, and a $20 million investment in Cold
Spring Harbor's bioinformatics program, the New York State delegation made Cold Spring
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Senator Dean Skelos, Jim Watson, Governor George Pataki, Bruce Stillman,
Colin Goddard, CEO, OSI Pharmaceuticals
Harbor Laboratory a cornerstone for this initiative. Due to this effort, Long Island is now poised
to become a center for biotechnology in the United States, and Cold Spring Harbor Laboratory
has been identified as one of the key players in this exciting transformation.
The Women's Cancer Gene Initiative
In October, a delegation of researchers from Cold Spring Harbor Laboratory traveled to Washington
to present to several New York legislators a new concept we call "The Women's Cancer Gene
Initiative" for research in breast and ovarian cancer. This new program incorporates the many suc-
Congressman Steve Israel, Bruce Stillman
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cesses of our breast cancer
research program, combining
Greg Hannon's new research
developments in RNAi with the
exciting cancer gene discovery
research in Mike Wig ler and
Robert Lucite's laboratories,
and the mouse models for can-
cer research in Scott Lowe's
laboratory. The initiative was so
well-received in Washington
that two local representatives-
Senator Hillary Rodham Clinton
and Congressman Steve
Israel-made visits in the fol-
lowing weeks to host press
conferences and pledge their
support to this exciting pro-
gram. Representatives Peter King and Carolyn McCarthy also toured our Woodbury Cancer
Genome Research Center, and spoke to researchers about their personal support of the program
in Congress.
Senator Hillary Rodham Clinton, Scott Lowe
Banbury Center
It is not often that writers at Sports Illustrated contact the Banbury Center, but for a few giddy
months at the beginning of 2002, Banbury was major news in the sports world. The March
meeting on Genetic Enhancement of Athletic Performance examined the use of gene therapy
in athletics. The World Anti-Doping Agency (\NADA) is worried that athletes may use gene ther-
apy to introduce "desirable" performance-promoting genes. The meeting was a fascinating mix
of scientists, policy makers, and athletes, including Johann Koss, winner of four Olympic gold
medals in speed skating.
Another highly topical meeting was prompted by the heightened awareness of the dangers
of biological terrorism. Microbial Forensics was devoted to molecular fingerprints that will allow
rapid identification of biowarfare agents and that could be used for tracing the source of the
agents. The meeting was notable for the mix of scientists from academia and from government
agencies-it also set a new record for the number of acronyms appearing in a program.
Robertson Research Fund
The Robertson Research Fund has been the primary in-house support for our scientists for
nearly three decades. Since 1973, the Fund has grown from $8 million to more than $95 mil-
lion. During 2002, Robertson funds supported cancer research in the labs of Gregory Hannon,
Eli Hatchwell, Winship Herr, Tatsuya Hirano, Yuri Lazebnik, Bud Mishra, Michael Myers, and
William Tansey; neurobiology research in the labs of Grigori Enikolopov, Josh Huang, Roberto
Malinow, Jerry Yin, and Yi Zhong; and plant research in the lab of Robert Martienssen.
Robertson funds also supported several new investigators, including Shiv Grewal, Alea Mills,
Senthil Muthuswamy, Terrence Strick, David Jackson, Marja Timmermans, Carlos Brody, Lee
Henry, Zach Mainen, and Tony Zador.
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Cold Spring Harbor Laboratory Board of Trustees
Cold Spring Harbor Laboratory's Board of Trustees led the
Laboratory through another exciting and eventful year,
continuing to shape the direction and vision of this institu-
tion.
This year, the Board welcomed the addition of four new
Trustees to its ranks: Titia de Lange, Ph.D., a professor of
Cell Biology and Genetics at The Rockefeller University;
Susan Lindquist, Ph.D., Director of the Whitehead
Institute for Biomedical Research; Kristina Perkin Davison,
Partner and cofounder of iEurope Capital, LLC; and Amy
Goldman, an Agricultural Preservationist and author. Mrs.
Evelyn Lauder was also elected to the Board as an
Honorary Trustee.
Helen A. Dolan, William L. Matheson, Leon B. Polsky,
and Mark Ptashne reached the end of their allotted terms
as Trustees and were honored at the Board's November
meeting for their outstanding service to the Laboratory. As
noted in previous pages, we were saddened to learn in
late 2002 of the death of William Matheson.
Dolan DNA Learning Center
Helen A. Dolan William L. Matheson
Mark Ptashne Leon B. Po !sky
The Dolan DNA Learning Center (DNALC) significantly expanded its educational reach in 2002
by embarking on major agreements to license DNALC "know-how" in the United States and
abroad. In the spring, the DNALC collaborated with North Shore-Long Island Jewish Research
Institute (NS-LIJ) to open DNALC West to better serve students in western Nassau County and
CSHL Trustee Arthur Spiro, Bruce Stillman, Michael Dowling, CEO, NS-LIJ
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New York City. This teaching laboratory, located adjacent to the NS-LIJ diagnostic laboratory in
Lake Success, is managed and staffed by the DNALC and uses its teaching curricula. In the
summer, the DNALC signed a three-year Memorandum of Understanding with the Ministry of
Education (MOE) to support expansion of life sciences education in Singapore. The contract
provides support for the DNALC and involves consultation and training of teachers. Initiated in
the context of a national thrust to make biotechnology the "fourth pillar" of Singapore's future
economy, the project revolves around the development of "sister" DNA centers at the Singapore
Science Centre and National Institute of Education. In the fall, the DNALC entered into a licens-
ing agreement with the Science EpiCenter of New London, Connecticut to develop a DNA
Learning Center there to serve southern Connecticut. These licensing agreements, in addition
to sponsored research by Carolina Biological Supply Company, and royalties on teaching kits
and CDs, contributed about $335,000 in revenue, or 14% of the 2002 operating income.
In September, the Dolan DNALC opened "The Genes We Share," the third major exhibition
in the DNALC's history. The exhibit celebrates the 50th anniversary of the discovery of the DNA
structure, which set the stage for the recent efforts to determine the entire DNA sequence of
the human genome. As visitors explore the exhibition, they are encouraged to view the human
genome as a record of our shared ancestry, an instruction manual for our bodies, and a source
of information that can foreshadow a person's future health. Visitors are greeted in the front hall
with photomurals that juxtapose New York "peoplescapes" with unique world populations, set-
ting the stage for thinking about human similarities and differences. An interactive area in the
main gallery encourages visitors to take stock of traits that make them unique, as well as
anatomical, cellular, and molecular features they share with all people.
In another area, an interactive map of the world shows our shared ancestry in Africa, migra-
tion paths followed by humans over the past two million years, and environmental factors that
account for some of our differences. Visitors then move into a recreation of a Neolithic cave,
complete with paintings and the first reconstruction of an adult Neandertal skeleton. Visitors are
asked to consider the anatomical, genetic, and behavioral changes that evolved to set humans
apart from other primates. A final gallery focuses on the modern "gene age," moving from an
eight-foot reconstruction of the original metal DNA model made by Watson and Crick in 1953
to a working DNA sequencer, which operates daily to sequence DNA submitted by student
classes from around the United States.
The November completion of Your Genes, Your Health (www.ygyh. org) marked the end of a
five-year, $1.3 million Web Site project funded by the Josiah Macy, Jr. Foundation. This multi-
media guide provides up-to-date, engaging information on 15 common genetic disorders:
Fragile X syndrome, Marian syndrome, hemophilia, cystic fibrosis, Duchenne/ Becker muscular
dystrophy, phenylketonuria, Huntington disease, neurofibromatosis, sickle cell disease,
hemochromatosis, Tay-Sachs disease, 13-thalassemia, Down syndrome, Alzheimer disease,
and polycystic kidney disease. Its companion site DNA from the Beginning (www. dnaftb. org),
an animated primer on genetics and molecular biology, was one of only 50 World Wide Web
sites chosen by Scientific American for its 2002 SciTech Award (www. scientificamerican.com).
The Macy-funded sites received more than 1.6 million visitors in 2002, accounting for 44% of
the 3.8 million visitors to the Gene Almanac "portal."
CSHL Press
The Cold Spring Harbor Laboratory Press enjoyed another successful year. Twelve new books
and two CDs were published and all four research journals grew in impact or circulation. But
the most prominent-and ambitious-Press project of the year had true worldwide impact.
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John Inglis, Executive Director of CSHL Press, was a member of a team of scientists and
educators committed to developing effective, innovative, and sustainable HIV/AIDS prevention
strategies for young people in South Africa and other vulnerable communities. Together, they
prepared an important book entitled Staying Alive: Fighting HIV/AIDS that presents life-saving
information in a direct, engaging, and age-appropriate manner to children aged 12 to 16. With
funds from the National Institutes of Health, Oxford University, and Cold Spring Harbor
Laboratory, 20,000 copies of Staying Alive were produced by the CSHL Press and distributed
free of charge in three provinces of South Africa in July and August.
Staying Alive was written by Professor Frances Balkwill of Bart's Hospital Medical School,
London, and illustrated by Mic Rolph. Balkwill and Rolph have previously collaborated on sev-
eral highly successful children's books for CSHL Press,
including Enjoy Your Cells, Germ Zappers, Have A Nice DNA, STAYING AEA
and Gene Machines. To gain a better understanding of the HIV/AfS.
book's audience before creating Staying Alive, Balkwill and
Rolph first visited schools, squatter camps, and orphanages
in the provinces of Gauteng (Johannesburg) and Kwa-Zulu
Natal (Durban), South Africa, where they met with students,
teachers, medical scientists, and health professionals. The
book resulting from these experiences incorporates artwork
created by children during workshops conducted by Mic
Rolph, as well as Rolph's own illustrations of the biology of Fran Balkwill & Mic Ralph
HIV and how abstinence, faithfulness, and the use of con - Staying Alive Book cover
doms can reduce the spread of AIDS. With its lively graphics
and direct language, Staying Alive gives explicit messages about the risks of disease, ways of
preventing infection, the building of relationships based on mutual care, and the need for com-
passion and respect toward people living with HIV.
The available copies of the book are being distributed free of charge to educators and stu-
dents from repositories in Gauteng, Kwa-Zulu Natal, and the Western Cape. Teachers, acade-
mics, and community activists have been recruited to conduct classroom exercises designed
to evaluate the book's effectiveness and provide feedback for the development of future edi-
tions of Staying Alive and other teaching materials. The book-distribution tour included recep-
tions in each province attended by local politicians and educators, as well as meetings with the
South African Minister of Education, Dr. Kadar Asmal, the well-known satirist and AIDS educa-
tor, Pieter-Dirk Uys, participants in the Memory Box Project at the University of Cape Town, and
representatives of Medecins Sans Frontieres ("Doctors Without Borders"). During and after the
tour, the creators of Staying Alive also received feedback from Christian missionaries, tradition-
al healers, and even soccer clubs interested in helping fight the spread of AIDS in South Africa.
After completing this pilot phase of their project, the Staying Alive team received substantial
funding from the Gates Foundation. With this support, a second edition of the book and relat-
ed educational materials will be created in several South African languages and distributed on
a much larger scale. In addition, a start will be made on addressing a newly identified need-a
program that deepens science teachers' knowledge of the immune system and virus biology
and increases their effectiveness as communicators of AIDS awareness.
CSHL Library and Archives
In 2002, the CSHL Library made great progress in its efforts to provide information electroni-
cally. On-line subscriptions to scientific journals, monographs, and reference materials have
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increased significantly. Inter Library Loan has seen an increased availability of articles in PDF for-
mat. This has facilitated the delivery of requested articles in a timely fashion. The Library has
acquired several new electronic databases such as BioKnowledge Library from Proteome,
First Search that includes BasicBIOSIS and several full text databases, and Faculty of 1000 from
BioMed Central. Web Cat, the on-line catalog, now includes most of the titles in the Library's
collection, including titles in video, electronic, and microfilm formats. The library has continued
to participate in the Biolnformation Synthesis Collaborative (BISC), which includes the libraries
of The Rockefeller University, the American Museum of Natural History, Woods Hole Marine
Biological Laboratory, and the New York Botanical Garden, which is developing several projects
for interlibrary loan purposes.
The Archives have undergone tremendous growth and development. The James D. Watson
Special Collection has been acquired and is beginning to be made available on our Web Site
through the use of finding aids. The oral history project to document the Laboratory's history
through the eyes of the scientists who worked and visited here has grown to 40 interviews and
will ultimately be made available through our laboratory web page. The James D. Watson
Photographic Archives are available on-line and the CSHL Symposium photo collection is also
near completion. This collection contains a remarkable history of biology in the latter two thirds
of the 20th century and into the new millennium. During this past year, a great deal of prepara-
tion has been made in planning the traveling exhibition "Seeking the Secret of Life: The DNA
Story in New York." This exhibition will mark the 50th anniversary of the discovery of the DNA
double helix and opened at the Science, Industry and Business Library of the New York Public
Library in February, 2003.
New Major Gifts
The Laboratory was successful in continuing and commencing major campaigns, despite eco-
nomic challenges in 2002. The campaigns to fund the Watson School of Biological Sciences,
the Cancer Genome Research Center, the Women's Cancer Gene Initiative, and the Dolan DNA
Learning Center all received substantial gift support. The philanthropic investments of our gen-
erous and supportive friends for the work of the educators and researchers at Cold Spring
Harbor Laboratory allow us to remain at the forefront of biomedical knowledge. The announce-
ment of New York State's commitment to the Laboratory of $20 million by Governor George
Pataki and the Long Island Senate team led by Senator Dean Skelos is a welcome recognition
of the accomplishments at Cold Spring Harbor. Through this special commitment and gener-
ous private funding, the Laboratory is increasing the pace of research to control cancer and
understand neurological diseases.
Watson School of Biological Sciences
Under the leadership of Dean Winship Herr, the Watson School of Biological Sciences contin-
ues to go from strength to strength. Not only has Winship introduced a strong graduate pro-
gram, but the Watson School now effectively oversees all research-based education at the main
laboratory campus, including the Undergraduate Research Program, the high school Partners
for the Future Program, and Postdoctoral Fellow training.
Led by Honorary Trustee David L. Luke III, the first phase of the Watson School of Biological
Sciences Campaign was completed this year, accomplishing an endowment of $32 million as
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a firm financial foundation for the Watson School. We are grateful for gifts from the William
Stamps Farish Fund of $300,000 and from the Estate of Elisabeth Sloan Livingston of
$2,200,000; and we appreciate gifts to build the Watson School's Innovative Education Fund,
including the final payment of a challenge gift from an anonymous donor to match gifts of
$62,103 from the Seraph Foundation; and of $10,000 from The William H. Donner Foundation;
with further gifts to the Fund of $50,000 from The G. Unger Vetelsen Foundation; of $25,000
from Dr. and Mrs. Mark Ptashne; of $10,000 from Mark and Karen Zoller; and of $1,000 from
the Packard Foundation; which collectively rounded out a solid campaign to provide funding for
graduate student fellowships, lectureships, and courses.
A second phase of fund-raising is being commenced to allow an increase in the enrollment
in the Watson School. This will enable the School to help fulfill the growing demand for
researchers in the biological sciences. Laboratory Trustee Robert D. Lindsay is leading this
phase. A gift of $500,000 from the William Randolph Hearst Foundation has provided the base
funding for a fellowship for disadvantaged students and is a welcome start to this important
expansion of the School.
The Cancer Genome Research Center
Now in its first full-year in operation, the value of commitments to the Cancer Genome Research
Center was evident, with the facilities underpinning many advances in cancer, neuroscience,
and plant genomics research. We are grateful for major new contributions to the facility and its
programs of $2,500,000 from The Starr Foundation; of $261,354 from the William and Maude
Pritchard Charitable Trust; and of $10,000 from Benjamin Development.
Dolan DNA Learning Center
Final gifts were made in support of "The Genes We Share" exhibit, which opened in September.
We are grateful for a $20,000 gift from the William Haseltine Foundation, the $50,000 gift from
the Richard Lounsbery Foundation, and the $30,000 gift from Dr. Laurie Landeau, all of which
helped to make "The Genes We Share" a success. Arrow Electronics also generously gave
$30,000.
Private Research Support
Private funding in 2002 advanced important research initiatives in cancer, neuroscience, and
other areas. We gratefully acknowledge major gifts in the $100,000 and above category, includ-
ing for cancer research the Marks Family Foundation for $500,000; The Miracle Foundation for
$100,000; The Breast Cancer Research Foundation/Lillian Goldman Trust for $1,000,000; the
Louis Morin Charitable Trust for $105,000; The V Foundation for $100,000, and for neuro-
science research The McKnight Endowment Fund for Neuroscience for $100,000; and Jeff
Hawkins and Janet Strauss for $100,000. We appreciate other support received from The Dana
Foundation for $100,000 and from Robert Gardner for $100,000.
Breast Cancer Support
The generous support from local breast cancer groups again made a real difference in 2002,
including from the Long Beach Breast Cancer Coalition; the Plainview-Old Bethpage Breast
Cancer Coalition; the Elizabeth McFarland Fund; the Babylon Breast Cancer Coalition; and,
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long-time supporters, 1 in 9: The Long Island Breast Cancer Action Coalition and Long
Islanders Against Breast Cancer (LIABC). As in past years, we are indebted to the many indi-
viduals from local breast cancer groups working so hard to make it possible for Cold Spring
Harbor Laboratory to continue its breast cancer research.
CSHL Planned Giving Advisory Board
The Cold Spring Harbor Laboratory Planned Giving Advisory Board-drawn from the financial
services, accounting, and legal professions-consists of accountants, tax advisors, trust offi-
cers, bank officers, investment advisors, investment bankers, and lawyers, representing firms
located on Long Island, in New York City, and in Connecticut. The Board was briefed on the
Laboratory's activities and accomplishments in 2002. I appreciate the advice members provide
in support of the Laboratory's goals.
President's Council
Members of the President's Council were once again invited to another successful one-day
meeting at the Laboratory. This years President's Council meeting explored the topic of "Human
Instincts and Evolutionary Psychology." Once again, our pre-
senting scientists were engaging speakers and leaders in the
field: famed science writer Dr. Matt Ridley, Dr. Richard
Wrangham from Harvard University, Dr. Patricia Wright from
Stony Brook University, and Dr. Randolph Nesse from the
University of Michigan. The event began with tea at Ballybung,
the home of Jim and Liz Watson. Guests were then invited to
meet the Cold Spring Harbor Laboratory Fellows, Drs. Lee
Henry and Terence Strick, followed by cocktails and then a dis-
cussion led by Matt Ridley on "Evolutionary Psychology of
Instincts." The lectures continued on Saturday morning with dis-
cussions on "The Origins of Human Violence," "Parenting:
Insights from Our Primate Cousins," and "Phobias and
Depression." All who attended said it was, as always, a worth-
while learning experience.Matt Ridley
Gavin Borden Visiting Fellows
The Gavin Borden Lecture series was named in memory of
Gavin Borden, a publisher whose Molecular Biology of the Cell
and other books made a lasting impression on many scientists, pt
both old and new. This year, Sir John Gurdon, former Governor
of the Wellcome Trust and former director of the Wellcome/
CRC Institute of Cancer and Developmental Biology, delivered
the eighth annual lecture titled, "Signal Factor Perception in
Development" on March 25, 2002. The annual Gavin Borden
Lecture was started by Jim Watson in 1995.
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Sir John Gurdon
Building Projects
In addition to continuous up-dates to many of the Laboratory's facilities, Art Brings, the
Laboratory's Chief Facilities Officer, and his team completed several major renovation and con-
struction projects.
The first phase of a new project to provide additional student housing at Uplands Farm has
begun. The completed project will provide high-quality, on-campus housing for up to 32 stu-
dents upon completion.
Three rooms in the Carnegie Library were renovated and converted for use as the new
Watson Archives, providing much-needed space and an area in which scholars and visitors may
view previously inaccessible material.
Several key scientific facilities were completed during the year. Microscopy suites were con-
structed in the Beckman and Hershey Buildings and several core scientific facilities-Flow
Cytometry, 2D Gel, and the Nucleic Acid Facilities-were relocated to newly expanded and ren-
ovated facilities.
Many of the Laboratory's administrative departments received upgrades to their offices as
well. The Institutional Advancement department moved into renovated offices previously occu-
pied by graduate students. The Nichols Building was virtually rebuilt from the ground up, pro-
viding the Accounting, Special Events, Technology Transfer, and Administrative departments
with the top-quality facilities they require to efficiently manage the increased demands placed
on them by the Laboratory's growth.
A team of craftsmen worked hard to prepare the Dolan DNA Learning Center for the open-
ing of "The Genes We Share" exhibit on September 18. From installing each of the kiosks to
wiring the lighting and computers, the team ensured that the exhibit was prepared for the
crowds who have already come. The exhibit looked fantastic when it was highlighted
New York Times and on News 12 Long Island.
Community Outreach
Traffic problems temporarily slowed down our runners and walkers, but 55 Laboratory employ-
ees still participated in the Cigna 5K Run/Walk for 1 in 9: The Long Island Breast Cancer Action
Coalition at Eisenhower Park on August 8. All were happy to be there for a group that has been
such a tremendous help to the Laboratory research for so many years. Overall, the event raised
more than $60,000 for the Laboratory.
Special Events
Public Lectures
After a successful first year, the Harbor Lecture Series doubled in size, featuring a total of six
lectures this year, and proved it would become an annual favorite at the Laboratory.
May 5
May 13
Michael Ruse, the Lucy le T. Werkmeist Professor of Philosophy at Florida State
University: "Can a Darwinian be a Christian?-The Relationship between Science
and Religion."
Dr. Chung S. Yang, Professor at the Laboratory for Cancer Research at Rutgers
and the Director of the Carcinogenesis and Prevention Program at the Cancer
Institute of New Jersey: "Beneficial Health Effects of Tea: Evidence, Myth, and
Perspectives."
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Bruce Stillman, Christopher Chyba, Edward Scolnick
May 20 Elof Axel Carlson, Distinguished Teaching Professor in the Department of
Biochemistry and Cell Biology at Stony Brook University: "Eugenics: When Science
and Society Go Astray."
June 14 Steven M. Block, a biophysicist at Stanford University; Christopher Chyba, co-
director of Stanford's Center for International Security; and Edward M. Scolnick,
CSHL Trustee and President of Merck Research Laboratories, and Executive Vice
President for Science and Technology for Merck & Company, Inc.: "Bioterrorism:
Protecting Our Country, Protecting Ourselves."
October 1 Dr. Cynthia Kenyon, the Herbert Boyer Distinguished Professor of Biochemistry
and Biophysics at the University of California, San Francisco: "Genetics of Aging
and Longevity: The Search for the Fountain of Youth."
October 8 Scott Lowe, CSHL Deputy Director of the Cancer Center: "Cancer: Mission
Possible."
Other Lectures
As usual, Cold Spring Harbor Laboratory hosted the Huntington Hospital Lecture Series on car-
diovascular health and related diseases in both the spring and fall in the Grace Auditorium.
The West Side School Lecture Program was again a hit with local, budding scientists in 4th
through 6th grades. This year, five Cold Spring Harbor Laboratory professors-Tony Zador,
Leemor Joshua-Tor, Alea Mills, Lee Henry, and Erik Vollbrecht-delivered lectures.
Concerts and Exhibits
The Music of the Harbor Concert Series was, as previously, a smashing success. All nine con-
certs were sold out between Meetings participants, CSHL Association members, and the gen-
eral public. Co-sponsored by Newsday, the concert series featured old favorites such as jazz
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guitarist Eric Johnson and off-the-beaten-path performances from people such as multiper-
cussionist Joseph Gram ley. The complete concert list included:
April 20
April 27
May 4
May 18
September 14
September 21
September 28
October 5
October 12
Ju-Young Baek, violinist
Alexander Fiterstein, clarinetist
Paavali Jumppanen, pianist
Courtenay Budd, soprano
Alpin Hong, pianist
Joseph Gram ley, multipercussionist
Imani Woods, woodwind quintet
Eric Johnson, jazz guitarist and his band
John Kamitsuka, pianist
One of Cold Spring Harbor Laboratory's own, Rachel von
Roeschlaub, presented an art exhibit in the Bush Fireplace
Room in June. von Roeschlaub is a self-taught artist who paints using a combination of abo-
riginal pointillism and American Folk Art. Her paintings are finished on modern mediums such
as record albums, CDs, and natural paper. She also uses her experience as a technician at Cold
Spring Harbor Laboratory to teach biotechnology professional development workshops. Last
February, she taught a science workshop for Tibetan monks living in India. Proceeds from this
art exhibition went toward promoting science education for the exiled Tibetans living in India.
Former photographer-in-residence, Doug Fogelson, returned to the Laboratory in July for a
month-long exhibit of the photographs he took during "Foto Lab l" in 2001. "Remember Far
Away" was a visual memory and response to Fogelson's time spent at the Laboratory. It
expressed sentiment-in some cases, through the use of manipulated images-inspired by
photographs of the surroundings at the Cold Spring Harbor Laboratory campus. The exhibit
also featured portraits of Dr. James Watson and myself.
John Kamitsuka
Laboratory Employees
Long-term Service
The following employees celebrated milestone anniversaries in 2002.
30 Years Terri Grodzicker
20 Years Patricia Bird, Arthur Brings, David Mick los, Clifford Sutkevich
15 Years Sadie Arana, Patricia Barker, Lisa Bianco, Joan Doxey, James Duffy,
Julie Ehrlich, Edward Haab, John Inglis, Barbara Peters, Susan Rose,
Stanley Schwarz, Inez Sialiano, Patricia Urena, Jan Witkowski
New Staff
Diane Fagiola has joined the Laboratory as Director of Development. Diane comes to CSHL
from a position as Director of Fundraising for the Locust Valley Library.
Gerry Holler has joined the Laboratory as Director of Security. Gerry comes to CSHL from
Photo Circuits, where he served as Assistant Director of Security.
Katie Raftery has joined the Laboratory as Director of Human Resources. Katie comes to
CSHL from a position as Director of Human Resources for Ericsson Internet Applications.
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Long-term Service Employees
First Row: Sadie Arana, Bruce Stillman, Bobbie Peters, Patty Bird, Terri Grodzicker, Inez Sialiano, Julie Ehrlich, Joan Doxey
Second Row: Pat Urena, Stanley Schwarz, Jim Watson, Clift Sutkevich, Lisa Bianco, Jan Witkowski, James Duffy, Pat Barker
Third Row: Dill Ayres, John Inglis, Dave Mick los
Promotions
On January 1, 2002, Lilian Gann was appointed Associate Dean of the Watson School of Biological
Sciences. Lilian joined the Laboratory in March 1999 as Assistant Dean of the Watson School.
Other promotions this year included Douglas Conklin to Research Investigator; Shivinder Grewal to
Associate Professor; Gregory Hannon to Professor; Eli Hatchwell to Investigator; John Healy to
Computer Scientist; David Jackson to Associate Professor; and Michael Zhang to Professor.
Departures
Michael Hengartner, Associate Professor, departed this year to take a position as Professor in
the Institute of Molecular Biology at the University of Zurich.
Concluding Remarks
The breadth of our highly successful research and education programs is a testament to the peo-
ple who work here and those who chose to support the Laboratory financially and otherwise. I
am most fortunate to work at an institution that savors past accomplishments, yet does not rest
on its laurels. We need to move forward, particularly in research that I believe will eventually help
to control cancer, and at the same time invest in research on understanding the brain, one of the
frontiers of modern biology that has a long way to go before we can comprehend how we learn,
think, and behave. But the core of our future success will be securing the necessary funds to
allow our scientists to do what they do best and not what grant reviewers think is best.
Bruce Stillman
Director
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ADMINISTRATION
One of the hopes of our neuroscience investigators is to gain a better understanding of the
mechanisms of cognitive disorders such as depression and bipolar disease. If a year could have
the characteristics of a disease, 2002 might be said to have been bipolar with its manic highs
and disappointing lows. On the one hand, the year in science at Cold Spring Harbor Laboratory
was as exciting and dynamic as any in recent memory, with great progress and breakthroughs
in cancer and other areas of research. The cold shower was provided by the persistently slug-
gish national economy, uncertainty on the international front, and the dismal performance of
U.S. equity markets.
Fortunately, what ultimately determines the success and stability of this institution is the sci-
ence, and the news on that front is excellent. Our investigators are quickly capitalizing on the vast
data provided by the completion of the human genome sequence. Genes implicated in various
cancers are being identified at an accelerating pace, and novel techniques developed here for
silencing individual gene expression have important implications for drug discovery. The work is
being recognized internationally by peer and lay press alike, with Science magazine recently
naming the research of Drs. Hannon, Grewal, and Martienssen on RNAi the #1 "Breakthrough of
the Year." Political leaders know a good thing when they see one, and Cold Spring Harbor
Laboratory has become "hot" in this respect. In the months of September and October alone,
we had visits and on-campus announcements from leaders as diverse as Governor Pataki,
Senator Clinton, Congressman Israel, and the Duke of York. The visit from the Governor was par-
ticularly meaningful, as he was here to announce a $20 million grant to the Laboratory from the
State of New York to fund the building of a new center for bioinformatics on the main campus.
The State leadership has recognized the importance of the biotechnology industry as an engine
for economic growth in the 21st century, and they see Cold Spring Harbor Laboratory as a cat-
alyst for the development of this industry in the New York metropolitan region.
Financially, we planned for a difficult year at the Laboratory in 2002, and we were not proven
wrong in our expectations. Fortunately, income from grants and from most of our operating
units remained strong so that total revenue grew 4.5% to $79 million. We strive to balance our
operating budget after full depreciation expense ($5.1 million in 2002) and have achieved or
exceeded this goal for 14 consecutive years. Unfortunately, we realized an operating deficit this
year of approximately $565,000 after the utilization of $1.8 million remaining in a reserve
account that had been set aside in prior years when we had operating surpluses. To minimize
the expected deficit, we instituted cost-control measures at the beginning of the year. These
included a hiring freeze and a cap on salary increases, as well as setting the capital spending
budget at $500,000 below depreciation expense to preserve cash. Despite the challenging
environment, the Laboratory was able to generate positive cash flow of $3 million for the year.
There were a number of factors contributing to our budgetary challenges and pressures. One
was a $500,000 increase in our depreciation expense resulting from the first full year of opera-
tions at the Cancer Genome Research Center at Woodbury and the expanded Dolan DNA
Learning Center. Income earned on our cash and short-term investments was down substan-
tially as interest rates plummeted to 40-year lows. While we had a relatively good year in fund-
raising for major capital projects and research, our two annual funds, which impact the operat-
ing budget, were understandably short of their combined goals.
After many years of growth and superior investment performance, the Laboratory's endow-
ment funds suffered for the second consecutive year as U.S. equities continued their dramatic
23
150,000,000
140,000,000 -
130,000,000 -
120,000,000-
110,000,000-
100,000,000-
90,000,000
8o,000,000
70,000,000
60,000,000
50,000,000
40,000,000
30,000,000
20,000,000 -
10,000,000-
0
24
1000
900
800
700
600
500
E
400
300
200
100
Operating
El Actual Expense
Expense Adjusted for Inflation
Consists of Full-time and Part-time Technical Support, Core Services, Publications,
Meetings, Library, Public Affairs, Building and Grounds, Administrative,
Personnel, Banbury Center, and Dolan DNA Learning Center
Staff
MN Scientists
Support
Total
82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 O1 02
Expense
1 1
Years
s 1
8000
7000
6000
5000
4000
E.
Years
Meetings & Course Participants
tilt
oao-
82 83 84 85 86 87 88 89
2000
1000
90 91 92 93 94
Years
95 96 -97 98 99 00 01 02
decline. At year-end 2002, the endowment totaled $187 million, down from $212 million at the
previous year end. Because stocks were down and bonds were up, the asset allocation of our
managed funds was 47%/53% equities to fixed income investments. Total return on these
funds was a negative 9.4%, somewhat below benchmark indices of similarly allocated funds.
Both our equity and fixed income managers had disappointing performances in an absolute
sense and relative to the benchmarks. While we are certainly not alone in this experience, we
are not satisfied, and the Finance & Investment Committee, chaired by Lola Grace, is taking
measures to reformulate the investment strategy and procedures. In difficult financial markets,
the Laboratory's endowment is well-served by its relatively conservative investment policy of
spending a maximum of 4% of the three-year moving average of year-end market value. With
two down years in the last three, this discipline now dictates that we budget for a smaller dol-
lar amount of spending from the endowment to support research in 2003.
In years like 2002, we are thankful for the overall financial strength of the Laboratory and
pleased that we were able to avoid the layoffs and other more draconian measures taken at less
secure academic institutions. While we prepare and budget for another challenging year ahead,
we have reason for optimism. Our various operating units-the Cold Spring Harbor Laboratory
Press, Meetings and Courses, the Banbury Center, and the Dolan DNA Learning Center-are
extremely well managed and make a positive contribution to operations. Our indirect cost rate,
the rate at which we are reimbursed for overhead expense by the government granting agen-
cies, has been renegotiated and will increase over the next several years. This sensitive and
complicated negotiation with the Department of Health and Human Services was deftly led by
our comptroller Lari Russo. The resulting rate increase will have a substantial positive impact on
revenue over the next several years. Another bright spot is technology transfer. John Maroney
has done a wonderful job of capitalizing on some of the recent research breakthroughs by
negotiating licensing and research support agreements with biotechnology and pharmaceutical
companies. These arrangements are also expected to contribute very positively to operating
revenue in the years ahead.
Last year, this report referred to the Laboratory's master plan and the expansion of facilities
on our main campus. The $20 million grant from New York State and other as yet unannounced
philanthropy will allow us to proceed with the planning for phase one of this project. We are in
the process of seeking the necessary village approvals as we work on engineering and archi-
tectural plans for the new research facilities. The plan is ambitious but now within our sights,
and we are excited about the prospect of being able to accommodate our world-class scien-
tists with much-needed space and facilities.
Critical to the ongoing health of the Laboratory is a strong base of volunteers from
Association Directors to our Board of Trustees. Four extraordinarily influential and generous
Trustees had their terms expire in 2002. We thank Helen Dolan, Leon Polsky, Mark Ptashne,
and Bill Matheson (see memorial on page viii) for their years of dedicated service. At the same
time, we welcome and look forward to working with newly elected Trustees Titia de Lange,
Susan Lindquist, Kristina Davison, Amy Goldman, and Honorary Trustee Evelyn Lauder.
Success in any administrative and managerial role is totally dependent on the quality of staff,
and it is here that the Laboratory is truly fortunate. From senior department heads to accoun-
tants, carpenters, cooks, and custodians, Cold Spring Harbor Laboratory has an extraordinary
staff of dedicated people who serve the institution with great pride. Thanks to all.
W. Dillaway Ayres, Jr.
Chief Operating Officer
25


CANCER: GENE EXPRESSION
Proteins called histones bind to DNA and wrap it into a coiled state called chromatin. Depending
on how histone proteins are modified by cellular enzymes, they wrap DNA into either a loose,
active structure or a compact, inactive structure called heterochromatin. In collaboration with
Rob Martienssen's group (see Plant Development and Genetics), Shiv Grewal's lab has shown
how RNA interference (RNAi) targets histone-modifying enzymes to specific regions of DNA,
leading to the formation of an inactive, heterochromatin structure. These studies have revealed
an entirely unexpected connection between RNAi and DNA structure and have profound impli-
cations for understanding many aspects of gene regulation and the formation and stable inheri-
tance of chromosome structure. For this reason, the work of Greg Hannon (see Cancer
Genetics), Shiv Grewal, and Rob Martienssen was recognized by Science magazine as the
"Breakthrough of the Year" among all of the sciences.
Nouria Hernandez and Winship Herr lead groups of researchers that explore the precise bio-
chemical mechanisms by which DNA is transcribed into RNA. Each group has revealed how spe-
cific protein-protein interactions control the action of enzymes called RNA polymerases, which
produce RNA using the information coded in DNA.
Leemor Joshua-Tor focuses part of her X-ray crystallography work on the events that trigger
papillomavirus DNA replication. She is collaborating with Arne Stenlund to unravel the crucial first
steps during the replication of papillomavirus DNA. Papillomavirus is associated with virtually all
cases of cervical cancer. By studying the biochemical and structural changes that initiate viral
DNA replication, Joshua-Tor and Stenlund have revealed key details not only about this cancer-
causing virus, but also about the process of DNA replication in general. Moreover, these studies
have uncovered specific molecular targets for the development of drugs to prevent or treat cer-
vical cancer.
Rui-Ming Xu focuses on determining the three-dimensional structure of proteins. Xu's lab
focuses on proteins that carry out RNA splicing, and on others that affect histone protein modi-
fication and thus the structure of DNA. By using X-ray crystallography to determine these protein
structures, Xu's lab has provided several clues about how the proteins carry out RNA splicing
and chromatin remodeling.
On the way from gene to protein, information passes through two RNA forms. The first is
called a pre-messenger RNA (pre-mRNA) transcript, which is a word-for-word translation of a
See previous page for photos of the following scientific staff.
Row 1: Yi-Chun Chen; Bhupinder Pal; Michelle Carmel!, Marjorie Brand;
Benjamin Boettner; Francois Grenier
Row 2: Hongzhen He; Emily Bernstein, Michael Ronemus, Amy Caudy;
Theresa Zutavern; Kimberly Scobie
Row 3: Gianluca Pegoraro; Rebecca Ewald; Eric Allemand, Michelle Hastings;
Andrey Revyakin, Terence Strick
Row 4: Nakaya Naoki; Anagha Matapurkar; James Egan; Anitra Austen
Inessa Hakker, Florinda Chaves; Patrice Lassus, Dominik Duelli
Row 5: Vivek Mittel; Sibel Kantarci; Marjorie Brand; Carlos Aizenman
Row 6: Eric Enemark; Sihem Cheloufi; Ramu Umamaheswari, Rulan Shen;
Amy Brady
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gene's DNA. Pre-mRNA RNA transcripts are then spliced to create mature mRNAs, the tem-
plates that cells use to make proteins. In many genetic diseases, gene mutations block RNA
splicing. The resulting aberrant mRNAs lead to the production of abnormal proteins that cannot
perform their functions properly. Adrian Krainer's lab has developed compounds that correct
such RNA-splicing defects. These compounds may ultimately be used as effective therapies for
diseases as diverse as breast cancer, muscular dystrophy, and cystic fibrosis.
By identifying all of the 40,000 or so proteins that govern human biology, the completion of
the human genome sequence has ushered in a new age of biological discovery. Assigning func-
tions to this myriad of proteins will involve several approaches. The lion's share of this functional
characterization may well stem from "proteomics" or the study of how proteins are modified in
the complex and dynamic environment of cells and tissues, and how they organize themselves
into coherent, highly interactive networks that determine cell function. Michael Myers's lab is
focused on identifying the global architecture of these protein networks. In particular, he is explor-
ing the features of protein networks that make them robust (error-tolerant) as well as how such
networks are altered in diseases such as cancer. These studies should provide key insights into
which network components are promising targets for treating cancer.
Jacek Skowronski's lab focuses on a protein encoded by the genome of the virus that caus-
es AIDS. The protein, called Nef, is an important determinant of HIV virulence and AIDS patho-
genesis. By purifying human proteins that specifically bind to Nef, Skowronski's lab has identified
several factors that are likely to control crucial events during AIDS pathogenesis. In so doing, they
have uncovered potential new targets for therapies to combat this disease.
William Tansey's lab studies a potent transcription factor implicated in cancer. They have
found that the factor, a protein called Myc, is regulated by another protein, Skp2, and that the
status of these proteins (normal versus abnormal) determines whether cells will grow as they
should, or instead become cancerous.
Elena Ejkova
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EPIGENETIC CONTROL OF GENE EXPPRESSION
S. Grewal I. Hat G. Shankaranarayana
A. Malikzay G. Xiao
K. Noma
Research in our laboratory is focused on the epigenetic
control of higher-order chromatin assembly. The
dynamic regulation of higher-order chromosome struc-
ture governs diverse cellular processes ranging from
stable inheritance of gene expression patterns to other
aspects of global chromosome structure essential for
preserving genomic integrity. The assembly of hete-
rochromatic structures at centromeres is essential for
accurate segregation of chromosomes during cell divi-
sion, whereas formation of specialized structures at
telomeres protects chromosomes from degradation by
nucleases and from aberrant chromosomal fusions. Our
earlier studies revealed the sequence of molecular
events leading to the assembly of heterochromatic
structures in the fission yeast Schizosaccharomyces
pombe. We found that covalent modifications of his-
tone tails by deacetylase and methyltransferase activi-
ties act in concert to establish the "histone code" essen-
tial for the assembly of heterochromatic structures.
Moreover, we showed that distinct site-specific histone
H3 methylation patterns dictate the organization of
chromosomes into discrete structural and functional
domains. Histone H3 methylated at Lys-9 is strictly
localized to silent heterochromatic regions, whereas H3
methylated at Lys-4, only a few amino acids away, is
specific to the surrounding active euchromatic regions.
We have continued to focus on the role of histone mod-
ifications and the factors that recognize specific histone
modification patterns (such as a chromodomain protein
Swi6 that specifically binds histone H3 methylated at
Lys-9) in the assembly of higher-order chromatin struc-
tures and have made significant progress in under-
standing the mechanism of higher-order chromatin
assembly. More importantly, we provided evidence
showing that RNA interference (RNAi), whereby dou-
ble-stranded RNAs silence cognate genes, has a critical
role in targeting of heterochromatin complexes to spe-
cific locations in the genome.
ROLE OF RNAi IN HETEROCHROMATIN ASSEMBLY
Our work provided a key connection between hete-
rochromatin assembly and RNAi machinery and sug-
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gested that RNAi might specifically target repetitive
DNA elements in the genome to promote their silenc-
ing and recombinational suppression. The fission yeast
genome contains a single homolog for three proteins
known to be involved in RNAi, an Argonaute family
member (agol), an RNase III-like enzyme similar to
Dicer (dcrl), and an RNA-dependent RNA poly-
merase (rdpl). In collaboration with R. Martienssen's
group here at CSHL, we showed that deletion of rdpl,
dcr 1, or agol results in loss of epigenetic silencing at
centromeres. Moreover, we discovered that deletion of
each of the RNAi factors results in a loss of Swi6 and
heterochromatin-specific histone modification such as
H3 Lys-9 methylation and hypoacetylation at cen-
tromeres.
We also discovered that specialized repetitive
DNA sequences and RNAi mechanisms cooperate to
nucleate heterochromatin assembly. Our previous
studies showed that a centromere homologous repeat
(cenH) sequence present at the mat locus (see Fig. 1,
top panel) has an important role in the initial estab-
lishment of heterochromatin throughout the silent
mating-type interval. We showed that the cenH
sequence, which is transcribed at low levels and pro-
duces double-stranded transcripts, has the ability to
recruit heterochromatin complexes and promote gene
silencing at an ectopic site. The capacity of 20-kb
cenH to confer epigenetic repression on a reporter
gene at an ectopic site is strictly dependent on the
RNAi machinery, suggesting that an RNAi-mediated
process also operates in heterochromatin formation at
the mating-type region. We also demonstrated that
cenH is a heterochromatin nucleation center at the
endogenous mating-type region. Unlike flanking
sequences within the silent mating-type interval, the
cenH repeat is a hot spot for H3 Lys-9 methylation
(Fig. 1). We found that cenH is able to recruit H3 Lys-
9 methylation in a Swi6-independent manner, but that
the spreading and maintenance of H3 Lys-9 methyla-
tion across the rest of the silent mating-type interval
require Swi6. This interdependence of Swi6 and H3
Lys-9 methylation suggested an "epigenetic loop"
mechanism for inheritance of the heterochromatic
FIGURE 1 Centromere homology (cenH) repeat
present at the silent mating-type region is a het-
erochromatin nucleation center. A physical map
of the mating-type region with matt, matt, and
mat3 loci is shown. The IR-L and IR-R inverted
repeat heterochromatin boundary elements
flanking the silent matt -mat3 interval are shown
as thick arrows. The cenH represents sequences
sharing homology with the centromeric repeats.
High-resolution mapping of H3 Lys-9 methylation
in wild-type and swi6 mutant cells was carried
out by chromatin immunoprecipitation (ChIP)
experiments. DNA isolated from immunoprecipi-
tated chromatin (ChIP) or whole-cell crude
extracts (VVCE) was subjected to multiplex poly-
merase chain reaction (PCR) to amplify DNA frag-
ments from the mat locus as well as actl serving
as internal control. The distribution of histone H3
methylated at Lys-9 is plotted in alignment with a
map of the mat locus. Although H3 methylated at
Lys-9 is enriched throughout the silent mating-
type interval surrounded by boundary elements,
this methylation mark in swi6 mutant cells is mainly restricted to a region encompassing cenH. Therefore, the recruitment of H3 Lys-
9 methylation to the cenH repeat occurs via an Swi6-independent mechanism, but Swi6 is required for spreading and maintenance
of H3 Lys-9 methylation across the rest of the silent mating-type region.
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state, whereby H3 Lys-9 methylation and Swi6 mutu-
ally support their own maintenance in a self-perpetu-
ating manner.
Despite the prominent role that cenHhas in silenc-
ing at the mating-type region and the strict require-
ment for the RNAi machinery in cenH-mediated
repression at an ectopic site, the endogenous mat
region does not display obvious defects when intro-
duced into RNAi mutant backgrounds. This apparent
paradox was resolved by the observation that the
RNAi machinery is required exclusively for the estab-
lishment of heterochromatin at the mating-type
region, but not for its subsequent inheritance. This
work revealed that the RNAi factors operate to nucle-
ate heterochromatin at the mating-type region, but
they are dispensable for the clonal propagation of the
pre-assembled heterochromatic state.
Considering the critical importance of higher-
order chromatin assembly in gene regulation and
maintenance of genomic integrity, and that most
eukaryotic genomes are extensively colonized by
repetitive elements such as transposons, our discovery
of the connection between RNAi and heterochromatin
formation will have important implications for under-
standing the mechanisms governing genome organiza-
tion and structure. We suggest that transcripts derived
from repeat elements such as cenH are processed by
the RNAi machinery and that the resulting RNA inter-
mediates directly recruit histone-modifying activities
to corresponding repeat sequences (Fig. 2). This initial
recruitment establishes the "histone code" for binding
of heterochromatin proteins such as Swi6. Once
bound to chromatin, Swi6 serves as a platform for the
recruitment of histone-modifying activities that create
additional Swi6-binding sites on adjacent nucleo-
somes, thus enabling spreading to occur in a stepwise
manner. Upon chromosome replication, parental his-
tone H3 and Swi6 are hypothesized to segregate ran-
domly to the daughter chromatids, and Swi6-based
activities serve to imprint the parental histone modifi-
cation pattern onto newly assembled nucleosomes,
leading to inheritance of the heterochromatic state.
RNAi AND CHROMOSOME DYNAMICS
Heterochromatin formation at centromeres has an
essential role in the proper segregation of chromo-
somes during cell division. We therefore investigated
the role of the RNAi machinery in chromosome
dynamics during mitosis and meiosis and found that the
RNAi machinery is required for the accurate segrega-
tion of chromosomes. Defects in mitotic chromosome
segregation are due to loss of cohesin at centromeres.
Although the telomeres of RNAi mutants maintain
silencing, length, and localization of the heterochro-
matin protein Swi6, we discovered defects in the prop-
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FIGURE 2 Model for heterochromatin formation at the mat-
ing-type region of fission yeast. Transcription from cenH
results in RNAs that yield small heterochromatic RNAs in a
process requiring Dcrl , Agol , and Rdpl . These small
RNAs specify the initiation of heterochromatin by interact-
ing with homologous DNA. Histone modification is initiated
in a process requiring an HDAC(s), the histone methyl-
transferase C1r4, the fl-propeller domain protein Rikl , and
potentially an unidentified protein (question mark). Swi6
recognizes deacetylated, H3 Lys-9-methylated histones
and binds to chromatin. Chromatin-bound Swi6 recruits
HDAC(s) and C1r4 to modify adjacent nucleosomes, which
are subsequently bound by additional molecules of Swi6.
Such a spreading process is repeated until the flanking IR-
L and IR-R boundaries are encountered, or until Swi6 is lim-
iting. Upon chromosome replication, parental histone
H3/H4 (darker nucleosomes) are randomly distributed to
daughter chromatids, and newly assembled histone H3/H4
(lighter nucleosomes) acquire parental histone modification
patterns by the same mechanism that allows spreading in
cis: Swi6 recruits HDAC(s) and C1r4 to modify adjacent
nucleosomes, which become bound by additional mole-
cules of Swi6.
er clustering of telomeres in interphase mitotic cells.
Furthermore, a small proportion of RNAi mutant cells
display aberrant telomere clustering during meiotic
prophase. Our analyses suggest that the RNAi machin-
ery is required for the proper regulation of chromosome
architecture during mitosis and meiosis.
HISTONE H3 LYS-4 METHYLATION AND ITS
ROLE IN MAINTENANCE OF ACTIVE
CHROMATIN STATES
We previously have shown that unlike histone H3
methylated at Lys-9, which is preferentially enriched
at heterochromatic loci, the methylation of histone H3
at Lys-4 defines active chromosomal domains.
However, in budding yeast, H3 Lys-4 methylation is
also necessary for silent chromatin assembly at telom-
eres and rDNA. It has been suggested that H3 Lys-4
methylation in combination with other histone modifi-
cations might perform distinct functions. We tested
whether H3 Lys-4 methylation is also required for
silencing in fission yeast. We found that deletion of
set), which encodes a protein containing a SET
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domain at the carboxyl terminus, abolishes H3 Lys-4
methylation in fission yeast. Unlike in budding yeast,
however, Setl -mediated H3 Lys-4 methylation is not
required for heterochromatin assembly at the silent
mating-type region and centromeres in fission yeast.
We showed that H3 Lys-4 methylation is a stable his-
tone modification present throughout the cell cycle,
including mitosis, and that the loss of H3 Lys-4
methylation in setIA cells is correlated with a decrease
in histone H3 acetylation levels, suggesting a mecha-
nistic link between H3 Lys-4 methylation and acetyla-
tion of the H3 tail. Our analyses suggest that methyla-
tion of H3 Lys-4 primarily acts in the maintenance of
transcriptionally poised euchromatic domains and that
this modification is dispensable for heterochromatin
formation in fission yeast, which instead utilizes H3
Lys-9 methylation.
HISTONE DEACETYLATION AND
MAINTENANCE OF GENOMIC INTEGRITY
We previously showed that histone deacetylase C1r6 is
essential for viability and that it acts in a partially over-
lapping manner with clr3 to silence the mating-type
region and centromeric repeats. In addition, clr6 is
necessary for genomic integrity, as a conditional muta-
tion in this gene results in severe chromosome loss.
Mutations in clr6 also cause UV light sensitivity, sug-
gesting a defect in general chromatin assembly. To gain
insight into the C1r6 function(s), we purified C1r6 and
identified its associated proteins. The proteins Pst2,
Prw 1 , and A1p13 copurified with C1r6. Furthermore,
all four proteins are predominantly colocalized in the
nucleus. These proteins share strong homologies with
mammalian components of histone-modifying com-
plexes. Alp13 is a member of the highly conserved
MORF4 (mortality factor on chromosome 4)-related
gene (MRG) family of chromodomain-containing pro-
teins involved in cellular senescence in humans. The
high level of conservation within the MRG proteins
among diverse species argues that their molecular
function is vital to eukaryotic organisms. Interestingly,
deletion of Alp13 or any of the other C1r6-associated
factors causes progressive loss of viability, sensitivity
to DNA-damaging agents, and cytokinesis defects; this
deletion also impairs condensation of chromosomes
during mitosis. This is accompanied by hyperacetyla-
tion of histone H3 and H4 tails. Therefore, modifica-
tion of histones by C1r6 HDAC is crucial for funda-
mental chromosomal functions.
In addition to the studies mentioned above, we also
collaborated with R.M. Xu's lab here at CSHL to
understand the structural basis of the histone H3 Lys-9
methylation by a SET domain protein C1r4. In another
collaborative project (Y. Murakami, Kyoto University),
the role of CENP-B proteins in the targeting of H3
Lys-9 methylation and formation of heterochromatin at
centromeres in fission yeast was investigated.
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MECHANISMS OF TRANSCRIPTION
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B. Ma K. Samudre Y. Sun A. Zia
Gene expression is regulated in large part at the level
of transcription, and consequently, many diseases
result, ultimately, from aberrant transcription. We are
interested in deciphering fundamental mechanisms of
transcription. For this purpose, we use the human
small nuclear RNA (snRNA) genes as a model system.
These genes present a number of advantages for such
studies. First, some of the snRNA genes are tran-
scribed by RNA polymerase II and some others are
transcribed by RNA polymerase III, but all snRNA
promoters are very similar to each other. These genes
therefore provide a good system to study how a pro-
moter recruits specifically the correct RNA poly-
merase. Second, the structure of snRNA promoters is
well defined, and many of the transcription factors
required for transcription of these genes have been
identified. Thus, we can address how these transcrip-
tion factors assemble to form a stable transcription ini-
tiation complex, and how the process is regulated.
RNA polymerase II snRNA promoters consist of a
proximal sequence element (PSE), which, on its own,
is sufficient to direct basal transcription in vitro, and a
distal sequence element (DSE), which serves to acti-
vate transcription. The RNA polymerase III snRNA
promoters contain these same elements as well as a
TATA box located downstream from the PSE. In the
human snRNA promoters, it is the presence or absence
of this TATA box that mainly defines the RNA poly-
merase specificity of the promoter.
The DSE contains two conserved sequence ele-
ments, an octamer sequence that recruits the POU
domain transcription factor Oct-1, and another ele-
ment that recruits the zinc finger protein STAR. In the
core promoter, the PSE recruits a complex called
SNAP that contains five types of subunits, and the
TATA box present in the RNA polymerase III snRNA
promoters recruits the TATA-box-binding protein
(TBP). Transcription from RNA polymerase II snRNA
promoters, which do not contain a TATA box, also
requires TBP, but in this case, it is not clear how TBP
is recruited to the promoter. In addition to these fac-
tors, RNA polymerase II transcription from snRNA
promoters requires TFIIA, TFIIB, TFIIF, and TFIIE,
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whereas RNA polymerase III transcription requires
the SANT domain protein Bdpl and the TFIIB-related
factor Brf2. One of our main goals is to identify the set
of factors required and sufficient to direct RNA poly-
merase II and III transcription from snRNA core pro-
moters in vitro. We are particularly interested in
achieving this with the RNA polymerase III snRNA
promoters, because a defined RNA polymerase III
transcription system has only been established in
yeast, and there only from a simplified core promoter
that does not exist in nature.
CHARACTERIZATION OF HUMAN
RNA POLYMERASE III
During the last few years, we identified and obtained
in recombinant form SNAP, Bdpl, and Brf2. We also
showed that these factors, when combined with mate-
rial immunoprecipitated with an antibody directed
against one of the RNA polymerase III subunits, were
capable of directing accurate and efficient RNA poly-
merase III transcription in vitro. It therefore became a
high priority to characterize human RNA polymerase
III. Indeed, unlike yeast RNA polymerase III whose 17
subunits had all been cloned, human RNA polymerase
III was poorly characterized. cDNAs for five of its
subunits, HsRPC4/HsRPC53, HsRPC1/HsRPC155,
HsRPC3/RPC62, HsRPC6/RPC39, and HsRPC7/
RPC32, had been cloned; however, orthologs of the
yeast RNA polymerase III subunits C128 and C37 had
not been identified, and for many of the remaining
subunits, the available information was limited to
database sequences with various degrees of similarity
to the yeast subunits. Last year, Ping Hu, with the help
of Si Wu, Yuling Sun, Chih-Chi Yuan, Ryuji
Kobayashi, and Michael P. Myers, completed a project
that started with the generation of cell lines stably
expressing a doubly tagged RNA polymerase III sub-
unit. These cells were then used to purify, through a
three-step protocol involving an ammonium sulfate
precipitation followed by two successive affinity chro-
matography steps against the two tags, the tagged sub-
unit and associated proteins. The resulting material
was fractionated on a gel, and the identity of each vis-
ible band was determined by mass spectrometry. This
led to a detailed characterization of human RNA poly-
merase III.
The mass spectrometry analysis confirmed the
presence of RPC1, RPC3, RPC4, RPC6, and RPC7 in
RNA polymerase III, as well as that of subunits that are
common to all three RNA polymerases, namely,
RPABC1, 2, 3, and 5. (RPABC4 was not detected, per-
haps due to its very small size.) It also gave a number
of matches to protein Genbank entries with strong sim-
ilarity to yeast RNA polymerase III subunits, thus
identifying RPC8, RPC9, RPC10, RPAC1, and RPAC2
as orthologs of the Saccharomyces cerevisiae C25,
C17, C11, AC40, and AC19 subunits. Interestingly,
RPC8 and RPC9 display sequence similarity to the
RNA polymerase II RPB7 and RPB4 subunits, respec-
tively, and we showed that they associate with one
another, paralleling the association of the RNA poly-
merase II subunits. Thus, RPC8 and RPC9 are paralogs
of RPB7 and RPB4. The analysis allowed us to assem-
ble a complete open reading frame encoding the sec-
ond largest subunit, RPC2, and it led to the identifica-
tion of an ortholog of the S. cerevisiae C37 subunit,
which we call RPC5.
RPC5 is an 80-1(D protein with limited sequence
similarity to the yeast 37-1(1) C37 subunit. Yet, RPC5
was found to associate with RPC53, paralleling the
known association of the yeast C37 and C53 subunits.
In addition, we could show that RPC5 is specifically
required for transcription from the type-2 VAI and
type-3 human U6 promoters, because one of our anti-
RPC5 antibodies apparently dissociates the subunit
from the rest of the RNA polymerase III enzyme.
Depletion of an extract with this antibody debilitated
U6 transcription, and transcription could be restored
by the addition of recombinant RPC5 produced in
Escherichia coli. Thus, the subunit itself is essential for
promoter-directed transcription. The characterization
of human RNA polymerase III opens the way to the
reconstitution of U6 transcription with defined factors.
REDUNDANT MECHANISMS FOR
ASSEMBLY OF A STABLE U6
TRANSCRIPTION INITIATION COMPLEX
Another focus has been to understand how transcrip-
tion factors assemble on promoters to form a stable
initiation complex. Last year, Beicong Ma completed
a project in which she studied how SNAP and TBP
bind cooperatively to DNA. Our previous studies had
shown that both SNAP and a subcomplex of SNAP,
which we call mini - SNAP, bind cooperatively with
TBP to the PSE and TATA box on the human U6 pro-
moter. SNAP contains five types of subunits:
SNAP190, SNAP50, SNAP45, SNAP43, and
SNAP19. Mini -SNAP consists of just the amino-ter-
minal third of SNAP190, SNAP50, and SNAP43. To
determine which region of mini -SNAP is required for
cooperative binding, Beicong generated complexes
smaller than mini -SNAP (stmSNAPs) and tested
them for cooperative binding. These experiments iden-
tified a 50-amino-acid region from amino acids 34 to
83 of SNAP190 that is required for cooperative bind-
ing with TBP in the context of mini -SNAP.
Furthermore, the amino-terminal 90 amino acids of
SNAP190 (including amino acids 34 to 83) are suffi-
cient for cooperative binding with TBP when fused to
either the SNAP190 RcRd Myb repeats, which are
part of the SNAP DNA-binding domain, or the het-
erologous GAL4 DNA-binding domain.
The stmSNAPcs were then tested for their activity
in RNA polymerase III transcription from the U6
snRNA promoter. Intriguingly, they were all active,
including those missing the first 90 amino acids of
SNAP190 and thus incapable of cooperative binding
with TBP. These results showed that an stmSNAP
containing only SNAP190 amino acids 84-505,
SNAP43 amino acids 1-268, and SNAP50
(stmSNAPc#8) is still capable of directing basal levels
of RNA polymerase III transcription and thus contains
all the information required for assembly of the initia-
tion complex . They also showed that stmSNAPcs inca-
pable of recruiting TBP to the DNA were functional,
suggesting that there is an alternative way to recruit
TBP to the U6 promoter.
Transcription from the U6 promoter requires a
protein named Brf2, for TFIIB-related factor 2. Brf2
had been shown to bind cooperatively with TBP, and
we therefore asked whether Brf2 could recruit TBP to
the U6 promoter in the presence of stmSNAPs.
Indeed, Brf2 could recruit TBP to the U6 promoter
even in the presence of stmSNAPcs incapable of bind-
ing cooperatively with TBP. This indicates that there
are redundant mechanisms to recruit TBP to the U6
transcription initiation complex. There are also redun-
dant mechanisms to recruit SNAP to the DNA.
Indeed, it can be recruited by cooperative binding not
only with TBP, but also with Oct-1. Such redundant
mechanisms may ensure efficient formation of the
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transcription initiation complex on chromatin tem-
plates in vivo. Furthermore, they probably ensure that
once the U6 transcription initiation complex is
formed, it remains stable for several rounds of tran-
scription.
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We all originate from a single cell that contains two
complete sets of instructions-one from each par-
ent-encoding how we should develop into a human
being. Those instructions direct the cells to proliferate
and at the appropriate time to differentiate into the
many different types of cells that make up an individ-
ual. Cells proliferate via repeated cycles of cell growth
and division, and differentiate by expressing specific
sets of genes that permit them to perform specific
functions. Both processes involve intricate patterns of
regulation of gene expression, which often result from
the regulation of gene transcription: the process by
which genes are copied into pre-messenger RNA for
subsequent translation into the protein products that
effect gene action. In eukaryotes, the genes are pack-
aged into chromatin, and the regulation of gene tran-
scription involves the ability of transcriptional activa-
tors and repressors to direct changes in the structure of
chromatin and to recruit one of three nuclear RNA
polymerases-pol I, pol II, and pol III-to specific
promoters.
We study transcriptional regulation in human cells
using herpes simplex virus (HSV), a prevalent human
pathogen, as a probe. Viruses provide simple regulato-
ry networks in which the cellular transcriptional
machinery is manipulated to achieve the goals of virus
infection. In a cell infected by HSV, the virus can grow
lytically or remain latent for many years. In the lytic
cycle, HSV gene expression is initiated by a viral tran-
scription factor called VP16, which is brought by the
infecting virion. Before activating transcription, VP16
forms a multiprotein-DNA complex-the VP16-
induced complex-on viral immediate-early promot-
ers with two cellular proteins: HCF-1, an abundant
chromatin-associated protein that regulates cell prolif-
eration, and Oct-1, a POU-homeodomain transcription
factor. Once the VP16-induced complex is assembled,
VP16 initiates viral gene transcription, in part,
through a potent transcriptional activation domain,
which stimulates the cell's basal transcriptional
machinery.
Our laboratory focuses on three principal issues:
(1) How do transcriptional regulators activate the basal
transcriptional machinery? (2) How do transcription
factors, as in the VP16-induced complex, modify their
transcriptional activity through selective protein-pro-
tein and protein-DNA interactions? (3) What are the
natural cellular roles of HCF-1 and Oct-1, and how do
they influence HSV infection? Our studies in each of
these three areas continue to elucidate new mecha-
nisms for transcriptional regulation in human cells.
Below is a description of two important discoveries we
reported this year that involve (1) the structure and
function of TBP and the TFIIB family of basal tran-
scription factors and (2) novel roles for the HCF-1
protein in cell proliferation.
A SHARED SURFACE OF TBP DIRECTS
RNA POLYMERASE II AND III TRANSCRIPTION
THROUGH ASSOCIATION WITH DIFFERENT
TFIIB FAMILY MEMBERS
Xuemei Zhao, in collaboration with Laura Schramm
and Nouria Hernandez here at CSHL, showed that a
common surface of TBP can direct both pol II and pol
III transcription through association with different
TFIIB family members. None of the three nuclear
RNA polymerases initiates a basal level of specific
transcription on its own. Instead, each RNA poly-
merase is recruited to its respective promoters by dif-
ferent sets of general transcription factors, together
forming the basal transcriptional machinery. Among
these basal factors, there is one-the TATA-box-bind-
ing protein TBP-that is used by all three RNA poly-
merases. TBP is not known, however, to associate with
any of these RNA polymerases directly. Instead, it
achieves its diverse transcriptional activities by associ-
ating with combinations of promoter- and polymerase-
selective basal factors, such as those of the TFIIB fam-
ily on promoters containing (TATA') and lacking
(TATA-) a TATA box.
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Among eukaryotes, TBP contains regions of low
and high sequence conservation: The amino-terminal
region varies among species in both length and
sequence, whereas the carboxy-terminal region, called
the TBP., is a highly conserved and structured 180 -
amino -acid domain, which binds the TATA box. We
have analyzed the role of the conserved TBPcour in
transcription from a set of four model pol II and pol
III TATA' and TATA- promoters. As model promoters,
we used (1) the adenovirus major late (AdML) TATA*
and human Ul small nuclear RNA (snRNA) gene
TATA- pol II promoters, and (2) the human U6
snRNA gene TATA' and adenoviral VAI TATA- pol III
promoters.
On these promoters, TBP associates with different
members of the TFIIB family of general transcription
factors. The TFIIB family proteins have key roles in
recruiting the RNA polymerase machinery to the pro-
moter. TFIIB is involved in pol II transcription from
both TATA' and TATA- promoters; the TFIIB-related
factor Brfl is involved in pol III transcription from
TATA- promoters and the human-specific Brf2 protein
is involved in pol III transcription from a unique set of
human TATA* promoters, called "type 3," which is
represented by the U6 snRNA gene promoter.
Interestingly, the yeast Saccharomyces cerevisiae
lacks a homolog of Brf2 and does not contain type-3
pol III promoters, suggesting that Brf2 and type-3 pol
III promoters are regulatory elaborations present in
human but not yeast cells.
We used these four model pol II and pol III TATA'
and TATA- promoters for a systematic analysis of the
effect of mutations across different surfaces of the
human TBPcour on both transcription from the four
model promoters and association with different fac-
tors involved in transcription from these promoters.
Our analysis demonstrates that human TBP utilizes
two modes to achieve its versatile functions. First, it
uses a different set of surfaces on the conserved and
structured TBPcour domain to direct transcription
from each of the four model promoters; this finding
offers an explanation for why the TBP.E is so high-
ly conserved: Each surface is involved in transcription
from some important promoter. Second, unlike yeast
TBP, human TBP can use a shared surface to interact
with two different TFIIB family members-TFIIB
and Brf2-to initiate transcription by different RNA
polymerases. Thus, by being able to interact with a
more diverse family of TFIIB-like proteins, TBP can
activate different types of transcription from diverse
contexts while utilizing the same TBP surface.
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LOSS OF HCF-1 FUNCTION LEADS TO BOTH CELL
PROLIFERATION AND CYTOKINESIS DEFECTS WHICH
CAN BE RESCUED BY INACTIVATION OF THE
RETINOBLASTOMA PROTEIN FAMILY
Our laboratory continues to place considerable empha-
sis on understanding the cellular functions of HCF-1.
Mammalian HCF-1 is a highly conserved and abun-
dant chromatin-bound protein that has a role in both
HSV immediate-early (IE) gene transcription and cell
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FIGURE 1 Loss of HCF-1 function leads to a conspicuous bi-
nucleation phenotype. (A) A representative phase-contrast
image of arrested tsBN67 cells after 72 hours at nonpermissive
temperature. The arrow points to a binucleated cell; two
mononucleated cells are also shown. (8) Nomarski and DAPI-
stained images of a field of arrested tsBN67 cells after 48 hours
at nonpermissive temperature; a complete binucleated and
mononucleated cell are shown. (Reproduced from Reilly and
Herr 2002.)
proliferation. Its role in cell proliferation has been evi-
denced through the analysis of a temperature-sensitive
hamster cell line called tsBN67. When placed at non-
permissive temperature, tsBN67 cells undergo a stable
and reversible proliferation arrest after a lag of 36-48
hours. This phenotype results from a single point
mutation in HCF-1, which disrupts HCF-1 association
with both chromatin and the HSV IE trans-activator
VP16 at nonpermissive temperature. This year, Patrick
Reilly (a graduate student in my lab) reported the iso-
lation and characterization of spontaneous tsBN67
growth-revertant cells that are able to proliferate at
nonpermissive temperature. These cells retain the
tsBN67 HCF-1 point mutation and grow in the
absence of evident HCF-1 chromatin association,
demonstrating that complete restoration of tsBN67
HCF-1 functions is not essential for cell proliferation.
Furthermore, microscopic analysis of the cells
showed that temperature-arrested tsBN67 cells display
a conspicuous multinucleated phenotype, primarily
binucleated, in a significant population of the arrested
cells, indicating that HCF-1 is necessary not only for
cell growth and proliferation, but also for proper
cytokinesis. Figure 1 shows examples of this binucle-
ated phenotype by both phase-contrast (A) and No-
marsh (B) imaging As is the tsBN67 cell prolifera-
tion defect, the cytokinesis defect is also a result of
loss of HCF-1 function, suggesting that HCF-1 has a
role in both progression through G, and cell exit from
mitosis.
Patrick Reilly also showed that the SV40 early
region, in particular large T antigen (Tag), and the ade-
novirus oncoprotein E1A can rescue the tsBN67 cell
proliferation defect at nonpermissive temperature. As
shown in collaboration with Joanna Wysocka, the
SV40 early region rescues the tsBN67 cell prolifera-
tion defect without restoring HCF-1 chromatin associ-
ation, indicating that these oncoproteins bypass a
requirement for HCF-1 function. The SV40 early
region also rescues the tsBN67 cytokinesis defect,
suggesting that the roles of HCF-1 in cell proliferation
and cytokinesis are intimately linked. The ability of
SV40 T antigen and adenovirus E1A to inactivate the
pRb protein family-pRb, p107, and p130-is impor-
tant for the bypass of HCF-1 function. These results
suggest that HCF-1 regulates mammalian cell prolif-
eration and cytokinesis, at least in part, by either
directly or indirectly opposing pRb family member
function. Our future goals are to elucidate the mecha-
nisms by which HCF-1 mediates its important and
diverse roles in cell proliferation.
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STRUCTURAL BIOLOGY OF REGULATION OF DNA
REGULATORY MOLECULES AND PROTEOLYSIS
L. Joshua-Tor A. Auster T. Messick N. To lia H. Zhou
E. Enemark P. O'Farrell A. Tovkach V. Patel
J. Jenco S. Smith E. Zarkowski B. Buckley
P.R. Kumar J.-J. Song
We study the molecular basis of cell regulatory process-
es, combining the tools of structural biology and bio-
chemistry, to examine the molecular interactions asso-
ciated with these processes. X-ray crystallography
enables us to obtain the three-dimensional structures of
individual proteins and their complexes with other mol-
ecules. We use biochemistry and molecular biology to
characterize properties that can be correlated with pro-
tein structure, and we use information from molecular
biology and genetics to study protein function.
Our current efforts center around two distinct
themes. The first involves structural studies of protein
complexes involved in nucleic acid regulatory
processes. The second theme in the lab is the regula-
tion of proteolysis. Here, we are studying caspase acti-
vation in apoptosis and a conserved family of
oligomeric self-compartmentalizing intracellular pro-
teases, the bleomycin hydrolases, which are involved
in drug resistance.
DNA Binding and Assembly of the
Papillomavirus Initiator Protein El
E. Enemark, A. Auster [in collaboration
with A. Stenlund, Cold Spring Harbor Laboratory]
Papillomaviruses are a large family of closely related
viruses that give rise to warts in their hosts. Infection of
the genital tract by the human papillomaviruses (HPV)
from this group represents one of the few firmly estab-
lished links between viral infection and the develop-
ment of cervical cancer, as HPV DNA is found in prac-
tically all cervical carcinomas. The El protein belongs
to a family of multifunctional viral proteins whose main
function is related to viral DNA replication. These pro-
teins bind to the origin of DNA replication, melt the
DNA duplex, possess DNA helicase activity, and recruit
other cellular replication proteins such as DNA poly-
merase a and replication protein A (RPA). Most likely,
different oligomeric forms of the two proteins are
responsible for the different activities, and the sequen-
tial assembly of T antigen and El complexes ensures an
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ordered transition between these different activities.
Ultimately, El forms hexameric ring helicases on each
strand which serve as replicative DNA helicases that
unwind the DNA in front of the replication fork.
In collaboration with Arne Stenlund's group here
at CSHL, we embarked on structural studies to provide
high-resolution structural information about El, its
DNA-binding activity, and its assembly on DNA.
These would provide general insight into the bio-
chemical events that are involved in viral DNA repli-
cation. They can also provide a basis for the develop-
ment of clinical intervention strategies. Second, the
viral DNA replication machinery itself represents an
obvious target for antiviral therapy, and detailed infor-
mation such as high-resolution structures of viral pro-
teins required for replication will greatly facilitate the
development and testing of antiviral agents.
The initial binding of an El dimer together with
E2 serves to recognize the double-stranded origin of
replication (ori) with high specificity. The subsequent
binding of additional El molecules leads to oti melt-
ing, most likely through the positioning of El mole-
cules in the proper arrangement necessary for melting
of double-stranded DNA (dsDNA). Ultimately, two
hexameric rings are formed on the on that could
unwind the DNA double helix. Thus, the transition
between these complexes represents a transition from
a tethering function for El to a function that modifies
the DNA structure. We have captured structural snap-
shots of two sequential steps in the assembly process
(Fig. 1). Loading of an initial El dimer on the origin
occurs at adjacent major grooves on one face of the
helix. Subsequently, a second dimer is loaded onto
another face of the helix. Binding occurs through two
DNA-binding modules, a DNA-binding loop (DBL),
and a DNA-binding helix (DBH), that bind to the two
separate strands of DNA. The majority of contacts are
made by the DBL, a long loop that is preorganized for
binding. Binding of two individual strands by separate
regions of the protein can provide a basis for a transi-
tion from double-stranded to single-stranded DNA
binding, leading to strand separation, with protein
maintaining binding to one strand while dissociating
AB
FIGURE 1 Crystal structures of two intermediates in the assembly of El -DBD subunits on the origin
of replication. (A) Structure of the El -DBD dimer bound to sites 2 and 4 determined from the [(El -
DBD9_.7)2(DNAd)] crystal structure. (B) Structure of the El -DBD tetramer bound to El-binding sites
1-4 determined from the [(El -DBIDi,03)4(DNA)] crystal structure viewed perpendicular and parallel to
the DNA helical axis.
from the other. Additional subunit-subunit contacts
formed in the assembly of the hexameric ring would
then compensate for lost protein-DNA interactions. A
more common recognition motif, such as "helix in the
groove," in which the same structural element con-
tacts both strands on either side of the groove, would
not allow such a facile transition. Since interactions
between DNA and the DBH are less extensive than
interactions with the DBL, the DBL is a more likely
candidate for the binding module that retains binding.
Moreover, in the tetramer, the two DBLs of the
upstream monomers of each dimer bind to the top
strand, whereas the DBLs of the downstream
monomers of each dimer bind to the bottom strand.
We therefore suggest that one hexameric helicase
assembles around the top strand on one side of the on
from the proteins at sites 3 and 4, and the other hexa-
meric helicase assembles around the bottom strand on
the other side of the on from the proteins at sites 1 and
2. As the hexameric helicases travel in opposite direc-
tions around their respective strands, the correct
3' -e5' polarity would occur (Fig. 2).
Bleomycin Hydrolases
P. O'Farrell [in collaboration with F. Gonzalez and
S.A. Johnston, University of Texas, Southwestern
Medical Center, and S.J. Keding and D.H. Rich,
University of Wisconsin, Madison]
Bleomycin hydrolase (BH) is a 300-kD cysteine pro-
tease with unusual structural and biological features. It
was discovered due to its ability to deactivate the gly-
copeptide antibiotic, bleomycin, which is used as a
therapeutic agent in the treatment of a number of dif-
ferent forms of cancer. The clinical use of bleomycin
is limited due to drug resistance and dose-dependent
production of pulmonary fibrosis. The endogenous
enzyme, BH, is overexpressed in some tumor cells and
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FIGURE 2 Schematic diagram of the proposed role of the DBL
in strand selection: A cartoon depicting a model for the assem-
bly of two hexameric helicases around single strands at the oh.
The two DBLs (black) of the upstream monomers of each dimer
bind to the top (black) strand, and the DBLs of the downstream
monomers of each dimer bind to the bottom strand (white). One
hexameric helicase assembles from the upstream monomers at
sites 3 and 4 (dark gray) around the top strand and the other
hexameric helicase assembles from the downstream
monomers at sites 1 and 2 (fight gray). This arrangement would
result in the correct 3"--)5" polarity for the helicases.
is thought to be a major cause of tumor cell resistance
to bleomycin therapy. It was shown that in both yeast
and mammalian cells, BH is the only enzyme with
bleomycin deamidation activity. Interest in its clinical
relevance was heightened by a recent report of the
genetic linkage of an allelic variant to the nonfamilial
form of Alzheimer's disease. BH was also found to
bind amyloid precursor protein (APP).
Since mammals rarely encounter bleomycin,
bleomycin hydrolysis is probably not the normal func-
tion of the enzyme. On the basis of studies with BH
knockout mice, it was shown that BH is important for
neonatal survival. BH is widely distributed throughout
nature. Homologs exist in bacteria, yeast, birds, and
mammals, with high sequence identity among the dif-
ferent forms. The yeast form negatively regulates the
galactose metabolism system and also binds single-
stranded DNA and RNA with high affinity. Nucleic-
acid-binding activity was also reported for other mem-
bers of the family.
We have previously determined the crystal struc-
tures of the yeast BH, Ga16, and the human enzyme
(hBH). These structures revealed several unique fea-
tures of these proteases. They both have a hexameric
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ring-barrel structure with the active sites embedded in
a central cavity. The only access to the active sites is
through the cavity. BH has little substrate specificity
so it is reasonable to assume that this sequestration of
the active sites is necessary to prevent indiscriminate
proteolysis. This places BH in the class of "self-com-
partmentalizing proteases" with, for example, the pro-
teasome and the tricorn protease. The carboxyl termi-
nus of BH lies in the active site, in much the same
position as that taken by inhibitors complexed with
papain. Our previous work on the yeast BH, Ga16, has
shown that it acts as a carboxypeptidase on its car-
boxyl terminus to convert itself to an aminopeptidase
and peptide ligase. The carboxyl terminus anchors the
substrate into the active site and confers "positional"
specificity. This model also serves to explain the
unique ability of BH/Ga16 to inactivate bleomycin.
In collaboration with Dan Rich's laboratory at the
University of Wisconsin, Madison, we embarked on an
iterative study to design specific, tight-binding active
site inhibitors of BH activity to increase the efficacy of
bleomycin, and perhaps reduce dosage levels in cancer
treatment. The emerging link between hBH and
Alzheimer's disease is another incentive, since an
inhibitor to hBH may be useful in understanding this
connection and may also be useful in therapy. We are
using our crystal structure to create novel inhibitors by
use of computerized structure-generating programs.
Using this approach, we can create both peptide-like
and nonpeptide inhibitors by a combinatorial process.
We identified four compounds in our initial screens that
are good inhibitors and have solved two cocrystal struc-
tures of hBH with these compounds. These structures
are the basis of further drug design.
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RNA SPLICING
A.R. Krainer E. Allemand
L. Cartegni
M. Hastings
R. Karni
L. Manche
H. Okunola
X. Roca
S. Shaw
CONSTITUTIVE AND ALTERNATIVE PRE -MRNA
SPLICING MECHANISMS AND REGULATION
P. Smith
A. Stella
Q.-S. Zhang
Z. Zhang
RNA splicing is required for expression of most
eukaryotic protein-coding genes. Splice-site selection
is a high-fidelity process that requires the recognition
of limited and dispersed sequence information present
throughout introns and exons. In humans, approxi-
mately 60% of genes are expressed via alternative
splicing, giving rise to multiple protein isoforms. The
choice of alternative splice sites is commonly regulat-
ed to alter gene expression, either tissue-specifically
or in response to a developmental program or to extra-
cellular signals. The fact that multiple protein iso-
forms can be expressed from individual genes demon-
strates that the classical "one gene-one enzyme" par-
adigm is no longer valid, and provides an explanation
for the relatively small number of genes uncovered by
genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve more than 100 protein components, as
well as RNA components that are part of a set of small
nuclear ribonucleoprotein (snRNP) particles. The work
in our lab focuses on the identification and molecular
characterization of protein factors and sequence ele-
ments that are necessary for the catalysis and fidelity
of splicing and/or for the regulation of alternative
splice-site selection. We are especially interested in
how the spliceosome correctly identifies and joins the
exons on each pre-mRNA, and how certain point muta-
tions in either exon or intron sequences cause aberrant
splicing, leading to numerous genetic diseases.
EXON-SKIPPING MUTATIONS IN CANCER AND
NEURODEGENERATION
We previously developed, based on our experimental
data and in collaboration with Michael Zhang's lab
here at CSHL, methods for predicting exonic splicing
enhancer (ESE) motifs responsive to particular human
SR proteins. A Web-based program, ESEfinder, is now
available (http://exon.cshl.edu/ESE) and can be used
to calculate ESE scores in any sequence of interest.
We applied this type of analysis to the human SMN1
and SMN2 genes, which are involved in spinal muscu-
lar atrophy (SMA), a common pediatric neurodegen-
erative disease. SMA patients lack a functional SMN1
gene but possess at least one copy of the nearly iden-
tical SMN2 gene. It was known that exon 7 in SMN1 is
constitutively included, whereas exon 7 in SMN2 is
skipped 80% of the time, giving rise to a defective pro-
tein. Moreover, this difference between the two
homologous exons is due to a single, translationally
silent point mutation. The low level of functional SMN
protein translated from the approximately 20% of
SMN2 pre-mRNA that is spliced correctly is essential
for viability, but is not sufficient to prevent the dis-
ease. We used mutational analysis, including compen-
satory mutations, in combination with in vitro splic-
ing, transient transfections, and RNA-protein interac-
tion studies, to show that the single C to T difference
at position +6 between SMN1 and SMN2 exon 7 maps
to an SF2 (splicing factor 2)/ASF (alternative splicing
factor)-dependent ESE heptamer motif The ESE is
active in SMN1 but inactive in SMN2, explaining why
a constitutive exon in SMN1 corresponds to a weak
alternative exon in SMN2 (Figs. 1 and 2).
We had previously carried out a similar analysis of
a breast cancer nonsense mutation that causes skip-
ping of a constitutive exon in BRCAL More recently,
we collaborated with Drs. Fackenthal and Olopade at
the University of Chicago to characterize a breast can-
cer missense mutation in BRCA2 that likewise inacti-
vates the gene by causing exon skipping, resulting in
breast and ovarian cancer susceptibility. In this case,
the sequence analysis with ESEfinder showed that the
point mutation inactivated three overlapping ESE
motifs, leading to the prediction that exon skipping
might result, which was then confirmed by analysis of
RNA from patient blood cells. These studies can
explain how single-base changes in exons allow genes
to evolve, e.g., transforming a constitutive exon into
an alternative one or vice versa. A further implication
is that many mutations traditionally classified as non-
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sense, missense, or silent, as well as some polymor-
phisms, can give rise to exon skipping, such that the
mutant or variant site is no longer present in some or
all of the mature mRNA. Thus, the effect of the muta-
tion or polymorphism on the protein product is very
different from, and usually more drastic than, what
would be predicted from analysis of the genomic
sequence. Analysis of mRNA splicing can therefore
SF2/ASF-/SC35
GGTTTCAGACAA(SMN1) 6C 3.87 3.76
6C11G GGTTTCAGACGA 3.87 6.34
(SMN2) 6T GGIIIIAGACAA 2.14 0.81 4-
61,11G GbiiiiAGACGA 2.14 3.39 4-
6A GGIIIAAGACAA 2.59 1.26 4-
6A11G GGTTTAAGACGA 2.59 3.83
6G GGTTTGAGACAA 2.95 2.18
6G11G GGTTTGAGACGA 2.95 4.78
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FIGURE 1 An SF2/ASF-dependent ESE motif promotes inclu-
sion of SMN exon 7. The SF2/ASF consensus heptamer motif
is shown at the top, with the preferred nucleotides shown in
gray. The size of each letter is proportional to the frequency of
that nucleotide at that position in an alignment of 26 ESE
sequences. The first 12 nucleotides from eight wild-type or
mutant versions of exon 7 are shown, with the mutated posi-
tions +6 and +11 shown in gray. The light and dark gray hori-
zontal bars indicate the position of the overlapping SC35 and
SF2/ASF motifs, respectively. The effect of the point mutations
used in transfection experiments on the calculated SC35 and
SF2/ASF motif scores is shown on the right (high scores in
boldface; subthreshold scores in lightface). The first and third
sequences correspond to SMN1 and SMN2, respectively. The
autoradiogram shows a semiquantitative RT-PCR analysis of
transiently expressed minigenes. The products corresponding
to exon 7 skipping and inclusion are indicated. Two of the mini-
genes give rise to exon skipping: 6T (SMN2) and 6A (dark gray).
When 6T and 6A are combined with the 11G suppressor muta-
tion to reconstitute an SF2/ASF high-score motif, exon inclu-
sion is restored (light gray). Note that the SC35 motif is neither
necessary nor sufficient to promote exon inclusion, whereas
the SF2/ASF motif is both necessary and sufficient.
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FIGURE 2 Model of SF2/ASF-dependent exon 7 inclusion in
SMN1 and SMN2. Binding of SF2/ASF to its cognate heptamer
ESE in SMN1 exon 7 (top) promotes exon definition so that
exon 7 is constitutively included, allowing for translation of full-
length SMN protein. The C6T change in SMN2 exon 7 (bottom)
prevents efficient SF/ASF binding to the corresponding hep-
tamer. Exon 7 is thus mostly skipped, resulting in the produc-
tion of defective SMN47 protein. Other ESEs in the exon can
mediate weak exon inclusion even in the absence of the
SF2/ASF motif, probably through binding of other SR or SR-like
proteins, including hTra2p1. Partial inclusion of SMN2 exon 7
generates a small amount of full-length SMN protein, identical
to that encoded by the SMN1 gene, since the C to T change is
translationally silent. Exons are represented as boxes and
introns as lines. The shaded portion of exon 7 encodes the last
16 amino acids of the SMN protein, which are missing from
SMN47. The shaded portion of exon 8 represents the last 4
amino acids of SMN47, which are not present in SMN. Open
boxes represent 3"-untranslated regions. The dark oval denotes
SF2/ASF and light ovals represent other SR or SR-like proteins.
Curved arrows denote promotion of exon definition and
chevrons indicate splicing patterns. Line thicknesses are
indicative of relative splicing efficiency. The percent values refer
to the extent of exon 7 inclusion in vivo. The diagrams of SMN
and SMN47 proteins show their different carboxy-terminal
domains.
be critical for correct disease diagnosis and assess-
ment of phenotypic risk in individuals with familial
predispositions.
RATIONAL DESIGN OF SYNTHETIC EXON
ACTIVATOR MOLECULES
On the basis of our current knowledge about ESEs and
SR proteins, we are designing novel synthetic exon
activator molecules that can promote inclusion of tar-
get exon in a specific manner. The synthetic mole-
cules consist of an antisense moiety covalently
attached to a small peptide. The sequence of the anti-
sense moiety is chosen to target a particular exon by
Watson-Crick base pairing, whereas the peptide moi-
ety is a minimal splicing activation domain analogous
to an SR protein RS domain. So far, we have used a
12-residue peptide-nucleic acid (PNA) backbone for
the antisense moiety, and RS domain peptides of 10,
20, or 30 amino acids. We found that compounds tar-
geted to BRCAI exon 18 could restore exon inclusion
in a mutant that causes skipping of this exon.
Likewise, compounds targeted to SMN2 exon 7
increased the inclusion of this exon. These experi-
ments were done in vitro, and specificity was demon-
strated by the fact that the compounds targeted to
BRCA1 did not affect SMN2 splicing and vice versa.
The synthetic RS domains become phosphorylated
under splicing conditions. We are presently optimizing
several parameters to improve the efficacy of these
exon activators, as well as to facilitate their cellular
uptake, to determine if they can affect splicing in vivo
and to adapt them for therapeutic purposes.
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PROTEOMICS
M. Myers S. Lopez L.L. Schmidt
G. Pegoraro
The completion of the human genome has ushered in
a new age of biological discovery. This accomplish-
ment has essentially identified all of the players gov-
erning human biology. The important work of assign-
ing functions to this myriad of proteins has become
one of the principal tasks of modern biology. Although
many functions will be assigned using genetics or
bioinformatics, the majority of this functional charac-
terization will be performed by proteomics.
The goal of my laboratory is to understand how
proteins and protein complexes regulate cellular
behavior. In the environment of a cell, almost all of the
proteins can be found in a highly interactive network.
My laboratory is focused on understanding the global
architecture of this network and how this network gen-
erates robustness (error tolerance) and adaptablility to
the system and how this network is altered to produce
and survive complex diseases, such as cancer.
Optimization of Protein
Identification
S. Lopez, L.L. Schmidt
Protein identification is the major tool of proteomics.
We have been optimizing mass spectrometry (MS) for
protein identification. MS has many advantages over
other techniques for protein identification, especially
its sensitivity. However, the improved sensitivity
comes at a price, as the sample preparation becomes
increasingly important to ensure success. We have
been optimizing a number of parameters to increase
this success rate. Importantly, we have found that the
method of staining the proteins prior to analysis can
greatly affect the outcome of analysis, and we have
begun to systematically explore different methods for
highly sensitive protein visualization that do not
adversely affect downstream MS analysis. We have
found that fluorescent stains, such as SYPRO Ruby
Red, give the greatest sensitivity without adversely
affecting our analysis. However, we have found that
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negative zinc staining gives the best mix of protein
visualization, ease of use, and MS sensitivity.
Monitoring Posttranslational
Modifications
L.L. Schmidt, G. Pegoraro [in collaboration with
R.-M. Xu, Cold Spring Harbor Laboratory]
One of the challenges in the postgenomic era is to
understand how proteins are regulated by posttransla-
tional modifications. These modifications are respon-
sible for controlling the activity of proteins and ulti-
mately determining how a cell responds to its environ-
ment. Phosphorylation is considered to be the most
common posttranslational modification, and its wide
use as a regulatory mechanism has been attributed to
its reversible nature. Alterations in protein phosphory-
lation have been shown to be the hallmark of many
pathological conditions including cancer and diabetes.
Therefore, efficient identification of phosphorylated
proteins, as well as mapping the specific phosphoryla-
tion sites, has become one of the primary goals of pro-
teomics. We have been attempting to develop sensitive
and robust MS methods for characterizing this impor-
tant posttranslational modification. Our efforts have
centered on developing reagents for the affinity purifi-
cation of phosphorylated proteins and peptides.
Initially, we tried immobilized iron as our affinity
reagent, as this has been shown to interact strongly
with phosphorylated residues. However, we found that
other metals are much more efficient for the affinity
purification of phosphorylated residues, gallium being
the strongest, followed by copper, iron, and nickel.
Using this technology, we estimate that 500 fmoles of
phosphorylated peptide is required for characteriza-
tion. We believe that the major nonphosphorylated
contaminants arise from proteins and peptides with
acidic regions. To circumvent this, we are developing
chemistries designed to methylate, and thereby neu-
tralize, glutamic and aspartic acid residues.
In collaboration with Rui-Ming Xu here at CSHL,
we have been developing MS-based assays to analyze
histone modifications. It is clear that modification of
histone residues has a major role in transcriptional
regulation, and histones have been found to be
methylated, acetylated, phosphorylated, and even
ubiquitinylated. Our interest in developing MS-based
assays was because of their speed and sensitivity. We
have been focusing on the methylation of the amino
terminus of histone H3 and have been able to detect
the methylation of lysine 4 and lysine 9 using recom-
binant proteins. We are able to detect the methylation
of either lysine residue using only a few femtomoles
of substrate and have found that the methylation of
both lysine residues is highly pH-dependent.
Significantly, we have also discovered that the recom-
binant enzymes are capable of using multiple methyl
donors.
Analysis of DNA
Interacting Proteins
M. Myers
We have developed a technique to analyze the proteins
that associate with a specified molecule of DNA in
vivo. We have also developed a sequence-specific
DNA affinity tag, termed a sequence seeker, which
has been designed to purify engineered episomal
DNA from mammalian cells. The sequence seeker we
have developed targets a sequence (AGCGGATGCG-
GA), which was picked because it occurs infrequently
in the human genome. Using a tagged episome that
also contained a transcription unit and an origin of
replication, we were able to identify a number of pro-
teins involved in transcription, recombination, and
other aspects of chromatin dynamics. Although this
technique can be used to analyze origins of replica-
tion, promoter sequences, silenced regions, etc., we
are planning to adapt this technique to study cellular
responses to DNA damage.
"Small World" Proteomics
M. Myers [in collaboration with R. Sachidanandam
and J. Faith, Cold Spring Harbor Laboratory]
We have modeled the data from several high-through-
put protein interaction screens as a network. We have
chosen to model these data as a network because it is
one of the only ways to make sense of these large and
complicated data sets. In this model, each protein is
treated as a node, and the interactions are treated as
links between the nodes. In this way, the yeast protein
network ends up looking very similar to the network
of computers that make up the World Wide Web or the
network of human social interactions that make this a
"small world." On the basis of the network properties
of the yeast protein network, we have been able to
classify the yeast network as a scale-free network, in
which only a fraction of the proteins are responsible
for making the lion's share of the connections. One
prediction from the network model is that these high-
ly connected proteins are essential for yeast viability.
In fact, we find that this is the case, as essential pro-
teins are highly enriched in the pool of highly con-
nected proteins. Importantly, not all highly connected
genes are essential, and we are focusing on trying to
understand the differences between these proteins and
those which are essential. The overall goal of this
study is to understand how these protein networks pro-
vide adaptability either to changes in environmental
conditions or to genetic alterations, such as loss or
duplication of a node (gene) that occurs during
tumorigenesis.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski B. Hill M. Kwofie
A. Janardhan T. Swigut
Our interest lies in understanding the molecular mech-
anisms underlying the pathogenesis of AIDS and, in
particular, understanding the functional consequences
of interactions between viral proteins and the cellular
regulatory machinery. The focus of our research is to
understand the functions of Nef, a regulatory protein
of human and simian immunodeficiency viruses (HIV
and SIV) that is an important determinant of viru-
lence. A major effort has been directed toward the
identification of mechanisms and downstream effec-
tors that mediate the effect of Nef on protein sorting
and signal transduction machineries, and our experi-
ments have been focused in two areas. First, we con-
tinued to study the mechanisms that mediate the selec-
tive down-regulation of cell surface receptors by Nef
via the AP-2 clathrin adaptor pathway. We found that
this involves cooperative interactions between Nef,
clathrin adaptors, and cytoplasmic domains of target
cell surface receptors. This will likely provide a gener-
al mechanism for selective cargo recruitment to the
sites of endocytosis by this small viral protein. Second,
we have focused heavily on the isolation and identifi-
cation of cellular proteins that mediate the effects of
Nef on signal transduction and endocytotic machiner-
ies. This has led recently to purification and microse-
quencing of several cellular factors that associate with
Nef in T lymphocytes. Among them are factors that
control critical events in the regulation of protein sort-
ing, signal transduction, and gene expression. Current
studies are aimed at verifying these novel interactions
and addressing their relevance to previously known
and possibly novel functions of Nef.
NEF INDUCES THE ENDOCYTOSIS OF
TCR:CD3-r,, CD4, AND CD28 VIA THE
AP-2 CLATHRIN ADAPTOR PATHWAY
Our previous studies revealed that Nef down-regulates
cell surface expression of several receptors, such as
CD4, CD28, and the T-cell antigen receptor
(TCR:CD3) complex, that mediate signal transduction
in T cells and are important for the normal function of
antigen-recognition machinery in infected T cells. In
the last year, we made significant progress in unravel-
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ing the general molecular mechanisms that underlie
the endocytosis of cell surface receptors by Nef.
Several lines of evidence from our studies support a
model whereby Nef induces the endocytosis of target
molecules (CD4, CD28, and TCR:CD3) by recruiting
them directly to AP-2 clathrin adaptor endocytic path-
ways. First, using immunofluorescence microscopy,
we showed that in cells expressing Nef, CD4 and
CD28 (and the CD3 -1 subunit of the TCR:CD3 in
cells expressing SIVmac 239 Nef) are translocated to
the regions of the plasma membrane coated by AP-2.
Second, we presented evidence that Nef directly binds
target sequences in the cytoplasmic domain of CD28.
Third, we were able to reconstitute the trimeric
Nef:CD3- cytoplasmic domain:AP-2 complex in
vitro. Finally, we presented evidence that HIV- l and
SIV Nef directly bind the AP-2 clathrin adaptor com-
plex. Together, these data support a general model in
which Nef, the AP-2 clathrin adaptor, and the target
receptor (cargo) form a trimeric complex that initiates
Nef-induced internalization of the target receptor.
SIV NEF POSSESSES AT LEAST TWO
STRONG AP-2-BINDING SITES EACH
WITH DIFFERENT FUNCTIONAL ROLES
The CD4, TCR:CD3, and CD28 down-regulation
functions of Nef are separable by specific mutations.
This indicated that each of these functions must
involve independent molecular interactions of Nef
with target molecules and/or the AP-2 clathrin adaptor.
To explain how the selectivity of Nef for endocytosis
of these cell surface receptors is generated, we studied
in detail the interaction of Nef with AP-2 both in vivo
using fluorescence microscopy colocalization assays
and in vitro using "pull-down" assays. We mapped the
regions and amino acid sequences in the HIV- l NA7
and SIVmac 239 Nef proteins that mediate the consti-
tutively strong interactions with AP-2 and found that
these proteins bind AP-2 by altogether different inter-
action surfaces. Specifically, we showed that SIV Nef
contains two constitutive high-affinity AP-2 interac-
tion determinants (CAIDs) located in the amino-ter-
minal region of the molecule. Each CAID can inde-
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FIGURE 1 Models for the cooperative assembly of heterotrimeric complexes containing SIV Nef, AP-2,
and CD3-C subunit of the TCR:CD3 as cargo. (4,8) "Connector" and "cooperative binding" models for
the recruitment of cell surface receptors by Nef to AP-2 clathrin adaptor. (4) A "connector" model where
Nef contacts AP-2 and the target site in the membrane receptor such as CD4, CD28, or CD3-C by inde-
pendent interactions. Data from the studies on the mechanism of CD3-C recruitment to the AP-2 by SIV
mac239 Nef provide strong support to an alternative model called a "cooperative binding" model, where
Nef and the target receptor bind cooperatively AP-2 (B). (C) A likely model for the induction of TCR:CD3
endocytosis by Nef. SIV Nef and the CD3-C cytoplasmic domain bind with high affinity to form a stable
239.Nef:CD3-C complex. Complexed together, 239.Nef and CD3-C produce a high-affinity binding site
for AP-2. This complex is competent to recruit CD3-C to clathrin-coated pits.
pendently target heterologous proteins to AP-2 in vivo
and promote association with AP-2 clathrin adaptors
in vitro. Notably, we found that the two CAIDs had
distinct functional roles. The N-distal CAID associ-
ates with the AP-2 clathrin adaptor via a novel inter-
action surface that lacks dileucine- or tyrosine-based
sorting motifs and is required for the induction of
CD4 and CD28 endocytosis. In contrast, the N-proxi-
mal CAID, which contains tyrosine-based sorting
motifs and can contact the 1i-subunit of the AP-2, is
neither required nor sufficient in vivo for any known
function of Nef that involves AP-2.
SELECTIVITY OF SIV NEF FOR TCR:CD3
ENDOCYTOSIS IS GENERATED BY
COOPERATIVE BINDING OF THE
NEF:CD3-c COMPLEX WITH AP-2
Our subsequent studies of the down-regulation of
TCR:CD3 cell surface expression by SIV Nef sug-
gested how the selectivity of Nef for cargo is generat-
ed. Since previous studies demonstrated that the core
domain of Nef binds the cytoplasmic domain of the
CD3- subunit of the TCR:CD3 complex with high
affinity, we initially thought that Nef may act as a
molecular linker to bridge CD3-c with AP-2.
However, when testing this model, we found that nei-
ther of the strong AP-2-binding elements in Nef were
required for Nef to induce endocytosis of molecules
containing the CD3-c cytoplasmic domain, nor to
recruit them to AP-2 in vivo. The mechanistic expla-
nation of this observation was provided by subsequent
in vitro biochemical studies in which we demonstrat-
ed that a recombinant SIV Nef and CD3-c in a com-
plex bind AP-2 cooperatively. This cooperative bind-
ing is a more likely model to explain the recruitment
by Nef of target receptors for endocytosis than a sim-
ple model in which Nef acts as a simple "connector"
that bridges the target receptor and AP-2 at the cell
surface via independent interactions. We think that the
cooperative binding of Nef, target receptor, and AP-2
is a general mechanism that confers the specificity of
Nef toward selected cargo. We are now testing this
possibility through similar biochemical studies of SIV
Nef interactions with CD4/CD28 and AP-2. These
data have two general implications for the mecha-
nisms that Nef uses to recruit target receptors to AP-2.
First, our observation that different surfaces of the Nef
molecule mediate the selective endocytosis of
CD4/CD28 and the TCR:CD3 complex indicates that
for each target receptor molecule, a distinct trimeric
complex is formed composed of Nef, the receptor, and
AP-2, in which Nef is oriented in a distinct and spe-
cific way with respect to AP-2. Second, multiple mod-
ular cooperative interactions of Nef and the target
receptor with AP-2 determine the selectivity of Nef for
its target receptor.
BIOCHEMICAL PURIFICATION AND
IDENTIFICATION OF PROTEINS ASSOCIATING
WITH NEF IN T LYMPHOCYTES
Previous studies have revealed that Nef acts through
associations with large protein complexes. One such
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example is the complex(es) that mediates the effects of
Nef on the protein-sorting machinery at the plasma
membrane and contains Nef and the AP-2 clathrin
adaptor described above. Another example is the poor-
ly characterized large complex(es) containing Nef and
PAK2 kinase. Some of our goals have been to identify
the targets of Nef in such complexes as well as addi-
tional downstream effectors of Nef that have escaped
detection by previous studies. The unbiased approach-
es that have been used so far to identify immediate
downstream effectors have relied heavily on the abili-
ty to reconstruct the relevant interactions in heterolo-
gous or in in vitro systems, including the yeast two-
hybrid interaction screen (YTH) and chromatography
of T-cell extracts on Nef-affinity columns. These
approaches have correctly identified a subset of Nef
ligands, but have been used exhaustively, and there-
fore, additional Nef-interacting polypeptides are not
likely to be revealed by such assays. Therefore, to
bypass the limitations of previously used methods, we
developed an immunoaffinity purification protocol to
isolate Nef and its associated protein complexes from
T-cell lines stably expressing Nef.
With this protocol, we detected a series of
polypeptides with apparent molecular masses ranging
from 20 kD to more than 250 kD that copurified with
HIV-1 and SIV Nef proteins from a model human T-
cell line. These additional polypeptides can be divided
into three sets: (1) those that copurify with both HIV-
1 and SIV Nef, (2) those that associate predominantly
or exclusively with HIV-1 Nef, or (3) SIV Nef. That a
set of common polypeptides copurifies with both HIV-
1 and SIV Nef is strong evidence that they are biolog-
ically relevant. The detection of polypeptides that
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associate with Nef in a strain- or allele-specific man-
ner is also expected, since it is well established that
HIV-1 and SIV Nef show different binding affinities to
several proteins such as CD3- or the Hck SH3
domain and display different functions as well. We
recently increased the scale of the purification of Nef-
associated proteins and started to determine their
sequences by mass spectroscopic analysis in collabo-
ration with Michael Myers here at the CSHL Protein
Chemistry Shared Resource. This led to the identifica-
tion of several common polypeptides associated with
both 7.AH Nef and 239.AH Nef as N-myristoyl trans -
ferase -1 (NMT-1, -60 kD), tubulin (-50 kD), and
Filamin (-250 kD). These polypeptides were identi-
fied in more than one independent purification/
sequencing experiment. Additionally, a component of
the 60 -kD polypeptide band gave a statistically signif-
icant hit to the product of the KIAA0942 gene.
KIAA0942 encodes a guanine nucleotide exchange
factor (GEF) most closely related to EFA6. EFA6 reg-
ulates ARF6, a small G-protein that regulates mem-
brane traffic in the endocytotic pathway, making
KIAA0942 a potentially important target of Nef. We
are continuing these studies with the goal of identify-
ing critical downstream effectors for the additional
Nef functions.
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TRANSCRIPTION AND PROTEOLYSIS
W. P. Ta nsey E. Ejkova
M.-J. Gething
A. Herbst
S.Y. Kim
E. Kurten
M. Muratani
S. Salghetti
K. Tworkowski
Gene transcription and ubiquitin (Ub)-mediated prote-
olysis are two processes that have seemingly nothing
in common: Transcription is the first step in the life of
any protein, and proteolysis the last. Despite the dis-
parate nature of these processes, a growing body of
evidence suggests that components of the Ub-protea-
some system are intimately involved in the regulation
of gene expression. Research in our laboratory is
geared at understanding how these two processes
intersect, and the consequences of this intersection for
cellular growth control.
TRANSCRIPTION FACTOR DESTRUCTION BY
THE UBIQUITIN-PROTEASOME PATHWAY
Many transcription factors, particularly those involved
in the control of cell growth, are unstable proteins that
are destroyed by Ub-mediated proteolysis, a process in
which the covalent attachment of Ub to target proteins
signals their destruction by the 26S proteasome. Ub-
mediated proteolysis is a highly specific process. For
a protein to be destroyed by this pathway, it must con-
tain a sequence element-termed a degron-that sig-
nals its destruction. Degrons function by interacting
with a class of proteins known as Ub-ligases that ulti-
mately catalyze the covalent transfer of Ub to lysine
residues somewhere on the target protein. Previous
work in our laboratory suggested that the destruction
of transcription factors might be linked to their ability
to activate transcription, when we discovered that
degrons overlap with transcriptional activation
domains (TADS) in most unstable transcription fac-
tors. We subsequently showed that this overlap is inti-
mate and, in some cases, essential for transcription.
For example, we found that activators bearing the pro-
totypical VP16 activation domain cannot activate tran-
scription in the yeast Saccharomyces cerevisiae unless
they are ubiquitylated. This requirement for ubiquity-
lation suggests not only that activators engage the Ub-
proteasome pathway as part of their modus operandi,
but also that ubiquitylation functions to "license" tran-
scription factors, by inexorably linking their activity to
their destruction by the proteasome. The role of ubiq-
uitylation in activator functioning, together with
recent work from other laboratories demonstrating
that histone ubiquitylation controls epigenetic gene
silencing and that the proteasome itself is required for
transcriptional elongation, suggests a multifaceted
role for the Ub-proteasome system in transcriptional
control that we are anxious to explore.
THE UBIQUITIN-LIGASE SKP2 REGULATES MYC
STABILITY AND ACTIVITY
As a paradigm for transcription factor destruction, we
study Myc. Myc is a basic helix-loop-helix transcrip-
tion factor that features prominently in the regulation
of cell proliferation and in cancer. Myc is also a high-
ly unstable protein that is destroyed by Ub-mediated
proteolysis. The link between Myc and mammalian
cell growth control provides an excellent opportunity
for us to understand the consequences and signifi-
cance of transcription factor regulation by the ubiqui-
tin system.
To understand how the Ub-mediated proteolysis
of Myc regulates its activity, we sought to identify a
Ub-ligase that targets Myc for destruction. We estab-
lished a heterologous yeast assay to measure Myc
turnover and used this assay to search for human pro-
teins that could direct appropriate, activation domain-
directed, destruction of Myc in vivo. This analysis
identified a single Ub-ligase, Skp2, that was capable
of directing Myc turnover in the yeast setting.
Subsequent experiments revealed that Skp2 can also
regulate Myc ubiquitylation and stability in human
cells; Skp2 associates with the Myc activation domain
and can promote Myc ubiquitylation in vivo, and
dominant-negative forms of Skp2-or Skp2 knock-
down via silencing RNAs (siRNAs)-stabilize the
Myc protein. The implication of Skp2 as a Ub-ligase
for Myc is intriguing because Skp2 is itself an onco-
protein with potent growth-promoting properties. A
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FIGURE 1 Skp2 activates Myc target genes and S-phase entry in a Myc-dependent manner. (A) Activation of Myc target genes in
wild-type Rat1 cells. Rat1 cells expressing the indicated ER-Myc and ER-Skp2 proteins were driven to quiescence by serum depri-
vation and density-arrest. ER-fusion proteins were then induced by addition of 4-hydroxytamoxiten and cellular RNA-collected.
Transcript levels from six Myc target genes ("amplicons") were determined by quantitative reverse transcription, real-time PCR (Q-
PCR). Signals are normalized to actin. (B) Activation of Myc target genes in Myc-null Rat1 cells. The experiment was performed as
in A, except that myc-null Rat1 cells were used. (C) Skp2 down-regulates p27 and induces S phase in wild-type Rat1 cells. ER-Myc
and ER-Skp2 fusion proteins were activated in quiescent Rat1 cells as described in A. S-phase entry was measured by FAGS or
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number of targets of Skp2 have been identified,
including the cyclin-dependent kinase (CDK)
inhibitor p27 and the human replication protein Orcl
(which we showed in collaboration with Bruce
Stillman's laboratory here at CSHL). Conventional
views would suggest that Skp2 promotes cell growth
by down-regulating p27, which in turn leads to liber-
ation of active cyclin-CDK complexes, and progres-
sion through S phase. In light of the activator licens-
ing model, however, we hypothesized that Skp2
might function, in part, as a transcriptional co-activa-
tor for the Myc protein, coupling Myc's activity to its
destruction by the proteasome.
To test this model, we engineered Ratl fibroblasts
to express an inducible form of Skp2, in which we
fused Skp2 to the hormone-binding domain of the
estrogen receptor (ER). We made these cells quiescent
by serum deprivation, activated ER fusions, and ana-
lyzed transcript levels from six Myc target genes. This
analysis (Fig. 1A) revealed that expression of AHCY,
CAD, Cdc2, ODC, and Rcl was stimulated by activa-
tion of full-length Skp2 (third bar from left), to a level
comparable to that seen by Myc (second bar from
left). In contrast, a mutant of Skp2 lacking Ub-ligase
function (Slcp2Ln failed to activate Myc target gene
expression (fourth bar from left), indicating that the
ubiquitylating activity of Skp2 is required for this
transcriptional effect. To determine whether the abili-
ty of Skp2 to activate Myc target genes is dependent
on Myc, we performed an analogous experiment in
Ratl fibroblasts in which both copies of the myc gene
were deleted by homologous recombination. In these
cells, Skp2 failed to activate the expression of any
genes tested (Fig. 1B), although these genes respond-
ed robustly to activation of ectopic ER-Myc. These
data reveal that the Ub-ligase Skp2 stimulates Myc
target genes in a Myc-dependent manner, consistent
with the notion that Skp2 is an upstream activator of
the Myc protein.
To test the significance of the Skp2-Myc interac-
tion, we asked whether the ability of Skp2 to signal S-
phase entry in Ratl cells is dependent on Myc. In
wild-type, quiescent, Ratl cells, ER-Skp2 down-regu-
lated p27 levels, and stimulated S-phase entry, as
judged from both FACS analysis and bromodeoxyu-
racil (BrdU) incorporation (Fig. 1C). In similarly
treated myc-null cells, however, ER-Skp2 down-regu-
lated p27 as expected (Fig. 1D), but the cells failed to
enter S phase. These results thus demonstrate that
down-regulation of p27 by Skp2 is not sufficient to
permit S-phase entry and reveal that Myc is an essen-
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tial downstream effector of the Skp2 protein. The find-
ing that Skp2 activates Myc's transcriptional activities,
and is dependent on Myc for some its functions, sug-
gests that the control of activator function by ubiqui-
tylation is important in the control of cell proliferation
in normal and cancer cells.
MYC BOX III IS A HIGHLY CONSERVED
ELEMENT IMPORTANT FOR MYC
DESTRUCTION AND FUNCTION
The connection between the activity of Myc and its
destruction provides the opportunity for us to learn
new aspects of how the Myc protein functions. For
example, during our analysis of Myc turnover, we
identified a second element-located within the inte-
rior of the Myc protein-that is important for its
destruction. At the core of this region is a highly con-
served, but little studied, sequence element called Myc
box III (MbIII), which is highly conserved among the
c-, N-, and S-Myc family members. Despite its con-
servation, however, very little is known about how
MbIII contributes to Myc activity. We had previously
shown that MbIII-together with the two other con-
served Myc boxes (MbI and MbII, located within the
Myc TAD)-is important for Myc destruction. We
have now asked whether MbIII is also important for
Myc function.
For this purpose, we generated an inducible (ER-
fusion) form of Myc in which we deleted the MbIII
element (AMbIII). For comparison, we also generated
Myc mutants with deletions in MbI (AMbI) and MbII
(AMbII). We then measured the activity of these
mutants in various assays of Myc function, including
the ability to induce S phase in quiescent fibroblasts,
transcriptional regulation, and cellular transformation.
We found that deletion of MbIII did not affect the abil-
ity of Myc to induce S-phase entry, demonstrating that
the AMbIII protein was correctly folded and localized.
Interestingly, however, we did find that deletion of
MbIII severely attenuated the ability of Myc to trans-
form Ratla fibroblasts (Fig. 2A). Moreover, analysis
of the transcriptional capabilities of the AMbIII
mutant revealed that transcriptional activation by Myc
was reduced, but not eliminated, by deletion of MbIII,
whereas transcriptional repression of the gadd45,
Gas] , and p15 genes was completely blocked (Fig.
2B). Thus, MbIII has an important role in cellular
transformation by Myc, presumably through its contri-
bution to Myc's transcriptional activities. The charac-
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FIGURE 2 Mblll is important for cellular transformation and transcriptional regulation by Myc. Mblll is important for transforma-
tion of Rat1a cells to anchorage-independent cell growth. Rat1a cells, expressing the indicated ER-Myc fusion proteins, were treat-
ed with 4-hydroxytamoxifen and assayed for colony formation in soft agar. (8) Mblll is important for activation of transcription by Myc.
Quiescent Rat1 cells, expressing the indicated ER-Myc fusion proteins, were treated with 4-hydroxytamoxifen and RNA-collected,
and transcript levels from Myc target genes were determined by Q-PCR. (C) Mblll is essential for repression of transcription by Myc.
The experiment was performed as in 8, except Myc-repressed genes were analyzed.
terization of MbIII is exciting because it reveals a pre-
viously unknown aspect of Myc function and because
it provides us with a new opportunity to delve deeper
into the biology of the Myc protein.
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STRUCTURAL BIOLOGY
R.-M. Xu Y. Huang J. Min
H.-C. Hsu Z. Li
H. Shi
We continue to focus on structural studies of proteins
involved in mRNA processing and proteins that are
important for higher-order chromatin structure.
During 2002, we determined the three-dimensional
structures of (1) the Drosophila Mago nashi-Y14
complex, two proteins that are part of the exon-exon
junction complex (EJC) produced by pre-mRNA
splicing; (2) human UAP56, a DECD RNA heli-
case/ATPase, which is a splicing factor and an EJC
component; (3) the catalytic domain of histone lysine
methyltransferase C1r4, which is a Su(var)39-like SET
domain protein that methylates Lys-9 of histone H3;
and (4) the catalytic domain of human Dotl, hDOT1L,
which is an evolutionarily conserved non-SET domain
histone lysine methyltransferase methylating Lys-79
of histone H3 located in the globular domain of the
nucleosome core particle. These projects are described
in more detail below.
PRE-mRNA SPLICING
Splicing of pre-mRNA is essential for generating
mature mRNA and is also important for subsequent
mRNA export and quality control. The splicing histo-
ry is imprinted on spliced mRNA through the deposi-
tion of a splicing-dependent multiprotein complex, the
exon junction complex (EJC), at approximately 20
nucleotides upstream of exon-exon junctions. The EJC
is a dynamic structure containing proteins functioning
in the nuclear export and nonsense-mediated decay of
spliced mRNAs. To date, at least eight EJC proteins
have been identified, including Y14, Mago, DEK,
RNPS1, SRm160, Upf3, UAP56, and REF/Aly. These
proteins have distinct and sometimes multiple func-
tions in various aspects of mRNA metabolism such as
splicing, nuclear export, and mRNA quality control.
Mago nashi (Mago) and Y14 are core components
of the EJC and they form a stable heterodimer that
strongly associates with spliced mRNA. We have
solved a 1.85-A resolution structure of the Drosophila
Mago-Y14 complex. Surprisingly, the structure shows
that the canonical RNA-binding surface of the Y14
RNA recognition motif (RRM) is involved in exten-
sive protein-protein interactions with Mago. The
structure also reveals that Mago has a protein fold
related to the structure of the peptide-binding domain
of the class I major histocompatibility complex
(MHC) protein. These findings provide important
insights into the molecular mechanisms of RNA bind-
ing and protein-protein interactions of the evolutionar-
ily conserved EJC components.
We have also determined the crystal structure of
another EJC protein, UAP56, which is also a splicing
factor containing a DECD ATPase/helicase sequence
motif. We are currently pursuing in-depth character-
izations of UAP56 based on the structural informa-
tion.
HISTONE METHYLTRANSFERASES
Posttranslational modifications of core histones have
important roles in the establishment and maintenance
of higher-order chromatin structures. The unstructured
tails of core histones are subjected to various forms of
covalent modifications. Histone methylation has
emerged as a major form of histone modification in
recent years. In particular, a large family of SET
domain-containing hi stone methyltransferase s
(HMTases) has been identified. SET domain proteins
methylate various amino-terminal lysine residues of
histones H3 and H4, and these modifications have
been associated with diverse biological processes
ranging from transcriptional regulation to the faithful
transmission of chromosomes during cell division.
C1r4, A SET Domain Histone Lysine Methyl-
transferase. The SET domain-containing C1r4 protein,
a close relative of Su(var)3-9 proteins in higher
eukaryotes, specifically methylates Lys-9 of histone
113 and is essential for silencing in Schizosaccha-
romyces pombe. In collaboration with Shiv Grewal
here at CSHL and Xiaodong Cheng at Emory
University, we have solved a 2.3-A resolution struc-
ture of the catalytic domain of C1r4 (Fig. 1). The struc-
ture reveals a distinct overall fold rich in 13-strands, an
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FIGURE 1 Crystal structure of the catalytic domain of C1r4.
active site consisting of an S-adenosyl-L-methionine
(SAM)-binding pocket, and a connected groove that
can accommodate the binding of the histone H3 tail.
The pre-SET motif contains a triangular zinc cluster
coordinated by nine cysteines distant from the active
site, while the post-SET region is largely flexible but
proximal to the active site. The structure provides
important insights into the architecture of SET
domain histone methyltransferases and establishes a
paradigm for further characterization of the Clr4 fam-
ily of epigenetic regulators.
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Human DOTIL, a Non-SET Domain Nuc leo-
somal Histone Lysine Methyltransferase. A recent
addition to the histone modification repertoire is his-
tone H3 Lys-79 methylation. In contrast to all other
known methylation sites, Lys-79 occupies a position in
the ordered core domain of histone H3 and resides in
a short turn connecting the first and second helices of
the conserved histone fold. Dotl is an evolutionarily
conserved protein that was originally identified in
Saccharomyces cerevisiae as a disruptor of telomeric
silencing. It also functions at the pachytene checkpoint
during the meiotic cell cycle. Dotl proteins do not
contain a SET domain, but they possess certain char-
acteristic SAM-binding motifs found in classical
SAM-dependent methyltransferases. Surprisingly,
yeast Dotl and its human counterpart hDOT1L exhib-
it intrinsic HMTase activity toward Lys-79 of histone
H3. This unexpected finding identifies the Dotl fami-
ly of proteins as the first non-SET domain containing
histone lysine methyltransferases.
In collaboration with Yi Zhang at the University of
North Carolina, Chapel Hill, we have solved a 2.5-A
resolution structure of the catalytic domain of
hDOT1L complexed with SAM (Fig. 2). The structure
reveals a unique organization of a mainly a-helical
amino-terminal domain and a central open a/13 struc-
ture. It also reveals an active site consisting of a SAM-
binding pocket and a potential lysine-binding channel.
Structure-guided biochemical analyses show that a
flexible, positively charged region at the carboxyl ter-
minus of the catalytic domain is critical for nucleo-
some binding and enzymatic activity. The structural
basis for nucleosome specificity of hDOT1L is
FIGURE 2 Crystal structure of the catalytic domain of hDOT1 L.
revealed from molecular modeling of nucleosome-
hDOT1L interactions. These analyses provide mecha-
nistic insights into the catalytic mechanism and nucle-
osomal specificity of Dotl proteins.
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CANCER: GENETICS
Cancer is caused by gene mutations. Mutations come in many forms: a change in the DNA sequence
of a gene, the movement of a chromosome segment to an abnormal location, the complete or partial
removal of a gene (deletion), or the addition of more than one copy of a gene (amplification). Michael
Wig ler and Rob Lucito have developed a method for scanning the entire human genome to detect
deletions and amplifications. By pinpointing areas where amplifications or deletions have occurred in
DNA isolated from tumor biopsies, the researchers can identify genes implicated in cancer. Work by
Masaaki Hamaguchi, Wig ler, and Lucito has identified several such genes in breast and ovarian can-
cer. These genes are prime targets for the development of new cancer therapies.
Greg Hannon and his colleagues have pioneered the study of a fascinating process called RNA
interference (RNAi) as well as the application of RNAi to cancer research. RNAi leads to the silencing
of gene expression, in part through the binding of small RNA molecules corresponding to particular
messenger RNAs and the subsequent enzymatic destruction of the messenger RNAs (which blocks
protein production). Hannon and his colleagues have discovered several of the molecules and mech-
anisms that carry out RNAi. Recently, they showed that they can use RNAi to permanently silence the
expression of virtually any gene in cultured cells, in living animals, or in organs reconstituted from stem
cells (the latter in collaboration with Michael Hemann of Scott Lowe's group). These findings have
opened the door for them to use RNAi to discover new targets for cancer therapy, or to use RNAi itself
as a therapy.
Approximately 1-2% of newborns have symptoms of sporadic genetic disease, or genetic disease
that neither parent suffered from but rather arises de novo as a result of a genetic change in a parent's
sperm or egg cell DNA. Eli Hatchwell's lab is developing methods for detecting subtle changes in DNA
that cause such sporadic human genetic disease. In one study, the researchers have managed to
detect a tiny deletion in human chromosome 8, which they suspect is associated with Kabuki syn-
drome (characterized by learning defects, short stature, and very high rates of congenital heart dis-
ease). The methods developed by Hatchwell's group should be useful for many applications, including
cancer research.
Yuri Lazebnik is exploring ways to use the programmed cell death machinery to improve the effi-
ciency and selectivity with which cancer treatments kill tumor cells. Paradoxically, although the hallmark
of oncogenes is that they are associated with causing cancer, oncogenes also sensitize cancer cells
to the lethal effects of chemotherapy drugs by inducing programmed cell death. This observation
means that oncogenes might provide a way to induce the programmed cell death machinery specifi-
cally in cancer cells. During the last year, Lazebnik's group has shown that chemotherapy activates an
enzyme called caspase-2, which in turn activates other caspases, leading to cell death. These findings
reveal crucial information about how programmed cell death works, how it is influenced by oncogenes,
and how it might be used against cancer.
Alea Mills has developed a "chromosome engineering" system for creating mouse models of human
disease. This approach allows her lab to generate mice with precise chromosome rearrangements that
mimic alterations found in human diseases such as cancer. The Mills lab is also studying the role of a
particular gene called p63 in stem cell maintenance, cancer, and aging.
Through a process called angiogenesis, the Idl and Id3 genes are involved in forming blood ves-
sels that supply growing tumors with the nutrients they need. Therefore, Id genes and their targets are
attractive candidates for anti-angiogenic cancer therapies designed to kill tumors by cutting off their
blood supply. Vivek Mittal's lab is using DNA microarray technology, RNA interference, and mouse
tumor models to identify Id targets. They recently identified four such targets and have validated them
as candidates for anti-angiogenic cancer therapies. Mittal's group has also created a method for rapid-
ly identifying the pieces of double-stranded RNA that are most effective at silencing any particular gene
through RNA interference.
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TUMOR SUPPRESSOR GENES INVOLVED IN BREAST
CANCER DEVELOPMENT
M. Hamaguchi M. Kanis R. von Roeschlaub
N. Kobayashi R. Shudo
J. Meth C. von Klitzing
D. Roberts
Our lab is interested in the discovery and characteriza-
tion of cancer-related genes, especially tumor suppres-
sor genes that are ablated in cancer cells. The recent
history of tumor suppressor gene investigation has been
revolutionary. The identification of these genes and
subsequent studies into their biological functions have
provided vast new insights into the development of can-
cer. A great deal is now known about the relationship
between cancer development and cellular functions.
In the case of breast cancer, the isolation of tumor
suppressor genes BRCA1 and BRCA2 has had an
impact on several aspects of cancer treatments as well
as cancer research. BRCA1 and BRCA2 genes can be
utilized for identification of individuals at high risk of
developing breast cancers, which has been crucial in
the development of risk assessment. There are also dif-
ferences in clinical outcomes between breast cancers
with BRCA I mutations and those with BRCA2 muta-
tions. These findings suggest that specific types of
breast cancers require specific screening methods and
therapeutic approaches. However, tumor suppressor
genes responsible for sporadic breast cancer remain to
be discovered.
We have isolated a previously uncharacterized
gene, DBC2 (deleted in breast cancer 2) that is likely
to be a tumor suppressor gene for sporadic breast can-
cer. It is homozygously deleted in 3.5% (7/200) of
breast tumor samples and silenced in 55% (12/22) of
breast cancer cell lines. Activation of DBC2 in a breast
cancer cell line resulted in growth arrest of the cells,
whereas naturally occurring DBC2 mutants did not
suppress tumor growth.
Functional Analysis of DBC2
M. Hamaguchi, J. Meth, D. Roberts, C. von Klitzing
[in collaboration with M. Wigler, Cold Spring Harbor
Laboratory, and S. Powers, Tularik Inc.]
Knowledge about this new tumor suppressor DBC2
will definitely facilitate clarifying the mechanisms of
breast cancer development. To study DBC2 functions,
we utilized an inducible gene expression system that
enables us to switch on/off a gene of interest as we
like. This system utilizes an insect hormone,
ecdysone, or its homolog, Muristerone A. Since these
chemicals do not normally exist in mammalian cells,
they will not affect most mammalian cells by them-
selves. To examine the function of interesting genes,
they are cloned into a specially designed vector con-
taining ecdysone-responsive elements so that the
genes will be activated only when the hormone is
administered. Wild-type (without mutations) and
mutated DBC2 genes were independently induced in
breast cancer cells and the consequences were moni-
tored. When wild-type DBC2 is induced, the breast
cancer cells stopped growing, indicating that DBC2
can suppress the growth of tumor cells. In contrast,
induction of mutated DBC2 did not hinder the growth
of tumor cells (Fig. 1). Since the mutants discovered in
clinical specimens (naturally occurring) were used in
this study, it is likely that breast cancer cells exploit
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FIGURE 1 Growth curve of tumor cells. Growth curves of a
breast cancer cell line, T-47D, were drawn after induction of
various genes. The ordinate is the percent increase of cell
count. The abscissa is hours after induction. After induction of
empty vector (x) and a DBC2 mutant (squares), the tumor cells
kept growing. In contrast, the tumor cells stopped growing after
induction of wild-type DBC2 (circles).
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inactivation of DBC2. These findings warrant impor-
tant research projects to answer intriguing questions.
Which types of breast cancers are sensitive to DBC2
tumor suppressor function? Besides breast cancer,
which cancer takes advantage of DBC2 inactivation?
How does DBC2 suppress the growth of tumor cells?
We are continuing our effort to answer these ques-
tions.
One of our approaches is a microarray analysis.
The microarray we utilize is a microscope slide carry-
ing 46,000 spots in 1-inch by 2-inch area. Each spot
contains a DNA probe representing a gene. When a
color-labeled sample is incubated with the microarray,
DNA fragments in the sample seek matching
sequences with the probe. As a result, the color inten-
sity of a probe corresponds to the amount of the
matching sequences in the sample. When cDNA from
a specimen is used, the color intensity indicates the
expression level of the gene represented by the probe.
This is particularly useful when we want to isolate
genes that are expressed differently in the two speci-
mens. If samples from two specimens are labeled with
different colors and analyzed by the microarray, the
intensity ratio of most genes will be close to one.
However, there will be genes with high- or low-inten-
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sity ratios since gene expression patterns are different
among cells. Using this system, we analyzed breast
cancer cells with and without DBC2 induction. After
induction of wild-type DBC2, approximately 100
genes demonstrated increased expression by more
than threefold (Fig. 2). We are currently studying how
DBC2 regulates the expression of these genes (direct-
ly or indirectly) and what roles DBC2 plays in the bio-
logical pathways involving these genes.
Expression of DBC2
M. Hamaguchi, J. Meth [in collaboration with
D. Broek, University of Southern California]
Tumor suppressor genes are inactivated by transcrip-
tional suppression in some cases. In fact, DBC2
expression is extinguished in approximately half of
breast and lung tumors, whereas its expression is
detected in other types of cancers. Modification of the
promoter region has been shown to cause transcrip-
tional inactivation. The most common mechanism for
such modification is methylation. Therefore, a number
of cancer cell lines derived from breast, lung, and
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FIGURE 2 Comparison of expression patterns of the cells with and without DBC2
induction. The ordinate is 'log ratio of signal intensity," which represents changes of
gene expression level. The base of log is two (e.g., value two indicates a fourfold
increase and three indicates an eightfold increase). The abscissa is "log of mean inten-
sity," which represents the abundance of the gene in the cell. For example, highly
expressed genes are displayed at the right side of the chart. Solid circles represent
genes whose expression is increased greatly (more than threefold) by DBC2 induction.
other cancers were screened for methylation status of
the DBC2 promoter. In several breast and lung cancer
cell lines that do not express DBC2, the promoter
region was found to be hypermethylated. Transcrip-
tional inactivation by hypermethylation can be
reversed in many cases when methylation is chemical-
ly blocked. A commonly used chemical for this pur-
pose is 5-aza-2'-deoxycytidine (5-Aza-C). We cul-
tured these cells with 5-Aza-C and demonstrated that
DBC2 expression was restored. Our findings suggest
that methylation of the DBC2 promoter is the main
mechanisms for silencing.
Structure of DBC2
M. Hamaguchi, N. Kobayashi, D. Roberts, R. Shudo,
[in collaboration with L. Van Aelst, Cold Spring Harbor
Laboratory]
Computational analysis revealed that DBC2 encodes a
protein with significant RAS homology and contains
known protein-protein interaction domains (BTB).
Presence of RAS domain implies DBC2's role in sig-
nal transduction. However, its novel combination of
structural domains, its lack of a membrane anchor
sequence at the carboxyl terminus, and its divergence
from the RAS proteins with known functions suggest
that its function may be distinct from other members
of the RAS superfamily.
Since DBC2 is likely to interact with other pro-
teins through the BTB domains, it is critical to isolate
these proteins. We utilized a yeast two-hybrid system
that allows identification of interacting proteins in
yeast cells. In this system, a collection of yeast cells
containing exogenous proteins are prepared. After
transfection of DBC2 into the yeast cells, they are cul-
tured under special environments where interaction of
an exogenous protein with DBC2 is essential for yeast
survival. Millions of yeast cells containing different
proteins were examined. Several proteins were found
to interact with DBC2 in yeast cells. These candidates
are currently being verified for interaction in mam-
malian cells.
Generation of DBC2
Knockout Mice
M. Hamaguchi, M. Kanis, J. Meth, R. von Roeschlaub
[in collaboration with the Genomic Targeting and
Transgenomic Mouse Shared Resouce, and M. Zhang,
Cold Spring Harbor Laboratory]
Analysis of a mouse model has advantages. First,
more information has been accumulated from mouse
genetics than any other vertebrate. Second, gene func-
tions can be studied in vivo. Analysis of tumor sup-
pressor genes has often been facilitated by studies of
tumor-suppressor-deficient mice.
We genetically engineered mouse embryonic stem
(ES) cells so that they had a disrupted DBC2 allele.
These ES cells were used to produce chimeric mice
that are partially originated from the ES cells. The
chimeric mice were examined, and successful intro-
duction of the engineered DBC2 allele was confirmed.
We will continue our efforts to establish a DBC2-defi-
cient mouse model from offspring of these mice hop-
ing that it will facilitate understanding the roles of
DBC2 in cancer development.
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RNA INTERFERENCE: MECHANISMS AND APPLICATIONS
G. Hannon S. Aruleba
E. Bernstein
M. Carmell
A. Gaudy
D. Conklin G. Katari K. Scobie
A. Den li J.D. Liu Y.R. Seger
J. Du H. Mizuno J.M. Silva
I. Hotta P.J. Paddison I. Sujka
The interests of my laboratory remain twofold. First,
we are striving to understand the biochemical mecha-
nism and biological function of a sequence-specific
silencing phenomenon, known as RNA interference
(RNAi). Second, we are exploiting RNAi as an exper-
imental tool in a large-scale effort to understand gene
function.
During the last two years, we have made signifi-
cant progress toward understanding how double-
stranded RNA (dsRNA) can trigger the silencing of
homologous genes at the posttranscriptional level. In
the past year, we have extended our understanding by
the identification of new subunits of the complex,
including a Drosophila homolog of a human disease
gene. As we gain a deeper understanding of the play-
ers in this silencing process, we gain opportunities to
use genetics to address the biological functions of
RNAi. Toward this end, we have begun the process of
creating mutant mice lacking known RNAi genes. The
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first of these to be completed is the Dicer mutant
mouse, which is beginning to reveal key roles for the
RNAi machinery in regulating mammalian develop-
ment. Finally, we have continued our efforts to deter-
mine how dsRNA can induce gene silencing in so
many different ways, ranging from mRNA degrada-
tion to translational suppression to chromatin remod-
eling. Efforts to address the particular aspects of this
process are moving forward on several fronts.
The past year has also seen a revolution in the
application of RNAi to mammalian systems. With our
development of approaches that permit stable silenc-
ing of genes by RNAi in mammalian cells, we have
begun to move toward the creation of a genome-wide
library of RNAi-inducing vectors. Initially, we will use
this in a search for novel anticancer targets through
genetic screens. However, this project will also create
a vast public resource that can be applied to an enor-
mous variety of biological questions. As genetic
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FIGURE 1 The mechanistic model for RNAi that we have developed over the past few years.
approaches in cell culture begin to yield substantive
information, it is critical to be able to extend our
analyses into animal systems. During the past year, we
have collaborated with a number of different investi-
gators, including Mark Kay at Stanford, Tom
Rosenquist at SUNY Stony Brook, and Scott Lowe,
here at CSHL, to probe the ability of RNAi to manip-
ulate gene function in vivo. These studies have
demonstrated not only that RNAi can be used to
silence gene expression in mice, but also that this
silencing can be used to create biological phenotypes
that permit a more detailed study of tumorigenesis.
When coupled with our continuing studies of the
transformation of human cells in vitro and of key ele-
ments of cell cycle control, we hope to exploit the
interdisciplinary nature of the programs in our lab to
identify new approaches to cancer therapy.
This year, we were joined by Ikuko Hotta as a
graduate student from the MCB program at SUNY
Stony Brook and by Kim Scobie and Hana Mizuno,
who began her CSHL career as a high school student
in Yuri Lazebnik's lab. Ji Dong Liu arrived as a post-
doctoral fellow from Yue Xiong's lab (University of
North Carolina, Chapel Hill). We were also visited by
Sarah Whitcombe as part of our undergraduate
research program and a student from Columbia
University. Scott Hammond became the first person
to depart from the lab for a faculty position at the
University of North Carolina, Chapel Hill. Patrick
Paddison and Michelle Carmell both received predoc-
toral fellowships from the U.S. Army Breast Cancer
Research Program, joining Yvette Seger, our previous
recipient of this fellowship, and Jian Du received a
postdoctoral fellowship from this same program. Amy
Caudy was honored by the receipt of the Harold
Weintraub Graduate Student Award in recognition of
her outstanding thesis work.
The Biochemical Mechanism
of RNA, Connections to
Human Disease
A. Gaudy
RNAi silences genes in response to a specific trigger.
Our work has shown that the triggering dsRNA initi-
ates formation of a nuclease complex that specifically
degrades homologous mRNAs in the cell. This year,
Scott Hammond and I discovered three additional
components of this nuclease complex: Tudor-SN,
Drosophila Fragile X mental retardation protein
(dFMR), and Vasa intronic gene (VIG). Tudor-SN is
the first component identified in the RNA-induced
silencing complex (RISC) that has a known nuclease
activity. Although Tudor-SN was discovered in flies,
our early data suggest it may have a similar role in
mammals.
Our discovery of the dFMR protein as a part of
RNAi complexes may open new paths to approach the
understanding of Fragile X, the most common inherit-
ed form of mental retardation. Our work shows that
the fly homolog of the human Fragile X mental retar-
dation protein is important for RNAi, which could
imply that some of the problems in Fragile X patients
could stem from defects in RNAi pathways.
The Biology of RNAi:
RNAi Is Essential for
Mammalian Development
E. Bernstein
A key player in the RNAi phenomenon, Dicer, is
responsible for the initial steps of this gene silencing
pathway by "dicing" dsRNA into short interfering
RNAs (siRNAs) that join the RISC complex to subse-
quently degrade their cognate mRNAs. This enzyme
exists in all organisms known to perform RNAi and is
quite unique in its structure. It contains a helicase
domain, a PAZ domain (also found in the Argonaute
homologs, which have been demonstrated to have var-
ious roles in RNAi), two RNase III catalytic domains,
a dsRNA-binding domain, as well as a domain of
unknown function (DUF283).
The Caenorhabditis elegans Dicer null worm was
shown to be RNAi-deficient, as well as having various
developmental phenotypes that correlated strongly with
those of a let7-1- worm. As it turns out, Dicer is respon-
sible for processing microRNAs (miRNAs), such as
let7, which are endogenously encoded RNA hairpins
that when processed bind the 3'-untranslated region
(3 'UTR) of target genes to inhibit translation. Thus,
Dicer was found to have roles both in the processing of
dsRNA, which results in mRNA degradation, and in the
processing of miRNAs to inhibit translation.
We therefore set out to create a Dicer null mouse in
order to investigate the function of this ribonuclease,
and of the RNAi machinery in general, in a mammalian
system. The null mouse is an embryonic-lethal, as
expected, dying at approximately day 7 during develop-
ment. The mutant embryo does not appear to have prop-
er polarity formation and does not undergo the gastru-
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lation process. Embryonic stem cell lines have been
produced and will be characterized for loss of RNAi
capabilities, the accumulation of miRNA sequences,
and the derepression of repetitive sequences such as
transposons and centromeres (the latter of which has
been demonstrated in Schizosaccharomyces pombe
Dicer knockout strains). This null mouse will allow us
to decipher not only the role Dicer has in RNAi, but
also its critical role in mammalian development.
RNAi and the Genome
A. Dent
The term RNAi refers to the sequence-specific gene
silencing induced by dsRNA. Although it was initially
discovered as a response to exogenous dsRNA, further
experiments suggested a role for RNAi in antiviral,
antitransposon defense and also endogenous gene reg-
ulation. One interesting aspect of endogenous gene
regulation is the formation of heterochromatin, a term
used for the compact chromatin structures in the cells.
Heterochromatin in the cells is found mainly in cen-
tromeres and telomeres, and methylation of histones at
lysine 9 is a hallmark for this chromatin structure.
Recent genetic experiments suggest a link between
centromere function and RNAi. On this end, I am try-
ing to reveal this link biochemically in the fission
yeast S. pombe and to identify protein complexes asso-
ciated with RNAi proteins in S. pombe. Since a good
system is established for heterochromatic silencing in
fission yeast, any new components that are identified
through biochemistry can be tested genetically and
functionally in this powerful model system. In the
future, the results from these studies can be helpful in
shedding light onto similar pathways in humans.
RNAi: The New Somatic Cell Genetics
P.J. Paddison, D. Conklin
Since the 1970s, the war on cancer has been based on
the notion that studying the disease will lead to the dis-
covery of vulnerabilities, which can be exploited in the
clinic. Although many underlying genetic determinants
of cancer have been identified, this knowledge has failed
to translate into new therapeutic strategies, with only a
handful of exceptions. This is largely due to the geneti-
cally intractable nature of cultured mammalian cells.
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In other model systems, the use of genetic screens to
explore functional dependencies has been an enabling
feature of countless discoveries. For example, analysis of
temperature-sensitive mutants in bacteriophage T4 led to
the discovery of viral morphogenesis modules (Edgar
and Wood, Proc. Natl. Acad. Sci. 55: 498 [1966]).
Similar approaches in yeast revealed functional hierar-
chies among genes regulating cell cycle progression
(Hartwell et al., Science 183: 46 [1974]; Hartwell and
Weinert, Science 246: 629 [1989]). The key to such dis-
coveries has been the ability to create recessive, geneti-
cally defined lesions in molecular pathways.
Since cancer arises from genetic lesions in somatic
cells, the concept of synthetic lethality has been herald-
ed as way to functionally define vulnerabilities in can-
cer cells (Hartwell et al., Science 278: 1064 [1997]).
Synthetic lethal interactions occur when mutations in
two or more nonallelic genes synergize to kill cells. For
example, a mutation in gene A or gene B may be toler-
ated when singly present in cells but, when combined,
result in a loss of viability. Thus, synthetic lethal inter-
actions reveal situations in which cellular homeostasis
is altered by a molecular lesion so that the action of
another gene or pathway is required to compensate. The
fact that cancer cells arise from genetic alterations
makes synthetic lethality ideally suited for identifying
cellular targets required by cancer cells for viability.
The emergence of RNAi as a technology to silence
gene expression in virtually every experimental
eukaryotic system, including mammals, holds promise
for identifying cancer lethal targets. My own work has
revolved around (1) demonstrating that dsRNA induces
sequence-specific gene silencing in mammalian cells
(Paddison et al. 2002a); (2) refining the method of
triggering RNAi so that it is useful in most cellular
contexts (Paddison et al. 2002b; Paddison and Harmon
2002); and (3) constructing genome-wide RNAi
libraries to make genetic screens feasible in mammals.
The Search for New Approaches
to Cancer Therapy Using Genetics
J.M. Silva
RNAi is probably the most powerful molecular tool for
gene function discovery in mammals. My research is
focused in the use of this phenomenon for large-scale
analysis of gene function. The approach is based on
the in vivo production of silencer hairpins encoded by
a transfected plasmid. Using this system, I will identi-
fy methods to modulate the growth of tumor cells.
The first step is the transient transfection of the
tumor cells lines with single hairpins. Tumor cells that
are affected by the action of a hairpin may go to apop-
tosis or be arrested in a cell cycle checkpoint. To detect
the first possibility, cells transfected with individual
hairpins from the library are cultured during several
doubling cycles, and the activation of caspase-3 (apop-
tosis-specific pathway) is measured. The induction of
apoptosis is quantified by a time-resolved fluorescence
caspase-3 detection assay.
I have set up the conditions for this assay and the
first hairpins are currently being tested. This approach
has been validated with 200 genes that are involved in
pro-apoptotic or anti-apoptotic affects, and, as expect-
ed, several caspases have revealed apoptotic protective
effects.
In addition, I am also developing an assay to
detect growth arrest in tumor cells. The assay is based
on the facts that in our assay, whole-cell populations
cannot be analyzed by traditional cell-cycle-phase
detection methods, because the variability of transfec-
tion efficiency may produce a high background. To
solve this problem, I am cotransfecting with the short
hairpin RNA (shRNA)-interfering vector, a gene that
produces a tagged protein that will be specifically
phosphorylated in G2/M phase (histone H3 and
Nucleolin). The capture of this protein with tag-spe-
cific antibodies and the detection with phosphospecif-
ic antibodies will show the cell cycle status of the
hpRNA-transfected cells.
Comparison of these data with control hairpin
assays will identify genes that arrest tumor cells in
G2/M. To detect other types of arrest, cells are treated
with nocodazole for 24 hours, and phosphorylated
forms are detected as described previously. In this
assay, cells arrested in G, or S cell cycle phases will be
detected as absence of G2/M phosphorylated forms
after nocodazole treatment. Several genes involved in
dNTP synthesis and in histone acetylation/deacetyla-
tion are currently being tested for their ability to mimic
the S and G, phase arrest produced by HU and TCA.
Heritable RNAi in Mice:
The Road toward the Creation
of Mouse Models
M. Carmel)
After the demonstration that RNAi in mammalian
cells can be mediated by vectors encoding shRNAs,
we sought to develop a system by which to create
transgenic mice using this technology. We demon-
strate that a stable, heritable RNAi trigger in the form
of a short hairpin was successfully passed through the
mouse germ line. These observations open the way to
the use of RNAi as a complement to standard knock-
out methodologies and provide a means to rapidly
assess the consequences of suppressing a gene of
interest in a living animal.
In addition to exploring RNAi as a tool for creation
of mouse models, conventional mouse knockouts of the
Argonaute gene family are under way. Argonaute fami-
ly members have been shown to be essential for
RNAi/PTGS (posttranslational gene silencing) in sever-
al organisms, including Neurospora (QDE-2), Arabi-
dopsis (AGO1), and C. elegans (rde-1). Evidence is also
mounting demonstrating a role for Argonaute genes in
silencing at the level of chromatin. Interestingly,
Argonaute proteins have been implicated in control of
development in several organisms, and at least a subset
have particular roles in stem cell maintenance.
Human Cell Transformation:
What Does It Have to Do
with RNAi?
Y.R. Seger
One of the long-standing interests of our lab is the
study of proliferation control in mammalian cells and
the development of molecular tools to determine how
these intricate cell cycle control mechanisms go awry
in cancer progression. Many cancer studies use actual
tumor samples as the starting material, but we have
taken the reverse approach, starting with genetically
normal human cells and using retroviral gene trans-
duction to manipulate these cells into cancer cells.
This method allows us to determine the minimum
pathways that must be disrupted in order to convert a
normal cell into a cancer cell. Utilizing this approach,
we have shown that primary human fibroblasts are
readily transformed by the coexpression of adenoviral
E1A, MDM2, and constitutively activated Ras (Ha-
RasV12) (ERM).
Although E1A is typically not expressed in human
tumors, it is an extremely well-characterized oncopro-
tein and can thereby be used as a genetic tool to deter-
mine a combination of cellular oncogenes capable of
transforming human cells. Coexpression of El A func-
tional mutants with MDM2 and Ha-RasV12 has indi-
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cated that the interactions between E1A and Rb, p300,
and p400/TRRAP are essential for transformation. We
are currently testing the ability of several cellular
oncogenes to rescue the transformation defects of
these E1A-binding mutants. For example, E 1A426-
35, which is defective for p400/TRRAP binding,
should be able to be rescued by c-Myc, a protein that
also interacts with p400/TRRAP.
This well-defined transformation model can also
serve as a useful tool for testing the range of RNAi in
cancer biology and therapeutics. Since we know pre-
cisely what genetic alterations resulted in transforma-
tion, we can use shRNAs to target and silence path-
ways that could make these cells initiate apoptotic or
senescence programs, or increase their sensitivity to
chemotherapeutic drugs.
Alterations in the Regulation
of Centrosome Duplication
Produce Aneuploidy
J. Du
The centrosome is the critical cell apparatus that deter-
mines the correct partition of the genome during mito-
sis. The eukaryotic centrosome, the cell's microtubule
organizing center and the counterpart of yeast spindle
pole body, is composed of two perpendicularly posi-
tioned centrioles and surrounding amorphous pericen-
triolar materials. It normally replicates once and only
once per cell cycle. The centrosome participates in
most mitotic events such as determining spindle bipo-
larity, assembling spindle microtubules, regulating
actin cytoskeleton dynamics, and determining the
plane for cytokinesis.
Among the proteins associated with centrosome,
protein kinases and phosphatases have important roles
in the centrosome replication cycle, including centri-
ole duplication, maturation, and separation. There are
four groups of protein kinases found to associate and
regulate these processes: cyclin-dependent kinases,
Polo-like kinases, NIMA kinases, and Aurora kinases.
Among these centrosomal kinases, only Aurora-A
has been identified as an oncogene candidate. Aurora-
A is overexpressed at both the mRNA and protein lev-
els in a number of cancer cell lines, as well as in breast
bladder cancer tissues. Increasing data show that
Aurora-A protein level correlates with the progress
and malignance of cancers and is suggested to be used
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as a diagnostic parameter. Overexpression of STK15
in 3T3 and Ratl cells causes cellular transformation
and growth in soft agar. The injection of the cells from
the soft agar colonies induces cancer in nude mice.
The overexpression of the protein in human near-
diploid MCF79 cells causes centrosome amplification
and aneuploidy/genomic instability, a plausible con-
tributor to cancer progression.
Another centrosome-associated protein, p16OROCK,
is a member of the ROCK family of Rho-associated ser-
ine-threonine protein kinases. ROCK kinases are
involved in various cellular functions downstream from
Rho, such as smooth muscle contraction, stress fiber
formation, and cytokinesis. p16OROCK can be phos-
phorylated by Rho and then further phosphorylates
LIM kinase and mDia. ROCK inactivates myosin phos-
phatase and cofilin to inhibit actin depolymerization to
stabilize actin cytoskeleton.
In 2002, we continued our studies on the mecha-
nisms by which STK15 may contribute to tumorigen-
esis. We showed that p 1 60ROCK associates with
STK15 in a protein complex (STK15-associated-fac-
tors, SAF) both by immunoprecipitation and by FPLC
purification. Kinase analysis revealed that p16OROCK
is a substrate of STK15 kinase in vivo. Half of the total
endogenous p 1 60ROCK associates with STK15, and
STK15 is a major kinase responsible for p16OROCK
phosphorylation in vivo. Suppression of p 1 60ROCK
by RNAi induces genomic instability, as evidenced by
the accumulation of polyploid cells and super mitotic
spindle reassembly capacity in human HeLa cells.
Knock out of STK15 by siRNA induces G2/M delay
and tetraploidy, as well as apoptosis in HeLa cells.
However, further deletion of p16OROCK by siROCK
together with siSTK15 can release the GIM cell cycle
delay and alleviate the apoptosis defect, thus leading
to more stable accumulation of aneuploidy. Thus, bio-
chemical and genetic evidence indicates that
p 1 60ROCK is a substrate of STK15 kinase, and the
two proteins interact genetically to induce the aneu-
ploidy phenotype.
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SPORADIC HUMAN GENETIC DISEASE
E. Hatchwell S. Kentaro' J. Widawsky
T. Lee C. Lindsay
Recent progress in the field of human genetics has
largely been limited to Mendelian (familial) disorders
because a powerful algorithm exists for tracking genes
in families (linkage analysis). No such general approach
exists for disorders that are primarily sporadic.
Mounting evidence, however, suggests that one fruitful
approach in this group of disorders is analysis of
genomic copy number, as many sporadic syndromes
which have been solved (almost always as a result of
serendipitous discoveries) are associated with copy
number abnormalities.
Microarrays have become ubiquitous in biological
research. However, most applications have been in the
field of gene expression analysis, and relatively few
have focused on direct analysis of the genome.
Analysis of gene expression in sporadic disorders is
unlikely to be useful for two main reasons: (1) It is
often difficult to define the primary tissue that is
affected, as most of these conditions are multi-system,
and (2) in cases where the relevant tissue is known
(e.g., the central nervous system), access is usually
impossible.
A number of different approaches to genome copy
number analysis currently exist:
Large clone arrays, based on bacterial artificial
chromosomes (BACs) from the library used to
sequence the human genome. Total human genomic
DNA is analyzed directly. BAC arrays are our cur-
rently favored method (see below).
The use of total genomic DNA on cDNA arrays.
This approach is difficult to implement in practice,
largely because the complexity of the human
genome results in poor signal:noise ratios at indi-
vidual elements of the array, although copy number
changes can be detected when local averages are
calculated for genes that map to the same chromo-
somal region.
The use of reduced-complexity representations of the
human genome (usually generated by amplification
using polymerase chain reaction [PCR]) onto
microarrays whose elements are designed to "match"
sequences in the representation (oligonucleotides or
PCR products may be arrayed). This approach suf-
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fers from two related drawbacks: (1) The unprovable
assumption that all sequences within the representa-
tion will have been amplified equally and be present
at the same relative copy number as in the starting
genome. (2) The analysis is of a representation of
the genome, not the genome itself.
We are studying individuals with a range of disor-
ders:
Congenital heart disease (CHD). We are collaborat-
ing with pediatric cardiologists in both the United
States and the United Kingdom to search for copy
number variations in children with CHD, who are
22q11 normal (22q11 deletions are the most com-
mon cause currently known of CHD).
Complex phenotypes, mostly involving mental
retardation in association with widespread physical
anomalies, in individuals with normal karyotypes.
Individuals with sporadic phenotypes in association
with de novo balanced translocations.
Autistic spectrum disorder.
We are also interested in studying a cohort of nor-
mal individuals, in order to assess the frequency of
some of the deletions/duplications that we have already
detected in those individuals we have been using as
"normal" controls when analyzing patients. We esti-
mate that, on average, each individual will have
approximately half a dozen cryptic genomic rearrange-
ments, and it is vital to characterize these changes in
the normal population, in order that the significance of
rearrangements detected in patients can be interpreted
intelligently.
Finally, we are cognizant of the fact that genomic
microarray copy number analysis is relatively novel
and that, in the short term at least, it will be necessary
to use complementary methods to confirm suspected
deletions/duplications, both in normals and in patients.
Traditional approaches to confirming copy number
changes include:
Fluorescence in situ hybridization (FISH) analysis.
This is the approach of choice, as chromosomal
homologs are visualized separately and loss/gain
can be demonstrated directly. However, live cells
are required, and these are not always available,
particularly when studying archival DNA.
Quantitative PCR. Detection of 2:1 changes is dif-
ficult using Q-PCR, which is mostly used for
detection of higher-fold changes.
Microsatellite analysis for deletions. This approach
may demonstrate stretches of homozygosity (com-
patible with but not proof of hemizygosity) or fail-
ure of inheritance, where parental samples are
available and the rearrangement is de novo. For
duplications, this method may be diagnostic where
three distinct alleles are demonstrable, but this con-
venient situation will not always be present.
Dosage analysis by Southern blotting, which is
labor-intensive and requires relatively large
amounts of genomic DNA.
Specific amplification of junction fragments. This
is an ideal method but requires the rearrangement
endpoints to be cloned and is not a short-term solu-
tion.
We are developing a PCR-based method that will
allow robust and rapid initial analysis of putative dele-
tions/duplications in tiny DNA samples.
JOUBERT SYNDROME IN A PATIENT
WITH A DE-NOVO-BALANCED
TRANSLOCATION
We have studied, using conventional and array-based
methods, an individual with Joubert syndrome associ-
ated with a de-novo (apparently)-balanced transloca-
tion [46,XY,t(2;22)(q13;q 11 .1)]. Joubert syndrome is a
rare disorder that results in partial agenesis of the cere-
bellar vermis, mental retardation, and episodic hyper-
pnea. It is thought to be autosomal-recessive, but thus
far, no genes have been cloned for this disorder. It is
known to be genetically heterogeneous, with one locus
mapped to 9q34 in a consanguineous Arabian-Iranian
family; this locus has been excluded in other families.
We have mapped the 2q13 breakpoint in our patient
to a 324-bp LINE (long interspersed nuclear element)
fragment, using a combination of microarray analysis
and STS-PCR of flow-sorted material (see Fig. 1). This
breakpoint interrupts a predicted gene, and we have
recently demonstrated that this gene is real and
expressed both in fetal brain and (at lower levels) in
adult brain, consistent with a likely developmental role.
We are currently searching for point mutations in
Joubert patients who show no evidence of linkage to
9q34 and who do not harbor obvious 2q13 rearrange-
ments.
A COMMON MICRODELETION POLYMORPHISM
AT 8q24.3
We initially discovered a heterozygous microdeletion
at 8q24.3 when investigating a patient with Kabuki
syndrome, a rare sporadic disorder manifest by short
stature, mental retardation, and characteristic facies.
This was detected in a genome-wide analysis using
BAC arrays and was subsequently confirmed by FISH
analysis of our index patient. Further analysis of a
cohort of Kabuki patients revealed the presence of the
same deletion in a further one individual (a total of
2/40 analyzed), but in each case, the deletion was also
present in a normal parent (a mother in the first case
and a father in the second case). After characterization
of the microdeletion in our index case, we cloned the
breakpoint and designed a PCR-based assay that
rapidly reports the genotype of any individual with
respect to this microdeletion. The microdeletion has
been found to be present in approximately 5% of the
normal population, although higher rates have been
seen in some groups, including Iraqi Jews (-10%).
The significance, if any, of this microdeletion poly-
morphism is unknown. However, the importance of
this discovery is twofold:
1. To the best of our knowledge, it is the first
microdeletion polymorphism described, and serves
to highlight the potential variation that is present in
normal genomes.
2. As with other rearrangement polymorphisms that
will be discovered, it is critical to evaluate the fre-
quency of this rearrangement in that population, so
that potentially disease-specific lesions can be
assessed intelligently.
GENOME-WIDE BAC ARRAYS
We have successfully generated, at relatively low cost,
two BAC arrays, each based on a distinct subset of the
RPCI-11 BAC library. One subset was defined by the
Cheung laboratory (http://genomics.med.upenn.edu/
genmapdb/) by genome-wide STS screening, and it
consists of 4200 BACs. The other was defined by the
Cancer Chromosome Aberration Project (CCAP; http://
cgap.nci.nih.gov/Chromosomes/CCAP_BAC_Clones),
and it consists of 1300 FISH-mapped BACs that were
selected on the basis that they had been completely
sequenced or else anchored to the consensus genome
by virtue of end sequences. We generate our BAC
arrays as follows:
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FIGURE 1 (Top) The result of array hybridization using differentially labeled material from two flow-sort-
ed derivative chromosomes. The experiment was conducted in both dark/light gray directions. Shown
here is the experiment in which the chromosome 2p derivative was labeled with Cy3 (depicted as light
gray) and the chromosome 2q derivative was labeled with Cy5 (depicted as dark gray). The BAC array
contains clones spanning both chromosomes 2 and 22, arrayed in triplicate. In this experiment, clones
from chromosomes 2p and 22 are seen as light gray and those from chromosome 2q (below the break-
point) are seen as dark gray. Using dark/light gray as the default ratio (i.e., Cy5:Cy3 ratios, after appro-
priate background correction, etc.), chromosome 2p clones have a ratio close to 0, whereas chromo-
some 2q clones have high ratios (see Bottom). (Bottom) Graphical output of analysis of Cy5:Cy3 ratios
from the array experiment depicted at the top. Cy5, Cy3 intensities were corrected for background, and
average ratios were obtained for each triplicate set. The position of the breakpoint is clearly visible on
chromosome 2. All the chromosome 22 BACs yielded very low ratios, implying that the breakpoint on
chromosome 22 lies centromeric to the most proximal BAC arrayed.
BAC DNA preparation from small cultures (200 t1
to 1 ml) in 96-well plates, most recently using an
automated robot.
Universal PCR of about 1 ng of BAC DNA, using a
method that we have developed.
Secondary PCR to attach an amino link to our prod-
ucts, followed by arraying onto aldehyde slides,
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ensuring a covalent attachment between DNA and
the surface of the slide.
We have generated BAC arrays at resolutions of
less than 1 Mb (for one set) and about 2 Mb for anoth-
er. We have commenced analysis on some of the
patient groups we are interested in and are currently
evaluating our results, particularly with respect to
FIGURE 2 BAC array output of male vs. female controls. Cy3:Cy5 ratios are plotted after
appropriate background corrections, removal of low-quality data, and averaging over trip-
licates. The vast majority of elements report a ratio between 0.9 and 1.1. All of the out-
liers seen are believed to represent true copy number changes, either deletions or dupli-
cations (they have been observed in other individuals). The elements are plotted starting
at 1 pter on the extreme left and ending with Yqter at the extreme right.
apparent deletions/duplications in normals. It is clear
that some of the copy number changes that we see are
the result of deletions, whereas others are the result of
duplications. Furthermore, in some cases, we have
observed subtler copy number changes but are uncer-
tain of their significance currently, although we
believe that there are two main possibilities: (1) The
lesion is present mosaically and (2) the lesion over-
laps one of our large clones, such that only a portion
of the clone is involved, thus "blunting" the reported
ratio. Our goal in 2003 is to generate a tiling path of
BAC arrays, using high-throughput methods, in col-
laboration with workers at the National Cancer
Institute, National Institutes of Health.
EPIGENETICS AND MONOZYGOTIC TWINS:
ANALYSIS USING HpaII REPRESENTATIONS
To a rough approximation, monozygotic twins share
identical germ-line genomes (although somatically
they are likely to differ). However, little is known of
the epigenetic similarity between monozygotic twins.
This is an area of importance when considering possi-
ble reasons for phenotypic discordance in monozygot-
ic twins, such as occurs in schizophrenia (50% con-
cordance). As an initial foray into techniques to
approach this problem, we have decided to look for
methylation differences between pairs of monozygotic
twins, using two approaches:
Representational difference analysis (RDA) using
HpaII (a methylation-sensitive enzyme that cleaves
at CCGG unless the internal cytosine is methylat-
ed).
cDNA microarray analysis using HpaII representa-
tions.
We have performed RDA on a set of twins and are cur-
rently evaluating the output.
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REGULATION OF APOPTOSIS IN CANCER CELLS
Y. Lazebnik D. Duelli
P. Lassus
S.-C. Lin
A. Matapurkar
X. Opitz-Araya
J. Raychaudhuri
J. Rodriguez
M. Yuneva
Apoptosis is a type of cell death that is critical for
maintaining tissue homeostasis. An intense effort to
understand apoptosis has been fueled in large part by
the hope that the apoptotic machinery will be used for
curing cancer. The accumulated knowledge is suffi-
cient to design and implement tools that kill cells
quickly and efficiently by inducing apoptosis.
However, because the apoptotic machinery is present
in most if not all mammalian cells, the major problem
is how to induce apoptosis in cancer cells selectively.
One approach to solving this problem is to learn how
apoptosis is induced by oncogenic transformation.
This approach is based on a paradoxical observation
that some oncogenes, including myc and adenovirus
E1A, either induce apoptosis or sensitize cells to cyto-
toxic agents, including those used for chemotherapy.
One implication of this observation is that some onco-
proteins are pro-apoptotic activities that are specific
for transformed cells. We think that understanding
how the apoptotic machinery is activated in response
to the expression of oncogenes, and how apoptosis is
prevented in transformed cells, will help to develop
ways to kill cancer cells selectively.
Central to the apoptotic machinery are caspases, a
family of cysteine proteases. Caspases are activated at
the onset of apoptosis and cause death by cleaving a
number of proteins in coordinated manner. If caspase
activation is prevented, a cell can become drug-resis-
tant. Caspase activation occurs in two steps. At the
first step, pro-apoptotic signals lead to autocatalytic
activation of caspases that are called initiators.
Activated initiator caspases process effector caspases,
which in turn cause cell collapse by cleaving a specif-
ic set of substrates. Each initiator caspase is activated
in response to a subset of signals, indicating that a pre-
requisite for understanding how a specific signal acti-
vates apoptosis is finding the initiator caspase that
mediates it. We investigate which caspases are
involved in apoptosis, and study how they are activat-
ed, how this activation leads to cell death, and what
prevents this activation in drug-resistant cells. The
ultimate goal is to understand how caspases can be
activated selectively in cancer cells.
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To investigate how caspases are activated by onco-
gene expression, we previously developed a cell-free
system that mimics apoptosis dependent on expression
of EJA, an adenoviral oncogene. Using this system,
we found that EJA- dependent apoptosis is mediated
by caspase-9 and that the expression of E1A sensitizes
cells to apoptosis by facilitating activation of this cas-
pase. This is achieved by at least two ways: facilitating
the release from mitochondria of cytochrome c, a
cofactor required for caspase-9 activation, and regula-
tion of an unidentified subsequent step in caspase-9
processing.
This model was consistent with the prevailing view
that cytotoxic stress, such as DNA damage, induces
apoptosis by regulating the permeability of mitochon-
dria. Mitochondria sequester several proteins that, if
released, kill by activating caspases, the proteases that
disassemble the cell. Another way to activate caspases,
which is used by cytokines, is to assemble receptor
complexes that activate caspases directly, although the
subsequent mitochondrial permeabilization acceler-
ates cell disassembly by amplifying caspase activity.
We found that cytotoxic stress causes activation of cas-
pase-2 and that this caspase is required for permeabi-
lization of mitochondria. Therefore, we concluded that
cytokine- and stress-induced apoptosis acts through
conceptually similar pathways in which mitochondria
are amplifiers of caspase activity, rather than initiators
of caspase activation.
Our findings have several implications. One is
related to a link between apoptosis and cancer.
Although strong evidence indicates that a failure of
apoptosis contributes to cancer progression in experi-
mental systems, the evidence is much weaker for such
a relationship in human cancers. Evidence for the lat-
ter has been primarily gathered by correlating tumor
properties with deficiencies in the apoptotic machin-
ery. Our findings imply that a critical part of a major
apoptotic pathway is yet to be considered by such
studies. Indeed, survival of cancer cells might be
enhanced by any changes that prevent caspase-2 acti-
vation. How this activation is regulated is unknown,
which indicates that even basic pathways of apoptosis
are yet to be sufficiently explored to allow the effi-
cient modulation of apoptosis to a therapeutic end.
Our study also highlighted truly novel opportunities
provided by RNA interference (RNAi) to study cancer
biology without relying only on observations made
with genetically modified mice.
Another implication is related to the basic design
of apoptotic pathways. Genetic studies in the nema-
tode Caenorhabditis elegans provided an outline of
the apoptotic machinery. In this organism, CED-4, an
activator of the caspase CED-3, is sequestered by a
Bcl -2 family member CED-9. EGL-1, another Bcl -2
family member, releases CED-4 from CED-9, thus
triggering CED-3 activation and cell death. Our find-
ing that caspase-2 is required early in apoptosis pro-
vides an experimental model to test the hypothesis
that in mammals, as in the nematode, the Bcl -2 pro-
teins control apoptosis by directly sequestering mole-
cules required for activation of a caspase.
Another implication is related to the current
model of how mitochondria permeability is regulated
during apoptosis. It is thought that cytotoxic stress,
such as DNA damage, activates Bax and other pro-
apoptotic proteins of the Bc1-2 family, which perme-
abilize mitochondria, thus releasing factors required
for caspase activation. Our observations argue that at
least in some cell types, the roles of Bax and caspase
activation are reversed, in that a caspase activity is
required for Bax translocation. This conceptual
change may help to understand how Bax is activated.
This year, we also continued our collaborations
with several laboratories. A collaboration with Scott
Lowe's laboratory here at CSHL, which was initiated
several years ago by former graduate student Lavina
Faleiro, came to fruition by uncovering a link between
oncogenic transformation and expression of caspases.
A collaboration with Emad Alnemri resulted in identi-
fying and characterizing a mitochondrial protease that
promotes apoptosis, and caspase-14, whose function
remains to be determined.
Overall, our studies continued to investigate how
apoptosis can be used to kill cancer cells.
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Apoptosis is a genetically controlled form of cell death
that is important for normal development and tissue
homeostasis. Senescence produces "genetic death" in
that the senescent cell is incapable of further propaga-
tion. Both processes are frequently disrupted in cancer
cells, implying that each can limit tumor development.
Moreover, radiation and many chemotherapeutic
agents can induce either apoptosis or senescence, rais-
ing the possibility that the integrity of these pro-
grammed responses influences the outcome of cancer
therapy in patients. The goal of our research is to
understand how cancer genes control apoptosis and
senescence in normal cells, and how mutations that dis-
rupt these processes impact tumor development and
therapy. Our approach emphasizes genetics, and we
typically exploit simple cellular systems to study can-
cer gene function. More recently, we have studied
human tumors and animal models to confirm the rele-
vance of our simple systems for tumor development
and cancer therapy in vivo.
Oncogene-induced Apoptosis
A. Bric, E. de Stanchina, M. McCurrach, Z. Nahle,
J. Zilfou [also involving former Laboratory member
A. Samuelson and in collaboration with Y. Lazebnik,
Cold Spring Harbor Laboratory; D. Bar-Sagi,
SUNY Stony Brook; T Mak, Ontario Cancer
Institute; and S. Powers, Tularik, Inc.]
Normal cells possess natural fail-safe mechanisms
that limit the consequences of aberrant proliferation.
One of these mechanisms involves their ability to cou-
ple excessive proliferation to cell death. For example,
deregulated expression of the c-Myc or disruption of
the Rb (retinoblastoma) pathway in normal cells can
force aberrant S-phase entry and predispose cells to
apoptotic cell death. This increased sensitivity to
apoptosis appears to limit tumor development, and, as
a consequence, mutations that disable oncogene-
induced apoptosis can contribute to tumorigenesis.
Consistent with this view, we have previously shown
74
A.M. Spector
H. Wendel
J. Zilfou
that oncogenes can engage the ARF-p53 pathway to
promote apoptosis and that disruption of this pathway
cooperates with oncogenes to promote oncogenic
transformation in vitro and tumor development in vivo
(reviewed in S. Lowe and C.J. Sherr, in press). We are
currently interested in identifying additional compo-
nents of the process, and understanding how they
function in a "tumor suppressor network."
Oncogenes can also contribute to cell death via
p53-independent mechanisms. Indeed, we recently
showed that deregulation of E2F by adenovirus El A,
Rb loss, or enforced E2F-1 expression results in the
accumulation of caspase pro-enzymes through a direct
transcriptional mechanism (Nahle et al. 2002).
Increased caspase levels appear to potentiate cell death
in the presence of p53-generated signals that trigger
caspase activation, for example, the presence of
cytosolic cytochrome c. Hence, p53-independent sig-
nals leading to caspase up-regulation cooperate with
p53-dependent signals, leading to caspase activation
during oncogene-induced cell death. Our results reveal
one way in which cell cycle progression can be direct-
ly coupled to the apoptotic machinery.
We also have been involved in several collabora-
tions relating to our apoptosis research. With Tak Mak,
we showed that Smac/DIABLO-a mitochondrial
protein with potent pro-apoptotic activity-is dispens-
able for apoptosis in oncogene-expressing cells
(Okada et al. 2002). This result is consistent with the
observation that Smac-deficient mice develop normal-
ly and suggests that Smac is not important for apopto-
sis or that there is redundancy at this level of the apop-
totic program. In another collaboration with Tak Mak,
we showed that Chk2 is dispensable for DNA-damage-
induced apoptosis in oncogene-expressing cells (Hirao
et al. 2002). This contrasts with the requirement for
Chk2 for p53-dependent apoptosis in other cell types,
and highlights the complexity of stress signaling to
p53. Finally, we contributed to Scott Powers' study
that identified a novel oncogene known as PPM1D (Li
et al. 2002). This gene is amplified in a substantial
fraction of breast cancers and acts as a phosphatase
that can inactivate p53 and suppress apoptosis.
Control of Cellular Senescence
E. de Stanchina, J. Fridman, M. Narita, M. Narita, S. Nunez
[also involving former laboratory member C. Schmitt]
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in
cultured human fibroblasts and is characterized by a
series of poorly understood markers. Senescent cells
remain metabolically active, but they are unable to
proliferate and display changes in gene expression that
could alter tissue physiology. As such, they are genet-
ically "dead" and cannot contribute to tumor develop-
ment. Although "replicative" senescence is triggered
by telomere attrition and can be prevented by telom-
erase, an identical endpoint can be produced acutely in
response to activated oncogenes, DNA damage, oxida-
tive stress, and suboptimal cell culture conditions. This
has led us to propose that senescence acts in parallel to
apoptosis as a cellular response to stress. Thus, our
studies on cellular senescence are guided, in part, by
lessons learned from our work on apoptosis.
Cellular senescence has been proposed to have
opposing effects on organismal aging and cancer,
although it has been difficult to demonstrate that the
process actually occurs in vivo. One of our most sig-
nificant advances in the last year was the demonstra-
tion that cellular senescence is relevant to tumor
behavior (Schmitt et al. 2002). This conclusion
stemmed from our efforts to uncover biologic and
molecular determinants of sensitivity to cancer
chemotherapy in the Eµ -myc transgenic mouse.
Specifically, we showed that Eµ -myc lymphomas can
respond to cancer chemotherapy by inducing both
apoptosis and cellular senescence and that lymphomas
with p53 or INK4a/ARF mutations respond poorly to
cyclophosphamide therapy in vivo. Moreover, tumors
harboring a Bc12-mediated apoptotic block undergo a
drug-induced cytostasis involving the accumulation of
p53, p 1 6im"a, and senescence markers and typically
acquire p53 or INK4a mutations upon progression to
a terminal stage. Finally, mice bearing tumors capable
of drug-induced senescence have a much better prog-
nosis following chemotherapy than those harboring
tumors with senescence defects. Therefore, cellular
senescence contributes to treatment outcome in vivo.
We are currently trying to identify other factors
that modulate drug-induced senescence and are mak-
ing a strong effort to understand the underlying genet-
ic and molecular mechanisms that control senescence.
For example, we are continuing to work on the regula-
tion and activity of the promyelocytic leukemia protein
(PML), and have uncovered a new link between PML
and the p53 tumor suppressor that we are characteriz-
ing in more detail. We have also noticed dramatic
changes in chromatin structure accompany senescence
and are determining whether these changes contribute
to the unique gene expression pattern of the senescent
state. Finally, we are pursuing strategies to reverse cel-
lular senescence and hope that these approaches will
provide insights into how the process is maintained.
Together, we hope that these studies will provide new
insights into the regulation of senescence and the activ-
ity of various tumor suppressor genes.
New Mouse Models of Cancer
J. Fridman, M. Hemann, C. Rosenthal, H. Wendel [also
involving former laboratory member C. Schmitt and in
collaboration with R. Hoffman, AntiCancer, Inc.; G. Hannon,
Cold Spring Harbor Laboratory; and C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center]
During the last several years, we have been adapting
retrovirus-mediated gene transfer and infection of
tumor cells or premalignant stem cells as an alternative
to germ-line transgenic or knockout mice to rapidly
produce tumors with compound genetic lesions. In one
approach, we use retrovirus-mediated gene transfer to
introduce genes into stem cells and then reconstitute
the hematopoietic compartment of lethally irradiated
mice (for review, see Schmitt and Lowe 2002). As a
consequence, normal mice are produced that contain a
"transgenic" hematopoietic system. Both the transgene
and the genotype of the stem cells can be varied, allow-
ing the rapid production of chimeric animals with mul-
tiple genetic changes. Moreover, since our retroviral
vectors often co-express a green fluorescent protein
(GFP) reporter, it is possible to track the infected cells
in vivo by whole-body fluorescence imaging. We have
used this system to study the action of various onco-
genes and tumor suppressor genes on the development
and treatment of leukemia and lymphoma.
In one study, we used this technology to examine
the p53 effector functions that are important for tumor
development in vivo (Schmitt et al. 2002). Although
the p53 tumor suppressor acts in a plethora of process-
es that influence cellular proliferation and survival, it
remains unclear which p53 functions are essential for
tumor suppression and, as a consequence, are selected
against during tumor development. By reconstituting
the hematopoietic compartment of recipient mice with
Ei.t-myc-derived stem cells infected with anti-apoptot-
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is genes, we showed that disruption of apoptosis down-
stream from p53 by Bc12 or a dominant-negative cas-
pase 9 confers-like p53 loss-a selective advantage
and completely alleviates pressure to inactivate p53
during lymphomagenesis. Despite their p53-null-like
aggressive phenotype, apoptosis-defective lymphomas
that retain intact p53 genes do not display the check-
point defects and gross aneuploidy that are character-
istic of p53 mutant tumors. Therefore, apoptosis is the
only p53 function selected against during lymphoma
development, whereas defective cell cycle checkpoints
and aneuploidy are mere by-products of p53 loss.
In collaboration with G. Hannon here at CSHL, we
investigated whether RNA interference (RNAi) tech-
nology could be used to suppress gene expression in
stem cells and produce phenotypes in reconstituted
mice (Hemann et al. 2003). As a proof-of-concept
experiment, we asked whether short hairpin RNAs
(shRNAs) against p53 could recapitulate the phenotype
of complete p53 deficiency during myc-induced lym-
phomagenesis. We introduced several p53 shRNAs
into hematopoietic stem cells derived from E.t -myc
mice and monitored tumor onset and overall pathology
in lethally irradiated recipients. Different p53 shRNAs
produced distinct phenotypes in vivo, ranging from
benign lymphoid hyperplasias to highly disseminated
lymphomas that paralleled the nullizygous setting. In
all cases, the severity and type of disease correlated
with the extent to which specific shRNAs inhibited p53
activity. Therefore, RNAi can stably suppress gene
expression in stem cells and reconstituted organs
derived from those cells. Moreover, intrinsic differ-
ences between individual shRNA expression vectors
targeting the same gene can be used to create an "epi-
allelic series" for dissecting gene function in vivo.
Molecular Genetics of Drug
Sensitivity and Resistance
J. Fridman, C. Rosenthal, S. Ray, M. Spector, H. Wendel,
J. Zilfou [also involving former laboratory member C. Schmitt
and in collaboration with R. Hoffman, AntiCancer, Inc.,
San Diego, California]
A major goal of our research is to understand the bio-
logical and molecular basis of drug sensitivity and
resistance in tumors (Johnstone et al. 2002).
Conventional approaches to identify factors that dictate
treatment sensitivity rely on human tumor cell lines
treated in vitro or as ectopic xenografts. As an alterna-
tive approach, we are using transgenic mouse models
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to study drug action in spontaneous tumors. Our sys-
tem exploits the Eg-myc transgenic mouse, which
develops B-cell lymphomas at short latency with high
penetrance. Using this system, we have identified bio-
logic and genetic determinants of treatment sensitivity
in vivo.
This year, we published a comprehensive study on
the effects of the chemotherapeutic drug cyclophos-
phamide (CTX) in Eg-myc lymphomas. CTX is an
alkylating agent that has been successfully used to
treat many human malignancies. Although CTX is not
subject to resistance mechanisms involving enhanced
drug efflux, many human tumors respond poorly or
become resistant to this agent. We showed that the
antitumor activity of CTX depends on its ability to
induce both apoptosis and senescence, which was con-
trolled by important cancer genes such as p.53,
plen"a, and bcl -2 (see Fig. 1). Tumors lacking both
programs rapidly progress to a lethal stage, suggesting
that post-damage responses are almost completely
responsible for CTX action. Our results established a
new paradigm for understanding drug action, as well
as the interconnections between tumorigenesis and
drug resistance. This paradigm will undoubtedly apply
to other conventional anticancer agents, and perhaps
many "targeted therapeutics."
It is worth noting that the Eg-myc system provides
a model of human cancer that is remarkably simple.
Each tumor analyzed is initiated by the same oncogene
(myc), arises in the same strain (C57BL/6), and is
treated with the same drug (CTX). Yet, these tumors
display an extraordinary heterogeneity in treatment
responses, ranging from cure to progression under
therapy depending on their genotype. Given the com-
plexities of human oncology, it is no wonder that treat-
ment responses are remarkably variable and difficult
to predict. Undoubtedly, this inherent variability will
remain a problem, even with targeted therapeutics.
Still, our studies provide a new paradigm to under-
stand drug action and inherent variations in treatment
sensitivity and provide support for the view that tumor
genotype is the most important determinant of treat-
ment outcome. These principles, when applied to
human tumors, provide a strong rationale for individ-
ualized cancer therapy based on knowledge of drug
action and tumor genotype.
In addition to using the Eg-myc system to identify
new processes and genes that modulate treatment sen-
sitivity, we are also using this as a model to test new
agents that might overcome or circumvent traditional
resistance mechanisms. We are also beginning to
apply genomics technology to the problem of drug
CTX day 0
ctrl.
p53-/-
BcI-2
day 1 day 7-10 day 13-17
FIGURE 1 Tumor genotype and treatment responses visualized by fluorescence imaging. Mice harboring GFP-
tagged lymphomas are treated with cyclophosphamide (CTX) and monitored by whole-body fluorescence imag-
ing. Note that control tumors harboring an intact p53 pathway (ctrl.) show a durable response to CTX, whereas
those with p53 mutations (p53-/-) or overexpressing Bcl -2 relapse or fail to respond altogether. The images were
produced in collaboration with R. Hoffman (Anticancer, Inc., San Diego, California).
resistance, as well as developing new models to study
drug action in malignancies besides lymphoma. Ann
and Herbert Siegel, who have provided funding for
some of these initial studies, have generously support-
ed these efforts. We intend to expand this area of
research over the coming year.
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GENOMIC MICROARRAY ANALYSIS
R. Lucito A. Brady
S. Gass
F. Oszolak
This work was carried out in collaboration with M.
Wig ler, J. Healy, A. Reiner, B. Mishra, and R.
McCombie here at CSHL. Cancer is a disease of muta-
tion of the genome. Mutations occur in the genome of
the precancerous cells and accumulate until the
growth of these cells proceeds unchecked. The genes
responsible for cancer must be identified if we are to
understand why a cell becomes cancerous. We propose
to survey the genome of the cancer to identify regions
that have undergone increased or decreased gene copy
number, namely, amplifications or deletions, since
these changes can be used as markers for the location
of oncogenes or tumor suppressor genes, respectively.
Once these regions are identified and tumor suppres-
sors and oncogenes are found, their function can be
investigated to understand the role that these genes
have in the progression to tumorigenesis. An innova-
tive strategy for the treatment for cancer can be seen
by the development of Herceptin for the treatment of
breast cancers with erbB2 gene amplification or for
Gleevec for the treatment of CML (chronic myeloid
leukemia) that has the Bcr-Abl translocation. Both of
these molecules target specific genes that are mutated
in the respective cancer. If the cancer has these lesions,
the patient becomes a candidate for treatment from
these modalities. We intend to take the first step by
identifying gene candidates that will later be the tar-
gets of such innovative therapies. In addition, the
regions themselves can be used for studies in progno-
sis and diagnosis.
We have developed a genomic microarray tech-
nique to identify copy number fluctuations, which bor-
rows the methodology of complexity-reducing repre-
sentations developed for representational difference
analysis (RDA) to increase hybridization efficiency
and increase signal to noise. A representation is a
reproducible sampling of the genome, produced by
first cleaving the genome with a restriction enzyme
such as BglII, ligation of adaptors, and polymerase
chain reaction (PCR) amplification. Amplification in
the presence of many fragments results in preferential
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amplification of the smaller fragments, so that the size
range of the representation is 200-1200 bp. Many of
the restricted fragments are lost during this preferen-
tial size selection caused by the PCR amplification,
resulting in a reduction in complexity of approximate-
ly 3% of the genome.
The array is composed of oligonucleotides based
on the sequence of the human genome. An in-silico-
based BglII representation was derived from the
sequence of the human genome. The 70-mer oligonu-
cleotides were derived from the predicted representa-
tional fragments. Oligonucleotides were chosen based
on uniqueness within the genome. The set of oligonu-
cleotides were culled by distribution across the
genome, maximizing oligonucleotide quality so that
the total numbered 30,000. The number 30,000 was set
due to the constraints of the number of fragments that
can be arrayed on a single slide with our current for-
mat. The average resolution on the array will be 1
probe every 100 kb. More oligonucleotides can be
added, increasing resolution further; however, a sec-
ond array would be produced.
BglII representations of tumor and normal that
were differentially labeled are compared on such an
array to identify copy number fluctuations as microar-
ray features having an intensity ratio deviating from
1:1 for tumor to normal. Although we will be using
this microarray method to categorize the mutations
that occur in many tumor types, we will be primarily
analyzing two tumor types initially. The first is pan-
creatic caner. There will be an estimated 30,000 cases
of pancreatic cancer this year. Of these, 29,700
patients will succumb to the disease. Although this
number is low in comparison to several other cancers
such as colon, lung, or breast cancer, the survival rate
for pancreatic cancer is one of the lowest. Treatments
can extend survival or alleviate pain but seldom cure
the patient. In fact, the mean survival time is approxi-
mately 6 months. We are collaborating with Dr. Daniel
Von Hoff of the Arizona Cancer Center, who will pro-
vide pancreatic specimens and invaluable clinical
information and expertise. We will analyze 100-150
primary pancreatic tumor specimens using the 30,000
probe representational oligonucleotide microarray
analysis (ROMA) array to identify regions of the
genome that have undergone copy number fluctua-
tions. We have already analyzed close to 10 samples
and have confirmed that the INK4a-ARF locus is
deleted at a very high frequency in this type of tumor.
In addition, several other regions are deleted frequent-
ly in this cancer, and we are continuing to study these
regions to identify possible gene candidate tumor sup-
pressors. Eventually, the results from this study will
be combined with clinical information associated with
the patient to determine whether there are any para-
meters that associate with specific tumor mutation
patterns.
The second cancer we will focus on is ovarian can-
cer, which has a relatively high incidence and approxi-
mately 50% survival rate. In many patients, the cancer
is diagnosed late due to location; often, the tumor has
already metastasized, the first symptoms being an accu-
mulation of fluid in the abdominal cavity. There are few
genes discovered that have a role in the progression of
ovarian cancer.
We will collaborate with Dr. Michael Pearl of
SUNY Stony Brook for access to tissue and clinical
information. We will be performing ROMA on ovarian
cancer samples to identify gene copy number fluctua-
tions to determine candidate tumor suppressors and
oncogenes. We will compare samples of the primary
cancer , metastatic tissue from the cell wall, metastatic
tissue found in the fluid in the abdominal cavity, and in
some cases, the metastatic tissue after chemotherapy.
We intend to analyze the tumors to trace the accumula-
tion of mutations from primary to metastasis with the
hope of identifying not only genes involved in the
development of the primary tumor, but also those genes
that may increase metastatic capability and genes
involved in chemotherapy resistance.
The regions identified from these studies will
serve as valuable diagnostic and prognostic indicators.
Of equal importance, these regions will serve to iden-
tify new oncogenes and tumor suppressor candidate
genes. The advantage to using genome-wide analysis
on a large set of tumors is that the time-consuming
step of positional cloning will have already been done,
although it will be necessary to compile the data.
Once compiled, the epicenter, or common region of
mutation, will be located in collaboration with B.
Mishra, who is developing algorithms and informatics
tools. Once the epicenter is identified, candidate genes
will be identified informatically in collaboration with
R. McCombie here at CSHL.
Colon Cancer
A. Brady, S. Gass [in collaboration with
IM. Wigler and R. McCombie, Cold
Spring Harbor Laboratory]
We are currently investigating a possible tumor sup-
pressor gene candidate located on chromosome 20p12
that is deleted homozygously in approximately 4% of
gastrointestinal tumors. This region was used for the
identification of gene candidates as possible tumor
suppressors. The region defined as the epicenter or
common region of deletion was used for gene candi-
date identification. On the initial freeze of the golden
path that was used for gene candidate searching, no
RefSeq genes were found and one spliced expressed
sequence tag (EST) was identified. Unfortunately,
homology searches performed have not revealed any
striking similarities that would yield clues to the func-
tion of this gene. The sequence of the EST was used to
generate primers for PCR analysis of exon deletion
status in the cell lines identified to have homozygous
deletion of the 20p12 region, finding exon 1 and 2 fre-
quently deleted. This EST is a 5' read and presumably
represents the 5' end of the gene. Therefore, it is like-
ly that the gene is not expressed in these tumor cell
lines.
Northern blots were performed to determine the
tissue distribution of the EST and to identify the full-
length product. This EST appears to be expressed pre-
dominantly in the skeletal muscle. Reverse transcrip-
tase-PCR (RT-PCR) was utilized to determine that the
EST is expressed in several colon tumor cell lines.
Northern blots of these cell lines are currently being
performed. Upon inspection of a more recent genome
build, two additional ESTs have been mapped to the
deleted region. Both of the ESTs are at least partially
deleted in the cell lines originally identified to harbor
deletion of the chromosome 20p12 region. The
sequence of these ESTs is currently being used for RT-
PCR of several colon tumor cell lines to determine
whether they are expressed in this tissue, and later for
northern blotting.
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Maize Mutagenesis Library
Screening
R. Lucito [in collaboration with R. Martienssen,
P. Rabinowicz, and E. Vollbrecht, Cold Spring
Harbor Laboratory]
We are developing a high-throughput microarray
screen of a maize insertion mutagenesis library. The
probes on the array are picked from a gene-enriched
methyl-filtering library. The basis of this library relies
on the fact that gene-rich regions of the maize genome
are not methylated, but repetitive regions are methy-
lated. The methyl-filtered clone library was further
screened to remove clones with remaining repetitive
content, and redundant clones. A mutant plant library
was produced by random insertion of a transposable
element. DNA from these plants was isolated, and
pooling was performed. Representations are prepared
from these samples by PCR amplification using the
sequence of the transposable element. The representa-
tions are then used for hybridization to the arrays to
identify which individual plants have a gene insertion.
This information will be cross-referenced to pheno-
typic data to identify the gene regions with transposon
insertions. We are optimizing the representational pro-
cedure and labeling procedures to improve the accura-
cy of the technique to identify pools with mutants.
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills A. Bagchi W. Keyes
S. Cheloufi T Riemels
E. Garcia Y. Wu
Our goal is to understand the genetic basis of human
disease. Although genome sequencing efforts have
generated an impressive amount of information about
the content of the mammalian genome, we know rela-
tively little about how specific genes function within
the organism. Thus, functional genomics-dissecting
the genome by determining the role of specific
genes-is essential for understanding normal develop-
ment and the disease process.
We are using the mouse as a model system to
probe the function of human genes. The mouse pro-
vides an excellent opportunity to explore gene func-
tion because of its reproductive, anatomical, physio-
logical, and genomic similarity to humans. Our ability
to genetically modify the mouse genome makes it pos-
sible to create mouse models that allow us to address
a multitude of specific biological questions.
In our laboratory, we use gene targeting in embry-
onic stem cells to generate mouse strains that have
precise modifications of the genome; these strains
serve as experimental models that allow us to define
gene function. We are using two different approaches
to achieve this goal: (1) analyzing the role of groups of
genes within specific regions of the genome, and (2)
analyzing the role of individual genes known to be
associated with the disease process. The first approach
uses chromosome engineering to generate mouse
strains that have precise chromosome rearrangements
that mimic those found in human diseases. These
mouse strains are useful for providing models of
human disease and for determining the function of
genes within specific regions of the genome. The sec-
ond research emphasis in the laboratory is to perform
an in-depth exploration of a single gene known to be
causal in several human disease syndromes. This gene,
p63, is related to the p53 tumor suppressor gene, a
gene that is mutated in approximately one half of all
human cancers. Understanding the molecular and
genetic mechanisms ofp63 action will allow us to gain
an insight into the processes of development, differen-
tiation, stem cell maintenance, and cancer.
Generation of Megabase
Chromosome Rearrangements:
Human Chromosome 1p
A. Bagchi, T. Riemels, Y. Wu
What do our genes normally do? How do chromosome
abnormalities lead to disease?
A substantial number of human diseases are associat-
ed with chromosomal rearrangements such as dele-
tions, duplications, and inversions. These abnormali-
ties are complex because they affect large numbers of
genes within specific chromosomal regions. To under-
stand how these rearrangements cause disease, we can
make mouse strains that have the same rearrangement
as those found in human patients. Defined chromo-
some rearrangements are made using chromosome
engineering, an approach that combines the power of
gene targeting with Crel loxP technology. Similarities
between the human and mouse genome make it possi-
ble to generate mouse models of human disease. We
are currently using this approach to generate models
for hereditary cancer syndromes. We are focusing our
efforts on human chromosome 1p, a region containing
several as yet unidentified tumor suppressor genes. A
diverse array of human tumors have deletions at 1p,
suggesting that genes underlying the tumorigenic
process are located in this region of the genome. We
are creating models of hereditary cancer by generating
mouse strains that have the same deletions as those
found in human tumors. We first make specific dele-
tions in embryonic stem cells, and then use these cells
to generate mouse models that transmit the modified
allele in the germ line. To make this approach feasible
on a genome-wide scale, we have created a system that
greatly reduces the substantial amount of effort
required for generating gene targeting constructs. This
system is composed of two genomic libraries of essen-
tially pre-made gene targeting vectors that contain all
of the features required for generating Cre-induced
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CFIGURE 1 Coat color markers are used to "tag" mice containing chromosome rearrangements. Mice
haploid (right) or diploid (center) for a 23-cM inversion on the distal portion of mouse chromosome 4
are visually distinguishable from wild-type albino mice (left). The Tyrosinase transgene that was insert-
ed into the rearranged chromosome produces a slight graying of the coat when a single copy is pre-
sent (left), and a more intense coat color when two copies are present (middle).
chromosome rearrangements. In addition, constructs
isolated from these libraries contain genes that alter
the color of mice that harbor them; this feature has the
advantage that mice containing a specific rearrange-
ment in their genomes are visibly distinguishable from
normal mice (Fig. 1). This greatly reduces the cost and
labor normally required for maintaining mouse
colonies and also allows these models to be imple-
mented in genetic screens.
Analyzing the Role of
Specific Disease Genes:
The p63 Locus
S. Cheloufi, E. Garcia, W. Keyes
How does p63 keep us young? What is the role of p63
in human cancer?
The p53 tumor suppressor gene has an important role
in cancer progression. Approximately one half of all
human cancers either have lost p53 altogether or have
inactivated it by mutation. Although mice lackingp53
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are viable, they develop tumors at a very early age.
Thus, p53-deficient models are extremely valuable for
investigating the molecular and genetic events associ-
ated with tumor formation.
We discovered p63-a gene that has striking simi-
larity to the p53 tumor suppressor gene. We used gene
targeting to create mice that lackp63; these mice have
severe defects that affect craniofacial, limb, and skin
development. Mice lacking p63 are devoid of all struc-
tures that are normally derived from the ectoderm dur-
ing development: They lack hair, teeth, mammary and
sebaceous glands, nails, and prostate. These observa-
tions provided an important clue which led to the dis-
covery that mutations in p63 cause five different
human developmental disease syndromes: EEC
(ectrodactyly, ectodermal dysplasia, clefting), AEC
(ankyloblepharon, ectodermal dysplasia, clefting), and
ADULT (acro-dermato-ungual-lacrimal-tooth) syn-
dromes, as well as LMS (limb-mammary syndrome)
and SHFM (split hand/foot malformation). These syn-
dromes are characterized by a spectrum of clinical fea-
tures that affect development of the limbs, skin, and
the craniofacial region. How mutations inp63 bring
about the striking defects in these patients is not yet
known.
We are currently investigating the role of p63 in
morphogenesis of the ectoderm and its related struc-
tures. This year, we generated a conditional p63 model
that allows us to first generate viable mice and then to
ablate p63 function within specific tissues at particu-
lar stages of development (Mills et al. 2002). Using
this approach, we are able to inactivate p63 within spe-
cific tissues of the adult. This is the first system that
provides a tool for direct genetic analysis of the role of
p63 in aging and tumorigenesis.
We are also using several mutagenesis approaches
to determine how specific alterations of p63 affect its
function. The first approach is to use site-specific
mutagenesis to generate mouse models that have the
same p63 mutations that are present in EEC patients.
We used gene targeting to replace the normal copy of
p63 with this mutated version. This model will allow
us to determine how mutations in p63 lead to the
abnormalities found in individuals afflicted with EEC
syndrome.
We are also investigating the role of p63 using a
phenotype-driven mutagenesis strategy-one that
makes random mutations throughout the entire
genome. The mutagen that we use is ENU; it is a
potent mouse mutagen that typically generates single-
nucleotide mutations. If an ENU-induced mutation
happens to occur within the p63 gene, this is
detectable in the screen because a visible phenotype
can be observed. This approach is extremely valuable
because it is random; it is unbiased because it is based
entirely on the resulting phenotype and not on our
understanding of gene structure. This approach will
provide a series of mouse models that harbor different
p63 mutations. This resource will be invaluable for
assessing the role ofp63.
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FUNCTIONAL GENOMIC APPROACHES IN BIOLOGY
V. Mittal J. Egan A. Kennedy K. La Vine
R. Kumar R. Schoer C. Catapano
S. Gupta R. Lindsay 0. Morris
During the past year, our laboratory has been carrying
out a systematic approach that combines the strengths
of methods such as RNA interference (RNAi)-mediat-
ed suppression of gene expression, DNA microarrays
for gene expression profiling, and functional analysis
to dissect the basic helix-loop-helix (bHLH) Id gene
regulatory pathways. Our approach is multidiscipli-
nary; it utilizes both mouse genetic models and cul-
tured primary cells. An understanding of these path-
ways will have implications in defining novel strate-
gies for blocking the process of angiogeneis as an
effective therapeutic modality.
We have recently begun to use similar functional
genomic approaches to dissect gene regulatory path-
ways by which components of an innate and adaptive
immune system (T cells and dendritic cells) respond to
immunity potentiating drugs. Below is a brief descrip-
tion of individual projects.
Using RNAi and DNA Microarrays
to Delineate Id-mediated
Angiogenic Pathways
S. Gupta, K. LaVine, A. Kennedy, R. Kumar, R. Schoer
[in collaboration with M. Ruzinova and R. Benezra,
Memorial Sloan-Kettering Cancer Center, New York]
The bHLH Id gene family of transcription factors (Idl,
Id2, Id3, Id4) are important regulators of key cellular
processes such as cell cycle regulation, cell differenti-
ation, and angiogenesis and are deregulated in a vari-
ety of cancers. In adults, Idl and Id3 are expressed
exclusively in the endothelium of the blood vessels of
tumors, and mice lacking Idl or Id3 do not support
growth and metastasis of tumors. Thus, Id and its
downstream targets serve as attractive candidates for
anti-angiogenic drug therapy.
IDENTIFICATION OF Id TARGETS IN
ENDOTHELIAL CELLS
To understand how Id regulates formation of intact
vasculature in tumors, we used DNA microarrays to
84
compare gene expression in hyperplastic lymphoid tis-
sue from Id wild-type (PTEN Idln and Id mutant
(PTEIr- Id1-1-) mice. Various control hybridizations
were performed, for example: (1) three separate pairs
of wild-type and mutant mice provided control for
variability; (2) each comparison was performed in
duplicate and color reversal (reciprocal labeling); (3)
at least four correlated data sets (coefficient of corre-
lation of >0.9 or more in normalized and filtered data)
were used for further analysis; and (4) tumors isolated
from two separate wild-type mice and two mutant
mice were used to measure variability from mouse to
mouse. The data obtained from these control experi-
ments were used to make an error model to identify
genes that showed random fluctuations in their ratios.
These were considered noise and were eliminated
from the final analysis. On average, per array
hybridization of a total of 10,000 features, 7,000
passed thresh filters set during analysis. Of these,
about 1% showed significant up-regulation and down-
regulation. A hierarchical clustering analysis filtered
data set was used to visualize for genes showing con-
sistent expression profiles across individual experi-
ments.
DOWNSTREAM ANALYSIS
OF Id TARGETS
In the initial phase, our priority was to study target
genes that were pro-angiogenic and whose expression
was down-regulated in Idl mutant samples. We rea-
soned that this approach would validate our experi-
mental strategy and identify candidate genes with a
potential for anti-angiogenic therapy targets. The fol-
lowing genes qualified our set criteria: 134 integrin
(AA407046), a6 integrin (AW556992), fibroblast
growth factor receptor-1 (FGFR1, AW557998), metal-
loprotease-2 (MMP-2, M84324), pleiotrophin
(AW550271), and chemokine (C-X-C) receptor 4
(AA409357). The down-regulation of these genes was
not due to the decrease in numbers of endothelial cells
in an Id14- background since endothelial markers
such as CD146 were not down-regulated. Semiquanti-
tative polymerase chain reaction (PCR) showed that
the relative amounts of transcripts for each gene cor-
related well with the microarray-based experiments,
suggesting that our microarray provides reliable mea-
sures of gene expression. Almost all except pleio-
trophin and C-X-C receptor 4 localized exclusively to
the endothelium of the blood vessels in Id wild-type
cells and not the contaminating tumor cells. Down-
regulation of MMP-2 expression was previously
shown in the defective tumor vasculature of Idl
mutant animals, consistent with the array data. Genes
that did not show endothelium-specific localization
were not investigated further.
FUNCTIONAL VALIDATION OF THE
DOWNSTREAM TARGETS
The biological relevance of target gene analysis was
demonstrated by performing an in vivo Matrigel
assay. This assay was used to establish whether loss of
function of the gene was sufficient to account for the
angiogenic defects in Id mutant mice. Control experi-
ments showed that VEGF-impregnated Matrigel plugs
implanted into Idl wild-type animals form multiple
channels by endothelial cells. As expected, Matrigel
plugs from Id 1 mutant animals failed to form
endothelial tubes. Strikingly, blocking antibodies to
integrin a6 and FGFR1 prevented endothelial cells
from forming luminized channels. Inhibition of
MMP-2 activity resulted in a more dramatic pheno-
type; there was absence of endothelial cell invasion of
Matrigel plugs. Thus, it seems that the inhibition of
FGFR1 prevents formation of endothelial tubes while
MMP-2 blocks invasion of endothelial cells into
Matrigel plugs. Thus, combined down-regulation of
these two factors may account for the reduced
endothelial cell invasion and tube formation seen in
Id- deficient mice. We showed that a6 integrin also has
a role in endothelial tube formation, but the effect may
be due to its dimerization with either 04 or 01 inte-
grins. We could not study inhibition of 04 integrin
because of a lack of reliable antibodies. Currently, we
are using RNAi to suppress expression of 04 integrin
gene suppression, and this will be followed by func-
tional analysis.
Previous findings suggest that pro-angiogenic
molecules identified in our studies may lie in the
same pathway. bFGF up-regulates the expression of
a604 integrins in endothelial cells and MMP-2
induces the migration of epithelial cells by cleaving
and regulating the function of laminin-5, a recognized
ligand for a6(34 integrin. Thus, if the same pathway
operates in endothelial cells, loss of Id may short-cir-
cuit it by down-regulation of three of its crucial com-
ponents.
In summary, our studies show how functional
genomic approaches combined with the strength of a
physiologically relevant mouse tumor model can be
used to define novel strategies for the development
and use of anti-angiogenic therapeutic drugs. Such an
approach should be directly applicable to the function-
al analysis of other disease models. A major interest in
our laboratory now is to identify components of the Id
gene network, analyze their mechanism of action, and
determine their relative impact on tumor progression.
We have started generating loss of function of Id genes
(Idl and Id3) by RNAi in murine and human endothe-
lial cell lines.
A Method of Screening
Effective siRNA Probes
R. Kumar
RNAi is a process of sequence-specific posttranscrip-
tional gene silencing mediated by double-stranded
RNA. More recently, RNAi has emerged as a powerful
generic tool to analyze gene function in mammalian
cells. However, the power of this method is limited by
the uncertainty in determining which region of the
mRNA can serve as the most effective target for short
interfering RNA (siRNA)-mediated gene silencing.
This feature has imposed serious limitations not only
for small-scale, but also for high-throughput RNAi
screening initiatives in mammalian systems.
We have developed a method for rapid and effi-
cient screening for a most effective siRNA against any
gene. The strategy is based on a rational assumption
that the expression of endogenous protein will be as
efficiently silenced as that of ectopically expressed
reporter-tagged mRNA by an effective siRNA candi-
date. We have shown correlation in the ability of
siRNA probes to suppress expression of ectopically
expressed and cognate endogenous counterparts using
a variety of genes with diverse biological functions, in
both murine and human cell types. Using microarray-
based cell transfections, we have shown that it is pos-
sible to identify very rapidly effective RNAi candi-
dates in large parallel screens.
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Dissection of Gene
Pathways of the
Immune System
J. Egan
The immune system is a highly adaptive defense sys-
tem that has evolved in vertebrates to protect them
from both invading pathogens and cancer. This is
accomplished by the elegant interaction of two unique
branches referred to as the innate and adaptive
immune systems. A functional breakdown in either of
these systems due to genetic lesions, disease, or age
has catastrophic consequences for the organism.
Additionally, it is becoming apparent that a potential-
ly powerful and specific therapy for diverse diseases
such as malaria, influenza, AIDS, and even cancer is
to harness the power of the immune system to combat
these diseases. Of the several compounds that stimu-
late both the innate and adaptive arms of the immune
systems, inosine 5 "-methyl monophosphate (MIMP) is
classified as a "thymomimetic drug" based on the fact
that it mimics the activity of hormones derived from
the thymus. Specifically, it augments the proliferative
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and secretory functions of mature T cells, a critical
cellular component of the adaptive immune system,
and it provides protection against a variety of
pathogens. MIMP has also been shown to reverse the
effects of aging on the immune system and overcome
various immunosuppressive influences. We are inter-
ested in further understanding the biological proper-
ties of MIMP as well as elucidating the signal trans-
duction pathways that MIMP stimulates. We are using
human Cal.+ and CD8+ T lymphocytes (derived from
peripheral blood) as a model for adaptive immune sys-
tem activation, coupled with DNA microarray tech-
nology, to study the global gene expression profile
changes induced by MIMP. Several candidate genes
have been identified and are currently undergoing val-
idation by independent methods. Parallel studies are
also being conducted on cellular components of the
adaptive immune system, such as dendritic and natur-
al killer cells. A more comprehensive insight into the
mechanism of action of MIMP in immune function
will allow for the design of more specific and effica-
cious therapies for diseases as disparate as AIDS and
cancer, as well as provide prophylactic therapies in the
form of more potent vaccines.
Christopher Catapano
MAMMALIAN CELL GENETICS
M. Wigler J. Alexander D. Esposito R. Lucito
A. Brady S. Gass A. Reiner
K. Chang H. Grasmo-Wendler M. Riggs
M. Chi J. Healy L. Rodgers
J. Douglas
It is a poor and unnecessary gamble to act as though
either our theory or our knowledge of cancer is nearly
complete. Future progress in detection, prognosis, and
treatment of cancer will depend on the accuracy and
completeness of our understanding of its specific mol-
ecular causes. This knowledge is likely to become
increasingly important as cancers, or suspected can-
cers, are detected at earlier and earlier stages.
There are simple tests for the completeness of our
understanding of how cancers survive in and kill their
hosts. If our knowledge were complete, we would see a
plateau in the number of genes commonly found mutat-
ed in cancers. If the principles were few, even advanced
cancers with a large number of accumulated genetic
lesions would show only a small number of commonly
affected pathways. It follows from this that if mutation
in af3ingle gene were sufficient to affect a given path-
way, then even advanced cancers would show only a
small number of commonly affected genes, the remain-
der of lesions being more-or-less random.
We have developed a microarray-based method that
can partially address these issues. We can readily iden-
tify loci in the genome that undergo amplification, dele-
tion, and imbalanced breaks. Although there are many
other possible mechanisms that alter critical genes, such
as point mutations, balanced translocations, and possi-
bly stable epigenetic changes, many if not most onco-
genes and tumor suppressor genes will eventually be
found in the types of lesions that we can readily detect.
Moreover, if a region is commonly found altered in can-
cers, that region harbors a good candidate cancer gene.
Therefore, the application of our method to a large
series of cancers, and the comprehensive comparative
analysis of such data, should reveal the position and
number of candidate cancer genes in cancers.
Using our methodology, we have also discovered,
as we predicted last year, that there are many examples
of copy number polymorphisms in the human gene
pool, i.e., large regions of the human genome that are
present in individuals in unequal amounts. It remains
to be shown that these regions of copy number varia-
tion are inherited as such, but it seems plausible to us
that some of these regions will be shown to be associ-
S. Rostan
E. Thomas
J. Troge
J. West
ated with disease resistance and sensitivity. We have
made great strides in developing our technology. We
are now at the beginning stages of accumulating data.
We also report on our progress at cancer gene identi-
fication, genome mapping techniques, and other
genomic studies.
THE TECHNOLOGY
The major obstacle to the implementation of our tech-
nology has been financial. The principles and pilot
demonstrations were established in previous years.
Fortunately, due mainly to the contributions of many
extraordinary philanthropic groups and individuals, and
through additional support from corporations and the
National Cancer Institute, we have been able realize our
plans on a large scale only this year. But financial con-
siderations aside, this work became possible because of
the publication of the assembled human sequence.
The basis of our technology, representational
oligonucleotide microarrays, or ROMA, has been
explained over the past years. It involves making com-
plexity-reducing representations of genomic DNA and
hybridizing such to microarrays of oligonucleotide
probes designed informatically from the published
human genome assembly. The probes are chosen from
the genome so that they are complementary to the
parts of the genome that are in the representations and
are further selected so that they have a minimal over-
lap with unrelated regions of the genomes.
The algorithms that minimize overlap were described
briefly in last year's Annual Report, and were developed
by John Healy in our group. They have now been sub-
mitted for publication. The algorithms allow counts of
exact matches of sequences of any length throughout a
sequenced genome and are based on a Burrows-Wheeler
transform of the genome sequence and the construction
of auxiliary data structures. The unintended uses for
these algorithms are described below.
We use two forms of oligonucleotide microarrays,
the printed form that we make ourselves, and a form in
which oligonucleotides are synthesized in situ on the
array surface using laser-directed photochemistry. A
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FIGURE 1 Two forms of oligonucleotide microarrays (see text).
company called Nimblegen makes the latter, and their
technology has given us substantially greater flexibility
in the design of arrays and the selection of representa-
tions. Pictures of these microarrays are shown in Figure
1, with the printed array on the left and the Nimblegen
array on the right. With Nimblegen, we can array
85,000 probes (85K format), average one probe per 30
kb, and even greater densities could be achieved readi-
ly. We have shown that each format yields very similar
measures, probe for probe. This work was conducted in
collaboration with Robert Lucito here at CSHL.
CANCER LESIONS
We have applied our method to both tumor biopsies
and cancer cell lines and have observed gross chro-
mosomal copy number alterations, and highly local-
ized amplification, imbalanced chromosome breaks,
and deletions. In the latter case, we expect that we
have observed both hemizygous and homozygous
deletions. Representative examples of these lesions
are illustrated in Figure 2. Clockwise from upper left,
we have an imbalanced chromosome break, a complex
series of amplifications, a homozygous deletion, and
a presumed hemizygous deletion. Ratios of probe
intensity are roughly proportional to copy number
alteration and are plotted for each probe in the order
that they occur on the genome. Averages of probe
ratios for segments with similar behavior are indicat-
ed. In our data analysis, we have used algorithms for
statistical segmentation designed by Adam B. Olshen
and E.S. Venkatraman of the Memorial Sloan-
Kettering Cancer Center. We observe a large number
of lesions, of varying sizes, per cancer. We do not yet
have enough examples of genomes analyzed at 85K
resolution to allow us to make generalizations, but in
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the two genomes that we have analyzed in great detail,
we observe on the order of 80 lesions each, a number
greatly exceeding our expectation.
In collaboration with Rob Lucito here at CSHL,
and L. Norton and W Gerald of Memorial Sloan-
Kettering Cancer Center (MSKCC), we have shown
that detection of amplification at the ErbB-2 locus in
breast cancer by ROMA is roughly comparable to its
detection by fluorescence in situ hybridization (FISH).
We therefore have initiated a far-ranging collaboration
with Anders Zetterberg at the Karolinska Institute of
Stockholm on a program to convert the findings of
ROMA into FISH assays. Dr. Zetterberg is one of the
world's foremost experts on FISH analysis of cancer.
Our future plans include a survey of a large num-
ber of breast, ovarian, and pancreatic tumors and cell
lines, and leukemias and lymphomas, after which we
will determine by epicenter mapping the minimal
regions of frequently recurring amplifications and
deletions and breakpoints. Candidate genes from these
regions will then be further explored by functional
analysis and sequencing. To complete this program,
we need to automate data processing and gene annota-
tion, so that our efforts for the next few years will
focus on computational methods. In these efforts, we
are currently collaborating with clinicians and
researchers at the MSKCC, the Karolinska Institute,
University of Toronto, Stony Brook University, Stony
Brook, New York University, LI-North Shore
University Hospital, and Johns Hopkins University
School of Medicine.
NORMAL VARIATION
We have applied our method to the comparison of nor-
mal genomes and have discovered that there are a large
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FIGURE 2 Representative examples of cancer lesions (see text).
number of extensive regions of copy number variation
between any two genomes. These regions could result
from polymorphic gene duplications or deletions, and
in further collaboration with Dr. Zetterberg, we are in
the process of determining precisely this question.
These regions must be categorized, otherwise they will
be mistaken for recurring cancer lesions in our cancer
surveys. Furthermore, these normal variations may be
associated with inherited disease susceptibility or resis-
tance. In a collaboration with Conrad Gilliam of Col-
umbia University College of Physicians & Surgeons,
we are planning to carry out a large survey of normal
genomes and genomes from families with children
with mental or psychiatric disorders.
CANCER GENES
We have continued our work on the relationship of
PTEN expression and TGF-I3, a growth factor. We have
demonstrated that the expression of PTEN squelches
the effects of TGF-I3 on gene expression and are trying
to determine the mechanism of action. Work with col-
laborator Masaaki Hamaguchi here at CSHL has led to
the discovery of the DBC2 tumor suppressor
(Hamaguchi et al. 2002). DBC2 expression is lost in the
majority of breast cancer cell lines, and in lung cancers
as well. Its function is unknown, but its forced expres-
sion arrests the growth of cancer cell lines that have lost
expression of the endogenous gene. For more details,
see Hamaguchi's annual report. Work with the collabo-
rator Scott Powers at Tularik has led to the discovery of
a new class of oncogene, KCNK9 (Mu et al. 2003).
KCNB (a.k.a. KCNK9) encodes a potassium channel,
and work from the Tularik group suggests that it is
involved in resistance to death by oxygen limitation.
PTEN, DBC2, and KCNB were all discovered through
the use of representational difference analysis (RDA), a
method that was developed by us in past years (Lisitsyn
et al., Nat. Genet. 6: 57 [1994]; Proc. Natl. Acad. Sci.
92: 151 [1995]) and is now supplanted by ROMA.
CELL TALK
We continue to examine the question of whether we
can use microarray expression analysis and other
means to detect "conversations" between cancer cells
and cancer cells and hosts. Our rationale is that cancer-
host interaction remains a large unexplored chapter of
cancer biology. We initiated with pairs of sarcoma-car-
cinomas and found evidence that the transcriptional
state in one is affected by the presence of the other. We
are now exploring the effect that these cells have on
each other in co-tumorigenesis experiments. In collab-
oration with Jan Kitajewski at Columbia University
College of Physicians & Surgeons, we are testing
whether microarrays can be used to detect the inter-
action between the notch receptor and its ligands.
These interactions depend on direct cell-cell contact.
GENOME MAPPING, ASSEMBLY AND EVOLUTION
In collaboration with Bud Mishra here at CSHL and
the Courant Institute for Applied Mathematics at New
York University, we have developed uses of microar-
ray hybridizations for the mapping of probes in
genomes. A graduate student, Joseph West, has recent-
ly collected a full set of data in a model organism,
Schizosaccharomyces pombe, which will enable us to
test these ideas. John Healy in our group and a Watson
School graduate student, Elizabeth Thomas, have
found that our exact matching algorithms have had
some unexpected uses beyond probe design, namely,
monitoring inconsistencies between human genome
assemblies and the discovery of new genomic repeats.
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CANCER: CELL BIOLOGY
David Helfman's lab is working to understand how oncogenes disrupt a cell's cytoskeleton, the inter-
nal framework that gives a cell its shape and strength and controls its interactions with neighboring
cells. Cancer is due in part to the loss of such controlled interactions among neighboring cells, a loss
of control which enables cells to break free from their biological moorings and become metastatic.
Most cancers arise from epithelial cells, which line organs and body cavities. Senthil Muthuswamy's
lab is investigating how cells in healthy breast epithelium form hollow spherical structures, and how
cancer-causing genes, called oncogenes, cause the cells in these structures to proliferate out of con-
trol and metastasize.
Tatsuya Hirano's lab studies the function of proteins that act to modulate large-scale chromosome
structure and behavior. One of these proteins, called condensin, is required for the condensation or
compaction of chromosomes that occurs prior to cell division. Another, called cohesin, holds chromo-
some pairs together until the time is right for the pairs to separate and for each newly freed chromo-
some to migrate into one or the other cell as one cell divides and becomes two.
To better grasp how genes direct cell function, David Spector's lab has engineered a cell line that
allows them to watch DNA, RNA, and proteins in concerted action. Carefully designed molecules allow
them to see RNA transcribed from DNA and then to visualize proteins translated from the RNA.
Spector and his colleagues have provided the first glimpses of the entire process of gene expression
in living cells.
Arne Stenlund focuses on the events that trigger DNA replication and is collaborating with X-ray
crystallographer Leemor Joshua-Tor to unravel the crucial first steps during the replication of papillo-
mavirus DNA. Papillomavirus is associated with virtually all cases of cervical cancer. By studying the
biochemical and structural changes that initiate viral DNA replication, Stenlund and Joshua-Tor have
revealed key details not only about this cancer-causing virus, but also about the process of DNA repli-
cation in general. Moreover, these studies have uncovered specific molecular targets for the develop-
ment of drugs to prevent or treat cervical cancer.
Bruce Stillman's lab explores events that initiate cellular rather than viral DNA replication. One focus
of their research is a protein complex called ORC that attaches to DNA and both triggers DNA repli-
cation and silences gene expression. This year, Stillman's lab has discovered new roles for ORC in
chromosome segregation (the sorting of chromosomes during cell division such that each cell receives
a complete set of chromosomes) and in cytokinesis (the process in which cells divide as one cell
becomes two). As the researchers piece together the multiple roles of ORC and its various protein part-
ners, they are uncovering vital clues concerning how the control of DNA replication and cell prolifera-
tion is lost in cancer cells.
Nicholas Tonks's lab studies particular enzymes-protein tyrosine phosphatases-which typically
function to counteract the effects of growth factors and hormones, thereby helping to control cell
growth. Some protein tyrosine phosphatases, or PTPs, have been linked to diseases including cancer
and diabetes. This year, Tonks's lab has shown that decreasing the level of PTP1B in cells may be an
effective approach to treating cancer.
Proteins called Ras and Rap have well-defined, antagonistic growth-promoting and growth-inhibit-
ing functions in non-neuronal cells which, when altered, can lead to cancer. Linda Van Aelst and
Roberto Malinow have discovered intriguing roles for Ras and Rap in cells of the nervous system. Van
Aelst, Malinow, and their colleagues have shown that Ras mediates the addition of AMPA receptors to
synapses during LTP (long-term potentiation of synaptic activity), whereas under conditions that induce
LTD (long-term depression of synaptic activity), Rap mediates the removal of AMPA receptors from
synapses. Moreover, Van Aelst and Malinow established a differential effect of Ras and Rap on differ-
ent types of AMPA receptors. The resulting dynamics of AMPA receptor replacement at synapses is
likely to be a principal mechanism of learning and memory.
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THE CYTOSKELETON AND ONCOGENIC TRANSFORMATION
D.M. Helfman E. Araya S.-W. Lee
L. Connell G. Pawlak
E. Kim
We are interested in the role of the cytoskeleton in
oncogenesis and tumor suppression. The importance
of the cytoskeleton in oncogenesis was first inferred
from studies almost 30 years ago showing that disrup-
tion of actin filament bundles (stress fibers) is a com-
mon feature following transformation by various
oncogenes. These changes in the cytoskeleton are a
result of changes in the expression of both specific
cytoskeletal proteins and signaling molecules, e.g.,
small GTPases and kinases. The changes in the cyto-
skeleton are more than simply a generic consequence
of cell reorganization characteristic for oncogenic
transformation. For example, work by our lab and oth-
ers has shown that ectopic expression of specific
cytoskeletal proteins can suppress many features of
transformation, including disruption of microfilament
bundles and focal adhesions, loss of contact-inhibited
cell growth, ability to grow in soft agar, and tumori-
genicity in nude mice, indicating that the loss of spe-
cific cytoskeletal proteins has a direct role in oncoge-
nesis. However, the mechanisms by which specific
components of actin structures are targeted and dereg-
ulated by oncogenes are unknown, and, more impor-
tantly, how the accompanying changes in actin fila-
ment organization contribute mechanistically to onco-
genesis remains to be established. We are studying the
molecular mechanisms involved in oncogene-mediat-
ed disruption of the cytoskeleton and how the actin
cytoskeleton participates in pathways linked to trans-
formation. Below is a description of our studies during
the past year to better understand the role of the
cytoskeleton in normal and transformed cells.
Anchorage-independent Activation of
ERK1/2 Depends on MLCK-mediated
Regulation of Myosin II
G. Pawlak
It has been suggested that oncogenes induce anchor-
age-independent growth by substituting for cell adhe-
sion, therefore causing aberrant activation of signaling
pathways that are normally regulated by adhesion.
Activation of the ERK1/2 pathway notably becomes
adhesion-independent in Ras-transformed fibroblasts
(NRK/ras cells). Since adhesion-dependent signaling
itself is regulated in part by the actin cytoskeleton, we
investigated the potential role played by the actin
cytoskeleton in the anchorage-independent activation
of ERK1/2 observed in NRK/ras cells. For that pur-
pose, we used specific pharmacological agents to
inhibit myosin II function or disrupt the actin
cytoskeleton. We then studied activation of ERK1/2 in
NRKIras cells. We found that activation of ERK1 /2
was strictly dependent on myosin light-chain kinase
(MLCK) activity, since inhibition of this kinase by
ML7 or ML9 leads to a complete inhibition of ERK1 /2
phosphorylation, even when NRK/ras cells are kept in
suspension. On the other hand, inhibition of Rho-
kinase did not have any effect on the level of ERK1 /2
phosphorylation. We also found that this effect was
specific for ERK1/2 since phosphorylation of Akt by
phosphatidylinositol 3-kinase (PI3K) was not affected
by inhibition of MLCK. MLCK is a known substrate of
ERK1/2, raising the interesting possibility that an
autocrine loop takes place in NRK/ras cells, in which
the MLCK-dependent actomyosin contractility allows
constitutive activation of the ERK. pathway, which, in
turn, keeps the MLCK active, irrespective of the adhe-
sion state of the cells. We are currently trying to define
the step along the Ras-Raf-MEK-ERK pathway that is
dependent on MLCK activity to obtain some insight
into the underlying mechanism.
The Cytoskeleton and
Programmed Cell Death
L. Connell
The association of cells with the extracellular matrix
(ECM) has an important role in maintaining cell sur-
vival. This interaction between a cell and the ECM
generates signals from focal adhesions that promote
growth and survival. Activation of myosin II is neces-
sary for the formation of focal adhesions. When nor-
mal cells detach from the ECM, they undergo a par-
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ticular kind of apoptosis due to loss of survival sig-
nals, called anoikis. Transformed cells do not undergo
anoikis, and loss of anchorage dependence in cells
correlates with tumor growth. Presumably, trans-
formed cells can activate signals that would normally
emanate from cell attachment to the ECM. We are
interested in elucidating the pathway between cell
attachment to the ECM and activation of actomyosin
contractility (myosin II) and generation of survival
signals. By utilizing pharmacological agents and
mutant proteins that can disrupt actin filament organi-
zation and inhibit myosin function, we are studying
the role of the actin cytoskeleton and myosin in cell
survival in normal and transformed epithelial cells.
Integrins also have an important role in the generation
of adhesion-dependent signaling. The expression and
activation states of different integrins in normal and
transformed epithelial cells are also being investigat-
ed to understand what role integrins may have in
anchorage-independent cell survival.
Mechanisms Underlying Ras-induced
Morphological Transformation and
Inactivation of Rho-dependent
Stress Fiber Formation
S.-W. Lee
Studies in our lab during the past year have investigat-
ed the signaling pathways by which oncogenic ras and
v-src disrupt the actin cytoskeleton (Pawlak and
Helfman 2002a,b). These studies demonstrated that the
sustained MAPK signaling in response to both types
on oncogenic stimuli results in down-regulating the
activity of Rho-kinase, a Rho effector required for
stress fiber formation (see Fig. 1). Thus, a critical func-
tion of sustained MAPK signaling is to uncouple Rho-
GTP from stress fiber formation. Furthermore, these
studies demonstrate that these functionally different
oncogenes, namely, the small GTPase ras and the tyro-
sine kinase v-src, use the same signaling pathway to
achieve morphological transformation of fibroblasts,
i.e., inactivation of Rho-mediated stress fiber assembly
through sustained activation of the ERK pathway.
However, the mechanism responsible for suppression
of Rho- kinase activity was not fully established. We
have continued to study the mechanism by which acti-
vation of MAPK leads to diminished Rho-kinase activ-
ity. During the past year, we have found a potential role
for p21c'Puwan in the regulation of cytoplasmic Rho-
kinase (ROCK).
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FIGURE 1 Constitutive MAP-kinase signaling uncouples Rho-
GTP from stress fiber formation.
p2 1 ciPuwan is best known as a broad-specificity
inhibitor of cyclin/CDK complexes, but, paradoxically,
the level of p21c'Pliwan expression is highly increased in
various human cancers. In recent years, accumulating
evidence has suggested that p2 1 ciPliwan located in the
cytoplasm might have a role in promoting transforma-
tion and tumor progression. Using NIH-3T3 fibrob-
lasts, we have found that activation of Ha-RasV12
causes a loss of actin stress fibers and focal contacts.
Ras-mediated transformation was also accompanied by
induced expression of p21c'Puwafl. Immunofluorescence
studies showed that more than 90% of the cells
expressed p2 1 cloiwan in the cytoplasm as well as in the
nucleus. Recently, Tanaka and colleagues reported that
cytoplasmic p21c'P''"fl has a role in regulation of neu-
rite remodeling by inhibiting ROCK activity in the
cytoplasm. Accordingly, we examined the hypothesis
that p21'0 /wan contributes to the disruption of actin
stress fibers in Ras-transformed cells by targeting the
ROCK/LIMK/cofilin pathway. We consistently
observed a decrease in the phosphorylation level of
cofilin in Ha-RasV12-transformed cells, which is
indicative of a compromised ROCK/LIMK/cofilin
pathway. Interestingly, inhibition of MEK using
U0126, in Ha- RasVl2- transformed NIH-3T3 cells,
caused a decrease in p21'Pl/wafi protein expression, fol-
lowed by an increased level of phosphorylated cofilin,
which is indicative of a restored ROCK/LIMK/cofilin
pathway, resulting in the restoration of actin stress
fibers. Furthermore, restoration of stress fiber by inhi-
bition of MEK in Ha-RasV12 cells was blocked fol-
lowing ectopic expression of a mutant form of
p21c'o'van that did not have the nuclear localization
signal and therefore was localized in the cytoplasm.
Coimmunoprecipitation experiments also showed that
p2lciolwan interacts with ROCK in vivo. Taken togeth-
er, these results suggest that p21'Pl''' is a novel regu-
lator of actin remodeling by inhibiting ROCK activity
in Ras-transformed cells.
Characterization of the
Metastasis-associated
Protein, S100A4
E. Kim
Elevation in expression of the small calcium-binding
protein S100A4 has been correlated with increased
invasiveness and with a worse prognosis in the case of
breast cancer. In vitro biochemical assays have sug-
gested calcium-dependent protein-protein interactions
between S100A4 and three cytoskeletal proteins:
actin, tropomyosin, and myosin. We have confirmed a
calcium-dependent interaction between S100A4 and
the heavy chain of nonmuscle myosin in vivo.
Specifically, we have demonstrated that S 100A4 inter-
acts with the myosin heavy-chain II-A isoform prefer-
entially over the II-B isoform in vivo. A mutant
S100A4 that is incapable of binding to calcium is
unable to interact with myosin heavy-chain II-A.
Through the use of mutants singly defective in calci-
um binding at either of the two EF-hand motifs, we
have found that the lower-affinity site dictates full
function. Furthermore, we have determined through
the study of these mutants deficient in calcium bind-
ing that S100A4 homodimerization is dependent on
the monomeric calcium-binding status.
To further study the S100A4 protein, we have per-
formed immunofluorescence studies of the endoge-
nous protein in the aggressively turmorigenic breast
cancer cell line, MDA-MB-231. When plated on col-
lagen, these cells demonstrate a polarized morphology
indicative of motile cells. S100A4 localizes to the
leading edge of these polarized cells. It also consis-
tently colocalizes with known markers or effectors of
lamellipodial formation. Interestingly, sublines stably
expressing tagged forms of either wild type or a calci-
um-binding-deficient mutant also localize to the same
leading-edge region. Further evidence that this local-
ization is not through a calcium-dependent interaction
with myosin heavy-chain II-A comes from prelimi-
nary immunofluorescence studies in COS cells which
lack myosin heavy-chain II-A, yet demonstrate similar
localization to the leading edge.
Molecular Organization and
Regulation of Actin Filaments
E. Araya
In nonmuscle cells, the formation of actin filaments
and their assembly into various structures, e.g., stress
fibers, contractile ring, filopodia, and lamellipodia, are
dynamic processes. How these different structures are
formed and regulated within a single cell is not known.
In addition to actin and its associated motor molecules
(myosin I and II), other actin-filament-associated pro-
teins, such as tropomyosin, have essential roles in the
assembly, function, and regulation of these structures.
We have begun to use RNA interference (RNAi) to
inhibit the expression of specific isoforms of
tropomyosin as well as other cytoskeletal proteins. By
using RNAi technology, we plan to carry out a system-
atic screen targeted to structural and regulatory com-
ponents of the cytoskeleton. These studies will deter-
mine the effects of disrupting the expression of specif-
ic proteins. For example, we will determine if loss in
the expression of specific proteins leads to changes in
the structure of the actin cytoskeleton, focal contacts,
and cell-cell contacts, as well as the motile and growth
properties of cells. It is anticipated that these studies
will identify key components of the cytoskeleton
involved in cell motility and growth control.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano 0. Cuvier A. Losada
P. Gillespie T. Ono
M. Hirano
Our laboratory is interested in understanding the mol-
ecular mechanisms by which mitotic chromosomes
are assembled and segregated during the cell cycle.
Our efforts are focused on the structural and function-
al analyses of two multisubunit protein complexes-
cohesin and condensin-that have central roles in sis-
ter chromatid cohesion and condensation, respectively.
Each of the complexes contains a different pair of
SMC (structural maintenance of chromosomes)
ATPase subunits, implicating a mechanistic similarity
between cohesion and condensation. SMC proteins are
also conserved in most bacterial and archaeal species.
It is therefore anticipated that elucidating the action of
this class of proteins is the key to understanding the
evolutionarily conserved, fundamental aspects of
higher-order chromosome dynamics.
Regulation of Cohesion and the
Establishment of Metaphase
Chromosomes
A. Losada, T. Hirano
The establishment of metaphase chromosomes is an
essential prelude to the synchronous and accurate seg-
regation of sister chromatids in anaphase. In meta-
zoans, this event involves at least two distinct process-
es. The first process is the loosening of sister chro-
matid cohesion, which accompanies the dissociation
of most cohesin from chromatin in prophase. The sec-
ond is the initiation of compaction, which is triggered
by the association of condensin with chromatin.
Although it is widely believed that the former process
may be the prerequisite of the latter, this idea has never
critically been tested before. We have used Xenopus
egg cell-free extracts to address the mechanistic rela-
tionship between the two processes. We show that the
prophase release of cohesin is completely blocked
when two mitotic kinases, polo-like kinase (Plxl) and
aurora B, are simultaneously depleted from the
extracts. To our surprise, we find that condensin is
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loaded onto chromatin despite the presence of abnor-
mally high levels of cohesin and that rod-shaped chro-
mosomes are produced with an apparently normal
degree of compaction (Fig. 1). Importantly, however,
the resolution of sister chromatids within these chro-
mosomes is severely compromised. Depletion of Plxl
and aurora B has little effect on the replication of chro-
mosomal DNA or on the activity of topoisomerase II
that decatenates intertwined sister DNAs. It is there-
fore most likely that the observed defect in sister chro-
matid resolution is a direct consequence of the failure
of cohesin release from chromatin. Plxl and aurora B
phosphorylate cohesin and histone H3, respectively, in
vitro, suggesting that the two kinases cooperate to
destabilize sister chromatid linkage through distinct
mechanisms. Thus, our results strongly suggest that
the bulk dissociation of cohesin is essential for sister
chromatid resolution, but not for condensin-mediated
compaction.
FIGURE 1 The resolution of sister chromatids is defective in the
absence of Plxl and aurora B. Sister chromatids are well-
resolved in a metaphase chromosome assembled in the control
extract (a), whereas they cannot be distinguished from each
other in a chromosome assembled in the Plxl/aurora B-deplet-
ed extract (b). Bar, 2 gm.
Establishment of Sister
Chromatid Cohesion
P. Gillespie, T Hirano
In eukaryotic cells, the physical linkage between dupli-
cated chromatids (sister chromatid cohesion) is con-
structed during S phase, and the cohesin complex is
part of the molecular "glue" that holds the sister chro-
matids together. Current models suggest that this
process involves at least two steps: the binding of
cohesin to chromatin, and the establishment of cohe-
sion that presumably accompanies a conformational
change or activation of cohesin. Although regulatory
components required for each step have been identi-
fied genetically in yeast and fungi, it remains to be
determined how the process is accomplished at a
mechanistic level. To address this question, we take
advantage of Xenopus cell-free extracts in which the
whole process of sister chromatid cohesion can be
reconstituted in vitro. Our effort is now focused on the
functional characterization of two conserved cohesion
factors, Scc2 and Ecol. Scc2 is implicated in directing
cohesin's association with chromatin, whereas Ecol
facilitates the establishment step by an unknown mech-
anism. As an initial attempt, we have cloned the corre-
sponding Xenopus cDNAs by reverse transcriptase-
polymerase chain reaction (RT-PCR). Interestingly, we
find that Xenopus has two isotypes of each protein. A
database search reveals that this is also the case in
humans. We have prepared a panel of antibodies
against individual polypeptides to further investigate
the cellular localization and functions of Scc2 and
Ecol. Moreover, we set up a series of experiments to
determine how the establishment of cohesion might
functionally be coupled to DNA replication. Prelimi-
nary evidence suggests that cohesin is loaded onto
chromatin at a stage between replication licensing and
elongation.
Role of Topoisomerase II in
Linking DNA Replication to
Chromosome Condensation
0. Cuvier, T. Hirano
Topoisomerase II (topo II) is an ATP-dependent,
DNA-strand-passing enzyme that passes one duplex
through a transient break in another and rejoins the
break in vitro. The condensin complex has a different
activity that introduces a superhelical tension into
DNA in an ATP-dependent manner. Previous studies
suggested that topo II and condensin are both required
for mitotic chromosome condensation in Xenopus egg
cell-free extracts. We are interested in understanding
how the two different molecular activities might con-
tribute to chromosome condensation and what the
exact roles of condensin and topo II might be in orga-
nizing higher-order chromosome structure. To this
end, we have used the egg extracts in which mitotic
chromosome assembly can be induced in the absence
or presence of preceding DNA replication. When
unreplicated chromatin is directly incubated with a
mitotic extract, condensin and topo II must function
together to assemble mitotic chromosomes. In con-
trast, when chromosome assembly is induced after
DNA replication, the requirement for topo II can tem-
porarily be separable from that of condensin. This
experimental setting allows us to find that in the
absence of condensin, topo II becomes enriched in an
axial structure within uncondensed chromatin.
Subsequent addition of condensin converts this struc-
ture into mitotic chromosomes in an ATP-hydrolysis-
dependent manner. Strikingly, prevention of DNA
replication by the addition of geminin or aphidicolin
disturbs the formation of topo-II-containing axes and
alters the binding property of topo II with chromatin.
Our results suggest that topo II has an important role
in an early stage of chromosome condensation and
that this function of topo II is tightly coupled with
prior DNA replication.
Condensin Functions In Vivo
T. Ono, T. Hirano
The condensin complex is composed of two SMC sub-
units (CAP-E/SMC2 and CAP-C/SMC4), and three
non-SMC subunits (CAP-D2, CAP-G, and CAP-H).
Although our previous work demonstrated that con-
densin has a central role in establishing and maintain-
ing mitotic chromosome structure in Xenopus egg
cell-free extracts, much less is known about how the
complex contributes to these processes in vivo. We
have taken three different approaches to address this
question in vertebrate cells. First, immunofluorescent
microscopy is used to obtain more insight into the spa-
tial and temporal regulation of condensin. Our previ-
ous work using a phosphospecific antibody showed
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that threonine-1314 of XCAP-D2 (Xenopus CAP-D2)
is phosphorylated in a mitosis-specific, cdc2-depen-
dent manner in vitro. Immunofluorescent staining of
Xenopus tissue culture cells shows that this phospho-
rylated epitope appears on chromosomes in prophase
and is maintained until metaphase. Interestingly, how-
ever, the epitope becomes undetectable in anaphase,
suggesting that the phosphorylation status of con-
densin is changed at the metaphase-anaphase transi-
tion. Second, we have established stable He La cells
expressing epitope-tagged subunits of the condensin
complex. We are currently expressing mutant forms of
the subunits to test whether different mutations may
cause specific, dominant-negative phenotypes. Third,
we use an RNA interference (RNAi) technique to
repress the expression level of individual condensin
subunits. We find that cells depleted of different sub-
units show distinct abnormalities, suggesting that each
subunit may have a different role in the formation of
higher-order chromosome structure in mitosis.
Structural and Functional
Dissection of SMC Proteins
M. Hirano, T. Hirano
SMC proteins are highly conserved among the three
phyla of life. To understand the basic action of this
unique class of chromosomal ATPases, we use the
SMC homodimer from the gram-positive bacterium
Bacillus subtilis (BsSMC) as a simple model system.
As judged by electron microscopy, BsSMC is com-
posed of two antiparallel, coiled-coil arms with a flex-
ible hinge. It has not been established, however, how
the two subunits dimerize to make such a two-armed
molecule. By using a site-directed cross-linking
approach, we show that dimerization of BsSMC is
mediated by a hinge-hinge interaction between self-
folded monomers. A coiled-coil interaction assay
shows that this architecture is also conserved in the
eukaryotic SMC2-SMC4 heterodimer. Analysis of dif-
ferent deletion mutants of BsSMC unexpectedly
reveals that the major DNA-binding activity does not
reside in the catalytic ATPase domains located at the
ends of a dimer. Instead, point mutations in the hinge
domain that disturb dimerization of BsSMC drastically
reduce its ability to interact with DNA. Furthermore,
we find that proper hinge function is essential for
BsSMC to recognize distinct DNA topology and that
mutant proteins with altered hinge structure cross-link
double-stranded DNA in a nucleotide-dependent man-
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net We propose that the hinge domain of SMC proteins
is not a simple dimerization site; rather, it acts as an
essential determinant of dynamic SMC-DNA interac-
tions.
Single-molecule Manipulation
T. Hirano, M. Hirano [in collaboration with T. Stick,
Cold Spring Harbor Laboratory]
In collaboration with Terence Strick's group here at
CSHL, we use a single-molecule manipulation tech-
nique to study the interaction of condensin and
BsSMC with DNA. This powerful technique should
provide us with the mechanistic information as to how
the SMC protein and protein complexes change the
structure of DNA at an unprecedented resolution.
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EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy T. Haire M. Moore
B. Xiang K. Farina
A. Lucs
EARLY EVENTS IN BREAST CANCER
Almost all malignant breast cancers originate from
epithelial cells. Several oncogenes and tumor suppres-
sor genes have been implicated in breast cancer; how-
ever, we do not understand the mechanisms by which
oncogenes initiate transformation of mammary epithe-
lial cells (MECs) that line the ducts and alveoli in the
breast. Early lesions, characterized by uncontrolled
proliferation and disruption of epithelial architecture,
are currently defined by histological features, and
their prognosis is imprecisely determined. Although
lesions within a category look alike, they must possess
molecular differences that allow some to become
malignant and others to remain benign. Understanding
the molecular mechanisms involved in initiation of
carcinoma will not only identify early diagnostic
markers, but also identify drug targets for treating pre-
malignant disease.
Conventional transformation assays (foci forma-
tion, soft agar growth, and tumor formation in nude
mice) do not allow us to investigate the cell and mole-
cular changes that take place in polarized epithelia that
line the ducts and alveoli in vivo. We have adapted a
cell culture technique where nontransformed MECs
form three-dimensional acinus-like structures contain-
ing a single layer of polarized, growth-arrested epithe-
lial cells when grown within a matrix rich in laminin
and collagen (Matrigel). The epithelial cells in these
structures, unlike cells grown on plastic dishes, share
several properties with those that line the ducts and
lobules in an adult breast. Interestingly, tumor-derived
epithelial cell lines or epithelial cell lines transformed
in culture fail to form acinus-like structures in three
dimensions. They either form filled spheroids or do
not growth-arrest or both, suggesting that acinus-like
structures formed by nontransformed MEC possess
unique properties that are lost during transformation.
Oncogenes in the ErbB family of receptor tyrosine
kinases have important roles in breast cancer. Among
its four members, ErbB2 overexpression is observed
in 25-35% of breast cancers and correlates with poor
clinical prognosis. ErbB2 is targeted for therapy using
anti-ErbB2 antibodies, i.e., Herceptin. ErbB3 is co-
overexpressed with ErbB2. Despite the compelling
evidence for a role of the ErbB family in breast cancer,
it has been challenging to decipher the signaling and
biological specificities of ErbB receptor activation,
because MECs express multiple ErbB receptors and
homo- and heterodimerization of ErbB receptors com-
plicate our ability to determine how specific ErbB
dimers transform mammary epithelia.
We have developed a novel method to control
dimerization and activation of ErbB receptors without
contribution from endogenous receptors. This method,
for the first time, will allow us to dissect out the mech-
anisms by which specific ErbB homo- and het-
erodimers transform normal mammary epithelial
cells. We have successfully integrated the controlled
dimerization strategy and the three-dimensional cell
culture method. Using this powerful and unique sys-
tem, we can now activate specific ErbB dimers of
choice in three-dimensional epithelial structures that
share several properties with cells that line the ducts
and alveoli in vivo. We believe that this approach will
take us a step closer to conditions in vivo and will
allow us to uncover molecular mechanisms involved in
initiation of transformation that cannot be readily
determined under standard culture conditions or with
the use of animal models.
ONCOGENESIS USING THREE-DIMENSIONAL ACINI
Activating ErbB Receptors in Three-dimensional
Acini: We have previously analyzed the differential
effects of activating ErbB1 and ErbB2 receptors in
preformed, growth-arrested, polarized acinar struc-
tures to mimic the conditions in which ErbB receptors
are amplified and activated in vivo. Activation of
ErbB2 in preformed mammary epithelial acini results
in reinitiation of proliferation, loss of polarized orga-
nization, and formation of structures containing multi-
ple acinar units. Each acinus within these structures
had a filled lumen, surrounded by an intact basement
membrane, and did not display any invasive proper-
ties. The phenotype displays aspects of a premalignant
stage of breast cancer in vivo referred to as carcinoma
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in situ, suggesting that activating oncogenes in three-
dimensional acini in culture will allow us to identify
the mechanisms that are involved in early stages of
cancer.
Our recent studies suggest that coactivation of
ErbB2 and ErbB3 not only induces reinitiation of pro-
liferation and formation of multi-acinar structures, but
also induces invasive behavior. Coactivation of ErbB1
and ErbB3 did not induce invasive properties, sug-
gesting that ErbB2/ErbB3 dimers possess the unique
ability to induce tumor progression. Our results are
consistent with clinical reports suggesting that coex-
pression of ErbB2 and ErbB3 in primary breast
tumors correlates with poor clinical prognosis. Thus,
three-dimensional epithelial acini can be used to iden-
tify early events in cancer and also to investigate
mechanisms involved in cancer progression.
Effect of Activating Receptor Tyrosine Kinases in
Three-dimensional Acini: We have begun to system-
atically analyze the effect of activating differentrecep-
tor tyrosine kinases in three-dimensional epithelial
cell acini. It is likely that we will be able categorize
receptor tyrosine kinases on the basis of the ability to
affect the three-dimensional organization of acini,
reinitiate proliferation, induce filling of the lumen,
and induce invasive properties and disruption of
epithelial cell polarity. Such categorization will allow
us to identify the mechanisms shared by receptor tyro-
sine kinases to transform three-dimensionally orga-
nized epithelial cells.
Cell Cycle Regulation on Three-dimensional Acini:
The mechanism by which oncogenes reinitiate prolif-
eration in growth-arrested epithelial acini is not
understood. We have begun to investigate how activa-
tion of ErbB2 induces reinitiation of proliferation.
Our initial observations suggest that activation of
ErbB2 induces down-regulation of a cell cycle
inhibitor p27/Kipl and a concomitant up-regualtion of
Skp2, a component of the SCF/Cullin/F-Box (SCF)
complex. It has been shown that growth-promoting
factors such as serum induce down-regulation of p27
by regulating the function of SCF complex. Whether
ErbB2 regulates the SCF complex to effect prolifera-
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tion of epithelial cells is not known. The relationship
between ErbB2 and the SCF complex in primary
breast tumors is not well understood.
ErbB RECEPTORS AND EPITHELIAL CELL POLARITY
Activation of ErbB2 but not ErbB2 induces disruption
of cell polarity as monitored by its ability to induce
mislocalization of tight-junction-associated proteins
ZO-1 and AF-6 and apical membrane-associatedpro-
tein GP135.
Recent studies have identified three protein com-
plexes conserved in Drosophila, Caenorhabditis ele-
gans, and mammals that regulate establishment of
epithelial cell polarity: the Par3/Par6/aPKC/CDC42
complex, crumbs/Pals 1 /PATJ complex, and Scribble/
Lgl/Dlg complex. It is thought that these protein com-
plexes regulate formation of polarity in an interdepen-
dent manner. It is not known whether oncogenes that
disrupt the architecture of epithelial cells regulate pro-
tein complexes involved in the formation of cell polar-
ity. Our results suggest that activation of ErbB2
induces mislocalization of the Par complex in polar-
ized epithelial cells. In addition, activation of ErbB2
also regulates the biochemical composition of the
Par3/Par6/aPKC complex. We are in the process of
investigating how activation of ErbB2 affects the com-
position of the Par complex and will determine the
role the Par complex has in ErbB2-induced transfor-
mation of epithelial cells.
We propose that understanding how oncogenes
deregulate proliferation and disrupt polarized archi-
tecture of growth-arrested, polarized epithelial cells
will allow us to identify novel mechanisms that regu-
late early events in epithelial cancers.
PUBLICATIONS
Debnath J., Mills KR., Collins N.L., Reginato M.J., Muthu-
swamy S.K., and Brugge J.S. 2002. The role of apoptosis
in creating and maintaining lumina' space within normal
and oncogene-expressing mammary acini. Cell 111:
29-40.
CELL BIOLOGY OF THE NUCLEUS
D.L. Spector Y.-C.M. Chen S.M. Janicki
L. Denis P. Kannanganattu
Y. Fang G. Lark
S. Hearn P. Sacco-Bubulya
Most cellular processes can trace their beginnings to
the nucleus where a gene is activated resulting in the
production of an RNA molecule which must get
processed and transported to the cytoplasm. Although
many genes are constitutively expressed, a large num-
ber are up-regulated and down-regulated at various
times during the cell cycle and development. Trans-
acting factors have the daunting task of locating and
gaining access to specific genes within the three-
dimensional nuclear space. Altering the transcription-
al status of a particular gene involves a series of events
including chromatin remodeling and the recruitment
of a large number of factors involved in either tran-
scription/RNA processing/export or silencing events.
However, a failure of the correct set of factors to asso-
ciate with their target substrates at the correct time
will result in changes in the gene expression program
which can lead to a disease phenotype. Although much
biochemical information is available regarding some
of the factors involved in these processes, the spatial
and temporal aspects of the regulation of gene expres-
sion/silencing and the dynamics of the nuclear
domains that they occupy are less well understood.
During the past year, we have focused a significant
amount of our efforts on two main areas: (1) the devel-
opment of a system to directly visualize gene expres-
sion in living cells, and (2) characterization of nuclear
speckles and PML nuclear bodies.
VISUALIZING GENE EXPRESSION
IN LIVING CELLS
We have developed a mammalian cell line that allows
us to directly visualize a stably integrated inducible
genetic locus as well as its RNA and protein products
in living cells. The locus is based on a 20-kb plasmid
that contains at its 5' end lac operator repeats that
when bound by a cyan fluorescent protein (CFP)-Lac
repressor fusion protein allows the integration site to
be visualized. A tetracycline-responsive element
enables the minimal cytomegalovirus (CMV) promot-
er to be regulated. Transcription by RNA polymerase
II (pol II) results in an RNA containing stem loop
structures that are specifically recognized by the bac-
teriophage MS2-binding protein. Expression of MS2-
binding protein fused to yellow fluorescent protein
(YFP) containing a nuclear localization signal allows
us to see the RNA as it is being transcribed. The RNA
encodes CFP with a peroxisome-targeting signal to
allow the protein product of this transcription unit to
be visualized as it concentrates in cytoplasmic peroxi-
somes. Using this system, we have observed the
dynamics of proteins associated with inactive (i.e.,
HP1, Suv39h1) as well as active (i.e., VP-16, RNA pol
II) chromatin. Activator arrival results in extensive
chromatin decondensation as well as initiation of tran-
scription (Fig. 1). Within 5-10 minutes of transcrip-
tion initiation, we can detect nascent RNA at the tran-
scription site in living cells. During this time period,
the nucleoplasmic pool of MS2-binding protein
changes from a diffuse distribution to a granular dis-
tribution suggestive of the formation of mRNP parti-
cles. In addition, we have observed components of the
RNA processing machinery, which localize in differ-
ent nucleoplasmic regions, recruited to the transcrip-
tion site. In addition to visualizing the dynamics of
transcription/RNA processing, we have also been able
to characterize the reorganization of the genetic locus
during its transition from a transcriptionally inactive
state to an active state. This system provides a power-
ful approach to examine the dynamics and coordina-
tion of gene expression in the context of the living cell.
Ongoing studies in the laboratory are utilizing this
system to examine the spatial and temporal events of
gene expression, silencing, and DNA replication.
NUCLEAR BODIES
Although the cell nucleus was once thought of as an
amorphous milieu containing little organization or
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FIGURE 1 Visualization of a stably integrated genetic locus in the transcriptionally active state. The 4-Mb locus appears
decondensed (arrow, left panel) and the protein product of the locus is concentrated in cytoplasmic peroxisomes. Messenger
ribonucleoprotein (mRNP) particles are observed concentrated at the locus (arrow, middle panel) as well as distributed in a
granular pattern in the nucleoplasm. Overlay of the two images is visualized in the right panel. Photo provided by Susan M.
Janicki (CSHL).
functional compartmentalization, more contemporary
studies have identified an increasing number of spe-
cialized domains or subnuclear organelles. In some
cases, these domains are dynamic structures, exhibit-
ing rapid protein exchange between the domain and
the nucleoplasm. To date, more than 12 different
nuclear domains have been identified. Ongoing stud-
ies in the laboratory are focusing on two of these
nuclear domains: PML (promyelocytic leukemia)
nuclear bodies and nuclear speckles.
PML nuclear bodies have received much attention
because they display a more dispersed intranuclear
pattern in blast cells from individuals with acute PML
carrying a t(15,17) translocation involving a fusion of
the PML protein and the retinoic acid receptor a.
Retinoic acid or arsenic trioxide treatment can induce
complete remission of the disease and results in refor-
mation of the PML bodies. In addition, PML bodies
are modulated by interferon or heat shock treatments,
and they are associated with the sites of initial DNA
tumor virus transcription/replication in infected cells
and are subsequently disrupted at later stages in the
infectious cycle. A clear function for these bodies has
as yet not been established; however, roles in tran-
scriptional regulation, as storage sites regulating the
levels of active proteins within the nucleus, or as sites
of active proteolysis have been pursued. To differenti-
ate between these possibilities, we have taken a bio-
chemical approach and have developed a strategy to
purify and biochemically characterize these nuclear
bodies. Thus far, we have obtained a nuclear fraction
enriched in these bodies, and ongoing studies are
attempting to further purify PML bodies and deter-
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mine their complete protein composition using mass
spectrometry.
RE-ESTABLISHING THE INTERPHASE
NUCLEUS AFTER MITOSIS
Pre-mRNA splicing factors are localized in a speckled
pattern, set within a diffuse nuclear distribution, when
mammalian cell nuclei are examined by immunofluo-
rescence microscopy using anti-splicing-factor anti-
bodies. At the electron microscopic level, this local-
ization pattern corresponds to interchromatin granule
clusters and perichromatin fibrils. Splicing factors are
recruited from interchromatin granule clusters to
regions of active transcription (perichromatin fibrils),
where they function in cotranscriptional pre-mRNA
processing. We have previously observed this recruit-
ment in living cells by time-lapse microscopy of green
fluorescent protein (GFP)-tagged splicing factors.
Although there is a continuous flow of GFP-tagged
splicing factors in and out of nuclear speckles, these
structures, as well as their positions within the nucle-
us, are maintained for many hours. We would like to
understand how interchromatin granule clusters
(IGCs) are established and organized within the nucle-
us and elucidate their relationship to specific aspects
of gene expression.
Interestingly, mammalian cell nuclei undergo
many changes upon entry into mitosis, including chro-
matin condensation, termination of transcription, and
disassembly of nuclear structures such as the nuclear
lamina, nucleoli, nuclear speckles, and other nuclear
bodies. When mitosis is completed, the chromatin
decondenses, transcription begins, and nuclear struc-
tures are reassembled in daughter nuclei. We have
been interested in how the pre-mRNA processing
machinery is reorganized into nuclear speckles in
daughter nuclei, and how this reassembly is coordinat-
ed with reactivation of gene expression. We have dis-
covered a novel pattern of splicing factor localization
in daughter nuclei during telophase, prior to reforma-
tion of nuclear speckles. Splicing factor SF2/ASF
transiently localizes in a ring of patches surrounding
transcriptionally active nucleolar organizing regions
(NORs) that contain UBF, fibrillarin, and rRNA tran-
scripts. The patches differ from mature nuclear speck-
les in that they do not contain stable poly(A)' RNA or
hyperphosphorylated SR proteins. A He La cell line
stably expressing YFP-SF2/ASF was used to examine
the dynamics of the patches in living cells.
Fluorescence recovery after photobleaching (FRAP)
has revealed a turnover of YFP-SF2/ASF within this
structure. As YFP-SF2/ASF nuclear entry proceeds,
we observe a "wave" of YFP-SF2/ASF entry that orig-
inates at the patches and progresses through the nucle-
us. We have also observed that YFP-SF2/ASF
telophase patches fragment, traverse the nucleoplasm,
and develop into nuclear speckles in G1 nuclei.
Intriguingly, we colocalized protein phosphatase 1
with SF2/ASF in the patches. On the basis of these
findings, we propose that localized phosphatase activ-
ity may dephosphorylate SR proteins upon their
nuclear entry, initiating RS domain-RS domain inter-
actions and facilitating formation of the patches as a
"seed" for nuclear speckle assembly in daughter
nuclei.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund M. Blennau S. Schuck
A. Lee T. Denkenberger
G. Karger
The papillomaviruses are a group of viruses that infect
and transform the basal epithelium inducing prolifera-
tion of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently, cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents the few firmly
established links between viral infections and the
development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These
viruses normally require specialized differentiating
cells that only with difficulty can be generated in cell
culture. However, for a bovine papillomavirus (BPV-1),
a convenient cell culture system exists where viral
gene expression, oncogenic transformation, and viral
DNA replication can be studied. Thus, BPV has
become a useful model for these aspects of the viral
life cycle. The DNA replication properties of the papil-
lomaviruses show some unique and interesting charac-
teristics. As part of their normal life cycle, these virus-
es can exist in a state of latency, which is characterized
by maintenance of the viral DNA as a multicopy plas-
mid in infected cells. The copy number of the viral
DNA is tightly controlled, and the viral DNA is stably
inherited under these conditions. Papillomaviruses
therefore provide a unique opportunity to study plas-
mid replication in mammalian cells. In addition, the
viral DNA replication machinery represents one of the
most promising targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. In recent years, we have direct-
ed our attention toward the biochemical events that are
associated with initiation of DNA replication. We are
studying the biochemical properties of the viral El
and E2 proteins and how these two proteins interact
with the viral origin of DNA replication and with the
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cellular replication machinery to generate initiation
complexes. Our studies demonstrate that the El pro-
tein has all of the characteristics of an initiator protein,
including on recognition, DNA-dependent ATPase
activity, and DNA helicase activity. The transcription
factor E2, whose precise function has remained more
elusive, appears to serve largely as a loading factor for
El. Through direct physical interactions with both El
and the ori, E2 provides sequence specificity for the
formation of the initiation complex.
We are currently attempting to elucidate how the
El and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication at
the viral ori. These events include binding of the ini-
tiator to the ori, the initial opening of the DNA duplex,
as well as the assembly and loading of the El replica-
tive helicase at the replication fork. Our studies so far
indicate that these activities are generated in an
ordered process that involves the sequential assembly
of El molecules on the ori. This sequential assembly
generates different complexes with different proper-
ties that in turn recognize ori, destabilize the double
helix, and function as the replicative DNA helicase.
STRUCTURAL CHANGES IN THE ORI
INDUCED BY BINDING OF El
The El-binding site in the ori consists of an 18-bp
inverted repeat. This El-binding site actually is com-
posed of multiple El recognition sequences that are
arranged in an overlapping array, and we have demon-
strated that a monomer of El recognizes the hexanu-
cleotide sequence AACAAT, a sequence which, with
slight variations, occurs six times in the 18 bp. Four of
the sites are arranged pair-wise and are bound pair-
wise by dimers of El DBD (DNA-binding domain).
To determine whether the overlapping sites could bind
El simultaneously. we examined DNA binding by the
El DBD utilizing high-resolution hydroxyl radical
footprinting. The results from these studies demon-
strated that binding of the El DBD to the El -binding
sites follows a particular sequence. At low concentra-
tion, a dimer of El DBD binds to sites 2 and 4. At
higher concentrations of El DBD, the overlapping
sites 1 and 3 are also filled, generating a structure
where two dimers of the El DBD bind to the on but
on different faces of the DNA helix. Two types of
observations indicate that the binding of four mole-
cules of El results in significant changes in the DNA
structure. First, formation of a stable complex con-
taining four molecules of El occurs only on short
probes, indicating that the ability to deform the DNA
is of importance for complex formation. Second, the
binding of four El DBD molecules results in signifi-
cant OH radical hypersensitivity outside the ori. These
results indicate that DNA binding by the El DBD pro-
vides initial structural changes in the template likely
related to subsequent melting of the ori. Although
full-scale melting depends on ATP hydrolysis by El,
limited base opening can be observed upon DNA
binding by the full-length El protein even in the
absence of ATP.
A
411VNIt
Non-specific Specific
DNA binding DNA binding
Alteration of Tethering
DNA structure to ori
(melting)
Extended footprint
Specific 4. Non-specific
DNA binding DNA binding -
Small footprint
Low Selectivity
STRUCTURE OF El DBD-DNA COMPLEXES
In collaboration with E. Enemark and L. Joshua-Tor
here at CSHL, we have determined the cocrystal struc-
tures of El DBD bound to the on DNA as a dimer and
as a tetramer. These structures provide information
about several aspects of El DNA binding. Most
importantly, specific information about how El DBD
recognizes its binding can be obtained. The majority
of the contacts between El DBD and the DNA are
phosphate backbone contacts, which provide little
specificity. In excellent agreement with the mutation-
al analyses which have indicated that only a single
position in the hexanucleotide sequence is invariant,
the base-specific contacts are largely confined to one
single position, which is contacted via van der Waals
interactions by multiple side chains. Furthermore, the
binding of the El DBD causes significant alterations
in the structure of the ori DNA. The DNA structure
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FIGURE 1 (A) A summary of the dual DNA-binding activities in El and the consequences for DNA-binding specificity. (8) A model
for the assembly of El monomers to form a double hexamer. See text for details.
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becomes progressively more deformed as additional
El DBD molecules are bound to the DNA, indicating
that the binding of the El DBD may provide the first
steps in melting of the ori.
GENERATION OF SEQUENCE SPECIFICITY
FOR INITIATOR DNA BINDING
Viral initiators of DNA replication are dependent on
the ability to find and recognize the viral origin of
DNA replication in a vast excess of host-cell DNA in
the infected cell. Interestingly, many viral initiators
appear to bind DNA with modest to low selectivity,
raising the question of how the ori is recognized. For
the papillomaviruses, the E2 protein contributes to
highly selective DNA binding by binding cooperative-
ly with El to the ori. We, as well as others, have
believed that the role of E2 is to recruit El to the ori.
Interestingly, we have recently determined that the E2
protein functions by an entirely different molecular
mechanism. By analyzing the DNA-binding properties
of the El protein, we found that although the full-
length El protein binds DNA with low specificity, the
DBD of El binds with high specificity. The explana-
tion for this apparent paradox is that two different
DNA-binding activities are present in the full-length
El protein (Fig. 1A). The El DBD is capable of high-
ly sequence-specific DNA binding, but a different
DNA-binding activity, present in the helicase domain
of the El protein, binds DNA nonspecifically. The net
result of the presence of both a nonspecific and a spe-
cific DNA-binding activity is that full-length El binds
DNA with low specificity. We now also understand
how E2 acts to provide high-specificity DNA binding.
E2 interacts with the El helicase domain and prevents
104
this domain from contacting DNA. As a result, in the
presence of E2, El binds DNA only via its DBD,
resulting in highly specific DNA binding. As E2 is
displaced, the El helicase domain is free to engage the
sequences flanking the El-binding sites, generating a
complex with intrinsically low sequence specificity,
but bound to a specific site. The reason for this com-
plex arrangement is clearly that the nonspecific DNA-
binding activity that resides in the El helicase domain
has an important role in later events where the El pro-
tein melts and unwinds the ori DNA. This raises the
interesting possibility that initiator proteins in general
may employ similar procedures for the generation of
highly sequence-specific DNA binding. Furthermore,
this mode of El binding provides us with a simple
model for how larger initiator complexes are assem-
bled on the ori (Fig. 1B). By addition of dimers in
ordered fashion, the final form, a double hexamer of
El, can be assembled without rearrangement of the
individual subunits.
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DNA REPLICATION AND CHROMATIN INHERITANCE
B. Stillman K. Braun M. Hoek Y.-J. Sheu Y.-C.N. Du
A. Chabes J. Mendez C. Speck K. Siddiqui
V. Ellison S.G. Prasanth Z. Zhang P. Wendel
Our research focuses on the inheritance of chromo-
somes and chromatin structures in eukaryotic cells.
The primary interest is how DNA replication occurs,
how it is regulated, and how it is coordinated with
other events such as chromosome segregation during
mitosis. Coupled to duplication of the DNA is the
copying of chromatin structures during S phase, the
period in cells when DNA is replicated. In the past
year, we have continued to study the mechanisms of
initiation of DNA replication at origins and the pro-
teins that function in this process. One of these, the
origin recognition complex (ORC) associates with ori-
gins of DNA replication and is the initial landing pad
on DNA for all subsequent protein complexes that par-
ticipate in replicating DNA. ORC is also involved in a
number of other processes, such as silencing of gene
expression. This year, we have discovered new func-
tions for ORC in human cells, including unexpected
roles for the smallest ORC subunit, Orc6 in chromo-
some segregation and cytokinesis, the process in
which cells actually divide after chromosomes are sep-
arated at mitosis.
ORC is also required for silencing of gene expres-
sion in yeast and associates in Drosophila with hete-
rochromatin proteins. In collaboration with Rui-Ming
Xu's laboratory here at CSHL, we have determined the
three-dimensional structure of a domain in the Orcl
subunit of ORC, called the BAH domain. This domain
interacts with one of the silent information regulatory
proteins, Sirl, only at the cis-acting sites of ORC
binding within silencer DNA elements that lie adja-
cent to the silent genes. In contrast, the other Sir pro-
teins, Sir2, Sir3, and Sir4, were found to localize over
the entire silent domain, not just at the silencers. The
resulting structures resemble heterochromatin found
in mammalian cells, supporting the suggestion that
ORC functions in organizing heterochromatin in high-
er eukaryotes.
THE PREREPLICATION COMPLEX IN YEAST
AND HUMAN CELLS
We continue to study the formation and regulation
during the cell division cycle of prereplication com-
plexes (pre-RCs) in both yeast and human cells. In
yeast, the proteins required for formation of the pre-
RC include the ORC, Cdtl, Cdc6, and the minichro-
mosome maintenance (MCM) proteins. One of the
final steps in forming the pre-RC is loading of the
MCMs onto DNA at replication origins in a manner
dependent on ORC, Cdc, and Cdtl. To better under-
stand this process, each of these proteins has been
expressed in either bacteria or baculovirus expression
vectors and the proteins purified. Using these proteins,
we have begun to study the detailed biochemistry of
formation of pre-RCs. It is still not known, however,
whether these proteins are sufficient for formation of
the pre-RC.
Once the pre-RC is formed, subsequent steps
require a number of proteins to be loaded onto the
DNA at origins that allow initiation of DNA replica-
tion to proceed. Proteins such as Cdc45, which is
loaded only after S-phase-specific cyclin-dependent
protein kinases are activated, are necessary before
actual DNA synthesis can occur. We have purified the
Cdc45 protein from yeast cells and have shown that it
is contained in a complex of proteins that includes,
among others, the MCM proteins. The precise nature
of this protein complex is under investigation.
The principal effort in the last year, however, has
been to translate our knowledge of initiation of DNA
replication in yeast to understanding the function of
these proteins in human cells. In pursuing this project,
we have encountered surprising results that expand the
known functions of the individual ORC subunits. Last
year, we reported that in rapidly proliferating cells, the
human Orcl subunit was loaded onto chromatin as
cells exited mitosis and remained bound throughout
the G1 phase of the cell division cycle. As cells entered
into S phase, Orcl was degraded and remained absent
from cells until late in mitosis when the pre-RC was
formed. Newly synthesized Orcl bound to chromatin
just prior to the time when the MCM proteins were
loaded onto chromatin during the very last stages of
telophase in mitosis, just before the cells divided.
Thus, like in yeast, in rapidly proliferating human
cells, the pre-RC formed as cells exited mitosis and
was inherited into the new daughter cells.
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FIGURE 1 View of a human cell metaphase plate viewed from
one centrosome that organizes the microtubules that attach to
the chromosomes. Anti-Orc6 antibodies stain two ring-like
structures that are shown by the white spots. The center ring of
spots represents Orc6 at the kineticores at each centromere on
the chromosomes, whereas the outer ring of staining repre-
sents association of Orc6 with a structure at the plane of cell
division.
Using specific antibodies against the Orc6 subunit
of the human ORC, we have shown that this protein
associated with the nuclear chromatin during inter-
phase of the cell division cycle, but surprisingly, at
prophase, there was a dramatic reorganization of this
protein into two separate structures. Orc6 associated
with kinetochores at centromeres during prophase and
remained associated with these structures throughout
the subsequent metaphase and anaphase stages of
mitosis, but was then removed from kinetochores dur-
ing telophase. Immunofluorescence colocalization
studies suggested that Orc6 associated with outer
kinetochore proteins, such as CENP-E, Mad3, and
BubR1, the latter two being a subset of proteins that
ensure that all chromosomes are aligned at the
metaphase plate before initiation of anaphase. The
localization of Orc6 suggests that it may have a role in
chromosome segregation during mitosis.
Concomitant with the association of some of the
Orc6 proteins with kinetochores at prophase of miosis
was the reorganization of the remaining Orc6 to a
reticular-like pattern that formed a ring around the
condensed chromosomes that were aligned at the
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metaphase plate. As cells underwent anaphase, this
reticular fraction of Orc6 protein aligned in the mid
plane of the cell division plane where cytokinesis
would ultimately occur. As cells divided, this fraction
of Orc6 protein remained at the mid plane until the
very end stages of cell division. During the very last
stages of cytokinesis, the majority of Orc6 associated
with the newly formed nucleus where it probably had
a role in formation of new prereplication complexes,
although we have not yet demonstrated this point. A
small fraction of Orc6 remained associated with the
mid body that joined the two separated cells through a
thin tube-like structure called the Fleming body. Orc6
localized in the middle of this structure that also con-
tained tubulin, actin, surviving and number of other
proteins. This localization suggested that Orc6 might
have a role in cytokinesis.
To further extend the cell biology observations that
Orc6 localized to two interesting structures and test
the possibility that it might be involved in the later
stages of cell division, we turned to a genetic analysis
of Orc6 function using short interfering RNA (siRNA)
that eliminated Orc6 from human cells. Two short
double-stranded synthetic RNA oligonucleotides
directed against different segments of the Orc6 mes-
senger RNA were introduced into human cells and
were compared
eliminate Orc6 from the cell. The first and obvious
phenotype upon elimination of Orc6 from human cells
was the formation of binuclear cells probably due to
the failure of cytokinesis after chromosome segrega-
tion and nuclear formation. This phenotype is consis-
tent with the localization of Orc6 to the mid plane of
cell division and to the Fleming body and suggested
that Orc6 was required for correct cytokinesis. A sec-
ond phenotype observed was a reduction in the num-
ber of cells incorporating the nucleotide analog bro-
modeoxyuridine (BrdU) into DNA, indicating a prob-
lem with DNA synthesis in cells with reduced Orc6
protein. Later, two prominent phenotypes were
observed. The first was the formation of multinuclear
cells containing two or more nuclei per cell, and some
of the nuclei in these cells contained less than a nor-
mal complement of DNA. A second late phenotype
was the formation of abnormal mitoses containing
multipolar spindles and misaligned chromosomes at
the metaphase plate. This later phenotype may be due
to a reduction in DNA synthesis in the cell since there
was a reduction in the BrdU incorporation prior to
accumulation of the aberrant microtubules. However,
because Orc6 associated with kinetochores at
prophase, some of the misalignment of chromosomes
may be due to the participation of Orc6 in correct reg-
ulation of kinetochore binding to microtubules during
the early stages of metaphase.
Prompted by the unexpected localization of Orc6
during mitosis, we have begun to look at the other
ORC subunits and have made the surprising observa-
tion that Orc2 associated with centrosomes during
mitosis. We are currently completing a genetic analy-
sis of Orc2 function using siRNA genetics in human
cells; however, initial results suggest that the Orc2
siRNA phenotype was significantly different from the
phenotype described for Orc6 siRNA, except for the
similar reduction in DNA synthesis by elimination of
these proteins from cells.
ANALYSIS OF THE BIOCHEMISTRY OF CHECKPOINT
SIGNALING IN HUMAN CELLS
When investigating the biochemistry of the replication
fork using human cell extracts that support SV40
DNA replication, we discovered replication factor C
(RFC), a five-subunit protein that loads the proliferat-
ing cell nuclear antigen (PCNA) clamp onto DNA.
When loaded onto DNA, PCNA tethers DNA poly-
merase 8 onto the template DNA as it synthesizes both
leading and lagging strands at the replication fork. The
trimeric PCNA clamp protein encircles the double-
stranded DNA and is loaded on by an ATP-driven
clamp loader protein RFC. Each RFC subunit is a
member of the AAA' family of ATPases, and the four
small subunits (Rfc2-5) form a complex that associ-
ates with a fifth and larger subunit (Rfcl) to form the
active clamp loader. During the past year, we have
demonstrated that the four small RFC subunits are
also associated with other RFC-like proteins, includ-
ing the human Rad17 protein and the Ctfl8 protein.
The former protein has been implicated by genetic
studies in yeast as being involved in a DNA-damage
response during S phase that is coupled to checkpoint
signaling. Damage to the replicating DNA during S
phase causes replication fork arrest and establishes a
signal that prevents further progression of the cell
cycle until the damage is repaired or replication forks
are restored.
In the last year, we have purified both the Rad17-
Rfc2-5 and Ctf18-Rfc2-5 complexes from human
RKO cells. We have demonstrated that the Rad17-
Rfc2-5 subunits form a complex that loads a DNA-
damage-induced PCNA-like clamp onto DNA. The
PCNA-like clamp consists of a heterotrimeric struc-
ture containing the Radl , Hus 1 , and Rad9 proteins
that form a protein complex we called RHR trimer.
Loading of the RHR trimer onto DNA requires ATP,
the five-subunit RHR loading complex containing
Rad17 and the Rfc2-5 subunits. Loading of the RHR
complex optimally requires the presence of the single-
stranded DNA-binding protein replication protein A
(RPA). RPA was previously shown to interact with
RFC and for loading of PCNA onto primer-template
DNA junctions. Although there are significant simi-
larities between the Radl7- Rfc2 -5 loading of the
RHR complex and the loading of PCNA by RFC, there
are, however, differences, including the types of DNA
on which the RHR complex is loaded and the ATPase
activities.
The Ctf18-Rfc2-5 complex from yeast was previ-
ously shown to be required for sister chromatid cohe-
sion, although the mechanism of action of this protein
is unknown. We have detected a similar complex in
human cells, although we have not analyzed the bio-
chemistry of this complex in great detail.
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PROTEIN TYROSINE PHOSPHATASES AND THE
CONTROL OF SIGNAL TRANSDUCTION
N.K. Ton ks J.N. Andersen T. Fukada H.L. Palka
D.A. Buckley S. Hinton M. Ye
H.H. Chen T.C. Meng L. Zhang
R.L. Del Vecchio
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects the activity of the kinases
that phosphorylate it and the protein phosphatases that
catalyze the dephosphorylation reaction. We study the
expanding family of protein tyrosine phosphatases
(PTPs), which, like the kinases, comprise both trans-
membrane, receptor-linked forms and nontransmem-
brane, cytoplasmic species and represent a major fam-
ily of signaling enzymes. We are utilizing a variety of
strategies to characterize the physiological function of
members of the PTP family. Disruption of normal pat-
terns of tyrosine phosphorylation has been implicated
in several human diseases. Therefore, insights into the
mechanisms involved in modulating PTP function
may ultimately yield important information to help
counter such diseases.
PTPs FROM A GENOMIC PERSPECTIVE:
DEFINING THE "PTP-OME"
With the availability of a near complete (>99%) draft
of the sequence of the human genome, it is now possi-
ble to define the complement of PTPs in humans. The
PTP family of enzymes are recognized by the presence
of a signature sequence [I/V]HCXXGXXR[S/T] and
can be divided into two broad categories: the Tyr-spe-
cific PTPs and the dual specificity phosphatases
(DSPs), the latter having the ability to dephosphory-
late Ser/Thr and Tyr residues in proteins. Previously, in
collaboration with Niels-Peter Moller and his col-
leagues at Novo Nordisk, we had searched the NCBI
Genbank database for the Tyr-specific (a.k.a. classi-
cal) PTPs and identified cDNA sequences corre-
sponding to 37 distinct PTP genes in humans, which
could be divided into 17 subtypes. Now, having
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searched the assembly and draft sequence of the
human genome for its complement of PTP-like
sequences, we have identified 1 additional, novel
human PTP gene, bringing the total to 38, and 12 PTP
pseudogenes. We believe that this is the first complete
catalog of the classical PIP-like sequences present in
the human genome.
In conjunction with this analysis, we are in the
process of collating chromosomal mapping data for all
known and novel PTP -like sequences for correlation
with cytogenetic data published in the "pregenomic"
era and an investigation of linkages between PTP loci
and genetic disease. We have also examined the exon
structure of PTP domains to explore the evolutionary
history of this enzyme family and to provide further
insight into the diversity and complexity within the
family that arises from mRNA splicing. We have set
up a Web Site describing our previous analysis
(Andersen et al. Mol. Cell. Biol. 21: 7117 [2001]) at
the following links, http: / /ptp.cshl.edu and http://sci-
ence.novonordisk.com/ptp, and this will be updated as
our studies are completed.
We are currently conducting a similar analysis of
the DSPs in collaboration with Ravi Sachidanandam
and Jeremiah Faith here at CSHL. Although the DSPs
contain the PTP signature motif, these enzymes dis-
play greater overall sequence diversity than the classi-
cal PTPs. An obvious major difference is in the design
of the active site. In the classical PTPs, the active site
is present as a deep cleft on the surface of the protein,
the depth of which is defined by a conserved Tyr
residue that restricts specificity only to phosphotyro-
sine residues. In the DSPs, this Tyr residue is absent
and the active site cleft is shallower, allowing it to
accommodate the shorter side chains of phopho-Ser
and phospho-Thr. The first DSP to be described was
the enzyme VH1, which is essential for infectivity of
the virions of vaccinia virus. In mammals, DSPs have
been implicated in the control of MAP kinase signal-
ing pathways and in regulating transition through the
cell cycle. The PTEN tumor suppressor, which is fre-
quently mutated in glioblastoma and prostate cancer,
is also a DSP, and the analysis of this enzyme expand-
ed the repertoire of potential physiological substrates
of members of the PTP family. PTEN recognizes
phosphatidylinositol phospholipids as substrates,
thereby regulating PI3 kinase-dependent signaling
pathways associated with cell survival and apoptosis.
By aligning published and expressed sequence tag
(EST)-predicted sequences, we have defined a mini-
mal DSP catalytic domain of 130 residues. Our search
of the human genome yielded 43 DSPs that contain
this domain, and we have mapped the chromosomal
location of each gene. Currently, we are performing
similar searches in other sequenced genomes to iden-
tify orthologs of human DSPs and investigate the evo-
lution of these enzymes.
In addition to the VH1-like DSPs, 11 myotubular-
in family DSPs have been identified. These enzymes
also recognize phosphatidylinositol phospholipids as
substrates, and disruption of their function has been
linked to human disease. The Cdc25s, A, B, and C,
regulate cell cycle transition through the dephospho-
rylation of cyclin-Cdk protein kinases. Finally, the
enzyme termed Low Mr PTP has been implicated in
regulation of receptor PTK (protein tyrosine kinase)
signaling. Thus, the total number of PTPs currently
stands at 96-large enough to introduce diversity in
structure and function, but small enough to study from
a family-wide perspective.
PTP1 B: A THERAPEUTIC TARGET FOR
TREATMENT OF DIABETES AND OBESITY
It is now apparent that PTP1B, the prototypic member
of the PTP family, is a major regulator of signaling
events induced by insulin and leptin. In fact, PTP1B is
now recognized in the pharmaceutical industry as an
important target for development of novel strategies
for therapeutic intervention in diabetes and obesity.
Previous studies from this lab defined in molecular
detail the interactions between PTP1B and the activa-
tion loop of the insulin receptor as substrate, leading
to the identification of the sequence E/D-pY-pY-R/K
as a consensus optimal substrate recognition motif for
the phosphatase.
These analyses were instrumental in identifying
the JAK family of PTKs, which regulate the signaling
response to leptin, as substrates for PTP1B. The active
site of members of the PTP family is highly charged,
consistent with its recognition of a charged, phospho-
rylated residue as substrate. This, and the fact that the
essential, nucleophilic Cys residue at the active site is
prone to oxidation, has presented challenges to the
design of therapeutic inhibitors, suggesting that alter-
native methods for manipulating PTP1B levels may be
of benefit. Therefore, we have been characterizing the
PTP1B promoter with the goal of identifying alterna-
tive targets through which to regulate PTP function.
Changes in the levels of PTP1B have been noted in
several human diseases, particularly those associated
with dysfunctional tyrosine phosphorylation. Previ-
ously, we had shown that the expression of PTP1B is
induced by the p210bcr-abl oncoprotein, a PTK that is
directly responsible for the initial manifestations of
chronic myelogenous leukemia. Interestingly, PTP1B
can antagonize p210bcr-abl-induced transformation.
The effects of p210bcr-abl on PTP1B expression are
manifested at the transcriptional level, and previously,
we had reported the identification of a p210bcr-abl-
responsive sequence (PRS) in the PTP1B promoter. In
extending these analyses, we have now identified an
enhancer sequence within the PTP1B promoter
upstream of the PRS. Through a protein purification
strategy, culminating in a DNA affinity chromatogra-
phy step that utilized the PTP1B enhancer sequence,
and various binding analyses, we demonstrated inter-
action between the enhancer and the transcription fac-
tor Y-box-binding protein-1 (YB-1). Y-box-binding
proteins comprise a hydrophilic carboxy-terminal
domain, which has been implicated in protein-protein
interactions, and an amino-terminal nucleic-acid-bind-
ing domain, which is implicated in transcriptional reg-
ulation.
This nucleic-acid-binding domain is highly con-
served throughout evolution from bacteria to humans,
displaying 43% identity with the cold shock response
protein (cs7.4) from Escherichia coli, suggestive of a
fundamentally important function. Y-box-binding pro-
teins have the ability to bind single- and double-strand-
ed DNA and RNA. They have been implicated in tran-
scriptional activation and repression, functioning
directly as transcription factors and indirectly by alter-
ing promoter conformation, through recognition of sin-
gle-stranded and H-form triplex DNA. Although origi-
nally identified in terms of their ability to recognize a
DNA sequence termed a Y box, the Y-box proteins are
now known to recognize motifs with little similarity to
the classical Y box. In fact, there is no recognizable Y-
box motif in the PTP1B enhancer, and so this interac-
tion could not have been predicted from analysis of the
promoter sequence.
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We observed that overexpression of YB-1 led to an
increase in the levels of PTP1B. Furthermore, deple-
tion of YB-1 protein, by expression of a specific anti-
sense construct, led to an approximately 70% decrease
in expression of PTP1B, but no change in the level of
TC-PTP, which is the closest relative of PTP1B.
Expression of antisense YB-1 resulted in increased
sensitivity to insulin and enhanced signaling through
the cytokine receptor gp130, which was suppressed by
re-expression of PTP1B. These data illustrate that by
targeting YB-1, the levels of PTP1B and signaling
through insulin and cytokine receptors can be manip-
ulated. Interestingly, we have observed a correlation
between the expression of YB-1 and that of PTP1B
across a panel of cancer cell lines. Furthermore, we
demonstrated that the reported increases in the expres-
sion of PTP1B in skeletal muscle of Goto-Kakazaki
non-obese, insulin-resistant type-II diabetic rats, com-
pared to control nondiabetic rats, coincided with
increased expression of YB-1. These data are consis-
tent with a functional relationship between PTP1B and
YB-1 under both physiological and pathophysiologi-
cal conditions and suggest that it may be possible to
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manipulate PTP1B activity therapeutically by control-
ling its level of expression.
REVERSIBLE OXIDATION AND THE
REGULATION OF PTP FUNCTION
One major area of interest in the lab is a characteriza-
tion of the regulation of PTP function by reversible oxi-
dation. The signature motif [IN]HCXXGXXR[S/T],
which defines the PTP family of enzymes, contains an
invariant Cys residue, which functions as a nucleophile
in catalysis. Due to the unique environment of the PTP
active site, this Cys residue displays an unusually low
pKot, which enhances its nucleophilic properties but
renders it susceptible to oxidation. It is becoming
apparent that a wide variety of physiological stimuli
that result in stimulation of tyrosine phosphorylation
are also accompanied by the production of reactive
oxygen species (ROS). Furthermore, ROS production
has been shown to be required for an optimal tyrosine
phosphorylation response (Fig. 1). Work from several
labs has demonstrated that PTPs are an important tar-
get of ROS in this context. The operating principle is
FIGURE 1 Regulation of PTP activity by reversible oxidation. Ligand-dependent activation of a recep-
tor protein tyrosine kinase (RTK) triggers the activity of a Rac-dependent NADPH oxidase, leading to
production of reactive oxygen species (ROS). ROS oxidizes the active-site Cys residue of members of
the PTP family, converting it from a thiolate ion (the active form) to sulfinic acid. Oxidation results in inhi-
bition of PTP activity, thereby promoting tyrosine phosphorylation. However, oxidation of the PTPs is
transient. Restoration of PTP activity following reduction back to the thiolate form of the active-site Cys
residue terminates the tyrosine-phosphorylation-dependent signal. A variety of growth factors, hor-
mones, and cytokines induce ROS production and stimulate tyrosine phosphorylation. We are devel-
oping methods to identify the PTPs that become oxidized in response to a physiological stimulus as a
way of establishing links between particular PTPs and the regulation of defined signaling pathways.
that the stimulus (hormone, growth factor, etc.)
enhances tyrosine phosphorylation directly, by activa-
tion of a PTK and/or indirectly by inactivation of a
PTP. Thus, one function of ROS produced following
agonist stimulation is to inactivate transiently the criti-
cal PTP that provides the inhibitory constraint upon
the system, thus facilitating the initiation of the signal-
ing response to that stimulus. We reasoned that by
identifying which PTPs are oxidized in response to a
particular stimulus, we would reveal which PTPs are
critical for down-regulating the signaling response to
that stimulus. The application of state-of-the-art tech-
nologies, such as RNA interference (RNAi) and the
use of substrate-trapping mutant PTPs, would allow us
then to define the function of the PTPs that were iden-
tified in this way.
Continuing with the study of insulin signaling, we
have demonstrated that stimulation of Ratl fibroblasts
with insulin leads to the production of ROS, in partic-
ular hydrogen peroxide. Expression of catalase inhib-
ited both tyrosine phosphorylation of the insulin
receptor and downstream signaling to PKB /Akt, thus
highlighting the importance of ROS production for an
optimal signaling response. Using a modified in-gel
phosphatase assay that we have developed, we showed
that two PTPs were rapidly and reversibly oxidized in
response to insulin in this system, and we have identi-
fied these enzymes as PTP1B and TC45. A role for
PTP1B in the regulation of insulin receptor (IR) sig-
naling is now well-established and provides validation
of this strategy. A role of TC45 in insulin signaling,
however, had not been appreciated. To examine this
role, we used RNA interference and generated short
interfering RNA (siRNA) oligonucleotides targeted
against TC45, demonstrating ablation of the PTP in
both Rat 1 fibroblasts and HepG2 cells, which express
higher levels of the insulin receptor. Specificity of the
siRNA was confirmed by the lack of an effect on
expression of PTP1B, the closest homolog of TC45. In
both Ratl and HepG2 cells, we observed that TC45
siRNA enhanced the activation of PKB/Akt induced
by insulin.
Focusing on HepG2 cells, we observed that the
substrate-trapping mutant form of TC45, but not the
wild-type enzyme, formed a complex with the I3-sub-
unit of the insulin receptor (IR-(3). Furthermore, RNA
interference with siRNA to TC45 led to hyperphos-
phorylation of IR-P, and blotting of immunoprecipi-
tates of IR-13 with phospho-specific antibodies sug-
gested that TC45 displays preferential recognition of a
particular site(s) within the receptor.
In a parallel series of studies, in collaboration with
Tony Tiganis (Monash University, Australia), we exam-
ined insulin signaling immortalized mouse embryo
fibroblasts (MEFs) generated from TCPTP-/- and
control TCPTP+/+ mice. Consistent with the data gen-
erated by RNA interference, we observed that ablation
of TCPTP led to enhanced and sustained activation of
PKB in response to insulin. Furthermore, insulin-
induced tyrosine phosphorylation of the IR-13 subunit
was enhanced in TCPTP-/- MEFs. Importantly, these
effects were suppressed by reexpression of TCPTP to
physiological levels. Therefore, these data illustrate
that in addition to PTP1B, the PTP TC45 is a negative
regulator of signaling in response to insulin and that
one of its substrates in this respect is the 13-subunit of
the insulin receptor.
IDENTIFICATION OF THE PTK MET, THE
RECEPTOR FOR HGF/SF, AS A SUBSTRATE
OF THE RECEPTOR PTP DEP-1
When we first identified the receptor protein tyrosine
phosphatase DEP-1 (density-enhanced PTP-1), we
noted that its expression is increased as cells in culture
approach confluence, suggesting a role as an inhibitor
of cell proliferation. This PTP has been implicated in
the regulation of cell growth, differentiation, and
transformation and, most recently, has been identified
as the product of a tumor suppressor gene mutated in
colon, lung, and breast cancers. We generated con-
structs comprising the cytoplasmic domain of DEP-1
fused to the maltose-binding protein to identify poten-
tial substrates, using our substrate-trapping mutant
technology, and thereby suggest a physiological func-
tion for DEP-1.
We have shown that the substrate-trapping mutant
form of DEP-1 interacted with a small subset of tyro-
sine-phosphorylated proteins from lysates of human
breast tumor cell lines. We have identified the hepato-
cyte growth factor/scatter factor (HGF/SF) receptor
Met as well as the adapter protein Gab 1 and the junc-
tional component p120 catenin as potential substrates
of DEP-1 in MDA-MB-231, T-47D, and T-47D/Met
cell lysates. Following ligand stimulation, phosphory-
lation of specific tyrosyl residues in Met induces mito-
genic, motogenic, and morphogenic responses. When
coexpressed in 293 cells, the full-length substrate-trap-
ping mutant form of DEP-1 formed a stable complex
with the chimeric receptor CSEMET and wild-type
DEP-1 dephosphorylated CSEMET. Furthermore, we
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observed that DEP-1 preferentially dephosphorylated
the Gab 1-binding site (Tyr1349) and a carboxy-terminal
tyrosine implicated in morphogenesis (Tyr'355), where-
as tyrosine residues in the activation loop of Met
(Tyri"°, Tyri234, Tyr1235) were not preferred targets of the
PTP. The tight regulation and appropriate execution of
Met signals are vital for normal growth and differenti-
ation, whereas aberrant signaling through Met can lead
to transformation. The ability of DEP-1 preferentially
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to dephosphorylate particular tyrosine residues that are
required for Met-induced signaling suggests that DEP-
1 may function in controlling the specificity of signals
induced by this PTK, rather than as a simple "off-
switch" to counteract PTK activity. This functional
interaction between Met and DEP-1 raises the possibil-
ity that up-regulation of Met may be coupled with
down-regulation of DEP-1 in the progression of certain
human tumors.
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SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner R. Packer
E.-E. Govek M. Zhao
S. Newey M. Watabe
The central research interest of my laboratory is the
study of signal transduction pathways involving mem-
bers of the Ras and Rho GTPases and the processes
that they regulate. Alterations that affect normal Ras
and Rho function have been found to result in the
development of several disease processes including
cancer, as well as inflammatory and neuropathological
disorders. Members of the Ras and Rho families
encode low-molecular-weight guanine-nucleotide-
binding proteins that function as binary switches by
cycling between an active GTP-bound state and an
inactive GDP-bound state. It is only in their GTP-
bound state that they are able to interact with down-
stream effector molecules which mediate their effects.
The ratio of the two forms is regulated by the oppos-
ing effects of guanine nucleotide exchange factors
(GEFs), which promote the exchange of bound GDP
for GTP, and the GTPase-activating proteins (GAPs),
which stimulate hydrolysis of bound GTP. During the
past year, efforts in my laboratory continued to focus
on defining the role and mechanisms by which these
GTPases exert their effects on specific aspects of
tumorigenesis and neuronal development.
ROLE OF RAS AND RHO SIGNALING IN
TUMORIGENESIS
During the development and progression of cancer,
cells undergo numerous changes in morphology, adhe-
sive properties, proliferation, and transcriptional pro-
file. During the past couple of decades, there have
been intense efforts to understand the molecular
mechanisms involved, and members of the Ras and
Rho GTPases have emerged as important players. Our
interest lies in obtaining a better understanding of how
alterations in Ras and Rho signaling affects cell
growth control and the invasive behavior of cells.
There are currently three projects ongoing in the lab.
One project aims to gain insights into the molecular
basis by which the Ras-related GTPase Rap 1 and its
effector AF-6 affect epithelial cell shape changes and
the coordinated movements of cells, which are pivotal
alterations governing tumor progression and wound-
healing processes. The second project focuses on
defining the mechanisms by which Racl, a Rho fami-
ly member, contributes to cell growth and invasive-
ness. The third project involves the functional charac-
terization of p62d°k, a Ras-GAP-associated protein,
which was found to be constitutively tyrosine-phos-
phorylated in chronic myelogenous leukemia (CML)
progenitor cells.
RAP1 AND AF-6/CANOE FUNCTION IN
EPITHELIAL MORPHOGENESIS
Several studies suggest a relationship between loss of
epithelial cell polarity and loss of growth control.
Studies in the laboratory using mammalian epithelial
cells have suggested a role for Rapl, a member of the
Ras family, and the junctional protein AF-6, which
associate with GTP-bound Rap, in the regulation of
epithelial cell shape changes and cell adhesion. Due to
the finding that AF-6 is largely refractory to both loss-
and gain-of-function analyses, we decided to explore
this hypothesis in the genetically more tractable
Drosophila system.
In Drosophila, a process called dorsal closure
(DC) relies on elongation and migration of epithelial
cells and has proved to be an excellent model system
for the study of the molecular basis underlying epithe-
lial cell shape changes. In collaboration with U. Gaul
(The Rockefeller University), we recently provided
biochemical and genetic evidence that Canoe
(Drosophila orthologs of AF-6) acts as a Drosophila
Rapl effector in the process of dorsal closure. To date,
no other protein has been reported to act as a mediator
or direct effector of the small GTPase Rapl in a phys-
iological context. Furthermore, we obtained evidence
that Canoe participates in DC through two cellular
pathways: One is controlled by DRap 1 and is inde-
pendent of the JNK cascade, whereas the second is not
activated by DRapl and feeds into JNK signaling. We
are currently setting out to identify additional Canoe-
interacting proteins to obtain further insights into
Canoe's mode of action in DC. To complement these
studies, we are planning to assess a role for the mam-
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malian counterparts of these Drosophila proteins in
mammary epithelial polarity and invasive behavior.
These studies will contribute to a better understanding
of the fundamental mechanisms that drive cell shape
changes and migration.
SIGNAL TRANSDUCTION PATHWAYS MEDIATING
THE EFFECTS OF RHO GTPASES ON CELL
GROWTH CONTROL AND INVASIVENESS
In addition to their role in cell cycle control, Rho-like
GTPases regulate both cell-cell and cell-matrix adhe-
sions and can influence the motile and invasive prop-
erties of tumor cells in vitro. We continued our studies
to define the signaling pathways that regulate and
mediate the effects of the Rho GTPases on cell prolif-
eration, adhesion, and invasion. Using the yeast 2-
hybrid system, we recently identified a novel class of
putative Rho activators, which contain a region of
homology with Dock180. The latter protein has previ-
ously been shown to activate Racl and to have a role
in phagocytosis, cell migration, and invasion of tumor
cells. We are currently investigating the roles of these
putative Rho activators in cell motility and invasion.
As an additional approach, we employed cDNA-RDA
(representational difference analysis) in combination
with microarray analysis to identify target genes of
Rac 1 (a member of the Rho GTPases) whose expres-
sion is altered as a result of constitutively active Racl
(Rac1V12) expression. These experiments were
assisted by Dr. R. Lucito here at CSHL. Among the
cDNAs isolated were cyclo-oxygenase 2 (COX-2) and
cyclin Dl, two genes whose expression has been pre-
viously shown to be up-regulated in many tumors. We
found that the expression levels of both of these genes
are up-regulated in Rac1V12 expressing epithelial and
glioblastoma cells. The further characterization of the
other cDNAs is presently ongoing in the lab and is
likely to identify additional relevant Rac 1 targets.
P62°°K IS A NEGATIVE REGULATOR OF
GROWTH FACTOR AND P210...-ABLINDUCED
CELL PROLIFERATION
p62"k is a protein initially identified as a prominent 62-
IcD constitutively tyrosine-phosphorylated RasGAP-
associated protein in p210ber-abl-expressing cells. This
protein was termed Dok (downstream of kinases), since
it was also found to be a common substrate of many
receptor- and membrane-associated tyrosine kinases.
To investigate the role of p62"*, we utilized different
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cell types derived from p62' null mice, generated by
P.P. Pandolfi (Memorial Sloan-Kettering Cancer Center,
New York). In collaboration with Pandolfi's group, we
obtained evidence that p62" acts as a negative regula-
tor of growth-factor-induced cell proliferation. We
observed that p62"k-deficient cells possess a higher
proliferation rate in response to growth factors and that
this increase in cell proliferation can be suppressed by
ectopic expression of p62"k. Furthermore, p62" inac-
tivation causes a significant shortening of the latency of
the fatal myeloproliferative disease induced by retro-
virus-mediated transduction of p210'"` -al" in bone mar-
row cells. We have also obtained data suggesting that
p62"k exerts its negative effect on growth-factor-
induced cell proliferation at least in part by negatively
influencing the Ras/MAPK (mitogen-activated protein
kinase) pathway. We are presently investigating the
underlying mechanism by which p62" inhibits the
Ras/MAPK pathway and growth factor and p210"" -am-
mediated signaling. We have already found out that
association of p62"k with RasGAP is not essential for
its negative effect on the PDGF (platelet-derived growth
factor)-triggered MAPK activation.
ROLE OF RAS AND RHO GTPASES IN
SYNAPTIC PLASTICITY AND NEURONAL
DEVELOPMENT
Evidence provided during the past few years demon-
strates that members of the Ras and Rho GTPases con-
trol important neuronal functions and have significant
effects on behavior. Furthermore, several diseases caus-
ing cognitive impairment (including neurofibromato-
sis, autism, and mental retardation) are associated with
mutations in members of the Ras and Rho GTPases or
in the molecules (GEFs and GAPs) that control their
activity. A major challenge remains to unravel how
these molecules affect neuronal functions and behavior.
We have investigated the role of Ras and Rapl in activ-
ity-dependent synaptic plasticity and have embarked on
the functional characterization of oligophrenin-1, a
RhoGAP, that is absent in unrelated MRX (nonspecific
X-linked mental retardation) families.
RAS AND RAP CONTROL AMPA-RECEPTOR
TRAFFICKING DURING SYNAPTIC PLASTICITY
This work was done in collaboration with R. Malinow
here at CSHL. In this study, we have investigated the
role of Ras and Rapl in activity-dependent synaptic
plasticity. The latter is believed to underlie key aspects
of brain development, learning, and memory. The
most widely studied examples of synaptic plasticity
are long-term potentiation (LTP) and long-term
depression (LTD) in the hippocampus. Recent studies
have revealed that AMPA (a-amino-hydroxy-5-
methyl-4-isoazole) receptor (AMPA-R) trafficking is
important in synaptic plasticity; however, the signal-
ing pathways regulating this trafficking are poorly
understood. We found that Ras and Rap I have indis-
pensable roles in synaptic plasticity and that they sig-
nal two independent pathways at synapses. Ras medi-
ates activity-induced synaptic enhancement by driving
synaptic delivery of AMPA-Rs containing long cyto-
plasmic tails requiring p42/p44 MAPK activation. In
contrast, Rap 1 mediates activity-induced synaptic
depression by removing synaptic AMPA-Rs contain-
ing short cytoplasmic tails requiring p38 MAPK acti-
vation. Taken together, these studies indicate that Ras
and Rap 1 serve as independent regulators for potenti-
ating and depressing central synapses.
FUNCTIONAL CHARACTERIZATION
OF THE X-LINKED MENTAL RETARDATION
GENE, OLIGOPHRENIN-1
Nonspecific X-linked mental retardation (MRX) is
characterized by mental impairment without any other
distinctive clinical features. Eight genes involved in
MRX have been cloned to date, and importantly, three
of these genes encode regulators or effectors of the
Rho GTPases. Members of this family of small
GTPases, including Cdc42, Rac, and RhoA, are key
regulators of the actin cytoskeleton and have been
shown to affect different aspects of neuronal morpho-
genesis. This has led to the hypothesis that abnormal
Rho GTPase signaling may be a prominent cause of
MRX. However, how alterations in Rho signaling
result in changes in neuronal connectivity and/or plas-
ticity that give rise to MRX remain unknown. As yet,
studies on the effects of Rho-linked MRX genes on
neuronal development have not been reported. We
have focused on the functional characterization of
oligophrenin -1, which encodes a Rho-GTPase-activat-
ing protein (RhoGAP), and whose loss of function is
associated with nonsyndromic or nonspecific MRX.
We found that oligophrenin-1 is highly expressed in
the developing rat hippocampus and is expressed in
axons, dendrites, and dendritic spines of pyramidal
hippocampal cells. We also showed that oligophrenin-
1 functions as a GAP for RhoA, Rac, and Cdc42 in a
cellular context. More recently, we obtained evidence
that down-regulation of oligophrenin-1 expression
affects dendritic spine morphology of hippocampal
neurons in brain slices. Our studies provide potential
insights into the cellular bases underlying MRX asso-
ciated with oligophrenin -1 mutations.
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BIOINFORMATICS AND GENOMICS
Computers play an indispensable role in the rapidly progressing arena of biomedical research. CSHL
scientists working in the allied disciplines of genomics and bioinformatics use computer science and
mathematics to explore the molecular basis of life from many angles. By developing sophisticated soft-
ware and novel databases, these scientists are creating tools that are vital for interpreting the volumes
of information that are emerging with increasing speed from many studies of genes, genomes, proteins,
and proteomes.
Lincoln Stein's lab uses computer science to give meaning to the tremendously large data sets that are
resulting from a variety of genome research projects. One of several databases they have developed allows
researchers to compare the genomes of rice, wheat, and corn and to identify genes that might be used
to engineer hardier, more productive varieties. Another allows scientists to explore gene and genome evo-
lution in the animal genus Caenorhabditis. Stein's lab is also creating a searchable database of funda-
mental processes in human biology called Genome Knowledgebase.
W. Richard McCombie's lab continues to contribute significantly to several genome sequencing pro-
jects. This year, McCombie and his colleagues in the International Mouse Genome Sequencing Consortium
have published a high-quality draft sequence of the mouse genome, along with a comparative analysis of
the mouse and human genomes. The laboratory mouse is an important animal model used widely in the
study of human disease. Consequently, this landmark sequencing study has profound long-term conse-
quences for medicine. It will help elucidate the molecular mechanisms of disease and will allow researchers
to design better therapies for many illnesses. Interestingly, the genetic variety of mouse whose genome was
sequenced in the study, C57BL16, was developed during the early 20th century by Clarence Little at what
is now Cold Spring Harbor Laboratory. McCombie's group is currently working with an international con-
sortium to sequence the entire genome of the world's most important food source, rice.
Bud Mishra's lab is bringing mathematics and computer science to bear on a challenging new field
known as systems biology. One of the lab's projects is to create a unified theoretical framework within
which scientists can understand life's biochemical pathways and the evolutionary processes that mold
them. These researchers merge math and biology to develop models of how genomes evolve, and to
explore how evolution generates particular networks and modules of interacting components that are
seen in biochemical pathways.
Michael Zhang's lab has created software for identifying signature sequences within DNA that reveal
the presence of important genetic elements such as promoters (DNA segments that control gene activ-
ity) or exons (DNA segments likely to code for proteins). They have also compared the public and pri-
vate versions of the mouse genome and have compared the human and mouse genomes. From these
comparisons, they have created a database of closely related DNA sequences shared by humans and
mice, and they have identified some 5000 new human genes.
Andrew Neuwald's lab has applied the power of statistical analysis to the prediction of protein struc-
ture and function. These researchers have developed a technique for identifying the most distinctive
molecular features of any particular family of proteins. Once identified among closely and moderately
related proteins, such features can be used to track down the most distant relatives of a protein fami-
ly. As a result, the scientists can infer the properties of poorly characterized proteins by assigning them
to protein families with known functions. Such analysis has revealed previously unrecognized roles for
certain proteins in human disease.
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GENOME SEQUENCE ANALYSIS
W.R. McCombie V. Balija S. Dike L. King L. Nascimento L. Santos
J. Baker K. Ferraro K. Kuit A. O'Shaughnessy L. Spiegel
M. de la Bastide M. Katari B. Miller L. Palmer M. Yu
N. Dedhia F. Katzenberger S. Muller R. Preston T Zutavern
Our long-range goal is to analyze the genomes of com-
plex organisms at the molecular level. To that end, we
have been working at developing tools and strategies
to obtain the salient information from these genomes
and have also been applying these strategies in the
analysis of several large and important genomes. That
work has continued this year. The next step in genome
analysis this year is the development of approaches to
determine the coding information within genomes and
its application at the pilot stage.
Rice Genome Sequencing
V. Balija, J. Baker, M. de la Bastide, N. Dedhia, S. Dike,
K. Ferraro, F. Katzenberger, L. King, K. Kuit, B. Miller,
S. Muller, L. Nascimento, A. O'Shaughnessy, L. Palmer,
R. Preston, L. Santos, L. Spiegel, M. Katari, T. Zutavern
[in collaboration with the University of Arizona Genome
Center (Rod Wing)]
We are members of the U.S. Rice Genome Sequencing
Consortium. This group in turn is a member of the
International Rice Genome Sequencing Consortium
(IRGSP). This year marked two major milestones by
these groups. The U.S. group completed the finished
sequence of rice chromosome 10. This chromosome is
about 22 million bases in size. The chromosome pre-
sented considerable difficulty in sequencing due to
large regions of heterochromatic DNA. The detailed
analysis of rice chromosome 10 is currently under way.
The IRGSP also finished a high-quality draft
sequence of the entire rice genome in 2002. This draft
sequence consists of ordered and oriented sequence
contigs linked to the genetic map of rice. In addition to
our contribution on chromosome 10, we participated
in the genome-wide draft by providing both finished
and draft sequence of rice chromosome 3. We have
done a total of more than 12 million bases of rice
sequence. The genome draft will be an important
resource for rice scientists around the world. Since it
is ordered and linked to the genetic map, it will be an
invaluable tool for both basic scientists and rice breed-
ers. We, together with the IRGSP, are continuing to
sequence rice with the goal of a finished sequence of
the entire genome by the end of 2004.
Mouse Genome Sequencing
V. Balija, J. Baker, M. de la Bastide, N. Dedhia, S. Dike,
K. Ferraro, F. Katzenberger, L. King, K. Kuit, B. Miller,
S. Muller, L. Nascimento, A. O'Shaughnessy, L. Palmer,
R. Preston, L. Santos, L. Spiegel, T. Zutavern
The mouse is an extremely important model organism.
We have been part of an effort to sequence the mouse
genome. The Mouse Genome Sequencing Consortium
published the results of a draft sequence of the mouse
genome. Our group sequenced about 13 million bases
of the mouse genome, and most of this was finished
sequence. The mouse sequence, in comparison with
the human sequence, will provide an important tool in
efforts to determine the workings of the mammalian
genome. This will be a major goal of groups around
the world including our own.
TABLE 1 Category-based Gene Count Distribution
Category
Gene Count
EPD
13
RefSeq B
27 23 50
Classification of genes in test set. EPD genes come from the
Eukaryotic Promoter Database and are our "gold standards." Much is
known about the EPD genes and their 5' exons have been experimen-
tally verified. These genes have experimentally defined transcriptional
start sites and serve as positive controls. RefSeq genes are a set of ref-
erence mRNAs from a genome as determined by NCBI. For our pur-
poses, we have excluded any genes from our RefSeq category that are
also in the more restrictive EPD data set. These non-EPD RefSeq genes
do not have well-defined experimentally verified 5' ends. Group B genes
are gene predictions that are supported by multiple EST matches but
whose structure is ambiguous. Group C genes represent a set of gene
predictions that are only supported by a single EST. Group C genes are
"below the radar" and are not typically annotated as genes. For each
gene or gene model, the closest 5' FirstEF prediction that also matched
the gene transcription direction was chosen.
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FIGURE 1 Location of nested primers used in RACE-PCR. (Black) RACE adapter; (hatched) mRNA transcript;
(dashed vertical fine) first exon/second exon boundary; (arrows) directionality of primers.
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Mouse Transcript Detection
V. Balija, S. Dike, L. Nascimento, L. Palmer, T. Zutavern,
M. Yu [in collaboration with G. Hannon and M. Zhang,
Cold Spring Harbor Laboratory]
The completion of the human genome sequence is a
first step toward understanding its formation. At this
time, however, there is considerable uncertainty about
even the number of mammalian genes. We have been
collaborating with Michael Zhang and Greg Harmon
here at CSHL to develop experimental tools combined
with computer predictions to identify the genes. These
same tools are also being used to identify the 5' ends of
genes. These regions are the most difficult to predict
computationally. However, since their location is
required in order to identify promoters, it is extremely
important to identify these 5' regions of transcripts.
We have chosen to use RACE-PCR (polymerase
chain reaction) to identify 5' regions of mouse tran-
scripts. We have begun this work with a sample set of
96 genes including a number of known genes. A
breakdown of these genes is shown in Table 1. Some
of the genes in this test set are unknown and many
have unresolved 5' ends. These initial efforts have
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been focused on developing techniques to identify the
5' ends of these genes. We have modified RACE-PCR
procedures to optimize a more scaleable process.
Figure 1 shows a diagram of the RACE-PCR proce-
dure; Table 2 shows the results of testing these 96 test
genes. We now have a robust approach for carrying out
this work and are expanding it to include more genes.
These techniques will also be very useful for a project
that we will be starting in 2003, which will require us
to analyze the gene content in regions of hemizygous
deletions in tumors (in collaboration with the Wigler
and Lucito labs here at CSHL).
PUBLICATIONS
Mardis E., McPherson J., Martienssen R., Wilson R.K., and
McCombie W.R. 2002. What is finished and why does it
matter. Genome New 12: 669-671.
Palmer L. and McCombie W.R. 2002. On the importance of
being finished. Genome Biol. 3: 2010.1-2010.4.
Waterston R.1-1., et al. 2002. Initial sequencing and comparative
analysis of the mouse genome. Nature 420: 520-562.
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TABLE 2 Results of Identifying the 5' Ends of Mouse Genes Using RACE-PCR, followed by Sequencing
Number matching expected size in Overall
expected size
Number
sequencing7-day 17-day
Category embryo embryo testes brain matching confirmed by
EPD (13) 5 5 3 3 8 12
RefSeq (27) 5 9 7 5 14 18
Cat B (23) 9 12 9 10 15 19
Cat C (50) 18 15 14 15 26 8
MODELS OF CELLULAR PROCESSES AND GENOME EVOLUTION
B. Mishra M. Antoniotti R. Daruwalla
P. Barbano J. Feng
W. Casey J. McQuown
V. Cherepinsky V. Mysore
S. Paxia M. Spivak
M. Rejali N. Ugel
A. Rudra Y. Zhou
Understanding biology by modeling cellular processes
and genome evolution has emerged as a challenging
new area: systems biology. Sitting at the interface of
mathematics and biology, this subject aims to address
many questions requiring consilience of elegant ideas
and concepts from applied mathematics, theoretical
computer science, logic, and physical modeling. The
impulse has come from a better understanding of
processes involved at the molecular level, technology
at a meso- and nanoscale, the ability to perform high-
throughput experiments, and the amount of genomic
and proteomic data that can now be generated and
made publicly available for processing. In response to
these challenges and with initial funding from
DARPA's BioCOMP program, scientists and mathe-
maticians from Cold Spring Harbor Laboratory and
the Courant Institute have begun to focus their collec-
tive attention on these questions.
Various projects pursued by this group are
described below: (1) Biochemical Process Theory
seeks to create a unified framework in which one can
understand biochemical pathways, and how the evolu-
tionary processes shaped them historically. (2)
Evolutionary Processes, Genomes, and Pathway
Models seeks to develop a set of genome evolution
models with solid mathematical and biological foun-
dations that allow the systematic understanding of the
underlying probabilistic processes, the constraints
they impose on biological systems, and deciphering
the modular structure of large-scale biochemical
processes. (3) Advanced Tool Architectures seeks to
create a set of reusable, inter-operating software mod-
ules integrated within a bioinformatics language and
environment. (4) Support for Experimental Research.
Traditionally, biology has proceeded as an obser-
vational science. Robert Hooke, whose work
"Micrographia" of 1665 included the first identifica-
tion of biological cells through his microscopical
investigations, had said,
The truth is, the science of Nature has already been
too long made only a work of the brain and the fancy.
It is now high time that it should return to the plain-
ness and soundness of observations on material and
obvious things.
Recently, we have seen an unprecedented progress
in our observational/experimental abilities, thus allow-
ing us to understand the structure of a largely unob-
servable transparent cell. But, much more importantly,
we have also become familiar with novel "computa-
tional" approaches that rely on simultaneous progress
in many fronts: (1) vast amounts of computing power
(distributed or tightly coupled parallel computers); (2)
accurate physical models at kinetic mass-action, sto-
chastic, spatiotemporal, and hybrid discrete/continu-
um levels; (3) algorithmic efficiency through symbol-
ic and qualitative computation; and (4) logical reason-
ing systems and other analysis tools at multiple reso-
lutions. These approaches borrow ideas from compu-
tational theories and logic, systems and engineering
sciences, and applied mathematics. Encouraged by
this confluence of breakthroughs, we have focused on
a novel research program combining mathematical
theories with experimental observations with an aim
of building the foundations of biological processes at
many levels.
BIOCHEMICAL PROCESS THEORY
The genome of an organism is a collection of its
genes, encoded by four chemical bases in its DNA
(deoxyribo nucleic acid), and it forms the genetic core
of a cell. The genes ultimately encode the protein (a
chain of amino acids), and in turn, the genes are regu-
lated by transcription factors and other operons, many
of which are proteins. The sequence of amino acids,
specified by the DNA through transcription and trans-
lation processes, determine the three-dimensional
structure and biochemical properties of the proteins as
well as the nature of their interactions. Furthermore,
mRNA stability, protein degradation, posttranslational
modifications, and many other biochemical processes
tightly regulate the time constants involved in the
resulting biochemical machinery.
Using a system of first-order differential equations
(in explicit form), one can construct a general model
of a rather complex biochemical reaction involving
many genes and proteins. One such model is Savageau
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and Voit's S-system. The basic differential equations
constituting the system take the following power law
form:
X; "'pi ITXii
.1=1 i=i
n+m
C.,(X,[r],..., X = Ey,llx,r, .0
k=1
where the a,s and [3,s are called rate constants and
govern the positive (synthesis) or negative (degrada-
tion) contributions to a given substance. The ys are the
rate constraints.
Such a system of differential equations (power
laws) as the above can be integrated to create "traces"
either symbolically-in particularly favorable cases-
or by numerical approximation using often standard
and in some cases novel algorithmic techniques.
The ideas behind describing the semantics of the
S-system with an automaton definition and construc-
tion are as follows: We start with snapshots of the sys-
tem variables' values that constitute the possible states
of the automaton. Transitions are inferred from traces
of the system variables' values. Final states are those
states in which the simulation reaches a recognizable
end and are supposed to represent equilibrium points
for the metabolic pathway to be modeled. The auto-
maton we construct allows us to capture qualitative
features of a biological system.
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A simple reasoning tool, based on the notions of
model checking with temporal logic, can analyze a
single trace of the automaton results, where the single
trace is created from only one "set-up" (e.g., initial
conditions, a set of values for the parameters, a set of
signaling events, etc.). To allow more than one trace, it
is necessary to consider different "set-ups," e.g., many
possible values for the parameters, such as rate con-
stants and kinetic orders (see Antoniotti et al. 2002,
2003a,b; Mishra 2002).
In Figure 1, we show an example of how our sys-
tems can be used to reason about the purine metabo-
lism process. For more details, see Curto et al.
(Biochem. J. 329: 477 [1998] and Math. Biosci. 151: 1
[1998]) and Voit (Computational Analysis of
Biochemical Systems, Cambridge [2000]). The main
metabolite in purine biosynthesis is 5-phosphoribosyl-
a- 1 -pyrophosphate (PRPP). A linear cascade of reac-
tions converts PRPP into inosine monophosphate
(IMP). IMP is the central branchpoint of the purine
metabolism pathway. IMP is transformed into AMP
and GMP. Guanosine, adenosine, and their derivatives
are recycled (unless used elsewhere) into hypoxan-
thine (HX) and xanthine (XA). XA is finally oxidized
into uric acid (UA). In addition to these processes,
there appear to be two "salvage" pathways that serve
to maintain IMP level and thus of adenosine and
guanosine levels as well. In these pathways, adenine
FIGURE 1 A simple (and incomplete model) of the metabolic scheme of purine metabolism in
humans. The model fails to satisfy the "robustness conditions."
FIGURE 2 A more complete model of the same purine metabolism in humans. Our tool, Simpathica, discovered that the modified
model satisfies the elusive "robustness conditions."
phosphoribosyltransferase (APRT) and hypoxanthine-
guanine phosphoribosyltransferase (HGPRT) combine
with PRPP to form ribonucleotides.
Using our system (Simpathica) and the approach-
es described earlier, one can automatically create the
model shown in Figure 1 and perform model checking
on the resulting qualitative automaton to show that the
model fails to satisfy the following temporal logic for-
mula (encoding robustness):
Eventually(Always (PRPP = 1.7 PRPP1)
implies
steady_state()
and Eventually(Always(IMP < 2 IMP1))
and Eventually(Always(hx_pool < 10.hx_pooll))).
The above formula states (in English) that "Persistent
increase in the initial concentration of PRPP does not
cause unwanted changes in the steady-state values of
some metabolites." This reasoning process and manip-
ulations with Simpathica ultimately lead to a more
complete model shown in Figure 2 that does satisfy
the robustness formula.
EVOLUTIONARY PROCESSES,
GENOMES, AND PATHWAY MODELS
Genome evolution is a dynamic process. A faithful
model of the evolution process can be based mainly on
the changes in the genomic sequences, which can fur-
ther lead to the corresponding changes in the cellular
elements at higher levels (proteome, transcriptome,
interactome). Of course, natural selection screens out
the disadvantageous changes in the genome at the phe-
notype level, and thus guides the direction of genome
evolution. Although different organisms may have
evolved under different evolutionary history and dif-
ferent selection pressure, some common statistical
features can be found on different levels of cellular
processes and can be obtained from analyzing the vast
amount of sequence data currently available. Our
research has provided credence to a hypothesis first
proposed in 1970 by Susumu Ohno, called "evolution
by duplication," that can now be verified with the
available genome sequence.
Using our models, one can explain the topology of
protein interaction networks, linguistic structures of
the amino acid sequences in protein domains, and
even the fast protein-folding dynamics in nature. The
power-law distribution with its "hubby" topology
(e.g., p53 was shown to interact with an unusually
large number of other proteins) can be explained if one
models the new proteins emerging from the older
ones, with a propensity to interact with only those pro-
teins that its other family members already interact
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with. Since the protein interaction network, as well as
other higher-level cellular processes, is thus encoded
in genomic sequences, the evolutionary structure,
topology, and statistics of many biological objects
(pathways, phylogeny, symbiotic relations, etc.) are
rooted in the genomic sequence's evolution dynamics.
To study the evolution processes of the kind just
described, we have developed an efficient "Sequence
Grammar" backend for low-level simulation tasks in
genomic evolution as well as various mathematical
models: an Eulerian random graph model and a model
based on Polya's urn.
ADVANCED TOOL ARCHITECTURES
In the domain of most immediate interest, namely,
postgenomic biology, the conventional concept of a
distributed set of tools, made available through a web-
browser interface, fails to adequately respond to the
challenges, complexity, and exponentially growing
demands. Thus, our approach focuses on creating tool
architecture with following properties: (1) Allows for
software modules that can be composed in a flexible
manner; (2) supports multiple sets of scripting lan-
guages, large numbers of library software, and multi-
ple computer architectures; (3) provides free-format
databases that hide the idiosyncrasies of multiple for-
mats; (4) allows for rapid prototyping for new experi-
ments and helps in experiment design; and (5) inte-
grates the domain-knowledge such that the tools
themselves become the conduit for communication.
In particular, we have focused on enhancing and
integrating the following three tools into the general
framework outlined earlier:
VALIS: a language-independent environment to
prototype bioinformatics applications.
Simpathica and the related XS-system to allow the
user to describe, reason about, and interact with
biochemical reactions.
NYU MAD: a system to maintain and analyze bio-
logical abundance data (e.g., microarray expres-
sion levels or proteomic data).
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EXPERIMENTAL RESEARCH
The most interesting data points for our study are the
time-course data describing genome, transcriptome,
and proteome within a single cell. In reality, we have
to make do with mRNA collected from a small popu-
lation of cells, where individual cells within the popu-
lation may be moving through the cell cycles in an
unsynchronized manner.
The required data sets can be collected using two
different technologies:
Microarray Data: measuring the mRNA abundance
through hybridization to selected cDNAs or oligos.
Mass-spectrometry Data: measuring gene-expres-
sion profiles using a mass-spectroscopy-based
approach to "resequencing."
Such new technology may have many advantages:
It creates less noisy data; it could potentially calibrate
for mRNA stability; and finally, as more and more
genes are identified, it could be easily adapted to
account for the new transcriptomes.
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PREDICTION OF PROTEIN STRUCTURE AND FUNCTION
Neuwald N. Kannan
A. Poleksic
We seek to uncover clues to protein structure and func-
tion through computational and statistical analyses of
available data. While analyzing specific proteins, we
develop new methods, as they are required, both to
identify significant features and to aid interpretation
of our findings. More specifically, we are developing
chemical, structural, sequence, and taxonomic rou-
tines and corresponding statistical procedures, which
are being integrated into a suite of programs for com-
prehensive protein characterization. Getting over the
necessary technological hurdles in setting up an infra-
structure that can integrate these various forms of
information has involved a substantial initial invest-
ment. This year, however, we have begun to reap the
benefits, and we now possess tools that allow us to
explore previously uncharted territory regarding vari-
ous aspects of protein structure and function.
In general, our research focuses on classes of pro-
biochemical, and genetic information from a wide
range of organisms. In the course of developing our
computational and statistical methods, for example, we
have used as a test set the P-loop GTPases, for which
there are more than 5000 sequences from all three
main divisions of life, over 100 distinct structures, and
tens of thousands of publications. More broadly, I am
investigating the class of proteins called P-loop
NTPases, while those within my group focus on other
major protein classes. My current postdoc, Natarajan
Kannan, is focusing on protein kinases and related
kinases, of which there are currently about 12,000
sequences in the database. There are several reasons to
focus on these proteins. First, the sheer volume of data
available, which may otherwise mask valuable infor-
mation, provides opportunities for computational
approaches designed to handle large data sets. Second,
large data sets make statistical approaches more pow-
erful. Third, these classes of proteins have essential
cellular roles, as is indicated by their high conservation
and prevalence, and thus the aim of understanding
their functions offers substantial biomedical benefit.
Finally, many of these proteins are highly relevant to
other research projects here at CSHL.
CHAIN ANALYSIS
This work was done in collaboration with Jun Liu,
Department of Statistics, Harvard University.
This year, we completed the initial version of a
major computational project called CHAIN (contrast
hierarchical alignment and interaction network) analy-
sis. Proteins comprising the core of the cellular
machinery are often highly conserved, presumably due
to selective constraints maintaining important structur-
al features. CHAIN analysis relies on statistical proce-
dures to decompose these constraints into distinct cat-
egories and to quantify corresponding selective pres-
sures, thereby pinpointing functionally critical struc-
tural features within each category (for an example,
see below). Completion of this project has involved
further development of (1) an important underlying
statistical procedure (now called Bayesian partitioning
with pattern selection), (2) automated taxonomic tools
based on the NCBI taxonomy database, (3) automated
tools for analysis of molecular interactions, and (4)
improved multiple sequence alignment routines (via
the addition of marginal probability trimming and PSI-
BLAST checkpoint file routines). It also involved the
incorporation of several new procedures including (1)
structurally based alignment routines; (2) design of a
structural visualization language and implementation
of a corresponding language parser; (3) tools for iden-
tifying correlations between aligned residues, which
allows us to identify key interactions involving residue
pairs; (4) routines for exploring the full range of vari-
ability at specific positions in homologous proteins;
and (5) a motif-based multiple alignment option that
allows analysis of subtly conserved patterns missed by
the default (PSI-BLAST) alignment algorithm. These
new automated features allow us to more rapidly ana-
lyze large sets of proteins and thereby speed up com-
prehensive analysis of large sequence sets.
SURVEY OF PROTEINS AMENABLE
TO CHAIN ANALYSIS
Using these CHAIN analysis tools, we have initiated a
broad search of the protein database in order to locate
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those protein domains most amenable to CHAIN
analysis. Ideally, candidate protein families should be
relatively highly conserved across diverse taxa and
should be a subset of a much larger protein class.
Automated routines for finding such proteins have
been implemented. Another valuable strategy is to
examine all such families in a class, which thereby
helps us interpret analyses of individual families by
leveraging information from other families. This sur-
vey has yielded various candidate protein domains of
particular current interest, including, for example,
members of the AAA+ and actin/hsp70 classes of
chaperones, protein and histidine kinases, and heli-
case superfamilies 1 and 2. While we are now focus-
ing our efforts on specific P-loop NTPases and kinas-
es, limited further analysis of these other groups has
been helpful, as it has revealed the nature of various
conserved structural motifs, thereby aiding interpreta-
tion of analyses for specific families of interest.
PROTEIN STRUCTURAL PRINCIPLES
Structural information gathered from this broad sur-
vey more generally aids our understanding of proteins
by revealing basic structural principles, which are
manifested as recurring conserved features. This
information is being interpreted in light of basic prin-
ciples gathered from the chemical and structural liter-
ature. Published principles have been and are being
incorporated into computer routines that, for example,
allow us to exhaustively search the structural database
for all proteins exhibiting a given feature. Several such
routines were merged into the CHAIN analysis suite
of programs. The utility of this approach is illustrated,
for example, in our description below of the role of
amino acid torsion angle strain in protein kinase
mechanisms.
CHAIN ANALYSIS OF "FY-PIVOT" GTPAsEs
We have completed our analysis of a subclass of Ras-
like proteins, which we term "FY-pivot" GTPases. In
particular, this analysis has revealed within Rab, Rho,
Ras, and Ran a canonical network of molecular inter-
actions centered on bound guanine nucleotide (see
Fig. 1). This network presumably performs a crucial
structural and/or mechanistic role, considering that it
has persisted for more than a billion years after the
divergence of these families. We call these "FY-pivot"
GTPases after their most distinguishing feature, a
phenylalanine or tyrosine that functions as a structur-
al pivot within this network. We found that specific
families deviate somewhat from canonical features in
interesting ways, presumably reflecting their function-
al specialization during evolution. In Ran, for exam-
ple, two conserved histidines that strikingly diverge
from their canonical counterparts appear to facilitate
alternative protein conformations coupling Ran's
"basic patch" and "carboxy-terminal switch" (two
prominent structural features of Ran) to guanine
Ras Racl Ran
FIGURE 1 Canonical structural features shared by Ras, Racl , and Ran as revealed through CHAIN analysis.
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nucleotide exchange and effector binding. Ran and
these related proteins, which have served as a test set
for development of CHAIN analysis procedures, have
very critical roles in cellular signaling events.
Publication of these findings thus has broad biological
implications and at the same time illustrates the utility
of CHAIN analysis.
PROTEIN KINASE STRUCTURAL MECHANISMS
CHAIN analysis of P+1-directed protein kinases has
revealed, as their most distinguishing feature, an argi-
nine that, by interacting with the backbone of a sub-
strate-binding residue, induces a strained conforma-
tion facilitating substrate recognition. This interaction
is initiated upon phosphorylation of the activation
loop via propagated conformational changes involving
other distinctively conserved residues. We predict sim-
ilar mechanisms for the glycogen synthase kinase
Gsk3I3 and the SR kinases, which processively phos-
phorylate tandem recognition sites and in which a pre-
viously phosphorylated substrate site functions as a
surrogate activation site, and for autophosphorylation
of dual-specificity tyrosine-phosphorylated and -acti-
vated kinases.
In a related analysis of atypical kinases, we found
(using a recently improved motif-based search proce-
dure) several new kinase families possessing the pro-
tein kinase structural fold. Moreover, this analysis
strongly suggests that four residues in this protein
class (two aspartates, one asparagine, and a histidine
or tyrosine) constitute the minimum requirement for
kinase activity. It appears that an essential role for this
histidine or tyrosine residue in the kinase mechanism
has not been proposed previously. Kinase mechanisms
are classified into two categories: those with associa-
tive modes of phosphoryl transfer and those with dis-
sociative modes of phosphoryl transfer. We found a
correlation between an associative versus a dissocia-
tive mechanism and the occurrence of tyrosine versus
histidine, respectively, at this site. A search of the
chemical literature revealed principles explaining this
correlation.
In Press
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COMMUNITY ACCESS TO GENOME RESOURCES
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GRAMENE: A COMPARATIVE MAPPING
RESOURCE FOR GRAINS
X. Pan G. Thorisson
L. Ren P. Van Buren
S. Schmidt D. Ware
L. Tegtelman W. Zhao
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
Gramene allows researchers to compare the genetic
and physical maps of the major monocot crops, name-
ly, maize, barley, oats, sorghum, and wheat, to the
emerging rice genomic sequence. This allows
researchers to identify candidate genes in the rice
genome that correspond to genetically mapped mutants
and quantitative traits in the non-rice crop they are
studying. Hence, the resource allows researchers
studying traits, for example, in maize and barley, the
benefit of genomic sequencing without waiting for the
sequencing of these much larger genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
mapped more than 900,000 monocot expressed
sequence tags (ESTs) to the rice genome, allowing
gene predictions to be further refined based on cross-
species comparisons. During this year, we developed a
new integrated map of the rice and maize genomes that
allows researchers to move back and forth between var-
ious genetic and physical maps of these species in order
to apply the knowledge developed in one organism to
finding functionally significant genes in the other.
Curation is an important component of Gramene.
In collaboration with Susan McCouch's laboratory at
Cornell, we have curated more than 12,000 rice pro-
teins, assigning them classifications in the Gene
Ontology (www.geneontology.org). In addition, we
have classified more than 700 rice mutants using a
trait ontology that we have developed. We are current-
ly curating the rice biological literature, much of
which is in non-English languages, and making this
information available via Gramene as well.
Version 1.00 of Gramene went live in December
2001 and has been followed by a new release every 3
months. Much of the software developed for Gramene
is novel and includes such useful software modules as
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a comparative map viewer (Fig. 1), an ontology brows-
er, and a physical map viewer. The work on Gramene
has resulted in three publications in prestigious scien-
tific journals.
WORMBASE: A RESOURCE FOR
C. ELEGANS GENOME AND BIOLOGY
During the past year, our lab received a major grant to
develop WormBase, an on-line resource for the small
free-living nematode, Caenorhabditis elegans. This
organism is favored as a simple model animal because
of its small genome size, experimental malleability,
and well-understood cellular anatomy. WormBase is a
curated model organism database developed as part of
an international collaboration with the California
Institute of Technology, Washington University at St.
Louis, and the Sanger Centre. Our lab is responsible
for the Web Site, user interface, and software architec-
ture for the project.
The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted genes,
alternative splicing patterns, oligonucleotide probes,
and evolutionarily conserved segments. It also contains
many other types of biological information, including
the C. elegans cell pedigree, the organism's neuroanato-
my, its genetic map, and the physical map from which
the genomic sequence was derived. During 2002, we
added the following key features to Wormbase:
A synteny viewer (Fig. 2), which allows researchers
to compare the C. elegans genome to orthologous
regions in Caenorhabditis briggsae, a worm that
diverged over 100 million years ago. This compari-
son allows researchers to refine the structures of
genes and to discover putative regulatory regions.
A redesigned gene page that gives researchers an
"at-a-glance" summary of the functional signifi-
cance of a confirmed or predicted gene.
Interfaces to the BLAST and BLAT sequence sim-
ilarity engines.
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FIGURE 1 The Gramene comparative map viewer interrelates the genetic and physical maps of maize and rice.
DISTRIBUTED SEQUENCE ANNOTATION
SYSTEM
DAS, the distributed sequence annotation system, is a
software architecture that allows researchers from
around the world to share and exchange annotations
on the genome without the need for error-prone and
time-consuming reformatting currently required. This
year saw the widespread adoption of DAS. It is now in
use as the data exchange format by the EBI/Sanger
EnsEMBL project, the UCSC Genome Browser,
TIGR, FlyBase, WormBase, JGI at OakRidge, and the
Whitehead Institute.
GENOME KNOWLEDGEBASE
The Genome KnowledgeBase (GK) is a collaboration
with Ewan Bimey of the EBI and Suzanna Lewis of
the Gene Ontology Consortium, to develop a Web-
accessible resource for curated information about bio-
logical processes.
The GK is organized like a review journal.
Practicing biologists are invited to create "summa-
tions" that summarize a particular aspect of their field.
Summations currently include "DNA Replication,"
"Protein Translation," and the basic pathways of inter-
mediate metabolism, such as the TCA cycle. New
modules for "RNA Splicing" and "Cycle Checkpoints"
are in progress. Summations are similar to minire-
views, except that each paragraph of text is reduced to
a series of logical assertions that is entered into a data-
base of processes and macromolecules. The database is
then used to drive a Web Site. The Web Site can be
browsed like a textbook, or searched with queries to
discover pathways and connections. The second major
release of GK occurred on February 1, 2003, and is
available at www.genomeknowledge.org.
GENERIC MODEL ORGANISM DATABASE
PROJECT
In collaboration with the model organism system data-
bases FlyBase, SGD, and MGD, the Generic Model
Organism Database (GMOD) project is developing a
set of database schemas, applications, and interfaces
suitable for creating a model organism system data-
base. The hope is to significantly reduce the time and
expense required to create new databases to curate
genomic information coming from various model
organism system sequencing projects (e.g., rat,
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corresponding region of the C. briggsae genome (lower panel).
Dictyostelium, and Plasmodium). As of the end of
2002, we released the following modules:
GBrowse, a genome browser and annotation tool.
CMap, a comparative mapping tool.
LabDoc, a system for creating and maintaining
standard operating procedure documents.
THE HUMAN HAPLOTYPE MAP
Following our successful participation in The SNP
Consortium, which culminated in the publication of a
map of 1.6 million human single-nucleotide polymor-
phisms (SNPs), our lab was selected to coordinate the
next SNP-based project, the HapMap. The HapMap
project is an international effort to find and define
regions of high linkage disequilibrium in the human
genome. These are regions in which genetic recombi-
nation is rare and across which most individuals in the
general population carry a small number of common
variants. The goal of the HapMap project is to charac-
terize more than 2 million SNPs in order to define
linkage disequilibrium blocks covering 85% of the
human genome. The outcome is called a "haplotype
map."
The significance of this map is that it will dramat-
ically reduce the time and cost necessary to perform
genetic screens to identify genes that are responsible
128
for human disease. It will also provide valuable
insights into human evolutionary history.
Our lab will be supporting the project by coordi-
nating the efforts of the various research groups and
by running the main database in which intermediate
results are stored.
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COMPUTATIONAL GENOMICS
M.Q. Zhang Z.Y. Xuan
J.H. Wang
N. Banerjee
L.H. Liu
I. Grosse
E Wang
J. Ou
N. Hata
G.X. Chen
K. Mamoru
Our research interest continues to be the identification
and characterization of the genetic elements in nucleic
acid sequences by computational means. As the Human
Genome Project is close to the finishing the sequencing
of the human genome, developing efficient computa-
tional methods for identification of genes and their con-
trol/regulatory elements has become extremely impor-
tant. Knowing the organization of a gene often becomes
the prerequisite for further functional studies. In the
past, we studied statistical characters of exons and
introns in protein-coding regions and developed cod-
ing-exon prediction programs by applying multivariate
statistical pattern recognition techniques. Recently, we
started looking into the more difficult problems of fmd
ing regulatory cis-elements in noncoding regions by
taking advantage of new resources, such as the mouse
draft genome and large-scale chromatin immunoprecip-
itation (ChIP) -chip data. Our main goal was to carry out
a whole-genome comparison between human and
mouse as well as between the public and Celera mouse
genome assemblies. As a result, we have developed the
Conserved Sequence Element database (CSEdb).
Furthermore, we have developed an annotation
pipeline, which enabled us to combine FirstEF and
mRNA/EST data to make a first-pass human genome
annotation of promoters and first exons. For our collab-
orative works, please see the Krainer, Tully, Lowe,
McCombie, and Hannon reports in this Annual Report.
We (J. Ou, N. Hata, Z.Y. Xuan, and M.Q. Zhang)
are also developing high-throughput experimental val-
idation technologies for first exon predictions in col-
laboration with the McCombie and Hannon labs.
First-pass Annotation of
Promoters and First Exons
in the Human Genome
I. Grosse, M.Q. Zhang [in collaboration with R. Davuluri,
Ohio State University]
The human genome contains a vast amount of cis-reg-
ulatory regions responsible for directing spatial and
temporal patterns of gene expression, and delineating
their locations is of paramount importance for our
understanding of gene expression and regulation.
However, due to the absence of full-length mRNA
transcripts, the identification and annotation of these
functional regions are behind that of coding regions.
Here, we present an initial computational annotation
of promoters and first exons for the 24 chromosomes
of the human genome, which we will make publicly
available at http: / /www.cshl.edu/mzhanglab/ once our
paper is accepted. We are currently working on the
mouse promoter and first exon annotation problem by
taking into account human-mouse comparison.
Computational Comparison of
Two Mouse Draft Genomes
and the Human Goldenpath
Z.Y. Xuan, J.H. Wang, M.Q. Zhang
The availability of both mouse and human draft
genomes has marked the beginning of a new era of
comparative mammalian genomics. The two available
mouse genome assemblies, namely, those from the
public mouse genome sequencing consortium and
Celera Genomics, were obtained by using different
clone libraries, as well as different assembling meth-
ods. By taking advantage of both public and private
mouse genome sequencing efforts, we were able to
present a critical comparison of the two latest mouse
genome assemblies. The utility of the combined
mouse genomes is further demonstrated by comparing
them with the human goldenpath and through a subse-
quent analysis of the resulting CSE database. In par-
ticular, the CSE information allows us to identify
more than 6000 potential novel genes and to derive
independent estimates of the number of human pro-
tein-coding genes. Although the Celera and public
mouse assemblies agree to a great extent, they differ in
about 10% of the mouse genome. Each assembly has
advantages over the other. Among the advantages, the
Celera assembly has higher accuracy in base pairs and
overall higher coverage of the genome. The public
mouse assembly, however, has higher sequence quali-
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ty in some newly finished BAC (bacterial artificial
chromosome) regions and the data are freely accessi-
ble. Perhaps most importantly, by combining both
assemblies, we can get a better annotation for the
human genome. In particular, we can obtain the most
complete set of CSEs. One third of these CSEs are
related to known genes. Some CSEs are related to
other functional regions in the genome, and more than
half of the CSEs are still functionally unknown. CSEs
allow us to estimate the total number of the human
protein-coding genes to be about 40,000. Since CSEs
can shed additional light on the functional regions of
the genome as we have demonstrated, making this
searchable CSEdb publicly available on-line will
expedite new discoveries through comparative
genomics. We are continuing on with comparative
genomics with more species, such as fish and rat.
The Argonaute Family: Tentacles
That Reach into RNAi, Developmental
Control, Stem Cell Maintenance,
and Tumorigenesis
Z.Y. Xuan, M.Q. Zhang in collaboration with
G. Hannon, Cold Spring Harbor Laboratory]
The Argonaute proteins are related to RNA interfer-
ence (RNAi), developmental control, and other biolog-
ical functions. Using a protein motif of the family
members (PIWI and PAZ), together with the expressed
sequence tags (ESTs) and the mouse genome of Celera
Genomics, we discovered five novel mouse argonaute
gene candidates and one novel human homolog. The
phylogenetic analysis of all seven human proteins and
eight mouse Argonaute proteins, together with other
family members in Drosophila, Arabidopsis, rabbit,
etc., have revealed potentially important functions of
these novel human and mouse genes.
Characterization and Prediction
of the Nanos Response Element
with Sequence Analysis in Drosophila
G.X. Chen, M.Q. Zhang [in collaboration with T. Tully,
Cold Spring Harbor Laboratory]
The Nanos response element (NRE) in the 3 '-untrans-
lated repeat (3 'UTR) of Drosophila hunchback (hb)
mRNA has been shown to be critical to normal abdom-
inal segmentation during Drosophila development.
NRE in hb mRNA is bound by Pumilio, which further
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recruits Nanos and another factor, Brain Tumor (Brat).
The formed complex represses the translation of hb
mRNA, possibly via a deadenylation mechanism.
Another protein Bicoid (Bcd), which establishes head
and thoracic development in Drosophila, is also shown
to be regulated by Nanos and contains NRE. We are
interested in characterizing the sequence pattern of
NRE and using this pattern to search for other potential
targets of Pumilio and Nanos. Fifteen 3 'UTR sequences
were retrieved from GenBank based on annotation,
including bcd mRNA from seven different Drosophila
species and hb mRNA from five Drosophila species as
well as one hb mRNA from Musca domestica. First,
Gibbs motif sampling was used to identify common
motif elements among the 15 3 'UTR sequences. Since
Gibbs sampling is a stochastic method, multiple runs
were performed with different parameters. The most
stable motif found included one element from every bcd
3 TTR and two elements from every hb 3 "UTR. To fur-
ther improve the alignment obtained from Gibbs, we
realigned the motif elements with T-Coffee. The re-
alignment revealed a motif with two highly conserved
cores separated by five or six bases, as regular expres-
sion GTTGT.{5,6}ATTGTA. To verify our local align-
ment result based on Gibbs sampling, we also carried
out global alignments (ClustalW) with bcd and hb
3 'UTR sequences, respectively. All of the elements
identified with Gibbs were aligned in conserved regions
except one of the elements in the M domestica 3 'UTR.
Next, we downloaded all Drosophila 3 VTR sequences
in the UTRdb (8998 in total, 6063 nonredundant) and
searched for potential NREs with the regular expression
defined previously. Besides bcd and hb, six other genes
were found to contain the pattern in the 3 .UTR. Little is
known about the function of those genes except one,
Serrate (Ser). Ser is shown to be involved in wing
development and is expressed in tissues including the
central nervous system and dorsal mesothoracic disc,
during specific development stages. Interestingly, it is
reported that misexpression of Brat suppresses growth
of the wing, suggesting that Ser may also be a target of
regulation by the Pumilio-Nanos-Brat complex.
Developing ChIP-chip and Promoter
Data Analysis Algorithm Package
N. Hata, M.Q. Zhang [in part in collaboration with the Ren
Lab at the University of California, San Diego]
We have been creating a comprehensive software
library for discovering transcription binding sites in
promoter sequences. The package includes a new
motif-finding algorithm, promoter database for mouse
and human, and incorporation of microarray gene
expression data and ChIP data. Our binding-site
search is based on motif counting by comparing pro-
moters identified by the expression or ChIP data with
respect to control (background) promoter sequences.
Our algorithm is robust, exhaustive, and quick enough
for genome-wide analysis. Our collection of mouse
and human promoter sequences based on the RefSeq
database is extremely useful in analyzing general
microarray/ChIP experiments. We are producing our
package to become the standard sequence analysis
tool for microarray/ChIP experimentalists. We have
applied our algorithm to mouse tissue-specific
microarray data from Riken and c-Myc-binding pro-
moter data obtained from the ChIP experiment by the
Ren lab. We found known as well as novel binding
sites for tissue-specific (liver, kidney, bone, brain,
etc.) promoters and obtained discrimination functions
that can be used in genome-wide search of tissue-spe-
cific cis-elements. The results were presented in an
invited talk at the Genome Informatics meeting in
Cambridge. The details and technical description of
the algorithm will be published separately. We have
obtained even cleaner and convincing motif candi-
dates from the c -Myc ChIP data. The predicted bind-
ing sites are new and have distinct spatial distribution.
There are also new results for co-occurring motifs.
Once the package is complete, there will be wide
applications. Our prediction of novel binding sites and
tissue specificity of genes should be validated by
experiments, and further feedback as well as new data
from biologists will improve our algorithm.
Genome Level Analysis of Alternative
Splicing, and Cross-species
Comparison between Human and Mouse
J.H. Wang, M.Q. Zhang [in collaboration with the Fu Lab
at the University of California, San Diego]
We are in the process of developing alternative tran-
script databases for the human and mouse and have
compared the alternative spliced transcripts of the
human and mouse. It is a great challenge to keep these
results in sync with the constant updating of the
genome assemblies. The growing amount of full-
length RefSeq mRNAs/cDNAs have turned out to be
most useful and provide us more insight into the vari-
ety of alternative splicing patterns.
We are classifying genes into two groups: One has
conserved splicing patterns and another has potential-
ly distinct splicing patterns.
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NEUROSCIENCE
With its 100 billion cells of many different types forming 100 trillion specific connections or "synapses"
among themselves via 300 million feet of biological wiring, few things are more mysterious or hold more
fascination than the human brain, and nothing is more biologically complex. CSHL neuroscientists are
tackling the epic task of sorting out how the brain develops, learns, remembers, experiences, and
recovers from injury or disease, and ultimately makes us who we are.
The brain is able to solve certain computations that remain far beyond today's fastest and most
sophisticated computers. Anthony Zador's lab is probing the brain's unique and powerful computa-
tional style by examining how the brain processes complicated auditory input we call sound. Zador's
lab has uncovered a code that neurons use to represent sound and is working to sort out the different
excitatory and inhibitory components that generate the code. These studies are helping us to understand
the unique and powerful but largely unexplored computational properties of the brain.
Dmitri Chklovskii's lab uses mathematics and physics to examine constraints on brain structure and
function. By uncovering such limits, they hope to delineate the "engineering" principles that govern brain
evolution. The scientists ask how neurons are connected and are working to understand how neurons
organize themselves into circuits and how those circuits produce behavior. By comparing the patterns of
brain structure between animals, they have begun to pinpoint features that are fixed and characteristics
that can vary.
By focusing on a part of the brain that is variable, or plastic, Hollis Cline's lab examines how sen-
sory experience shapes the ways neurons connect during development. Cline and her colleagues study
the development of the visual system in amphibian tadpoles. They address how sensory activity stim-
ulates mechanisms within brain neurons and thereby guides visual system development. Many animals
share mechanisms of brain development. Therefore, Cline's research is revealing fundamental process-
es that govern brain development in a wide range of species, including humans.
Brain plasticity comes into play not only during brain development, but also during learning and
memory formation. Karel Svoboda's lab investigates how sensory experience triggers the long-term
changes in brain architecture believed to underlie memory. Using custom-made, state-of-the-art imag-
ing technology, the scientists have taken pictures of synaptic connections between neurons in the
brains of adult mice. From the images, they detailed the first measurements of the stability of synaps-
es, measuring how often the connections form and disappear in a part of the adult brain called the bar-
rel cortex. They found that some connections are stable for months while others disappear within a day
and that synapse turnover was influenced by experience. Their research suggests that the new con-
nections encode memories.
Roberto Malinow's lab studies how the molecular composition of synapses changes in response to
sensory experience. Perhaps their most exciting finding this year was their demonstration that experi-
ence drives neurotransmitter receptor proteins called AMPA receptors into synapses. This is the first
experience-induced specific molecular modification of a synapse to be discovered. Malinow's findings
indicate that the dynamics of AMPA receptor replacement at synapses is likely to be a principal mecha-
nism of learning and memory.
Josh Huang's lab also studies molecular responses to sensory experience and has focused on a
specific type of inhibitory synapse or "off switch" defined by a molecule that it releases (GABA). They
have developed techniques for studying these special synapses in animals and cell cultures, which
allow them to investigate how a myriad of crucial "off" switches are built into complex brain circuitry
during development.
Because the same proteins implicated in human Alzheimer's disease are present in the fruit fly brain,
Yi Zhong is using the power of fruit fly genetics to model and unravel the causes of Alzheimer's dis-
ease in humans. Zhong's group has found that buildup of one particular protein (A1342) is sufficient to
cause nerve cell death and memory loss in flies. Zhong's "Alzheimer's Flies" can be used to identify
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new molecular targets for treating the disease, or to screen large numbers of drugs for those that might
slow or prevent nerve cell death in the brain of Alzheimer's patients.
Tim Tully's lab studies memory formation by using genetics to isolate fruit fly mutants ("Pavlov's
Flies") that display defects in memory formation. They have identified 42 genes that may work to form
memories in flies. Interestingly, many of these genes have counterparts in mice and humans. Therefore,
Tully has tapped into the genetic basis of a fundamental memory mechanism.
Jerry Yin's lab investigates a process believed to underlie memory called synaptic tagging. Yin's lab
is interested in how the interaction of particular proteins during synaptic tagging drives the formation
and maintenance of memory. They have characterized several proteins that might control memory for-
mation and have investigated how neurons might confine proteins to particular synapses via synaptic
tagging. Once memories are formed, Yin and others theorize that sleep plays a role in memory consol-
idation, perhaps by providing time for memories to be "replayed" and thereby strengthened. In one test
of this idea, Yin's lab has devised a genetic method for manipulating how much sleep flies get.
While several CSHL researchers study long-term memory, Carlos Brody explores short-term mem-
ory, which is essential for carrying on a conversation and many other vital functions. In collaboration
with neurophysiologists at several institutions, Brody and others in his lab have studied the electrical
impulses of neurons that support short-term memory. They have also created mathematical models of
neural networks that recapitulate the patterns of real-world neural activity they observe. Such models
explain the mechanism of short-term memory in a rigorous, testable fashion and may also predict unex-
pected properties of short-term memory.
Zachary Mainen's lab studies rodent behavior that is influenced by smell to explore awareness,
motivation, and decision-making. The group studies small- and large-scale events, from how single
olfactory neurons send out signals to how large ensembles
of neurons enable rats to make decisions based on what
they smell. Last year, Mainen's group found that rats get a
complete take on their olfactory world with each 150-mil-
lisecond sniff, a discovery that guides how we interpret the
brain activity that underlies decision making.
Part of what makes the brain so powerful is the extra-
ordinary array of diverse cell types it comprises. In study-
ing adult stem cells, or unspecialized cells that can devel-
op into many different cell types, Grigori Enikolopov's lab
has found that the compound nitric oxide can guide stem
cells to become neurons. In related research, the lab has
found that the stem cells in the mouse brain are remarkably
plastic, capable of adopting any one of several fates.
Enikolopov's studies support the notion that coaxing stem
cells down particular developmental pathways might be an
effective strategy for treating brain disease or injury.
Koichi lijima
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COMPUTATIONAL SYSTEMS
C.D. Brody S. Chakraborty
C. Machens
A. Penel
During 2002, we continued to pursue our investigation
of mechanisms of short-term memory. Here, we use
"short-term" to mean the type of memory that lasts a
few seconds, for example, the type of memory one
uses to hold a telephone number actively "in mind," in
between seeing it on a page and dialing it. In collabo-
ration with Ranulfo Romo (National University of
Mexico), we published a paper on the role of monkey
secondary somatosensory cortex in the short-term
memory and decision-making components of a vibro-
tactile stimuli discrimination task. Santanu Chakra-
borty (Watson School graduate student) began a col-
laboration with David Tank (Princeton) to develop
methods to study the anatomy of the neuronal circuits
in the goldfish brain that support short-term memory
of eye position. Amandine Penel (postdoc) joined our
lab in September to work on human psychophysics of
short-term memory of temporal patterns. In separate
projects, Christian Machens (postdoc), collaborating
with the Zador lab here at CSHL, submitted a paper on
using natural sounds to discover the structure of recep-
tive fields of cortical auditory neurons; and collabo-
rating with John Hopfield (Princeton), we submitted a
paper on using spike timing synchronization to robust-
ly recognize odors.
Timing Effects in the
Representation of Short-term
Memories in the Prefrontal
Cortex
C.D. Brody [in collaboration with R. Romo,
National University of Mexico]
Collaborating with the awake monkey laboratory of
Ranulfo Romo, we have studied the time-dependence
of short-term memory neural activity in the prefrontal
cortex. A central idea behind current models of short-
term memory activity is that neurons involved in it
represent memories through activity patterns that per-
sist long after the stimulus that induced them is gone.
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For example, the neuron with responses illustrated in
Figure 1 has a firing rate that, even after the stimulus
is over, depends on fl, the remembered stimulus.
Current models of such activity posit that this fl-
dependent firing rate should be constant in time dur-
ing the delay period-the lines in the lower part of
Figure 1 a should be flat. If this were so, then for each
firing rate, there would be a single corresponding
value of fl, and knowing the firing rate would tell us
the value of fl. But we have found that in fact most
neurons have responses like those illustrated in Figure
la: The lines are most decidedly not flat. One cannot
straightforwardly decode what 11 spikes/sec means,
because it means quite different things during the first
vs. middle vs. last seconds of the delay period (see Fig.
lb). However, if we knew which part of the delay peri-
od we were in, then we could correctly decode the fl
value that corresponds to 11 spikes/sec. The brain
faces precisely the same problem. We hypothesize that
some time-dependent neurons in the prefrontal cortex
have an explicit timekeeping role, thus enabling accu-
rate decoding of short-term memory firing rates, and
enabling completion of the sequential discrimination
task. We are constructing models of mechanisms
behind such time-keeping neurons, and how they
could interact with fl- dependent neurons.
Perception and Short-term
Memory of Temporal Patterns
A. Penel, C.D. Brody
Recordings such as the one illustrated in Figure 1 sug-
gest that timing has an important role in short-term
memory. We will manipulate timing in human psy-
chophysics experiments, using tasks similar to the one
illustrated at the top of Figure 1. First, we will investi-
gate in detail how short-term memory decays as a func-
tion of delay period length. We are now asking whether
timekeeping is important for decoding on an ongoing
basis during the delay period, or whether decoding of
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short-term memory firing rates is carried out only at
the end of the delay period. In the latter case, delay
periods terminated at unexpected points in time should
lead to significantly higher errors than those of trials
with a similar, but expected, delay period length. In the
former case, there should be no significant difference.
Requisite experiments will be carried out to distin-
guish between these two possibilities. We will also
develop a discrimination task similar to the one of
Figure 1 but based on discriminating temporal patterns
of pulses. This task will be used to investigate the prop-
erties of short-term memory of temporal patterns.
Computational Modeling
of the Olfactory Bulb
C.D. Brody [in collaboration with J. Hopfield, Princeton
University]
Collaborating with John Hopfield, we have studied
models of how synchronization of cells in different
glomeruli of the mammalian olfactory bulb can lead
FIGURE 1 Time dependence of the firing rate of a short-term mem-
ory neuron in monkey prefrontal cortex. The monkey has been
trained to perceive the frequency of two mechanical vibrations
sequentially applied to a fingertip, and to report which of the two was
the higher (see task schematic at top of figure; PB indicates the time
at which the monkey makes its report). To carry out this task, the
subject must remember stimulus fl during the 3-second-long delay
period. (a) Responses of a neuron in the prefrontal cortex during the
task. Each row represents a trial, and each tick mark represents the
time of an action potential. Trials are grouped according to the value
of stimulus f1, indicated at the left. The lines below indicate
smoothed estimates of firing rate as a function of time for each fl
value. Although firing rates are a function of fl throughout the delay
period, they also change markedly during the delay period. (b) Firing
rate of the neuron as a function of fl for four different nonoverlapping
periods, as indicated.
to odor identification in a manner that is invariant to
changes in concentration of the target odor, and also
invariant to the presence of background odors. Our
model makes specific predictions regarding both syn-
chronization properties of mitral cells, and the condi-
tions under which synchronization and odor recogni-
tion should break down. In a model in the computer,
the designers can carefully specify each connection.
But in a biological system, connections are specified
through a combination of genetics and experience. We
are using our olfactory bulb model to investigate unsu-
pervised connection learning rules that would allow
the model to automatically self-wire, based on the
experience of being exposed to odors.
Structure of Auditory Neuron
Receptive Fields
C. Machens
Although it is widely agreed that the primary visual
cortex decomposes images into components such as
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oriented edges, the corresponding decomposition of
acoustic sounds in the primary auditory cortex
remains somewhat obscure. In the last few years, a
candidate approach for characterizing the function of
auditory neurons by describing their responses in
terms of a spectrotemporal receptive field (STRF) has
been explored. The appeal of the STRF rests, in part,
on its conceptual simplicity: Like its successful visual
counterpart, the spatiotemporal receptive field, the
STRF offers a straightforward linear description of a
neuron's behavior.
In a collaboration with Mike Wehr and Anthony
Zador here at CSHL, however, we showed that the
STRF can describe only part of what cortical neurons
do. Using in vivo whole-cell recordings, we tested the
ability of the STRF to predict the responses of cortical
neurons to natural sounds. In contrast to the simple,
artificial sounds usually employed in neurophysiolog-
ical experiments (such as sine tones, ripple stimuli, or
random chord stimuli), natural sounds such as animal
communication calls are far more complex and thus
probe a greater range of the system's capabilities. Our
results show that a few of the sounds lead to quite rea-
sonable predictions, whereas most responses could
only partially be estimated and some not at all. Hence,
in a more natural mode of operation, the responses of
neurons in the auditory cortex are mostly dominated
by nonlinearities.
The estimation of STRFs from natural sounds is
severely complicated due to the fact that natural
sounds do not sample all directions in stimulus space
in a natural manner. The methods that neurophysiolo-
gists usually employ for the computation of STRFs
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from the actual data are therefore no longer suited in
this specific case. Hence, we developed an improved
estimation procedure using regularization methods
specifically tailored toward the STRF estimation task.
These tools allowed us to overcome the severe overfit-
ting problems associated with the estimation of para-
meters from natural sounds.
Our next step is to explicitly model the encoun-
tered nonlinearities in order to gain a greater under-
standing of the neural code in the auditory cortex.
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PRINCIPLES OF BRAIN DESIGN
D.B. Chklovskii A. Stepanyants S. Song
M. Reigl
The following are two main questions in neuroscience:
How do neurons organize themselves into highly inter-
connected circuits? How do these circuits function to
produce behavior? Neither of these questions can be
answered without thoroughly understanding neuronal
connectivity. Therefore, our immediate goal is to build
a theoretical framework that would help establish neu-
ronal connectivity. We work toward this goal from sev-
eral different directions. First, we analyze physical
constraints on brain design and function in order to
determine "engineering" principles that govern brain
evolution. These principles, like the laws of conserva-
tion in physics, can narrow down the set of plausible
neuronal circuits and help focus our efforts in the
search for the models of brain function. Second, we
determine which features of neuronal connectivity are
conserved and which can vary from animal to animal
and within the same animal over time. Understanding
these different features exposes biological substrates
for individual variability and neural plasticity. Third,
we analyze wiring diagrams of neuronal circuits in an
attempt to find parsimonious descriptions of connec-
tivity. This should allow us to make a connection
between the wiring diagram of the brain and its func-
tion. In 2002, we made excellent progress on all of
these research directions.
Relationship between Neurite
Diameters and Branching Angles
in Cultured Neurons
D.B. Chklovskii [in collaboration with A. Ayali,
Tel-Aviv University]
The wiring economy principle allows one to derive a
relationship between branching angles of neurites and
their diameters. The derivation is based on balancing
virtual forces on neurite branches. Although this rela-
tionship makes interesting experimental predictions,
testing these predictions in vivo is problematic
because angles are modified due to high density of
entangled neurite branches. Therefore, we decided to
perform the test of this theory in a low-density inver-
tebrate neuronal culture. We measured neurite diame-
ters and angles with optical microscopy and compared
them with our theoretical predictions. Preliminary
results show that the predicted relationship seems to
hold, although the measurements are obscured by the
adhesion of neurite branches to the substrate.
Search for Repeating Motifs in
Biological Networks
D.B. Chklovskii, M. Reigl [in collaboration with
U. Alon, Weizmann Institute]
The functioning of living organisms relies on numer-
ous complex networks: from gene transcription regu-
lation to neuronal circuits in the brain. Although these
networks have been mapped out in simpler cases-
Escherichia colt (transcription regulation) and
Caenorhabditis elegans (synaptic connectivity)-their
function is not understood. Identifying functional
modules out of subsets of the whole network may help
our understanding of these networks. The goal of this
project is to search for functional modules, including
several neurons in C. elegans. The hope is that the
modules which have a stereotypically functional role
are present more often than at chance. To find them,
we perform a statistical analysis on a real network and
compare the outcome with the randomized network.
We found several overrepresented motifs that may per-
form a stereotypical function.
Correlation Analysis of the Spatial
Locations of Dendritic and
Axonal Branches
D.B. Chklovskii, A. Stepanyants [in collaboration with
G. Tamas, University of Szeged, Hungary]
Potential connectivity between neuronal pairs is often
evaluated by calculating the overlap between their
axonal and dendritic arbors. This procedure is justified
only if the spatial locations of dendritic and axonal
137
branches in the arbors are independent. We determine
whether this is the case by performing a statistical
analysis of three-dimensional reconstructions of neu-
ronal pairs. If we find that the locations of dendritic
and axonal branches are independent, arbor overlap
can be used to predict potential connectivity. If the
locations of dendritic and axonal branches are found
to be correlated, we will modify this procedure. In
addition, detecting correlations in branch locations
would indicate the existence of developmental mech-
anisms that need to be investigated experimentally.
Plasticity Potential due to
Rearrangement of Synapses
on GABAergic Interneuron
D.B. Chklovskii, A. Stepanyants [In collaboration
with Z.J. Huang, Cold Spring Harbor Laboratory]
Changing synaptic strength of existing synapses
(through LTP or LTD) is a commonly studied plastic-
ity mechanism, but it is not the only one. Another
plasticity mechanism is formation and elimination of
synapses. Knowing whether this plasticity mechanism
can reorganize neuronal circuits by connecting previ-
ously unconnected neurons (in addition to changing
connection strength) is important for the study of
learning and memory. We will evaluate the plasticity
potential of such a mechanism for GABAergic
interneurons by analyzing the geometry of cortical
circuits. In addition to evaluating plasticity potential,
this analysis will aid in inferring actual connectivity
from potential connectivity.
Optimal Stimulus Design
D.B. Chklovskii
Neurons in the brain respond to sensory stimuli by fir-
ing action potentials. The firing rate of a particular
neuron depends on which stimulus is presented to the
animal. Stimulus to which a neuron responds with the
highest firing rate is called the optimal stimulus.
Therefore, a neuron can be thought of as a detector for
an optimal stimulus. Although we know what the
optimal stimulus is for some neurons, it remains
unknown for the majority of neurons. Our goal is to
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design a computer algorithm that would perform a
search for an optimal stimulus automatically. This is a
very difficult task because the dimensionality of the
stimulus space is extremely high. Currently, we are
designing an appropriate algorithm and testing it
against a computer model of a neuron with a known
optimal stimulus.
Statistical Analysis of
Spine Growth and Retraction
D.B. Chklovskii, S. Song [in collaboration with
K. Svoboda, Cold Spring Harbor Laboratory]
Previously, we have shown that the reorganization of
the pyramidal neuron circuit through growth and
retraction of spines is a potential plasticity mechanism
with high information storage capacity. Subsequently,
2-photon in vivo imaging experiments have confirmed
the existence of this plasticity mechanism in adult ani-
mals. Next, we need to determine what rules govern
spine growth and retraction. We will start addressing
this question by analyzing the statistics of spine
growth and retraction from chronic in vivo 2-photon
imaging in transgenic mice.
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BRAIN DEVELOPMENT AND PLASTICITY
H.T. Cline M. Agathocleous K. Bronson
C. Aizenman I. Cantallops
C. Akerman A. Carlberg
J. Bestman R. Ewald
K. Haas V Thirumalai
A. Javaherian E. Rial Verde
K. Jensen E. Ruthazer
W.C. Sin
Activity that arises from sensory input is known to
have a prominent role in organizing brain connectivity
and circuit function during development. We have only
a limited understanding of the cellular and molecular
mechanisms that are called into play by sensory activ-
ity, or how they regulate brain development and plas-
ticity. The goal of the work in our laboratory is to
determine the effect of activity on brain development
and plasticity. We address this issue by examining the
structural and functional development of the visual
system in amphibian tadpoles. We collect time-lapse
imaging of neurons in vivo to assess structural plastic-
ity. In addition, we assess neuronal function using
electrophysiological assays of synaptic connectivity
and synaptic plasticity. We combine these studies with
gene transfer methods, which allow us to test the func-
tion of genes of interest in brain development.
Visual Stimulation Regulates
Dendritic Arbor Development
and Visual System Responses
C. Aizenman, C. Akerman, W.C. Sin, K. Haas, E. Ruthazer,
H.T. Cline
One of the highlights of our research this year was the
direct observation that visual stimulation increases the
structural development of neurons and strengthens the
synaptic connections in the visual system in such a
way as to increase the signal to noise of visual inputs.
Although the role of sensory experience in the devel-
opment of neuronal circuits has been firmly estab-
lished, most conclusions have been based on long-
term deprivation experiments. Our recent work uses a
novel approach in which freely swimming tadpoles are
presented with a simulated motion stimulus for 1-8
hours. This allows us to draw conclusions about the
positive effects of visual experience over a relatively
short timescale.
W.C. Sin and K. Haas demonstrated by in vivo
time-lapse imaging of optic tectal neurons that
enhanced visual activity driven by a light stimulus
promotes optic tectal cell dendritic arbor growth. The
stimulus-induced dendritic arbor growth requires glu-
tamatergic synaptic transmission. Increasing synaptic
activity with optic nerve stimulation down-regulates
endogenous RhoA activity and increases endogenous
Rac activity (Li et al. 2002). These same changes in
Rho GTPases are required for light-induced elabora-
tion of dendritic arbors. The results delineate a role for
Rho GTPases in the structural plasticity driven by
visual stimulus in vivo.
One central question is how neurons maintain a
constant level of activity when faced with an enhanced
sensory environment, and thus prevent the system from
overloading. C. Aizenman explored the role of the
polyamine-mediated modulation of AMPA (cc-2-
hydroxy-5-methy1-4-isoazole) receptor-mediated re-
sponses (Aizenman et al. 2002). Intracellular poly-
amine levels are increased by increased levels of visual
activity. The intracellular polyamines decrease conduc-
tance through calcium-permeable AMPA receptors.
This may function to compensate for increased levels of
activity experienced during visual stimulation and thus
maintain a constant level of excitation. More recently,
we found that visual system activity changes two other
properties of neurons in the optic tectum: One is an
increased responsiveness to bursts of synaptic input and
the second is an increase in the intrinsic excitability of
neurons. Together, these results indicate a multifaceted
and coordinated homeostatic response of the brain to
periods of increased sensory input, which ensures opti-
mal operation of the brain under a wide range of expe-
riential conditions.
The Function of Activity-regulated
Genes in Brain Development
and Plasticity
I. Cantallops, A. Javaherian, K. Jensen, E. Rial Verde,
K. Bronson, H.T. Cline [in collaboration with R. Malinow,
Cold Spring Harbor Laboratory, E. Nedivi, Massachusetts
Institute of Technology, and P. Worley, Johns Hopkins]
Neural activity changes the expression of several
genes, including Arc, CPG15, and Homer. We study
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the function of these activity-regulated genes in the
Xenopus central nervous system and spinal cord and
in hippocampal slice cultures.
arc (activity-regulated cytoskeleton-associated
protein) is among a small set of activity-responsive
genes whose mRNA is targeted to active dendrites.
Despite the potential for arc to act as a local regulator
of synaptic function in response to activity, there is lit-
tle information about its function. E. Rial Verde finds
that expression of green fluorescent protein (GFP) -
tagged ARC in CAl hippocampal pyramidal cells
resulted in a significant depression of AMPA-recep-
tor-mediated synaptic transmission. This effect of
ARC relies on activation of protein phosphatases to
induce depression. We postulate that upon activity-
dependent mRNA localization to dendritic sites, ARC
protein is translated and exerts its depressing action.
This mechanism can operate to maintain the synapses
in an operational range as a way to maximize the sig-
nal-to-noise ratio among potentiated and nonpotenti-
ated neighboring synapses.
CPG15 (also known as Neuritin) is an activity-
induced GPI-anchored axonal protein. Previous work
in our lab has shown that CPG15 promotes dendritic
and axonal growth and accelerates synaptic matura-
tion in vivo. More recently, I. Cantallops has shown
that intracellular CPG15 is localized to synaptic vesi-
cles and endosomes, is trafficked to the axonal surface
by a depolarization- and calcium-dependent mecha-
nism, and is endocytosed in an activity-regulated
manner. To assess CPG15 trafficking in vivo, she
expressed an ecliptic pHluorin (EP)-CPG15 fusion
protein in retinal ganglion cells of intact Xenopus tad-
poles. Intraocular kainic acid (KA) injection rapidly
increased cell surface EP-CPG15 in retinotectal
axons, but coinjection of TTX and KA did not. The
results indicate that the delivery of the neurotrophic
protein CPG15 to the axon surface can be regulated
on a rapid time scale by activity-dependent mecha-
nisms in vivo.
A. Javaherian has found that CPG15 is heavily
expressed in the developing spinal cord of Xenopus
tadpoles. He has examined the function of CPG15 in
the morphological development of motor neuron axons
by collecting time-lapse in vivo images of axons from
neurons expressing GFP or GFP plus CPG15. These
studies are the first to characterize Xenopus motor neu-
ron axon development in vivo over a period of several
days. CPG15 expression causes a significant increase
in elaboration of motor neuron axon arbors and corre-
sponding postsynaptic specializations.
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FIGURE 1 Time-lapse images of GFP-expressing neurons
were collected on a 2-photon microscope three times over an
8-hour period in anesthetized Xenopus tadpoles. Animals were
brought out of anesthesia after imaging sessions and either
placed in a dark chamber, for the first 4-hour period, or placed
in a chamber with a simulated motion stimulus, for the second
4-hour period. The dendritic arbor of the neurons grows signif-
icantly more during the 4-hour period with the visual stimulation
than during the 4-hour period without visual stimulation.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov J. Hemish T. Michurina M. Packer A. Vaahtokari
P. Krasnov J. Mignone N. Peunova X. Wang
B. Kuzin B. Mish V. Scheinker D. Herman
M. Maletic-Savatic N. Nakaya Y. Stasiv
Our laboratory is interested in stem cells in the adult
organism and the signaling pathways that control their
division and maturation. Among many signals that
guide the cells along pathways of differentiation, we
focus on the signals initiated by a versatile messenger
molecule, nitric oxide (NO). We found that NO regu-
lates the transitions of adult stem cells through the dif-
ferentiation cascades in several settings, including
hematopoiesis and neurogenesis. This year, we have
been focusing on the genetic and molecular interactions
of NO with major signaling pathways, especially those
that control cell division. In our most significant
advances, we have demonstrated an essential role for
NO in regulating the generation of new neurons in the
adult brain using two independent lines of inquiry. We
have also demonstrated a role of NO in regulating
hematopoiesis. Furthermore, we have identified a large
number of genes that are activated by NO, and we are
studying how some of them may link NO signals with
cell division. We also used Drosophila as a model to
reveal the link between NO and genes that control cell
cycle progression. Finally, we have found a novel form
of a NO synthase gene that acts as an endogenous neg-
ative regulator of NO production.
Several other projects in our lab make use of trans-
genic mouse models in which selected classes of cells
in the adult brain are marked. By investigating these
animals, we have been able to isolate stem cells from
the adult brain as well as other tissues and have found
that they are able to adopt an unexpectedly wide range
of cell fates.
Negative Regulation of
Adult Neurogenesis
M. Packer, Y. Stasiv [in collaboration with S. Goldman,
Cornell Medical School, and H. Westphal, National
Institutes of Health]
Negative regulators of neurogenesis have been postu-
lated on the basis of in vivo and in vitro data. Indeed,
progenitor cells are widespread throughout the adult
central nervous system but only give rise to neurons in
specific loci. However, the mechanisms for suppres-
sion of adult neurogenesis are unclear. Our experi-
ments demonstrate that NO acts as an important nega-
tive regulator of cell proliferation in the adult mam-
malian brain. We used two independent approaches to
examine the function of NO in adult neurogenesis. In
a pharmacological approach, we suppressed NO pro-
duction in the rat brain in vivo by intraventricular infu-
sion of a nitric oxide synthase (NOS) inhibitor. In a
genetic approach, we generated a null mutant neuronal
NOS (nNOS) mouse line by targeting the active center
of the enzyme. In both models, the number of new
cells generated in neurogenic areas of the adult brain,
the olfactory subependyma and the dentate gyrus, was
strongly augmented. This indicates that division of
neural stem cells in the adult brain is controlled by NO
and suggests a strategy for enhancing neurogenesis in
the adult central nervous system.
Neural Stem Cells in the
Adult Nervous System
J. Mignone, A. Vaahtokari, M. Maletic-Savatic, B. Mish
To follow the transitions of neural stem and progenitor
cells in the developing and adult nervous system along
the differentiation cascade, we generated a series of
transgenic reporter mouse lines. In these animals, dif-
ferent classes of neural cells are labeled with different
fluorescent proteins. We used those animals that
express fluorescent proteins under the control of the
regulatory elements of the nestin gene to visualize and
isolate neural stem cells. We characterized the expres-
sion of a panel of differentiation markers in nestin-
GFP (green fluorescent protein) cells and found that
they can be divided into groups, based on the intensi-
ty of their fluorescence. These groups represent dis-
tinct classes of neuronal precursors in the adult mam-
malian brain and may reflect different stages of neu-
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ronal differentiation. Furthermore, by isolating nestin-
GFP cells using a fluorescence-activated cell sorter
(FACS) and testing their ability to form multipotential
neurospheres, we found that these cells encompass the
majority of neural stem cells in the adult brain. We are
now studying the ability of nestin-expressing cells
from nonneural tissues to reveal their neural potential
in in vitro and in vivo settings.
NO and Hematopoiesis
T. Michurina, P. Krasnov
We examined whether NO may be involved in the con-
trol of hematopoiesis. We found that in a model of
bone marrow transplantation, inhibition of NO syn-
thase activity increases the number of early hemato-
poietic progenitor cells, as revealed by several in vitro
and in vivo assays. We are now testing human
hematopoietic progenitor cells to determine whether
they can be similarly expanded through the use of
NOS inhibitors. Furthermore, we are studying the iso-
forms of NO synthases that may be responsible for the
regulatory action of NO in the bone marrow.
NO and Xenopus
Development
N. Peunova, V. Scheinker
We have recently cloned the neuronal NOS gene
XNOS from the Xenopus genome. XNOS transcripts
are present in unfertilized oocytes and thus are stored
as maternal RNAs. The complex changes in the pat-
terns of XNOS expression following fertilization sug-
gest its involvement in the early development and
organogenesis of the tadpole. We found that the
appearance of some of the transcripts marks specific
stages of the embryo development; for instance, tran-
scription of some isoforms marks the zygotic induc-
tion of the genome, and the appearance of others
specifically mark gastrulation, neurulation, and
organogenesis. We used the information about the
structure of XNOS to generate recombinant con-
structs that code for potent dominant-negative
inhibitors of NOS action. These recombinant
inhibitors suppress XNOS activity, probably by pre-
venting the formation of the enzymatically active
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homodimers of XNOS. We used these reagents as well
as recombinant XNOS, in parallel with chemical NOS
inhibitors and NO donors, to investigate the early
development of the nervous system in Xenopus. We
found that NO suppresses neural induction so that
deficit of NO results in an enlarged nervous system of
the tadpole. Furthermore, deficit of NO leads to pro-
found defects in gastrulation movement and forebrain
patterning. We are now investigating the components
of the major development pathways affected by the
NO signals.
NO and Drosophila
Development
Y. Stasiv, B. Kuzin Fri collaboration with M. Regulski
and T. Tully, Cold Spring Harbor Laboratory]
There is only one NOS gene in the Drosophila
genome, but it generates a large family of mRNAs and
potential protein products through the use of alterna-
tive promoters and splice sites. We focused on one of
the short isoforms, DNOS4, to show that it is
expressed in vivo and that it acts as a negative regula-
tor of NOS activity in the developing Drosophila by
forming inactive heteromers with the active enzyme
DNOS1 in vitro and in vivo. The ectopic expression of
DNOS4 resulted in increased cell proliferation in the
imaginal discs and an increased cell number in the
pupae and adults, suggesting that DNOS4 suppresses
the antiproliferative activity of DNOS1 during fly
development. This inhibitory role of DNOS4 was sup-
ported by the analysis of genetic interactions of
DNOS4 with various components of the Drosophila
cell cycle machinery, such as RBF and dE2F. We are
now trying to define the stages in Drosophila devel-
opment when selective activation and suppression of
DNOS activity regulates the progression through the
cell cycle.
Mechanisms of NO Action
N. Nakaya, J. Hemish in collaboration with V. Mittal,
Cold Spring Harbor Laboratory]
To understand the mechanisms of long-term action of
NO, one approach is to identify the genes that are con-
trolled by NO. We employed transcriptional profiling
using microarrays to identify some of the direct and
indirect targets of NO-related signaling cascades. We
determined the temporal expression profiles of NO
action in cells and verified the hits using cytokine-
induced NO production. We next used specific chem-
ical inhibitors and cells from mutant mice to probe the
signaling pathways that are used by NO to induce gene
activity. Our results demonstrate that NO uses multi-
ple signaling pathways to regulate gene expression.
Among the identified NO-inducible genes, we
focused on a novel gene, which we called noxin.
Expression of noxin is strongly up-regulated by NO
and is related to cell cycle progression. We are now
investigating whether noxin serves as link between NO
signaling and the cell cycle control.
As another approach to understanding the signal-
ing events that mediate the action of NO in the cell, we
used bivariate fluorescent-activated sorting of cells
from various mutant mice to determine the stages in
the cell cycle that are affected by NO. Our results sug-
gest that NO affects several independent checkpoints
within the cell cycle machinery.
Vladimir Scheinker
Tatyana Michurina
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CONSTRUCTION AND PLASTICITY OF GABAERGic CIRCUITS
Z.J. Huang F. Ango G. diCristo T. Pal
B. Chattopadhyaya S. Kulhman C. Wu
C. Chiariello Q. Wang
The appropriate wiring of neuronal circuits in the mam-
malian neocortex forms a basis to generate and process
patterns of neuronal activity which underlie perception
and cognition. GABAergic inhibitory circuits consist of
an array of interneuron cell types with distinct mor-
phology, physiological properties, and synaptic connec-
tivity patterns and may constitute a scaffold to organize
local cortical connectivity and activity. A defining fea-
ture of GABAergic innervation is their specific target-
ing to restricted subcellular compartments (i.e., soma,
dendrite, axon initial segment) of pyramidal neurons,
which allow precise spatial and temporal control of
neuronal signaling, dynamics, and plasticity.
Although GABAergic connectivity is essential for
the construction of functional cortical circuits, the for-
mation and maturation of GABAergic synapses in gen-
eral are poorly characterized. The mechanisms underly-
ing the subcellular domain-specific targeting of distinct
classes of GABAergic synapses are almost entirely
unknown. To a large extent, this is due to the extraordi-
nary complexity of neocortical tissue and the hetero-
geneity of GABAergic neurons. In the past year, we
have made great strides in establishing both in vivo and
in vitro experimental systems which allow visualization
and genetic manipulation of identified GABAergic cell
types and their postsynaptic pyramidal neurons with
synaptic resolution. Using cell-type-specific promot-
ers, bacterial artificial chromosome (BAC) engineer-
ing, and 2-photon imaging, we have shown that the
development of GABAergic synaptic connectivity pro-
ceeds in a cortical slice culture system, in the absence
of experience- and afferent-driven activity. The recapit-
ulation of GABAergic circuits in vitro opens unprece-
dented opportunity to characterize its developmental
process at synaptic resolution, in real time, and to dis-
sect the underlying molecular mechanisms.
Development of Somatic Innervation by
Basket Interneurons in Visual Cortex
G. diCristo, Z.J. Huang [in collaboration with
G. Knott, University of Laussane, Switzerland]
We have generated BAC transgenic mice in which bas-
ket interneurons in neocortex express green fluores-
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cent protein (GFP) from the GAD67 gene promoter. In
these GAD67-GFP mice, GFP expression labels soma,
dendrite, axon, and synaptic boutons of basket
interneurons in visual cortex. In mature visual cortex,
these basket interneurons form perisomatic bouton
rings around pyramidal cell soma. The identification
of green boutons as GABAergic synaptic terminals
was confirmed by colocalization with the GABAergic
presynaptic enzyme GAD65 and by immunoelectron
microscopy. All GFP-positive boutons were presynap-
tic components of symmetric synapses located on
soma or proximal dendrites. At 2 weeks of age (P14),
rather few somatic boutons were observed. The matu-
ration of perisomatic bouton rings in visual cortex is a
prolonged process, which continues well into the
fourth postnatal week. Our results provide the first
description of the development of somatic synapses in
visual cortex. These mice allow reliable characteriza-
tion of the development of somatic synapses and
examination of whether visual experience influences
the development of somatic innervations at ultrastruc-
tural resolution.
Experience and Afferent-independent
Development of Subcellular
GABAergic Synapse Targeting
in Neocortex
B. Chattopadhyaya, G. diCristo, Z.J. Huang
We have established an in vitro brain slice culture sys-
tem that recapitulates the development of GABAergic
circuits. This was made possible by the cloning,
through BAC engineering, of a segment of the GAD67
gene promoter that conferred basket-cell-specific gene
expression in vitro. We have also identified a transcrip-
tional promoter that conferred bitufted cell-specific
gene expression in slice culture. Using these reagents,
we have demonstrated that the development of dendrite
and axonal arbors of basket, chandelier, and bitufted
interneurons, and the subcellular-domain-specific tar-
geting of GABAergic synapses, proceeded in cortical
slice cultures in vitro, in the absence of experience and
afferent activity. These results suggest that subcellular-
domain-specific targeting of GABAergic synapses is
FIGURE 1 A region of the GAD67 promoter, subcloned through BAC engineering, confers basket
and chandelier-cell-specific gene expression in slice culture. Pgad67 directs red fluorescent pro-
tein (RFP) (left) and GFP (right) expression only in parvalbumin-positive GABAergic neurons but not
in somatostatin, calretinin, VIP GABAergic neurons, and pyramidal neurons (data not shown).
Basket and chandelier cells develop their elaborate axon arbors and highly distinct synapses
(insets) in slice culture, in the absence of experience and afferent activity. Bars: Basket cell, 50 gm;
(lower right) chandelier cell, 2 gm. P21 = postnatal day 5 + 16 days in vitro.
likely driven by interactions between genetically deter-
mined cell surface labels displayed on the axons of dis-
tinct GABAergic cell types and on appropriate subcel-
lular compartments of pyramidal neurons. We have ini-
tiated experiments to identify and test putative subcel-
lular-domain-specific molecular labels.
Activity-dependent GABAergic
Synapse Formation and
Maintenance in Neocortex
G. diCristo, B. Chattopadhyaya, Z.J. Huang
We have shown that the time course of the develop-
ment of somatic innervation in slice culture was
remarkably similar, if not identical, to that observed in
visual cortex in vivo. Using 2-photon microscopy, we
have succeeded in chronically imaging the dynamics
and developmental process of somatic innervation in
slice culture for up to 4 days. We have also demon-
strated that the formation and maintenance of
GABAergic synapses, although they do not require
experience and afferent activity, are critically depen-
dent on spontaneous activity within the slice culture.
Because we can selectively label and manipulate
GABAergic interneurons and their postsynaptic pyra-
midal neurons, we are in a position to pinpoint the pre-
cise nature of neuronal activity required for
GABAergic synapse formation and maintenance. For
example, we are testing (1) whether neuronal firing in
presynaptic GABAergic or postsynaptic pyramidal
neurons are required; (2) whether GABAergic trans-
mission is required; and (3) whether bone-derived neu-
rotrophic factor (BDNF)/trkB signaling is required.
Role of Basket Interneurons in
Critical Period Plasticity
in Visual Cortex
B. Chattopadhyaya, Z.J. Huang [in collaboration with
L. Maffei, Institute of Neurophysiology, Italy]
GABAergic inhibitory circuits have been implicated
in the regulation of experience-dependent develop-
ment of visual cortex. For example, ocular dominance
(OD) plasticity, the capacity of visual cortical neurons
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to modify their eye preferences following visual depri-
vation to either eye, was abolished in mice deficient in
an isoform of the GABA synthetic enzyme (GAD65).
Because GAD65-4- mice show no critical period, yet
are normal in other aspects of visual physiology and
function, this mutant strain provides an ideal genetic
background to systematically study the role of specif-
ic classes of interneurons in OD plasticity using a
transgenic "rescue" approach. We have generated
BAC transgenic mice expressing GAD65 under the
control of the parvalbumin promoter. We are introduc-
ing the BAC transgene expressing GAD65 in basket
interneurons into the GAD654- mice by breeding. We
will then test whether expression of GAD65 in a spe-
cific class of interneurons can restore critical period
plasticity in GAD65-1- mice. In addition, this strategy
will allow us to correlate the specific types of inhibito-
ry mechanisms that are restored by cell-type-restricted
expression of GAD65 with the rescue of critical peri-
od plasticity.
Cellular Mechanisms of Critical
Period Plasticity in Visual Cortex
S. Kuhlman, Z.J. Huang
The cellular mechanisms by which GABAergic cir-
cuits regulate ocular dominance plasticity and the crit-
ical period are unknown. We hypothesize that during
critical period plasticity, maturation of synaptic inhibi-
tion allows cortical circuits to detect the difference
between the temporal patterns of open- and closed-eye
inputs, thus engaging spike-timing-dependent plastic-
ity rules to drive synaptic competition and OD plastic-
ity. This hypothesis makes several predictions. First,
maturation of GABAergic transmission should corre-
late with the time course of the onset of critical peri-
od. Second, before the onset of the critical period, the
cortical circuit is incapable of distinguishing closed-
eye input from that of open-eye, due to the immature
state of GABA transmission, and therefore cannot
subject closed-eye input to synaptic depression. Third,
at the peak of the critical period, maturation of synap-
tic inhibition allows cortical circuits to distinguish
closed-eye inputs from open-eye inputs, and readily
subject closed-eye inputs to synaptic depression
through spike-timing-dependent mechanisms. We are
testing these predictions using in vitro brain slice
preparations.
146
Our parvalbumin-GFP BAC transgenic mice allow
reliable and efficient identification of basket interneu-
rons in acute brain slice. We have shown that in
response to somatic current injection over a range of
intensities, there is a dramatic developmental increase
in the firing rate of FS interneurons which corre-
sponds to the onset of OD plasticity. There was a
twofold increase in maximal firing rate between 2
weeks (149 ± 31 Hz) and 3 weeks (302 ± 25 Hz, p
>0.05), and a further 1.7-fold increase between 3
weeks and 5 weeks (507 ± 37 Hz, p >0.05). The first
interspike interval of a train of spikes induced by cur-
rent injection decreased with age (ANOVA on ranks,
p >0.01) by an average of 30% between 2 and 3 weeks
of age across a range of current intensities, and
decreased further by 25% between week 3 and 5.
There was a concomitant decrease in action potential
spike width and decay rate. Both the spike width at
threshold and falling phase decreased by 75%
between 2 and 5 weeks of age. These changes are like-
ly due to the compliment of ionic conductances that
these neurons express, and promote rapid, high-fideli-
ty spike transmission important for feedforward inhi-
bition. Current studies are examining the functional
consequence of increased inhibition on the input inte-
gration window of pyramids.
We are also developing a "two-pathway synaptic
competition" preparation in a visual cortical brain
slice, which captures properties of OD plasticity in
vivo. Our goal is to demonstrate that GABAergic inhi-
bition promotes synaptic competition during experi-
ence-dependent synaptic refinement via precise and
rapid regulation of a fundamental parameter of neu-
ronal excitability, the membrane time constant. We
will then test whether the regulation of input discrim-
ination by a specific cell type, fast-spiking basket
interneuron, is a prerequisite for induction and expres-
sion of OD plasticity.
Molecular Mechanisms of
Subcellular Domain-specific
Synapse Targeting in
Cerebellum
F. Ango, Z.J. Huang
Another good example of subcellular domain-specific
synaptic innervation comes from the cerebellum.
Cerebellar basket and stellate interneurons selectively
innervate Purkinje cell soma/axon initial segments and
dendrites, respectively. The cellular and molecular
mechanisms underlying such subcellular synaptic tar-
geting are unknown. In our GAD67-GFP and parval-
bumin-GFP BAC transgenic mice, cerebellar inter-
neurons can be visualized at unprecedented resolution.
These mice have allowed us to systematically
describe, for the first time, the process of the innerva-
tion of the Purkinje cell axon initial segment by cere-
bellar basket interneurons. We found that basket
intemeuron axons first contacted Purkinje cell soma
about postnatal day 12. These contacts were then guid-
ed toward axon initial segments and concentrated
there at P18. Because of their striking subcellular
localization, we hypothesized that an ankyrin-based
localization of L1 immunoglobulin-type cell adhesion
molecules at the axon initial segment of Purkinje neu-
rons may be necessary for its somatic and axon initial
segment (AIS) innervation by cerebellar basket
interneurons.
We tested this hypothesis using ankyrin G knock-
out mice in which AIS localization of L 1 CAMs was
abolished. We found that basket cell innervation at
AIS of Purkinje cells in ankG-1- mice was either great-
ly reduced or extended far beyond their usual boarder.
This result provides the first evident that L1
immunoglobulin-type cell adhesion molecules may
serve as subcellular-domain-specific molecular labels
that guide GABAergic synapse targeting. We are in the
process of testing the role of specific L1CAMs in sub-
cellular-domain-specific synapse targeting in the cere-
bellum.
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THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen N. Uchida A. Kepecs C. Feierstein
V Egger S. Ranade E. Friedman
M. Quirk H. Zariwala
Our laboratory is interested in how brains make deci-
sions. For several years, we have been developing new
paradigms for tackling this problem using rodent olfac-
tory-guided behavior as a model system. In 2002, we set
up technology to make multiple single-neuron record-
ings from behaving animals. This brings a new and
powerful physiological approach to CSHL that, in con-
junction with tightly controlled psychophysical para-
digms pioneered in our lab, yields a powerful model
system for understanding the biological substrates of
cognitive function. Our approach encompasses multiple
levels of analysis ranging from single spines to behav-
ior, and the past year has produced breakthroughs on
both ends of this spectrum. In the olfactory bulb slice,
we have completed a study of the signaling properties
of the granule cell, a type of neuron responsible for net-
work computations in the olfactory bulb. Using 2-pho-
ton calcium imaging, we discovered that these cells reg-
ulate their output using the same voltage-sensitive T-
type calcium channel that underlies the gating of senso-
ry information by the thalamus. This is the first evi-
dence that T channels underlie action-potential-mediat-
ed synaptic release and suggests novel regulatory mech-
anisms for computations in the olfactory system. At the
behavioral end of the spectrum, in the last year, we
completed a detailed study of an olfactory discrimina-
tion in the rat. The surprising result of this study is that
each sniff, an event lasting only 150 msec, is a complete
and independent picture of the olfactory world. This
result establishes important constraints on the timing of
both sensory-coding and decision-making processes
and has strong implications for understanding the orga-
nization of the neural activity underlying decisions.
Temporal Constraints on Olfactory
Coding and Decisions
N. Uch da
Olfaction is sometimes thought of as a slow sense, and
thus it has been proposed that processing neuronal
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activity over time might have a role in odor coding. In
insects and zebrafish, population activity in the olfac-
tory bulb evolves such that neuronal firing patterns to
similar odorants are decorrelated in the course of 1-2
sec, facilitating discrimination of similar odors. This
year, we tested this idea using an odor mixture dis-
crimination task in rats (Fig. 1). Rats discriminated
odors very rapidly, with a median odor sampling dura-
tion of <300 msec. Moreover, accuracy of perfor-
mance saturated with just 200 msec of odor sampling,
regardless of the difficulty of the discrimination. More
surprisingly, measurement of the rats' sniffing
revealed that optimal performance was achieved with
only one sniff at theta frequency (-7 Hz). The fact that
odor information fails to be integrated over cycles of
sniffing rules out, as a potential olfactory code, slow
temporal modulation occurring over periods longer
than about 100-200 msec and suggests that the sniff-
ing (theta) cycle is a fundamental feature component
of the neural mechanisms of olfactory perceptual deci-
sions in the rat.
Concentration Invariant
Odor Quality Discrimination
N. Uchida, S. Ranade, E. Friedman
Any odor activates a specific combination of odorant
receptors, and it has been postulated that combinations
of activated receptors define odor quality ("combina-
torial receptor coding"). However, changes in concen-
tration also lead to changes in activated receptors, yet
perceived odor quality usually remains constant over a
range of concentrations for a given odorant ("concen-
tration-invariance"). This animal could recognize an
odor as belonging to the same source despite variable
amounts of dilution that will occur depending on dis-
tance.
Using an odor mixture discrimination task (Fig. 1),
we tested explicitly the idea that a rat perceives mix-
ture qualities to be invariant to the ratios of their com-
Odor
Odor port -- I
Choice port
1.0
co
0
5
0 0.5
0
0
20 32 44 56 68 80 100
Odor A (%)
FIGURE 1 Odor mixture discrimination task. (Top) Still frame
from a video of a discrimination task. The
rat is shown performing a "nose poke" at the odor port. This trig-
gers the delivery of an air stream containing a mixture of two
pure odorants (4 and 8) in one of eight different ratios (e.g.,
0/100%, 80/20%, etc.). Responses at the choice port corre-
sponding to the dominant odorant are rewarded as correct.
(Middle) Timing of task events. The odor sampling or response
time (RT) is the period between odor onset and odor poke with-
drawal. Median observed RT was 280 ± 30 msec (n = 10 rats,
52,760 correct and error trials; mean ± so). (Bottom)
Performance of one rat in discriminating mixtures of caproic acid
and hexanol. The fraction of caproic acid (Odor A) is indicated
on the abscissa. (Closed circles) Performance from single ses-
sions (-250 trials); (open circles) average performance (10 ses-
sions). The data are well-fit using a logistic function.
ponents. After training, rats were tested using probe
stimuli with ratios identical to the training set but at
different absolute concentrations. Performance was
predicted by a ratio-based discrimination strategy but
not by alternatives such as an intensity-based discrim-
ination strategy. This result indicates that molar ratios
of the components of a mixture are the critical deter-
minants of choice in this task. We propose that odor
quality is coded by the ratios of ligand coverage of
odorant receptors, "ratio coding." To understand how
ratio coding might arise from ensemble activity in the
olfactory bulb, we are currently measuring the popu-
lation response of receptors using both electro-olfac-
togram (EOG) and intrinsic signal imaging.
Using Categories to
Guide Behavior
C. Feierstein, M. Quirk
To better understand the function of olfactory cortical
areas in guiding behavioral decisions, we are making
multineuron extracellular recordings using tetrodes
implanted in the orbitofrontal and piriform cortices of
rats performing an odor mixture discrimination task
(Fig. 1). Neurons representing purely sensory infor-
mation should show graded responses varying with
the smoothly varying stimulus parameter. On the other
hand, neurons representing a motor response should
show categorical (binary) responses reflecting the
assignment of two stimulus groups. By comparing
neuronal responses with behavioral choices on a trial-
by-trial basis for correct and error trials, we will be
able to assess the relationship between neuronal activ-
ity in different cortical areas and the formation of an
olfactory-guided decision. We are also interested in
tracking the changes in neuronal activity that result
from shifting the boundary that defines categories
("recategorization"). Adaptation to changes in task
contingencies is thought to depend on orbitofrontal
activity, and therefore, relearning of relevant cate-
gories should be reflected in the activity of this corti-
cal area and possibly in the piriform cortex as well.
With this experimental design, we expect to learn
about the roles of both piriform and orbitofrontal cor-
tices in the processing and learning of task-relevant
information, as well as to clarify the contribution of
these brain areas to decision making.
Serotonin Activity during
Goal-directed Behavior
M. Quirk
Although numerous behavioral, pharmacological, and
genetic studies have demonstrated that serotonin has a
critical role both in the processing of behaviorally rel-
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evant stimuli and in the execution of appropriate
actions, little is known about the functional role of
serotonin in the neural processes underlying goal-
directed behaviors. The problem stems in large part
from our lack of knowledge about the conditions
under which serotonin neurons are activated in a
behavioral context. To address this issue, we are
recording from serotonin-producing cells located
within the dorsal raphe nucleus of freely behaving rats
during the performance of an olfactory-based two-
choice discrimination task (Fig. 1). By recording from
serotonin neurons during this well-controlled task, we
will be able to directly relate the moment-by-moment
activation of these cells to specific sensory, motor, and
motivational task variables. We are particularly inter-
ested in characterizing how raphe cells respond to the
anticipation of reward, as well as the failure of an ani-
mal to receive a reward following an incorrect behav-
ioral response. Furthermore, during the odor-sampling
portion of the task, we are interested in determining
whether fluctuations in raphe activity correlate signif-
icantly with an animal's behavioral choices.
Role of the Theta Cycle
in Perceptual Decisions
A. Kepecs
Rhythmic oscillations in the theta frequency band
(4-10 Hz) are observed in local field potentials
recorded from many different cortical and subcortical
brain regions in rodents. The presence and amplitude
of theta oscillations are correlated with specific
behavioral states, being particularly prominent during
active, exploratory behaviors. In addition, the phase of
theta oscillations can be reset by behaviorally relevant
stimuli. Although theta oscillations may have different
functional roles in different brain regions and behav-
ioral contexts, anatomical and physiological evidence
suggests that theta oscillations may coordinate infor-
mation flow between brain regions and thereby
instruct or facilitate sensorimotor integration. We will
examine the role of theta rhythm in an olfactory dis-
crimination task (Fig. 1). In this task, we have found
that a simple perceptual decision (from sensory input
through decision and motor execution) requires only a
single respiration cycle taking only 200 msec, which
corresponds to one cycle of theta. To elucidate the
neural mechanisms underlying sensory-motor integra-
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tion in this task, we will record local field potentials
(LFPs) in behaving animals in several sensory and
motor regions from olfactory bulb to motor cortex.
We will analyze the spectral characteristics of LFPs to
determine the correlation of the theta rhythm across
brain regions and between sensory and motor behav-
ioral events as a function of task contingencies.
Interaction of Reward
and Sensory Information
in Decision Making
H. Zariwala, A. Kepecs, N. Uchida
Decisions are determined not only by sensory cues,
but also by the consequences of actions taken in the
presence of those cues. In the context of simple behav-
ioral choice tasks, learning theory suggests that ani-
mals make decisions so as to maximize reward over
some time horizon. To understand even a simple per-
ceptual decision, it is therefore crucial to consider how
sensory information interacts with the reward struc-
ture of the task. With the eventual goal of elucidating
the neural basis of this interaction, we have begun to
characterize the effects of manipulating the reward
contingencies in the odor mixture discrimination task
(Fig. 1). Whereas under standard conditions, the rat
always receives a water reward for a correct choice, in
this series of experiments, we are systematically vary-
ing the probability of reward. By changing the ratio of
reward probability at the two choice ports, we expect
to introduce a bias toward responding to the port with
a higher reward, as shown in classical "matching"
experiments. By changing reward probability of both
choice ports equally, we expect to manipulate the
motivation to complete task problems, which may
increase error rates. The use of a gradient of mixture
stimuli should allow the detection of small effects of
these kinds.
Spike-evoked Calcium Dynamics in
Olfactory Bulb Granule Cells
V. Egger [in collaboration with K. Svoboda, Cold Spring
Harbor Laboratory]
Granule cells are axonless GABAergic interneurons
that mediate recurrent coupling between the principal
neurons (mitral cells) in the olfactory bulb. To exam-
ine the properties of action potential propagation
within the granule cell dendritic tree, we imaged AP-
evoked dendritic Ca" transients using 2-photon imag-
ing in rat olfactory bulb slices (Egger et al. 2002). We
determined that action-potential-mediated calcium
influx in the dendritic output region is robust and,
hence, will contribute to synaptic release via the den-
drodendritic reciprocal mitral-granule cell connec-
tion. We call this pathway global lateral inhibition.
Interestingly, we found that action-potential-evoked
Cam` transients were dramatically modulated by small
changes in the resting membrane potential. Blockers
of the low-threshold, fast-inactivating T-type Ca'
channel reduced the Ca.-' transient amplitudes and
blocked their voltage dependence.
In the past year, we have further corroborated this
finding with additional experiments and explored its
implications for signaling in the olfactory bulb. Thus,
we have demonstrated that the blockade of T-type
channels reduces synaptic transmission from granule
to mitral cells, which is the first example of a role for
T-type channels in neurotransmitter release. We have
also observed that voltage dependence evolves with a
time constant of about 300 msec, making it likely that
the prominent theta-frequency rhythmic activity in the
olfactory bulb will interact with global lateral inhibi-
tion.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow A. Barria
C. Becamel
J. Boehm
N. Dawkins
I. Ehrlich
H. Hsieh
F. Kamenetz
C. Kopec
A. Piccini
Our laboratory collaborates with the following labora-
tories here at CSHL: David Borchelt, Carlos Brody,
Hollis Cline, Mark Ellisman, Rick Huganir, Takeshi
Iwatsubo, Rob Malenka, Mike Myers, Linda Van
Aelst, Karel Svoboda, Guy Seabrook, Sangram
Sisodia, Roger Tsien, and Tony Zador.
Our laboratory is directed toward an understand-
ing of learning and memory by studying the physiolo-
gy of synapses. We study synaptic transmission and
plasticity in rodent brain slices. This preparation is
sufficiently complex to show glimpses of emergent
properties as well as simple enough to allow hard-
nosed biophysical scrutiny. To monitor and perturb the
function of synapses, we use a combination of electro-
physiology, microscopic imaging, and molecular
transfection techniques, which allows us to examine
the cellular and molecular basis for changes in elec-
trophysiological function. This year, we added a new
preparation, in which we acutely deliver genes of
interest into living animals with viruses and examine
the impact of experience on the subcellular distribu-
tion of these gene products. With this preparation, we
have been able to show that experience strengthens
transmission by driving AMPA (a-amino-3-hydroxy-
5-methy1-4-isoazole) receptors (AMPA-Rs) into
synapses. Such experiments provide support to our
philosophy that synapses have key properties whose
understanding will provide insight into phenomena at
higher levels of complexity. Below are examples of
projects recently published, and their subsequent
progress.
INCREASING MOLECULAR REQUIREMENTS
FOR SYNAPTIC PLASTICITY WITH AGE
Synaptic plasticity has an important but distinct role
throughout life. Early in development, synaptic plas-
ticity controls establishment of neural connections.
Later in life, plasticity controls learning and memory.
Here, we compare molecular mechanisms controlling
synaptic plasticity at different ages. We find that PKA
152
K. Seidenman
T. Takahashi
H. Hsin
phosphorylation of AMPA-Rs has a key role through-
out. Activity-driven PKA phosphorylation of G1uR4 is
necessary and sufficient for delivery of receptors to
synapses during early development, making synapses
functional. Phosphorylation relieves a retention inter-
action that in the absence of synaptic activity, main-
tains GluR4-containing receptors away from synapses.
In contrast, phosphorylation of G1uR1 by PKA is nec-
essary but not sufficient for delivery of receptors to
synapses in older animals; CaMKII (calcium/calmod-
ulin-dependent protein kinase II) activity is also
required. Thus, a mechanism that mediates plasticity
early in development becomes a gate for plasticity
later in life. Increasing requirements may be one way
that plasticity becomes more specific and also recalci-
trant with age.
We are currently identifying additional phosphory-
lation sites on AMPA-Rs that control plasticity. Our
current view is that multiple phosphorylation steps are
involved in various aspects of receptor trafficking,
such as relief from extrasynaptic retention, integration
into the dendritic surface, access to the perisynaptic
region, integration into synapse, anchoring to the
synapse, and removal from the synapse. For instance,
by mimicking phosphorylation at four sites on the
AMPA-R cytoplasmic tail, we can drive receptors into
synapses. We are also taking a proteomic approach to
determine what protein-protein interactions are
enhanced/removed by phosphorylation events.
MONITORING AMPA-R TRAFFICKING DURING
PLASTICITY WITH FLUORESCENCE AND
ELECTRON MICROSCOPY
Interactions between AMPA-R subunits and PDZ
domains are critical for the proper delivery of recep-
tors to synapses. Synaptic delivery of GluR1 -contain-
ing AMPA-Rs can be driven by CaMKII activity or
long-term potentiation (LTP) and requires an interac-
tion between G1uR1 and a type-I PDZ domain.
Synaptic delivery of AMPA-Rs with only G1uR2
occurs continuously, and this requires an interaction
between G1uR2 and a type-II PDZ domain. We now
show that mutations on G1uR1 or G1uR2 that perturb
these critical PDZ domain interactions lead to the
accumulation of these receptors at different subcellu-
lar sites. G1uR1 mutants accumulate in the dendrite,
whereas GluR2 mutants accumulate in dendritic
spines. This suggests that the critical PDZ-domain
interactions are required for entry into spines, for
G1uR1, and into synapses, for G1uR2.
We are currently using dual emission two-photon
scanning laser microscopy to monitor AMPA-R redis-
tribution as well as structural changes simultaneously
during plasticity-inducing stimuli (LTP and LTD). We
find that during LTP-inducing stimuli, G1uR1 AMPA-
Rs are primarily driven to existing synapses and
enhance their size; newly formed synapses have few
(if any) synaptic AMPA-Rs. Long-term depression
(LTD)-inducing stimuli remove G1uR2-containing
receptors, leading to a decrease in size; some synaps-
es are lost completely. Interestingly, LTP-inducing
stimuli also lead to removal of some GluR2-contain-
ing receptors, but not GluRl-containing receptors.
This indicates that LTP-inducing stimuli likely induce
LTD at some synapses.
We are also developing tagging methods that will
allow us to detect the distribution of AMPA-Rs with
electron microscopic resolution. Such techniques will
allow us to determine where receptors containing spe-
cific mutations stop trafficking and thereby associate
phosphorylation as well as protein-protein interac-
tions with particular trafficking functions.
RAS AND RAP CONTROL AMPA-R TRAFFICKING
DURING SYNAPTIC PLASTICITY
Recent studies have shown that AMPA-R trafficking
has an important role in synaptic plasticity. However,
the intracellular signaling pathways controlling this
trafficking remain largely unknown. Small GTPases
can signal diverse neuronal processes, and their per-
turbation is responsible for several mental disorders.
Here, we have examined the role of small GTPases
Ras and Rap in the postsynaptic signaling that medi-
ates synaptic plasticity. We show that Ras is the down-
stream effector for NMDA (N-methyl-o-aspartate)
receptor (NMDA-R) and CaMKII signaling during
LIP. Ras activity drives synaptic delivery of AMPA-
Rs. In contrast, postsynaptic activation of Rap medi-
ates NMDA-R-dependent removal of synaptic AMPA-
Rs that occurs during LIP. Ras and Rap exert their
effects on AMPA-Rs that contain different subunit
compositions. Thus, Ras and Rap, whose activity can
be controlled by postsynaptic enzymes, serve as inde-
pendent regulators for potentiating and depressing
central synapses. Our studies may have general impli-
cations as Ras and Rap have opposing functions in
synaptic plasticity as well as oncogenesis and T-cell
activation.
We are currently identifying the connection
between Ras activity and phosphorylation events on
AMPA-Rs.
CONTROL OF NMDA-R TRAFFICKING TO SYNAPSES
BY THE NR2 SUBUNIT
To elucidate the mechanisms controlling the number
and subunit composition of synaptic NMDA-Rs in
hippocampal slice neurons, the NR1, NR2A, and
NR2B subunits were optically and electrophysiologi-
cally tagged. The NR2 subunit directs delivery of
receptors to synapses with different rules controlling
NR2A and NR2B. NR2B-containing receptors incor-
porate into synapses in a manner that is not limited by
synaptic transmission nor enhanced by increased sub-
unit expression. NR2A-containing receptors, whose
expression normally increases with age, replace
synaptic NR2B-containing receptors. Replacement is
enhanced by increased NR2A expression, requires
synaptic activity, and leads to reduced NMDA-R
responses. Surprisingly, a spontaneously released
transmitter acting on synaptic NMDA-Rs is sufficient
for replacement. Thus, as with AMPA-Rs, synaptic
trafficking of NMDA-Rs is tightly regulated and has
unique rules.
We are currently testing the impact of the NR2B to
NR2A switch on synaptic plasticity. Our preliminary
results indicate that driving this switch reduces the
generation of LIP. We will test what differences
between NR2B and NR2A are responsible for this
change in plasticity.
HOMEOSTATIC FEEDBACK BETWEEN NEURONAL
ACTIVITY AND APP PROCESSING
A large body of work implicates the accumulation of
Al3 peptides and other derivatives of the amyloid pre-
cursor protein (APP) as central to the pathogenesis of
Alzheimer's disease. However, little is known regard-
ing the relationship between neuronal electrophysio-
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logical function and APP processing. Here, we find
that neuronal activity controls the formation of A13.
Furthermore, increased formation of AP reversibly
depresses synaptic function. These results suggest that
APP cleavage products act as negative feedback
homeostatic regulators that keep neuronal hyperactiv-
ity in check. Pathology that disrupts this homeostatic
system could increase the production of AP and/or
produce neuronal hyperactivity, events that may con-
tribute to Alzheimer's disease.
We are currently determining the impact of longer-
term (1-2 weeks, rather than the 1-2 days used to
determine the feedback described above) overexpres-
sion of A13. Our preliminary evidence indicates struc-
tural as well as physiological aberrations. Our plan is
to determine the mechanisms underlying the short-
and long-term effects of increased All production.
EXPERIENCE STRENGTHENS TRANSMISSION
BY DRIVING AMPA-R INTO SYNAPSES
To elucidate the mechanisms underlying experience-
dependent plasticity in the brain, the trafficking of the
AMPA subclass of glutamate receptors into synapses
was examined in the developing rat barrel cortex. In
vivo gene delivery was combined with in vitro record-
ings to show that experience drives recombinant
G1uR1, an AMPA-R subunit, into synapses formed
between layer 4 and layer 2/3 neurons. Furthermore,
expression of the GluRl cytoplasmic tail, a construct
that inhibits synaptic delivery of endogenous AMPA-
Rs during LTP, blocked experience-driven synaptic
potentiation. In general, synaptic incorporation of
AMPA-Rs in vivo conforms to rules identified in vitro
and contributes to plasticity driven by natural stimuli in
the mammalian brain. We are currently testing whether
a similar process occurs during learning paradigms.
PSD-95 AS A CRITICAL SYNAPTIC SCAFFOLD
REQUIRED FOR LTP
The regulated delivery of AMPA-type glutamate
receptors (AMPA-Rs) to synapses is one mechanism
underlying synaptic plasticity. Here, we investigate
how the synaptic scaffolding protein PSD-95 partici-
pates in AMPA-R trafficking to synapses during plas-
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ticity. Overexpression of PSD-95 specifically increas-
es AMPA-R-mediated transmission by delivering
G1uR1- containing receptors to synapses, thus mimick-
ing LTP. Consistent with a role in LTP, wild-type PSD-
95 occludes LTP, and dominant-negative forms block
LTP. The action of PSD-95 on G1uR1 is independent
of LTP signaling downstream from NMDA-R activa-
tion, although it appears to require ligand binding to
NMDA-Rs. The assembly of scaffolding complexes
containing PSD-95 may be an important step in
recruiting AMPA-Rs to synapses during plasticity.
Currently, we are examining the role of PSD-95
during experience-driven plasticity. Our preliminary
results indicate that this protein is required for experi-
ence to drive G1uR1 into synapses.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission and plasticity and are testing how these mech-
anisms participate in experience-driven plasticity.
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PLASTICITY OF CORTICAL NEURONS AND THEIR CIRCUITS
K. Svoboda B. Burbach M. Maravall V. Scheuss R. Yasuda
I. Bureau E. Nimchinsky G. Shepherd C. Zhang
B. Chen T. Oertner J. Trachtenberg K. Zito
A. Karpova T. Pologruto
The cortex underlies most cognitive functions in mam-
mals. Cortical tissue is dauntingly complex: 1 mm3
contains nearly a million neurons, each of which con-
nects to thousands of other neurons. To begin to unrav-
el neocortical function, we are studying how the basic
units of the network, neurons, and their synapses work
within the intact network and how they change in
response to experience. We build and use sensitive
optical tools. 2-photon laser-scanning microscopy
(2PLSM) allows us to detect the excitation of single
synapses in brain slices with single-receptor sensitivi-
ty. Excitation of neuronal elements by focal uncaging
of neurotransmitters allows us to efficiently probe the
connectivity of neural networks. We combine these
optical methods with electrophysiological measure-
ments of synaptic currents and potentials and molecu-
lar manipulations of neurons.
We use both in vivo measurements, to address sys-
tem-level questions, and in vitro methods, to get at
detailed mechanisms. As a model system, we use the
rodent barrel cortex. Similar to other sensory areas in
the mammalian cortex, the barrel cortex is arranged in
maps. Each whisker is represented by a small cortical
region (barrel). Whisker maps are shaped by experience
during development and reshaped in the adult. Plasticity
in these maps can be induced by trimming specific
whiskers for hours to days. The cellular mechanisms
underlying sensory map plasticity are likely to share
mechanisms with those underlying learning and memo-
ry. Because of the precision of the barrel map, it is pos-
sible to predict where in the brain experience-dependent
changes are likely to occur, simplifying the search for
the cellular, synaptic, and molecular basis for plasticity.
[Ca"] Signaling in Single
Dendritic Spines
R. Yasuda, V Scheuss, E. Nimchinsky
Long-term changes in synaptic efficacy are triggered
by increases in [Cal in the postsynaptic neuron. We
have used whole-cell patch-clamp recordings and
2PLSM to measure [Cal signals that are evoked in
spines and small dendrites of CAl pyramidal neurons
by back-propagating action potentials and synaptic
stimuli. By contrasting the properties of action-poten-
tial-evoked [Cal transients in the main apical den-
drite with those of distal dendrites and spines, we were
able to define functionally distinct neuronal compart-
ments for Ca" signaling. We now have a complete
understanding of the life cycle of Ca" ions in dendrit-
ic spines. We have developed a variety of assays to
learn about the molecular pathways of Ca" influx,
including the counting of individual Ca" permeable
channels and receptors in spines. Recently, we have
discovered that Ca" extrusion is inhibited by long-
duration Ca" elevations, which could be an important
factor underlying the induction of synaptic plasticity.
We have also probed the plasticity of voltage-gated
Ca" channels in single spines. The activation voltage of
spines can be shifted for long times by neuronal activi-
ty in a Ca "- dependent manner. This modulation is pro-
duced stochastically and requires the activity of calci-
um/calmodulin protein kinase (CaMKII). All of the
channels in a spine (-10) are modulated together, sug-
gesting that we are witnessing either the output of a sin-
gle enzyme or the result of an autophosphorylation cas-
cade involving several copies of CaMKII. Finally, we
find that calcium entering the same synapse through
different types of channels is able to activate different
signal transduction pathways. This discovery may help
to explain how one second-messenger system, calcium,
can have a large variety of functions in neurons.
Optical Studies of Single Synapses
E. Nimchinsky, T. Oertner, R. Yasuda, T. Pologruto
Central nervous system (CNS) synapses release vesi-
cles of glutamate stochastically in an all-or-none fash-
ion. We can detect these successes and failures at single
synapses by imaging Ca" in postsynaptic spines. We
can also measure the amount of glutamate released dur-
ing a success as follows: N- methyl- o- aspartate recep-
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tors (NMDA-Rs) have high affinities for glutamate and
are therefore perfect detectors for synaptic glutamate.
We have previously shown that NMDA-Rs sense gluta-
mate in a roughly linear manner. Furthermore, NMDA-
Rs admit Ca" which can be measured in spines. Thus,
the amount of glutamate released can be inferred from
the Car' accumulations mediated by NMDA-Rs.
The ability to image transmission at single synaps-
es allows us to address old questions in synaptic phys-
iology that have important implications for the nature
of information transmission in the brain and the mech-
anisms of plasticity. Our studies show that synaptic
glutamate receptors are not saturated by the release of
a single vesicle. We counted the number of receptors
opened by synaptic transmission and found that this
number is surprisingly small, -1. Thus, only a small
fraction of receptors open during low-frequency
synaptic transmission, and the dynamic range of
synapses is large. Furthermore, stochastic interactions
between ligand and receptor and molecular fluctua-
tions of synaptic channels contribute to noise in synap-
tic transmission. We analyzed transmitter release at
single synapses during synaptic transmission showing
that the number of vesicles released at single active
zones is variable, with a larger number of vesicles
released in potentiated synapses. In conclusion, we
find that synaptic transmission couples action poten-
tials into graded and noisy postsynaptic responses. The
magnitude of postsynaptic responses, not only their
probability, depends on the history of the synapse.
Do synapses in fact function as independent infor-
mation transmission channels? Can mixing of signals
occur by diffusion of glutamate released at one
synapse to postsynaptic receptors of a neighboring
synapse? To investigate cornstalk synapses, we mea-
sured Car' responses in individual spines and moni-
tored signals in their neighbors less than 1 pm away.
We find that under a wide range of conditions,
spillover of glutamate to neighboring synapses does
not occur. However, during intense bursts of stimuli,
glutamate escapes the cleft and activates extrasynaptic
receptors. Using genetic and molecular tools, we have
evidence that astrocytic glutamate transporters are
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significant players in limiting the spread of glutamate
in the extracellular space.
Experience-dependent Plasticity
in Adult Cortex In Vivo
A. Holtmaat (sabbatical visitor from the University of
Amsterdam), B. Chen, J. Trachtenberg
The rodent somatosensory cortex contains a map of the
facial whiskers (barrel cortex) where the neuronal
responses in each barrel-column are dominated by a
particular principal whisker. Whisker deprivation
changes the responses in the whisker map. It has long
been debated whether changes in neuronal structure
underlie such experience-dependent cortical plasticity.
We used time-lapse 2PLSM of layer-5 pyramidal neu-
rons in adult mouse barrel cortex to image the structur-
al dynamics of dendritic spines. We are using transgenic
mice that express green fluorescent protein (GFP) and
other fluorescent proteins in specific subpopulations of
mouse neurons. These animals allow us to look at the
structure of neurons and their synapses over chronic
time scales. We made the surprising discovery that even
in the adult brain, some synapses turn over. Other
synapses are stable over months. We also analyzed the
ultrastructure of previously imaged synapses at the
electron microsocopy level. Induction of experience-
dependent plasticity is associated with synaptic growth,
suggesting that memories are encoded in new synaptic
connections. We are currently investigating the differ-
ences between stable and transient synapses.
Cellular Basis of Experience-dependent
Plasticity in the Developing
Cortex In Vivo
I. Bureau
How do the ordered connections of the brain form?
How does sensory experience early in life shape the
development of topographic maps in the barrel cortex?
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8
EINSPENEINE
FIGURE 1 Experience-dependent synaptic plasticity in the adult neocortex in vivo. (Left) Images collected 24
hours apart. Note stable (closed arrows) and transient (open arrow) spines. (Right) Electron micrograph of
new spine indicating that it participates in synaptic transmission.
To address these issues in layer 2/3, we performed
whole-cell recordings of sensory-evoked synaptic
potentials at the earliest ages possible. Whole-cell
recordings allow us to perform voltage-clamp experi-
ments and to figure out the identity of the synaptic
receptors underlying the sensory response. To our sur-
prise, we found that at PND 8, highly ordered sensory
maps already exist and that these are mostly support-
ed by synapses dominated by NMDA-Rs. Thus, high-
ly ordered sensory maps form much earlier than pre-
viously thought.
Cellular Basis of Experience-dependent
Plasticity in the Developing
Cortex In Vitro
G. Shepherd, M. Maravall [in collaboration with T. Takahashi
and R. Malinow, Cold Spring Harbor Laboratory]
Some subtle experience-dependent changes in cellular
properties are difficult to study in the intact brain. For
example, the sizes of quantal synaptic currents cannot
be measured in vivo but they can be measured in brain
slices. We are comparing the properties of neocortical
pyramidal neurons in brain slices derived from
deprived and control animals. To discover possibly
diverse cell-autonomous modes of plasticity, we are
using a barrage of electrophysiological and imaging
approaches to look for effects of sensory experience
on neuronal Ca-" dynamics, excitability, and synaptic
currents. We found that sensory experience remodels
the dendritic structure of cortical neurons and shapes
the membrane conductances that produce mature fir-
ing properties in cortical neurons, during a sharp crit-
ical period. We have also found that sensory experi-
ence drives glutamate receptors into synapses.
In addition, we have developed tools that allow us
to look at circuit-wide changes produced by sensory
experience. We adopted and improved laser-scanning
uncaging to rapidly and efficiently probe the structure
of neural circuits. To determine the locus of plasticity,
we used laser-scanning photostimulation, which allows
us to rapidly map intracortical synaptic connectivity in
brain slices. Layer-2/3 neurons differed in their spatial
distributions of presynaptic partners: Neurons directly
above barrels received, on average, significantly more
layer-4 input than those above the septa separating bar-
rels. Complementary connectivity was found in
deprived cortex: Neurons above septa were now
strongly coupled to septal regions, whereas connectiv-
ity between barrel regions and layer 2/3 was reduced.
These results indicate competitive interactions between
two thalamocortical circuits, the VPM-barrel and
POm- septal pathways, in the establishment of precise
intracortical circuits.
Experience-dependent Gene
Expression in the Neocortex
K. Zito, B. Burbach [in collaboration with F. Naef and
M. Magnasco, The Rockefeller University]
Progress in sequencing the mouse genome and the
availability of cDNA and oligonucleotide expression
arrays offer an opportunity to discover genes ("plas-
ticity genes," pgs) regulated by sensory experience.
We trim mouse whiskers to induce receptive field
plasticity in particular neocortical barrels. To isolate a
population of neurons that has undergone plasticity,
we have developed protocols to rapidly isolate and
freeze tissue from particular barrels of the living
mouse. The procedure is brief (20 minutes per ani-
mal), allowing large quantities of tissue (hundreds of
milligrams) and mRNA (micrograms) to be harvested,
sufficient for expression array studies. mRNA is iso-
lated from deprived and control brains at various times
after deprivation and used to make a fluorescent
probe. The probe is then hybridized to microarrays.
Presently, we are using Affymetrix oligonucleotide
arrays. Fluorescence images of the arrays are analyzed
for patterns of expression.
Cellular and Molecular
Mechanisms of Dendritic
Spine Morphogenesis
K. Zito
How are synaptic connections formed between neu-
rons in the mammalian brain? Most of the excitatory
synapses in the cortex occur on dendritic spines, small
protrusions extending from neuronal dendrites. Spines
are highly motile during development, suggesting a
role for spine dynamics in synapse formation. We
searched for molecules that altered the dynamics of
spine morphogenesis by examining the effects of over-
expression of wild-type, activated, and dominant-neg-
ative versions of candidate genes on spine number,
density, morphology, and dynamics. We are studying
Neurabin-I (NrbI), a neuronal-specific actin-binding
157
FIGURE 2 Dendrites and spines from neurons transfected with
GFP-Neurabin (A) or truncated GFP-Nrbl (version]) (8).
protein. NrbI is a 122-kD protein that contains an
amino-terminal actin-binding domain, a protein phos-
phatase I (PPI)-binding site, a PDZ domain that binds
p70S6K, and a carboxy-terminal coiled-coil dimeriza-
tion domain. GFP-tagged NrbI localized specifically
to dendritic spines in neurons in slice culture, and this
localization required an intact actin-binding domain.
Remarkably, a severely truncated GFP-NrbI caused a
dramatic increase (-5-fold) in the number of spine-
like protrusions. We are presently characterizing the
ultrastructural and physiological properties of these
cells to determine whether the observed morphologi-
cal changes are reflected in altered numbers of func-
tional synapses.
Molecular Methods to Reversibly
Inactivate Synapses In Vivo
A. Karpova, K. Svoboda [in collaboration with J. Huang,
Cold Spring Harbor Laboratory]
A major roadblock in gaining an understanding of
neural networks is our inability to modulate selected
circuit elements in vivo with temporal control and
specificity. We have begun a research program to har-
ness recent insights about the molecules that regulate
neurotransmitter secretion to design genetically deliv-
erable systems that can interfere with synaptic function
in a rapidly inducible manner. Interference is achieved
with dimerization induced by rapamycin-like com-
pounds. The first two systems, based on synaptophysin
and VAMP, are currently being tested in in vitro sys-
tems. These systems will be introduced into specific
cell populations using specific promoters or BAC (bac-
terial artificial chromosome) transgenic technology.
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Instrumentation
K. Svoboda, T. Pologruto, G. Shepherd, R. Yasuda [in
collaboration with R. Eifert, Cold Spring Harbor Laboratory]
Our instrumentation efforts during the last year have
focused on developing two new approaches to study-
ing signaling in neurons and their networks. To mea-
sure intracellular signal transduction in single synaps-
es, we developed a microscope that measures fluores-
cence lifetime. The fluorescence lifetime can be used
as a sensitive and robust read-out of fluorescence ener-
gy transfer and thus allows measurements of protein-
protein interactions inside neuronal microcompart-
ments, such as synapses. We have also set up experi-
mental stations that allow us to efficiently probe neur-
al circuits with laser scanning photostimulation. This
has advanced our analysis of experience-dependent
changes in neural circuits.
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NEUROBIOLOGY OF MEMORY IN DROSOPHILA
T. Tully J. Barditch
S. Gossweiler
M. Regulski
F. Bolduc
L. Grady
P. Smith
J. Dubnau
J. McNeil
S. Xia
A.-S. Chiang
From DNA microarray experiments using wild-type
(normal) flies, we have (1) developed a novel statisti-
cal method to analyze these data and (2) confirmed 42
candidate memory genes (CMGs) that are transcrip-
tionally regulated during long-term memory forma-
tion. One pathway implicated from this analysis
involves microtubule-dependent transport of mRNA
to subcellular compartments and local regulation of
translation. The genetic components are pumilio,
staufen, orb, moesin, and eIF2G. We have provided
biological validation that staufen is involved in mem-
ory formation by showing defective one-day memory
after spaced training for a conditional staufen mutant.
From a traditional mutagenesis, we have identified
60 new memory mutants. Molecular lesions have been
characterized for 58 of these mutants, defining 49 new
candidate memory genes. Notably, three of these behav-
ioral mutants also carry defects in the pumilio/staufen
pathway: pumilio, oskar, and eIF5C. Taken together
with recent studies from other labs, these convergent
data from complementary forward- and reverse-genetic
approaches have succeeded in identifing several molec-
ular components of the cellular mechanism likely re-
sponsible for synapse-specific modification during
long-term memory formation.
Identification of New
Genes Involved with
Olfactory Memory
T. Tully, J. Dubnau, L. Grady, J. Barditch,
S. Gossweiler, P. Smith
A behavioral screen (forward genetics) for defects in
olfactory memory has yielded 60 new mutant lines.
The molecular lesion has been identified for 58 of
these, defining 49 new genes: 25 carry P-element
transposon insertions (molecular lesions) within iden-
tified transcripts, and 24 carry transposon insertions
between identified transcripts. Thus, the data suggest
73 candidate memory genes, which appear to be
involved in several cellular processes including gene
regulation, RNA processing, translational control,
trafficking, signal transduction, and cell adhesion.
Two independent transposon insertions were iden-
tified in the large intron of pumilio, a "developmental"
gene involved in regulation of translation. Genetic
complementation with an extant allele of pumilio and
milord-2 demonstrates that pumilio is involved in
memory formation (Fig. 1).
We also have used DNA microarrays to detect
transcriptional responses during memory formation in
normal flies. By comparing mRNA from flies subject-
ed to spaced training versus massed training, nonspe-
cific transcriptional changes are minimized. Full-
genome analyses have detected more than 3900 statis-
tically significant candidate memory genes at 0, 6, or
24 hours after training. To date, 49 candidate memory
genes have been confirmed with follow-up assays.
Here again, several candidate memory genes are
involved in gene regulation, RNA processing, transla-
tional control, trafficking, signal transduction, and cell
adhesion.
El control
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FIGURE 1 The milord-2 memory mutation fails to complement
an extant allele of pumilio (oumFc8). One-day memory after
spaced training in wild-type flies (control), milord -1 homozy-
gotes, milord-2 homozygotes, pumF°8/, and milord-2/, het-
erozygotes, and milord-2/pumFG8 heteroallelics. These data also
show that the pun'''. allele is recessive to wild-type (+), and
milord-2 is semi-dominant to +. Together, these results demon-
strate that pumilio is involved in Drosophila memory formation.
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Of these, temperature-sensitive mutants exist for
staufen. Behavioral experiments on these mutants
have demonstrated defective long-term memory for-
mation after spaced training only when flies were
stored at restrictive temperature during the retention
interval. These results provide biological validation of
an acute role for staufen during long-term memory
formation.
Anatomical Studies
T. Tully, A.-S. Chiang, F. Bolduc, J. Dubnau,
J. McNeil, L. Grady
Twenty nine of the mutant strains carry a PGAL4 P-
element insertion, which allows "enhancer-trap"
reporter-gene expression of green fluorescent protein
(GFP). Three-dimensional reconstructions of confocal
images through whole-mount brains of adult flies has
revealed a "circuit" for olfactory memory, which
extends beyond mushroom bodies, one well-estab-
lished anatomical site involved in olfactory learning.
A subset of these enhancer-trap strains suggest inputs
to, and outputs from, mushroom bodies.
Thirty one of the mutant strains carry a PlacW P-
element insertion, which allows enhancer-trap
reporter-gene expression of 13-galactosidase. These
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allow cell-body expression patterns but not neuronal
processes. Nonetheless, these 60 enhancer-trap lines
reveal 70% with expression that includes mushroom
bodies. These observations support the notion that
mushroom bodies participate in memory formation
but not exclusively.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin E. Drier
K. lijima
C. Margulies
L. Moy
E. Paniagua
M.Tello
P. Wu
DaPKC and Synaptic Tagging
E. Drier, P. Wu, J. Yin [in collaboration with P. Schedl,
Princeton University; A. Wodarz, Duesseldorf;
J. Knoblich, IMP, Vienna, Austria]
In all systems where it has been tested, long-term
memory requires the synthesis of new proteins around
the time of training. This acute requirement for tran-
scription and translation in the cell body is necessary
for long-lasting increases in the strength of synaptic
connectivity. However, the universal requirement for
de novo gene expression begs the question of synaptic
specificity: How do neurons that participate in behav-
ioral circuits only strengthen the synapses that are
behaviorally relevant? How does an individual neuron
only strengthen the few synapses that participate in the
behavior, when it has thousands of neurons? The
synaptic tag hypothesis has been proposed, and it is
hypothesized that tagging enables neurons to confine
the products of transcription and translation to partic-
ular synapses, thereby maintaining synaptic specifici-
ty when neuron-wide events such as gene expression
occur. The cellular processes and molecular partici-
pants in tagging remain undescribed.
We have shown that DaPKIII, a truncated isoform
of the DaPKC (Drosophila atypical protein kinase C)
gene, is sufficient to enhance memory formation
(under certain circumstances) and is necessary for its
formation. The Sacktor lab (Drier et al. 2002) has
shown that aPKIVg is necessary and sufficient for the
maintenance of long-term potentiation (LTP) in hip-
pocampal slices. What functions do atypical proteins
perform when they participate in memory formation
and LTP? Based on a wealth of information from
developmental biology, we postulate that aPKC, the
full-length protein, and aPKM participate in tagging
recently active synapses. The hypothetical tag allows
recently active synapses to uniquely utilize macromol-
ecules made and transported ubiquitously.
The aPKC protein, and its partners Par3 (Bazooka)
and Par6, have been extensively studied in the process
of asymmetric cell division in the Drosophila embry-
onic neuroblast. In this process, aPKC/Par3/Par6 are
localized on the apical side of the neuroblast and scaf-
fold a large number of other proteins and translation-
ally silent mRNAs. Among these are Staufen, an
mRNA- binding protein that has been shown to be
important in neuronal plasticity. In the process of
establishing cell polarity, the aPKC/Par3/Par6 com-
plex is localized on the apical/lateral border of
Drosophila epithelial cells. These cells contain a num-
ber of other localized protein complexes, including the
cadherin/catenin complex (located more basally along
the lateral membrane) and the Dlg/Lgl/Scribble com-
plex, which is even further down (basally) on the later-
al face. All of these proteins are also located in synaps-
es of neurons. The dlg gene can produce at least two
different protein isoforms, one of which is the fly
homolog of PSD-95, the other being the homolog of
SAP97. These are important scaffolding proteins at the
mammalian synapse that bind NMDA (N-methyl-o-
aspartate), and AMPA (a-amino-3-hydroxy-5-methy1-
4-isoazole) subtypes of glutamate receptors. These
large complexes all mutually interact with each other
in setting "boundaries" to their localization. Finally, in
oogenesis, a stem cell undergoes four rounds of cell
division with incomplete cytokinesis, producing a 16-
cell cytocyst where the cells are interconnected by ring
canals. Macromolecules can be transferred between the
16 cells through these channels. Early on, one of the 16
cells is fated to become the oocyte, and the other 15
cells begin to traffic proteins and translationally silent
mRNAs into the 16th cell. The repressed mRNAs traf-
fic to a particular location in the 16th cell, where
aPKC/Par3/Par6 are localized, and are translated there.
Mutations in any of the three genes (DaPKC, par3 or
bazooka, or par6) do not affect mRNA trafficking, but
lead to ectopic translation of the mRNAs all around the
16th cell, and the future oocyte loses its fate. Among
the proteins that are important in this process are the
RNA-binding protein dFMR1 (the fly Fragile X pro-
tein) and Orb, the fly cytoplasmic polyadenylation
enhancer-binding protein (CPEB). These have been
shown to be critical synaptic plasticity and activity-
dependent translation. Therefore, in oogenesis,
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aPKC/Par3/Par6 are required for the localized transla-
tion of silent mRNAs. Our conceptualization of tag-
ging involves the subcellular processes in which
aPKC/Par3/Par6 participate, namely, localization,
scaffolding, interacting with other localized complex-
es, and localization of translation.
We have begun purifying the DaPKM p60 isoform
from adult heads. Using column chromatography and
an immunoaffinity column, we have partially purified
the protein. In the eluted fraction from the antibody
column, we detect Dlg, the SAP97 form of Dlg, and
truncated forms of Par3, Par6, and dFMR1. We are
currently trying to detect some of these interactions in
the other direction and carrying out further biochemi-
cal steps to increase the stringency of our interaction
data. In our cleanest fraction, we detect about 50 dis-
crete protein bands using the most sensitive silver
stain technique that we can find. We have cut out 25
of these bands and will analyze them using mass spec-
trometry. The presumed DaPKM p60 band is very
prominent, and we hope to positively identify it by
sequencing and peptide analysis. Future work will
focus on detecting phosphorylation, further biochem-
ical purification of discrete subcomplexes, and func-
tional tests in development and behavior.
Molecular Analysis of
the DaPKC gene
M. Tello, E. Drier, E. Paniagua, P. Wu, J. Yin
We have continued our characterization of the
DaPKC gene. There are at least three major mRNA
transcripts of approximately 6.5, 5.5, and 4.5 kb in
length. These three transcripts initiate from three dif-
ferent locations in the gene. The largest transcript (A)
starts from the 5' end of the internal intron located
between coding exons 2 and 3. Transcript B initiates
from the same 12-kb intron, but in the last 3' third of
the intron. Transcript C initiates from upstream of the
entire coding region, but it is the shortest of the tran-
scripts. Because of these locations, transcripts A and
B are likely to have extensive 5'- and 3 '-untranslated
regions (UTRs). At the 3' end of the gene are two
short exons that are alternatively spliced into mRNAs
in a mutually exclusive manner. These exons are
almost identical in the number of amino acids that
they encode, and nothing is known about their func-
tional significance. One of the exons is exclusively
connected with transcript C, whereas the other one is
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found with all three classes of transcripts. We have
not characterized alternative splicing, or alternative
polyadenylation, of possible 3 'UTRs.
The protein-coding capacity of the different tran-
scripts is not entirely clear. Three protein bands are
visualized on a western blot using a mammalian-spe-
cific, atypical PKC antibody raised against a peptide at
the very carboxy-terminal end of the rat atypical PKC
protein. These three bands of apparent molecular
weights p73 (aPKC or full-length), p60 (aP1CMp60),
and p50-55 (aPICMp50) are detected in adult head and
embryonic extracts. We are using a P-element insertion
in the 12-kb internal intron, and precise and imprecise
excisions of this element, to assign transcript coding
capacity to the different protein bands. It is probable
that the p73 protein is made exclusively off transcript
C, whereas the p60 isoform is internally initiated from
transcript B. We hypothesize that the p50 isoform is a
proteolytic product of p73.
Imprecise excisions of the P element that remove
sequence distal to the insertion site result in a loss of
transcript B. Together with 5' RACE analysis, RNase
protection, and northern analysis using probes made
from across the intronic region, we have localized the
region where transcript B probably initiates transcrip-
tion. Interestingly, there is a perfect CRE sequence and
TATA box nearby the cluster of RACE start sites. This
transcript has the potential to encode many different
internally initiated proteins, since there are many in-
frame methionine codons prior to the point where the
transcript becomes identical to the full-length tran-
script. Our preliminary evidence (see below) suggests,
though, that the last one or two in-frame methionines
are used for internal translation initiation.
DaPKC and Neuronal Dysfunction
P. Wu, L. Moy, J. Yin in collaboration with B. Ganetzky,
University of Wisconsin]
We have screened 29 different temperature-sensitive
paralytic mutants (obtained from Barry Ganetzky).
These mutants, all in different genes, result in hyper-
neuronal activity and seizure-like behavior when flies
are shifted to the nonpermissive temperature. Of the
29 mutants, 14 vastly overproduce the aPICMp60 iso-
form, without appreciably changing the levels of p73.
Northern analysis of eight of these mutant lines does
not show any dramatic changes in the relative ratios of
the three transcripts, nor in their absolute amounts.
Two of the mutants, though, have altered patterns of
transcripts. One is missing transcript A, whereas the
other has an insertion similar to that of all three tran-
scripts. Collectively, all of these data suggest that
overproduction of p60 occurs posttranscriptionally
and, at least in the case of the last two mutants, proba-
bly at the level of translation. These results suggest
that a major step in the regulation of p60 occurs at the
level of translation.
The correlation of overproduction of p60 with
seizure-like behavior is particularly interesting. Given
our hypotheses about synaptic tagging, it is easy to
imagine how overproduction of p60 might participate
in seizures, whether in the ectopic spread of neuronal
activity through different circuits, or in the prolonged
synaptic transmission at various synapses, or both.
Since it is likely that many genes, when mutant, pre-
dispose to seizure-like behavior, it is potentially very
useful to identify genes and signaling pathways that are
commonly recruited to seizures, since these are poten-
tially useful drug targets for therapeutic intervention.
Sleep and Memory Formation
P Wu, J. Yin [in collaboration with J. Hendricks
and A. Sehgal, University of Pennsylvania]
We have shown that dCREB2, and the PKA pathway,
is important for rest homeostasis in flies. We have also
investigated the participation of various genes known
to be involved in the circadian system for their effects
on sleep homeostasis. Loss-of-function mutations in
clock and cycle, or induced disruption of their activi-
ties, interfere with normal homeostasis, shortening the
average amount of rest that flies get. We are currently
investigating the role of disruption and overexpression
of these proteins on sleep homeostasis and memory
formation.
Anatomy of Long-term
Memory Formation
C. Margulies
The standard methodology used in Drosophila to
investigate anatomical requirements for a gene is to
use the Ga14/UAS system. When the dCREB2-b
(blocker) isoform is expressed pan-neuronally,
depending on the driver, we either detect no effect on
memory after spaced training or an effect that is larg-
er than what is seen with a heat shock transgene. This
latter result suggests that expression of the blocker is
partially affecting memory after massed training
(ARM), hinting at a developmental effect. Therefore,
it is necessary to use the spatially restricted, temporal-
ly regulated Tet-On system to define anatomical loca-
tions where dCREB2 is needed during adult memory
formation.
dCREB2 and Neuronal Dysfunction
K. lijima
Overexpression of activator or blocker isoforms of the
dCREB2 in a pan-neuronal pattern during develop-
ment has negative effects on eclosion and viability.
When the dCREB2-b (blocker) isoform is overpro-
duced, there is a decrease in the expected number of
mutant progeny. These adults have shorter longevity,
and show deficits in learning, without effects on the
peripheral behaviors (olfactory acuity and shock reac-
tivity). When the dCREB2-a isoform is overproduced,
almost no adult flies eclose. When these isoforms are
overproduced in the adult eye, they do not result in a
"rough" eye phenotype, suggesting that developmen-
tal effects are specific to the nervous system. When
crossed to genetic models of neuronal degeneration,
perturbations of dCREB2 can enhance the phenotypes
of certain dysfunctions, suggesting that part of the
dysfunctional effects occurs through the dCREB2-
responsive transcription pathway.
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NEURAL SUBSTRATE OF SELECTIVE AUDITORY
ATTENTION IN THE CORTEX
A. Zador M. DeWeese G. Otazu L.-H. Tai
T. Hromadka S. Rumpel M. Wehr
M. Moita
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our goal
is to understand this computation at the synaptic, cel-
lular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one
voice at a cocktail party and tune out the others-a
task that remains beyond the capacity of modem com-
puters-we are engaging in a form of selective audito-
ry attention. Our ability to attend selectively is not lim-
ited to the auditory domain: Analogous tasks demand
selective attention in the visual and even somatosenso-
ry domains. In monkeys, visual attention selectively
enhances neural activity even in the earliest stages of
visual cortical processing. This enhancement is sur-
prising because the areas associated with these first
stages of visual processing have traditionally been
thought of as representing the sensory world faithfully,
in a way that depends only on the properties of the sen-
sory input itself. The discovery of attentional modula-
tion overturns the notion that the peripheral sensory
cortex is a passive "TV screen" available for viewing
by a "homunculus" buried deep within the cortex.
The specific projects in our laboratory fall into
two main categories. First, we are interested in how
neurons represent auditory stimuli, and how these rep-
resentations are computed from the cochlear inputs
half a dozen synapses away. To address these ques-
tions, we are using electrophysiological and imaging
approaches in anesthetized rats, as well as computa-
tional approaches, to characterize the properties of
natural sounds. Second, we are interested in how these
representations are modified dynamically-within
seconds-in awake behaving rats by the demands
imposed by attentional tasks.
Binary Coding in the Auditory Cortex
M. DeWeese
Cortical neurons have been reported to use both rate
and temporal codes. We have discovered a novel
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mode, in which each neuron generates exactly zero or
one action potential, but not more, in response to a
stimulus. Cortical responses recorded using conven-
tional extracellular techniques typically show respons-
es to be highly variable. However, in our studies, we
have been using a technique adapted from in vitro
studies, cell-attached recording, which has the advan-
tage of ensuring that the recorded responses all arise
from a single neuron. Surprisingly, we have found that
most neurons exhibit binary behavior, with few multi-
spike responses; some responses consist of exactly one
spike on 100% of trials, with absolutely no trial-to-
trial variability. We are currently investigating the
computational implications of this previously unde-
scribed coding scheme.
Variability of Coding in the
Auditory Cortex
M. DeWeese
Computers rely on extremely precise, low-noise com-
ponents to compute, whereas the components that
make up neural circuits appear to be very noisy. Never-
theless, brains outperform computers on the kinds of
hard computational problems required for survival in
the real world. To understand how brains compute in
the presence of such high levels of apparent noise, we
are characterizing the sources of variability (i.e., noise)
in single neurons. Using in vivo whole-cell patch-
clamp recording techniques, we are examining the
trial-to-trial variability of the postsynaptic potential
(PSP) elicited by brief tone pips. In some neurons,
trial-to-trial variability in the PSP is small, consistent
with "private" sources limited to only the neuron under
study; but for other neurons, "shared" sources of vari-
ability produce circuit-wide fluctuations in the synap-
tic drive to the neuron and its neighbors, greatly
increasing the apparent noise in the PSP. These stimu-
lus-independent correlations could provide a substrate
for feedback underlying cognitive processes, such as
attention and motivation.
In Vivo Whole-cell Patch-clamp
Recordings of Sound-evoked
Synaptic Responses in
Auditory Cortex
M. DeWeese, L.-H. Tai
Neurons in the auditory cortex respond to some
sounds but not to others. What determines this selec-
tivity? We are using whole-cell patch-clamp recording
methods in vivo to measure the synaptic currents
elicited by simple and complex auditory stimuli.
Patch-clamp recordings provide a much richer source
of information than do conventional single-unit extra-
cellular recordings because they allow us to monitor
not just the output of the neuron-the spike train-but
the input as well. These data provide clues about the
representations with which the cortex solves hard
problems in auditory processing.
Optimal Stimulus for
Auditory Cortex
T. Hromadka [in collaboration with M. Chklovskii,
Cold Spring Harbor Laboratory]
Single neurons in auditory cortex respond differently
to different sounds. What are the sound features that
evoke the strongest response? To answer these ques-
tions, we use in vivo cell-attached recordings in awake
Mongolian gerbils in combination with evolutionary
algorithms to search for the most appropriate stimulus
for the individual neurons. In addition, we are charac-
terizing the responses of single neurons to a wide vari-
ety of conventional stimuli, including pure tone pips,
sweeps, and moving ripples.
Role of Auditory
Cortex in Frequency
Discrimination
M. Moita
Cells in the primary auditory cortex respond selec-
tively to pure tone frequencies. However, most studies
on the effect auditory cortex lesions have on frequen-
cy discrimination show that frequency discrimination
is intact after auditory cortex lesions. These studies
normally test discrimination between frequencies far
apart. Thus, failure to observe an effect of auditory
cortex lesions in frequency discrimination might arise
from the possibility that auditory cortex is only neces-
sary for fine-grained frequency discriminations. We
are developing a task that tests frequency discrimina-
tion between a wide range of frequency distances in
rats. We will then use this paradigm to test the role of
auditory cortex in frequency discrimination, using
both gain-of-function and loss-of-function approach-
es. In the first case, we will use microstimulation of
auditory cortex cells, and in the second case, we will
temporarily inactivate the auditory cortex during per-
formance of this task.
Separation of Sound
Sources by Awake
Behaving Animals
G. Otazu, M. Moita
Sounds in the natural world rarely occur in isolation,
but rather as part of a mixture. To survive, the audito-
ry system must be able to selectively attend to one
sound source and ignore others-and it does so more
effectively than any artificial system yet devised. To
understand how this is performed, we are using multi-
electrode recording (tetrode) technology to monitor
the activity of many neurons simultaneously in awake,
behaving rodents performing an auditory discrimina-
tion task.
Analysis of AMPA Receptor
Trafficking during Learning-induced
Reorganization of the
Auditory Cortex
S. Rumpel [in collaboration with R. Malinow,
Cold Spring Harbor Laboratory]
Does learning change the strength of neuronal con-
nections in the brain? Insertion of new postsynaptic
AMPA (a-2-hydroxy-5-methyl-4-isoazole) receptors
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has been identified as a major process leading to
increased synaptic strength. However, these results
have been obtained primarily in cultured neurons, and
the relationship of these processes to learning in the
intact animal has remained unclear. We have been
investigating whether reorganization of the auditory
cortex induced by classical conditioning leads to
increased insertion of AMPA receptors. We are using
virus-mediated overexpression of specially engineered
recombinant AMPA receptors as a marker of this in
vivo plasticity. These properties will enable us to
detect added recombinant receptors after a learning
protocol and thereby establish the role of AMPA inser-
tion in vivo. If the molecular rules of learning identi-
fied in cultured neurons should apply in vivo, we will
also have developed a valuable tool for identification
of synaptic circuits involved in memory formation.
Responses to Complex
Stimuli
M. Wehr [in collaboration with C. Machens and
C. Brody, Cold Spring Harbor Laboratory]
How do neurons in the auditory cortex encode com-
plex stimuli, such as animal calls or the sound of rain
falling on leaves? Sensory physiologists often ignore
this question, dismissing it as too difficult to approach
in a systematic fashion. Instead, they often limit their
inquiries to simple stimuli, such as (in the auditory
system) brief tone pips or sweeps. We have instead
tackled this problem head-on, by measuring the
responses of neurons in the auditory cortex to a wide
variety of natural sounds. We then use these responses
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to construct and test models of how cortical neurons
encode natural sounds.
Inhibitory and Excitatory
Contributions Underlying
Synaptic Responses
M. Wehr
The cortical responses to sensory stimuli such as
sounds consist of a mix of excitation and inhibition.
Conventional extracellular recording techniques using
tungsten electrodes provide information only about
excitatory responses. We have developed an approach
using whole-cell patch-clamp recording in vivo in
voltage-clamp mode to tease apart the temporal
dynamics of the excitatory and inhibitory drive under-
lying responses to auditory stimuli.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong H.-F. Guo K. lijima
I. Hakker J. Tong
F. Hannan Y. Wang
I. Ho
We combine genetic manipulation and functional
analyses in the study of neural basis of learning and
memory in Drosophila. Two approaches are being
taken to identify the players and events that are critical
to the learning and memory process. One approach is
modeling human pathological conditions in Drosoph-
ila that impair learning and memory. Specifically, we
focus on neurofibromatosis 1 (NF1) and Alzheimer's
disease (AD). Mutations in the NF1 tumor suppressor
gene in humans cause neurofibromas and other symp-
toms including learning defects. We are investigating
the hypothesis that NF1 not only acts as a Ras-specific
GTPase-activating protein (GAP), but also is involved
in mediating adenylyl cyclase (AC) activation, and this
NF1-dependent AC pathway is required for learning.
AD is a neurodegenerative disorder accompanied by
deterioration of memory. A major hypothesis concern-
ing the pathogenesis of AD is that accumulation of
toxic fragments of the amyloid precursor protein
(APP), 442, leads to pathologic progression. We have
tested the hypothesis by introducing into Drosophila
human minigenes that encode the A1342 and A., the
less toxic APP fragment. The other approach is through
examining physiological processes and activities that
may underlie learning and memory at the synaptic and
neuronal network levels.
At the synapse level, we continue our tradition of
examining functions of genes in regulating synaptic
plasticity at the Drosophila neuromuscular junction
(NMJ) and find that a serine/threonine kinase is
involved in the long-term depression of NMJ activities.
At the neuronal network level, our newly constructed
transgenic flies expressing a green fluorescent protein
(GFP)-based Ca" probe in combination of 2-photon
imaging have allowed us to examine with single-cell
resolution odor-evoked neuronal responses in a large
number of neurons in a higher olfactory center of the
fly brain, the mushroom body (MB). Currently, the
effort is focused on odor representation in the MB.
Since the MB is involved in associative olfactory learn-
ing and memory, the next step is to examine how such
a process is achieved in the MB.
Requirement of Protein
Kinase B (Akt) for
Long-term Depression
at the Drosophila
Neuromuscular Junction
H.-F. Guo
Several forms of short-term synaptic plasticity have
been reported at the Drosophila NMJ, including paired-
pulse facilitation, short-term facilitation, augmentation,
and post-titanic potentiation. Genetic dissection has
provided insights into the mechanism of synaptic trans-
mission and plasticity, and conversely, analyses of these
forms of synaptic plasticity have helped to elucidate the
function of learning and memory-related genes in
synaptic transmission and plasticity.
We have discovered a new form of long-term
synaptic plasticity at the Drosophila NMJ. A titanic
stimulation (30 Hz, 20 sec) induced a long-term
depression (LTD) of evoked-synaptic currents (EJC),
which lasts at least for 1 hour. The amplitude of EJC
was reduced to 30-50% after the titanic stimulation.
The induction of LTD is calcium-concentration-
dependent, which can be induced at 0.35-0.4 mat
Ca", but not at 0.7 mm (or higher concentration) Ca*',
and it is expressed on specific muscle fibers (e.g., #13
but not on #6). Quantal analyses revealed that the
quantal size was not changed, whereas the quantal
content was reduced to less than 50%. In addition,
direct application of glutamate-induced synaptic cur-
rents did not change significantly after the titanic
stimulation, suggesting a presynaptic mechanism of
this plasticity.
Genetic analyses indicate that protein kinase B
(Akt), which is a major target of the phosphoinositol-
3 (PI-3) kinase, is required for this LTD. Mutations of
the akt gene largely attenuated the depression. We are
currently conducting more detailed analyses of the
role of akt in this LTD. This long-term plasticity can
be used as a model for studying gene function and sig-
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nal transduction underlying synaptic plasticity and
learning and memory mechanism.
Site-directed Mutagenesis
in Human NF1
F Hannan, I. Hakker
The NF1 tumor suppressor gene encodes a protein
with a centrally located GTPase-activating protein
(GAP)-related domain (GRD) that negatively regu-
lates Ras activity. Studies of NF I have focused on its
role in the Ras pathway, but we have demonstrated
that NF1 also regulates AC activity in Drosophila and
that the NF I -regulated AC pathway is essential for
learning in Drosophila. Recently, we have shown that
NF1 affects neuropeptide- and G-protein-stimulated
AC activity in mice and that expression of a human
NF I transgene in NF1 mutant flies rescued small
body size and G-protein-stimulated AC activity
defects. We have since found that normal human NF I
can also rescue the learning defect seen in NF1
mutant flies. These phenotypes are all cAMP-depen-
dent, thus demonstrating that vertebrate neurofi-
bromin can regulate AC activity in both mammals
and flies.
The neurofibromin protein is very large (-250
kD), and regions outside the central GRD domain are
also critical for its function since clinically observed
missense mutations resulting in single-amino-acid
changes occur throughout the entire length of the pro-
tein. Our current studies show that human NF 1 s with
a number of different missense mutations, both with-
in and outside the GRD, allow partial rescue of some
cAMP-dependent phenotypes, including body size
and learning defects, when expressed in transgenic
NF1 mutant flies. This suggests that none of the muta-
tions assayed to date affect a region critical for cAMP-
dependent phenotypes.
Preliminary results have shown that NF1 mutant
flies expressing human NF1 with a mutation in the
GRD domain have reduced memory compared to
those expressing normal human NFL This suggests
that the GAP activity of NF1 may be important for
long-term memory formation. Normal human NF1 is
also able to fully rescue a circadian rhythm defect in
NF1 mutant flies. This phenotype has been shown to
be Ras-dependent; thus, we predict that mutations in
the GRD will not allow rescue of the circadian defect.
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We have begun an analysis of NF1-dependent gene
expression profiles in Drosophila, using oligo-
nucleotide-based microarrays. Preliminary data indi-
cate several genes whose expression is altered consis-
tently in NF I mutant heads. The microarray results are
being confirmed by quantitative reverse transcrip-
tase-polymerase chain reaction (RT-PCR) and north-
ern analysis. The effect of expressing wild-type and
mutant human NF1 transgenes on NF1 mutant flies is
also being assessed using microarrays.
A Novel Ras- and NF1-mediated
Pathway Regulating Adenylyl
Cyclase in Drosophila
I.S. Ho, J. Tong
Ras is essential in various cellular signaling pathways,
being the molecular switches in governing cell sur-
vival, cell death, proliferation, and differentiation. We
found that in Drosophila head extract, human Ha-Ras
protein can stimulate AC activity. This stimulation
requires the presence of neurofibromin, a GAP-relat-
ed domain (GRD)-containing protein encoded by the
NF I gene. Previous studies showed that NF1 regulates
AC activity in Drosophila, and this regulation is
important for learning.
To substantiate that the Ras-stimulated AC activi-
ty is of physiological significance, we tested the effect
of epidermal growth factor (EGF) on stimulating AC
activity. EGF activates receptor tyrosine kinases
(RTKs), which leads to Ras activation. It has been
shown that an EGF receptor homolog, DER, is present
in Drosophila. Since there is no known EGF homolog
in Drosophila, we used mouse EGF (mEGF). Third-
instar larval brains were treated with mEGF and test-
ed in an AC assay. We found that mEGF is able to con-
sistently stimulate AC activity approximately 150% of
the basal level. This stimulation was largely abolished
in DER, Ras, and NF1 mutants, indicating that DER,
Ras, and NF1 are essential for regulating EGF-stimu-
lated AC activity.
Our study revealed a novel EGF receptor (EGFR)
signaling pathway that leads to the activation of AC.
Since cAMP is a secondary messenger involved in
various neuronal functions such as synaptic plastici-
ty, and learning and memory, we are interested in
examining the role of this EGFR signaling pathway
in neuronal functions.
A Drosophila Model of
Alzheimer's Disease:
Dissecting the Pathological
Roles of A[342 and A1340
K. lijima [in collaboration with H. -P. Liu and A-S. Chiang,
National Tsing Hua University, Taiwan, and M. Konsolaki,
Novartis Institute for Biomedical Research]
AD is a neurodegenerative disorder characterized clin-
ically by progressive decline in memory accompanied
by histological changes, including neuronal loss and
the formation of neurofibrillary tangles and senile
plaques. It has been proposed that accumulation of A13
peptides, the major component in the senile plaques, is
the primary event in the AD pathogenesis. The
strongest support for this hypothesis comes from
genetic analysis of familial AD (FAD). All FAD muta-
tions identified appear to cause excessive accumula-
tion of AP. The hypothesis, however, remains contro-
versial because of a number of concerns, including a
weak correlation between Ar3 deposits and decline in
cognitive functions, mild neurodegeneration in mice
with excessive accumulation of A13 and abundant
senile plaques, and difficulties in defining in vivo the
specific species of Aft and the nature of its neuronal
effects. To address these concerns, we examined the
effects of expression of two transgenic minigenes that
encode the secreted form of either human A1342 or A1340
in the Drosophila brain. It was revealed that accumu-
lation of A1342 led to age-dependent learning defects
and extensive neurodegeneration. In contrast, expres-
sion of Af340 did not induce degeneration, although it
affected learning when expressed at a high level. This
study demonstrates that accumulation of Af342 is suffi-
cient to cause progressive memory loss and neurode-
generation in an organism with a very short life span.
Imaging of Stereotyped
Odor Representation in the
Mushroom Body of
Drosophila with a
GFP-based Ca++ Sensor
Y. Wang [in collaboration with T. Pologruto and
K. Svoboda, Cold Spring Harbor Laboratory]
Recent development in understanding odor receptors
and anatomic organization of the olfactory nervous
system has strongly implicated a spatial mechanism
for olfactory coding. This prompted us to investigate
odor representation in the Drosophila mushroom body
(MB), a higher olfactory center that is required for for-
mation of olfactory-related memory. For this purpose,
we have generated transgenic flies that express GFP-
based Ca++ sensor specifically in the MB. Combined
with 2-photon microscopy, this has allowed us to map
odor-evoked neuronal responses with single-cell res-
olution throughout the MB of a living fly. We find that
each odor evokes large-amplitude fluorescence tran-
sients in the somata of distinct subsets of MB neurons
(Kenyon cells [KCs]) and in subregions of the calyx,
the neuropil of the MB. The spatial distribution of
odor-evoked activities are similar from fly to fly, indi-
cating a stereotyped representation of odors in the
MB. Our data suggest that olfactory information is
represented by sparse population coding and that spa-
tial patterns of activity encode olfactory information
in MBs.
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PLANT DEVELOPMENT AND GENETICS
Like animals, plants use unspecialized stem cells to create new organs and tissues. One question funda-
mental to all multicellular life is how organisms trigger stem cells to proliferate and subsequently adopt spe-
cial properties characteristic of a particular organ or tissue, a process called stem cell patterning. David
Jackson and Marja Timmermans are investigating the signals that plants use to guide stem cell patterning.
Their findings are shedding light on some processes that are common to plant and animal development,
and on others-unique to plants-that could ultimately have significant impacts on agriculture, horticulture,
and forestry.
One mechanism that appears to be involved in stem cell patterning, and that is unique to plants, is the
movement of proteins between cells through structures called plasmodesmata. Jackson and his col-
leagues have created several methods for investigating how proteins move through plasmodesmata to
carry out stem cell patterning. That understanding could also help block the spread of devastating plant
viruses, which travel along the same intercellular highways.
Genes and proteins studied by Timmermans's lab are also emerging as key players in guiding stem
cell patterning and organ development. She has identified several proteins that act in a complex way to
turn key genes on or off at the correct time and in the correct location as plants develop, a process that
is required, for example, for the proper outgrowth of leaves and for differentiating the top layers versus the
bottom layers of leaves. Timmermans's lab has also uncovered evidence that leaf patterning is controlled
by RNA interference.
Part of Rob Martienssen's interest in exploring plant genetics and development has focused on a spe-
cialized type of DNA structure called heterochromatin. By virtue of the fact that heterochromatin is typical-
ly rich in "transposable elements" (segments of DNA that usually stay put but can move to other chromo-
somal locations), most often stays tightly packaged, and has few canonical protein-coding genes, hete-
rochromatin has a unique impact on chromosome structure and function. Martienssen's lab is exploring
the activity of genes located within heterochromatin and how such genes are silenced through the influ-
ence of transposable elements (or ancient remnants of such elements). In both plants and yeast, the lab
has found that RNA molecules transcribed from remnants of transposable elements trigger the formation
of heterochromatin, and hence establish gene silencing, through RNA interference.
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PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
R. Martienssen J.-M. Arroyo
M. Byrne
J. Fontana
A. Groover
C. Kidner
Z. Lippman J. Simorowski
B. May R. Shen
M. Ronemus A. Tang
P.D. Rabinowicz G. Teng
D. Roh U. Umamaheswari
We are using genomics and developmental genetics to
investigate epigenetic mechanisms of gene regulation,
transposon silencing, and stem cell function in plants.
Arabidopsis chromosome-4 tiling microarrays are being
used to investigate transposons and heterochromatin. We
are investigating the role of asymmetric leavesl, bell-
ringer; ramosal, and argonaute in stem cell function and
leaf patterning. Argonaute has an important role in RNA
interference (RNAi), and our studies in fission yeast have
revealed a role for centromeric transcripts and RNAi in
histone modification and chromosome segregation. We
have demonstrated parallel mechanisms in plants.
During the summer, we were joined by our URP, Grace
Teng, and guest postdoc Andreas Madlung from Seattle,
as well as Ruth Bastow from the John Inns Institute. We
said goodbye to Cristy Yordan, who was a research asso-
ciate in the lab for almost 10 years and is greatly missed.
She moved to Harvard Medical School in the summer
and we wish her well in her new appointment.
Role of ramosal in
Inflorescence Architecture
E. Vollbrecht, R. Martienssen
In the domesticated cereals and other grasses, the pres-
ence or absence of long inflorescence branches defines
panicle and spike architectures, respectively. For exam-
ple, the maize tassel bears both long and short (spikelet
pair) branches, whereas the ear bears only short branch-
es. Mutations in the ramosal (ral) and ramosal (ra2)
genes transform most spikelet pair branches from short
to long. Thus, ral, which encodes a small zinc finger
protein, imposes short branch identity. ral expression
defines a boundary between nascent spikelet pair
meristems and the primary inflorescence. ra2 mutants
are phenotypically similar to weak ral, although ra2
also represses internode elongation. In the spike, ra2
positively regulates ral expression levels, and ra2 ral
double mutants resemble ral, indicating that a single
M. Vaughn
E. Vollbrecht
T. Volpe
C. Yordan
pathway assigns spikelet pair identity. Molecular popu-
lation genetic tests indicate that ral was a target of
selection during maize evolution or domestication from
the teosintes and Tripsacum. Within the sugar cane
tribe, which diverged some 20 million years ago,
Miscanthus sinensis and Sorghum bicolor have more
extensive branching, and delayed onset of ral expres-
sion. Moreover, Sorghum BAC (bacterial artificial
chromosome) sequencing demonstrated that rice lacks
a ral ortholog, consistent with the branched architec-
ture of rice. These findings implicate the ramosa path-
way in the evolution of grass inflorescence diversity.
ASYMMETRIC LEAVES1 Reveals
Homeobox Gene Redundancy
in Arabidopsis
M. Byrne, J. Simorowski, R. Martienssen
The shoot apical meristem comprises undifferentiated
stem cells and their derivatives, which include founder
cells for lateral organs such as leaves. Meristem main-
tenance and lateral organ specifications are regulated
in part by negative interactions between the Myb
domain transcription factor ASYMMETRIC LEAVES]
(AS1), which is expressed in lateral organ primordia,
and homeobox transcription factors, which are
expressed in the shoot apical meristem (knox genes).
The knox gene SHOOT MERISTEMLESS (STM) neg-
atively regulates ASI which, in turn, negatively regu-
lates other knox genes, including KNATI and KNAT2,
and positively regulates the novel gene LATERAL
ORGAN BOUNDARIES (LOB) identified through
enhancer-trap analysis. Genetic interactions with a
LOB-related gene AS2 indicate that it acts at the same
position in this hierarchy as AS1. We have used a sec-
ond-site suppressor screen to isolate mutations in
KNATI, and we have shown that KNAT1 is partially
redundant with STM in regulating stem cell function.
Mutations in KNAT2 show no such interaction.
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BELLRINGER Regulates Phyllotactic
Patterns and Stem Cell Fate
M. Byrne, A. Groover, J. Fontana, R. Martienssen
Lateral organs in plants arise from the meristem in a
stereotypical pattern known as phyllotaxy (Greek for
leaf order). In most plants, such patterns comprise
individual leaves and flowers at spiral positions which
are related to each other by consecutive terms in the
Fibonacci series. Stem cell lineages also expand
according to the Fibonacci series when daughter cells
are delayed from acquiring stem cell fate, raising the
possibility that stem cells are responsible for phyl-
lotactic patterns (Klar, Nature 417: 595 [2002]). We
demonstrate that a homeodomain protein related to the
BELL] gene, which we have named BELLRINGER, is
required to maintain the phyllotactic pattern in
Arabidopsis. In the absence of BELLRINGER, the reg-
ular pattern is disturbed and lateral organs are initiated
more frequently. BELLRINGER is also required for
maintenance of stem cell fate in the absence of STM
and AS1. We propose a model whereby BELLRINGER
coordinates the maintenance of stem cells with differ-
entiation of daughter cells in stem cell lineages.
ARGONAUTE Regulates Leaf Polarity in
Arabidopsis via a Small RNA Signal
C. Kidner, M. Ronemus, R. Martienssen
argonautel (agol) is a pleiotropic mutation in
Arabidopsis defective in gene silencing via RNAi. We
have collected an allelic series of agol with defects in
meristem function, organ polarity, and organ identity.
Altered reporter gene expression and double-mutant
analysis suggest that AGO1 controls meristem func-
tion mediated by STM, and floral organ identity medi-
ated by LEAFY. Weak ago] -11 resembles and strong-
ly enhances weak carpel factory (can, a homolog of
Drosophila DICER, indicating that phenotypic effects
of agol are due to its role in RNAi. The partial rescue
of agol by loss-of-function mutations in CURLY
LEAF (CLF), a SET domain gene, suggests a link
between RNAi and polycomb-mediated gene silenc-
ing. Weak ago] -12 resembles dominant PHABU-
LOSAl-D (PHB) and is enhanced by revoluta (rev),
indicating a central role for RNAi in leaf polarity. A
21-nucleotide microRNA (miRNA) matches a con-
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tiguous 19-bp sequence of PHB/REV homologous
mRNA and has been shown to guide cleavage.
Dominant PHB alleles disrupt this homology, and
result in ectopic PHB expression. We have shown that
this miRNA is expressed in the abaxial domain of
early primordia and over-accumulates in agol. Thus,
miRNA acts as a signal to specify leaf polarity. We
have used Affymetrix microarray analysis of ago and
caf mutants to detect targets of RNAi. Up-regulated
genes include several that have unique regions of
homology with miRNA sequences, which have been
recently obtained in Arabidopsis. We are investigating
the basis for increased transcript accumulation.
Regulation of Histone H3 Lys-9
Methylation, Centromeric Silencing,
and Centromere Function by RNAi
T Volpe, C. Kidner, G. Teng, R. Martienssen
[in collaboration with R. Allshire, Wellcome Institute,
and S. Grewal, Cold Spring Harbor Laboratory]
Eukaryotic heterochromatin is characterized by a high
density of repeats and transposons, as well as by mod-
ified histones, and influences both gene expression
and chromosome segregation. In the fission yeast
Schizosaccharomyces pombe, we deleted the arg-
onaute, dicer, and RNA-dependent RNA polymerase
gene (RdRP) homologs, which encode part of the
machinery responsible for RNAi. Deletion results in
the aberrant accumulation of complementary tran-
scripts from centromeric heterochromatic repeats.
This is accompanied by transcriptional de-repression
of transgenes integrated at the centromere, and loss of
histone H3 Lys-9 methylation. We propose that dou-
ble-stranded RNA arising from centromeric repeats
targets formation and maintenance of heterochro-
matin through RNAi. A subfragment of the cen-
tromeric repeat (dg) is known to induce silencing of
marker genes at euchromatic sites and is required for
centromere formation. We have shown that the RNAi
components, Argonaute (Agol), Dicer (Dcrl), and
RNA-dependent RNA polymerase (Rdpl), are
required to maintain silencing, Lys-9 methylation of
histone H3, and association of Swi6 at the dg ectopic
silencer. Deletion of Agol, Dcrl, or Rdpl disrupts
chromosome segregation, leading to a high incidence
of lagging chromosomes on late anaphase spindles
and sensitivity to a microtubule poison. Analysis of dg
transcripts at the ectopic site indicates that csp
mutants, which are defective in centromere silencing
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FIGURE 1 A model for maintenance of centromeric silencing
by RNAi. Centromeric repeats (block arrows) are constitutively
transcribed from one strand, but the transcripts are rapidly
turned over by RNAi. RdRP binds the centromeric repeats and
somehow recruits the histone modification (octagon). Histone
H3 methyl-Lys-9 then recruits Swi6, which silences the other
strand.
and chromosome segregation, are also defective in the
regulation of noncoding centromeric RNAs. In addi-
tion, recruitment of Swi6 and cohesin to centromeric
repeats is disrupted in these mutants. Thus, the forma-
tion of silent chromatin on dg repeats and the devel-
opment of a fully functional centromere depend on
RNAi (Fig. 1).
Role of RNAi, Chromatin Remodeling,
DNA, and Histone Modification in
Transposon Silencing and Inheritance
Z. Lippman, B. May, C. Yordan, R.A. Martienssen
[in collaboration with V. Co lot, IGRV, Evry France]
The Arabidopsis gene DDMI is required to maintain
DNA methylation levels and is responsible for trans-
poson and transgene silencing. DDM1 has similarity
to the SWI/SNF family of adenosine triphosphate-
dependent chromatin remodeling genes, and we have
shown that DDM1 is also required to maintain histone
H3 methylation patterns. In wild-type heterochro-
matin, transposons and silent genes are associated
with histone H3 methylated at Lys-9, whereas known
genes are preferentially associated with methylated
Lys-4. In ddml heterochromatin, DNA methylation is
lost, and methylation of Lys-9 is largely replaced by
methylation of Lys-4. Because DNA methylation
depends on histone H3 Lys-9 methylation, our results
suggest that transposon methylation may be guided by
histone H3 methylation, potentially accounting for the
epigenetic inheritance of hypomethylated DNA once
histone H3 methylation patterns are altered. Both
DNA methylation and chromatin remodeling mutants
strongly reactivated transposons, and in most cases,
this correlated with a loss of H3mK9 methylation and
a gain of methylation on histone H3 Lys-4. When
these mutants were crossed to wild type, the trans-
posons were inherited as dominant epialleles, retain-
ing chromatin modifications characteristic of tran-
scribed genes. In contrast, transposon activation in his-
tone modification mutants was typically not inherited.
Although RNAi mutants exhibited changes at a subset
of the transposons analyzed, they did not reveal chro-
matin defects to the extent observed in other mutants.
Thus, plants have redundant mechanisms that main-
tain heterochromatic silencing, which involve chro-
matin remodeling and DNA methylation. These mech-
anisms may be responsible for presetting the heritable
alteration of transposon activation first described by
B. McClintock in maize. We have found that strand-
specific centromeric repeat transcripts accumulate in
mutant but not wild-type Arabidopsis. Accumulation
is not always accompanied by loss of DNA and/or his-
tone methylation, which may indicate that only a sub-
fraction of the repeats are transcribed.
Chromatin Profiling of the
Chromosome 4 Heterochromatic
Knob in Wild-type and ddml
Arabidopsis
Z. Lippman, M. Vaughn, R. Martienssen [in collaboration
with V Colot, IGRV, France, and W.R. McCombie and
V. Mittal, Cold Spring Harbor Laboratory].
Arabidopsis chromosome 4 carries an interstitial hete-
rochromatic knob on the short arm, which was com-
pletely sequenced by the CSHL/Washington Univer-
sity consortium during the Arabidopsis genome se-
quencing project. We have designed and printed a
genomic tiling microarray that covers this knob and
flanking euchromatic sequences. Our results show that
transposons within the knob, as well as numerous
hypothetical genes and some unique genes, are dra-
matically up-regulated in ddml plants, indicating that
DDM1 has a global role in maintaining silent epige-
netic states. Using chromatin immunoprecipitation
(ChIP) and a genomic DNA fractionation method
based on the methylation-sensitive enzyme McrBC,
we have used these microarrays to show that DNA
methylation and Lys-9 methylation of histone H3 are
enriched at repetitive sequences in wild-type plants,
but erased in ddml mutants. We are presently expand-
ing our array to cover all of chromosome IV.
173
Genes and Transposons Are
Differentially Methylated in Plants but
Not in Mammalian Cells
P.D. Rabinowicz, B. May, R. Martienssen [in collaboration
with W.R. McCombie and S. Lowe, Cold Spring Harbor
Laboratory]
In plants, transposable elements are typically methylat-
ed, but methylation in genes is restricted to the 5'- and
3'-flanking regions. In animals, there are two alterna-
tive views concerning the role of DNA methylation.
One suggests that DNA methylation silences trans-
posons as it does in plants, and retrotransposon tran-
scripts accumulate in methylation-defective mutant
mice. The second view is that methylation targets both
genes and repetitive DNA to decrease transcriptional
"noise." Only promoters are protected from methyla-
tion to allow gene expression. We have studied the
methylation status of plant and animal genes using a
sensitive, high-throughput PCR (polymerase chain
reaction) method we call McrPCR. We have shown that
most mammalian exons are methylated while plant
exons are not. Repetitive elements are methylated in
both organisms. We speculate that the mechanistic
basis of this difference may involve RNAi, as mam-
malian genomes lack RdRP, which targets heterochro-
matin formation in yeast (see above).
Functional Genomics Using Transposon
Populations in Maize and Arabidopsis
B. May, M. Vaughn, D. Roh, J. Simorowski, J.-M. Arroyo,
R. Shen, A. Tang, U. Umamaheswari, R. Martienssen
[in collaboration with W.R. McCombie and L. Stein,
Cold Spring Harbor Laboratory]
MTM (maize-targeted mutagenesis) is an efficient
system for site-selected transposon mutagenesis. As a
service to the maize community, MTM selects inser-
tions in genes of interest from a library of 45,000
plants using the PCR. Pedigree, knockout, sequence,
phenotype, and other information are stored in a pow-
erful interactive database (mtmDB) that enables
analysis of the entire population as well as handling
knockout requests. By monitoring Mutator activity,
we can demonstrate that seed phenotypes depend on
it. We conclude that more than one half of all muta-
tions arising in this population are suppressed on los-
ing Mutator activity. We also maintain and expand a
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collection of approximately 20,000 Arabidopsis gene-
trap and enhancer-trap transposon lines, about half of
which have been mapped to the genome by PCR and
sequencing. The resulting knockouts, along with phe-
notypic and expression data, are made available to the
public via TRAPPER, an interactive database and
ordering system. More than 200 orders were filled for
maize andArabidopsis lines in 2002.
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PLANT CELL SIGNALING AND GENETICS
D. Jackson K. Aliano M. Cilia J. Hsieh A. Mohanty
U. Au W. Deleu R. Jain N. Satoh
S. Aw A. Giulini J.Y. Kim J. Wang
S. Bangaru L.A. Haller C. Kopec Z. Yuan
We are attempting to understand the genetic program-
ming of plant morphology. This is a fundamental ques-
tion in developmental biology, with obvious applica-
tions to crop yields. Specifically, we aim to define the
molecular genetic pathways that control development.
In recent years, we have been studying how cells sig-
nal each other to coordinate their development and
fate. We are also developing new projects to extend
what we learn from model systems to other cereal crop
plants such as wheat, barley, and rice, to learn how
developmental genes have contributed to the selection
of these different crop species.
A Novel Assay for Intercellular
Protein Trafficking
J.Y. Kim, J. Hsieh
We previously reported the specific intercellular traf-
ficking of GFP (green fluorescent protein) fusions to
the maize KNOTTED1 (KN1) protein, and to viral
movement proteins (MP). These proteins presumably
traffic through plasmodesmata (PD), small channels
that connect plant cells, to control development and
virus spread, respectively. Plasmodesmata are still
very poorly characterized, and we envisage that a
genetic approach will allow us to identify regulatory
or structural components of these elusive channels. We
therefore developed a novel intercellular trafficking
assay system using trichomes (hairs) on the
Arabidopsis leaf as a visual output. The GLABROUS]
(GL1) gene, which encodes a MYB-related transcrip-
tion factor, is normally expressed in epidermal cells
that will make trichomes. When we expressed GL1 in
mesophyll cells in gll mutant plants, these plants
failed to make trichomes, presumably because GL1
protein was in the wrong cell type. However, fusions
of GL1 to KN1 were able to complement trichome
production, because the fusion protein could traffic
from mesophyll to epidermal cells and initiate tri-
chomes. This provided us with a sensitive screen to
define regions of KN1 involved in intercellular target-
ing, and we have also initiated screens to identify other
loci required for trafficking of KN1. These screens
should identify genes required for intercellular target-
ing of KN1.
Genetic Screens for Protein
Trafficking Mutants
M. Cilia, S. Aw, K. Aliano
Cytoplasmic GFP can freely diffuse between plant
cells in the Arabidopsis epidermis when driven by the
Glabra2 promoter (Fig. 1A), and unloads out of the
phloem into the root tip when driven by the Sucrose
symporter promoter (Fig. 1C), because it is small-
er than the size exclusion limit of the plasmodesmata
on these tissue boundaries. In contrast, the endoplas-
mic reticulum (ER)-localized version of GFP driven
by the Glabra2 (Fig. 1B) or Sucrose IA' symporter
(Fig. 1D) promoters does not move between cells, pre-
sumably because the ER lumen in the plasmodesmata
becomes appressed during formation of the pore. We
designed genetic screens for mutants defective in reg-
ulating the size exclusion limit of the plasmodesmata
using transgenic Arabidopsis lines expressing GFP
under the control of the Glabra2 or Sucrose sym-
porter promoters. We have identified several putative
mutants that do not permit the intercellular trafficking
of cytoplasmic GFP. Preliminary analysis of the
mutants indicates that regulation of the plasmodesma-
ta size exclusion limit may be essential for develop-
ment, because these mutants display a range of devel-
opmental phenotypes. We are presently making map-
ping populations with the goal of isolating these genes
that regulate plasmodesmata permeability. The
mutants will also be characterized for other related
phenotypes such as plasmodesmata structure and viral
transport.
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BFIGURE 1 Cytoplasmic GFP can freely diffuse
between plant cells in Arabidopsis epidermis
when driven by the Glabra2 promoter (A), and
unload out of the phloem into the root tip when
driven by the Sucrose FP' symporter promoter (C)
because GFP is smaller than the size exclusion
limit of the plasmodesmata on these tissue
boundaries. An ER-localized version of GFP
does not move when driven by the Glabra2 (8)
and Sucrose H* symporter (D) promoters
because the ER in the plasmodesmata is
oppressed. We designed a genetic screen for
mutants defective in regulating the size exclusion
limit of the plasmodesmata using transgenic
Arabidopsis lines expressing the cytoplasmic ver-
sion of GFP under the control of the Glabra2 and
Sucrose Fi* symporter promoters. We identified
several putative mutants that do not permit the
intercellular trafficking of cytoplasmic GFP.
Preliminary analysis of the mutants indicates that
regulation of the plasmodesmal size exclusion
limit is essential for development.
A Pilot Screen to Localize
Proteins of Unknown
Function in Arabidopsis
C. Kopec, A. Mohanty
The recent completion of the Arabidopsis genome
sequence delivered a catalog of approximately 25,000
genes that function together to form a higher plant.
However, approximately one third of these genes have
no known function in plants or other systems. As an
initial approach to characterize these "genes of
unknown function," we plan to localize their encoded
protein products using fusions to the yellow fluores-
cent protein (YFP). We developed a high-throughput
overlap polymerase chain reaction (PCR) procedure to
fuse the YFP-coding sequence at our chosen site with-
in any gene-coding sequence. The fusions will be
transformed into Arabidopsis plants for analysis of tis-
sue-specific and subcellular localization of the protein
under its native regulatory sequences. This project
should discover novel developmental and subcellular
domains and may identify proteins that localize to
known plant structures for which we currently do not
have molecular components, such as plasmodesmata.
176
Microarray Analysis of Maize
Inflorescence Development
N. Satoh [in collaboration with V. Brendel, University
of Iowa, and S. Hake, Plant Gene Expression Center,
Albany, California]
The maize inflorescence is a complex developmental
system, involving the progression of meristems
through several distinctive states with different char-
acteristics and potentials. Although several genes
involved in these progressions have been characterized
already, the recent availability of maize expressed
sequence tag (EST) and genomic sequence collections
permits a broader survey of developmental genes.
With assistance from Rob Lucito and the CSHL
microarray facility, we constructed a pilot oligonu-
cleotide array and probed it with cDNAs from devel-
oping inflorescences and leaves. The initial results
indicate that we can detect many of the known inflo-
rescence developmental transcripts on our pilot array,
and so we plan to proceed to the discovery phase by
making arrays of all known maize genes. These arrays
will be probed with cDNAs prepared from different
inflorescence stages as well as from mutants that
arrest development at defined points. We will test
novel candidate developmental genes using the maize
targeted mutagenesis system here at CSHL.
High-resolution QTL
Analysis of Seed Row
Number in Maize
D. Jackson, U. Au, L.A. Haller, N. Satoh [in collaboration
with T. Rocheford, University of Illinois, and E. Buckler,
North Carolina State University]
A major factor in the human selection of maize as a
crop was a huge increase in the number of seeds pro-
duced per plant. This was achieved by a combination
of factors, but one major factor was a selection for an
increase in the number of seed rows on the ear. For
example, teosinte, the wild ancestor of maize, has only
a single row of seeds, whereas modem maize cultivars
have 12 to 18 rows. We have measured inflorescence
meristem size in a range of maize cultivars and found
a strong positive correlation with seed row number.
This indicates that regulation of meristem size is an
important factor in seed row number. Evidence that
thefasciated ear2 (fea2) gene may be important in this
process has come from two independent lines of
research. fea2 mutants have unregulated meristem
growth, and we found an association between fea2
sequence haplotypes and seed row number in a diverse
collection of maize germ plasm.
Our interest was also sparked by the observation
that fea2 maps close to a quantitative trait locus (QTL)
for row number. In the past, QTL analysis in maize has
been a relatively imprecise method to identify genom-
ic regions controlling a particular trait, with relatively
low resolution. A new mapping population, the inte-
grated B73-Mo 1 7 (IBM) population, has now been
developed and is ideal for the fine mapping of quanti-
tative traits. We have used this resource by measuring
seed row number in the different IBM families. Our
preliminary QTL analysis indicates that row number is
under the control of a small number of loci, some of
which map to previously identified row number QTL
and some of which are novel. Of particular interest,
one of the QTLs maps to the same region as fea2, and
now with much higher resolution than shown in previ-
ous studies. Therefore, fea2 is an excellent candidate
for this QTL, and we will test this directly by a trans-
genic approach.
A Protein Complex Involved
in Restriction of Stem Cell
Proliferation
J. Wang, W. Deleu
The fea2 gene has a role in restriction of stem cell pro-
liferation; fea2 mutants have massive inflorescence
apical meristems due to a mis-specification of cell fate
in the meristem tissues. fea2 encodes a leucine-rich
repeat receptor-like protein, and to ask what other pro-
teins might be involved in this pathway, we generated
a polyclonal antibody to a carboxy-terminal FEA2
peptide. We detected FEA2 protein in membrane-
enriched fractions, and it runs slightly larger than its
predicted size due to glycosylation. By gel filtration
chromatography, we found that FEA2 is part of a com-
plex of approximately 450 kD, and we are attempting
to purify this complex. We will also ask if other fasci-
ated mutants that we have characterized encode com-
ponents of the FEA2 complex.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans T. Phelps-Durr J. Thomas
M. Juarez E. Wurtmann
Plants have the unique property to initiate new organs,
such as leaves and flowers, throughout their lifetime,
which frequently extends over many years. The grow-
ing tips of plants are called meristems and consist of a
small group of indeterminate stem cells. These cells
divide to maintain the stem cell population and inde-
terminate growth of the plant and to differentiate into
determinate founder cells from which lateral organs
arise. Coincident with their initiation, lateral organs
are patterned along three axes: (1) the proximodistal
axis, which leads to the differentiation of distinct tis-
sues and cell types at the base and the tip of the devel-
oping organ; (2) the dorsoventral axis, leading to dis-
tinct cell fates in the upper and lower surfaces of the
organ; and (3) the mediolateral axis, which distin-
guishes central and marginal domains of the organ.
Early surgical experiments suggested that signals
from the meristem have an important role in the pat-
terning of lateral organs. However, the genes involved
in the initiation and patterning of lateral organs in
plants are still largely unknown. We are using forward
and reverse genetic approaches to generate mutants in
maize and Arabidopsis that affect these processes. In
particular, we are studying the repression of stem cell
fate during organ initiation and growth, and we are
analyzing the genetic pathways leading to dorsoventral
polarity in leaves and leaf-like lateral organs.
Variations in the expression patterns of such genes are
likely to contribute to the diversity of leaf shapes
among many plant species.
REPRESSION OF STEM CELL FATE
DURING ORGAN DEVELOPMENT
The mechanism that distinguishes stem cells from
organ founder cells in the shoot apical meristem
(SAM) is largely unknown, but the regulation of knot -
tedl -like homeobox (Knox) gene expression appears to
be one of the key determinants. Knox genes are
expressed in the meristem and are required for indeter-
minate growth, i.e., stem cell fate. Initiation of deter-
minate lateral organs such as leaves is correlated with
the down-regulation of Knox gene expression in a sub-
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set of cells within the meristem, the organ founder
cells. We have previously shown that the rough sheath2
(Rs2) gene from maize encodes a MYB-domain pro-
tein that acts as a negative regulator of Knox gene
expression. Recessive mutations in rs2 cause the mis-
expression of KNOX proteins in developing leaf pri-
mordia. Interestingly, KNOX protein accumulation in
leaves of rs2 null mutants occurs in just a subset of
cells that express Rs2 in wild type. KNOX proteins
accumulate in patches with sharp lateral boundaries,
suggesting that rs2 leaves are clonal mosaics of Knox+
and Knox sectors. The numbers and sizes of such sec-
tors vary among leaves and do not correlate with nor-
mal developmental domains. Furthermore, the down-
regulation of Knox gene expression during leaf initia-
tion precedes the onset of Rs2 expression, suggesting
that Rs2 is required for maintenance of Knox gene
repression. On the basis of these observations, we pro-
posed that Rs2 acts as an epigenetic regulator to keep
Knox genes in an "off" state. Rs2 thus prevents differ-
entiated cells within lateral organs from reverting into
indeterminate stem cells.
We are currently studying the mechanism by which
Rs2 represses Knox gene expression. Using a yeast 2-
hybrid screen and glutathione S-transferase pull-down
assays, we have identified seven RS2 interacting pro-
teins (1252-IPs). These have homology with the protein
phosphatase 2A regulatory subunit A (PP2A-A), PP2A
regulatory subunit B' (PP2A-B'), a zinc finger tran-
scription factor, ASYMMETRIC LEAVES2 (AS2)
from Arabidopsis, a highly conserved hypothetical pro-
tein, histone 2B (H2B), and a known nucleosome
assembly protein. Several of these proteins are known
to function in the nucleus, consistent with a role in
transcriptional regulation. We are testing the subcellu-
lar localization of the remaining RS2-IPs by transient-
ly expressing chimeric proteins consisting of the RS2-
IP fused to green fluorescent protein (GFP) in leaf tis-
sue. Both the PP2A regulatory subunits were found to
be localized in the nucleus. Interestingly, the fusion
protein between GFP and the RS2-IP with unknown
function colocalized with chromosomes in dividing
cells, suggesting that it is associated with chromatin.
This result together with the confirmed interaction
between RS2, H2B, and the nucleosome assembly fac-
tor suggested that the RS2 complex maintains Knox
genes silenced by altering the organization of chro-
matin at these loci. Actively transcribed genes usually
have a more open chromatin structure, whereas chro-
matin at silenced genes is densely packed. Nuc leo-
some density can be determined using the enzyme
micrococcal nuclease, which cuts DNA once between
adjacent nucleosomes. We are analyzing the chro-
matin organization at the Knox loci in Arabidopsis.
The ASYMMETRIC LEAVES1 (AS1) gene is the Rs2
ortholog and functions in the repression of several
Knox genes during Arabidopsis leaf development. We
have found that the nucleosome density at the pro-
moter of one of the Knox genes, KNAT1, is indeed
higher in wild-type leaves than in as1 mutant leaves.
To determine the roles of the RS2-IPs in plant
development, particularly in stem cell function, we are
using reverse genetic resources available in Arabidop-
sis. Loss-of-function mutations in AS2 are known to
affect Knox gene silencing during leaf development,
but our results indicate that AS2 acts in the same com-
plex as AS1/RS2. We have isolated mutations in
Arabidopsis orthologs of the unknown protein and the
nucleosome assembly protein. Loss-of-function
mutants in the unknown protein are indistinguishable
from wild type, but loss of the nucleosome assembly
protein causes embryo lethality. Using an RNA inter-
ference (RNAi)-like approach, we have generated
transgenic plants that have reduced levels of the nucle-
osome assembly protein. These transgenic plants have
defects in leaf and floral development that resemble
the defects observed in the as1 and as2 mutants. The
sepals, petals, and stamens of the flower are reduced in
size, such that the carpel is prematurely exposed.
Leaves of these transgenic plants are asymmetrically
lobed, and like as1 and as2, they misexpress three of
the four Arabidopsis Knox genes. AS2 expression is
unaffected and AS1 transcript levels are increased in
these mutants, indicating that the defects in these trans-
genic plants do not result from loss of ASl or AS2.
However, loss of the nucleosome assembly protein in
these transgenic plants affects the chromatin organiza-
tion at the Knox loci in that the density of nucleosomes
is reduced.
Taken together, our observations suggest that AS1/
RS2 and AS2 assemble into a protein complex which
targets a nucleosome assembly factor to the Knox loci
in organ founder cells. This nucleosome assembly fac-
tor establishes a condensed, silenced chromatin state
at the Knox loci. As a result, stem cell fate remains
repressed in determinate, differentiating cells of devel-
oping lateral organs.
DORSOVENTRAL PATTERNING OF
LATERAL ORGANS IN MAIZE
Normal maize leaves develop as flattened dorsoventral
organs with distinct cell types on the upper/dorsal and
lower/ventral sides. We previously reported that
Leafbladelessl (Lbll) is required for the specification
of dorsal identity in leaves and leaf-like lateral organs
and that dorsoventral polarity in the developing organ
is needed to grow out laterally into a flattened leaf.
Loss of Lbll gene function results in the formation of
ventralized, radially symmetric leaves, or in ectopic
laminar outgrowth surrounding ventralized sectors on
the dorsal leaf surface. We have identified several addi-
tional loci required for dorsoventral patterning.
Recessive mutations in two of these loci result in phe-
notypes resembling lbll, indicating that these genes
also function in the specification of dorsal cell fate.
The Rolled leafl-Original (R1d1-0) mutant is semi-
dominant and is characterized by a curled leaf pheno-
type in which the leaf blades roll up toward the mid-
vein. This phenotype results from a partial inversion in
dorsoventral polarity. Cell types that are normally con-
fined to the dorsal epidermis are ectopically expressed
in the ventral epidermis of the mutant, and vice versa.
To dissect the genetic pathway(s) leading to dorsoven-
tral polarity, we are analyzing the double-mutant inter-
actions between these dorsoventral patterning mutants.
The vegetative phenotypes of lbll Rld1-0 double
mutants are much less severe than those observed in
either single mutant. Depending on the environmental
conditions, double-mutant leaves frequently appear
normal. This mutually suppressive interaction indicates
that RLD1 and LBL I either have opposing functions or
regulate each other.
We are also characterizing maize homologs of sev-
eral Arabidopsis genes that are expressed specifically
in either the dorsal or ventral domains of the leaf. The
Arabidopsis YABBY genes act in the ventral domain of
lateral organs and are required for the specification of
ventral cell types in the leaf. As in Arabidopsis, the
maize Yabby genes are expressed in the incipient pri-
mordium, but interestingly, expression is restricted to
the dorsal side of the leaf. Moreover, Yabby expression
is restricted to the margins of young leaf primordia.
This expression pattern is altered in lbll and Rld1-0
mutants. The overall level of expression is reduced in
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lbll, and the narrow leaf primordia show no Yabby
expression in the mutant margins. Weak lbll mutants
frequently develop ectopic blade outgrowths on the
dorsal side of the leaf. The Yabby genes are expressed
in these outgrowths. In Rld1-0, the level of expression
of the Yabby genes is increased and expression is pro-
longed, but it remains dorsally localized. In contrast to
lbll, Rldl -0 mutant leaves develop ectopic out-
growths on the ventral leaf surface. The Yabby genes
are also expressed in these ventral ectopic outgrowths.
These results suggest that the Yabby genes act down-
stream from LBL1 and RLD1. The Yabby genes may
mediate dorsoventral polarity signals to direct lateral
growth at the leaf margins. The establishment of Yabby
expressing cells next to nonexpressing cells could be
required for lateral growth. If so, there would be no
evolutionary constraints to limit Yabby expression to,
for instance, the ventral side of the leaf. Alternatively,
the maize Yabby genes function in dorsoventral pat-
terning. If so, their role and upstream regulators have
diverged between maize and Arabidopsis, or the path-
way for dorsoventral axis specification is conserved
but inverted between Arabidopsis and maize.
We recently cloned the Rldl gene. It encodes a
member of the class III homeodomain-leucine zipper
(HD-ZIP III) family of proteins, which are known to
function in dorsoventral patterning in Arabidopsis. In
addition to the DNA-binding domains, HD-ZIP III
proteins contain a START lipid-sterol binding-like
domain, suggesting that they may function as nuclear
receptors. Sequence homology suggests that expres-
sion of Rldl may be regulated at the posttranscription-
al level by microRNAs (miRNAs). miRNAs are
20-24-nucleotide RNA molecules that negatively reg-
ulate expression of mRNAs which contain a comple-
mentary sequence. Both Arabidopsis and rice were
shown to produce miRNAs that specifically regulate
the HD-ZIP III family members by an RNAi-related
mechanism. The miRNA complementary site is con-
served in the maize Rldl gene, and all three dominant
Rldl mutations result from a single-nucleotide change
in this complementary site. This suggests that the
dominant Rldl -0 mutant phenotype results from mis-
expression of Rldl. Mosaic analysis has shown that
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FIGURE 1 Model for the specification of dorsoventrality in
maize leaves.
expression of the Rldl -0 mutant allele in just the ven-
tral epidermis is sufficient to invert the polarity of the
leaf. This suggests that the miRNA normally repress-
es Rldl expression on the ventral side of the leaf such
that Rldl functions on the dorsal side of the leaf.
These results can be reconciled with the model for
dorsoventral patterning shown in Figure 1. The pattern
of expression, at the margins and in ectopic out-
growths, is consistent with a role for the Yabby genes
in lateral outgrowth. In addition, lbll leaves frequent-
ly fail to grow out laterally, which could result from
the loss of Yabby expression. Lbll is also required for
dorsal cell specification, and this function could in
part be mediated via the Yabby genes, which are
expressed dorsally and act downstream from Lbll.
Rldl expression is limited to the dorsal domain due to
the posttranscriptional negative regulation by an
miRNA in the ventral domain. The Rld1-0 mutation
may lead to increased RLD1 activity in both the dor-
sal and ventral domains. This would result in increased
LBL1 activity and Yabby expression. This model can
thus explain the double-mutant data that Rld1-0 sup-
presses lbll, and the observed increased Yabby expres-
sion in Rldl -O. RLD1 activity in the ventral domain of
Rld1-0 mutant leaves could cause ectopic Lbll func-
tion and dorsalization of the leaf. Consistent with this,
the Rld1-0 lbll double-mutant analysis showed that
Rld1-0 requires Lbll in order to affect dorsoventral
polarity.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to 3 years on proj-
ects of their own choosing. Fellows are provided with a salary, research support, and technical assis-
tance so that they can accomplish their goals free of distraction. The interaction among research
groups at the Laboratory and the program of courses and meetings on diverse topics in biology con-
tribute to a research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1987) and Scott Lowe (1995) are
currently members of the faculty at the Laboratory. After 9 years at the Laboratory, Carol Greider (1988)
left to join the Department of Molecular Biology and Genetics at Johns Hopkins University School of
Medicine. Eric Richards (1989) is currently in the Department of Biology at Washington University. After
finishing his fellowship, David Barford (1991) returned to the Laboratory of Molecular Biophysics at
Oxford University. Ueli Grossniklaus (1994) was a member of our faculty before leaving to join the
Friedrich Miescher Institut in Basel, Switzerland in 1998. Marja Timmermans, who joined us from Yale
in 1998, ended her fellowship in June of this year, when she became an assistant professor at the
Laboratory.
The two current CSHL Fellows, Gilbert (Lee) Henry and Terence Strick, joined the Laboratory in
2000. Their reports are listed below. Lee joined us from Doug Melton's laboratory at Harvard University
where he earned his Ph.D. for studies on Xenopus development. Lee is studying taste bud develop-
ment and the role of innervation in this process. Terence joined us after earning his Ph.D. in molecular
and cellular biology at Eco le Norma le Sup6rieure in Paris with David Bensimon and Vincent Croquette.
Terence is using single-molecule biophysics to study the mechanical response of DNA to stretching
and twisting by enzymes that alter DNA topology, thus elucidating the properties of these enzymes.
L. Henry
T. Strick
Structural and Functional
Studies of the Vertebrate
Taste Bud
L. Henry, Y. Zhu
The goal of our research is to understand the molecular
mechanisms that are required for the formation of taste
buds during embryogenesis and the maintenance of
their structure and function in the adult. The sensory
cells of gustation are housed within ovoid structures
called taste buds, which are embedded in the epitheli-
um of the tongue, and to a lesser extent the epithelium
of the palate and upper pharynx. Consisting of 70-100
cells, the vertebrate taste bud is a highly dynamic struc-
ture that possesses both epithelial and neuronal quali-
ties. Like all other sensory cell types, the taste receptor
cell membrane depolarizes in the presence of a suitable
stimulus. Similar to the epithelial cells that line the
intestine and other areas of the gut, cells within the bud
turn over at a rapid rate (-8-10 days in rodents). Unlike
the olfactory system, where the axons of newly formed
receptor cells project for some distance back toward
and synapse on to neurons in the glomeruli of the olfac-
tory bulb, newly formed taste receptor cells lack classi-
cal projections and synapse on to sensory afferents that
are associated with the taste bud.
Mammalian taste buds are embedded in epithelial
specializations called papillae. On the surface of the
tongue, three classes of papillae are easily distin-
guished. Toward the back of the tongue, there is a cen-
trally located circumvallate papilla, two groups of
foliate papillae are found to the lateral extremes of the
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posterior tongue, and scattered over the anterior
tongue are reddish colored fungiform papillae. The
papillae form late during embryogenesis in the mouse
(E13-E16) as the tongue begins to bud away from the
pharynx. Soon after their formation, sensory afferents
enter the papillae, and approximately 8-10 days after
birth (P8-P10), taste buds form. In rodents, there is a
single bud per fungiform papilla, tens of buds within
the two foliate papillae, and hundreds of buds are
found in the single circumvallate.
An intimate relationship between both the devel-
oping papillae and the mature taste bud with innervat-
ing sensory afferents has been established through a
number of denervation studies. Papilla formation does
not require innervation; however, the maintenance of
these structures does in some way require contact with
sensory afferents. Similarly, in adult animals, dener-
vation of the tongue leads to the loss of taste buds. We
are currently trying to understand the molecular basis
for this neuroepithelial interaction. However, before
regulatory mechanisms can be understood, it is first
necessary to understand exactly what is being regulat-
ed. Toward this end, a primary aim of our current work
is to understand, in molecular detail, how many differ-
ent types of cells reside in the developing papilla and
adult taste bud. What, if any, lineage relationships
exist among these cell types? Is the distribution of the
different cell types that reside in these structures spa-
tially patterned?
DEVELOPMENT OF A QUANTITATIVE METHOD FOR
THE ANALYSIS OF mRNA IN SINGLE CELLS?
A prerequisite for much of our work is the develop-
ment of a quantitative method for the analysis of
mRNA expression in single cells or small numbers of
cells. A typical eukaryotic cell contains picogram
amounts of mRNA, whereas the vast majority of the
analytical procedures that we use to analyze gene
expression require microgram amounts of material.
Thus, the mRNA expressed in a single cell must be
amplified before it can be studied. We have developed
a novel scheme for performing such amplifications. In
this technique, mRNA is bound to a magnetic bead,
covalently coupled cDNA is produced, and after a
series of molecular manipulations, the cDNA is
released and amplified by either polymerase chain
reaction (PCR) or in vitro transcription. The advan-
tage of performing such manipulations in the solid
phase is that precipitation and chromatographic steps
are not required between manipulations, which allows
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the user a great deal of flexibility in modifying the
cDNA so that it can be amplified. We have success-
fully amplified mRNA from single adult taste receptor
cells and taste buds. Additionally, we are using
microarray technology to assess the quantitative abili-
ties of our procedure. These experiments simply
involve comparing the expression profiles of diluted
and amplified material versus undiluted material.
HOW DIVERSE ARE BOTH THE MATURE
RECEPTOR CELL POPULATION AND
THE PROGENITOR POOL FROM
WHICH IT IS DERIVED?
Our goal is to develop a molecular fingerprint for each
of the different cell types that reside in the adult taste
bud. By fingerprint, we essentially mean a transcrip-
tional profile. From the perspective of cell division,
there are two types of cells within the adult taste bud:
mitotically active progenitor cells at the base of the bud
and differentiated quiescent cells at the apex. Mature
taste receptor cells fall into the later category. In addi-
tion, the differentiated cells of the taste bud are highly
elongated as compared to the progenitors and can
release the neurotransmitter onto the sensory afferent
network with which they form multiple synapses.
These properties allow basal cells to be distinguished
from their mature, apically located, daughter cells by
the presence of mRNA transcripts that encode proteins
which support the aforementioned processes. For
example, there are a small number of genes known that
are only expressed in dividing cells, and the production
of certain neurotransmitters requires biosynthetic
enzymes that are only expressed by the cells that make
and release the transmitter. Altogether, we have isolat-
ed just more than 100 cDNA clones that can be used to
pre-sort cells. Each of these clones has been spotted
onto a low-density microarray which is hybridized to
amplified and labeled cDNA derived from single cells.
This pre-sorting hybridization allows progenitor and
mature cells to be distinguished, as well as bitter-,
sweet-, sour-, and salt-responsive cells.
HOW MANY TYPES OF CELLS ARE CONTAINED
WITHIN THE DEVELOPING PAPILLAE?
To understand how papillae are formed and innervated,
it is imperative that we first ask what are papillae, at the
molecular level? The papillae of the tongue are very
similar in structure to the various ectodermal placodes
that cover the epidermis and give rise to hair, feathers,
and teeth. The secreted signaling factor sonic hedgehog
(shh) is expressed in cells that will form these struc-
tures, and that expression is maintained after the papil-
lae or placode has formed. We plan to exploit this find-
ing by using the shh locus to ectopically express green
fluorescent protein (GFP) in developing papillae.
Bacterial artificial chromosome (BAC) clones carrying
the shh gene have been isolated, and using a recently
described recombination technique, a GFP cassette has
been inserted into this locus. Transgenic mice will be
generated using the modified BACs. Single GFP-posi-
tive cells from the lingual epithelium of E12-E17
embryos will be isolated and transcriptionally profiled
using a single-cell cDNA synthesis method. Profiles
will be obtained by screening microarrays and direct
sequencing of cDNAs. From this work, we hope to
determine the molecular diversity of the papilla during
its formation and innervation. Once we can "finger-
print" the cells of the papillae in this manner, it should
be possible to analyze the mechanisms that regulate
this diversity, in particular, the contribution of innerva-
tion to the development of papillae.
Single-molecule DNA
Analysis
T. R. Strick
We have been using single-molecule techniques to
manipulate and study the structure and topology of
DNA in processes ranging from transcription to pack-
aging. We are particularly interested in the role played
by DNA supercoiling. In our experiments, a single,
linear 4-kb DNA molecule is tethered to a glass sur-
face at one end and to a micron-sized magnetic bead
at the other. Using a magnetic field to manipulate the
bead, one can mechanically stretch and twist the mol-
ecule and thus reproduce the mechanical constraints it
encounters in vivo (such as negative supercoiling).
Determining the bead position gives the DNA end-to-
end extension, which can be used to detect structural
fluctuations along the double helix, as well as protein-
DNA interactions in real time. These methods yield
important new mechanistic insights into the molecular
motors (such as polymerases and topoisomerases)
which access the genome and maintain its integrity. At
the same time, they also shed light on the nature of
DNA structural transitions and their role in regulating
gene activity. In this report, we briefly describe our use
of DNA micromanipulation to observe spontaneous
denaturation fluctuations in negatively supercoiled
DNA. We also discuss the real-time measurement of
the interaction between a single RNA polymerase and
its promoter site. Finally, we consider the use of this
technique to study the SMC (structural maintenance
of chromosome) proteins responsible for compacting
DNA into mitotic chromosomes.
The real-time observation of protein-DNA interac-
tions involved in gene regulation and compaction is
made possible by the detection and manipulation of
single molecules. Continuous monitoring of a single
pair of interacting molecules, such as bacterial RNA
polymerase and DNA, gives a time course of their
reaction. From this, the time scales of interactions can
be measured between the protein and its DNA sub-
strate and a quantitative analysis of association and
dissociation rates can be performed. In addition,
micromanipulation of the DNA substrate provides a
way to study structural and mechanical features of the
interaction, such as twist and bend deformations in the
DNA that result from protein binding. Finally, the
mechanical control of DNA topology enables us to
change and measure DNA supercoiling in real-time,
and to better understand the fundamental role of DNA
topology in interactions with proteins. Here, we
describe recent advances made in the study of struc-
tural fluctuations in DNA, transcription initiation by
RNA polymerase, and the compaction of DNA by pro-
teins belonging to the condensin family.
FIGURE 1 Depiction of the experimental setup. (Inset) DNA is
tethered at one end to the wall of a glass capillary tube and at
the other end to a magnetic bead. (Overview) The capillary tube
is mounted on an inverted microscope whose focus is con-
trolled by a computer. The computer also controls the displace-
ments (translation and rotation) of the magnets used to manip-
ulate the bead. A CCD camera connected to the microscope
relays video images of the magnetic bead to the computer. The
computer extracts from these images the mean position and the
Brownian fluctuations of the bead, which can be used to deter-
mine the DNA's end-to-end extension / which results from an
applied stretching force F and a supercoiling of n turns.
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FIGURE 2 Observation of promoter melting by a single RNA polymerase. (Left) Sketch of the experiment.
DNA containing a single bacterial promoter site is negatively supercoiled, causing it to form supercoiled
loops and reducing the end-to-end extension. When RNA polymerase melts the promoter site, topological
coupling in the DNA causes a supercoil to disappear and the extension increases. When the promoter site
reanneals, the supercoil reappears and the extension decreases. (Right) In the presence of RNA poly-
merase, the DNA extension does indeed fluctuate between a low-extension and a high-extension position.
The single-molecule experiment we have imple-
mented is depicted Figure 1. A 4-kb linear DNA mol-
ecule is shown anchored at one end to a glass surface
and at the other end to a 1-p.m-diameter magnetic
bead. The field generated by magnets located above
the sample is used to pull on and rotate the magnetic
bead, thus stretching and twisting the tethered DNA.
The stretching force applied to the DNA via the bead
is calibrated as a function of magnet position (the
closer the magnets, the higher the force). The torsion
imparted to the DNA is exactly equal to the number of
clockwise or counterclockwise rotations performed by
the magnets and imposed on the bead. The double
helix is thus quantitatively and reversibly supercoiled
while held under tension. By determining the position
of the magnetic bead, one measures and calibrates the
end-to-end extension of the DNA molecule, and thus
its mechanical response to stretching and twisting.
unwind a single DNA molecule, real-time monitoring
of its end-to-end extension reveals large-scale fluctua-
tions in DNA extension. This occurs for degrees of
supercoiling for which DNA is expected to denature
(a - -0.025). These fluctuations do not appear on
overwound DNA, suggesting that they are due to loss
of regular B-DNA structure and the formation of alter-
native secondary structures (such as denaturation bub-
bles or cruciforms). As with the folding/unfolding
transitions in RNA hairpins and protein domains
observed by other groups in recent years, these fluctu-
ations obey Poisson statistics and are well-described
by a simple two-state model where thermal activation
provides the energy for the system to flip between a
"native" and an "unwound" state. The quantitative
study of how DNA torsion affects its unwinding
allows us to better understand the role of DNA topol-
ogy in protein-DNA interactions.
Observation of Denaturation
Fluctuations in Unwound DNA
R. Sachidanandam, T. Strick
We have been studying spontaneous denaturation
fluctuations in negatively supercoiled DNA. Such
fluctuations could have a role in the initiation of DNA
transcription and replication, which occurs at AT-rich
sequences that are prone to unwinding. When we
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Real-time Study of
Transcription Initiation
A. Revyakin, R.H. Ebright, T. Strick
In the past year, we have made substantial progress in
our efforts to observe promoter melting by RNA poly-
merase at the single-molecule level. One goal of these
experiments is to determine how the topological state
of the DNA molecule affects transcription initiation, a
fundamental process in the regulation of gene expres-
sion. A sketch of single-molecule detection of pro-
moter melting is provided Figure 2.
For these experiments, we prepared a 4-kb DNA
molecule containing a unique bacterial promoter site.
Upon addition of RNA polymerase holoenzyme, we
are able to observe fluctuations in the DNA end-to-end
extension (see Fig. 2). Since these fluctuations are not
observed if the DNA does not contain the promoter
site, they must be due to interactions between an RNA
polymerase and the promoter site. By measuring the
amplitude of these fluctuations, we can estimate the
extent of DNA untwisting that takes place at promoter
melting, as well as observe a subtle compaction effect
presumably due to association of the melted DNA
with the surface of the RNA polymerase.
Since these observations are performed in real-
time, we are also able to study the dynamics of forma-
tion and disappearance of this promoter-open complex
known as RPo. Indeed, the high-extension state of the
DNA is consistent with the protein-induced formation
of an unwound region of DNA at the promoter site.
Promoter melting and reannealing display single-
exponential dynamics. As expected for a process
where the rate-dependent step is affected by mechani-
cal constraints on the DNA substrate, negative DNA
supercoiling causes both the rate of promoter melting
and the lifetime of melted complexes to increase. The
propensity of different promoter sequences to melt can
be studied in this manner, as can the role of activators
such as CAP protein. By adding all four nucleotides,
we confirm that these promoter-open complexes are
transcriptionally competent. In this case, we observe
the accumulation of several unwound bubbles on the
DNA, as the same promoter is successively used by
RNA polymerases to initiate transcription. This work
shows that DNA micromanipulation is a robust
methodology for the study of a broad range of protein-
DNA interactions, and in particular those involved in
transcription initiation. In principle, processes such as
the origin of replication could also be studied using
this technique. In the future, we will combine this
micromanipulation technique with single-molecule
fluorescence detection in order to measure protein
conformational changes in parallel with our measure-
ments on DNA topology.
DNA Compaction by
SMC Proteins
T. Kawaguchi, M. Hirano, T. Hirano, T. Stick
A third project we have been pursuing involves the
study of DNA compaction by the SMC proteins such
as Bacillus subtilis SMC and Xenopus laevis con-
densin complex. Using DNA micromanipulation, we
are able to observe progressive compaction of the mol-
ecule upon addition of purified X laevis condensin
and ATP. Discrete and transient changes in DNA
extension are observed at low protein concentration
and correspond to the association and dissociation of
single condensin complexes from DNA. From these
experiments, we can estimate the step-size of DNA
compaction as well as the dynamics of the process. We
are currently working to understand the role of DNA
supercoiling in this compaction.
In Press
Revyakin A., Ebright R.H., Allemand J. -F., Croquette V. and
Stick T.R. 2003. Single-molecule DNA nanomanipulation:
Detection of promoter melting events by RNA polymerase.
Methods Enzymol. (in press).
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
Just four years ago, in September 1998, Cold Spring Harbor Laboratory received accreditation from
New York State to grant the Ph.D. degree and the Watson School of Biological Sciences was found-
ed. In August of this year, the fourth class of Watson School students matriculated, bringing a full
cohort of students for the Watson School's four-year Ph.D. program. The School now has 26 students
from across the country and around the world. Indeed, except for Antarctica, all of the continents are
represented in our student body! The international flavor of the student body reflects the long-stand-
ing tradition of Cold Spring Harbor Laboratory as an international center of excellence in the biological
sciences.
These first years of the Watson School have been exciting indeed. Its innovative doctoral curricu-
lum has taken hold and is rapidly achieving success owing in large part to the high quality of the stu-
dents and to the dedication of students and faculty alike to the success of the program. Other estab-
lished programs under the auspices of the Watson School-the Nature Study Program for young chil-
dren, the Partners for the Future high-school student program, and summer Undergraduate Research
Program-continued to flourish. This year, however, the School could begin to cast its attention
beyond the doctoral and established programs and focus as well on establishing a program for post-
doctoral research and education.
A Postdoctoral Program
Across our nation, postdoctoral education in the biomedical sciences is receiving much well-deserved
attention. Cold Spring Harbor Laboratory is no exception. This year saw important progress in this
regard. A postdoctoral working group, chaired by Lilian Gann and consisting of faculty (Zachary
Mainen, Nicholas Tonks, and Linda Van Aelst), postdoctoral fellows (Frances Hannon, Alyson Kass-
Eisler, Michael Packer, and Karen Zito), and the Laboratory Research Administrator Denise Roberts,
completed its mission by summarizing the results of a survey of postdoctoral fellows and, together with
me, prepared a series of recommendations to the Laboratory Director, Bruce Stillman, to enhance the
postdoctoral experience at the Laboratory. Bruce Stillman was enthusiastic about the set of recom-
mendations and he invited the entire postdoctoral community for an open discussion on the postdoc-
toral experience at the Laboratory. This meeting, in which there was a free-flowing exchange of ideas
and opinions, represented the first of what will become an annual event, sponsored by the Watson
School, to promote communication between the postdoctoral community and the Director.
A Postdoctoral Program Office
A major result of the postdoctoral working group's efforts and recommendations will be the establish-
ment in 2003 of a formal postdoctoral program guided by Nicholas Tonks and Associate Dean Lilian
Gann. With Bruce Stillman's encouragement and financial support, a postdoctoral program office will
be established with the appointment of Alyson Kass-Eisler as postdoctoral program officer. As one of
the postdoctoral representatives in the postdoctoral working group, Alyson has a firsthand awareness
of the complex issues pertaining to postdoctoral education and success. And of course it is pleasing
that she is no stranger to the Laboratory, as she was a postdoctoral fellow here with Carol Greider. I
believe that these continued efforts and new resources for postdoctoral education will serve to improve
the Laboratory's postdoctoral experience, which will aid in the recruitment of the best postdoctoral fel-
lows to the Laboratory, who continue to represent the largest element of the Laboratory's research.
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Postdoctoral program office members Lilian Gann, Nicholas Tonks, and Alyson Kass-Eisler
The Curriculum
The Watson School's Ph.D. curriculum continues to grow and develop. Both the spring and fall curric-
ula of the Watson School are described in detail in the course descriptions following this report. Below
are summarized the important new developments in the curriculum.
A New Topics in Biology Course
During the spring term, all Watson School students attend a one-week-long course at the Banbury
Center arranged by Lilian Gann and Jan Witkowski. At these course "retreats," students attend lectures
and seminars, read papers, and participate in discussions from morning till evening. The courses are
an important and highly acclaimed element of the Watson School curriculum as they serve to extend
the students' knowledge of the biological sciences beyond the Laboratory's scope by inviting experts
from outside the Laboratory to teach the courses. Additionally, by having students attend a Topics in
Biology course each year, the School engenders an appreciation that learning is a lifelong endeavor.
With each new arriving class, more students enter the Watson School and it is not possible to have the
intimate level of instruction that the School promotes with just one Topics in Biology course each year.
Thus, this year, for the first time, two different Topics in Biology courses were offered. Hidde Ploegh
from Harvard Medical School, returned to teach the entering class of 2001 his highly acclaimed
Immunology course and Stanley Maloy and Ronald Taylor offered a new course on Microbial
Pathogenesis to the entering classes of 1999 and 2000.
Stan Maloy came from the University of Illinois, Urbana, and Ron Taylor from Dartmouth Medical
School to teach the course. The course and its instructors were extremely well-received, and the
instructors were likewise very impressed by the quality of the students. The instructors implemented a
number of novel didactic elements including daily "one-minute" quizzes in which students were posed
a question, permitted five minutes to discuss the issue with their fellow students, and then given one
minute to provide a written answer. The answers were then submitted for evaluation by the instructors
and discussed together in class. These quizzes provided an easy and effective mechanism to evaluate
the students performance in the course without requiring additional work by the students after the end
of the one-week course. Although some students at the start of the week were not eager to take time
away from their research to learn about microbial pathogenesis, by the end of the course, the students
were unanimous in their enthusiasm for the time they spent in the course and how much they learned-
a true compliment to the instructors. The instructors returned the compliment by noting that "this is the
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Stan Maloy conversing with Rebecca Ewald of the Watson School and Anna Lena Chabes
from Umea University in Sweden.
best group of graduate students we have seen at any institution we have visited in the United States
and abroad."
An Intensive Fall-Term Curriculum
The School continued to benefit from faculty commitment to didactic instruction of the students. This
year, the same set of three Specialized Discipline courses-The Genome, Systems Neuroscience, and
Cellular Structure and Function-were offered as in 2001. This conservation of courses permitted the
instructors to improve upon each one by virtue of experience. The Scientific Reasoning and Logic
course-the School's flagship core course-saw new leadership with Gregory Hannon taking over the
reins from Scott Lowe as lead instructor and was joined by Hollis Cline and Senthil Muthuswamy as
new instructors. We are indebted to founding course instructors Grigori Enikolopov and Scott Lowe
who rotated off the course. I feel confident that we
will be able to rely on their continued input in the 17
future.
The Scientific Exposition and Ethics core
course-an innovative course that melds student
instruction in communication and ethics-contin-
ued to benefit from William Tansey's leadership.
Together with the other course instructors-
Adrian Krainer and Jan Witkowski-Bill is prepar-
ing a book based on the course to be published
by the Cold Spring Harbor Laboratory Press. This
development will go a long way toward one of the
Watson School's goals of influencing graduate
education beyond the confines of the Watson
School itself.
By the end of the intensive Fall-Term .itithaft
Curriculum, the newly entering students had
made great strides in acquiring the tools to
become scholars in the biological sciences.
Watson School students Patrick Paddison (left) and Santanu
Chakraborty.
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DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
ENTERING CLASS OF 1999
Amy Anne Caudy
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Michelle Lynn Cilia
William R. Miller Fellow
Ahmet M. Den li
David Koch Fellow
Emiliano M. Rial Verde
David and Fanny Luke Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Elizabeth Ellen Thomas
Farish-Gerry Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Niraj H. To lia
Leslie C. Quick, Jr Fellow
ENTERING CLASS OF 2000
Santanu Chakraborty
George A. and Marjorie H. Anderson Fellow
Elena S. Ejkova
Engelhom Scholar
Rebecca C. Ewald
Engelhom Scholar
Ira Hall
Beckman Graduate Student
Zachary Bela Lippman
Beckman Graduate Student
Marco Mangone
Charles A. Dana Foundation Fellow
Masafumi Muratani
George A. and Marjorie H. Anderson Fellow
Patrick J. Paddison
Beckman Graduate Student
ENTERING CLASS OF 2001
Catherine Y. Cormier
Beckman Graduate Student
Claudia E. Feierstein
George A. and Marjorie H. Anderson Fellow
Tomas Hromadka
Engelhorn Scholar
Charles D. Kopec
Lindsay-Goldberg Fellow
Ji-Joon Song
Bristol-Myers Squibb Fellow
Dougal G.R. (Gowan) Tervo
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Hollis Cline Gregory Hannon The biological function of RNA interference
Nouria Hernandez
Adrian R. Krainer
Jan A. Witkowski
William Tansey
David Helfman
Michael Wigler
Jan A. Witkowski
Bruce Stillman
Alexander A.F. Gann
William Tansey
Linda Van Aelst
Nouria Hernandez
Adrian R. Krainer
David J. Stewart
Linda Van Aelst
William Tansey
Anthony Zador
Scott Lowe
Carlos D. Brody
David Jackson
Gregory Hannon
Hollis Cline
Mechanisms of intercellular trafficking via
plasmodesmata
Biochemical analysis of RNA-induced gene
silencing
Arc role in synaptic function
Michael Wigler A de novo approach to identifying repetitive
elements in genomic sequences
Leemor Joshua-Tor Structural analysis of a malarial surface antigen
Carlos D. Brody
William Tansey
Hollis Cline
Shiv Grewal
Robert Martienssen
Winship Herr
William Tansey
Gregory Hannon
Yuri Lazebnik
Zachary Mainen
Anthony Zador
Roberto Malinow
Mechanisms of robust short-term memory in
biological networks
Role of the proteasome in transcription
NMDA receptor trafficking and its impact on
neuronal functionality and morphology
Initiation, assembly, transfer, and genome-wide
distribution of heterochromatin in Schizo-
saccharomyces pombe
Comprehensive analysis of chromatin status
on Arabidopsis chromosome 4
The role of HCF-1 in cell proliferation
Gene regulation by ubiquitin-mediated
proteolysis
An RNAi-based screen in mouse embryo fibro-
blasts for transformation-lethal gene targets
Caspase activation in unidentified apoptotic
pathways
Odor coding and neural correlates of behavioral
choice in the olfactory cortex
Stimulus optimization in the auditory cortex
Mapping the trafficking of AMPA receptors in
dendritic compartments
Leemor Joshua-Tor Structural studies of RNAi
Karel Svoboda An inducible and reversible lesion of the
corticothalmic projection
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Students Progress toward a Four-Year Ph.D. Degree with Research Successes
The students who matriculated in the first three classes-1999, 2000, and 2001-all progressed well
throughout the course of the year. The students in the entering class of 2001 all passed the qualifying
exam, selected research mentors, and as the year ended had prepared thorough descriptions of their
proposed doctoral research (see box). These students were
joined by 13 other students from Stony Brook University, who
began their doctoral research at Cold Spring Harbor Laboratory
this year.
A founding principle of the Watson School is that a Ph.D.
degree need not take longer than on average four years. A ques-
tion that has been posed by many is whether such an accelerat-
ed program can permit students the time to participate in serious
research contributions. I am pleased to report that this year
served as proof that this is indeed possible as demonstrated by
the third- and fourth-year students. Fully one-half of the 14 third-
and fourth-year students had already authored a published study
by year's end and many had multiple publications. Additionally,
these publications were in the very best of journals, including
Science (five publications), Proceedings of the National Academy
of Sciences (three), Genes and Development (two), and Nature
(one).
Additionally, third-year student Ira Hall participated in seminal
contributions to the new field of RNA interference, which together with other studies from Cold Spring
Harbor Laboratory and elsewhere, were deemed the "Breakthrough of the Year" by Science Magazine.
The School could not have imagined such stellar successes such as these when it first opened its
doors. The success is made possible by the joined commitment of students, research and academic
mentors, thesis committees, and the School administration. This early success augurs well for stellar
dissertations emanating from the Watson School.
Graduate students from the Hannon lab,
Ahmet Denli (Watson School) and Yvette
Seger (Stony Brook University).
A Fourth Entering Class
This year saw the recruitment of the
Watson School's fourth entering
class, thus completing a full set of
four classes in the School's four-
year Ph.D. degree program. Of this
year's six matriculating students,
three come from the United States
and the rest are from Australia,
England, and Taiwan (see box and
photo). They are from among 200
applicants reviewed by the
Admissions Committee chaired by
Nouria Hernandez and ably assist-
ed by Janet Duffy. Two students,
including Angelique Girard (see
below), to whom we offered admis-
sion deferred the offer to join the
entering class of Fall 2003. Others
who turned down our offer of admission chose to attend the very best schools here and abroad, pro-
viding strong evidence of the high quality of the School's applicants.
Darren Burgess meets the Duke of York
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ENTERING CLASS OF 2002
Allison L. Blum, American University, Washington, D.C.
Barbara McClintock Fellow
Darren J. Burgess, Christ Church, Oxford University, United Kingdom
Engelhom Scholar
Beth L. Chen, Massachusetts Institute of Technology and University
of California, Berkeley
George A. and Marjorie H. Anderson Fellow
Shu-Ling Chiu, National Tsing Hua University, Taiwan
Elisabeth Sloan Livingston Fellow
Jonathan S. Kui, Cornell University, Ithaca, New York
Alfred Hershey Fellow
Elizabeth Murchison, University of Melbourne, Australia
Elisabeth Sloan Livingston Fellow
Standing (left to right): Jonathan Kui, Allison Blum, Darren Burgess
Seated (left to right) Elizabeth Murchison, Beth Chen, Shu-Ling Chiu
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A Successful Capital Campaign is Completed
One of the special features of the Watson School has been the establishment of an endowment com-
mitted to the School. This year saw the completion of the first phase of the Watson School Campaign,
in which, under the direction of the former chairman of the Laboratory Board of Trustees, David Luke
III, $32 million were raised to support the students, faculty efforts, administration, and building renova-
tions for both the School and first-year student housing. As has been commented upon extensively
elsewhere, the School will be forever indebted to David Luke and his colleagues for their generous effort
and support. We are also thankful that Laboratory Trustee Robert Lindsay has agreed to lead the sec-
ond phase of the Watson School Campaign. The goal of the second phase is to raise $15 million in the
form of student fellowships so that the School may continue to grow.
An Endowment Opens Doors
The establishment of a committed endowment for the Watson School has had influences on the School
that extend well beyond providing financial support. First, it has required the students and School
administration to maintain regular contact with the donors to let them know how the students and
School curriculum are developing. This exercise provides the students the opportunity to reflect on their
development in the School and to appreciate that as scientists we are often the beneficiaries of others'
generosity. For the School administration, it has taken much effort to monitor and maintain these con-
tacts. In this regard, Janet Duffy, the Admissions and Academic Records Administrator, has played an
invaluable role. Second, in some instances, the endowment has been provided to initiate specific pro-
grams, as exemplified by the Engelhorn Scholars program, which has become an illustrious program
to support European students in the Watson School.
One of the School's endowed fellowships is the Florence Gould Fellowship, which is dedicated to
the sponsorship of French students in the School. This year saw the appointment of the first Florence
Gould Fellow with the recruitment of AngOlique Girard from the Ecole Polytechnique outside Paris. Ms.
Girard is combining her doctoral studies at the Watson School with a degree from the French Corps
des Mines, a prestigious three-year government program in policy and administration, and she will
begin her doctoral studies in the Watson School in the fall 2003. During the process of recruiting a
Florence Gould Fellow, the School had to learn much about the French educational system. This
process has involved considerable effort, including my visiting the Ecole Norma le Suparieure and Ecole
Polytechnique during the summer, but, combined with the novelty of a four-year Ph.D. program in the
United States, these efforts are likely to result in a source of outstanding students for the Watson
School. These developments would not have come to pass were it not for a School endowment that
arises from diverse sources with likewise diverse wishes.
National Institutes of Health Training Program Established
In the spring 2001, with the encouragement of the School's External Advisory Committee, the Watson
School submitted a proposal for a doctoral training grant to the National Institutes of Health (NIH). As
a result of the review of the proposal and a site visit in the fall 2001, the application was highly recom-
mended for funding and accordingly the School has been awarded support for the training program
from the NIH. The two inaugural appointments to the NIH-sponsored training program are Allison Blum,
who is the Barbara McClintock Fellow, and Jonathan Kui, who is the Alfred Hershey Fellow, from the
entering class of 2002.
A Diverse Doctoral Program
One of the joys of the Watson School is the diversity of its students and faculty who come from differ-
ent backgrounds and different nationalities. An important challenge, however, for the School is to attain
increased diversity by the inclusion of individuals from underrepresented minorities. Success in this
endeavor will enrich the lives and education of our students and address a national agenda. With this
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in mind, it is imperative that the Watson School receive effective advice from as many sources possi-
ble. Thus, at Lilian Gann's instigation, the Watson School has established a working group composed
of representatives of the different Laboratory educational programs, all of which have an interest in the
inclusion of underrepresented minorities-the Undergraduate Research Program (Leemor Joshua-Tor),
the doctoral (Lilian Gann and Winship Herr) and postdoctoral (David Helfman) programs, Meetings and
Courses (David Stewart), and the Dolan DNA Learning Center (David Mick los). The working group also
includes current or former underrepresented minority students studying at the Laboratory to provide
advice: two Stony Brook University students (Michelle Juarez and Hazeem Okunola) and Gilbert (Lee)
Henry, a former student of the Undergraduate Research Program. Lee performed his doctoral studies
with Doug Melton at Harvard University (before we had a doctoral program to offer!) and is now a Cold
Spring Harbor Laboratory Fellow-an independent postdoctoral fellow position.
We are also obtaining advice from outside our institution. and in this regard the School's External
Advisory Committee has been an important resource. Indeed, as described further below, this year the
School recruited Victor Corces, who comes recommended by the NIH for having been successful in
recruiting underrepresented minorities to his doctoral training program at Johns Hopkins University. At
our August External Advisory Committee site visit, Victor, along with the other committee members,
provided invaluable advice and encouragement.
The Watson School is additionally taking active measures to become recognized by students from
underrepresented minorities. This fall, Lilian Gann and I attended the Annual Biomedical Research
Conference for Minority Students in New Orleans. The meeting largely consisted of poster presenta-
tions by undergraduates and booths representing different American educational institutions, as well as
programs dedicated to the sponsorship of underrepresented minority students. Lilian and I had the
pleasure of being "official" judges of student posters. We were both extremely impressed with the qual-
ity of the research and the poise of the students in their research presentations. We also manned a
booth on the last day of the meeting and were very excited to find considerable interest in the Watson
School.
This year, we were also very fortunate to obtain private support for the Watson School endowment
directed to the inclusion of underserved and underrepresented student populations in the School. The
William Randolph Hearst Foundation provided the funds to establish a William Randolph Hearst
Scholarship expressly to support students from underrepresented minorities-another example of how
directed support can help the School achieve its diverse goals.
Mentoring: The Thesis Committee
One of the founding principles of the Watson School is that mentoring is a key component to an effi-
cient and rewarding education. The School's administration and faculty provide one important mentor-
ing process in the form of effective thesis advisory committees. The School's administration ensures
that the students have regular thesis committee meetings, and the committee members have shown
great dedication to making certain that the meetings are rewarding and promote student progress.
Each student meets with his or her committee every six to nine months, and given that each commit-
tee is composed of five faculty members, some coming from outside the institution, arranging the
meetings involves considerable administrative effort, largely shouldered by Lilian Gann. Additionally, the
faculty show immense dedication, often serving on multiple thesis committees. The effort is very much
appreciated by the students, research mentors, and School alike as good sound advice on which ways
to proceed with the research is provided-an important ingredient to a four-year doctoral program. The
results of the thesis committee meetings as well as student progress generally are monitored by the
Watson School's Executive Committee, a dedicated group of School faculty, students, and adminis-
tration.
In speaking to non-Watson School students studying at the Laboratory, from both Stony Brook
University and other institutions, the heavy Watson School emphasis on thesis committee meetings
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and the effort taken by the School administration in arranging the meetings for the students is consid-
ered one of the most attractive features of the School's curriculum. I am indebted to all those involved
for their dedication to this process.
Two-tier Mentoring
As I have described amply in previous reports, I believe that the Watson School academic mentoring
program, led by William Tansey, has had an indelible imprint on the success of the School. In this pro-
gram, entering students select by mutual agreement a member of the research or nonresearch faculty
to serve as an academic mentor-a guardian angel to look over and encourage the student through
the, sometimes trying, process of a doctoral education. This program continues to receive much sup-
port from the faculty who volunteer to be academic mentors. This program has been a vital ingredient
in the Watson School's excellent record in retaining the students who matriculate-none of the Watson
School students has yet chosen not to complete a Ph.D. This year's new academic mentors for the
entering class of 2002 are:
Allison L. Blum Leemor Joshua-Tor
Darren J. Burgess Nicholas Tonks
Beth L. Chen Senthil K. Muthuswamy
Shu-Ling Chiu Alea A. Mills
Jonathan J. Kui David Jackson
Elizabeth Murchison John R. Inglis
A School also Needs Mentoring
A Watson School Executive Committee Dedicated to the Success of the Doctoral Program
To develop a successful curriculum and for it to evolve and improve requires the effort of many people
dedicated to the success of the School. In this regard, the School is most fortunate to have an exec-
utive committee dedicated to excellence. The Watson School Executive Committee meets monthly to
oversee the graduate program and the progress of the students, and to address the wide range of
related issues. The objectives of the committee are to oversee the graduate program including:
the roles of faculty in the program,
the committee for admissions,
the qualifying examinations committee,
graduate student progress in the program,
curriculum development and monitoring,
the welfare of the graduate student community,
advice on ways of enhancing relationships with other graduate programs, and
training grants awarded to the Watson School.
The Executive Committee meetings are characterized by thoughtful and lively discussions of issues
important to the School. Its highly committed members have devoted considerable time and intellec-
tual resources to the program's development, for which I am most grateful. This year, we had the ben-
efit of input from Zachary Lippman of the Watson School and Sabrina Nunez of the Stony Brook
University Genetics Program.
The External Advisory Committee Gains a New Member
In addition to generous financial support, the School has benefited greatly from a distinguished exter-
nal advisory committee for advice on how to achieve the goals of the Watson School. Under Keith
Yamamoto of the University of California at San Francisco, the committee continues to provide sage
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Zachary Lippman educates local school children about plants.
and erudite as well as down-to-earth advice on how to succeed in graduate education in the biologi-
cal sciences. An important element of this program is to include individuals from underrepresented
minority groups in the School's student body. The School has made recruitment of these individuals a
top priority. The School's associate dean, Lilian Gann, is coordinating our efforts in this regard.
Additionally, to replace Shirley Tilghman, who stepped down from the School's external advisory com-
mittee upon becoming president of Princeton University last year, the School recruited Victor Corces
from Johns Hopkins University, who has considerable experience in involving underrepresented minor-
ity students in graduate education.
Dean's Teas
Another important element of monitoring how things are going and providing mentoring to the students
has been regular Dean's Teas that Lilian Gann and I attend. These teas are biweekly in the fall term and
monthly in the spring term for the first-year students and bimonthly for the more senior students. These
teas provide an opportunity for the students to raise common concerns as well as provide Lilian and
me an opportunity to ensure that the students attend to important curricular requirements and their
academic progress.
Quality of Life
In addition to the continuing success of the School's curriculum, much effort was placed this year on
improving the quality of student life at the Laboratory. This effort saw increases in student stipends, a
new housing development at Uplands Farm for students and postdocs, and a shuttle service to the
train station and the Cancer Genome Research Center in Woodbury. Additionally, a program was
developed to help introduce first-year students from Stony Brook University to research at the
Laboratory. These developments were the result of efforts by the Facilities and Human Resources
Departments led by Art Brings and Katie Raftery, respectively, as well as cooperation and encourage-
ment from Lawrence Martin, dean of the graduate school at Stony Brook University, and the leaders of
Stony Brook University graduate programs in the biomedical sciences.
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NEW STUDENTS FROM SHARED STONY BROOK UNIVERSITY GRADUATE PROGRAMS
Student CSHL Research Mentor Program
Alyssa Car lberg Hollis Cline Genetics
Sihem Cheloufi Alea A. Mills Genetics
Yi-Chun Chen David L. Spector Molecular and Cell Biology
Carmine Chiariello Z. Josh Huang Genetics
Ikuko Hotta Greg Hannon Molecular and Cell Biology
Helen Hsieh Roberto Malinow Neurobiology and Behavior
Michael Kwofie Jacek Skowronski Genetics
Alexandra Lucs Senthil K. Muthuswamy Molecular Genetics and Microbiology
Marissa Moore Senthil K. Muthuswamy Genetics
Hazeem Okunola Adrian R. Krainer Physiology and Biophysics
Togay Oztaskin Nouria Hernandez Genetics
Andriy Tovkach Leemor Joshua-Tor Genetics
Hatim Zariwala Zachary Mainen Molecular and Cell Biology
One of the main concerns from students last year was the level of the Watson School stipend, which
was, in and of itself, arguably lower than those of the other institutions with which we compete for stu-
dents (although, unlike Cold Spring Harbor Laboratory, many other institutions do not provide free
health insurance and subsidized food and housing to their students). In response to this challenge, the
School has worked with Stony Brook University to raise graduate student stipends on Long Island. As
a result, student stipends at both institutions continued to increase, with Watson School students
receiving a $21,500 stipend for the 2002-2003 academic year. Additionally, coordinated with Stony
Brook University, students now receive a 10% stipend bonus if they obtain their own independent pre-
doctoral fellowship.
Departures
With each year come new departures. This year saw the following graduate students and postdoctor-
al fellows depart from the Laboratory:
Graduate Students
Sanae Irimura
Flavio Kamenetz
So Young Kim
John McNeil
Postdocs
Isabel Cantallops
Marc Davenne
Jose Esteban
Robert Filipkowski
Jordan Fridman
Anna Giulini
Hirac Gurden
Scott Hammond
Troy Messick
Patrick Reilly
Andrew Samuelson
Jason Stajich
Edward Hofmann
Junjiro Horiuchi
Peter Krasnov
Miguel Maravall
Naoki Nakaya
Michael Packer
Emmanuelle Querido
Jyotishankar Raychaudhuri
Hongjae Sunwoo
Jiayuan Tong
Xiaorong Wang
Zhengwei Zhu
David Roberts
Jose Rodriguez
Aravinthan Samuel
Gurumurthy Shankaranarayana
Maria Soengas
Yuri Stasiv
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Staff Changes
Over the summer, Janet Silver, the Watson School's cheerful first
point of contact, was taken away from us by an offer she could not
refuse. Fortunately, we were able to replace her with Mark Beavers,
our new Administrative Assistant, otherwise the person at the nexus
of the operation. Prior to joining the Watson School staff, Mark was
the Assistant to the Chair at the Department of Music and
Performing Arts Professions at New York University's Steinhardt
School of Education, where he received a Bachelor of Science in
Music Education and Piano Performance in 1989. We have been
very fortunate to recruit such a warm person to help make the
Watson School a comfortable home for its students.
Mark Beavers
Dean Steps Down as Assistant Director
As the School has developed and grown, it has required more effort-not less-to ensure its success.
Early on, the School was simply an idea-or a series of ideas-developed by the Cold Spring Harbor
Laboratory faculty and administration, with advice from outside the Laboratory. Although developing
those ideas took much effort, to implement them and to create the reality of a new school requires con-
siderably more effort from all concerned. Indeed, I have learned that it takes more effort to ensure con-
tinued success than to generate initial success. The School is now at a critical stage with the first
cohort of students expected to graduate next year with the Ph.D. degree. It then will begin to be known
whether scientists of the highest quality can be trained and compete effectively in the scientific com-
munity after just four years of graduate training. I therefore decided to devote every effort possible to
ensuring the success of the Watson School while maintaining a vigorous research program. I am there-
fore very grateful to Bruce Stillman for accepting and supporting my decision to resign as assistant
director of the Laboratory. I look forward to continuing to work closely with Bruce in the upcoming years
for both the Watson School and the Laboratory.
As the New Year begins, it seems most fitting that in this year of the 50th anniversary celebrations
of the discovery of the structure of DNA by James Watson and Francis Crick, the School will also cel-
ebrate by conferring its first Ph.D. degrees.
April, 2003 Winship Herr
202
SPRING CURRICULUM
TOPICS IN BIOLOGY
ARRANGED BY Lilian Gann
Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting
Lectureship; The Fairchild Martindale Visiting Lectureship; The Lucy and
Mark Ptashne Visiting Lectureship; The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer seven-day courses at the Banbury Conference
Center to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory facul-
ty. These courses include morning or evening lectures as well as afternoon sessions during which stu-
dents read assigned papers. These intensive courses are modeled on the Cold Spring Harbor
Laboratory Lecture Courses held each summer at the Banbury Conference Center. In the Spring 2002,
for the first time, there were two such courses: Immunology and Microbial Pathogenesis.
Immunology
Attended by the entering class of 2001
INSTRUCTOR Hidde Ploegh, Harvard Medical School
GUEST LECTURERS Diane Mathis, Jos lin Diabetes Center
Uli von Andrian, Harvard Medical School
TEACHING FELLOWS Margot Furman, Harvard Medical School
Marianne Boes, Harvard Medical School
This course introduced the elements of the immune system, illustrating its unique characteristics as well
as those it shares with other biological systems. The course ran from Sunday to Saturday, February
17-23, and was organized and largely taught by Hidde Ploegh. Two guests-Diane Mathis and Uli von
Andrian-also lectured in the course, and two teaching fellows participated in all aspects of the course.
As in previous years, the course was highly rated by all of the students, including course auditors.
Standing (left to right): Sabrina Nunez,
Claudia Feierstein, -roma§ Hromadka,
Elizabeth Murchison, Hidde Ploegh,
Charles Kopec, Ji-Joon Song, Gowan
Tervo. Seated (left to right): Marianne
Boes, Margot Furman, and Catherine
Cormier, accompanied by Nellie the dog!
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Microbial Pathogenesis
Attended by the entering classes of 1999 and 2000
INSTRUCTORS Stanley Maloy, University of Illinois
Ronald K. Taylor, Dartmouth Medical School
GUEST LECTURERS James Bliska, Stony Brook University
Darren Higgins, Harvard Medical School
Theresa Koehler, University of Texas-Houston Medical School
Karen Skorupski, Dartmouth Medical School
This course focused on mechanisms of microbial pathogenesis and the host response, and the sci-
entific approaches that are used to investigate these mechanisms. How do microbes adhere to host
cells? How do environmental cues direct the response of microbial pathogens? How do microbial
pathogens modulate host cells to expedite virulence? How do host cells respond to microbial
pathogens? How does the host immune system react to microbial pathogens? What does genomics
tells us about how microbial pathogens evolve? How do emerging pathogens take advantage of new
ecological niches? Although there are numerous microbial pathogens, the answers to these questions
indicate that many pathogens use similar approaches to solve common problems.
The course ran from Sunday to Saturday, May 5-11, and was organized and largely taught by
Stanley Maloy and Ronald Taylor. It integrated lectures by the instructors, daily quizzes, readings of
research papers, and seminars by the instructors plus the four invited lecturerS who specialize in vari-
ous aspects of bacterial pathogenesis. The students rated the course very highly, many of whom had
little prior awareness of the subject.
(Left to right) Stan Maloy, Marco Mangone, Emiliano Rial Verde, Elizabeth Thomas, Ira Hall, Rebecca Ewald,
Michelle Cilia, Anna Lena Chabes, Elena Ejkova, Niraj Tolia, Amy Gaudy, Zachary Lippman, Ahmet Den li,
Santanu Chakraborty, Masafumi Muratani, Patrick Paddison, and Ron Taylor.
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Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Mick los
INSTRUCTORS Scott Bronson
Jenny Eisenman
Trisha Maskiell
Amanda Mc Brien
As science plays an increasing role in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory's Dolan DNA Learning Center,
where students teach laboratory courses to high school and middle school students. From these
teaching experiences, they learn how to communicate with nonbiologists and to inspire and educate
creative young minds. The teaching module entailed pairs of students teaching one morning or after-
noon a week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the
Watson School students the didactic process-it was not until the fifth week that the graduate students
taught on their own. At the end of the 12 weeks, the students were very excited about their teaching
experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in
laboratory rotations. These rotations provide students and faculty the opportunity to get to know each
other and to explore possibilities for doctoral thesis research. At the end of each rotation, students
make short presentations of their studies to the other students and their rotation advisors. These talks
give students an opportunity to share their laboratory experiences and to learn how to give a scientific
presentation. With this latter goal in mind, in addition to the research mentors, the instructors of the
Scientific Exposition and Ethics core course attend the talks and give individual feedback to students
on their presentations. This year, 15 faculty members served as rotation mentors, some mentoring
more than one student.
ROTATION MENTORS Carlos D. Brody
David Helfman
Winship Herr
David Jackson
Leemor Joshua-Tor
Yuri Lazebnik
Scott Lowe
Zachary Mainen
Roberto Malinow
Andrew Neuwald
Jacek Skowronski
Lincoln Stein
Karel Svoboda
Tim Tully
Anthony Zador
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FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Beckman Foundation
INSTRUCTORS Gregory Hannon (Lead)
Hollis Cline
Winship Herr
Leemor Joshua-Tor
Senthil K. Muthuswamy
Arne Stenlund
GUEST LECTURERS Alexander A.F. Gann Michael P. Myers
Shiv Grewal Jacek Skowronski
Nouria Hernandez Bruce Stillman
David Jackson William Tansey
Adrian R. Krainer Marja Timmermans
Scott Lowe Tim Tully
Zachary Mainen Linda Van Aelst
Robert Martienssen Rui-Ming Xu
Alea A. Mills
VISITING LECTURER Michael Hengartner, University of Zurich
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the Fall Course Curriculum, students (1) acquired a broad base of knowledge
in the biological sciences, (2) learned the scientific method, and (3) learned how to think critically about
biological concepts. This course consisted of 12 weekly segments, each of which had a different
End of fall term celebratory breakfast. Standing (left to right): Lilian Gann, Elizabeth Murchison, Beth Chen,
Jonathan Kui, Darren Burgess, Allison Blum, and Winship Herr. Front: Shu-Ling Chiu.
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theme. Each week, students read an assigned set of research articles (generally four articles) and pro-
vided written answers to a problem set that guided them through two (or, on occasion, one) of the arti-
cles. Twice weekly, students attended lectures related to the week's topic, which included concepts
and experimental methods. During the week, the students met to discuss the assigned papers not
covered by the problem set among themselves. At the end of each weekly segment, the students sub-
mitted their problem sets and spent the evening discussing with faculty the articles not covered by the
problem set. The course culminated in the thirteenth week with a final exam. Studying for the final exam
gave the students the opportunity to synthesize and integrate what they had learned over the course
of the fall term. The weekly topics were:
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
Week 7
Macromolecular Structure
Genetics
Transcriptional Regulation
Posttranscriptional Regulation
Mobile Genetic Elements
Chromosome Structure and Function
Signal Transduction
Week 8 Cell Division Cycle
Week 9 Cancer Genes
Week 10 Cell-Cell Communication
Week 11 Development
Week 12 Neurobiology
Week 13 Final Exam
The Darrell Core Course on Scientific
Exposition and Ethics
FUNDED IN PART BY The Beckman Foundation
The John P. and Rita M. Cleary Visiting Lectureship
The Seraph Foundation Visiting Lectureship
The Susan T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS William Tansey (Lead)
Adrian R. Krainer
Jan A. Witkowski
GUEST LECTURERS Terri Grodzicker
Winship Herr
VISITING LECTURERS Robert P. Charrow, Esq., Crowell & Moring LLP
Carol Ezzell, Editor and Staff Writer, Scientific American
Jane Maienschein, Ph.D., Department of Philosophy, Arizona State University
Mary Morry, Partner, Morgan & Finnegan, LLP
Philip Reilly, JD, MD, CEO of Interleukin Genetics
This core course offered instruction about the fundamental elements of scientific exposition-writing
skills and public speaking-and ethics. The ability to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of
example-based lectures and discussion groups. This year, the course continued a novel format estab-
lished in 2000 in which the course was organized around the scientific process starting with how the
ideas for an experiment develop and covering execution of the experiment, presentation of the results
at seminars and in publication, funding, and the implications of the experimental results on scientists
and society. As a part of learning how to make oral presentations, together with the instructors, the
students also critiqued formal seminar presentations at the Laboratory. A primary objective of the
course was for students to consider exposition and ethics as an integral part of scientific research.
207
Research Topics
ARRANGED BY Lilian Gann
David Helfman
This core course provided students with an in-depth introduction to the fields of research that the
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, at
which faculty members presented their current research topics and methods of investigation each
Wednesday evening over dinner. The students learned how to approach important problems in biolo-
gy. These seminars, together with the annual fall Laboratory in-house symposium, provided students
with a basis for selecting laboratories in which to do rotations. Due to the increasing number of Faculty
at the Laboratory, this year for the first time the Research Topics seminars were extended into January
2003. The weekly speakers were:
Week 1 Leemor Joshua-Tor, Scott Lowe, Rui-Ming Xu
Week 2 Gregory Hannon, Eli Hatchwell, W. Richard McCombie
Week 3 Nouria Hernandez, Winship Herr, William Tansey
Week 4 Roberto Malinow, Michael P. Myers, Marja Timmermans
Week 5 Hollis Cline, Robert Martienssen, Andrew Neuwald
Week 6 Shiv Grewal, Zachary Mainen, Anthony Zador
Week 7 Carlos D. Brody, Dmitri Chklovskii, Tatsuya Hirano
Week 8 Karel Svoboda, Yi Zhong
Week 9 Grigori Enikolopov, Nicholas Tonks, Linda Van Aelst
Week 10 Jacek Skowronski, Arne Stenlund, Bruce Stillman
Week 11 Yuri Lazebnik, Alea A. Mills, Michael Wig ler
Week 12 David Helfman, Senthil K. Muthuswamy, David L. Spector
Week 13 David Jackson, Lincoln Stein, Jerry Yin
Week 14 Z. Josh Huang, Adrian R. Krainer, Tim Tully
Week 15 Masaaki Hamaguchi, Robert Lucito
Week 16 Josh Dubnau, Vivek Mittal
SPECIALIZED DISCIPLINES COURSES
The Genome
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship; The Pfizer Lectureship;
The George B. Rathmann Lectureship; The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Robert Martienssen
W. Richard McCombie
Lincoln Stein
GUEST LECTURERS Eli Hatchwell
Andrew Neuwald
Tim Tully
Jan A. Witkowski
VISITING LECTURER Marc Vidal, Harvard Medical School
The first draft of the human genome sequence has been completed, and the new science of genomics
promises to revolutionize biological concepts and approaches, making the computer a tool for research
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as essential as the microcentrifuge and electrophoresis unit. With computer software, scientists can
digest the enormous amount of genetic information produced by the genome project and answer ques-
tions about evolution, model complex processes such as signal transduction and gene regulation, and
manage and organize experiments.
This course provided essential background as to how sequence and mapping information is gen-
erated and interpreted, the principles of microarray and other functional strategies, and the history of
the genome project. It also provided a practical introduction to bioinformatics, including computation-
al biology, biological data modeling, and laboratory workflow management. Topics covered included
genetic and physical mapping, DNA sequence acquisition and interpretation, Web-based resources for
genome data, gene modeling and protein- and DNA-sequence analysis, phylogenetic analysis, and
functional genomics.
Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship; The Klingenstein Lectureship;
The William Stamps Farrish Lectureship
INSTRUCTORS Carlos D. Brody
Zachary Mainen
Anthony Zador
GUEST LECTURERS Hollis Cline
Roberto Malinow
Cognition and behavior arise from complex interactions between billions of neurons. This systems neu-
roscience course examined fundamental properties of neurons, including synaptic transmission and
plasticity, and how in higher-order organization they give rise to brain functions such as visual percep-
tion.
Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship; The Sigi Ziering Lectureship;
The Martha F. Gerry Visiting Lectureship
INSTRUCTORS David Helfman
David L Spector
GUEST LECTURERS Tatsuya Hirano
Yuri Lazebnik
VISITING LECTURERS Fred Chang, Columbia University
Graham Warren, Yale University
With the complete set of instructions available for many organisms-i.e., their genome sequence-
there is now an increasing emphasis on understanding the function of the gene products. This under-
standing will require an increasing appreciation of the structure and function of the cell. This course
provided a basic overview of the structural and functional organization of cells with particular empha-
sis on cellular compartmentalization and communication. In addition, it provided insight into the basic
toolbox of the cell biologist of the twenty-first century.
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UNDERGRADUATE RESEARCH PROGRAM
Program Director: Leemor Joshua-Tor
Associate Program Director: Gregory Hannon
Program Administrator: Jane Reader
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time faculty members. Since
the program was initiated in 1959, 604 students have participated, and many have gone on to pro-
ductive careers in the biological sciences.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, molecular, cellular, and structural
biology, neuroscience and genomics; and (4) a personal acquaintance with research, research work-
ers, and centers for study.
Left to Right: (Front row) Hiroki Asari, Gautam Agarwal.
(Second row) Sarah Whitcomb, Rachel Kalmar, Erin Kurten, Honor Hsin, Boo Shan Tseng, Grace Teng, Daniel
Herman, Cindy Lee, Marisa Rodriguez, Jonathan Hertz, Jacqueline Ou.
(Third row) Anna Belkina, Lieven van der Veken, Vishal Patel.
(Back row) Thomas Denkenberger, Jamie Newman, Michalis Agathocleous, Cory Lindsay, Winfred Frazier, Sherry
Aw, Renatta Knox.
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During the program, the students are housed together on the Laboratory grounds. Nearly all of the students arrive
at the same time and share the entire experience. For programmatic reasons, we limit the number of students to 25.
In this manner, we ensure a cohesive program with substantial scientific and social interactions among the students.
The students are required, at the beginning of the program, to present to their peers a concise oral description of the
background and the design of their experiments. At the end of the ten-week program, the undergraduates present a
20-30-minute seminar describing the background, design, and results of the experiments they have been involved in
during the course of a two-day undergraduate symposium. During their stay, the participants attend a series of Faculty
Talks given by both young and established scientists at the Laboratory. These seminars are attended by only the stu-
dents and Program Directors to assure that the seminars remain at a level appropriate for the undergraduates. It also
encourages questions in an informal and comfortable setting. In addition to scientific discussion, these presentations
cover important issues such as personal experiences and choices that led the scientists to their current area of
research and position. The following students, selected from 443 applicants, took part in the 2002 program:
Gautam Agarwal, University of Texas
Advisor: Zachary Mainen
Sponsor: Burroughs Wellcome
Modeling odor recognition by neural synchrony.
Michalis Agathocleous, Trinity College
Advisor: Hollis Cline
Sponsor: Burroughs Wellcome
CPG expression changes tyrosine phosphorylation
in vivo.
Hiroki Asari, University of Tokyo
Advisor: Masaaki Hamaguchi
Sponsor: The Emanuel Ax Fund
Suppression of DBC2 by RNA interference.
Sherry Aw, University of Wisconsin
Advisor: David Jackson
Sponsor: Burroughs Wellcome
Protein trafficking via plasmodesmata in Arabidopsis
thaliana.
Anna Belkina, Russian State Medical University
Advisor: David Helfman
Sponsor: The Read Fund
Characterization of S100A4 function.
Thomas Denkenberger, Penn State University
Advisor: Arne Stenlund
Sponsor: Burroughs Wellcome
Studies of the bovine papillomavirus El helicase.
Winfred Frazier, University of Houston
Advisor: Senthil K. Muthuswamy
Sponsor: National Science Foundation
Phenotypic consequences of activating ErbB2 receptor
mutants in epithelial cells.
Daniel Herman, Massachusetts Institute of Technology
Advisor: Grisha Enikolopov
Sponsor: Burroughs Wellcome
Characterization of noxinl function using hairpin RNA interfer-
ence.
Jonathan Hertz, Massachusetts Institute of Technology
Advisor: Z. Josh Huang
Sponsor: Glass Fund
Subcellular localization of protocadherins in GABAergic
interneurons and their role in synaptic plasticity.
Honor Hsin, Harvard University
Advisor: Roberto Malinow
Sponsor: Jephson Educational Trust
Neurons ReAsHed: Imaging a molecular model of memory.
Rachel Kalmar, University of California, San Diego
Advisor: Anthony Zador
Sponsor: National Science Foundation
How does the auditory cortex encode complex sound?
Renatta Knox, Harvard University
Advisor: David L Spector
Sponsor: National Science Foundation
Visualizing UAP56 in living cells.
Erin Kurten, University of Wisconsin
Advisor: William Tansey
Sponsor: National Science Foundation
Developing tools to study interactions between the protea-
some and Med 8.
Cindy Lee, Stony Brook University
Advisor: Jerry Yin
Sponsor: Jephson Educational Trust
Molecular mechanism of atypical PKM regulation.
Cory Lindsay, Wayne State College
Advisor: Eli Hatchwell
Sponsor: Libby Fund
A common microdeletion at 8q24.3: Population frequency
analysis.
Jamie Newman, Amherst College
Advisor: Yuri Lazebnik
Sponsor: Olney Fund
Can Primus regulate apoptosis?
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Jacqueline Ou, Duke University
Advisor: Michael Q. Zhang
Sponsor: National Science Foundation
Toward genome-wide first exon annotation: Computational
prediction and experimental protocol.
Fatih Ozsolak, Washington University
Advisor: Rob Lucito
Sponsor: Burroughs Wellcome
Gene copy number changes in breast and prostate cancers.
Vishal Patel, University of Illinois
Advisor: Leemor Joshua-Tor
Sponsor: Garfield Fund
Expression, purification, and crystallization trials of candidate
plasticity gene 15.
Marisa Rodriguez, University of Houston
Advisor: Alea A. Mills
Sponsor: National Science Foundation
Using chromosome engineering to study functional genomics.
Grace Teng, Yale University
Advisor: Robert Martienssen
Sponsor: Bliss Fund
Analysis of Schizosaccharomyces pombe centromeric
transcripts.
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Boo Shan Tseng, Massachusetts Institute of Technology
Advisor: Winship Herr
Sponsor: National Science Foundation
Life without HCF-1: A way to create Siamese cells.
Lieven van der Veken, Leuven University
Host: Linda van Aelst
Sponsor: Frederica van Stade Fund
Molecular and cellular characterization of oligophrenin and
potential partners.
Sarah Whitcomb, Columbia University
Advisor: Gregory Hannon
Sponsor: Shakespear Fund
Attempting to assay RNA-dependent RNA-polymerase
activity of a putative RdRp from Schizosaccharomyces
pombe.
Elisabeth Wurtmann, Carleton College
Advisor: Marja Timmermans
Sponsor: National Science Foundation
Regulation of knox genes by rough sheath2 in maize leaf
initiation.
PARTNERS FOR THE FUTURE
Program Director: Yuri Lazebnik
Program Administrator: Lynn Hardin
The CSHL Partners for the Future program, established in 1990, gives young students who are inter-
ested in science an opportunity to do real biomedical research. Each year, six to eight Long Island high
school students entering their senior year are chosen on the basis of a written application and an inter-
view. Selected students are assigned to scientists at CSHL who become their mentors and supervise
their research, which usually continues from October through March. During the six months of the pro-
gram, students give several scientific presentations, including one to describe a plan of research and
another to report how research is progressing. At the conclusion of the program, students present the
results of their research projects to an audience of scientific mentors, high school teachers, friends, and
relatives. Participants in the program frequently credit it for the first spark of their scientific imagination.
To date, 68 students have completed the program, all of whom have enrolled in top-ranked colleges
or universities. The 2002-2003 Partners for the Future are:
Partner High School CSHL Mentor Laboratory
Kristen Aliano Cold Spring Harbor High School Michelle Cilia David Jackson
Brandon Buckley Cold Spring Harbor High School Eric Drier Jerry Yin
Andrew Chang Jericho High School Ravi Sachidanandam Ravi Sachidanandam
Adam Graver Friends Academy Michael Regulski Tim Tully
Marie Mizuno Cold Spring Harbor High School Dom Duelli Yuri Lazebnik
Jonathan Lee Mogen Half Hollow Hills High School West Frances Hannan Jerry Yin
Theresa Reimels St. Dominic High School Anindya Bagchi Alea A. Mills
Jonathan Widawsky Huntington High School Eli Hatchwell Eli Hatchwell
(From left to right) Jonathan Widawsky, Adam Graver, Marie Mizuno, Brandon Buckley, Theresa Reimels,
Kristen Aliano, Jonathan Mogen, and Andrew Chang.
213
NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to acquire
a greater knowledge and understanding of their environment. Through a series of specialized field
courses, younger students can engage in introductory programs such as Nature Bugs, Nature
Detectives, and Nature Discovery, and older students can enroll in more advanced programs such as
Marine Biology.
During the summer of 2002, students participated in 24 courses within the program. The major
change to the program this year was the location. Instead of holding classes at the West Side School in
Laurel Hollow, the classes were held outdoors, weather permitting, at Southdown School in Huntington.
This facility is used as a base for the students' exploration
of the local environment. Continuation of the program in its
present location would be beneficial but this is yet to be
determined. Field classes are held on Laboratory grounds,
St. John's Preserve, Fire Island National Seashore, the
Nature Conservancy, the Cold Spring Harbor Fish Hatchery
and Aquarium, as well as other local preserves and sanctu-
aries.
In addition to the three, two-week sessions, the
Adventure Education course met on July 26, 2002, for a
six-mile canoe trip on the Nissequogue River in Smithtown
to navigate and explore the waters of Long Island. The
course emphasizes the plant and animal life indigenous to
the area as well as historic points of interest.
PROGRAM DIRECTOR: William M. Payoski, MA., Adjunct Professor, Nassau Community College
REGISTRAR: Sharon Bense, Cold Spring Harbor Laboratory
INSTRUCTORS: Alison Smith, B.S., Marine Science, University of Rhode Island
Michael Zarzicki, B.A. in English, Ade 1phi University
Amy Friedank, B.S. in Marine Science, Long Island University, Southampton
Jessica Badalucco, B.S. in Biology, Ade 1phi University
Ann Marie LaRuffa, B.A in Natural Science, Ade 1phi University
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COURSES
Nature Bugs (Kindergarten): Exploration, games, stories, and dramatics are used to introduce the young child to
a variety of natural habitats.
Nature Detectives (Grades 1-2): An introductory course in nature study, stressing interrelationships between
plants and animals. A variety of habitats are explored.
Nature Discovery (Grades 1-2): Students continue their discovery of nature through activities and concepts.
Ecology Explorers (Grades 3-4): Natural communities, food webs, and a succession of communities are studied in
this course. Students study the diversity of plant and animal forms native to the Cold Spring Harbor Laboratory area.
Pebble Pups (Grades 3-4): Elementary geology for students interested in a basic study of rocks and minerals
available on Long Island. Each student completes a rock and mineral collection. Dinosaurs and fossils are featured
themes. Some of the highlights of this course include field trips to local museums.
Frogs, Flippers, and Fins (Grades 3-4): Program designed for younger students as an introduction to aquatic
ecosystems. Fresh water and marine habitats are explored.
Seashore Life (Grades 5-7): Children examine plant and animal life found below the tidemark. Fish, marine
worms, algae, shellfish, beach plants, and shore birds are studied.
Freshwater Life (Grades 5-7): Students consider the vertebrate, invertebrate, and plant life found in area bogs,
ponds, lakes, and streams.
Adventure Education (Grades 6-10): This course is a 6-mile canoe trip up and down the Nissequogue River
exploring the flora and fauna of the waterway.
Marine Biology (Grades 8-10): This course offers a more sophisticated study of plants and animals native to the
inner and outer harbors and provides field trips, dissection, using the microscope, and laboratory experiments.
f
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ACADEMIC AFFAIRS
The academic program of meetings and courses has evolved from a group of summer laboratory
courses and the annual symposium to a diversified year-round effort. It now includes advanced labo-
ratory courses, summer lecture and workshop courses held at the Laboratory's Banbury Center, large
meetings and winter biotechnology conferences held in Grace Auditorium, short bioinformatics cours-
es at Woodbury, and even off-campus meetings. Scientists ranging from graduate students to senior
faculty participate in the program.
The 27 laboratory and lecture courses held in 2002 covered a diverse array of topics in molecular
biology, neurobiology, structural studies, and bioinformatics. The primary aim of these courses remains
to teach students the latest advances in techniques and concepts that can be immediately applied to
the students' own research. New courses are always being started to reflect current needs and exist-
ing courses are updated by the instructors. This year, a laboratory course on Proteomics was begun,
as well as a new lecture course on Stem Cells. Both proved to be immensely popular, were heavily
oversubscribed, and will be taught again in future years. The Advanced Bacterial Genetics course, now
more than 50 years old, has taken advantage of the knowledge of the genome sequence of many
organisms to teach genetic analysis of pathogenic and "undomesticated" bacteria. Similarly, the
Eukaryotic Gene Expression course now teaches students sophisticated in vivo methods, such as
chromatin immunoprecipitation analysis, and has devised a plan for the use of RNA interference to
make mutations in mammalian cells. Additionally, a new short course covering introductory bioinfor-
matics, the Genome Access course, was initiated at the Genome Research Center.
Instructors, course assistants, and course lecturers come from universities, medical schools,
research institutes, and companies around the world to teach at Cold Spring Harbor. Their extraordi-
nary enterprise and dedication make the course program possible. The full program of 2002 courses
and instructors are listed below.
Courses are supported by grants from a variety of sources, including multiple grants from the
National Institutes of Health and National Science Foundation. We also depend on a large education
grant from the Howard Hughes Medical Institute for the support of new courses and neurobiology
courses and are grateful for the support of a neurobiology course grant from the Esther and Joseph A.
Klingenstein Fund. Funds from the John Merck Fund and the Eppley Foundation have also supported
neurobiology lecture courses at the Banbury Center. The courses also depend on equipment and
reagents loaned or donated by a large number of vendors, without which the faculty and students
would not have access to the latest techniques and technology.
Twenty meetings were held at the laboratory this year and brought almost 6000 scientists from more
than 50 countries to discuss their latest research findings. Almost all of the meetings have no-or very
few-"pre-invited" speakers. Talks are selected from submitted abstracts by the meeting organizers.
This format ensures that the latest findings will be presented and that young scientists will have a
chance to describe and discuss their work. The regular meeting season started with a conference on
the Evolution of Developmental Diversity and finished with one on Human Origins and Disease. Several
of the meetings were oversubscribed including those on Genome Sequencing and Biology
Retroviruses, Translational Control, and Axon Guidance and Neural Plasticity. Many of the meetings
have become exciting and essential for their respective fields and are held on a biannual basis. This
year, three winter biotechnology conferences, including a new conference on Tissue Engineering, were
held outside of the regular meetings schedule. In a new initiative, archived streaming videos of the oral
sessions of each meeting were made available to meeting attendees on a short-term basis via a pri-
vate web portal called The Leading Strand. The limited access period of the Web Site is designed to
prevent the material from being considered as competitive with publications. Partial support for indi-
vidual meetings is provided by federal agencies, foundations, and companies, while core support for
the program is provided by our Corporate Benefactors, Sponsors, Affiliates, and Contributors.
The Symposium continues to be the centerpiece of the meetings program. This year, the topic was
The Cardiovascular System. The Symposium addressed many aspects of cardiovascular science
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including normal heart and cardiovascular development and function, the failing heart, hypertension,
atherosclerosis, vascular biology, angiogenesis, and tumor angiogenesis. The Symposium attracted
256 participants and featured 68 talks and 108 posters. Opening night speakers included Richard
Harvey, Mark Fishman, Jonathan Seidman, and Rakesh Jain, and the summary was presented by
Christine Seidman. Richard Lifton delivered the Dorcas Cummings lecture on "Salt and Blood Pressure:
New Insights from Human Genetic Studies" to a mixed audience of scientists and lay friends of the
Laboratory.
The success of the very large number of courses and meetings is also due to the skilled work of
many Cold Spring Harbor staff and faculty who contribute their expertise, efforts, and good humor to
the program. They include Drew Mendelsohn, Associate Director for Marketing and Planning; Andrea
Stephenson, Course Registrar and Operations Manager; Ed Campodonico, Manager of Audiovisual
Services; Barbara Zane, the Course Coordinator; and Mary Smith, the Abstracts Coordinator. The staff
of the Meetings and Courses office also include Joe Carrieri, Andrea Newell, Maureen Morrow, Val
Pakaluk, Lauren Postyn, Marge Stellabotte, Jenna Williams, and various part-time staff. Audiovisual
services under Ed Campodonico's management are ably provided by William Dickerson, Gerald
McCloskey, John Parsons, and the part-time audiovisual staff. In the latter part of 2001, Michael
Cannavarro transferred from the Information Technology Department to the Meetings and Courses pro-
grams because computer support for all of the courses and meetings has become a full-time occupa-
tion. Staff from several other departments also do crucial work for the courses and meetings. They
include: Wendy Crowley, the Educational Grants Manager; Cliff Sutkevitch and his staff, who set up and
maintain course equipment; and Leigh Johnson in the Library, who handles the book and journal needs
of the courses. 2002 saw the departure of two valuable staff members, Michael Glaessgen and Nancy
Weeks, to new pastures. We are grateful to them all.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Executive Director, Meetings and Courses
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67TH COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
The Cardiovascular System
May 29-June 3 257 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
David Stewart, Cold Spring Harbor Laboratory
It has been unusual to hold the Cold Spring Harbor Symposium on Quantitiative Biology on a topic
devoted to a single organ. One notable exception was the successful Symposium in 1990 on the brain,
in part to mark President Bush's proclamation of the 1990s being the decade of the brain and also to
mark the beginning of the current Cold Spring Harbor initiative in neuroscience. There has been no
such presidential pronouncement about the heart, and Cold Spring Harbor has not focused its own
research on the cardiovascular system, but there have been remarkable developments in molecular
understanding of the cardiovascular system over the last decade. It seemed only fitting, therefore, that
this year's Symposium focus on such an important biological system.
Development of the cardiovascular system during embryogenesis has appropriately been a major
area of research, particularly the patterning that forms the branches of the peripheral blood and lym-
phatic systems and development of the heart itself. Developmental biologists now have a good gen-
eral understanding of how the system comes about. Equally important has been the focus on signal-
ing pathways that function in the cardiovascular system to maintain its function. Perhaps most impor-
tant is the relevance of this topic to human disease. The cardiovascular system remains a major focus
of research and efforts to tame the western world's most common cause of death. Thus, in planning
this Symposium, appropriate attention was paid to the various aspects of disease in the cardiovascu-
lar system.
Help in organizing this Symposium came form many sources, particularly my co-organizer David
Stewart, Executive Director of our Meetings and Courses program, who played a key role in identify-
ing speakers and topics for this Symposium. I wish to thank Shaun Coughlin, Richard Litton, Eric
Olson, Christine Seidman, Celeste Simon, and Sandy Williams for their generous advice about a field
whose details were rather foreign to me.
The meeting ran for five days and included 257
participants with 108 oral presentations and 68
poster presentations. I wish to thank Dr. Richard
Litton for his superb presentation at the Dorcas
Cummings Memorial public lecture of the genetics of
hypertension, an example of how the human genome
project is having a large impact on understanding
human disease. I also wish to thank the first-night
speakers, Drs. Richard Harvey, Mark Fishman,
Jonathan Seidman, and Rakesh Jain, for their superb
overview presentations, and I particularly thank Dr.
Christine Seidman for agreeing to summarize the
Meeting.
Essential funds to run this meeting were obtained
from the National Cancer Institute, a branch of the
National Institutes of Health. In addition, financial help
R. Lifton, Dorcas Cummings Lecture
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from the corporate benefactors, sponsors, affiliates, and contributors of our meetings program is
essential for these Symposia to remain a success and we are most grateful for their continued sup-
port. Corporate Benefactors: Aventis Pharma AG; Bristol-Myers Squibb Company; Eli Lilly and
Company; GlaxoSmithKline; Novartis Pharma AG; Pfizer Inc. Corporate Sponsors: Abbott
Laboratories; Amgen Inc.; Amersham Biosciences, Inc.; Applied Biosystems; AstraZeneca;
BioVentures, Inc.; Chugai Pharmaceutical Co., Ltd.; Cogene BioTech Ventures, Ltd.; Diagnostic
Products Corporation; Forest Laboratories, Inc.; Genentech, Inc.; Hoffmann-La Roche Inc.; Johnson
& Johnson Pharmaceutical Research & Development, LLC; Kyowa Hakko Kogyo Co., Ltd.; Merck
Research Laboratories; New England Biolabs, Inc.; OSI Pharmaceuticals, Inc.; Pall Corporation;
Pharmacia Corporation; Res Gen, Inc.; Schering-Plough Research Institute; Wyeth Genetics Institute.
Plant Corporate Associates: Mead Westvaco Corporation; Monsanto Company; Pioneer Hi-Bred
International, Inc. Corporate Affiliates: Affymetrix, Inc.; Ceptyr, Inc. Corporate Contributors: Biogen,
Inc.; EpiCentre Technology.; Immuno-Rx, Inc.; Integrated DNA Technologies, Inc.; Invitrogen;
Key Gene; Lexicon Genetics, Inc.; Prolinx, Inc.; Qbiogene; ZymoGenetics, Inc. Foundations: Albert B.
Sabin Vaccine Institute, Inc.
B. Stillman, R. Hynes, C. Seidman,
R. Benezra
R. Harvey, P. Krieg, M. Nemer
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R. Hynes, D. Stewart
PROGRAM
Introduction
Chairperson: C. Simon, University of Pennsylvania School of
Medicine, Philadelphia
Angiogenesis and Lymphangiogenesis
Chairperson: E. Olson, University of Texas Southwest
Medical Center Dallas
Early Cardiogenesis
Chairperson: M. Rupnick, Brigham and Women's Hospital,
Harvard Medical School, Boston, Massachusetts
Congenital Heart Disease and the Failing Heart
Chairperson: P. Krieg, University of Arizona College of
Medicine, Tucson
Reginald G. Harris Lecture: Class II Histone Deacetylases
Act as Signal-responsive Repressors of Cardiac
Hypertrophy and Heart Failure
Speaker: Eric Olson, University of Texas Southwestern
Medical School
Genetics and Genomics of the Heart
Chairperson: E. McNally, University of Chicago, Illinois
Blood Pressure/Atherosclerosis/Lipid Homeostasis
Chairperson: R.S. Williams, Duke University Medical Center
Durham, North Carolina
Cardiovascular Development
Chairperson: R. Pasqualini, University of Texas/M.D.
Anderson Cancer Center, Houston
Vascular Biology
Chairperson: D. Stainier, University of California, San
Francisco
Regulation of the Heart
Chairperson: T. Mohun, National Institute for Medical
Research, London, United Kingdom
Dorcas Cummings Lecture: Salt and Blood Pressure:
New Insights from Human Genetic Studies
Speaker: Richard Lifton, Yale University School of
Medicine
Angiogenesis and Disease
Chairperson: K. Moulton, Children's Hospital, Boston,
Massachusetts
Cardiovascular Repair and Therapy
Chairperson: R. Hynes, Massachusetts Institute of
Technology Cambridge
Summary
Christine Seidman, Harvard Medical School
U. Savla N. Rosenthal
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MEETINGS
Evolution of Developmental Diversity
April 17-21 149 participants
ARRANGED BY Richard Behringer, The University of Texas/M.D. Anderson Cancer Center
Nipam Patel, HHMI/University of Chicago
This first Evolution of Developmental Diversity meeting brought together a diverse group of scientists
from around the world studying various molecular genetic and developmental aspects of animal and
plant biology, with a strong emphasis on morphological and functional comparisons of organismal
diversity and evolution.
The meeting opened with a keynote lecture given by Walter Gehring (Basel) on eye evolution. The
meeting was organized into eight sessions whose topics reflected the most advanced and interesting
areas of study in the evolution and development field, including genetics, the evolution of gene regu-
lation, genomics, axial pattern, segmentation, and regionalization, speciation, and organogenesis.
Each session had three invited talks from senior researchers. Between these more in-depth talks, six
speakers per session were selected from the abstracts for more concise presentations. The meeting
also included the presentation of many posters in two afternoon sessions.
Research utilizing the primary animal and plant model systems to understand developmental mech-
anisms has made great strides over the last few decades, providing a strong molecular and cellular
understanding of conserved developmental pathways. However, it is clear that the very few primary
model organisms are not sufficient to understand the tremendous diversity of animal and plant life on
earth. Understanding the generation of this diversity, honed over eons of evolution, most likely will pro-
vide important insights into the mechanisms that cause organ variation and the evolution of species.
These insights should provide novel information for understanding human health and disease mecha-
nisms. Thus, it is now clear that other animal and plant models must be used to complement studies
utilizing the primary model organisms. This use of diverse organisms to study biological questions was
most evident during the session on Axial Pattern chaired by Nori Satoh (Kyoto) who introduced the
session as nine talks on nine different organisms!
This meeting was funded in part by the National Science Foundation. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
R. Behringer, A. Godwin, R Thummel
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PROGRAM
Genetics I
Chairperson: M. Felix, Institut Jacques Monod, Paris,
France
Evolution of Gene Regulation
Chairperson: S. Carroll, University of Wisconsin, Madison
Genomics
Chairperson: J. Postlethwait, University of Oregon, Eugene
Axial Pattern
Chairperson: N. Satoh, Kyoto University Japan
Segmentation and Regionalization
Chairperson: T. Kaufmann, Indiana University Bloomington
Genetics II
Chairperson: D. Weigel, Salk Institute for Biological Studies,
La Jolla, California
Speciation
Chairperson: C.-I. Wu, University of Chicago, Illinois
Organogenesis: Morphological Innovation
Chairperson: A. Burke, Wesleyan University Middletown,
Connecticut
N. Patel, C. Sackerson, N. King, S. Carroll
L. Pick, U. Schmidt-Ott
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Gene Expression and Signaling in the Immune System
April 24-28 385 participants
ARRANGED BY Richard Flavell, Yale University, New Haven, Connecticut
Rudolf Grosschedl, University of Munich, Institute for Biochemistry and Gene
Center, Munich, Germany
Stephen Smale, HHMI/University of California School of Medicine, Los Angeles
This meeting included eight platform and two poster sessions that covered 275 abstracts. The first
session on stem cells and early developmental decisions highlighted presentations on signaling in
hematopoietic stem cells and on the role of PaxS in B-cell commitment. The second session on the
regulation of immune cell differentiation included presentations on mouse knock-out models for sever-
al key transcriptional regulators of differentiation. The session on chromatin structure and epigenetic
regulation was highlighted by presentations on the role of Runx proteins in CD4 silencer function and
on the relationship between histone acetylation, chromatin accessibility, and V(D)J gene rearrangement
at T-cell receptor loci. In the session on control of antigen receptor gene assembly, the molecular dis-
section of the V(D)J recombination pathway was described. In addition, groundbreaking studies of a
recently discovered regulator of both somatic hypermutation and Ig class switching, the activation-
induced cytidine deaminase, were discussed. The session on antigen receptor signaling included pre-
sentations on the role of a G-protein-coupled receptor in the regulation of lymphocyte pools and on
the effect of the T-cell maturation state on the formation of the T-cell synapse. The session on cytokine
signaling and cell activation included presentations on the activation of cytokine genes by STAT pro-
teins and on development of autoimmunity in IL-6-deficient mice. Highlighting the session on cell death
were presentations on pro-apoptotic and anti-apoptotic Bcl -2 family members and on the production
of autoantibodies in Fas-deficient mice. In the last session on T helper cell differentiation, the function
of the transcription factor T-bet in the activation of the Thl differentiation program and in B-cell isotype
switching was discussed. This session was also highlighted by presentations on the role of the tran-
scription factor Gata-3 in Th2 differentation and on functional antagonism between T-bet and Gata-3.
This meeting was funded in part by Amgen, Inc.; Boehringer Ingelheim Pharmaceuticals; Immunex;
Pfizer; Wyeth-Ayerst Pharmaceuticals; Abbott Laboratories; Biogen; and Merck & Co., Inc. Contributions
from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate
Associates, Corporate Contributors, and Foundations also provided core support for this meeting.
R. Grosschedl, S. Smale, R. Flavell
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PROGRAM
Stem Cells and Early Developmental Decisions
Chairperson: I. Weissman, Stanford University School of
Medicine, California
Regulation of Immune Cell Differentiation
Chairperson: K. Ca lame, Columbia University College of
Physicians & Surgeons, New York
Chromatin Structure and Epigenetic Regulation
Chairperson: A. Rao, Harvard Medical School, Boston,
Massachusetts
Control of Antigen Receptor Gene Assembly
Chairperson: D. Schatz, Howard Hughes Medical Institute,
Yale University School of Medicine, New Haven,
Connecticut
Antigen Receptor Signaling
Chairperson: 0. Witte, Howard Hughes Medical Institute,
University of California, Los Angeles
Cytokine Signaling and Cell Activation
Chairperson: J. Darnell, The Rockefeller University New
York
Cell Death
Chairperson: C. Thompson, University of Pennsylvania,
Philadelphia
T-helper Cell Differentiation
Chairperson: L. Glimcher, Harvard School of Public Health,
Boston, Massachusetts
A. Feeney, P. Goebel, M. Nussenzweig
F. Radtke, H. Salminen, 0. Lassila, P. Nieminen
X. Zhang, A. Khlaed
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Molecular Chaperones and the Heat Shock Response
May 1-5 299 participants
ARRANGED BY Elizabeth Craig, University of Wisconsin, Madison
Carol Gross, University of California, San Francisco
Arthur Horwich, HHMINale University School of Medicine
Twenty years after the inaugural molecular chaperones and the heat shock response meeting, this
meeting featured advances in the areas of structure and mechanism of action of molecular chaper-
ones; mechanisms of induction of the stress response; and nature and mechanism of protein misfold-
ing in disease. In the first area, further advances were described for the classic heat shock proteins,
the Hsp20, 60, 70, 90, and 100 classes, as well as more recently identified chaperones such as
Hsp33. In a session of particular interest, the relationship between chaperone function and proteolysis
was featured, with talks emphasizing the proteosome regulatory particle, targeting of substrates to Clp
proteases, and the interaction between classic molecular chaperones and cellular proteolytic machin-
ery. In the area of regulation of stress responses, a highlight of the meeting was a discussion of a sys-
tems approach to the complex problem of a stress response. In addition, progress toward an under-
standing of the function of heat shock transcription factors in complex organisms was discussed. In
the area of protein misfolding and disease, a number of talks dealt with progress in the use of model
systems in yeast, flies, and worms to attack this complex problem, particularly with regard to polyglu-
tamine diseases. In addition, a number of talks discussed the biogenesis and maintenance of prions
in yeast, and the roles that different chaperones have in this process.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health; Invitrogen Life Technologies; Merck & Co., Inc.; and the
Alzheimer Association. from our Corporate Benefactors, Corporate Sponsors, Plant
Corporate Associates, Corporate Associates, Corporate Contributors, and Foundations also provided
core support for this meeting.
A. Howrich, C. Gross, E. Craig
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J. Carver, A. Aquiline, T. Treweek
PROGRAM
Diseases of Protein Misfolding Regulation of the Stress Response
Chairperson: C. Dobson, University of Cambridge, United Chairperson: R. Morimoto, Northwestern University,
Kingdom Evanston, Illinois
Quality Control and Protein Trafficking
Chairperson: P. Walter, Howard Hughes Medical Institute,
University of California, San Francisco
Chaperones and Proteolysis
Chairperson: D. Finley, Harvard Medical School, Boston,
Massachusetts
Cellular Response to Stress
Chairperson: B. Bukau, Albert-Ludwigs-University, Freiburg,
Germany Chaperone Biochemistry and Protein Folding
Chairperson: K. Wdttrich, Swiss Federal Institute of
Chaperone Function in Disease and Development Technology Zurich
Chairperson: A. Norwich, Yale University School of Medicine,
New Haven, Connecticut
D. Toft, M. Welsh
A. Chadli, N. Benaroudj
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Genome Sequencing and Biology
May 7-11 521 participants
ARRANGED BY Pui-Yan Kwok, Washington University
Jane Rogers, The Sanger Center
Edward Rubin, Lawrence Berkeley National Laboratory
This meeting marked the 15th annual gathering of genome scientists in this setting. The past decade
or more has seen remarkable progress in the mapping, sequencing, and annotation of the genomes
of many "model organisms" and publication of a "working draft" of the mouse and human genome
sequences and several "finished" human chromosomes. Just over 500 people from around the world
attended the meeting, with 331 abstracts presented describing a broad array of topics relating to the
analysis of genomes from a number of different organisms.
The session topics included areas such as biological insights from comparative genomics, func-
tional genomics, organismal biology, computational genomics, and the use of sequence variations to
study populations and mechanisms of disease. Once again, projection-style, interactive computer
demonstrations in Grace Auditorium effectively highlighted the critical new bioinformatics tools being
developed for storing, organizing, and analyzing various genomic data sets, including expression,
mapping, and sequence data. An ELSI (Ethical, Legal, and Social Implications) panel discussion, mod-
erated by Francis Collins, focused on issues surrounding genetic enhancement and in-depth function-
al analysis and annotation of human chromosome 21.
The major themes of the meeting included the analysis and comparisons of the human and mouse
draft genome sequences and in-depth functional analysis and annotation of human chromosome 21.
Specific presentations continued to report major achievements in the sequencing of model organisms,
including Fugu rubripes and Ciona intestinalis, the development of new technologies for genetic analy-
sis, and various high-throughput approaches aimed at comparative sequence-based strategies
"cracking" the gene regulatory code. The Friday afternoon keynote talks were delivered by Richard
Gibbs and Svante Paabo.
Kwok, M. Boguski, J. Rogers
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This meeting was funded in part by the National Human Genome Research Institute, a branch of
the National Institutes of Health. Contributions from our Corporate Benefactors, Corporate Sponsors,
Plant Corporate Associates, Corporate Associates, Corporate Contributors, and Foundations also pro-
vided core support for this meeting.
PROGRAM
Human Mouse Symposia
Chairpersons: J. McPherson, Washington University School
of Medicine, St. Louis, Missouri; T Taylor, RIKEN Genomic
Sciences Center, Tokyo, Japan
Variations I
Chairpersons: A. Gnirke, Exelixis, Inc., South San Francisco,
California; L. Cardon, University of Oxford, United Kingdom
Bioinformatics
Chairpersons: J. Mullikin, Wellcome Trust Sanger Institute,
Cambridge, United Kingdom; D. Haussler, Howard Hughes
Medical Institute/University of California, Santa Cruz
Comparative Genomics
Chairpersons: L. Pachter, University of California, Berkeley;
A. Bradley, Sanger Centre, Hinxton, United Kingdom
ELSI Panel Discussion: Pharmacogenomics, Identified
Populations, and Group Stigma
Moderator
Francis Collins, M.D., Ph.D., National Human Genome
Research Institute
Panelists
Mark A. Rothstein, J.D., University of Louisville School of
Medicine
Pamela L. Banker, Ph.D., University of Pennsylvania Center
for Bioethics
Organismal Genomics
Chairpersons: D. Kingsley, Stanford University California;
M. Fishman, Massachusetts General Hospital/Harvard
Medical School, Boston
High-throughput Biology
Chairpersons: J. Ahringer, University of Cambridge,
United Kingdom; U. Landegren, University of Uppsala,
Sweden
Keynote Speakers
Richard Gibbs, Baylor College of Medicine
Svante Paabo, Max-Planck Institute for Evolutionary
Anthropology
Variations II
Chairpersons: H. Hobbs, University of Texas Southwestern
Medical Center, Dallas; L. Almasy, Southwest Foundation
for Biomedical Research, San Antonio, Texas
J. Kere, M. Daly
Laptops, Laptops, Laptops!! a,
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The Cell Cycle
May 15-19 346 participants
ARRANGED BY Stephen El ledge, Baylor College of Medicine
J. Wade Harper, Baylor College of Medicine
David 0. Morgan, University of California, San Francisco
This seventh biannual meeting was held this year at Cold Spring Harbor. This conference is interna-
tionally recognized for its ability to bring together scientists who study cell cycle regulation in eukary-
otes ranging from yeast to humans. We were particularly fortunate this year, due to the fact that the
Nobel Prize in Physiology or Medicine was awarded in the fat of 2001 to three pioneers in cell cycle
research: Paul Nurse, Tim Hunt, and Lee Hartwell. The meeting featured two exciting plenary lectures
given by both Tim Hunt and Paul Nurse. Paul Nurse presented a wide-ranging and exciting talk describ-
ing the discovery of the central genes that control the cell division cycle in Schizosaccharomyces
pombe, and their role in the discovery of parallel systems in human cells. This was followed by a mid-
meeting lecture from Tim Hunt on the biochemical discovery of cyclins and their role in embryonic cell
cycles. Three broad themes were dominant throughout the meeting: the interaction of cell cycle con-
trol with developmental and cancer biology; the mechanisms of action of cell cycle checkpoints and
their integration with signal pathways that control mitotic transitions; and the emerging use of high-
throughput and whole-genome approaches to uncover new aspects of cell biology.
Research in proteolysis for both G1 /S and GJM regulation in particular continues to receive intense
focus, with much progress reported. As in previous years, there was also emphasis on the long-stand-
ing problem of regulation of DNA replication in the cell cycle, its onset, and its restriction to once per
cell cycle. New to the discussion was a more detailed understanding of how DNA-damage checkpoint
pathways interface with replication pathways. There was also an emphasis on the use of emerging
technologies, both in tissue culture cells and in live animals such as Caenorhabditis elegans, to study
the dynamics of signaling pathways and rapid changes in the localization of components of the mitot-
ic apparatus in response to checkpoint activation. As in other years, scientists studying cell cycle reg-
ulation in yeast, Xenopus, Drosophila, nematodes, and mammals were well represented. Once again,
the striking phylogenetic conservation of cell cycle regulatory mechanisms was readily evident. This
meeting also served to demonstrate the impact of whole-genome analysis on basic cell biology, and
E Luca, D. Morgan, W. Harper
230
these achievements will no doubt continue to drive rapid progress in this field. The cell cycle confer-
ence brought together 353 scientists for the presentation of 240 abstracts. It was another landmark
meeting for the cell cycle field, and the participants all continued to look forward to equally exciting
meetings in future years.
This meeting was funded in part by the National Cancer Institute, a branch of the National Institutes
of Health, and the National Science Foundation. Contributions from our Corporate Benefactors,
Corporate Sponsors, Plant Corporate Associates, Corporate Associates, Corporate Contributors, and
Foundations also provided core support for this meeting.
PROGRAM
Keynote Speaker
Paul Nurse, Cancer Research, United Kingdom
CDK Regulation
Chairperson: R. Deshaies, California Institute of Technology
Pasadena
G, Control
Chairperson: B. Andrews, University of Toronto, Canada
Replication
Chairperson: J. Diffley, Imperial Cancer Research Fund,
South Mimms, United Kingdom
Mitosis I
Chairperson: A. Amon, Massachusetts Institute of
Technology Cancer Center/Whitehead Institute, Cambridge
Mitosis II
Chairperson: E. Salmon, University of North Carolina, Chapel
Hill
Mitotic Checkpoints
Chairperson: S. Reed, Scripps Research Institute, La Jolla,
California
Controls
Chairperson: A. Carr, University of Sussex, Falmer, United
Kingdom
Development and Cancer
Chairperson: J. Lees, Massachusetts Institute of Technology
Center for Cancer Research, Cambridge
K. Deb J. Claycomb, I. Ivanovska
J.D. Watson, L. Gann, T. Hunt, P. Nurse
J. Singer, S. Elledge
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Retroviruses
May 21-26 450 participants
ARRANGED BY Karen Beemon, Johns Hopkins University
Julie Overbaugh, Fred Hutchinson Cancer Research Center
This annual meeting originated in 1975 as a meeting on RNA Tumor Viruses and evolved to its current
focus on Retroviruses in 1993. This 27th meeting was enriched by two keynote speakers, who dis-
cussed challenges of HIV-1 prevention and treatment, both in Africa and in the United States. Julie
Overbaugh gave a moving talk on "The HIV-1 epidemic in Africa-What are the opportunities and chal-
lenges for molecular retrovirologists?" This was followed by a talk by Bob Siliciano who discussed
"Mechanisms of viral persistence in HIV infection-Basic science and clinical implications."
This meeting included 369 platform and poster presentations, distributed into 13 scientific sessions.
The field seems to be shifting from studies of a single viral gene product and its role in the viral life cycle
toward more complex events such as viral assembly or pathogenesis, involving host-virus interactions.
Due to the great interest in virus assembly this year, two sessions were devoted to this topic. In addi-
tion, this meeting introduced a new session on evolution, which included discussions of both viral and
host evolution and presented genomic data. Another new session was devoted to RNA processing,
export, and translation. Three poster sessions, including one evening session, were arranged alpha-
betically rather than topically this year. The meeting was particularly enjoyable due to perfect weather
and wonderful cuisine.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations also provided core support for this
meeting.
K. Beemon, J. Overbaugh
R. Swanstrom, G. Kalpana
PROGRAM
Entry
Chairpersons: L. Albritton, University of Tennessee Health
Sciences Center, Memphis; J. Kimata, Southwest
Foundation for Biomedical Research, San Antonio, Texas
Assembly I
Chairpersons: C. Carter, State University of New York, Stony
Brook; S. Goff, Howard Hughes Medical Institute/Columbia
University New York
Assembly II
Chairpersons: L. Parent, Pennyslyania State University
College of Medicine, Hershey; A. Rein, National Cancer
Institute, Frederick, Maryland
Transcription and Packaging
Chairpersons: F Yoshimura, Wayne State University Detroit,
Michigan; M. Linial, Fred Hutchinson Cancer Research
Centel; Seattle, Washington
RNA Processing, Export, and Translation
Chairpersons: D. Purcell, University of Melbourne, Parkville,
Australia; K. Boris-Lawrie, Ohio State University Columbus
Keynote Address: The HIV-1 epidemic in Africa: What are the
opportunities and challenges for molecular retrovirologists?
Speaker: Julie Overbaugh, Fred Hutchinson Cancer Research
Center
Pathogenesis
Chairpersons: S. Ross, University of Pennsylvania, Philadel-
phia; C.-Z. Giam, Uniformed Services University Bethesda,
Maryland
Keynote Address: Mechanisms of viral persistence in HIV
infection: Basic science and clinical implications.
Speaker: Bob Siliciano, Johns Hopkins University
Evolution
Chairpersons: H. Levin, National Institutes of Health,
Bethesda, Maryland; J. Coffin, Tufts University School of
Medicine, Boston, Massachusetts
RT and Recombination
Chairpersons: R. Bambara, University of Rochester Medical
Center; New York; V Pathak, National Cancer Institute,
Frederick, Maryland
Integration and FV1
Chairpersons: M. Katzman, Pennsylvania State University
Medical Center, Hershey; P. Bieniasz, Aaron Diamond AIDS
Research Center; New York
Therapy and Vectors
Chairpersons: V KewalRamani, National Cancer Institute,
Frederick, Maryland; P Pitha-Rowe, Johns Hopkins
University School of Medicine, Baltimore, Maryland
M. Laughrea, M. Mougel, P Boulanger
J. Coffin, L. Hammarskjold, C. Carter
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New York Structural Biology Group
June 26 230 participants
ARRANGED BY Larry Shapiro, Mount Sinai School of Medicine
Leemor Joshua-Tor, Cold Spring Harbor Laboratory
The summer meeting of the New York Structural Biology Discussion Group was the fifth in day-long
meetings allowing structural biologists from all over the region to meet and discuss their latest results.
The meeting was open to structural biologists from different disciplines, including crystallographers,
spectroscopists, computational biologists, and biochemists, with more than 225 participants from
academia and industry from the tri-state area. The program featured nine talks and a poster session
and concluded with a beach barbecue, allowing a wonderful opportunity for informal interactions. This
meeting complements the bimonthly evening meetings of the group held at The Rockefeller University.
No registration was required and participants were encouraged to set up posters.
This meeting was co-sponsored by the New York Academy of Sciences. Financial support was pro-
vided by Amersham Pharmacia Biotech Inc., Bruker Nonius Crystallographic Systems, Hampton
Research, New York Structural Biology Center, and Rigaku/MSC.
PROGRAM
SESSION I
Chairperson: Marilyn Gunner, City College, New York
Eddy Arnold, Rutgers University: Structural basis of HIV
reverse transcriptase resistance to AZT and other nucleo-
side analog drugs.
David Eliezer, Weill Medical College of Cornet University:
NMR studies of a-synuclein.
Stewart Shuman, Memorial Sloan-Kettering Cancer Center:
RNA repair.
SESSION II
Chairperson: Hermann Schindelin, SUNY, Stony Brook
Andre] Sali, The Rockefeller University: 3D modeling of pro-
tein assemblies.
Terrence Strick, Cold Spring Harbor Laboratory: Single-mole-
cule detection of mechanically and enzymatically driven
DNA denaturation.
SESSION III
Chairperson: Larry Shapiro, Mount Sinai School of
Medicine
Qun Shen, Cornet University: Direct phasing using a refer-
ence beam.
David Stokes, New York University: Electron tomography of
desmosomes.
Wayne Hendrickson, Columbia University College of
Physicians & Surgeons: Signal transduction by histidine
kinase sensors.
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H. Schindelin, L. Joshua-Tor
W. Hendrickson, H. Wu, L. Shapiro, D. Eliezer
Cancer Genetics and Tumor Suppressor Genes
August 14-18 429 participants
ARRANGED BY Doug Hanahan, University of California, San Francisco
Jacqueline Lees, MIT Center for Cancer Research
Scott Lowe, Cold Spring Harbor Laboratory
Charles Sherr, HHMI/St. Jude Children's Research Hospital
This fourth cancer meeting focused on topics related to cancer genetics and cancer biology. More than
425 scientists, most of whom presented unpublished research through oral or poster presentations,
attended the conference. The talks were highlighted by two keynote lectures: Anton Berns discussed
recent advances in the use of mouse models to model human cancer, highlighting their potential utili-
ty for identifying new cancer genes and use for studying cancer therapeutics. Steven El ledge dis-
cussed recent advances in DNA, including the molecular framework of cellular DNA damage respons-
es and their roles in tumor damage responses.
An international team of established investigators, whose expertise covered many of the topics
highlighted during the meeting, chaired the talks. The first oral session discussed new mouse models,
which continue to be an important topic at the meeting. Indeed, many other talks and posters high-
lighted the use of these mice to study gene function and to model human cancer. Other sessions high-
lighted recent advances in our understanding of DNA-damage responses, apoptosis, and cellular
senescence, the Rb and p53 tumor suppressor pathways, and signal transduction pathways that are
altered in human tumors. One session highlighted technological advances for identifying and charac-
terizing cancer genes, which included a presentation by Greg Hannon on RNA interference. The meet-
ing again featured a special session called "NCI Listens," chaired by William Kaelin, and also had a spe-
cial presentation by Cheryl Marks (NCI) on the Mouse Models of Human Cancer Consortium. This
meeting continued to be enthusiastically supported, and all sessions found the lecture and poster halls
packed with extensive discussions and exchanges of information and ideas.
This meeting was funded in part by the National Cancer Institute, a branch of the National Institutes
of Health. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate
Associates, Corporate Associates, Corporate Contributors, and Foundations also provided core sup-
port for this meeting.
S. Lowe, D. Hanahan, C. Sherr, J. Lees
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PROGRAM
Mouse Models
Chairpersons: S. Cory, Walter and Eliza Hall Institute of
Medical Research, Melbourne, Australia; L. Chin, Harvard
Medical School, Boston, Massachusetts
Keynote Address: Mouse Models for Cancer Have Come a
Long Way
Speaker: Anton Berns, The Netherlands Cancer Institute
Checkpoints and DNA-damage Responses
Chairpersons: M. Jasin, Memorial Sloan-Kettering Cancer
Center, New York; J. Petrini, University of Wisconsin,
Madison
Keynote Address: The DNA Damage Response
Speaker: Stephen Elledge, Baylor College of Medicine
Signaling and Transcription in Oncogenesis
Chairperson: J. Downing, St. Jude Children's Research
Hospital, Memphis, Tennessee; R. Hynes, Massachusetts
Institute of Technology Cambridge
RB/E2F
Chairpersons: D. Livingston, Dana-Father Cancer Institute,
Harvard Medical School, Boston, Massachusetts; J. Lees,
MIT Center for Cancer Research, Cambridge, Massachusetts
"NCI Listens"
Chairperson: William G. Kaelin, Jr., M.D., Associate
Investigator for Howard Hughes Medical Institute; Associate
Professor, Department of Adult Oncology, Dana Farber
Cancer Institute; and Harvard Medical School
Speaker: Dinah S. Singer, National Cancer Institute,
National Institutes of Health: An Overview of NCI
Programs and Initiatives.
Moderator: Paulette S. Gray, National Cancer Institute,
National Institutes of Health
The p53 Family
Chairpersons: C. Prives, Columbia University, New York;
G. Evan, University of California Comprehensive Cancer
Center, San Francisco
Apoptosis and Tumor Progression
Chairpersons: J. Adams, Walter and Eliza Hall Institute of
Medical Research, Melbourne, Australia; L. Matrisian,
Vanderbilt University School of Medicine, Nashville,
Tennessee
Senescence and Immortalization
Chairpersons: D. Galloway, Fred Hutchinson Cancer
Research Center, Seattle, Washington; T de Lange,
The Rockefeller University New York
New Cancer Genes, Targets, and Therapies
Chairpersons: L. lruela-Arispe, University of California,
Los Angeles; G. Hannon, Cold Spring Harbor
Laboratory
M. Fried
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C. Richardson, C. Mueller, J. Adams
S. Cony, V. lvanov
Molecular Genetics of Bacteria and Phages
August 20-25 205 participants
ARRANGED BY Robert Landick, University of Wisconsin, Madison
Thomas Silhavy, Princeton University
Catherine Squires, Tufts University School of Medicine
The meeting featured 90 talks arranged in 10 sessions, two poster sessions, and a special workshop.
Young scientists gave most of the talks, and a senior scientist who presented an introductory overview
moderated each session. Topics included The Bacterial Genome: Structure, Recombination, and
Transposition; RNA Polymerase Structure and Function, Regulation of Transcription; Posttranscrip-
tional Control, Ribosomes, and Translation; Signaling and Global Circuits; Cell Surfaces, Secretion and
Import; Chaperones, Heat Shock, and Protein Degradation; Cell Division and Development; and
Host/Pathogen Interactions. One of the themes that emerged from this meeting was the remarkable
conservation in biology. van den Ent (representing the Gerdes, University of Southern Denmark, and
Lowe, MRC, Cambridge England, groups) reported that the shape-determining protein MreB from
Bacillus has a three-dimensional structure remarkably similar to actin, and this finding complements
the previously identified bacterial homolog of tubulin, FtsZ. The structures of the multisubunit bacteri-
al and eukaryotic RNA polymerases are strikingly similar, and this conservation of structural motifs
across great evolutionary distances was highlighted in the afternoon workshop on RNA polymerase.
Two new structures of active transcription elongation complexes formed by the single-chain phage T7
RNA polymerase were described in detail by Vassylyev (Riken Cell Signalling Group, Japan) and Yin
(Steitz group, Yale). Although T7 RNA polymerase exhibits little if any sequence similarity to the multi-
C. Squires, R. Landick
T. Silhavy, L. Rothman-Denes, 0. Amster-Choder
subunit polymerases, the structures bore remarkable resemblance to the previously determined struc-
ture of the yeast RNAP polymerase II transcription elongation complex.
This meeting was funded in part by the National Science Foundation. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
PROGRAM
Cell Surfaces, Secretion, and Import
Chairperson: R. Misra, Arizona State University, Tempe
RNA Polymerase: Structure, Function, and Catalysis
Chairperson: W. McAllister, State University of New York
Downstate Medical Center, Brooklyn
Posttranscriptional Control, Ribosomes, and Translation
Chairperson: A.E. Dahlberg, Brown University Providence,
Rhode Island
Signaling and Global Circuits
Chairperson: L. Kenney, Oregon Health Science University
Portland
Workshop: New Insights into RNA Polymerase Structure
R. Landick, University of Wisconsin, Madison
Regulation of Transcription I
Chairperson: S. Wickner, National Institutes of Health,
Bethesda, Maryland
Chaperones, Heat Shock, and Protein Degradation
Chairperson: B. Bukau, Albert-Ludwigs-University Freiburg,
Germany
Cell Division and Development
Chairperson: P. Levin, Washington University St. Louis,
Missouri
The Bacterial Genome: Structure, Recombination, and
Transposition
Chairperson: S. Rosenberg, Baylor College of Medicine,
Houston, Texas
Host/Pathogen Interactions
Chairperson: A. Camilli, Tufts University Boston,
Massachusetts
Regulation of Transcription Initiation and Elongation
Chairperson: M. Gottesman, Columbia University New
York
T. Inada, K. Kvint
W. Williams, K. Ramamurthi
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Mouse Molecular Genetics
August 28-September 1 334 participants
ARRANGED BY Richard Behringer, The University of Texas/M.D. Anderson Cancer Center
Carmen Birchmeier, Max Delbruck Center, Germany
Hiroshi Hamada, Osaka University
Terry Magnuson, University of North Carolina, Chapel Hill
This meeting, held every other year, attracted more than 325 researchers from across the globe. The
meeting brings together a vast cadre of scientists with very diverse backgrounds who are linked by the
common thread of working with mouse mutants. Consequently, the scope of the biology presented at
the meeting is enormous, covering topics from early developmental decisions in gastrulating embryos
to the behavior of mice.
The meeting opened with the 2nd Annual Rosa Beddington Lecture given by Kathryn Anderson.
Following a historically successful format, the meeting was organized into eight sessions each
arranged so that a session begins and ends with an invited senior researcher. Between these more in-
depth talks (which are selected to be of general interest), eight to nine speakers per session were
selected from the abstracts for more concise presentations. The meeting also included the presenta-
tion of several hundred posters in two afternoon sessions. To highlight current interests in the mouse
molecular genetics community, two workshops on Sperm Cryopreservation and Recovery of Mouse
Strains by Assisted Reproduction (Larry Mobraaten, discussion leader) and BAC Modification and
Transgenesis (Francis Stewart, discussion leader) were arranged where several speakers presented
technical information and their approaches. Although the workshops partially overlapped with the
poster sessions, these workshops were very well attended.
The mouse meeting has evolved over the years to have a stronger genetic and organogenesis/dis-
ease emphasis, and this year, invited presentations included detailed presentations on the newly
assembled and annotated public mouse genome, complex genetic traits, and models of neural tube,
breast, prostate, skeleton, germ cell, and endoderm development and disease. Richard Palmiter, one
of the organizers of the first meeting and a pioneer in transgenic research, returned to give an invited
lecture in the Neurobiology session. The meeting exemplified
some of the special characteristics of the mouse genetics com-
munity-sharing of unpublished data and reagents (including
mice). Inevitably, this meeting is also a mouse dating service! Mice
described in the meeting have found their may to new homes to
mate with other mutants to prove (or disprove) hypotheses devel-
oped during interactions at Cold Spring Harbor.
This meeting was funded in part by the National Cancer
Institute, The National Institute of Diabetes and Digestive and
Kidney Diseases, the National Institute of Child Health and Human
Development, and the National Institute of Neurological Disorders
and Stroke, all branches of the National Institutes of Health.
Contributions from our Corporate Benefactors, Corporate
Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core sup-
port for this meeting.
R. Behringer, C. Birchmeier
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PROGRAM
Rosa Beddington Lecture: Genetic Analysis of Early
Embryonic Patterning
Speaker: K. Anderson, Memorial Sloan-Kettering Cancer
Center, New York
Functional Genomics
Chairperson: L. Stubbs, Lawrence Livermore National
Laboratory, California
Signals, Receptors, and Transcription
Chairperson: R. Grosschedl, University of Munich, Germany
Workshop I: Sperm Cryopreservation and Recovery of
Mouse Strains by Assisted Reproduction
L. Mobraaten, Jackson Laboratory, Bar Harbor, Maine
Patterning
Chairperson: Y. Saga, National Institute of Genetics, Mishima,
Japan
New Technologies
Chairperson: J. Schimenti, Jackson Laboratory Bar Harbor;
Maine
Workshop II: BAC Modification and Transgenesis
F. Stewart, Technische Universitat Dresden, Germany
Organogenesis
Chairperson: L. Hennighausen, National Institutes of Health,
Bethesda, Maryland
Neurobiology
Chairperson: R. Palmiter, Howard Hughes Medical Institute/
University of Washington, Seattle
Models of Human Disease
Chairperson: C. Abate-Shen, UMDNJ-Robert Wood Johnson
Medical School, Piscataway, New Jersey
Genetics
Chairperson: E. Li, Massachusetts General Hospital,
Charlestown
S. Duncan, K. Zaret
J. Hadchovel, F. Relaix, T Natoli
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SECOND CSHL/WELLCOME TRUST CONFERENCE
Genome Informatics
September 4-8 232 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Suzanna Lewis, University of California, Berkeley
Lincoln Stein, Cold Spring Harbor Laboratory
This second conference on Genome Informatics again focused on large-scale genome annotation and
utilization. We chose to repeat the conference in this joint venue following the overwhelmingly positive
reception of the first conference given in August 2001. The conference was again held September 4-8
at the Hinxton Hall Conference Centre, located several miles south of Cambridge in the United Kingdom,
which forms part of the Wellcome Trust Genome Campus, together with the Wellcome Trust Sanger
Institute, the European Bioinformatics Institute, and the HGMP-MRC Resource Centre. The conference
followed a format similar to that of traditional Cold Spring Harbor meetings, in that the majority of oral
presentations were drawn from openly submitted abstracts.
The explosion of biological data requires a concomitant increase in the scale and sophistication of
information technology. This ranges from the storage of data and their associated data models, to the
design of effective algorithms to uncover nonobvious aspects of these data sets, to ontologies to con-
cisely describe biological information, and finally to software systems to support curation, visualization,
and exploration. The conference brought together some of the leading scientists in this growing field, and
researchers from other large-scale information-handling disciplines were also invited to attend. In addi-
tion to the organizers, discussion leaders included Arek Kasprzyk, Fritz Roth, Lior Pachter, Sean Eddy,
James Gilbert, Mark Yandell, Wyeth Wasserman, and Michael Eisen. The keynote speaker was Nobel
Laureate Sydney Brenner. More than 50% of delegates came from North America, a highly unusual sta-
tistic for a European meeting, and the meeting hosted 111 scientific presentations in talks and posters.
PROGRAM
In Silico Data Discovery I
Chairpersons: A. Kasprzyk, EMBL-EBI, Hinxton, United
Kngdom; E Roth, Harvard Medical School, Boston,
Massachusetts
Comparative Genomics
Chairpersons: L. Pachter, University of California, Berkeley; S.
Eddy, Washington University School of Medicine, St. Louis,
Missouri
Annotation Pipelines
Chairpersons: J. Gilbert, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; M. Yandell, University of California,
Berkeley
The Hinxton Hall
Conference
Center
Functional Genomics
Chairpersons: W. Wasserman, Karolinska Institute, Stockholm,
Sweden; M. Eisen, Lawrence Berkeley National Laboratory
California
In Silico Data Discovery II
Chairpersons: A Kasprzyk, EMBL-EBI, Hinxton, United Kingdom;
F Roth, Harvard Medical School, Boston, Massachusetts
Keynote Address
Speaker: Sydney Brenner, Salk Institute for Biological Studies
Integrative Biology
Chairpersons: R. Stevens, University of Manchester, United
Kingdom; C. Mungall, Berkeley Drosophila Genome
Project, California
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Translational Control
September 10-15 462 participants
ARRANGED BY Matthias Hentze, European Molecular Biology Laboratory
Alan Hinnebusch, National Institute of Child Health and Human Development, National
Institutes of Health
Robert Schneider, New York University School of Medicine
The meeting included three keynote speakers, eight platform sessions, and three poster sessions that
covered a record 387 oral and poster presentions. Highlights in the area of translation mechanisms
included the three-dimensional structures of elongation factors eEFs 2 and 1By and the binding
domains in eIF4G (the scaffolding subunit of eIF4F) for cap-binding protein eIF4E, helicase eIF4A, and
eIF4E kinase, Mnkl . It was shown that eIF4G interacts with elF1 and participates in AUG selection,
and multiple contacts between elF3 and eIF2 in the multifactor complex containing elFs 1 and 5 were
shown to function downstream from initiator tRNA binding. The binding sites for elF3, eIF1A, and elF1
on the ribosome have been mapped, and it was proven that GTP hydrolysis by eIF5B is required for
its release from the ribosome following subunit joining. Translation reinitiation can be stimulated by
interaction of poly(A)-binding protein (PABP) with termination factor eRF3. The 60S protein L3 stimu-
lates peptidyltransferase activity of the ribosome by enhancing peptidyl-tRNA binding to the P-site.
On the regulation of translation factors, it was reported that p53 down-regulates general translation ini-
tiation, tumor suppressor protein Pdcd4 inhibits eIF4A helicase activity, and p21-activated protein kinase
y-PAK inhibits eIF4G by phosphorylation. The GEF for elF2, eIF2B, is inhibited during sepsis through phos-
phorylation by GSK-3, and elF2a kinase GCN2 is regulated by TOR kinases and UV irradiation. The
resumption of translation following ER stress requires the inhibition of elF2a kinase PERK by p58-IPK and
GADD34, a positive regulator of elF2a phosphatase. PERK is critically involved in the secretion of extra-
cellular matrix proteins during skeletal development in mice. The d5RNA- activated elF2a kinase PKR is
inhibited during HSV-1 infections by the viral protein Usl 1, which antagonizes PKR activator PACT.
Adenovirus 100K protein inhibits host protein synthesis by competing with Mnkl for eIF4G binding.
In the arena of gene-specific translational control, it was reported that translation of Sendai virus
P/C mRNA involves a ribosomal shunt and methionine-independent translation initiation. A pseudoknot
in interferon-y mRNA inhibits translation in cis by localized activation of PKR, and c-Src activates 15-
LOX mRNA translation by overcoming the repressing effects of hnRNPs K and E1, acting through the
3"UTR element DICE. Mitogen activation of TOP mRNA translation requires PI3 kinase but not mTOR
M. Hentze, A. Hinnebusch, R. Schneider
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or S6 kinase-1. The inhibitory uORF in arg-2 mRNA can mediate arginine-dependent translational
repression when embedded in the coding sequence, and the uORF-encoded peptide in the CMV UL4
gene inhibits its own termination and other initiation events downstream by interacting with release fac-
tor eRF1. The ELAV protein HuD negatively regulates the internal ribosome entry site (IRES) that con-
trols p27Kip1 translation, whereas eIF2A inhibits the IRES in yeast URE2 mRNA in vivo. The binding
site for cricket paralysis virus (CrPV) IRES was mapped on the 40S ribosome, and translation by this
IRES was reconstituted with purified ribosomes and elongation factors, confirming its independence of
elFs. Programmed frameshifting in bacteria can be modulated by tRNA modification, or by a Shine-
Delgarno sequence that destabilizes E-site tRNA.
Regarding translational control in development, a new cytoplasmic poly(A) polymerase, GLD-2,
involved in regulating germ-line fate and early embryogenesis, was discovered in C. elegans. The worm
GLD-1 regulates tra-2 translation through interaction with PABP, and also represses glp-1 mRNA via
the 3"UTR. Drosophila sex-lethal (SXL) protein represses msl2 mRNA in vitro by blocking mRNA bind-
ing to the 43S complex. The cytoplasmic polyadenylation element-binding protein (CPEB) and maskin
positively and negatively regulate cyclin B mRNA translation, respectively, in Xenopus embryo extracts.
Src negatively regulates RNA binding by QKI protein, regulating accumulation of myelin basic protein
mRNA in the developing nervous system of the mouse. Finally, a cellular IRES in egg-laying hormone
mRNA was shown to be regulated by physiological activity in Aplysia neurons.
This meeting was funded in part by the National Cancer Institute and the National Institute of Child
Health and Human Development, branches of the National Institutes of Health. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
PROGRAM
Keynote Lectures
Speaker: Gideon Dreyfuss, HHMI/University of Pennsylvania
School of Medicine: The SMN complex: An assembly
machine for RNPs.
Speaker: Phillip Sharp, Massachusetts Institute of Technology:
siRNAs.
Speaker: Eric Kandel, HHMI/Columbia University: Translational
control in long-term memory and its persistence.
Initiation
Chairperson: O. Meyuhas, Hebrew University-Hadassah
Medical School, Jerusalem, Israel
Translation Mechanisms
Chairperson: P. Farabaugh, University of Maryland, Baltimore
Regulation of Translation Factors
Chairperson: D. Ron, New York University School of Medicine,
New York
Viral Strategies of Translational Control
Chairperson: V. Pain, University of Sussex, Brighton, United
Kingdom
Regulatory Elements in mRNAs
Chairperson: M. Berry, University of Hawaii, Manoa, Honolulu
Internal Initiation
Chairperson: T Pestova, State University of New York Health
Sciences Center, Brooklyn
Developmental Regulation of Translation
Chairperson: J. Richter, University of Massachusetts Medical
School, Worcester
Mechanisms of mRNA Turnover
Chairperson: G. Brewer, University of Washington, Seattle
J. Richter, A. Jacobson J. Li, S.-H. Chiu, L. Maquat
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Dynamic Organization of Nuclear Function
September 18-22 377 participants
ARRANGED BY Wendy Bickmore, MRC Human Genetics Unit
Gideon Dreyfuss, HHMI/University of Pennsylvania School of Medicine
David L. Spector, Cold Spring Harbor Laboratory
Katherine Wilson, Johns Hopkins University School of Medicine
The meeting brought together a diverse group of investigators to discuss the relationship between
nuclear structure and function. In the opening session devoted to diseases, infection, and DNA dam-
age, D.M. Livingston discussed recent observations indicating that the tumor suppressor protein
BRCA1 may promote the localization of Xist RNA to the inactive X chromosome and thereby have a role
in the maintenance of X chromosome inactivation. In BRAC1' cells, an absence of both the Xist RNA
signal and histone H3 lysine 9 methylation was observed. Other talks on the role of BRAC1/BARD1 and
RNA polymerase II in coordinating the response to DNA damage (FE. Kleiman), laminopathies (T.
Haraguchi, J.M. Holaska, K. Hoffmann), Emery-Dreyfus muscular dystrophy (B. Reichart), the assembly
of DNA repair foci (R. Rothstein, C.M. Green), DNA replication checkpoints (C. Smythe), and dysmyeli-
nation (J. Pilotte) all highlighted the close association of nuclear structure to disease.
Numerous talks demonstrated the dynamics of chromatin and chromatin-associated proteins in liv-
ing cells. S. Gasser discussed the dynamics of yeast chromatin in living cells using the lac
operator/repressor system. Telomeres, centromeres, as well as silent mating-type loci exhibited con-
strained motion. Telomere anchoring to the nuclear periphery was shown to involve both the Sir and
Ku proteins, suggesting that parallel pathways may exist. Interestingly, upon loss of silencing,
increased chromosome motion was observed. In mammalian cells, J.R. Chubb demonstrated that
chromatin associated with the nucleolus or nuclear periphery is more constrained in its movement than
more nucleoplasmic loci, and D. Gerlich showed that chromosomes exhibit ordered positions that are
inherited through mitosis in mammalian cells. S. Janicki discussed the development of a stable cell line
in which an inducible DNA locus as well as its RNA and
protein products could be directly visualized in living cells.
Using this system, a loss of HP1 was observed as the
locus transited from an inactive to an active state. In addi-
tion, RNA was detectable at the locus within 5 minutes of
induction. Using FRAP analysis, T. Cheutin also demon-
strated the dynamic nature of HP1 which exhibited com-
plete recovery within 1 minute. G. Hager showed that
whereas the glucocorticoid receptor and its coactivators
exhibit short residence times at a promoter (5 sec), RNA
polymerase II exhibited a longer residency time of 12-15
minutes. By combining advances in computational fluo-
rescence microscopy with multiplex probe design, R.H.
Singer described studies in which the expression of many
genes can be visualized simultaneously inside single cells
with high spatial and temporal resolution.
Several studies reported on unexpected chromatin
associations. P. de Lanerolle showed that nuclear myosin
1 coimmunoprecipitated with RNA polymerase II, and
antiactin antibodies inhibited transcriptional initiation but
not elongation. T. Kohwi-Shigematsu showed that SATB1
localized in a framework-like structure around heterochro-
matin in thymocyte nuclei and was resistant to DNase I
D. Spector, R. Nayak
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and salt extraction. SATB1 was shown to form protein complexes with ATP-dependent chromatin
remodeling enzymes and histone deacetylases. M.S. Schmidt-Zachmann reported on N0145, a pro-
tein that localizes to a thin cortical layer forming a cage-like perinucleolar structure composed of a
meshwork of filaments.
Proteomics was also widely discussed as R. Reed presented a comprehensive analysis of the
human spliceosome, indicating that it contains 145 distinct proteins, and J.M. Cronshaw described a
proteomic analysis of the mammalian nuclear pore complex that has identified 29 nucleoporins and 18
nuclear-pore-associated proteins. In addition, W. Bickmore described the development of a nuclear
protein database that contains information on more than 1000 vertebrate nuclear proteins.
Numerous studies discussed the dynamic associations of the nuclear lamins (R.D. Goldman, T.
Dechat, Y. Gruenbaum) and the dynamic organization of the nuclear pore complex (G. Rabut). In par-
ticular, R.D. Goldman reported that disruption of lamin organization resulted in an inhibition of RNA
polymerase II, but not polymerases I and III transcription, and Y. Gruenbaum reported that reduction
in C. elegans lamin protein causes embryonic lethality. Analysis of protein components of the nuclear
pore complex by FRAP analysis indicated that individual nucleoporins exhibited very different dynam-
ics, with average residency times ranging from a few seconds to several hours. The most stable nucle-
oporins appeared to be components of the spoke ring complex, whereas the most dynamic ones were
found at the nuclear basket. A variety of other studies were presented on the dynamics of various
nuclear bodies as well as nuclear import and export processes.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations also provided core support for this meeting.
PROGRAM
Nuclear Structure in Disease, Infection, and Damage
Chairperson: D.M. Livingston, Dana-Farber Cancer Institute,
Boston, Massachusetts
Genome Organization and Transcription
Chairperson: S.M. Gasser, ISREC, Epalinges, Switzerland
RNA Processing
Chairperson: J.A. Steitz, Yale University School of Medicine,
New Haven, Connecticut
Dynamic Properties of the Nuclear Envelope/Lamina
Chairperson: R.D. Goldman, Northwestern University Medical
School, Chicago, Illinois
Nucleoli and Other Organelles
Chairperson: A.I. Lamond, University of Dundee, United
Kingdom
New Approaches to Study Nuclear Structure/Function
Chairperson: R.H. Singer, Albert Einstein College of Medicine,
Bronx, New York
Chromosomes and the Cell Cycle
Chairperson: W.A. Bickmore, MRC Human Genetics Unit,
Edinburgh, United Kingdom
Nuclear Transport
Chairperson: I.W. Matta], European Molecular Biology
Laboratory, Heidelberg, Germany
T. Pederson, R. Goldman, S. Krauss, G. Maul
L. Wieslander, J. Steitz
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Axon Guidance and Neural Plasticity
September 25-29 450 participants
ARRANGED BY Con Bargmann, HHMI/University of California, San Francisco
Tobias Bonhoeffer, Max-Planck Institute of Neurobiology, Germany
Larry Zipursky, HHMI/University of California, Los Angeles
The remarkable feats of information processing performed by the human brain are determined by the
intricate network of connections between nerve cells (or neurons). The magnitude of the task involved
in wiring the nervous system is staggering. In adult humans, each of over a trillion neurons makes con-
nections with, on average, over a thousand target cells in an intricate circuit whose precise pattern is
essential for the proper functioning of the nervous system. How can this pattern be generated during
embryogenesis with the necessary precision and reliability? Neuronal connections form when each
developing neuron sends out an axon, tipped by a growth cone, which migrates through the embry-
onic environment to its synaptic targets, guided by attractive and repulsive proteins that instruct it to
migrate in particular directions. Once in their appropriate target regions, axons must seek out particu-
lar target cells with which to form synaptic connections. These connections are then further refined,
through the making and breaking of synaptic contacts, under the control of specific patterns of elec-
trical activity in the neurons and targets, until a highly tuned circuit is established.
In the past decade, our understanding of the mechanisms that control axon growth and guidance,
synaptogenesis, and the remodeling of neural circuits during development has progressed rapidly from
phenomenology to the identification of specific molecular control mechanisms. Progress has been
assisted by the finding that these mechanisms are highly conserved across evolution, so that both bio-
chemical approaches in vertebrates and genetic approaches in
invertebrates (and increasingly, in vertebrates as well) have led to
mutually reinforcing discoveries that have helped fuel further
advances.
As the pace of discovery has quickened, the field has grown
enormously, making it more difficult for scientists to keep abreast
of new developments. To help facilitate communication in the field,
a biennial CSHL conference series on "Axon Guidance and
Developmental Plasticity of the Nervous System" was initiated in
1998. This year, the third of these meetings involved sessions
devoted to particular stages in the assembly of the nervous sys-
tem, with speakers chosen from among the participants submit-
ting abstracts by session chairs who are leaders in the field. Other
abstracts were presented as posters.
As for the first two meetings, the response of the field to this
conference was one of overwhelming enthusiasm. Of the 450
registrants, 300 submitted abstracts; 65 abstracts were selected
for talks, in eight sessions. Senior researchers, starting Assistant
Professors, postdoctoral fellows, and graduate students were all
well represented. All of the major areas of research in the field
were covered, as were all of the major approaches (cellular, phys-
iological, anatomical, biochemical, and genetic). In addition, there
were two special lectures: Dr. Tom Pollard focused on basic
mechanisms controlling the cytoskeleton, and Dr. Eric Knudsen
focused on mechanisms of development, function, and plasticity
of the auditory system in the barn owl. The meeting provided an
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C. Bargmann, J. Witkowski
important clearing house for ideas and approaches, and helped scientists in the field to get the most
up-to-date information, as well as enabling them to meet, to network, and to establish collaborations.
From the uniformly enthusiastic comments of the participants, the intensity of the oral and poster ses-
sions, and the large crowds that stayed up late every night at the bar to discuss science further, the
meeting was deemed a great success.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health. Contributions from our Corporate Benefactors, Corporate
Sponsors, Plant Corporate Associates, Corporate Associates, Corporate Contributors, and
Foundations also provided core support for this meeting.
PROGRAM
Guidance I: Semaphorins and Slits
Chairpersons: B. Dickson, Institute of Molecular Pathology,
Vienna, Austria; M. Tessier-Lavigne, Stanford University,
California
Synaptic Plasticity and Behavior
Chairpersons: M. Stryker, University of California, San Fran-
cisco; H. Cline, Cold Spring Harbor Laboratory
Special Lecture I
Speaker: Tom Pollard, Yale University
Regeneration
Chairpersons: C. Holt, University of Cambridge, United
Kingdom; M.-M. Poo, University of California, Berkeley
Gene Expression and Translation
Chairpersons: R. Axel, Columbia University New York; Y. Jin,
University of California, Santa Cruz
Cytoskeleton and Signaling
Chairpersons: L. Luo, Stanford University, California; T.
Pawson, Samuel Lunenfeld Research Institute, Toronto,
California
Targeting and Synapse Formation
Chairpersons: S. Smith, Stanford University California;
E. Schuman, California Institute of Technology
Pasadena
Special Lecture II
Speaker: E. Knudsen, Stanford University
Guidance II
Chairpersons: C. Goodman, Renovis, Inc., South San
Francisco, California; J. Sanes, Washington University
St. Louis, Missouri
Guidance Ill: Netrins and Ephrins
Chairpersons: R. Klein, Max-Planck Institute of Neurobiology
Martinsried, Germany; J. Flanagan, Harvard Medical
School, Boston, Massachusetts
T. Godenschwege, K. Hofmeyer
C. Sabatier, J. Flanagan, M. Tessier-Lavigne
T. Bonhoeffer
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Molecular Genetics of Aging
October 2-6 232 participants
ARRANGED BY Ronald DePinho, Dana Farber Cancer Institute
Terri Grodzicker, Cold Spring Harbor Laboratory
Leonard Guarente, Massachusetts Institute of Technology
Cynthia Kenyon, University of California, San Francisco
Aging is a process that leads to many degenerative changes and death. Recently, specific processes
closely associated with aging as well as genes that may regulate aging have been identified. This meet-
ing focused on these advances and provided a forum for discussion of many theories, old and new.
Two regulators of aging were featured in several sessions, one involving signaling pathways by insulin-
like molecules and the other, a novel class of NAD-dependent deacetylases, called SIR2 proteins.
Altering these pathways was shown to extend life span in yeast, Caenorhabditis elegans, Drosophila,
and mice. There was also a session dedicated to stem cell biology and transcription profiling of aging
cells. Two other sessions related to telomere biology and cellular senescence. Premature aging syn-
dromes and diseases of aging were also featured. Finally, recent findings relating aging to metabolism
and oxidative stress closed the conference. It was clear that very rapid progress is being made to
understand aging and its regulation at a molecular level.
This meeting was funded in part by the National Institute on Aging, a branch of the National
Institutes of Health. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant
Corporate Associates, Corporate Associates, Corporate Contributors, and Foundations also provided
core support for this meeting.
C. Kenyon, A. de Grey
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L. Guarente
V. Lundblad, J. Mitchell
PROGRAM
Model Systems I
Chairpersons: L. Guarente, Massachusetts Institute of
Technology, Cambridge; J. Tower, University of Southern
California, Los Angeles
Stem Cells and Genomics
Chairperson: H. Blau, Stanford University School of Medicine,
California
Telomere Dynamics and DNA Damage Pathways
Chairpersons: S. Jackson, University of Cambridge, United
Kingdom; T de Lange, The Rockefeller University New York
Cellular Senescence, Telomeres, and Cancer
Chairpersons: J. Campisi, Lawrence Berkeley National
Laboratory, California; S. Lowe, Cold Spring Harbor
Laboratory
Model Systems II
Chairpersons: G. Ruvkun, Massachusetts General Hospital,
Boston; V. Lundblad, Baylor College of Medicine, Houston,
Texas
Aging Syndromes and Diseases
Chairpersons: G. Martin, University of Washington, Seattle;
D. Hanahan, University of California, San Francisco
Special Lecture from the Director
Speaker: Richard Hodes, Director, National Institute on
Aging
Metabolism, Stress, and the Biology of Aging
Chairpersons: D. Wallace, Emory University School of
Medicine, Atlanta, Georgia; A. Richardson, Audie L.
Murphy Memorial VA Hospital, San Antonio, Texas
R. McKay, R. DePinho
L. Cao, T Ide
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Germ Cells
October 9-13 224 participants
ARRANGED BY David Page, Massachusettes Institute of Technology
Ruth Lehmann, New York University School of Medicine, Skirball Institute
Germ cells, by the virtue of the next generation, are the only cells in the body that have the potential
of being immortal. Over the past few years, it has become apparent that many of the fundamental
developmental mechanisms required for the establishment and function of germ cells have been con-
served during evolution. This fourth Germ Cells meeting was organized with the goal of bringing
together researchers who study germ-line development in both vertebrate and invertebrate systems
and researchers studying human reproduction. The questions addressed in this meeting were: How
are germ cells initially specified? Are germ cells a "totipotent" stem cell population? How do primordial
germ cells acquire stem-cell character in the ovary or testis? Despite the apparent differences in the
way germ cells are specified in the early embryo of different organisms, several genes, such as nanos,
DAZL, pumilio, piwi, and vasa, show a remarkable degree of conservation, whereas other important
players, such as the Caenorhabditis elegans pie-1, mouse oct-4, and Drosophila oskar, seem not have
direct counterparts. An important and far-reaching issue dealt with the control of gene expression in
the germ line. Whereas reprogramming of somatic nuclei is hampered by epigenetic factors such as
gene silencing and imprinting, germ-line cells have evolved mechanisms to set and erase these marks,
thereby allowing the perpetuation of the species. Given our growing understanding of the molecular
mechanisms that control germ-line development and maturation in model organism, the implications
of these findings for human reproduction were vividly discussed during the meeting. The next Germ
Cells meeting will be held in the fall of 2004 with Judith Kimble and Blanche Capell serving as the orga-
nizers.
This meeting was funded in part by the National Institute of Child Health and Human Development,
a branch of the National Institutes of Health; La lor; and the March of Dimes. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
J. Maldonado, D. Page
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PROGRAM
Germ Cell Origins
Chairpersons: G. Seydoux, Johns Hopkins University School
of Medicine, Baltimore, Maryland; C. Wylie, Children's
Hospital Research Foundation, Cincinnati, Ohio
The Embryonic Germ Line
Chairpersons: A. Spradling, Carnegie Institution of Washing-
ton, Baltimore, Maryland; B. Hogan, Howard Hughes
Medical InstituteNanderbilt University Medical Center,
Nashville, Tennessee
Germ Line Stem Cells
Chairpersons: J. Kimble, Howard Hughes Medical Institute/
University of Wisconsin, Madison; M. Fuller, Stanford
University School of Medicine, California
Spermatogenesis
Chairpersons: M.A. Handel, University of Tennessee,
Knoxville; T. Schedl, Washington University School of
Medicine, St. Louis, Missouri
Transcription
Chairpersons: R. Lehmann, New York University School of
Medicine, New York; D. Page, Massachusetts Institute of
Technology Cambridge
Gamete Success and Evolution
Chairpersons: A. Clark, Cornell University Ithaca, New York;
J. Schimenti, Jackson Laboratory Bar Harbor, Maine
Oogenesis
Chairpersons: J. Eppig, Jackson Laboratory Bar Harbor;
Maine; J. Richter, University of Massachusetts Medical
School, Worcester
Germ Line-Soma Interactions/Sex Determination
Chairpersons: A. McLaren, Wellcome/CRC Institute,
Cambridge, United Kingdom; S. DiNardo, University of
Pennsylvania Medical School, Philadelphia
J. Kreidberg, R. Jaenisch
B. Hogan, J. Eppig
J. Kimble, J. Morris, T. Marty
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Human Origins and Disease
October 30-November 3 150 participants
ARRANGED BY Mary-Claire King, University of Washington
Christopher Stringer, Natural History Museum
Douglas Wallace, University of California, Irvine
This fourth in a series of Cold Spring Harbor meetings on the evolution of modern humans brought sub-
stantial amounts of molecular genetic information together with fossil, archeological, and linguistic find-
ings in an attempt to achieve a new synthesis in our understanding of human origins. Molecular anthro-
pological studies of maternally inherited mitochondrial DNA and paternally inherited Y chromosomes con-
tinue to indicate that Africa harbors both the greatest genetic diversity and the oldest lineages. Most of
the evidence points toward emigration of a small group of humans out of Africa between 40,000 and
50,000 years ago who populated first Asia and then Europe. But genetic evidence also hints at possible
earlier emigrations along coastlines stretching to Papua New Guinea and Australia, a hypothesis itself
challenged by the proposal that this variation may have become fixed through random genetic drift.
Besides being used to address global questions of human origins, molecular anthropology has per-
mitted novel approaches to the study of more recent migrations and historical events. Meeting highlights
included the reconstruction and analysis of a worldwide tree of the Y chromosome, which tracks the
movements of humans across the globe. The tree suggests that while the cultural and linguistic contri-
bution made by invaders may be large, the genetic contribution may be quite small if the conquered pop-
ulation is large in comparison with the invading force. In parallel, analyses of mitochondrial DNA lineages
track the journeys of human females, which largely echo but sometimes differ from the Y-chromosome
data, presumably because of different migratory behavior. The meeting also was host to intense specu-
lation about genes that appear to be under strong and differential selective pressure, perhaps in response
to particular diets, parasites, climates, or diseases. Most of the evidence for selective pressure comes
from gene variants that are protective against malaria, but it is clear that we can expect other examples
of rapid natural selection to emerge as research progresses. A number of intriguing examples were pre-
sented, without a clear picture of the underlying selective pressure yet being available. And finally, last
year's discovery of the human-specific language gene present in all but a rare few human families is pro-
voking debate about whether the acquisition of rapidly spoken language was the defining transition that
M.-C. King
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pre-dated the appearance of many cultural artifacts and modern behaviors, a hypothesis hotly contest-
ed by the majority of archeologists who favor culture rather than genes to explain their findings.
The meeting was profiled in a November 12 New York Times piece by Nicholas Wade, entitled
"Geneticists Track More of Earliest Humans' First Itineraries."
This meeting was funded in part by the Grace Professorship. Contributions from our Corporate
Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates, Corporate
Contributors, and Foundations also provided core support for this meeting.
PROGRAM
Of Apes and Men
Chairpersons: D.C. Wallace, University of California Irvine;
M.M. Lahr, University of Cambridge, United Kingdom
Africa and Early Human Evolution
Chairpersons: C.B. Stringer, Natural History Museum,
London, United Kingdom; A.C. Stone, University of New
Mexico, Albuquerque
Out of Africa Dispersals and Processes
Chairpersons: A.S. Brooks, George Washington University
Washington, D.C.; S. Paabo, Max-Planck Institute for
Evolutionary Anthropology Leipzig, Germany
Global Human Genetic Variation
Chairpersons: A. Torroni, Urbino University Italy; P.
Underhill, Stanford University California
African Radiation of Homo Sapiens
Chairpersons: S. McBrearty, University of Connecticut,
Storrs; M. Hammer, University of Arizona, Tuscon
Southeast Asia, Australia, and Oceania
Chairpersons: M. Stoneking, Max-Planck Institute for
Evolutionary Anthropology Leipzig, Germany; J.C.
Stephens, Genaissance Pharmaceuticals, New Haven,
Connecticut
Asia and the Americas
Chairpersons: P. Forster, University of Cambridge,
United Kingdom; R. Villems, Estonian Biocentre, Tartu
Western Eurasia and Europe
Chairpersons: K.K. Kidd, Yale University School of Medicine,
New Haven, Connecticut; M. Seielstad, Genome Institute
of Singapore
Human Radiation and Infectious Disease
Chairpersons: N.K. Yankovsky, Institute of General Genetics,
Moscow, Russia; J. Hey, Rutgers University Piscataway
New Jersey
Human Variation and Disease
Chairpersons: M.G. King, University of Washington, Seattle; J.
Bertranpetit, Universitat Pompeu Fabra, Barcelona, Spain
J. Swanson, S. Paabo
A. Lovell, R. King
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BIOTECHNOLOGY CONFERENCE
Tissue Engineering
November 21-24 101 participants
ARRANGED BY Farshid Guilak, Duke University Medical Center
Rocky Tuan, National Institute of Arthritis, Musculoskeletal, and Skin Diseases
The goal of this Tissue Engineering Biotechnology Conference, a first of its kind for Cold Spring Harbor
Laboratory, was to bring together investigators in this emerging research and biotechnology discipline
to exchange ideas, present new discoveries, and interact in order to develop novel concepts for the
scientific enhancement of the field. The meeting consisted of both platform and poster presentations
by researchers from a wide spectrum of research areas related to tissue engineering. Presenters
included established investigators as well as graduate students and postdoctoral fellows. The topics
for the platform sessions represented areas of key, active research development in tissue engineering,
and included (1) biology of tissue progenitor cells; (2) application of progenitor and stem cells; (3) novel
biomaterials, biomimetics, and bioinspired materials; (4) functional tissue engineering; (5) gene-based
approaches in tissue engineering; and (6) applications and in vivo models of engineered tissues. The
experimental approaches reported covered cellular and molecular biology, gene therapy, stem cells,
biomaterials, biomechanics, biomechanical engineering, computer-aided design, bioinformatics, biore-
actors, and in vivo models, reflecting the inherently multidisciplinary nature of the field of tissue engi-
neering.
Some of the highlights included new insights on the biology of adult tissue-derived, multipotential,
mesenchymal stem cells, novel biomaterials based on natural and synthetic polymers, novel approach-
es to the design of bioreactors for tissue engineering, integration of mechanically active environment
in functional tissue engineering, and how to bring tissue-engineered products to the market. Because
tissue engineering is a new, emerging discipline, the Conference was a wonderful opportunity to bring
together investigators of diverse background and expertise to a congenial, interactive setting to fully
explore the scientific concepts necessary to develop and enhance the sophistication of the field. The
quality of the presentations was very high, and many exciting impromptu discussions, among both
senior and junior investigators, took place during and after the presentations, and late into the night
R. Tuan, J. Huard, D. Stewart
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throughout the course of the Conference. The Conference was viewed as a wonderful beginning to
foster the translation of basic scientific principles of biology, in conjunction with the principles of engi-
neering, into research areas that have tremendous potential in biomedicine, particularly in the new field
of regenerative medicine. The environment here at CSHL further contributed to the highly interactive
nature of the Conference. Many attendees expressed the hope that the CSHL will continue to host
meetings on tissue engineering in the future.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations also provided core support for this
meeting.
PROGRAM
Biology of Tissue Progenitor Cells
Chairperson: A. Caplan, Case Western Reserve University,
Cleveland, Ohio
Application of Progenitor and Stem Cells in Tissue
Engineering
Chairperson: F. Guilak, Duke University Medical Center,
Durham, North Carolina
Novel Biomaterials, Biomimetics, and Bioinspired
Materials I
Chairperson: J. Elisseeff, Johns Hopkins University
Baltimore, Maryland
Novel Biomaterials, Biomimetics, and Bioinspired
Materials II
Chairperson: S. Hollister, University of Michigan, Ann Arbor
Functional Tissue Engineering
Chairperson: R. Tuan, NIAMS, National Institutes of Health,
Bethesda, Maryland
Gene-based Approaches in Tissue Engineering
Chairperson: J. Huard, University of Pittsburgh, Pennsylvania
Applications and In Vivo Models of Engineered Tissues
Chairperson: J. Glowacki, Brigham and Women's Hospital,
Boston, Massachusetts
C. Williams, R. Mauck
A. Ratcliffe, J. Elisseeff
R. Oki, J. Gimble
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BIOTECHNOLOGY CONFERENCE
Therapeutic Opportunities in Neurodegenerative Diseases
December 5-8 108 participants
ARRANGED BY Sam Gandy, Farber Institute for Neuroscience at Thomas Jefferson University
Harry Le Vine III, Pfizer Inc.
Marcy MacDonald, Massachusetts General Hospital/Harvard Medical School
As many as one half of those aged 65 years or older will develop debilitating degenerative disease of
the central nervous system, usually characterized by a decade or more of dependent living, accom-
panied by progressive failure of cognitive function and/or coordinated movement. Although these ill-
nesses appear most commonly in the absence of obvious hereditability or identifiable genetic muta-
tions, it has been possible over the past 20 years to discover risk-modifying DNA changes in some
examples and predictable causative changes in others. From these findings, transgenic technology has
rapidly led to the development of mouse, fruit fly, and nematode model systems that partially recapit-
ulate the behavioral abnormalities of the human diseases, as well as some of the hallmark molecular
and morphological pathology of the conditions.
Rational biochemical and cell-based screens have generated lead compounds that show promise
in the living animal models. Most importantly, the animal models have enabled discovery of entirely
unanticipated therapeutic strategies (such as amyloid immunotherapy). In December 1999, some of
these rationally discovered compounds and unexpected immunotherapies entered Phase I clinical
trials. The progress of compounds and rational strategies from the animal model to the human clinical
trial; the design, results, and conclusions of trials; and the return to the animal model with questions
raised during human trials are the areas of particular emphasis for these biannual Winter Biotechnology
Conferences instituted in December 2000 with the explicit goal of facilitating the translation of "break-
through" science into effective medicines.
H. Le Vine, S. Gandy, M. MacDonald
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For the 2002 meeting, six 3.5-hour platform sessions were organized around common technologi-
cal themes. Chairpersons, invited speakers, and speakers selected from submitted abstracts were
drawn from the academic and pharmaceutical sectors. Although the discussion of new unpublished
data was emphasized, the group was tolerant of a wide range of intellectual property conventions.
Poster presentations were also encouraged: Posters were displayed throughout the meeting, and
poster viewing was especially encouraged during the cocktail hours before the evening meals.
Topics of the meeting included protein aggregation inhibitors, protein processing enzymology and
pharmacology, gene transfer, stem cell transfer, immunotherapy, human genetics, design and interpre-
tation of genomic analyses in mammalian and lower systems, bioinformatics, mouse and fly models of
neurological disease, mechanisms of neurodegeneration, metabolic and hormonal influences on dis-
ease protein metabolism in cell culture and living animal models as well as in human clinical trials, and
the legal and regulatory obstacles to drug discovery for neurodegenerative diseases. Diseases consid-
ered at the 2000 meeting included Alzheimer's, Huntington's, spinocerebellar atrophies, ALS, prion dis-
eases, Parkinson's, tauopathies, and synucleinopathies.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations also provided core support for this
meeting.
PROGRAM
Prion and Triplet Diseases: Heat Shock Proteins as Model
Therapeutics
Chairpersons: S. Lindquist, Howard Hughes Medical
Institute/University of Chicago, Illinois; M. MacDonald,
Massachusetts General Hospital, Charlestown
Alzheimer's AO: Targeting Secretase Enzymes and Protein
Aggregation
Chairpersons: H. LeVine, Pfizer, Ann Arbor, Michigan;
D. Frail, Pharmacia Corporation, Kalamazoo, Michigan
Immunopathology and Immunotherapy of Neurode-
generation
Chairpersons: L. van Eldik, Northwestern University Medical
School, Chicago, Illinois; G.E. Landreth, Case Western
Reserve University School of Medicine, Cleveland, Ohio
Challenges in Bringing Neurodegeneration Drugs to the
Clinic: Patient Selection, Quantitative Outcomes,
Unprecedented Trial Expense, and Regulatory
Disincentives
Chairpersons: D. Murphy, NINDS, National Institutes of
Health, Rockville, Maryland; N. Ishaque, Advanced
Technology Leader; Niskayuna, New York
Optimizing Animal and Cellular Models for Drug Evaluation
Chairpersons: K. Duff, Nathan Kline Institute, New York
University Orangeburg; J.Q. Trojanowski, University of
Pennsylvania School of Medicine, Philadelphia
New Genes, New Strategies
Chairpersons: M. Gurney, deCode Genetics, Reykjavic,
Iceland; R. Mayeux, Columbia University College of
Physicians & Surgeons, New York M. Gurney
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BIOTECHNOLOGY CONFERENCE
Comparative Plant Genomics
December 12-15 98 participants
ARRANGED BY Mike Bevan, The John Innes Centre, United Kingdom
Susan Mc Couch, Cornell University
This meeting featured 37 talks in 8 sessions, a poster session, and a workshop of evolutionary
genomics. The keynote lecture given by Rob Martienssen from Cold Spring Harbor Laboratory in honor
of the Centenary of Barbara McClintock's birth fittingly described the deep insights recently gained into
the epigenetic mechanisms involved in establishing and maintaining plant heterochromatin and regulat-
ing transposon activity. Talks, which were mostly selected from abstracts, covered progress in sequenc-
ing plant genomes, genome dynamics, functional genomics, and genome-related informatics and data-
bases. Since the completion of the Arabidopsis genome sequence in 2000, several new plant genome
projects have been initiated, including rice, representing the first cereal genome to be sequenced, Lotus
and Medicago representing the legume family, poplar representing tree species, and Brassica and toma-
to. Furthermore, strategies for tackling larger and more complex genomes such as maize were dis-
cussed. Arabidopsis functional genomics activities, including progress toward the goal of obtaining dis-
ruptions of all 27,000+ genes by the end of the year, were reviewed at a meeting of the Multinational
Arabidopsis Steering Committee. An impressive total of more than 200,000 independent T-DNA and
transposon insertions in the Arabidopsis genome were cataloged. A workshop on Evolutionary
Genomics, organized by Gloria Coruzzi and Rob Martienssen, focused on reviewing the tools needed
Z. Lippman, S. Mc Couch, E. Vollbrecht
R. McCombie, M. Bevan, R. Martienssen
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to establish and interpret relationships between plant genomes, and on identifying the species provid-
ing the most insight into the evolution of higher plants. These so-called nodal species include the prim-
itive seed plants called cycads that bear seeds on leaves, and Ginkgo and Gnetum, two early gym-
nosperms. Extensive expressed sequence tag sequencing of these plants will form important founda-
tions for understanding the evolution of seed-bearing plants.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations also provided core support for this
meeting.
PROGRAM
Sequence and Analysis of Plant Genomes I Genome Dynamics
Chairperson: M. Bevan, John Ines Centre, Norwich, United Chairperson: J. Bennetzen, Purdue University W Lafayette,
Kingdom Indiana
The McClintock Centenary Lecture: Heterochromatin,
Transposable Elements, and Epigenetics of the Plant
Genome
Speaker: R. Martienasen, Cold Spring Harbor Laboratory
Sequence and Analysis of Plant Genomes II
Chairperson: S. Mc Couch, Cornell University Ithaca, New
York
Evolutionary Genomics Workshop
R. De Salle, American Museum of Natural History New
York: Tools for evolutionary phylogenomics.
V. Irish, Yale University New Haven, Connecticut: Genomics
and plant evolution.
G. Coruzzi, New York University New York: Future direc-
tions for plant evolutionary genomics.
Functional Genomics I
Chairperson: R. McCombie, Cold Spring Harbor
Laboratory
Functional Genomics II
Chairperson: J. Ecker, The Salk Institute for Biological
Studies, La Jolla, California
Informatics and Databases
Chairperson: C. Town, The Institute for Genomic Research,
Rockville, Maryland
MAJOR DON
'No CENTURY 2C92A
M. Rosso
kr.
I. Small, C. Town
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that they are not
adequately treated by universities. Our aim is to provide intensive study in the most recent develop-
ments and techniques in these subjects and to prepare students to enter directly into research in a par-
ticular area. To ensure up-to-date coverage of current research work, we bring together course faculty
from many laboratories around the world and supplement this staff with a series of seminar speakers.
Acquiring and Analyzing Genomic Sequence Data
March 12-28
INSTRUCTORS E. Birney, EBI, Hintxon, United Kingdom
E. Mardis, Washington University School of Medicine, St. Louis, Missouri
W.R. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Washington University School of Medicine, St. Louis, Missouri
T. Wood, Bryan College, Dayton, Tennessee
ASSISTANTS
V. Balija, Cold Spring Harbor Laboratory
M. Clamp, The Sanger Centre, Hinxton, United Kingdom
M. de la Bastide, Cold Spring Harbor Laboratory
J. Kramer, Millennium Pharmaceuticals, Watertown,
Massachusetts
D. Main, Clemson University Genomics Institute,
Clemson, South Carolina
L. Nascimento, Cold Spring Harbor Laboratory
A. O'Shaughnessy, Cold Spring Harbor Laboratory
L. Palmer, Cold Spring Harbor Laboratory
T. Rohifing, Washington University School of
Medicine, St. Louis, Missouri
L. Spiegel, Cold Spring Harbor Laboratory
T. Zutavern, Cold Spring Harbor Laboratory
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This year's course consisted of four modules, which featured (1) production sequencing and sequence
finishing, (2) sequence variation analysis, (3) cross-species sequence comparison, and (4) gene predic-
tion and annotation. The first part of the course emphasized the technical and management aspects of
large-scale physical mapping and sequencing projects, including polymorphism detection. The second
part focused on computational analysis of sequence data, including sequence variation (such as single-
nucleotide polymorphisms [SNPs]), comparative genomics, gene prediction, and sequence annotation.
Where appropriate, the computational analysis was coupled with data acquisition. A sequencing pro-
ject was carried out during the course, with an emphasis on the technical nuances of large-scale
sequencing. In the past years, this phase has targeted a bacterial artificial chromosome (BAC) clone
from various species, including Arabidopsis thaliana, mouse, chimpanzee, and human. Techniques for
generating both "working draft" and completely finished genome sequences were covered. Whole-
genome shotgun and clone-based sequencing methods utilizing capillary-based sequence acquisition
was taught. The project this year was a low-coverage whole-genome shotgun of a bacterium.
Sequence variation analysis featured SNP generation and detection methods. A laboratory project
included sequencing of targeted regions from multiple individuals and additional SNP analysis.
Computational analysis focused on using readily available tools for comparative genomics, gene pre-
diction, and annotation methods. Data from the course production sequencing module was utilized, as
were examples from the publicly accessible sequence archives. Sequence homology was used to ana-
lyze orthologous and parologous sequences. Ab initio gene prediction as well as supporting evidence
using expressed sequence tags (EST), mRNA, and homologous sequences were profiled. These mod-
ules focused on the use of the tools themselves and on the underlying algorithms. For a more in-depth
coverage of sequence analysis theory, the Computational Genomics Course was recommended.
PARTICIPANTS
Dore, C., DipL., Montreal Genome Center, Montreal, Canada
Elgin, S., B.A., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Jungerius, B., B.Sc., M.Sc., Wageningen University, The
Netherlands
La Rota, C., B.S., M.S., Cornell University, Ithaca, New York
Liu, X., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Moody, Adrian, B.Sc., Ph.D., AstraZeneca, Cheshire, United
Kingdom
Orjeda, G., M.S., Ph.D., Genoscope, Evry, France
Ortega, M., Tech., Institute of Biochemical Research,
Argentina, Buenos Aires
Peterlongo, R, B.S., Ph.D., Memorial Sloan-Kettering Cancer
SEMINARS
Altshuler, D., Massachusetts General Hospital, Boston: SNPs
and association studies I.
Altshuler, D., Massachusetts General Hospital, Boston: SNPs
and association studies II.
Green, E., National Institutes of Health, NHGRI, Bethesda,
Maryland: Comparative sequence analysis.
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Center, New York
Song, Z., B.S., Ph.D., Massachusetts Institute of Techology,
Cambridge
Turpeinen, H., M.Sc., Ph.D., University of Turku, Finland
Wan, K.-L., B.Sc., Ph.D., Universiti Kebangsaan Malaysia,
Malaysia
Wang, Y.-C., B.A., Ph.D., National Taiwan Normal University,
Taiwan, Republic of China
Young, KS., B.A., Samsung Advanced Institute of
Technology, Taejon, Korea
Zhu, C., M.D., Ph.D., Karolinska Hospital, Stockholm,
Sweden
Zuccolo, A., M.Sc., University of Udine, Italy
Martienssen, R., Cold Spring Harbor Laboratory: DNA
methylation.
Wilson, R., Washington University School of Medicine, St.
Louis, Missouri: Sequence-finishing challenges.
Protein Purification and Characterization
April 3-16
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
K. Severinov, Waksman Institute, Rutgers University, Piscataway, New Jersey
ASSISTANTS L. Anthony, University of Wisconsin, Madison
V. Bergendahl, University of Wisconsin, Madison
K. Earley, M.D. Anderson Cancer Center/University of Texas, Houston
M. Galfione, M.D. Anderson Cancer Center/University of Texas, Houston
S. Jia, University of California, Los Angeles
D. Markov, Columbia University, New York
S. Nechaev, University of California, San Diego, La Jolla
G. Ratnaparkhi, University of California, Los Angeles
N. Thompson, University of Wisconsin, Madison
J. Yuzhenkova, Waksman Institute, Rutgers University, Piscataway, New Jersey
This course was intended for scientists who are not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with dis-
cussion session every evening. Each student became familiar with each of the major techniques in pro-
tein purification by actually performing four separate isolations including (1) a regulatory protein from
muscle tissue; (2) a sequence-specific, DNA-binding protein; (3) a recombinant protein overexpressed
in E. coli; and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and chro-
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matographic techniques included precipitation by salts, pH, and ionic polymers; ion-exchange, gel fil-
tration, hydrophobic interaction, and reverse-phase chromatography; lectin affinity, ligand affinity,
oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel electrophoresis, and
electroblotting; and high-performance liquid chromatography. Procedureswere presented for solubiliz-
ing proteins from inclusion bodies and refolding them into active monomeric forms. Methods of protein
characterization were utilized to include immunological and biochemical assays, protein-protein inter-
action studies by far-western analysis, peptide mapping, aminoacid analysis, protein sequencing, and
mass spectrometry. Emphasis was placed on strategies of protein purification and characterization.
Guest lecturers discussed protein structure, modification of proteins, methodologies for protein purifi-
cation and characterization, and applications of protein biochemistry to cell and molecular biology.
PARTICIPANTS
K. Barton, B.S., Ph.D., Carnegie Institute of Washington,
Stanford, California
Brandi, L, B.S., Ph.D., University of Camerino, Italy
Brodersen, P. B.S., M.S., University of Copenhagen,
Denmark
Cegelski, L., B.S., Washington University, St. Louis, Missouri
Chamberlin, M.E., B.S., Ph.D., Ohio University, Athens, Ohio
Chipuk, J.E., B.S., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Dangond, F., B.A., M.D., Brigham & Women's Hospital,
Boston, Massachusetts
Labib, K., B.A., M.D., Paterson Institute for Cancer Research,
Manchester, United Kingdom
Malashkevich, V., B.S., Ph.D., Whitehead Institute,
Cambridge, Massachusetts
SEMINARS
Burgess, R., University of Wisconsin, Madison: Overview of
protein purification, immunoaffinity purification; biochemical
studies of RNA polymerase/Sigma factor interactions.
Courey, A, University of California, Los Angeles: Mechanisms
of activation and repression by the dorsal morphogen.
Guidotti, G., Harvard University, Cambridge, Massachusetts:
Membrane proteins and extracellular ATP.
Hart, G., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Dynamic interplay between O- glycosy-
lation and 0-phosphorylation in cell signaling and metabolic
regulation.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Proteins in
3-D.
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Melnick, A., M.D., Mount Sinai School of Medicine, New
York
Rogers, M., B.S., Ph.D., Stanford University School of
Medicine, Stanford, California
Saccani, S., B.S., Ph.D., Institute of Research in
Biomedicine, Bellinzona, Switzerland
Sato, T, B.S., Ph.D., The Scripps Research Institute, La
Jolla, California
Shureiqi, I., B.S., M.D., University of Texas/M.D. Anderson
Cancer Center, Houston
Smeets, M., M.Sc., Ph.D., University Medical Centre,
Utrecht, The Netherlands
Stehr, F.C., DipL., University Institute of General Botany,
Hamburg, Germany
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Strategies for identification of prostate cancer bone metas-
tasis-related factors and 16-kD fragment of prolactin as an
angiogenesis inhibitor.
Mische, S., Boehringer-Ingelheim Pharmaceuticals,
Ridgefield, Connecticut: Proteomics and why pharmaceuti-
cal companies are interested in it.
Sauer, B., Massachusetts Institute of Technology,
Cambridge: Energy-dependent protein degradation and
unfolding.
Severinov, K., Waksman Institute, Rutgers, Piscataway, New
Jersey: Regulation of host RNA polymerase during viral
development.
Cell and Developmental Biology of Xenopus
April 6-16
INSTRUCTORS J. Christian, Oregon Health Sciences University, Portland
K. Cho, University of California, Irvine
ASSISTANTS I. Blitz, University of California, Irvine
C. Degnin, Oregon Health and Sciences University, Portland
R. Hackenmiller-Paradis, Oregon Health Sciences University, Portland
N. Hirsch, University of Virginia, Charlottesville
The frog Xenopus is an important vertebrate model for studies of maternal factors, regulation and mol-
ecular mechanisms of tissue inductions, and regulation of cell fate decisions. In addition, Xenopus
oocytes and embryos provide a powerful system in which to conduct a number of cell biological and
gene regulation assays. This course provided extensive laboratory exposure to the biology, manipula-
tion, and use of oocytes and embryos of Xenopus. The course consisted of intensive laboratory ses-
sions, supplemented by daily lectures and demonstrations from experts in cellular, experimental, and
molecular development. Areas that were covered included (1) care of adults; (2) oocyte isolation and
embryo production; (3) stages of embryonic development and anatomy; (4) whole-mount in situ
hybridization and immunocytochemistry; (5) microinjection of eggs and oocytes with lineage tracers,
DNA constructs, mRNA, and antisense oligonucleotides; (6) micromanipulation of embryos, including
explant and transplantation assays; (7) in vivo time-lapse confocal imaging; (8) preparation of trans-
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genic embryos; and (9) use of Xenopus tropicalis for genetic analyses. This course was suited both for
investigators who have had no experience with Xenopus and for those who have worked with Xenopus
and wished to learn new and cutting edge techniques. All applicants had current training in molecular
biology and some knowledge of developmental biology.
PARTICIPANTS
Brownawell, A., M.S., Ph.D., University of Virginia,
Charlottesville
Dave, V. M.S., Ph.D., University of Cincinnati, Ohio
Dorey, K., B.Sc., Ph.D., Imperial Cancer Research Fund,
London, United Kingdom
Kee, Y., B.Sc., M.S., Ph.D., Caltech, Pasadena, California
LaFollette-Shumway, K., B.A., Ph.D., University of Texas
Health Science Center, Houston
Leung Wai Lun, A., B.Sc., Ph.D., The University of Hong Kong,
Hong Kong
Manson, F., B.Sc., Ph.D., Western General Hospital,
Edinburgh, United Kingdom
Morris, A., B.S., Ph.D., Emory University School of Medicine,
Atlanta, Georgia
SEMINARS
Amaya, E., Welcome, CRC Institute, United Kingdom:
Transgenesis and insertional mutagenesis in Xenopus.
Cho, K., University of California, Irvine: Probing vertebrate
development using DNA microarrays.
Christian, J., Oregon Health Sciences University, Portland:
Regulation of BMP activity by proprotein processing.
Danilchik, M., Oregon Health Sciences University, Portland:
Membrane dynamics during cleavage in Xenopus.
Harland, R., University of Californa, Berkeley: Signaling and
morphogenesis.
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Nasipak, B., BA., Columbia University, New York
Palmer, M., B.S., Emory University, Atlanta, Georgia
Reddy, R, M.B.B.S., Cincinnati Children's Hospital Medical
Center, Cincinnati, Ohio
Strouboulis, J., Ph.D., Erasmus University, Rotterdam, The
Netherlands
Sun, H., B.S., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Toreejon, M., B.S., Ph.D., National Research Council, Moffett
Field, California
Vottari, T., Laurente, University of Pisa, Italy
Walsh, S., B.S., Ph.D., Duke University, Durham, North
Carolina
Heasman, J., Children's Hospital Medical Center, Cincinnati,
Ohio: Maternal control of embryonic cell fates.
Cline, H., Cold Spring Harbor Laboratory: Analysis of activity-
regulated genes in brain development in Xenopus.
Moody, S., George Washington University Medical Center,
Washington, D.C.: Introduction to early embryology; the
role of FoxD5 in expanding the neural plate.
Ueno, N., National Institute for Basic Biology, Japan: A new
player controlling Xenopus gastrulation.
Advanced Bacterial Genetics
June 5-25
INSTRUCTORS K. Hughes, University of Washington, Seattle,
W. Metcalf, University of Illinois, Urbana
P. Youderian, Texas A&M University, College Station
ASSISTANTS P. Aldridge, University of Washington, Seattle
L.T. Socias, Texas A&M University, College Station
M. Wilson, University of Illinois, Urbana
The course presented logic and methods used in the genetic dissection of complex biological process-
es in eubacteria. The following laboratory methods were used: classical mutagenesis using trans-
posons, mutator strains, and chemical and physical mutagens; the mapping of mutations using genet-
ic and physical techniques; modern approaches to the generation and analysis of targeted gene dis-
ruptions and fusions using polymerase chain reaction (PCR) and cloning methods; epitope insertion
mutagenesis; and site-directed mutagenesis. Key components of the course were sophisticated
genetic methods in the analysis of model eubacteria and the use of the wealth of new genomic
sequence information to motivate these methods. Invited lecturers presented various genetic
approaches to study eubacterial mechanisms of metabolism, development, and pathogenesis.
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PARTICIPANTS
Bach ler, C., B.S., M.S., Universitat Bern, Switzerland
Bartoli, F., B.S., M.Sc., Institute Venezolano Investigaciones,
Cientificas, Caracas, Venezuela
Cowart, R., B.S., Ph.D., University of Dubuque, Iowa
Ferguson G B Sc Ph D Massachusetts Institute of
Technology, Cambridge
Herskovits, A., B.S., M.S., Weizmann Institute of Science,
Rehovot, Israel
Johansson, C., M.S., Uppsala University, Sweden
Laal, S., M.S., Ph.D., New York University School of
Medicine, New York
Maeder, C., B.S., Johns Hopkins University, Baltimore,
Maryland
SEMINARS
Camilli, A., Tufts University, Boston, Massachusetts:
Investigation of pathogen gene expression during infection
using in vivo expression technology CIVET).
Galan, J., Yale University, New Haven, Connecticut: Close
encounters of Salmonella with host cells: Type III secretion
at work.
Groisman, E., Washington University School of Medicine, St.
Louis, Missouri: Two-component signal transduction in
Salmonella and E. coll.
Hughes, K., University of Washington, Seattle: Coupling fla-
gellar gene expression to organelle assembly.
Jenal, U., University of Basel, Switzerland: Temporal and spa-
tial control mechanisms during the Caulobacter cell cycle
and development.
Kenney, L., Oregon Health Science University, Portland:
OmpR regulation of porin gene expression.
Lory, S., Harvard Medical School, Boston, Massachusetts:
Listening to conversations between pathogens and their
268
Martins, L., B.S., Ph.D., Institute de Tecnologia Quimicae
Biologica, Oeiras, Portugal
Meng, J., B.S., Ph.D., University of Maryland, College Park
Nilsen, T., M.Sc., Ph.D., Massachusetts General Hospital,
Cambridge
Putteet-Driver, A., B.S., University of California, Irvine
Rao, C., B.S., Ph.D., University of California, Berkeley
Sjolund, M., M.Sc., Ph.D., Uppsala University, Sweden
Srinivasan, B., B.S., M.S., Ph.D., Stanford University,
Stanford, California
Tankson, J., B.S., M.S., Ph.D., USDA/Agricultural Research
Services, Athens, Georgia
hosts with DNA microarrays.
Maloy, S., University of Illinois, Urbana: Genetics of host
specificity in Salmonella.
Metcalf, W., University of Illinois, Urbana: The global phos-
phate cycle.
Normark, S., Karolinska Institute, Stockholm, Sweden:
Bacterial interactions with the innate immune system.
Roth, J., University of Utah, Salt Lake City: Adaptive muta-
tion: A misinterpreted bacterial artifact reveals a genetic
process that may be central to bacterial adaptation, evalu-
ation of new genes, and origins of cancer.
Rothman-Denes, L., University of Chicago, Illinois: Expanding
the family of single-subunit DNA-dependent RNA poly-
merases.
Silhavy, T., Princeton University, Princeton, New Jersey:
Coping with envelope stress.
Youderian, R, Texas A&M University, College Station: Are
bacterial outer-membrane channels ligand-gated?
Molecular Embryology of the Mouse
June 5-25
INSTRUCTORS R. Behringer, University of Texas/M.D. Anderson Cancer Center, Houston
A. Goss ler, Institut fur Molekularbiologie, Hannover, Germany
A. Nagy, Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
CO-INSTRUCTORS S. Colin, National Cancer Institute/FCRDC, Frederick, Maryland
T. Lufkin, Mount Sinai School of Medicine, New York
ASSISTANTS A. Kobayashi, M.D. Anderson Cancer Center, Houston, Texas
M. Gerstenstein, Samuel Lunenfeld Research Institute, Toronto, Canada
K. Serth, Institut fur Molekularbiologie, Hannover, Germany
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse embryonic development. Laboratory components provided an intro-
duction into the technical aspects of working with and analyzing mouse embryos, and lectures provid-
ed the conceptual basis for contemporary research in mouse development. Experimental techniques
were covered in the practicals including in vitro culture and manipulation of pre- and postimplantation
embryos, transgenesis by DNA microinjection, embryo transfer, establishment, culture and genetic
manipulation of embryonic stem cells, production of chimeras by aggregation with and injection of
embryonic stem cells, and the analysis of development by whole-mount in situ hybridization, skeletal
preparation, and transgene expression.
On the last weekend of the course, a special reunion celebrating the 20th anniversary of the mouse
course was arranged. The reunion included a series of talks by past and present instructors, and also
featured a piano concert by Phillipe Soriano at Robertson House and an evening banquet around the
Banbury pool. As well as the instructors, co-instructors, assistants, and students, reunion participants
included Siew-Lan Ang, Kathryn Cheah, Frank Costantini, Susan Dymecki, Brigid Hogan, Randy
Johnson, Alexandra Joyner, Peter Koopman, Elizabeth Lacy, Robin Lovell-Badge, Terry Magnuson,
Gail Martin, Anne McLaren, Paul Overbeek, Virginia Papaioannou, Roger Pedersen, Nadia Rosenthal,
Janet Rossant, Davor Solter, Philippe Soriano, and Patrick Tam.
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PARTICIPANTS
Cambronero, F, M.D., Ph.D., Stowers Institute for Medical
Research, Kansas City, Missouri
Christian, J., B.S., Ph.D., Oregon Health Sciences University,
Portland
Filippova, G., M.S., Ph.D., Fred Hutchinson Cancer Research
Center, Seattle, Washington
Jechlinger, M., Mag., Institute of Molecular Pathology, Vienna,
Austria
Kobielak, A., M.Sc., Ph.D., The Rockefeller University, New York
Krummel, K., B.S., Ph.D., Salk Institute, La Jolla, California
Lossie, A., B.S., Ph.D., Baylor College of Medicine, Houston, Texas
SEMINARS
Aizawa, S., Kumamoto University School of Medicine, Kumamoto,
Japan: Forebrain development.
Behringer, R., The University of Texas/M.D. Anderson Cancer
Center, Houston: Transgenesis and gene targeting.
Church, D., National Institutes of Health, Bethesda, Maryland:
Mouse genomics.
Cross, J., University of Calgary, Canada: Development of extra-
embryonic tissue.
Goss ler, A., Medizinische Hockschule, Hannover, Germany:
Somitogenesis.
Gridley, T, The Jackson Laboratory, Bar Harbor, Maine: Notch
signaling.
Hogan, B., Howard Hughes Medical InstituteNanderbilt
University Medical Center , Nashville, Tennessee: Genetic reg-
ulation of organogenesis.
Jessell, T, Columbia University/Hammer Health Sciences
Center, New York: Regionalization and neuronal specification
in the spinal cord.
Joyner, A., New York Medical Center, Skirball Institute of
Biology, New York: Neural patterning.
Justice, M., Baylor College of Medicine, Houston, Texas: ENU
mutagenesis.
Lovell-Badge, R., MRC National Institute for Medical Research,
London, United Kingdom: Sex determination: Building genetic
pathways.
Lufkin, T., Mount Sinai School of Medicine, New York: HOX
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Martin de Lara, F., B.S., M.S., CIB Spanish Research Council,
Madrid, Spain
Naz, S., B.S., Ph.D., National Institute on Deafness and Other
Communication Disorders, Rockville, Maryland
Nieto, M., M.S., National Center of Biotechnology, Madrid, Spain
Sachidanandan, C., M.Sc., Ph.D., Cancer Research UK,
London, United Kingdom
Savage, J., BA., M.S., Indiana University Purdue University,
Indianapolis
Vokes, S., BA., University of Arizona Health Sciences Center,
Tucson
Vong, L., B.S., Ph.D., Albany Medical College, New York
genes and patterning.
Magnuson, T, University of North Carolina, Chapel Hill:
Model system mouse: A synthesis and examples.
Martin, G., University of California, San Francisco: FGFs and
limb development.
McLaren, A., Wellcome/CRC Institute, Cambridge, United
Kingdom: Germ cells.
Nagy, A., Mount Sinai Hospital, Toronto, Canada: Embryonic
stem cells and the biology of chimeras.
Rosenthal, N., EMBL-Monterotondo, Monterotondo-Scala,
Italy: Heart development.
Schimenti, J., The Jackson Laboratory, Bar Harbor, Maine:
Modern and classical forward approaches in mice for iden-
tifying novel developmental genes.
Scholer, H., University of Pennsylvania, Kenneth Square:
Gene funciton and regulation in pluripotent stem cells.
Shen, M., UMNDJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Left-right patterning.
Solter, D., Max-Planck Institut fur Immunbiologie, Freiburg,
Germany: Fertilization and preimplantation development.
Stewart, A.F., Technische Universitaet Dresden, Dresden,
Germany: Targeting strategies: Design, construction, and
integration of conditional options.
Stewart, C., National Cancer lnstitute/FCRDC, Frederick,
Maryland: Implantation.
Tam, P., Children's Medical Research Institute, Wentworth-
villa, Australia: Postimplantation development and body
plan.
Mouse Course Reunion
Physiological Approaches to Ion Channel Biology
June 5-25
INSTRUCTORS M. Hausser, University College London, United Kingdom
N. Spruston, Northwestern University, Evanston, Illinois
L. Trussell, Oregon Health Sciences University, Portland
ASSISTANTS J. Dzubay, University of California, Los Angeles
S. Malin, Washington University, St. Louis, Missouri
P. Monsivais, University College London, United Kingdom
N. Staff, Northwestern University, Evanston, Illinois
This intensive laboratory/lecture course introduced the students to electrophysiological approaches for
the study of ion channels in their native environments. Hands-on exercises included patch-clamp
recording of ion-channel activity in cultured cells or neurons in brain slice preparations. Different record-
ing configurations (e.g., extracellular, whole-cell, cell-free patches, and single channel) were used. The
advantages and disadvantages of each method and preparation were considered in order to match
experimental approaches to scientific questions. Similarly, various methods for ligand/drug application
were demonstrated. A primary goal was to identify properties of ion channels that allow neurons to
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carry out their unique physiological or systems-level roles. These properties are related to information
previously gained from molecular cloning and heterologous expression of ion-channel genes. Areas of
particular interest included channels that (1) are activated by neurotransmitter at central and peripher-
al synapses, (2) interact with other channels to shape the response properties of neurons, (3) respond
to neuromodulators with changes in functional properties, or (4) are developmentally required and reg-
ulated. The research interests of guest lecturers complemented and expanded this list. This course
was intended for students with specific plans in applying these techniques to a defined problem.
PARTICIPANTS
Cass ler, C., B.S., M.S., International School for Advanced
Studies, Trieste, Italy
Chin, J., B.Sc., University of Alberta, Edmonton, Canada
Cho, W.K., B.A., B.S., M.D., Indiana University, Indianapolis
Craig, AM., B.Sc., Ph.D., Washington University School of
Medicine, St. Louis, Missouri
Feranchak, A., B.S., M.D., University of Colorado, Denver
Karpova, A., B.S., M.S., Ph.D., Cold Spring Harbor
Laboratory
SEMINARS
Diamond, J., National Institutes of Health, Bethesda,
Maryland: Glutamate transporters and synaptic transmis-
sion.
Farrant, M., University College London, United Kingdom:
GABAergic synaptic transmission.
Hausser, M., University College London, United Kingdom:
Recording voltage-gated and synaptic currents. Purkinje
cells: Dendritic excitability and synaptic integration.
Huguenard, J., Stanford University Medical School, Stanford,
California: Cortical synaptic networks.
Llinas, R., New York University School of Medicine, New
York: A historical look at ion channel physiology.
Mc Bain, C., National Institutes of Health, Bethesda,
Maryland: Ion channels in interneurons.
Nerbonne, J., Washington University School of Medicine, St.
Louis, Missouri: Molecular basis of functional voltage-gated
Kt- channel diversity.
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Luneborg, N., B.A., University College London, United
Kingdom
McKay, B., B.S., M.S., University of Calgary, Alberta, Canada
Metz, AE., BA., Northwestern University, Evanston, Illinois
Ramos, R., BA., MA., University of Connecticut, Storrs
Roseberry, A., B.A., M.S., Ph.D., The Rockefeller University,
New York
Wise, D., B.S., University of Texas, Austin
Malin, S., Washington University School of Medicine, St.
Louis, Missouri: K channels in cardiac muscle. K channels
in neurons.
Siegelbaum, S., Columbia University, New York: Cyclic-
nucleotide-gated channels.
Spruston, N., Northwestern University, Evanston, Illinois:
Cable theory and synaptic integration. Dendritic excitability
and synaptic integraton in the hippocampus.
Stuart, G., John Curtin School of Medical Research,
Canberra, Australia: Dendritic excitability and synaptic inte-
gration, neocortex layer V
Sullivan, J., University of Washington, Seattle: Cannabinoid
receptors and synaptic transmission.
Svoboda, K., Cold Spring Harbor Laboratory: Imaging den-
dritic spines.
Trussell, L., Oregon Health Sciences University, Portland:
Synaptic transmission in the auditory system.
Computational Neuroscience: Vision
June 13-26
INSTRUCTORS E.J. Chichilnisky, The Salk Institute, La Jolla, California
P. Glimcher, New York University, New York
E. Simoncelli, New York University, New York
ASSISTANTS A. Church land, University of California, San Francisco
J. Pillow, New York University, New York
Computational approaches to neuroscience produced important advances in our understanding of
neural processing. Prominent success came in areas where strong inputs from neurobiological, behav-
ioral, and computational investigation can interact. The theme of the course was that an understand-
ing of the computational problems, the constraints on solutions to these problems, and the range of
possible solutions can help guide research in neuroscience. Through a combination of lectures and
hands-on experience in a computer laboratory, this intensive course examined color vision, spatial pat-
tern analysis, motion analysis, oculomotor function, attention, and decision-making.
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PARTICIPANTS
Alitto, H., B.S., University of California, Davis
Allred, S., B.S., University Washington, Seattle
Borghuis, B., M.A., Utrecht University, Holland
Boucher, L., B.A., Ph.D., Dartmouth College, Hanover, New
Hampshire
Chatterjee, S., A.B., Salk Institute, La Jolla, California
Corrado, G., BA., Stanford University, Stanford, California
Curnow, T., M.Sc., University of Oxford, United Kingdom
Hillis, J., B.Sc., University of Berkeley, California
Knappmeyer, B., M.S., Max-Planck Institute for Biological
Cybernetics, Tuebingen, Germany
Lau, B., B.A., New York University, New York
Mante, V., M.S., ETH Zurich, Switzerland
Ned, P., D.Phil., Stanford University, Stanford, California
Olman, C., B.S., University of Minnesota, Minneapolis
Osindero, S., B.A., M.Sc., Gatsby Computational
SEMINARS
Adelson, E., Massachusetts Institute of Technology,
Cambridge: Elements of vision/lightness.
Brainard, D., University of California, Santa Barbara:
Trichromacy.
Brainard, D., University of California, Santa Barbara: Color
vision: Trichromacy and context effects.
Chichilnisky, E.J., The Salk Institute, La Jolla, California:
Contextual effects.
Chichilnisky, E.J., The Salk Institute, La Jolla, California:
Retinal processing. White noise analysis. Tetinal adaptation.
Cullen, K., McGill University, Montreal, Canada: Eye move-
ments II.
Glimcher, P., New York University, New York: Review: Signal
detection theory. Eye movements. Perceptual decisions II.
Grill Spector, K., Stanford University, Stanford, California:
Object/shape human physiology (fMRI).
Heeger, D., Stanford University, Stanford, California: Human
physiology (fMRI) of attention.
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Neurosciences Unit, London, United Kingdom
Peirce, J., Ph.D., New York University, New York
Rokers, B., BA., MA., University of California, Los Angeles
Ruppertsberg, A., M.Sc., Ph.D., Kee le University, United
Kingdom
Rust, N., B.S., New York University, New York
Schluppeck, D., MA., D.Phil., University of California, Los
Angeles
Smith, M., BA., MA., York University, Toronto, Canada
Swinehart, C., B.S., Brandeis University, Waltham,
Massachusetts
Tcheang, L., M.Sc., University of Oxford, United Kingdom
Troncoso, X., B.S., University College London, United
Kingdom
Wyder, M., BA., Wake Forest University School of Medicine,
Winston Salem, North Carolina
Movshon, J.A., New York University, New York: LGNN1
physiology. MT physiology.
Rieke, F., University of Washington, Seattle: Photoreceptors
and photon detection. Spikes and information.
Simonceli, E., New York University, New York; Mathematical
tools: Linear systems, Fourier, probability/statistics. Image
statistics and visual processing. Motion perception and
modeling.
Kersten, D., University of Minnesota, Minneapolis: Object/
shape psychophysics.
Newsome, W., Stanford University, Stanford, California:
Motion: Linking physiology and perception.
Shad len, M., University of Washington, Seattle: Neural noise
and perception. Perceptual decisions I.
Treue, S., University of Tuebingen, Germany: Attention physi-
ology.
Verghese, P., Smith Kettlewell Eye Research Institute, San
Francisco, California: Attention psychophysics.
Making and Using DNA Microarrays
June 18-25
INSTRUCTORS J. DeRisi, University of California,
V. lyer, University of Texas, Austin
ASSISTANTS
A. Carroll, University of California, San Francisco
M. Diehn, Stanford University School of Medicine,
Stanford, California
R Killion, University of Texas, Austin
J. Lieb, University of North Carolina, Chapel Hill
M. Llinas, University of California, San Francisco
PARTICIPANTS
San Francisco
C. Murphy, University of California, San Francisco
B. Pulliam, University of California, San Francisco
C. Seidel, University of California, Berkeley
A. Sil, University of California, San Francisco
D. Wang, University of California, San Francisco
Alberola, T., B.S., Ph.D., University of Valencia, Spain
Jarlebark, L., B.Sc., Ph.D., Karolinska Institute, Stockholm,
Switzerland
Al-Murrani, S., B.Sc., Ph.D., Pennsylvania State College of
Medicine, Hershey
Koukoulas, I., B.Sc., Ph.D., The University of Melbourne,
Australia
Armstrong, L., B.S., M.S., University of Texas, San
Antonio
Kovacs, S., B.A., Ph.D., California State University, Fresno
Chakraborty, S., B.Sc., Ph.D., Jawaharial Nehru University,
New Delhi, India
Laloraya, S., M.Sc., Ph.D., Indian Institute of Science,
Bangalore, India
Collett, H., B.Sc., Ph.D., University of Cape Town, South
Africa
Linney, E., B.S., Ph.D., Duke University Medical Center,
Durham, North Carolina
Eudy, J., B.S., Ph.D., University of Nebraska Medical Center,
Omaha
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Minois, N., B.A., Ph.D., Max-Planck Institute for
Demographic Research, Rostock, Germany
Feng, Q., B.S., Ph.D., Great Lakes Forestry Centre, Ontario,
Canada
Shirsat, N., M.Sc., Ph.D., Tata Memorial Centre, Mumbai,
India
Fowlks, E., B.S., Ph.D., Hampton University, Virginia
Simmons, S., B.A., Ph.D., Woods Hole Oceanographic
SEMINARS
Carroll, A., University of California, San Francisco: Core.
DeRisi, J., University of California, San Francisco: Introduc-
tion. Field overview.
Diaz, E., University of California, Berkeley: Spatial and tempo-
ral maps of gene expression in the developing nervous sys-
tem.
Diehn, M., Stanford University School of Medicine, Stanford,
California: Genomic expression programs and the integra-
tion of the CD28 costimulatory signal on T-cell activation.
Imam, F., Stanford University, Stanford, California: A tran-
scriptional analysis of development in Drosophila
melanogaster.
lyer, V., University of Texas, Austin: Exploring transcriptional
programs and mechanisms on a genome-wide scale.
Jamieson, C., University of California, San Francisco: How I
set up a microarray consortium: An evolutionary concept!
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Institute Massachusetts
Gadea, J., B.S., Ph.D., Universidad Politecnica de Valencia,
Spain
Vallar, L., M.A., Ph.D., CRP-Sante, Good Duchy of
Luxembourg
Griffith, B., B.S., M.S., University of New Mexico Health
Sciences Center, Albuquerque
Weaver, D., B.S., Ph.D., Medical College of Ohio, Toledo
Li, J., University of California, San Francisco: Genome-wide
analysis of DNA replication.
Lieb, J., University of North Carolina, Chapel Hill: Exploring
specificity in protein-genome interactions.
Lines, M., University of California, San Francisco: Micro-
array-based whole-genome approaches.
Murphy, C., University of California, San Francisco: Discovery
of novel lifespan genes through microarrays analysis of the
DAF-2 pathway.
Seidel, C., University of Berkeley, California: Robotics funda-
mentals.
Sil, A., University of California, San Francisco: Using genomics
to probe pathogenesis in Histoplasma capsulatum.
Wang, D., University of California, San Francisco: Microarray-
based detection and genotyping of viruses.
Biology of Developmental Disabilities
June 28-July 3
INSTRUCTORS B.J. Casey, Weill Medical College of Cornell University, New York
Y. Munakata, University of Denver/University of Colorado
This lecture course explored basic developmental principles of the brain and behavior and their appli-
cation to understanding the biology of developmental disabilities. Leading developmental neurobiolo-
gists, neuroscientists, and psychologists presented models of typical and atypical brain development.
Students were exposed to a wide spectrum of methods currently being used in developmental science
including neuroimaging, computational modeling, and animal models.
PARTICIPANTS
Amso, D., B.S., Ph.D., Cornell University, Ithaca, New
York
Ansari, D., B.A., M.Sc., Institute of Child Health, London,
United Kingdom
Bonte, M., B.A., M.A., University of Maastricht, The
Netherlands
Byrd, D., B.A., M.S., University of Florida, Gainesville
Creel, S., B.A., BS, University of Rochester, New York
Dyer, J., B.A., University of Michigan, Ann Arbor
Edgin, J., B.S., M.S., University of Denver, Colorado
Griffin, A., B.A., University of Texas, Austin
Hamilton, E., B.A., University of Michigan, Ann Arbor
Marcus, D., B.A., M.A., University of Minnesota, Minneapolis
Menzer, D., A.B., Wake Forest University, Winston-Salem,
North Carolina
Raitano, N., B.S., M.A., University of Denver, Colorado
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Rueda-Cuerva, M., B.S., Ph.D., Sack ler Institute for
Developmental Psychobiology, New York
Shohamy, D., B.A., Ph.D., Rutgers University, Newark, New
Jersey
Snyder, K., B.S., University of Minneapolis, Minnesota
Stedron, J., B.A., M.A., University of Denver, Colorado
SEMINARS
Amaral, D., University of California, Davis: Amygdala, social
behavior, and neurodevelopmental disorders.
Bates, E., University of California, San Diego, La Jolla:
Plasticity and reorganization of language.
Casey, B.J., Weill Medical College of Cornell University, New
York: Development of frontostriatal circuitry and cognitive
control.
Davidson, M., Weill Medical College of Cornell University,
New York: Basic principles and acquisition of fM.
Fosse Ila, J., Weill Medical College of Cornell University, New
York: Genetics workshop.
Gould, E., Princeton University, Princeton, New Jersey:
Neurogenesis in the adult brain.
Greenough, W., University of Illinois, Urbana: Environmental
and genetic factors.
Kennedy, D., Massachusetts General Hospital Center for
Morphometric Analysis, Charlestown: Basic principles and
acquisition of MRI and DTI.
Lewis, D., University of Pittsburgh, Pennsylvania: Development
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Townsend, E., B.A., MPT, University of Minnesota,
Minneapolis
Webb, S., B.A., Ph.D., University of Washington, Seattle
Wilbrecht, L., BA., The Rockefeller University, New York
Ziergler, D., B.S., Massachusetts General Hospital/Harvard
University
and disruption of prefrontal cortex.
McCandliss, B., Weill Medical College of Cornell University,
New York: Development and plasticity of reading and
speech.
Mc Ewen, B., The Rockefeller University, New York: Impact of
stress on developmental and learning.
Munakata, Y., University of Denver/University of Colorado,
Boulder: Computational modeling workshop.
Nottebohm, F., The Rockefeller University, New York: Vocal
learning and neuronal replacement in the songbird.
Thomas, K., Weill Medical College of Cornell University, New
York: Development of the amygdala response: Applications
of fMRI.
Watts, R., Weill Medical College of Cornell University, New
York: Hands-on workshop on DTI analysis.
Worden, M., Weill Medical College of Cornell University, New
York: Basic principles and acquisition of EEG/ERP. Hands-
on workshop on EEC/ERP analysis.
Mouse Behavioral Analysis
June 28-July 11
INSTRUCTORS S. Anagnostaras, Emory University, Atlanta, Georgia
M. Mayford, The Scripps Research Institute, La Jolla, California
ASSISTANTS A. Matynia, University of California, Los Angeles
S. Mitchell, Emory University, Atlanta, Georgia
L. Reijmers, The Scripps Research Institute, La Jolla, California
B. Wiltgen, University of California, Los Angeles
This course was intended to provide a theoretical and experimental introduction to behavioral analysis
in the mouse, with a focus on learning and memory. It was specially designed for geneticists, molecu-
lar biologists, pharmacologists, and electrophysiologists with a need for a hands-on introduction to
behavioral analysis of the mouse. Additionally, the course covered the principles of using mutant mice
in behavioral studies, as well as the issues involved in integrating behavioral, neuroanatomical, neuro-
physiological, and molecular findings. Among the methods presented were the water maze, cued and
contextual fear conditioning, natural/ethologically relevant learning, open field behavior, and the rotor-
rod and other activity tests.
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PARTICIPANTS
Battaglia, M., B.A., M.D., S. Raffaele University, Milan, Italy
Furukawa, T., M.D., Ph.D., Osaka Bioscience Institute,
Osaka, Japan
Murphy, B.A., B.S., M.S., Merck, Rahway, New Jersey
Pietras, M., B.Sc., M.Sc., Astrazeneca, Wilmington, Delaware
Pozueta, J., B.A., M.A., Universidad Autonoma de Madrid,
Spain
Sadhu, A., M.S., Friedrich Meischer Institute, Basel,
Switzerland
SEMINARS
Anagnostaras, S., Emory University, Atlanta, Georgia:
Statistics.
Blanchard, R., University of Hawaii, Honolulu: Aggressive and
defensive behavior in the rat and mouse. Crosspieces gen-
erality of aggression and defense.
Costa, R., University of California, Los Angeles: Mouse mod-
els of cognitive disorders.
Crawley, J., National Institutes of Mental Health, Bethesda,
Maryland: Strategies for behavioral phenotyping of a new
transgenic or knockout mouse.
Eichenbaum, H., Boston University, Massachusetts: The hip-
pocampus.
Hen, R., Columbia University, New York: Genetic studies of 5-
HT function.
Matynia, A., University of California, Los Angeles: Phenotypic
screen for long-term memory mutants.
Mayford, M., The Scripps Research Institute, La Jolla,
Seong, E., B.S., M.S., University of Michigan, Ann Arbor
Thomas, M., B.A., Ph.D., University of Michigan, Ann Arbor
Van Amerongen, R., M.Sc., Netherlands Cancer Institute,
Amsterdam, The Netherlands
Watson, J., Vet.M.B., Johns Hopkins University, Baltimore,
Maryland
Zhao, B., B.S., Ph.D., Karolinska Institute, Stockholm,
Sweden
California: Ca" signaling in long-term memory. Genetic
background issues in mice.
Quirk, M., Massachusetts Institute of Technology,
Cambridge: CA3-specific knockout of NMDA receptors.
Disruption of LTP and pattern completion.
Reijmers, L., The Scripps Reseach Institute, La Jolla,
California: ENU screen for memory mutants.
Robinson, T, University of Michigan, Ann Arbor: Drug-
induced neurobehavioral plasticity.
Stephan, A., Emory University, Atlanta, Georgia: Introduction
to behavioral psychology I. Introduction to behavioral psy-
chology II.
Wiltgen, B., University of California, Los Angeles: CA1-spe-
cific GIuR1 KO mice exhibit enhanced LTP and impaired
hippocampal-dependent learning.
Young, L., Emory University, Atlanta, Georgia: Selective loss
of social recognition in oxytocin knockout mice.
Arabidopsis Molecular Genetics
June 28-July 18
INSTRUCTORS J. Bowman, University of California, Davis
U. Grossniklaus, University of Zurich, Switzerland
R. Pruitt, Purdue University, West Lafayette, Indiana
ASSISTANTS U. Akinci, University of Zurich, Switzerland
J.-Y. Lee, University of California, Davis
J. Victor, Purdue University, West Lafayette, Indiana
This course provided an intensive overview of topics in plant growth, physiology, and development,
focusing on molecular genetic approaches to understanding plant biology. It emphasized recent results
from Arabidopsis thaliana and other model plants and provided an introduction to current methods
used in Arabidopsis research. It was designed for scientists with experience in molecular techniques
or in plant biology who wish to work with Arabidopsis. The course consisted of a vigorous lecture
series, a hands-on laboratory, and informal discussions. Discussions of important topics in plant
research were presented by the instructors and by invited speakers. These seminars included plant
morphology and anatomy; plant development (including development of flowers, roots, meristems, and
leaves, male and female gametophytes, and embryos); perception of light and photomorphogenesis;
and synthesis, function, and perception of hormones. Lectures describing bioinformatics tools avail-
able to the Arabidopsis community, and the resources provided by the Arabidopsis genome project to
accelerating Arabidopsis research, were also included. Speakers provided overviews of their fields, fol-
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lowed by in-depth discussions of their own work. The laboratory sessions provided an introduction to
important techniques currently used in Arabidopsis research. These included studies of Arabidopsis
development, mutant analysis, in situ detection of RNA, histochemical staining, transient gene expres-
sion, applications of green fluorescent protein fusions, protein interaction and detection, proteomics
approaches, transcription profiling, and techniques commonly used in genetic and physical mapping.
The course also included several short workshops on important themes in genetics.
PARTICIPANTS
Bullis, D., B.S., Torrey Mesa Research Institute, San Diego,
California
Chakraborty, S., B.Sc., Ph.D., Jawaharlal Nehru University,
New Delhi, India
Des Marais, D., BA., Duke University, Durham, North
Carolina
Farrell, G., B.Sc., University of Wales, Aberystwyth, Wales
Hark, A., B.S., Ph.D., Michigan State University, East Lansing
Havecker, E., B.S., Iowa State University, Ames
Hems ley, R., B.Sc., Ph.D., John Innes Centre, Norwich,
United Kingdom
SEMINARS
Banks, J., Purdue University, West Lafayette, Indiana:
Gametophytes and evolution.
Bent, A., University of Wisconsin, Madison: Plant pathogen.
Bowman, J., University of California, Davis: Flowers.
Coup land, G., The John Innes Centre, United Kingdom:
Flowering time.
Deng ler, N., University of Toronto, Canada: Plant anatomy.
Ecker, J., The Salk Institute for Biological Sciences, La Jolla,
California: Genomics.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophyte.
Hangarter, R., Indiana University, Bloomington: Light responses.
Harper, J., The Scripps Research Institute, La Jolla,
California: Calcium and signaling.
Jackson, D., Cold Spring Harbor Laboratory: Meristem and
leaf.
Jorgensen, R., University of Arizona, Tucson: Epigenetics II.
Juenger, T, University of California, Berkeley: Quantitative
genetics.
Kellogg, E., University of Missouri, St. Louis: Evolution.
Malamy, J., University of Chicago, Illinois: Roots.
Martienssen, R., Cold Spring Harbor Laboratory: Enhancers
traps.
Mc Court, P., University of Toronto, Canada: Hormone net-
works.
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lsraelsson, M., B.S., Ph.D., Swedish University of Agricultural
Sciences, Umea, Sweden
Jennings, C., B.Sc., LaTrobe University, Victoria, Australia
Kaplinsky, N., BA., Ph.D., University of California, Berkeley
Kim, M.J., B.S., M.S., Korea University, Seoul, Korea
Kumari, N., B.S., M.S., Ohio State University, Columbus
Leiber, R., DipL., The Scripps Research Institute, La Jolla,
California
MacDonald, T., B.Sc., Ph.D., Goteborg University, Sweden
Ramon, M., B.S., M.S., Catholic University Leuven, Belgium
Sangster, T, BA., Ph.D., University of Chicago, Illinois
Nasrallah, J., Cornell University, Ithaca, New York: Self
incompatibility.
Ogas, J., Purdue University, West Lafayette, Indiana:
Embryogenesis.
Peck, S., John Innes Centre, Norwich, United Kingdom:
Proteomics.
Penna, D.D., Michigan State University, East Lansing:
Secondary metabolism.
Pruitt, R., Purdue University, West Lafayette, Indiana: Male
gametophyte and signaling.
Quatrano, R., Washington University, St. Louis, Missouri: Cell
biology.
Schaller, E., University of New Hampshire, Durham: Ethylene.
Smyth, D., Monash University, Clayton, Australia: The big
picture.
Spector, D., Cold Spring Harbor Laboratory: Microscopy.
Sussex, I., Yale University, Newtown, Connecticut:
Introduction.
Vance, V., University of South Carolina, Columbia:
Epigenetics I.
Walbot, G., Stanford University, Stanford, California:
Transposons.
Zhu, T, Torrey Mesa Research Institute, San Diego,
California: Affymetrix chips.
Molecular Cloning of Neural Genes
June 28-July 18
INSTRUCTORS J. Boulter, University of California, Los Angeles
L. Henry, Cold Spring Harbor Laboratory
K. Jensen, The Rockefeller University, New York
C. Lai, Scripps Research Institute, La Jolla, California
D. Lavery, Glaxo Wellcome Experimental Research, Lausanne, Switzerland
ASSISTANTS J. Arjomand, University of California, Los Angeles
I. Cheung, The Scripps Research Institute, La Jolla, California
C. Cottiny, Institut de Biologie Cellulaire et Morphology, Lausanne, Switzerland
C. Ferrara, The Scripps Research Institute, La Jolla, California
T. Fischer, The Scripps Research Institute, La Jolla, California
J. LeMieux, Tufts University Medical School, Boston, Massachusetts
E. Ruchti, Institut de Biologie Cellulaire et de Morphology, Lausanne, Switzerland
M. Samson, Harvard Medical School/HHMI, Boston, Massachusetts
This intensive laboratory and lecture course taught neuroscientists current approaches to molecular
neurobiology. The course consisted of daily lectures and laboratory exercises on the practice of mole-
cular neurobiology, with an emphasis on modern approaches to cloning and analyzing the expression
of neural genes. A series of evening research seminars by invited speakers focused on the ways in
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which these molecular techniques have been successfully applied. In the past, evening seminar topics
have included expression cloning, single-cell cloning, subtractive cDNA-cloning strategies, and genet-
ic and mechanistic studies of neurologic disease, acquisition of cell identity, and axon guidance in the
developing nervous system. The laboratory portion of the course began with instructions in a series of
basic molecular biological techniques and rapidly advanced to more sophisticated methodologies.
Students learned to prepare genomic, phage, and plasmid DNAs and total and poly(A)* RNAs and to
generate and screen cDNA libraries. Additional topics and methods covered included restriction map-
ping; agarose and polyacrylamide gel electrophoresis; northern and Southern blotting; subcloning;
oligonucleotide primer design; a selection of polymerase chain reaction (PCR)-based techniques; and
the use of nucleotide and protein sequence databases. Gene expression studies included the produc-
tion of fusion proteins in bacteria and mammalian cell transfection. The advanced techniques featured
the construction of cDNA libraries from single cells and the use of subtractive cDNA methods to clone
genes expressed in limited populations of cells.
PARTICIPANTS
Ango, F., Ph.D., Cold Spring Harbor Laboratory
Croft, C., B.S., University of Virginia, Charlottesville
Dulawa, S., A.B., Ph.D., Columbia University, New York
Engblom, D., B.M., University of Linkoping, Sweden
Glosmann, M., M.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Jontes, J., B.A., Ph.D., Stanford University, Stanford,
California
Kato, T., M.D., Ph.D., Brain Science Institute, Saitama,
Japan
SEMINARS
Barres, B., Stanford University, Stanford, California: Neuron-
glial interactions in the developing CNS.
Darnell, B., The Rockefeller University, New York: RNA-bind-
ing proteins in human neurological disease.
Eberwine, J., University of Pennsylvania, Philadelphia:
Molecular analysis of dendritic funcioning: mRNA localiza-
tion, mRNA transport, and local protein synthesis.
Fishell, G., Skirball Institute, New York University: Prolifera-
tion, patterning, and migration in the mouse forebrain.
Lemke, G., Salk Institute, La Jolla, California: Vex genes and
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Klemenhagen, K., B.A., Ph.D., Columbia University, New York
Korvatska, E., M.S., Ph.D., University of California, Davis
Macinnis, B., B.Sc., Ph.D., University of Alberta, Canada
Pao letti, F, SISSA-International School for Advanced Studies,
Trieste, Italy
Pongrac, J., B.Sc., Ph.D., University of Pittsburgh,
Pennsylvania
Rosenstrom, H., M.Sc., University of Helsinki, Finland
Tashiro, A., B.S., Columbia University, New York
the axial specification of the eye.
Nairn, A., Yale University, New Haven, Connecticut:
Dopamine signaling in the central nervous system.
Patapoutian, A., The Scripps Institute, La Jolla, California:
The sense of touch: A genomic approach.
Picciotto, M., Yale University, New Haven, Connecticut:
Nicotine, addiction, and learning: Using knockout mice to
go from gene to behavior.
Weinmaster, G., University of California School of Medicine,
Los Angeles: On the fringes of Notch signal transduction.
Neurobiology of Drosophila
June 28-July 18
INSTRUCTORS S. De Belle, University of Nevada, Las Vegas
A. Di Antonio, Washington University School of Medicine, St. Louis, Missouri
D. Van Vactor, Harvard Medical School, Boston, Massachusetts
ASSISTANTS Y. Ben-Shahar, University of Illinois, Urbana
K. Johnson, Harvard Cancer Center, Boston, Massachusetts
S. Marrus, Washington University School of Medicine, St. Louis, Missouri
This laboratory/lecture course was intended for researchers at all levels from beginning graduate stu-
dents through established primary investigators who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The three-week course was divided into the study of develop-
ment, physiology/function, and behavior. Daily seminars introduced students to a variety of research
topics and developed those topics by including recent experimental contributions and outstanding
questions in the field. Guest lecturers brought original preparations for viewing and discussion and
direct laboratory exercises and experiments in their area of interest. The course provided students with
hands-on experience using a variety of experimental preparations that were used in the investigation
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of current neurobiological questions. The lectures and laboratories focused on both the development
of the nervous system and its role in controlling larval and adult behaviors. In addition to an exposure
to the molecular genetic approaches available in Drosophila, students learned a variety of techniques
including embryo in situ hybridization, labeling of identified neurons, electrophysiological recording from
nerves and muscles, and the analysis of larval and adult behavior. Collectively, the course provided a
comprehensive and practical introduction to modern experimental methods for studying the Drosophila
nervous system.
PARTICIPANTS
Belay, A., B.S., University of Toronto, Ontario, Canada
Ge, X., B.S., Tsinghua University, Beijing, Peoples Republic of
China
Ghose, A., B.Sc., Ph.D., Harvard Medical School, Boston,
Massachusetts
Gilestro, G., M.S., Institute of Molecular Pathology, Vienna,
Austria
Krupp, J., B.S., University of Michigan, Ann Arbor
Li, C., Washington University, St. Louis, Missouri
Merrill, C., B.S., Vanderbilt University, Nashville, Tennessee
SEMINARS
Auld, V, University of British Columbia, Vancouver, Canada:
Embryonic glial development.
Budnick, V, University of Massachusetts, Amherst: Cell biolo-
gy of the synapse.
De Belle, S., University of Nevada, Las Vegas: Introduction to
fly behavior. Learning and mmory: hardware.
Di Antonio, A., Washington University, St. Louis, Missouri:
Synaptic plasticity.
Ferrus, A., Institute Cajal, Madrid, Spain: Postembryonic
peripheral nervous system.
Gaul, U., The Rockefeller University, New York: The develop-
ment of the visual system.
Kernan, M., SUNY, Stony Brook, New York: Mechanotrans-
duction.
Knoblich, J., Institute of Molecular Pathology, Vienna, Austria:
Embryonic neurogenesis and asymmetric cell.
Landgraf, M., Cambridge University, Massachusetts: Deter-
mination of neuronal identity.
Murphey, R., University of Massachusetts, Amherst: Giant
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Serway, C., B.A., University of Nevada, Las Vegas
Steinhilb, M., B.S., Harvard Medical School, Boston,
Massachusetts
Wakefield, S., B.Sc., King's College, London, United
Kingdom
Watson, F., B.Sc., Ph.D., Dana Farber Cancer Institute,
Boston, Massachusetts
Zhai, R.G., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
fiber system.
Nash, H., NIMH, National Institutes of Health, Bethesda,
Maryland: Anesthesia.
Shaw, P., Neuroscience Institute, Can Diego, California:
Sleep.
Sokolowski, M., University of Toronto, Canada: Foraging.
Stewart, B., University of Toronto, Canada: Synaptic trans-
mission.
Strauss, R., Theodor-Boveri-Institute, Wurzburg, Germany:
Motor behavior. Visual system.
Tepass, U., University of Toronto, Canada: Introduction to the
fly embryo.
Tully, T., Cold Spring Harbor Laboratory: Learning and mem-
ory: Software.
Van Vactor, D., Harvard University, Cambridge, Massa-
chusetts: Axon guidance mechanisms in the embryo.
Vosshall, L., The Rockefeller University, New York: Olfaction.
Waters Shuler, J., Harvard University, Cambridge, Massa-
chusetts: Fundamentals of light microscopy.
Molecular Mechanisms of Human Neurological Diseases
July 6-12
INSTRUCTORS A. Aguzzi, University Hospital of Zurich, Switzerland
S. Gandy, Thomas Jefferson University, Philadelphia, Pennsylvania
J. Hardy, Mayo Clinic, Jacksonville, Florida
How and why do neurons dysfunction or die in specific acute or chronic human neurological disorders?
What are the molecular and biochemical manifestations of specific genetic lesions in specific neuro-
logical disorders? Do different pathological dysfunctions share common mechanisms? What practical
treatments are being contemplated? This lecture course explored possible answers to these important
questions. Recent advances in neurogenetics and in molecular and cell biology have begun to shed
light on the mechanisms that underlie nervous system injury in disease states such as stroke, epilep-
sy, channelopathies, Alzheimer's disease, frontotemporal dementia, prion diseases, lissencephaly,
Fragile X mental retardation, and polyglutamine repeat disorders. Taking advantage of small class size
and extensive discussion, invited faculty lecturers examined critical issues in their area of expertise.
Overview was provided and course participants did not need to have familiarity with neurological dis-
eases, although a background in basic nervous system structure and organization was extremely help-
ful. The course focused principally on the specific hypotheses and approaches driving current research.
Emphasis was placed on the highly dynamic interface between basic and clinical investigation, includ-
ing the interdependence of clinical research and disease model development, and the value of disease
research in understanding the function of the normal nervous system.
287
PARTICIPANTS
Aarum, J., M.S., Karolinska Institutet, Stockholm, Sweden
Ajit, S., M.Phil., Ph.D., Wyeth Ayerst Research, Princeton,
New Jersey
Anikeeva, P., St. Petersburg State Technical University,
Russia
Bark, N., M.D., M.S., Karolinsa Instituet, Stockholm, Sweden
Bergman, A., M.S., Karolinska Institutet, Stockholm, Sweden
BugajGaweda, B., M.S., Memory Pharmaceuticals Corp.,
Montvale, New Jersey
Cohen-Kupiec, R., B.A., M.A., Ph.D., Tel Aviv University,
Israel
Genoud, N., B.S., M.S., University Hospital Zurich,
Switzerland
Gerwien, J., M.S., B.S., Lundbeck A/S, Valby, Denmark
Goren, 0., B.S., M.S., Tel Aviv University, Tel Aviv, Israel
Howard, V, BA., Mayo Clinic, Jacksonville, Florida
SEMINARS
Aguzzi, A., University Hospital of Zurich, Switzerland:
Molecular biology of prion diseases.
Capecchi, M., University of Utah School of Medicine, Salt
Lake City: The role of Hoxb8 in normal grooming behavior.
Darnell, R., The Rockefeller University, New York: Molecular
biology of paraneoplastic diseases.
Fischbeck, K., NINDS, NIH, Bethesda, Maryland:
Polyglutamine expansion neurodegenerative diseases.
Frackowiak, R., University College London, United Kingdom:
Functional neuroimaging.
Gandy, S., Thomas Jefferson University, Philadelphia,
Pennsylvania: Regulation of the metabolic fate of the
Alzheimer amyloid precursor.
Hardy, J., Mayo Clinic Jacksonville, Florida: Approach to neu-
rogenetics.
ladecola, C., University of Minnesota, Minneapolis: Molecular
pathology of stroke.
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Labunskiy, D., B.S., Institute of Neurology, Moscow, Russia
Klingeborn, M., B.S., M.S., Swedish University of Agricultural
Sciences, Uppsala, Sweden
Lockhart, P., B.S., Ph.D., Mayo Clinic Jacksonville, Florida
Lopes, M., B.A., M.S., Ludwig Institute for Cancer Research,
Sao Paulo, Brazil
Myre, M., B.Sc., University of Toronto, Mississauga, Canada
Pickford, E, BA., Mayo Clinic, Jacksonville, Florida
Silverman, S., B.S., Ph.D., Wyeth Research, Princeton, New
Jersey
Taylor, J., B.Sc., Mayo Clinic, Jacksonville, Florida
Venneti, S., M.D., Ph.D., University of Pittsburgh,
Pennsylvania
Voisine, C., B.S., Ph.D., Massachusetts General Hospital,
Charlestown
Wood, C., M.B., University of Leeds, United Kingdom
McNamara, J., Duke University Medical Center, Durham,
North Carolina: Molecular pathology of epilepsy.
Murphy, D., HIND, National Institutes of Health, Rockville,
Maryland: Research programs in neuroscience at NIH.
Nitsch, R., University of Zurich, Switzerland: Molecular biolo-
gy of Alzheimer's disease.
Orr, H., University of Minnesota, Minneapolis: SCA1: The
molecular basis of a polyglutamine disorder.
Schofield, P., The Garvan Institute of Medical Research,
Sydney, Australia: The inhibitory glycine receptor: Molecular
studies of structure.
Walsh, C., Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Neuronal migration disorders.
Williamson, R.A., The Scripps Research Institute, La Jolla,
California: Prions: Conformations, diagnosis, and therapy; a
role for antibody in multiple sclerosis.
Drosophila Genetics and Genomics
July 14-27
INSTRUCTORS M. Ashburner, EMBL-EBI, Cambridge, United Kingdom
K. Burtis, University of California, Davis
R.S. Hawley, Stowers Institute for Biomedical Research, Kansas City, Missouri
ASSISTANT J.E. Van Veen, Stowers Institute for Medical Research, Kansas City, Missouri
This intensive seminar course provided an introduction to the theory and practice of methods used to
analyze and manipulate the Drosophila genome. It was suitable for graduate students and researchers
with some experience with Drosophila who are interested in expanding their knowledge of the wide
range of genetic and genomic techniques now available for use with this organism. Topics covered
included chromosome mechanics, the design and execution of genetic screens, and the use of trans-
posable elements as genetic tools. We reviewed the current understanding of the genome sequence
and discussed methodologies for genomic analysis (e.g., microarrays, gene-finding methods, compar-
ison with the sequences of related species, and the heterochromatin genomic project) and proteomics
in Drosophila.
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PARTICIPANTS
Bennion, J., B.Sc., Friedrich Miescher Institute, Basel,
Switzerland
Bettencourt-Dias, M., B.S., Ph.D., Cambridge University,
United Kingdom
Blanton, H., B.A., University of North Carolina, Chapel Hill
Cabernard, C., B.S., M.S., University of Basel, Switzerland
Dandy, T, B.S., Tennessee State University, Nashville
Gong, W., B.S., Stowers Institute for Medical Research,
Kansas City, Missouri
Grade, S., B.S., University of Iowa, Iowa City
Iliopoulos, 0., B.S., M.D., Massachusetts General Hospital,
Boston
Jin, P., B.S., Ph.D., Emory University, Atlanta, Georgia
Kenyon, K., B.A., Ph.D., MEEI/Harvard Medical School,
SEMINARS
Ashburner, M., EMBL-EBI, Cambridge, United Kingdom:
Introduction to the biology of Drosophila.
Hawley, S., Stowers Institute Biomedical Research, Kansas
City, Missouri: The genetics of Drosophila Parts I and II. The
genetics of Drosophila Part III.
Bier, E., University of California, San Diego: Drosophila as a
model system for neurodegenerative diseases.
Burtis, K., University of California, Davis: Drosophila genome
biology.
Golic, K., University of Utah, Salt Lake City: Mosaic systems
and targeted insertions.
Hawley, S., Stowers Institute for Biomedical Research,
Kansas City, Missouri: The genetics and cell biology of
meiosis.
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Boston, Massachusetts
Lee, A., B.S., Harvard Medical School, Boston,
Massachusetts
Lokere, J., B.S., Harvard University, Boston, Massachusetts
Oikemus, S., B.S., University of Massachusetts Medical
School, Worcester
Paternostro, G., M.D., Ph.D., Burnham Institute, La Jolla,
California
Qian, L., B.S., Ph.D., University of Michigan, Ann Arbor
Skjesol, A., B.S., M.S., University of Iowa, Iowa City
Wikllund, M.-L., B.S. , Ph.D., Umea University, Sweden
Williams, V., B.A., University of Alabama, Birmingham
Xie, H., B.S., Stowers Institute for Medical Research, Kansas
City, Missouri
Heberlein, U., University of California, San Francisco: Genetic
analysis of behavior.
Henikoff, S., Fred Hutchinson Cancer Research, Seattle,
Washington: Heterochromatin and centromeres.
Langley, C., University of California, Davis: Genome structure
of Drosophila populations.
Lehmann, R., Skirball Institute, New York: Genetic screens.
Lewis, S., University of California, Berkeley: The fly genome:
2002 version.
Rorth, P., EMBL, Heidelberg, Germany: P-element technolo-
gies.
White, K., University of Washington, Seattle: Drosophila
microarrays.
C. elegans
July 23-August 12
INSTRUCTORS B. Bowerman, University of Oregon, Eugene
A. Chisholm, University of California, Santa Cruz
R. Korswagen, Hubrecht Laboratory, Utrecht, The Netherlands
ASSISTANTS D. Coudreuse, Hubrecht Laboratory, Utrecht, The Netherlands
R. Harrington, University of California, Santa Cruz
T. Kurz, University of Oregon, Eugene
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome pro-
ject. The course was suited both for those who have a current training in molecular biology and some
knowledge of genetics, but have no experience with C. elegans, and for students with some prior worm
experience who wished to expand their repertoire of expertise. The following topics were covered both
in the laboratory and by lectures from experts in the field: worm pushing, C. elegans databases and
worm bioinformatics, anatomy and development, forward genetics, chemical and transposon mutage-
nesis, generation of transgenic animals, expression pattern analysis, reverse genetics, construction and
screening of deletion libraries, and RNA inactivation. The course was designed to impart sufficient train-
ing to students in the most important attributes of the C. elegans system to enable students to embark
on their own research projects after returning to their home institutions.
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PARTICIPANTS
Chandra, A., B.Sc., Baylor College of Medicine, Houston,
Texas
Chang, M.-S., D.D.S., Ph.D., New York University School of
Medicine, New York
Decker, J., B.S., University of Arizona, Tucson
Deken, S., B.S., Ph.D., Washington University, St. Louis,
Missouri
Ferkey, D., B.S., Massachusetts General Hospital,
Charlestown
Ghazi, A., M.Sc., Ph.D., National Centre for Biological
Sciences, Bangalore, India
Guarin, E., B.S., Ph.D., Hoffmann-La Roche, Basel,
Switzerland
Hamza, I., B.Sc., Ph.D., Washington University School of
SEMINARS
De Bono, M., MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom: Using C. elegans to study
behavior.
Driscoll, M., Rutgers, The State University of New Jersey,
Piscataway: Using C. elegans to study neurodegeneration
and cell death.
Gonczy, P., Swiss Institute for Experimental Cancer
Research, Lausanne, Switzerland: Using C. elegans to
study cell biology.
Hall, D., Albert Einstein College of Medicine, Bronx, New
York: Exploring nematode anatomy by TEM.
Harris, T., Cold Spring Harbor Laboratory: Wormbase
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Medicine, St. Louis, Missouri
Hu, C., M.D., Ph.D., University of Michigan, Ann Arbor
Jantti, J., B.S., Ph.D., VTT Biotechnology, Espoo, Finland
Jayasena, S., B.Sc., Ph.D., University of Colombo, Sri Lanka
Jeffries, M., B.S., M.S., Eli Lilly & Company, Greenfield,
Indiana
McDonald, R, B.S., Ph.D., Vanderbilt University, Nashville,
Tennessee
Parusel, C., B.S., M.S., Friedrich Miescher Institut, Basel,
Switzerland
Schafer, J., B.S., University of Alabama, Birmingham
Van Binsbergen, E., MA., University Medical Center Utrecht,
The Netherlands
Hobert, 0., Columbia University, New York: Transgenes:
Uses and abuses.
Kim, S., Stanford University Medical Center, Stanford,
California: Microarray analysis.
Koelle, M., Yale University School of Medicine, New Haven,
Connecticut: Reverse genetics and G-protein signaling.
Mango, S., University of Utah, Salt Lake City: RNA interfer-
ence.
Sundaram, M., University of Pennsylvania, Philadelphia:
Genetic suppressor and enhancer screens.
Van den Heuvel, S., Massachusetts General Hospital Cancer
Center, Charlestown: Genetics of cell division control.
Eukaryotic Gene Expression
July 23-August 12
INSTRUCTORS L. Attardi, Stanford University, Stanford, California
B. Dynlacht, Harvard University, Cambridge, Massachusetts
W.L. Kraus, Cornell University, Ithaca, New York
M. Timmers, Utrecht University, The Netherlands
ASSISTANTS M.L. Acevedo, Cornell University, Ithaca, New York
E. Hammond, Stanford University, Stanford, California
M. Klejman, Utrecht University, The Netherlands
J. Rayman, Harvard University, Cambridge, Massachusetts
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the dynamic area of gene regulation. The course focused on state-of-the-art strategies and
techniques employed in the field. Students made nuclear extracts, performed in vitro transcription, and
measured RNA levels using primer extension. Emphasis was placed on biochemical studies of protein-
DNA and protein-protein interactions. Detailed characterizations of the DNA-binding properties of site-
specific transcription factors were carried out using electrophoretic mobility shift and DNase I foot-
printing assays. These assays were used to study protein-DNA interactions in crude extracts and using
recombinant proteins. Coimmunoprecipitation and binding assays were employed to investigate pro-
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tein-protein interactions with the general transcription machinery. In addition, students learned tech-
niques for the assembly and analysis of chromatin in vitro. Techniques using the in-vitro-assembled
chromatin included transcription assays, chromatin footprinting, chromatin remodeling assays, and
enzyme assays for the posttranscriptional modification of histones.
Over the past few years, the gene regulation field has begun to emphasize the importance of in vivo
approaches to studying protein-DNA and protein-protein interactions. Students were therefore
exposed to the chromatin immunoprecipitation technique. Experience with basic recombinant DNA
techniques was a prerequisite for admission to this course. Lectures by the instructors covered the cur-
rent status of the gene expression field, theoretical aspects of the methodology, and broader issues
regarding strategies for investigating the regulation of gene expression in eukaryotes. Guest lecturers
discussed contemporary problems in eukaryotic gene regulation and technical approaches to their
solution.
PARTICIPANTS
Briones, M., B.S., Universidad Nacional Autonoma de
Mexico, Mexico City
Ehmsen, J., B.S., University of Oxford, United Kingdom
Federico, M., B.S., University of Wisconsin, Madison
Heissig, F., B.A., M.S., Max-Planck Institute for Evolution,
Leipzig, Germany
Henriet, P., Universite Catholique de Louvain, Brussels,
Belgium
Hertzano, R., B.S., Tel Aviv University, Tel Aviv, Israel
Holmstrom, S., B.A., University of Michigan, Ann Arbor
Kalogeraki, V., B.S., Ph.D., Stanford University, Stanford,
California
Lund, C., B.S., Ph.D., The Scripps Research Institute, La
Jolla, California
SEMINARS
Attardi, L., Stanford University, Stanford, California:
Identification of apoptosis-specific p53 target genes.
Burtis, K., University of California, Davis: Array-based meth-
ods for high-throughput analysis of gene expression.
Dynlacht, B., Harvard University, Cambridge, Massachusetts:
Transcriptional control of the cell cycle.
Freedman, L., Memorial Sloan-Kettering Cancer Center, New
York: Mechanisms of transcriptional activation by nuclear
hormone receptors.
Goodrich, J., University of Colorado, Boulder: Mammalian
mRNA transcription: Mechanism and regulation.
Grewal, S., Cold Spring Harbor Laboratory: Histone tail modi-
fications, boundary elements, and epigenetic control of
higher-order chromatin assembly.
Hernandez, N., Cold Spring Harbor Laboratory: Transcription
of the human snRNA genes by RNA polymerases II and III.
Jenuwein, T, Institute of Molecular Pathology, Vienna,
Austria: Epigenetic organization of the mammalian genome.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Crystal struc-
tures of two intermediates in the assembly of the papillo-
mavirus replication initiation complex.
Kraus, L., Cornell University, New York: Coactivators, chro-
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Meriluoto, T., M.S., National Public Health Institute of Finland,
Helsinki, Finland
Monesi, N., B.Sc., M.S., Ph.D., Faculdade De Ciencias
Farmaceuticas, Brazil
Nisha, P., M.Sc., Carnegie Mellon University, Pittsburgh,
Pennsylvania
Otteson, D., B.S., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Sanders, V., B.S., Ph.D., The Ohio State University,
Columbus
Woo, E., A.B., University of California, San Francisco
Yates, K, BA., Ph.D., Oregon Health and Science University,
Portland
matin, and epigenetic modifications in estrogen-dependent
gene regulation.
Lees, J., Massachusetts Institute of Technology, Cambridge:
The role of the E2F transcription factors in development
and tumorigenesis.
Lis, J., Cornell University, Ithaca, New York: Heat shock
genes of Drosophila: A robust model for dissecting mecha-
nisms of transcription and regulation.
Meisterernst, M., GSF-National Research Center for Environ-
mental Health, Munich, Germany: Regulation of RNA poly-
merase II transcription by global transcription cofactors.
Meyer, B., University of California, Berkeley: X-chromosome
dosage compensation in C. elegans.
Thanos, D., Columbia University, New York: Mechanisms of
transcriptional regulation in higher eukaryotes.
Timmers, M., Utrecht University, The Netherlands: Dynamics
of RNA polymerase II transcription.
Tsukiyama, T., Fred Hutchinson Cancer Research Center,
Seattle, Washington: Functions of ISWI chromatin remodel-
ing factors.
Yamamoto, K., University of California, San Francisco:
Making and breaking transcriptional regulatory complexes.
Imaging Structure and Function in the Nervous System
July 23-August 12
INSTRUCTORS K. Delaney, Simon Fraser University, Burnaby, B.C., Canada
F. Helmchen, MPI fur Medizinsche Forschung, Heidelberg, Germany
T. Murphy, University of British Columbia, Vancouver, Canada
V. Murthy, Harvard University, Cambridge, Massachusetts
K. Svoboda, Cold Spring Harbor Laboratory
ASSISTANTS G. Di Cristo, Cold Spring Harbor Laboratory
K. Haas, Cold Spring Harbor Laboratory
A. Kreitzer, Harvard University, Boston, Massachusetts
Y. Otsu, University of British Columbia, Vancouver, Canada
J. Waters, MPI Heidelberg, Heidelberg, Germany
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes presented expanding opportunities for investigating the nervous system, from
synaptic spines to networks in the brain. This intensive laboratory and lecture course provided partici-
pants with the theoretical and practical knowledge to utilize emerging imaging technologies. The pri-
mary emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as the use of different types of electronic cameras, laser-scanning systems, func-
tional fluorophores, delivery techniques, and digital image-processing software. In addition to transmit-
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ted light microscopy for viewing cellular motility, the course examined a variety of molecular probes of
cell function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated ("caged") com-
pounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological
methods were covered. Particular weight was given to multi-photon laser-scanning microscopy and to
newly available biological fluorophores, especially green fluorescent protein (GFP) and its variants. We
used a spectrum of neural and cell biological systems, including living animals, brain slices, and cul-
tured cells. Applicants had a strong background in the neurosciences or in cell biology.
PARTICIPANTS
Engel, U., Diplom., Ph.D., Harvard Medical School, Boston,
Massachusetts
Fall, C., B.S., Ph.D., New York University, New York
Gerencser, A., M.D., M.Sc., Semmelweis University,
Budapest, Hungary
Kawasaki, F., B.S., Ph.D., Pennsylvania State University,
University Park
Kerr, J., Dip.Sci., Ph.D., National Institute of Mental Health,
Rockville, Maryland
Lambe, E., A.B., Ph.D., Yale University, New Haven,
Connecticut
SEMINARS
Ahlmers, W., Oregon Health and Science University, Portland:
TIRF.
Betz, B., University of Colorado, Denver: Imaging secretion,
FM-1-43.
Cline, H., Cold Spring Harbor Laboratory: In vivo imaging of
morphogenesis.
Coppey-Moisan, M., Institut Jacques Monod, Paris, France:
FLIM microscopy.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Imaging, past and future.
Fetcho, J., SUNY, Stony Brook, New York: In vivo imaging
zebrafish.
Forscher, P, Yale University, New Haven, Connecticut: DIC
and multimodal microscopy.
Helmchen, F., Max-Planck Institute, Heidelberg, Germany: Ca
imaging: Applications of 2-photon microscopy.
Keller, E., Zeiss Co., Thorwood, New York: Basics of
microscopy.
Kleinfeld, D., University of California, San Diego, La Jolla: In
vivo imaging of blood flow.
Lanni, F., Carnegie-Mellon University, Pittsburgh, Pennsyl-
vania: Fluorescence microscopy.
Lichtman, J., Washington University, St. Louis, Missouri:
Confocal microscopy.
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Lee, W.-C., S.B., Massachusetts Institute for Technology,
Cambridge
Murthy, M., B.S., Harvard Medical School, Boston,
Massachusetts
Solecki, D., B.S., Ph.D., The Rockefeller University, New
York
Stutzmann, G., BA., Ph.D., University of California, Irvine
Tyler, W., B.S., University of Alabama, Birmingham
Zhu, Y., B.S., M.S., Ph.D., The Salk Institute for Biological
Studies, La Jolla, California
Maruno, T, Hamamatsu Corporation, Bridgewater, New
Jersey: CCD cameras.
Mertz, J., Ecole Superieure de Physique at de Chimie
Industrielles, Paris, France: Nonlinear microscopies.
Moomaw, B., Hamamatsu Photonic Systems, Spring
Branch, Texas: CCD cameras.
Murphy, T, University of British Columbia, Vancouver,
Canada: Imaging synaptic structure and function.
Murthy, V., Harvard University, Cambridge, Massachusetts:
Imaging secretion, FM-1-43. GFP probes to image secre-
tion.
Shepherd, G., Cold Spring Harbor Laboratory: Glutamate
uncaging.
Sorkin, A., University of Colorado Health Sciences Center,
Denver: GFP basics: FRED basics and applications.
Svoboda, K., Cold Spring Harbor Laboratory: Basic optics.
2-photon microscopy.
Tsien, R., University of California, San Diego, La Jolla: Bapta
and synthetic Ca.* indicators. Imaging intracellular signal-
ing.
Ziv, N., Technion Faculty of Medicine, Haifa, Israel: Immuno-
fluorescence. Imaging synaptic proteins.
Zucker, R., University of California, Berkeley: Ca** uncaging.
Yeast Genetics
July 23-August 12
INSTRUCTORS D. Amberg, SUNY, Syracuse, New York
D. Burke, University of Virginia, Charlottesville
0. Cohen-Fix, NIDDK, National Institutes of Health, Bethesda, Maryland
ASSISTANTS A. Allison, University of Virginia, Charlottesville
B. Bettinger, SUNY Upstate Medical University, Syracuse, New York
M. Ng, NIDDK, National Institutes of Health, Bethesda, Maryland
The Yeast Genetics course is a modern, state-of-the-art laboratory course designed to teach the stu-
dents the full repertoire of genetic approaches needed to dissect complex problems in the yeast
Saccharomyces cerevisiae. Combinations of classical genetic approaches were emphasized, including
the isolation and characterization of mutants, tetrad analysis, complementation, and mitotic recombi-
nation. Molecular genetic techniques, including various types of yeast transformation, gene replace-
ment with plasmids and polymerase chain reaction (PCR), construction and analysis of gene fusions,
and generation of mutations in cloned genes, were also emphasized. Students used classical and mol-
ecular approaches to gain experience in identifying and interpreting various kinds of genetic interac-
tions, including suppression and synthetic lethality. Students were immersed in yeast genomics and
performed and interpreted experiments with DNA arrays. Students gained first-hand experience in
modern cytological approaches such as epitope tagging and imaging yeast cells using indirect
immunofluorescence, green fluorescent protein (GFP)-protein fusions, and a variety of fluorescent indi-
cators for various subcellular organelles. Lectures on fundamental aspects of yeast genetics were pre-
sented along with seminars given by outside speakers on topics of current interest.
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PARTICIPANTS
Bellows, D., B.S., Samuel Lunenfeld Research Institute,
Toronto, Canada
Brace, J., B.S., Ph.D., University of Chicago, Illinois
Buainain, L., B.A., Katholieke Universiteit Leuven, Belgium
D'Agostino, J., B.S., Brandeis University, Waltham,
Massachusetts
Dai, J., B.S., M.S., Iowa State University, Ames
Hamilton, C., National Institutes of Health, Bethesda,
Maryland
Ewing, D., Jr., A.S., B.S., Uniformed Services University of
Health Sciences, Bethesda, Maryland
Lorenz, A., Mag., University of Vienna, Austria
Lundkvist, R, M.S., Ph.D., University of Stockholm, Sweden
SEMINARS
Amon, A., Massachusetts Institute of Technology,
Cambridge: Regulation of mitosis and meiosis by the pro-
tein phosphatase Cdc14.
Bi, E., University of Pennsylvania School of Medicine,
Philadelphia: The Rab GTPase-activating proteins Msb3p
and Msb4p are involved in coupling actin organization to
polarized secretion.
Cunningham, K., Johns Hopkins University, Baltimore,
Maryland: Calcium regulation in yeast.
Dawson, D., Tufts University, Boston, Massachusetts: Finding
your partner without losing your sister: Challenges of the
meiotic chromosome.
Hampton, R., University of California, San Diego, La Jolla:
Mechanisms of ER protein degradation.
Konopka, J., SUNY, Stony Brook, New York: Mating
pheromone receptor signaling: Classical genetics to chemi-
cal genetics.
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Ramanathan, S., M.Sc., Ph.D., Lucent Technologies, Murray
Hill, New Jersey
Swain, P., B.A., Ph.D., The Rockefeller University, New York
Torres-Ramos, C., B.S., M.S., Ph.D., University Central del
Caribe, Bayamon, Puerto Rico
Van Oevelen, C., M.S., Ph.D., University Medical Centre,
Utrecht, The Netherlands
Waters, L., B.A., Massachusetts Institute of Technology,
Cambridge
Williams, B., B.S., Howard Hughes Medical Institute and
University of Wisconsin, Madison
Zakrzewska, A., M.S., University of Amsterdam, The
Netherlands
Kron, S., University of Chicago, Illinois: Genetic analysis of
yeast dimorphism.
Luca, F., University of Pennsylvania, Philadelphia: MOB con-
trol of the yeast cell cycle.
Meluh, P., Memorial Sloan-Kettering Cancer Center, New
York: Of yeast and man: 21st century centromeres.
Smith, M., University of Virginia, Charlottesville: Histones:
Deviants studying variants.
Stearns, T., Stanford University, Stanford, California: Making
mutants the old-fashioned way: Earning them!
Toczyski, D., University of California, San Francisco: Control
of mitotic progression.
Tyers, M., Lunenfeld Research Institute, Toronto, Canada;
Boone, C., University of Toronto, Canada: Large-scale
methods to solve a small problem: Toward a global genetic
interaction map for yeast.
Stem Cells
July 30-August 12
INSTRUCTORS B. Hogan, Vanderbilt University Medical Center /HHMI, Nashville, Tennessee
G. Keller, Mount Sinai School of Medicine, New York
R. McKay, National Institutes of Health, Bethesda, Maryland
This two-week course brought together leading researchers in the stem cell field with a small group of
international students. Stem cells construct organs in development. They sustain tissues in the adult
and restore them after injury. Because of these properties, stem cell technology promises to become
a major new element in biomedical science. This lecture and discussion course covered a series of
subjects including the methods that allow stem cells to be identified and grown in the laboratory; the
mechanisms that control the number of stem cells and their longevity; the stability and transformation
of cell types; and the clinical potential and difficulties of stem cell technology. This material was pre-
sented in depth by invited speakers. The course instructors and the invited lecturers were accessible
for informal discussion. The purpose of the course was to provide participants with a background in
medicine or biology an advanced understanding of the scientific and clinical importance of stem cells.
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PARTICIPANTS
Andersson, E., B.Sc., M.Sc., Lund University, Lund, Sweden
Batista, C., B.S., Ph.D., Univesidade Federal De Rio de
Janiero, Brazil
Desponts, C., B.S., University of South Florida, Tampa
Dimos, J., B.S., Princeton University, Princeton, New Jersey
Drew, C., B.A., University of California, Los Angeles
Ferri, A., Laurea, University of Milano-Bicocca, Milan, Italy
Galande, S., B.Sc., Ph.D., National Centre for Cell Science,
Pune, India
Hansson, M., B.S., M.S., Hagedorn Research Institute,
Gentofte, Denmark
Kotton, D., B.A., M.D., Boston University School of Medicine,
Massachusetts
Kumar, R., M.Sc., Ph.D., Cold Spring Harbor Laboratory
SEMINARS
Alison, M., Imperial College, London, United Kingdom:
The stem cell repertoire in the gastrointestinal tract and
liver.
Cossu, G., University of Rome"La Sapienza: Mesoangio-
blasts, vessel-associated, pluripotent stem cells.
Downing, G., National Institutes of Health, Bethesda,
Maryland: The politics and policy of stem cells in the United
States of America.
Edelberg, J., Cornell University, New York: The vascular sys-
tem.
Hochedlinger, K., Whitehead Institute, Massachusetts
Institute of Technology, Cambridge: The biology and appli-
cations of nuclear cloning.
Hogan, B., Howard Hughes Medical Institute/Vanderbilt
University Medical Center, Nashville, Tennessee: Branch,
bud, and stem: The embryonic mouse lung as a model
system for organogenesis.
Iscove, N., The Ontario Cancer Institute, Toronto, Canada:
Hematopoietic stem cells.
Itescu, S., Columbia University, New York: Hemangioblasts
and the heart vascular system.
Keller, G., Mount Sinai School of Medicine, New York:
Mesoderm commitment to the hematopoietic system.
Krause, D., Yale University, New Haven, Connecticut:
Plasticity of bone-marrow-derived stem cells.
Krumlauf, R., Stowers Institute for Medical Research, Kansas
City, Missouri: Plasticity and patterning of cell populations in
vertebrate craniofacial development.
Kulesa, P., California Institute of Technology, Pasadena: Intra-
vital imaging of neural crest cells and neural progenitors.
Lemischka, I., Princeton University, Princeton, New Jersey:
Specific gene expression in stem cells.
Marvin, M., Harvard Medical School, Boston, Massachu-
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Liang, Y., B.S., Ph.D., University of Kentucky Medical Center,
Lexington
McGiffert, C., B.S., M.S., University of California, San Diego
Mira, H., M.S., Ph.D., Karolinska Institute, Stockholm,
Sweden
Pirvola, U., B.S., University of Helsinki, Finland
Roth, M., A.B., Ph.D., University of Medicine and Dentistry of
New Jersey, Piscataway
Sivertsson, M., M.S., Ph.D., Royal Institute of Technology,
Stockholm, Sweden
Tiscornia, G., Ph.D., The Salk Institute, La Jolla, California
Yin, Y., M.D., M.S., National University Medical Institutes,
Singapore
Zettervall, C., MA., Ph.D., Umea University, Sweden
setts: The stem cell repertoire in the gastrointestinal tract
and liver.
McKay, R., National Institutes of Health, Bethesda, Maryland:
Stem cells in development and disease.
McLaren, A., University of Cambridge, United Kingdom:
Germ cells.
Millar, S., University of Pennsylvania, Philadelphia: Stem cells
of the skin and its appendages.
Nusse, R., Stanford University, Stanford, California: Wnt sig-
naling and stem cells.
Pappaioannou, G., Columbia University, New York: Stem
cells of the early embryo.
Sanchez, A., University of Utah School of Medicine, Salt
Lake City: The planarian neoblasts: An experimentally
accessible stem cell population,
Sorrentino, B., St. Jude Children's Research Hospital,
Memphis, Tennessee: Hematopoiesis: The side population
and gene therapy.
Spradling, A., Carnegie Institute of Washington, Baltimore,
Maryland: Stem cells in their natural context: The stem cell
niche,
Stoffel, M., The Rockefeller University, New York: The
endocrine pancreas.
Van der Kooy, D., University of Toronto, Canada: The life his-
tory of neural stem cells.
Verfaillie, C., University of Minnesota, Minneapolis: Unexpect-
ed potential of multipotent adult stem cells.
Wright, C., Vanderbilt University, Nashville, Tennessee: Gene
inactivation and lineage-labeling studies of pancreas forma-
tion.
Zhong, W., Yale University, New Haven, Connecticut: Asym-
metric cell division and its potential roles in stem cell main-
tenance and differentiation.
Macromolecular Crystallography
October 16-29
INSTRUCTORS W. Furey, V.A. Medical Center, Pittsburgh, Pennsylvania
G. Gilliland, National Institute of Standards and Technology, Gaithersburg, Maryland
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku/MSC, Inc, The Woodlands, Texas
ASSISTANT D. Kuzmanovic, National Institute of Standards and Technology,
Gaithersburg, Maryland
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensive laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who were new to macromolecular crystal-
lography. Topics covered included crystallization (proteins, nucleic acids, and complexes), crystal char-
acterization, X-ray sources and optics, synchrotrons, crystal freezing, data collection, data reduction,
multiple isomorphous replacement, multiwavelength anomalous diffraction phase determination, sol-
vent flattening, molecular replacement and averaging, electron density interpretation, structure refine-
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ment, molecular graphics, noncrystallographic summary, simulated annealing, and coordinate despo-
sition. Participants learned through extensive hands-on experiments. They crystallized and determined
a protein structure, along with lectures on the theory and informal discussions behind the techniques.
Applicants were familiar with the creation and editing of simple text files on UNIX workstations, using a
screen-based editor such as vi, emacs, or jot.
PARTICIPANTS
Chakravarthy, S., B.Sc., M.Sc., Colorado State University,
Fort Collins
Chmiel, N., Ph.D., University of California, Berkeley
Deaconescu, A., B.E., The Rockefeller University, New York
Finkielstein, C., Ph.D., University of Colorado, Denver
Golan, G., B.Sc., Hebrew University, Jerusalem, Israel
Kennedy, M., Ph.D., Pacific Northwest National Laboratory,
Richland, Washington
Langley, D., Ph.D., University of Sydney, Australia
Loewen, M., Ph.D., National Research Council of Canada,
Saskatchewan
Loschi, L., Ph.D., The University of British Columbia,
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, Berkeley,
California: Introduction to CNS. CNS macromolecular
refinement.
Furey, W., V.A. Medical Center, Pittsburgh, Pennsylvania:
Patterson group therapy. Isomorphous replacement and
anomalous scattering I. Isomorphous replacement and
anomalous scattering II. Phase improvement by solvent flat-
tening/negative density truncation. Noncrystallographic
symmetry averaging. Crystallographic symmetry operations
and their application.
Hendrickson, W., Columbia University, New York: MAD phas-
ing.Theory and practice.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Two interme-
diates in the assembly of the papillomavirus replication initi-
ation complex. Structure presentation.
Kjeldgaard, M., Aarhus University, Denmark: Electron density
fitting from A to 0.
Kleywegt, G., University of Uppsala, Sweden: Just because
it's in Nature, doesn't mean it's true...(macromolecular
structure validation)
McPherson, A., University of California, Irvine: Crystallization
of macrmolecules I. Crystallization of macromolecules II.
Vectors, waves, symmetry, and planes. Introduction to X-
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Vancouver, Canada
Lubahn, B., B.A., Ph.D., University of Missouri, Columbia
Murray, D., Ph.D., Weill Medical College, New York
Ogawa, H., B.S., Ph.D., Cleveland Clinic Foundation, Ohio
Prat Gay, G., Ph.D., University of Buenos Aires, Argentina
Schroeder, S., Ph.D., Yale University, New Haven,
Connecticut
Thomas, S., Ph.D., University of Texas Health Sciences
Center, San Antonio
Waugh, D., Ph.D., National Cancer Institute, Frederick,
Maryland
ray crystallography. Preliminary crystal characterization
crystallographic symmetry and unit cells. Fundamental dif-
fraction relationships I. Fundamental diffraction relationships
II. Fourier transforms and the electron density equations.
Patterson techniques. Heavy atoms and anomalous scat-
terers.
Pflugrath, J., Rigaku/MSC, Inc., The Woodlands, Texas: X-
ray beams, images, and reflections. Data collection. Design
and setup. Cryocrystallography. Crystallization review and
optimization. Application of anomalous scattering from sul-
fur atoms.
Richardson, D., Duke University Medical Center, Durham,
North Carolina: Detection and repair of model errors using
all atom contacts.
Terwilliger, T., Los Alamos National Laboratory, New Mexico:
Automated structure solution, density modification, and
model building for M.A.D, SAD, and MIR.
Tronrud, D., University of Oregon, Eugene: Macromolecular
refinement I. TNT tutorial.
Westbrook, T., University of Rochester School of Medicine,
New York: The protein data bank.
Xu, R.-M., Cold Spring Harbor Laboratory: Structural studies
of histone methyltransferases.
Bioinformatics: Writing Software for Genome Research
October 16-29
INSTRUCTORS
ASSISTANTS
S. Lewis, University of California, Berkeley
L. Stein, Cold Spring Harbor Laboratory
J. Barnett, Massachusetts Institute of Technology,
Cambridge
K. Clark, Cold Spring Harbor Laboratory
A. Day, University of California, Los Angeles
R. Halgren, Michigan State University, East Lansing
S. Lembark, Workhouse Computing, Chicago,
Illinois
B. Marshall, University of California, Berkeley
V. Mootha, Whitehead Institute, Cambridge,
Massachusetts
C. Mungall, Lawrence Berkeley Laboratories,
Berkeley, California
L. Palmer, Cold Spring Harbor Laboratory
S. Prochnik, University of California, Berkeley
L. Teytelman, Cold Spring Harbor Laboratory
The desktop computer is rapidly becoming an indispensable tool in the biologist's toolchest. The suc-
cess of the human genome project created an explosion of information: Billions of bits of biologicalinformation stashed electronically in databases around the globe just waiting for the right key to unlockthem. New technologies such as DNA microarrays and high-throughput genotyping are creating aninformation overload that the traditional laboratory notebook cannot handle. To exploit the information
revolution in biology, biologists must move beyond canned Web interfaces and Excel spreadsheets.
They must take charge of the data by creating their own software to fetch, manage, and integrate it.
The goal of this course was to provide biologists with the tools needed to deal with this changing land-
scape. Designed for students and researchers with little prior knowledge of programming, this two-
week course taught the fundamentals of the Unix operating system, Perl scripting, dynamic Web page
development with the CGI protocol, and database design. The course combined formal lectures with
hands-on experience in which students worked to solve a series of problem sets drawn from common
scenarios in biological data acquisition, integration, and laboratory workflow management. For their
final projects, students were posed problems using their own data and worked with each other and
the faculty to solve them. Note that the primary focus of this course was to provide students with the
practical aspects of software development, rather than to present a detailed description of the algo-
rithms used in computational biology.
PARTICIPANTS
Barrasa, I.M., B.S., Ph.D., University of Pennsylvania,
Philadelphia
Birkeland, M., B.A., Ph.D., GlaxoSmithKline, King of Prussia,
Pennsylvania
Bultrini, E., B.S., Istituto Superiore di Sanita, Rome, Italy
Caenepeel, S., B.S., Sugen, South San Francisco, California
Costain, W., M.Sc., Ph.D., Dalhousie University, Halifax, Nova
Scotia, Canada
Deng, D., B.S., Ph.D., Alabama A&M University, Normal
Doniger, S., B.S., Gladstone Institute, San Francisco,
California
Girke, T, M.A., Ph.D., University of California, Riverside
Gutierrez, R., B.S., M.S., MSU-Plant Research Laboratory,
East Lansing, Michigan
Hue, S., B.Sc., M.Sc., Central Public Health Laboratory,
London, United Kingdom
Hur, J., B.S., Ph.D., Massachusetts General Hospital Cancer
Center, Charlestown
Koch, B., B.S., University of Heidelberg, Heidelberg,
Germany
SEMINARS
Gilman, B., Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Managing large genotyping
projects.
Hide, W., University Western Cape, SANBI, South Africa:
EST clustering techniques.
Hughey, R., University of California, Santa Cruz: Hidden
Markov models.
Jamison, C., George Mason University, Manassas, Virginia:
Using genome databases effectively.
Marth, G., NIH/National Center for Biotechnology Information,
Bethesda, Maryland: Pipelines for nucleotide sequence
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McKay, S., M.Sc., Ph.D., British Columbia Cancer Agency,
Vancouver, Canada
Qi, W., B.S., Ph.D., University of Maine, Orono
Ringquist, S., B.A., Ph.D., University of Pittsburgh,
Pennsylvania
Robb, S., B.S., University of Utah, Salt Lake City
Smith, J., B.S., Ph.D., University of Alabama, Birmingham
Somerville, C., B.S., Ph.D., Marshall University, Huntington,
West Virginia
Tang, J., B.S., Ph.D., Delaware Biotechnology Institute,
Newark, Delaware
Tanguay, D., B.S., Ph.D., Zycos Pharmaceuticals, Lexington,
Massachusetts
Taylor, J., B.S., Ph.D., University of Victoria, Canada
Tello-Ruiz, M., B.S., Cold Spring Harbor Laboratory
Tewari, M., B.A., Ph.D., Dana-Farber Cancer Institute,
Boston, Massachusetts
Yamada, C., B.Sc., University of Cambridge, United
Kingdom
Yang, X., B.S., Ph.D., University of Texas, Dallas
analysis.
Pearson, W., University of Virginia, Charlottesville: Sequence
alignment.
Peitzsch, R., Pfizer Global Research and Development
Bioinformatics, Groton, Connecticut: Practical and flexible
database design.
Slonim, D., Genetics Institute, Wyeth-Ayerst Research,
Cambridge, Massachusetts: Expression chips.
Stajich, J., Duke University, Durham, North Carolina: Using
BioPerl 1. Using Bio Perl 2.
Immunocytochemistry, In Situ Hybridization, and
Live Cell Imaging
October 19-November 1
INSTRUCTORS A. Dernburg, Lawrence Berkeley National Laboratory, Berkeley, California
J. Murray, University of Pennsylvania, Philadelphia
J. Swedlow, University of Dundee, United Kingdom
ASSISTANTS T. Howard, University of New Mexico, Albuquerque
K. Hu, University of Pennsylvania, Philadelphia
M. Johnson, University of California, Berkeley
M. Platani, University of Dundee, United Kingdom
This course focused on specialized techniques in microscopy, in-situ hybridization, immunocytochem-
istry, and live-cell imaging related to localizing DNA, RNA, and proteins in fixed cells as well as protein
and RNA dynamics in living cells. The course emphasized the use of the latest equipment and tech-
niques in fluorescence microscopy, including confocal laser-scanning microscopy, deconvolution meth-
ods, digital image processing, and time-lapse imaging of living specimens. The course was designed
to present students with state-of-the-art technology and scientific expertise in the use of light
microscopy to address basic questions in cellular and molecular biology. The course was designed for
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the molecular biologist who was in need of microscopic approaches and for the cell biologist who was
not familiar with the practical application of the advanced techniques presented in the course. Among
the methods presented were the preparation of tagged nucleic acid probes, fixation methods, detec-
tion of multiple DNA sequences in single nuclei or chromosome spreads, comparative genomic
hybridization, cellular localization of RNA, localization of nucleic acids and proteins in the same cells,
use of a variety of reporter molecules and nonantibody fluorescent tags, indirect antibody labeling,
detection of multiple proteins in a single cell, and the use of green fluorescent protein (GFP) variants to
study protein expression, localization and dynamics. In each method, several experimental protocols
were presented that allowed the students to assess the relative merits of each and to relate them to
their own research. Students were encouraged to bring their own nucleic acid, protein, or antibody
probes to the course, which were used in addition to those provided by the instructors. The laborato-
ry exercises were supplemented with lectures given by invited distinguished scientists, who presented
up-to-the-minute reports on current methods and research using the techniques that were presented.
PARTICIPANTS
Al-Rashid, S., M.S., University of Toronto, Canada
Carter, R., B.S., University of Alabama, Birmingham
Caste lo Branco, P., B.S., Ph.D., Oxford University, United
Kingdom
Drea, S., BA., Ph.D., John Incas Centre, Norwich, United
Kingdom
Ehmsen, J., B.S., Oxford University, United Kingdom
Gustafsson, M., B.A., Goteborg University, Sweden
Holter, E., Karolinska Institute, Huddinge, Sweden
Hance, N., Ph.D., Karolinska Institute, Huddinge, Sweden
SEMINARS
Day, R., University of Virginia, Charlottesville: Seeing colors:
Applications and limitations of the fluorescent proteins.
Dernburg, A., Lawrence Berkeley National Laboratory,
Berkeley, California: Basic of FISH.
Hostetter, G., National Institutes of Health, Bethesda,
Maryland: Applications and challenges of interphase FISH.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Basic introduction to light and fluorescence
microscopy. Immunocytochemistry. Cameras and digital
imaging fundamentals. Principles of confocal microscopy
and deconvolution techniques.
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Hodges, E., BA., Karolinska Institute, Huddinge, Sweden
Ku, C.-C., Ph.D., Stanford University, Stanford, California
Martins, R., M.S., Instituto de Biofisica, Rio de Janeiro, Brazil
Sansam, C., B.S., Vanderbilt University, Nashville, Tennessee
Soutoglou, E., PhD., IGBMC, Strasbourg, France
Uno, E., B.S., The Rockefeller University, New York
Usborne, A., D.V.M., Wisconsin National Primate Research
Center, Madison
Wadum, M., BA., University of Southern Denmark, Odense
Ried, T., National Cancer Institute/NIH, Bethesda, Maryland:
Mechanisms and consequences of chromosomal aberra-
tions in cancer cells.
Rieder, C., New York State Department of Health, Albany:
Laser microbeam studies on how mitosis works in mam-
mals.
Spector, D., Cold Spring Harbor Laboratory: Localization of
gene expression by FISH and in living cells.
Swedlow, J., University of Dundee, United Kingdom: Live-cell
imaging. Quantitative fluorescence microscopy. When and
how to use F-words.
Phage Display of Combinatorial Antibody Libraries
November 5-18
INSTRUCTORS C. Barbas, Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, San Diego, La Jolla
ASSISTANTS R. Fuller, Scripps Research Institute, La Jolla, California
C. Goodyear, University of California, San Diego, La Jolla
J. Struthers, University of California, San Diego, La Jolla
C. Tuckey, New England Biolabs, Beverly, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and prac-
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tical aspects of constructing combinatorial libraries from immune and nonimmune sources as well as
the construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification, and characterization of Fab fragments expressed in E. coli were also covered.
Epitopes were selected from peptide libraries and characterized.
The lecture series, presented by instructors and a number of invited speakers, emphasized poly-
merase chain reaction (PCR) of immunoglobulin genes, the biology of filamentousphage and the utili-
ty of surface expression libraries, expression of antibodies in E. coli and mammalian cells, antibody
structure and function, catalytic antibodies, directed protein evolution, retroviral and cell display
libraries, the immunobiology of the antibody response, and recent results on the use of antibodies for
diagnostics and therapy. The theory and practical implications for selection from phage displayed
libraries of random peptides, cDNA products, and semisynthetic proteins were also explored.
PARTICIPANTS
Astatke, M., Ph.D., Kirkegaard and Perry Laboratories,
Cessna, Connecticut
Crowley, J.M. Centeno M.S., Institute of Biochemical
Research, Buenos Aires, Argentina
Duchala, C., Ph.D., Cleveland Clinic Foundation, Ohio
Edwards, B., Ph.D., Wayne State University, Detroit, Michigan
Fermer, C., Ph.D., CanAg Diagnostics AB, Gothenburg,
Sweden
Finlay, W., Ph.D., Food and Drug Administration, Bethesda,
Maryland
Gearhart, D., Ph.D., Medical College of Georgia, Augusta
Habib, A., B.S., Medical Research Council, London, United
SEMINARS
Arap, W., University of Texas/M.D, Anderson Cancer Center,
Houston: In vivo panning.
Barbas, C., Scripps Research Institute, La Jolla, California:
Software and hardware for genomes: Polydactyl zinc finger
proteins and the control of endogenous genes.
Lowman, H., Genentech, Inc., San Francisco, California: SAR
of peptides using phage.
McHeyzer-Williams, M., The Scripps Research Institute, La
Jolla, California: Regulation and development of antibody
responses in vivo.
Nolan, G., Stanford University School of Medicine, Stanford,
California: Retroviral libraries.
Noren, C., New England Biolabs, Beverly, Massachusetts:
Kingdom
Healy, S., Ph.D., University of California, San Francisco
Hilgers, M., Ph.D., Syrrx, San Diego, California
Huff, I., B.S., Center of Excellence for Structural Biology,
Knoxville, Tennessee
Poersch, C., B.S., Molecular Biology Institute of Parana,
Curitiba, Brazil
Schulz, R., BA., Louisiana State University, Baton Rouge
Sousa, R., M.S., National Institute of Health, Portugal
Stubbs, D., M.S., Georgia Institute of Technology, Atlanta
Wang, Y., MD, Ph.D., Harvard Medical School, Boston,
Massachusetts
Phage peptide libraries: The Ph.D. for peptides.
Sidho, S., Genentech, Inc., San Francisco, California: Use of
antibody-phage libraries to develop antibodies as reagents
and potential therapeutics.
Siegel, D., University of Pennsylvania Medical Center,
Philadelphia: Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego, La Jolla:
Repertoire cloning of SLE autoantibodies.
Webster, R., Duke University, Durham, North Carolina: The
biology of filamentous phage.
Wilson, I., Scripps Research Institute, La Jolla, California:
Structural biology of the immune system.
Proteomics
November 5-18
INSTRUCTORS P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Medical School, Boston, Massachusetts
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
ASSISTANTS P. Braun, Harvard Medical School, Boston, Massachusetts
M. Fernandez, Harvard Medical School, Boston, Massachusetts
J. Jennings, Vanderbilt University School of Medicine, Nashville, Tennessee
S. Vazquez, University of Michigan, Ann Arbor
This intensive laboratory and lecture course focused on two major themes inproteomics. In the profil-
ing section of the course, students learned methodologies of protein preparation from diverse samples,
sample analysis by two-dimensional gel electrophoresis, high-sensitivity mass spectrometric analysis
of proteins utilizing both peptide mass mapping and tandem mass spectrometry, and the application
of bioinformatics tools to identify proteins and posttranslational modifications and assess their relative
abundance. In the functional proteomics section of the course, students learned the use of recombi-
national cloning to move many genes simultaneously to different expression vectors, how to apply
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robotics to high-throughput methods, and how to perform high-throughput expression, purification,
and characterization of proteins. Students learned approaches to identify protein interactions utilizing
affinity isolation techniques coupled with mass spectrometric protein identification. The overall aim of
the course provided students with the fundamental knowledge and hands-on experience necessary to
be able to perform and analyze proteomics experiments, and to learn to identify new opportunities in
applying proteomics approaches to their own research.
PARTICIPANTS
Alexander, J., B.S., Ph.D., Virginia Commonwealth University,
Richard, Virginia
Baars, L., B.S., M.S., Stockholm University, Sweden
Burgess, S., Ph.D., Mississippi State University, Starkville
Fast, B., B.S., M.S., University of Bergen, Norway
Francis, M., B.S., University of California, Los Angeles
Gardiner, K., B.S., Ph.D., Eleanor Roosevelt Institute, Denver,
Colorado
Karpuj, M., M.S., Ph.D., University of California, San
Francisco
Kimbro, K., B.A., Ph.D., Clark Atlanta University, Atlanta,
Georgia
Kulkarni, R., B.S., Ph.D., North Carolina State University,
Raleigh
SEMINARS
Bach land, P., National Institutes of Health, Bethesda,
Maryland: Interpretation of MS/MS spectra: De novo
sequence analysis.
Chait, B., The Rockefeller University, New York: Identification
of posttranslational modifications by MS/MS.
Clauser, K., Millennium Pharmaceuticals, Inc., Cambridge,
Massachusetts: Applications of proteomics/protein
Informatics.
Good lett, D., Proteomics, Seattle, Washington: Applications
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McPherson, J., B.S., Ph.D., Washington University School of
Medicine, St. Louis, Missouri
Methe, B., B.S., Ph.D., The Institute for Genomic Research,
Rockville, Maryland
Puthanveettil, S., B.Sc., Ph.D., Columbia University, New
York
Rogers, A., B.Sc., Ph.D., British Antarctic Survey, Cambridge,
United Kingdom
Sorin, M., B.S., Albert Einstein College of Medicine, Bronx,
New York
Tsai, Y.C., B.S., MSE, Johns Hopkins University, Baltimore,
Maryland
Zhang, S., B.S., Columbia University, New York
of ICAT for protein quantitation.
Jebanthirajah, J., Harvard Medical Center, Boston,
Massachusetts: Quantitative proteomics: ICAT and beyond.
Mac Beath, G., Harvard University, Cambridge, Massachu-
setts: Protein microarrays.
Tasto, J., Vanderbilt University, Nashville, Tennessee: Tandem
affinity purifications (TAP) of protein complexes.
Weil, T., Vanderbilt University, Nashville, Tennessee: Protein
purification/transcriptional complexes.
Computational Genomics
November 6-11
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT A. Mackey, University of Virginia, Charlottesville
Beyond BLAST and FASTA-This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics include gene recognition (exon/intron prediction), identifying sig-
nals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. The course made extensive use of local
VVWW pages to present problem sets and the computing tools to solve them. Students used Windows
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and Mac workstations attached to a UNIX server; participants had to be comfortable using the Unix
operating system and a Unix text editor. The course was designed for biologists seeking advanced
training in biological sequence analysis, for computational biology core resource directors and staff,
and for scientists in other disciplines, such as computer science, who wish to survey current research
problems in biological sequence analysis. The primary focus of this course was the theory and prac-
tice of algorithms used in computational biology, with the goal of using current methods more effec-
tively and developing new algorithms. Students more interested in the practical aspects of software
development were encouraged to apply to the Bioinformatics: Writing Software for Genome Research
course.
PARTICIPANTS
Adams, R., BA., Ph.D., Edinburgh University, United
Kingdom
Bangarusamy, D., B.S., M.S., Genome Institute of Singapore
Bates, E., B.Sc., Ph.D., University of Dentistry and Medicine
of New Jersey/New Jersey Medical School, Newark
Belfiore, N., BA., Ph.D., Purdue University, West Lafayette,
Indiana
Bordo, D., B.S., Ph.D., National Cancer Research Institute,
Genova, Italy
Carroll, M., B.S., Ph.D., Xavier University of Louisiana, New
Orleans
Chen, C., B.S., Ph.D., National Yang-Ming University, Taipei,
Taiwan
Cheung, K. -H., B.S., Ph.D., Yale Center for Medical Informa-
tion, New Haven, Connecticut
Engel, A., Ph.D., Roche Diagnostics GmbH, Penzberg,
Germany
Fjelistrom, R., B.S., Ph.D., USDA-Agricultural Research
Service, Beaumont, Texas
Gilchrist, M., B.A., Ph.D., Cambridge University, United
Kingdom
SEMINARS
Altschul, S., National Institutes of Health, Bethesda,
Maryland: Statistics of sequence similarity scores. Iterated
protein database searches with PSI-BLAST
Cooper, P., National Institutes of Health, Bethesda, Maryland:
Introduction to the databases and tools at the National
Center for Biotechnology Information. Genome resources of
the NCBI.
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Holford, I., B.A., Ohio State University, Wooster
Kim, S.-W., B.A., Ph.D., Brigham & Women's Hospital,
Boston, Massachusetts
Korpelainen, E., B.S., Ph.D., Center of Scientific Computing,
Espoo, Finland
Landers, M., B.Sc., Ph.D., University of Connecticut Heath
Center, Farmington
Li, J., B.S., Ph.D., GlaxoSmithKline, Bioinformatics, Research
Triangle Park, North Carolina
Lin, Y., B.S., M.S., Institute of Botany, Taipei, Taiwan
Meneely, R, B.S., Ph.D., Haverford College, Haverford,
Pennsylvania
Rohacs, T, M.D., Ph.D., Mount Sinai School of Medicine,
New York
Rose, A., Ph.D., Ohio State University, Columbus
Schmuth, M., M.D., University of Innsbruck, Austria
Silverman, G., B.S., Ph.D., University of Massachusetts,
Worcester
Vaughn, M., B.S., Ph.D., Cold Spring Harbor Laboratory
Wu, J., B.S., Human Genome Sequencing Center, Houston,
Texas
Hardison, R., Pennsylvania State University, University Park:
Mammalian genome comparison. Databases and browers
for mammalian genomes.
Lewis, S., University of California, Berkeley: Gene ontologies:
From structure to function.
Yandell, M., University of California, Berkeley: Eukaryotic
gene identification.
The Genome Access Course
February 6-7 (internal), April 30-May 1, August 27-28, October 1-2, December 4-5
TRAINERS J. Gergel, M. Katari, and L. Palmer, Cold Spring Harbor Laboratory
U. Hilgert, Dolan DNA Learning Center
The Genome Access Course is an intensive two-day introduction to bioinformatics that was held mul-
tiple times in 2002 and trained almost 150 participants in total. The core of the course was designed
to cover the manipulation and analysis of sequence information. The course was broken into modules
designed to give a broad overview of a given topic, with ample time for examples chosen by the
instructors. Each module included three parts: a discussion of theory and methods, coverage of soft-
ware and web resources, and use of selected tools with examples (including those supplied by the stu-
dents). The modular design allowed the instructors to tailor the presentation to the interests of the stu-
dents. Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple
Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis. Applications to the course were open
to all on a first come-first served basis, subject to basic eligibility requirements. The course was held
at the Laboratory's newly opened Genome Research Center at Woodbury, located seven miles south
of the main Laboratory campus. Each student was provided with a PC laptop with wireless modem for
the duration of the course. Students were encouraged to supply problem sets and sequences of inter-
est to the trainers for possible incorporation as examples in the modules. Materials were made avail-
able on the Web, and students continued to ask questions of the trainers as they applied what they
had learned in their individual endeavors. The curriculum of The Genome Access Course was devel-
oped in conjunction with staff at the Wellcome Trust Sanger Centre and the European Bioinformatics
Institute (Hinxton, United Kingdom) who separately have been teaching a parallel series of courses in
the United Kingdom (the open-door workshops).
Genome Access Course, February 2002
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April 30-May 1
Arulnayagam, L., B.Sc., GlaxoSmithKline, RTP, North Carolina
Balkovski, E., Ph.D., Rutgers University, Piscataway, New Jersey
Chen, C.-R., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
Collins, A., Ph.D., Johnson & Johnson Research and
Development, Raritan, New Jersey
Derham, B., Ph.D., University of Oxford, United Kingdom
Dong, M., B.Sc., Novartis Pharmaceutics, Summit, New Jersey
Flockhart, I., B.Sc., Alphagene, Woburn, Massachusetts
Foster, J., Ph.D., New England Biolabs, Beverly, Massachusetts
Huang, X., B.Sc., Bristol-Myers Squibb, Pennington, New
Jersey
Jeng, A., Ph.D., Novartis Pharmaceuticals Corporation, Summit,
New Jersey
Kaushal, S., Ph.D., University of Minnesota, Minneapolis
Kim, M.-Y., B.Sc., Otsuka Maryland Research Institute, Rockville
Kuo, F-S., B.Sc., Orchid BioSciences, Inc., Princeton, New
Jersey
Kustka, A., Ph.D., SUNY, Stony Brook, New York
Laszlo, A., Ph.D., Washington University School of Medicine,
St. Louis, Missouri
Meyer, S., Ph.D., Cephalon, Inc., West Chester, Pennsylvania
Nollen, E., Ph.D., Northwestern University, Evanston, Illinois
Noorwez, S., Ph.D., University of Minnesota, Minneapolis
Nykanen, R, B.Sc., Abo Akademi University, Turku, Finland
Petti, F, B.Sc., OSI Pharmaceuticals Inc., Uniondale, New
York
Pollard, H., Ph.D., Uniformed Services University, Bethesda,
Maryland
Preston, R., B.Sc., Rensselaer, Hartford, Connecticut
Scott, K., B.Sc., Orchid BioSciences, Inc., Princeton, New
Jersey
Thierse, H.-J., Ph.D., Max-Planck Institute for Immunobiol-
ogy, Freiburg, Germany
Xu, D., Ph.D., Johnson & Johnson Research and Develop-
ment, Raritan, New Jersey
Genome Access Course, April 2002
August 27-28
Briggs, J., Ph.D., National Institutes of Health, Bethesda,
Maryland
Chang, D., B.Sc., Baylor College of Medicine, Houston, Texas
Chen, X., B.Sc., Bristol-Myers-Squibb, Princeton, New Jersey
Cheng, K., Ph.D., Pennsylvania State College of Medicine,
Hershey
D'adamio, L., Ph.D., Albert Einstein College of Medicine, Bronx,
New York
De Bias, A., Ph.D., University of Connecticut, Storrs
Denney, N., B.Sc., Merck & Co., Inc., West Point, Pennsylvania
Dunne, C., B.Sc., The Rockefeller University, New York
Jim, S., B.Sc., The Rockefeller University, New York
Lee, T-L. (Cindy), B.Sc., Cold Spring Harbor Laboratory
Levine, A., Ph.D., The Rockefeller University, New York
Michels, C., Ph.D., Queens College of CUNY, Flushing, New York
Miralles, C., B.Sc., University of Connecticut, Storrs
Parnassa, A., B.Sc., Weill Cornell School of Medicine, New York
Pollak, E., Ph.D., University of Pennsylvania Medical Center,
Philadelphia
Qi, Zhenhao, Ph.D., Boehringer Ingelheim Pharmaceutical Inc.,
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Danbury, Connecticut
Rios, C., Ph.D., Bristol-Myers-Squibb, Pennington, New Jersey
Roccanova, Louis, Ph.D., New York Institute of Technology,
Old Westbury
Rush, J., Ph.D., Howard Hughes Medical Institute and Yale
School of Medicine, New Haven, Connecticut
Sadeghi, N., B.Sc., Mount Sinai School of Medicine, New York
Salero, E., Ph.D., The Rockefeller University, New York
Sepulveda, M., B.Sc., Albert Einstein College of Medicine,
Bronx, New York
Singh, K., Ph.D., VA Medical Center (New York University
School of Medicine), New York
Smyth, B., Ph.D., University of Pennsylvania, Philadelphia
Wake land, E., Ph.D., University of Texas Southwestern
Medical Center, Dallas
Wang, C., Ph.D., Bristol-Myers-Squibb, Lawrenceville, New
Jersey
Webb, E., Ph.D., Woods Hole Oceanographic Institution,
Massachusetts
Yang, C., Ph.D., The Rockefeller University, New York
October 1-2
Balinsky, C., B.Sc., USDA, Agricultural Research Service,
Greenport, New York
Bennett, J., B.Sc., Skirball Institute, New York University
School of Medicine
Bhatt, A., Ph.D., Howard Hughes Medical Institute/Albert
Eiinstein College of Medicine, Bronx, New York
Canaan, A., Ph.D., Yale University, Medical School, New
Haven, Connecticut
Caradonna, S., Ph.D., University of Medicine and Dentistry of
New Jersey, Stratford
Dackour, R., B.Sc., Long Island Jewish Medical Center, New
Hyde Park, New York
Eastman, S., B.Sc., Lehigh University, Bethlehem,
Pennsylvania
Euskirchen, G., B.Sc., Yale University, New Haven,
Connecticut
Fischer, J., Ph.D., University of Dentistry and Medicine of New
Jersey-Graduate School of Biomedical Sciences, Stratford
Gadura, N., B.Sc., Queens College, CUNY, Flushing, New York
Henegariu, 0., Ph.D., Yale University, New Haven, Connecticut
Holman, A., B.Sc., Tufts University, Boston, Massachusetts
Jacobs, W., Ph.D., Albert Einstein College of Medicine/
Howard Hughes Medical Institute, Bronx, New York
Li, X.-C., Ph.D., The Rockefeller University, New York
McMahan, L., Ph.D., The Rockefeller University, New York
Murphy, K., Ph.D., Children's Hospital of Philadelphia,
Pennsylvania
Pongrac, J., Ph.D., University of Pittsburgh, Pennsylvania
Pumfery, A., Ph.D., The George Washington University,
Washington, D.C.
Rinn, J., B.Sc., Yale University, New Haven, Connecticut
Severinova, E., Ph.D., Rutgers University, Piscataway, New
Jersey
Silver, J., Ph.D., North Shore University Hospital, Manhasset,
New York
Simha, R., Prof., The George Washington University,
Washington, DC
Svoboda, K., Ph.D., Howard Hughes Medical Institute/Cold
Spring Harbor Laboratory
Tulman, E., B.Sc., Plum Island Animal Disease Center,
USDA, Greenport, New York
Tyurina, 0., B.Sc., University of Massachusetts, Amherst
Unniraman, S., Ph.D., Yale University School of Medicine,
New Haven, Connecticut
Wang, X., B.Sc., Queens College, CUNY, Flushing, New York
Xu, Ks, Ph.D., NIAAA, National Institutes of Health, Rockville,
Maryland
Zuk, D., Ph.D., Cell Press, Cambridge, Massachusetts
Genome Access Course, October 2002
December 4-5
Ascherio, A., Ph.D., Harvard School of Public Health, Boston,
Massachusetts
Beg, A., Ph.D., Columbia University, New York
Cheung, K.-H., Ph.D., Yale Center for Medical Informatics, New
Haven, Connecticut
Dranginis, A., Ph.D., St. Johns University, Jamaica, New York
Freire-Moar, J., Ph.D., Forest Laboratories, New York
Friedman, C., B.Sc., College of Staten Island-CUNY, New York
Gerstbrein, B., B.Sc., Rutgers University, Piscataway, New
Jersey
Grabowski, P., Ph.D., University of Pittsburgh/Howard
Hughes Medical Institute, Pennsylvania
Grech, A., B.Sc., Yale University, New Haven, Connecticut
Gunderson, S., Ph.D., Rutgers University, Piscataway, New
Jersey
Hong, P., Ph.D., Harvard University, Cambridge,
Massachusetts
Hopkins, N., Ph.D., Massachusetts Institute of Technology,
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Cambridge
Laal, S., Ph.D., New York University School of Medicine, New York
Lai, K., B.Sc., Massachusetts Institute of Technology, Cambridge
U, L, B.Sc., St. John's University, Jamaica, New York
Marasco, W., Ph.D., Dana Farber Cancer Institute, Boston,
Massachusetts
Maston, G., Ph.D., University of Massachusetts Medical School,
Worcester
Monteiro, A., Ph.D., Cornell Medical College, New York
Murray, D., Ph.D., Weill Medical College of Cornell University,
New York
Nickas, M., Ph.D., SUNY, Stony Brook, New York
Oliveira, M.B., B.Sc., Tufts University School of Medicine,
Boston, Massachusetts
Rivlin, P., Ph.D., Cornell University, Ithaca, New York
Rossi, P., Ph.D., Columbia University, New York
Royal, D., Ph.D., Rutgers, The State University of New
Jersey, Piscataway
Scamborova, P., B.Sc., Yale University, New Haven, Connecticut
Tallarico, A., Ph.D., Dana-Farber Cancer Institute, Boston,
Massachusetts
Vilinsky, I., B.Sc., Cornell University, Ithaca, New York
Wang, H., Ph.D., Thomas Jefferson University, Philadelphia,
Pennsylvania
Worms ley, S., Ph.D., Yale University, New Haven, Connectcut
Yarilina, A., B.Sc., Columbia University, New York
The Laboratory would like
ment and reagents to the
Actimetrics
Affymetrix Inc.
Agencourt Bioscience Corporation
Agilent Technologies, Inc.
Ambion Inc.
Amersham Biosciences
A.M.P.I.
Applied Biosystems
Applied Precision Inc.
Astro-Med Inc.
Axon Instruments
Becton Dickinson Labware
Berthold Technologies USA, LLC
Biocrest Manufacturing
Bio-Rad Laboratories
Bioptechs Inc.
BioVision Technologies
BioVVhittaker Molecular Applications
Brinkmann Instruments
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Genome Access Course, December 2002
to acknowledge the generosity of the following companies who loaned equip-
various courses:
Clontech Laboratories, Inc.
Codonics Inc.
Coherent Laser
Cooke Corporation
Corning Inc.
Dagan Corporation
Dage-MTI Inc.
David Kopf Instruments
Delaware Diamond Knives
Diagnostic Instruments, Inc.
Drummond Scientific Company
Dynal
Eastman Kodak Company
Erie Scientific Company
Fisher Scientific
Fotodyne Inc.
Galil Motion Control
Hamamatsu Photonic Systems
Hampton Research
Harvard Apparatus, Inc.
Hitachi Denski America
Improvision Inc.
Instrutech Corp.
Integrated DNA Technologies, Inc.
Intelligent Imaging Innovations Inc.
Invitrogen Corporation
Jackson lmmunoresearch
Laboratories
The Jackson Laboratory
Jouan, Inc.
Kinetic Systems Inc.
Kleindiek Nanotechnik
Leica Microsystems Inc.
Luigs & Neumann
Mcmaster Carr Supply Company
Majer Precision Engineering Inc.
Marsh Bio Products
Med Associates Inc.
Micro Video Instruments
Millipore Corporation
minus K Technology
MJ Research Inc.
Modulation Optics, Inc.
Molecular Devices Corporation
Molecular Dynamics
Molecular Probes Inc.
Nalge Nunc International
Narishige International USA, Inc.
New England Biolabs, Inc.
Newport Corp.
Nikon Inc.
Novagenlnc.
Olympus America Inc.
Operon Technologies Inc.
Optronics
PE Biosystems
Perkin Elmer Life Sciences
Pierce Chemical Co.
Promega Corp.
Qiagen Inc.
Robbins Scientific Corporation
Roche Diagnostics
SD Instruments Inc.
Santa Cruz Biotechnology Inc.
Schleicher & Schuell Inc.
Sigma-Aldrich
Sutter Instruments
Photonics Gmbh
Universal Imaging Corporation
VVVR Scientific Products
Vector Laboratories
Vincent Associates
Warner Instruments
Waters Corp.
SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings on a weekly basis. These seminars keep the CSHL staff current on the latest developments
and broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar
speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in
an informal setting. In addtion to the Invited Speaker Program, there are many other speakers pre-
senting seminars at Cold Spring Harbor each year.
January
Dr. Ralph Greenspan, The Neurosciences Institute, San Diego.
Gene networks and the subtleties of behavior in Drosophila.
(Host: Tim Tully)
Dr. Angelika Amon, Howard Hughes Medical Institute, Massa-
chusetts Institute of Technology. Cell cycle control in yeast.
(Host: Nick Tonks)
Dr. John Kuriyan, Molecular and Cell Biology, University of
California, Berkeley. Structural studies on E. coli DNA poly-
merase clamp loading. (Host: Leemor Joshua-Tor)
February
Dr. Titia de Lange, The Rockefeller University. The telomerase
tumor suppressor pathway. (Host: Scott Lowe)
Dr. Martin Heisenberg, Theodor-Boveri-Institut fuer Biowissen-
schaften Lehrstuhl fuer Genetik and Neurobiologie. Behavior-
al analysis and genetic intervention in a small brain. (Host:
Jerry Yin)
Dr. Joe Gall, Department of Embryology, Carnegie Institution.
Cajal bodies: Their role in transcription and processing of
RNA. (Host: David Spector)
March
Dr. Frank McCormick, Department of Microbiology &
Immunology, University of California, San Francisco.
Cancer therapy based on Ras and p53. (Host: Scott
Lowe)
Dr. Dennis Bray, Department of Zoology, University of
Cambridge. Molecular events in a small volume of cyto-
plasm. (Host: Yuri Lazebnik)
Dr. Cynthia Kenyon, Department of Biochemistry, University of
California, San Francisco. Genes and cells that regulate the
aging of C. elegans. (Host: Winship Herr)
Dr. Tom Ellenberger, Department of Biological Chemistry
and Molecular Pharmacology, Harvard Medical School.
The anatomy of infidelity. Structures of error-prone and
accurate DNA polymerases. (Host: Leemor Joshua-Tor)
April
Dr. Pietro De Camilli, Howard Hughes Medical Institute, Yale
University School of Medicine. Phosphoinositides in the mor-
phogenesis of the plasma membrane at the synapse and in
muscle. (Host: Jacek Skowronski)
Dr. Roderick MacKinnon, Howard Hughes Medical Institute, The
Rockefeller University. Ion channels. (Host: Karel Svoboda)
Dr. David J. Anderson, Howard Hughes Medical Institute,
California Institute of Technology. Molecular mechanisms of
neural cell fate determination. (Host: Grisha Enikolopov)
October
Dr. David Baulcombe, The Sainsbury Laboratory. Roles, mecha-
nisms, and applications of RNA silencing. (Host: David
Jackson)
Dr. Mike Tyers, Samuel Lunenfeld Research Institute, Mount
Sinai Hospital, Canada. Ultrasensitivity and commitment to
cell division. (Host: Bruce Stillman)
Dr. Linda Buck, Howard Hughes Medical Institute, Fred
Hutchinson Cancer Research Center. Deconstructing smell.
(Host: Yi Zhong)
Dr. Martin Nowak, Institute for Advanced Study, Princeton, New
Jersey. Evolution of cooperation. (Host: Mitya Chklovskii)
November
Dr. W. James Nelson, Stanford University School of Medicine.
Role of spatial cues in generating cell polarity. (Host: Senthil
Muthuswamy)
Dr. Stephen P. Bell, Howard Hughes Medical Institute, Massa-
chusetts Institute of Technology. The duplication of eukaryot-
ic chromosomes. (Host: Bruce Stillman)
December
Dr. Carl Wu, National Cancer Institute, NIH. ATP-dependent
chromatin remodeling protein complexes for transcription.
(Host: Winship Herr)
Dr. Craig C. Mello, Howard Hughes Medical Institute, Univer-
sity of Massachusetts Medical School. RNA interference and
development in C. elegans. (Host: Greg Hannon)
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In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in organizing, pre-
senting, and defending their research.
January
Juan Mendez (Stillman Lab): Control of initiation of DNA repli-
cation in human cells.
Eli Hatchwell: Sporadic human genetic disease.
Tomek Swigut (Skowronski Lab): Mechanisms for down-regu-
lation of cell surface proteins by Nef.
February
Erik Vollbrecht (Martienssen Lab): Regulation of meristem
activity and inflorescence architecture in maize.
Adrian Krainer: Listening to silence and understanding non-
sense: Coding-sequence mutations that affect splicing.
Bud Mishra: A random walk down the genomes: A case study
of DNA evolution in VALIS.
March
Xuemei Zhao (Herr Lab): Mechanisms of TATA-box-binding
protein function: Teaching an old dog new tricks.
Esther Nimchinsky (Svoboda Lab): Optical studies of individual
synapses with single receptor resolution.
Greg Hannon: RNAi: Mechanisms and applications.
April
Yuri Lazebnik: Assisted suicide, promiscuous cells, and the joy
of the unexpected.
Tatsuya Hirano: Molecular basis of chromosome condensation
and cohension.
Linda Van Aelst: The rap on Ras and Rho signaling.
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October
Amy Caudy (Hannon Lab): Thinking about RNA: Fragile X
mental retardation protein and RNA interference.
Ping Hu (Hernandez Lab): A minimum set of factors for
RNA polymerase III transcription from the human U6
promoter.
Mary Jane Gething: Unraveling the unfolded protein
response.
Takuya Takahashi (Malinow Lab): Experience strengthens
transmission by driving AMPA receptors into synapses.
November
Jordan Fridman (Lowe Lab): Dissecting the Mdm2 oncogene
in vivo: Is full length the full story?
Zach Mainen: What the rat's nose knows: Strategies and
mechanisms for odor perception.
Terence Strick: Single-molecule observation of DNA denatura-
tion fluctuations and RNA polymerase-induced promoter
melting.
December
Tom Volpe (Martienssen Lab): RNAi in S. pombe: Getting to
the core of chromatin.
John Mignone (Enikolopov Lab): The identification of stem
cells using fluorescent transgenics.
Tim Tully: An attempt to understand signal-to-noise from DNA
microarray data.
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BANBURY CENTER
DIRECTOR'S REPORT
The Banbury Center continues to be used throughout the year, with the exception of the few weeks
during the depth of the winter. There were 24 meetings in 2002 and Laboratory scientists used the
Center for four group meetings. The Watson School of Biological Sciences held two week-long "Topics
in Biology" courses, and there were the usual five neuroscience lecture courses. Finally, two local
groups made use of the Center.
There were 654 participants in Banbury Center meetings, 75% of whom came from the United
States, drawn from 36 states. As usual, New York, Maryland, California, and Massachusetts supplied
most visitors; these four states accounted for almost 50% of the U.S. participants. 164 visitors came
from around the world-from no fewer than 22 countries, demonstrating the high international reputa-
tion of the Center.
The topics for the meetings were varied as always, although this year, the program was largely con-
cerned with genetics and cancer, and there were fewer neuroscience meetings than usual.
Genomics
Banbury Center's 24 years encompasses the revolution in human genetics brought about by gene
mapping and sequencing. Now, with the human genome sequence available for nucleotide-by-
nucleotide examination, new strategies should be devised to exploit this remarkable resource.
Sequenced-based Disease Gene Hunts, organized by Aravinda Chakravarti (April 28May 1), dis-
cussed how this might be done. It is especially important for complex traits such as schizophrenia or
asthma, where progress has been slow using standard family linkage methods. New tools that allow
the scanning of the entire genome, for expression differences or sequence variation, promise to change
this situation.
The impact of genome sequences is not limited, of course, to human beings. Plant scientists have
been at the forefront of sequencing efforts, and crop geneticists are making intensive use of the data.
John Doebley and Antoni Rafalski organized the meeting Sequence Diversity in Crop Plants: Results,
till
Graduate School Course held at Banbury Center
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Robertson House provides housing accommodations at Banbury Center.
Interpretations, and Applications (November 3-6) to examine new information coming from sequence
comparisons of crop plants and wild species. These are being used to examine crop plant domestica-
tion, the evolution of polyploidy, and associations between traits and alleles. Some of the results have
been surprising and some conflicting, and the meeting was intended to increase collaborations
between experimentalists and theoreticians, as well as encourage the exchange of information
between those interested in crop plants and those working with wild species or model systems.
Human Genetics
Fragile X is an example of a genetic disorder that has progressed from the gene-hunting stage to the
functional analysis of the gene and its protein. Banbury Center has held annual meetings on Fragile X,
and the advances in understanding the disorder are remarkable. RNA Metabolism and the Fragile X
Syndrome, organized by Robert Darnell, Steve Warren, and David Nelson (April 7-10), continued the
analysis of the role of the key protein-FMRP-that appears to bind to mRNA in the dendritic spines
of neurons. The working hypothesis is that FMRP regulates specific mRNA transcripts that are critical
in mediating communication between neurons. Such studies require the interactions of scientists
drawn from diverse fields of research, and Banbury, as always, provides an ideal environment in which
to promote collaborations.
Collaborations are very powerful ways of getting ahead through the pooling of resources and ideas.
The Huntington's Disease Society of America and the Amyotrophic Lateral Sclerosis Association joint-
ly sponsored the meeting on Neurodegenerative Disease Models: From Pathogenesis to Therapeutics
(Christopher Ross and Lucie Bruijn; February 10-13). The theme of the meeting was that a set of neu-
rodegenerative diseases including Huntington disease and amyotrophic lateral sclerosis seem to result
from protein misfolding and aggregation. Perhaps, then, there are commonalities of mechanisms and
questions to be answered: What are the roles of misfolding and aggregation in pathogenesis? Which
are likely to be advantageous models for screening for therapeutics? Why are certain cells differential-
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ly vulnerable in the different diseases? Answers were not found at the meeting, but new collaborations
were fostered.
Gene Therapy
It is not often that a Banbury Center meeting attracts the attention of Sports Illustrated, but the meeting,
Genetic Enhancement of Athletic Performance (Ted Friedmann, Gary Wadler, and Jan Witkowski; March
17-20), did so. Gene therapy has yet to live up to its promise, and it has suffered repeated setbacks,
most recently the development of leukemia in children treated with retroviral vectors. However, the pres-
sures and financial rewards of success in sport are so great that athletes may use gene therapy to intro-
duce "desirable" performance-promoting genes while ignoring the dangers of gene therapy. Participants
in this meeting, funded by the World Anti-Doping Agency (VVADA), reviewed the current means by which
athletes use medical treatments to promote performance and the current state of gene therapy, and dis-
cussed the future risks. It was hoped that the meeting would assist in the development of appropriate
policy to anticipate and regulate extension of genetic therapy techniques and other emerging technolo-
gies to sports. The meeting was followed by a press conference in the New York City.
Infectious Diseases
Two meetings were prompted by the heightened awareness of the dangers of biological terrorism. The
first, organized by Bud Mishra, was called Designer Molecules for Biosensor Applications (August
12-14) and discussed the potential of current state-of-the-art and possible short-term and long-term
technology for rapid detection of pathogenic microorganisms. The relative merits of various technolo-
gies, based on genomic expression (mRNA), genome structure (DNA/RNA), protein structure, and
other physical and geometric properties, were reviewed. Participants discussed the requirements of
sensors for an advanced warning system against a biochemical attack, quick diagnosis of bio-warfare
agents involved in the attack, and the forensics needed to determine the source of the attack.
The second meeting, Microbial Forensics (Steven Schutzer, Bruce Budowle, and Roger Breeze;
November 10-13) was, in some ways, a descendant of the historic Banbury Center meeting on DNA
fingerprinting held in 1989. Indeed, some of the participants in this meeting had been here in 1989.
Participants discussed how to detect and identify pathogens, in particular using what might be called
DNA signatures for pathogens. The meeting was initiated in part by new legislation that will change dra-
matically how certain dangerous pathogens are handled in the United States and that will subject aca-
demic laboratories to special physical, personnel, and pathogen security measures. The meeting was
notable for the mix of scientists from academia and from government agencies-it set a new record for
the number of acronyms appearing in a program.
The third meeting on infectious diseases-Phage Therapy: Potential and Challenges (Janakiraman
Ramachandran, Gary Schoolnik, and Suresh Subramani; November 13-15)-discussed an antibacte-
rial strategy that has been available for more than 80 years. Bacteriophages are viruses that attack bac-
teria, and their use as antibacterial agents was urged by Felix d'Herelle, codiscover, with Frederick
Twort, of bacteriophage in the early part of the 20th century. However, phage therapy was ineffective
because of the poor understanding of the biology of phages, especially their specificity, by the early
practitioners. Recent global emergence of antibiotic-resistant bacterial pathogens, especially in hospi-
tals, has led to the reevaluation of the potential of bacteriophages for the treatment of these infections.
Phage therapy also has enormous potential for medical care in the developing world.
Cancer
The four meetings on cancer ranged from fundamental research through clinical trials of therapeutics
to an evaluation of possible therapies. Cell Immortalization and Transformation (Gordon Peters and
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John Sedivy; September 22-25) reviewed critically the current data on human cell immortalization and
transformation, events that set a normal cell on the path to cancer. Here, an understanding of the
pathways involved has been confused by the differing responses of rodent and human cells in assays;
for example, two cooperating oncogenes are sufficient for transformation of primary rodent cells but
not for transformation of human cells. Participants reviewed the data from different cell types and dif-
ferent species and tried to come to some consensus on what is going on.
The therapy of advanced melanoma remains a great challenge to researchers and physicians.
Although there has been considerable progress in our understanding of the immune response in
melanoma, clinical results based on this knowledge have not yet realized their full potential.
Nonimmunological therapies may hold much promise, but relatively little has been done in this area,
and it is not clear what these therapies might be. Meenhard Herlyn and Scott Lowe organized the
meeting on A Critical Review of Melanoma: Biology and Therapy (September 29 to October 2) to bring
together investigators working on the fundamental biology of melanomas, physicians developing and
using therapies, and scientists working on related topics but not directly on melanoma. It was hoped
that this combination of participants would foster critical reviews of current research and therapies for
melanoma and suggest new strategies to attack this intractable cancer.
Control of angiogenesis as a strategy for controlling cancer has received intense study over the past
few years. In particular, a considerable amount of research-laboratory and clinical-is taking place on
endostatin, and it seemed the right time to examine what is known of endostatin and its activities.
Judah Folkman organized the meeting A Critical Review of Endostatin and Its Biology (March 10-13)
that focused on topics such as the production of recombinant endostatin, studies of its mechanism of
action in vitro and in animals, endostatin gene therapy, and clinical trials.
Innumerable "folk" remedies have been used for centuries to treat the all manner of illnesses. Green
tea is said to have protective effects against cancer, but although some laboratory studies in vitro and
in animals have found evidence that green tea contains cancer-preventing chemicals, these results are
at variance with epidemiological studies that find no effect or are themselves inconsistent. Banbury
Center excels in this sort of situation, bringing together researchers who have conflicting data to dis-
cuss-rationally one hopes-what is going on. Chung Yang undertook to bring the relevant parties
together for a fascinating meeting Green Tea and Cancer: A Critical Review (May 12-15), which includ-
ed a public lecture and demonstration of the Japanese tea ceremony in Grace Auditorium.
Cell Biology
Two meetings followed a rather unusual format, pioneered some years ago by Winship Herr, Robert
Kingston, and Keith Yamamoto in a meeting on transcription factors. Instead of having a meeting with
36, 30-minute presentations, each of five sessions was devoted to a specific topic, introduced by one
or two short talks that set the background for the topic. Anyone who had data relevant to the topic
could then contribute, and could do so several times in the same session or in different sessions. To
encourage short and to-the-point contributions, participants could use no visual aids other than the
chalkboard or the overhead projector.
DNA Recombination and Repair (James Haber and Scott Hawley; October 20-23) reviewed the
flood of new information about the proteins that carry out recombination, and the new methods being
used to look in vivo at how DNA strands are being manipulated. The goal of the meeting was to see
whether a consensus could be reached about the essential elements in the several types of homolo-
gous and nonhomologous recombination pathways.
The second meeting- Glucocorticoid Regulatory Mechanisms and Pathophysiology (Daryl Granner
and Keith Yamamoto; December 8-11)-also looked at a well-established field. The corticosteroid hor-
mones and their agonist and antagonist derivatives are among the most widely used therapeutic
agents, and the glucocorticoid receptor is one of the best-understood eukaryotic transcriptional regu-
latory factors. The meeting brought together investigators working across the spectrum of studies of
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Meier House Provides housing accommodations for meeting participants at Banbury Center.
glucocorticoid action, as well as several experts in related areas, to integrate knowledge in the field,
identify specific challenges and opportunities, and bridge intellectual gaps.
Meetings of this format are much harder work for the participants, but they can be very rewarding.
Indeed, both meetings worked extremely well and participants were enthusiastic, once the shock of
not using Power Point presentations had worn off!
Gary Bokoch and Ulla Knaus organized a meeting on Oxidases in Inflammation and Cellular
Signaling (November 17-20). Reactive oxygen species were recognized nearly 30 years ago as prod-
ucts generated by phagocytic leukocytes for the purpose of bacterial killing. During subsequent years,
the system responsible for generating oxidants in a controlled fashion has been defined, and it is now
apparent that oxidants may also have roles as intracellular signaling molecules or second messengers.
Here again, disparate areas of research find common elements, and a discussion meeting of investi-
gators drawn from these different fields can help promote new research.
Neuroscience
The neuroscience meeting took as its subject a topic that goes all the way from basic neurological
processes to the highest levels of psychology. Understanding the neural and psychological basis of
emotions is essential since emotional responses pervade all aspects of cognition and behavior and can
give insight into psychiatric illnesses, including depression, anxiety, and aspects of drug addiction.
Emotion has been a neglected topic for scientific discussion, but there is now a revival of interest from
several different viewpoints, not least the advances in neurobiology and the increasing convergence of
animal and human studies.
Psychobiology of Emotion (Ray Dolan and Lewis Wolpert; October 27-30) included biologists, imag-
ing scientists, experimental psychologists, and pharmacologists, all attempting to understand how we
come to experience these most personal experiences.
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Vaccines
Banbury Center has hosted a series of meetings for the Albert B. Sabin Vaccine Institute devoted to
many aspects of vaccines, scientific as well as social. Global Vaccine Shortage: The Threat to Children
and What to Do About It (Lance Gordon, Lewis A. Miller, and Nancy Tomich; October 23-25) was one
that dealt with social and policy issues. The participants, drawn from academia, government, and
industry, discussed the most feasible approaches to solving the recurring vaccine supply problems in
the United States and in developing nations.
Education
The Dolan DNA Learning Center and Banbury Center continue to work together on the eugenics Web
Site (http://www.eugenicsarchive.org/eugenics/), funded by a grant from the ELSI program of the
National Human Genome Research Institute. The most recent grant includes an education compo-
nent-funding for a series of workshops on American Eugenics and the New Biology: Perspectives and
Parallels (David Mick los and Jan Witkowski; April 14-16). This workshop, which was targeted at opin-
ion leaders and policy makers from government, science, healthcare, education, and the mass media,
provided an opportunity to learn about America's past involvement in eugenics from leading experts
and to interact with them in the context of a small meeting.
Watson School of Biological Sciences
This year, for the first time, we held two Topics in Biology courses so as to keep the class size small.
The first was the return visit, by popular demand, of Hidde Ploegh from Harvard to teach an immunol-
ogy course. The second was a new course on microbial pathogenesis, taught by Stan Malloy and Ron
Taylor. They teach the summer Bacterial Genetics course at the main campus and are wonderful teach-
ers. By all accounts, their course was a tremendous success.
Acknowledgments
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MEETINGS
DNA Interactive Advisory Panel
January 17-19
FUNDED BY Howard Hughes Medical Institute
ARRANGED BY D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory:
Welcome and procedures.
D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor
Laboratory: Purpose and overview of the Genetic Journey/
DNA/ project,
Introductions: Participants, CSHL, HHMI, Windfall Films
Ltd., and RGB Company Ltd.
P. Bruns and D. Liu, Howard Hughes Medical Institute, Chevy
Chase, Maryland: Funding perspective and DNAi mini-courses.
J.D. Watson, Cold Spring Harbor Laboratory: Genetic Journey,
evolution of the project, thoughts in the DNA structure, and
key points of the series.
D. Dugan, Windfall Films Ltd., London, United Kingdom, and
Max Whitby, The Red Green & Blue Company Ltd., London,
United Kingdom: Production perspective.
D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor
Laboratory: Concept for DNAL
SESSION 2
D. Mick los and DNALC Staff, Dolan DNA Learning Center, Cold
Spring Harbor Laboratory: Tour of Dolan DNALC.
D. Mick los and DNALC Staff, Dolan DNA Learning Center, Cold
Spring Harbor Laboratory: Discussion of DNAi template and
Technology I.
Exploration of Innovative WWW Sites and Technology
D. Mick los and DNALC Staff, Dolan DNA Learning Center, Cold
Spring Harbor Laboratory: Discussion of DNAi template and
Technology II.
SESSION 3
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory:
Introduction to five content areas of Genetic Journey.
Small Group Brainstorming on Five Content Areas,
Concepts, and Innovative Approaches
Summary of group findings
Next Steps: WWW Site as Interaction Tool and Summer
Internships
Dolan DNALC Focus Group
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Neurodegenerative Disease Models: From Pathogenesis
to Therapeutics
February 10-13
FUNDED BY Huntington's Disease Society of America and the Amyotrophic Lateral
Sclerosis Association
ARRANGED BY C.A. Ross, Johns Hopkins University School of Medicine and Huntington's
Disease Society of America, Baltimore, Maryland
L. Bruijn, Amyotrophic Lateral Sclerosis Association, Guilford, Connecticut
Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Opening Remarks: C.A. Ross, Johns Hopkins University School of Medicine, Baltimore,
Maryland and Huntington's Disease Society of America
L. Bruijn, Amyotrophic Lateral Sclerosis Association, Guilford, Connecticut
SESSION 1: Biochemical Systems
Chairperson: S.L. Lindquist, Whitehead Institute, Cambridge, Massachusetts
R. Wetzel, University of Tennessee Medical Center, Knoxville:
Polyglutamine aggregation and interactions.
A. Ciechanover, Technion-Israel Institute of Technology, Haifa,
Israel: Ubiquitin activation of transcriptions: NF-KB as a par-
adigm.
T.M. Dawson, Johns Hopkins University School of Medicine,
SESSION 2: Cell Systems
Chairperson: K. Duff, Nathan Kline Institute, Orangeburg, New York
Y. Lazebnik, Cold Spring Harbor Laboratory: Cell death.
R.R. Kopito, Stanford University, California: Protein aggrega-
tion and the ubiquitin proteasome system.
M.E. MacDonald, Massachusetts General Hospital, Charles-
town: Early events in HD.
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Baltimore, Maryland: The syns of PD.
J.F. Gusella, Massachusetts General Hospital, Charlestown:
Genetic criteria for evaluating HD models.
R.H. Brown, Massachusetts General Hospital, Charlestown:
ALS genetics and pathogenesis: Insights from studies of
SOD1.
D. Sulzer, Columbia University, New York: Is macroautophagy
a desperate attempt at neuroprotection?
H.D. Durham, Montreal Neurological Institute, Quebec,
Canada: Physiology of aggregation in motor neurons.
R. Morimoto, M. MacDonald
SESSION 3: Invertebrate Model Systems
Chairperson: R.R. Kopito, Stanford University, California
M. Feany, Brigham and Women's Hospital, Boston, Massa-
chusetts: Fly models for neurodegeneration.
L.M. Thompson, University of California, Irvine: Therapeutic
implications of transcriptional dysregulation and aggregation
in HD.
S.L. Lindquist, Whitehead Institute, Cambridge, Massachu-
setts: Neurodegenerative disease models: Lessons from
SESSION 4: Vertebrate Model Systems
Chairperson: L.M. Thompson, University of California, Irvine
S.B. Prusiner, University of California, San Francisco: Trans-
genic studies of prion diseases.
M. Hutton, Mayo Clinic, Jacksonville, Florida: Tau in neurode-
generative disease.
C.A. Ross, Johns Hopkins University School of Medicine,
Baltimore, Maryland and Huntington's disease Society of
SESSION 5: Models and Therapeutics
Chairperson: J.D. Rothstein, Johns Hopkins University School
K. Duff, Nathan Kline Institute, Orangeburg, New York: Seques-
tration of peripheral A-beta as a therapeutic approach.
D.R. Borchelt, Johns Hopkins Medical Institutions, Baltimore,
Maryland: Protein aggregation in neurodegenerative disease.
Q. Liu, Harvard Medical School. Boston, Massachusetts:
yeast.
R.I. Morimoto, Northwestern University, Evanston, Illinois:
Stressing worms by polyglutamines: Effects of aging on
aggregation and toxicity.
C. Link, University of Colorado, Boulder: R amyloid-chaperone
interactions in a transgenic C. elegans model.
America: Polyglutamine pathogenesis: Proteolysis, aggrega-
tion, and transcription.
J.D. Rothstein, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Astroglia, glutamate, and transporters:
Pathway for cell death and target for neuroprotection.
of Medicine, Baltimore, Maryland
Chemical screens for compounds that affect mutant SOD1-
induced aggresome formation.
P.T. Lansbury, Brigham and Women's Hospital, Boston,
Massachusetts: From Parkinson's genes to new therapeutic
strategies.
R. Abendroth, S. Lindquist
R. Brown, T. Maniatis
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A Critical Review of Endostatin and Its Biology
March 10-13
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Folkman, Children's Hospital, Boston, Massachusetts
SESSION 1: Discovery and Structure-Function of Endostatin
Chairperson: J. Folkman, Children's Hospital, Boston, Massachusetts
M.S. O'Reilly, MD Anderson Cancer Center, Houston, Texas:
The discovery and characterization of endostatin.
Y-H. Ding, Pfizer Inc., Cambridge, Massachusetts: Crystal
structure of human endostatin and its implications.
R. Kalluri, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Cross-talk between endogenous inhibitors
of angiogenesis.
A.W. Griffioen, University Hospital Maastricht, The Netherlands:
Development of novel angiostatics by peptide design based
on the structure of known angiogenesis inhibitors.
Summary and Discussion
SESSION 2: Production of Recombinant Endostatin
Chairperson: S. Libutti, National Cancer Institute, Bethesda, Maryland
J. Shiloach, National Institutes of Health, Bethesda, Maryland:
Production and recovery of recombinant endostatin from
pichiapastoris.
I.S. Chung, Kyung Hee University, Suwon, Korea: Production
of recombinant endostatin from stably transformed lepi-
dopteran and dipteran insect cells.
SESSION 3: In Vitro Biology Mechanism of Action
Chairperson: S. Libutti, National Cancer Institute,
Bethesda, Maryland
T Pihlajaniemi, University of Oulu, Finland: Diverse roles of the
endostatin precursor, type XVIII collagen, and its homologue,
type XV collage.
L. Claesson-Welsh, Uppsala University, Sweden: Is endo-
statin's effect on endothelial cell migration receptor-indepen-
dent and is it critical in anti-angiogenesis?
D.S. Milstone, Brigham & Women's Hospital, Boston,
Massachusetts: E-selectin and the antiangiogenic activity of
endostatin.
B.K. Lee Sim, Entremed, Inc., Rockville, Maryland: Endostatin
interacts with tropomyosin and actin: A potential modulator
of the antitumor activity of endostatin.
W.D. Figg, National Cancer Institute, Bethesda, Maryland:
Comparison of murine and human endostatin in pre-clinical
models.
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L. Claesson-Welch, J. Folkman
SESSION 4: In Vivo: Laboratory Experiments I
Chairperson: M.S. O'Reilly, MD Anderson Cancer Center, Houston, Texas
B.D. Ackley, University of California, Santa Cruz: The C. elegans
homologue of collagen XVIII /endostatin regulates aspects of
cell motility and neurogenesis.
F. Bertolini, European Institute of Oncology, Milan, Italy: Effect
of endostatin on mobilization, clonogenic potential, and dif-
ferentiation of endothelial progenitors.
B.R. Olsen, Harvard Medical School, Boston, Massachusetts:
Phenotypic abnormalities of collagen VIII/endostatin null mice:
Implications for biological function.
0. Kisker, University Hospital Marburg, Germany: Continuous
administration of endostatin improves the efficacy and
potency of therapy in a mouse xenograft tumor model.
S. Soker, Children's Hospital, Boston, Massachusetts: Novel
functions of endostatin, or what have we missed in vitro that
can explain the antitumor activity of endostatin in vivo.
M.R. Passos-Bueno, Universidade de Sao Paulo, San Paulo,
Brazil: Characterization of novel SNP5 (single nucleotide
polymorphisms) in endostatins derived from collagens X\./
and XVIII and their impact in the susceptibility of cancer.
SESSION 5: In Vivo: Laboratory Experiments II
Chairperson: N.M. Pinedo, VU Medical Center, Amsterdam, The Netherlands
K. Moulton, Children's Hospital, Boston, Massachusetts: Endo-
statin inhibition of angiogenesis in atherosclerotic plaques.
B. Fenton, University of Rochester Medical Center, New York:
Disparate effects of endostatin on tumor vascular perfusion
and hypoxia in two murine mammary carcinomas.
R. Bjerkvig, University of Bergen, Norway: Delivery of endo-
statin to brain tumors from engineered cells encapsulated in
alginate.
S. Libutti, National Cancer Institute, Bethesda, Maryland: Anti-
angiogenic gene therapy and endothelial cell gene expres-
sion profiling.
R.M. Blaese, National Cancer Institute, Bethesda, Maryland:
Commentary.
SESSION 6: Preclinical and Clinical Translation
Chairperson: W.D. Figg, National Cancer Institute, Bethesda, Maryland
J.G. McArthur, Cell Genesys, Inc., Foster City, California: The
impact of vector 5 decisions on antiangiogenic gene therapy.
H.M. Pinedo, VU Medical Center, Amsterdam, The Nether-
lands: Intrapatient comparison of pharmacokinetics following
subcutaneous and intravenous administration of endostatin.
C. Sidor, Entre Med, Inc., Rockville, Maryland: The issues in
designing trials using endostatin.
R.S. Herbst and M.S. O'Reilly, MD Anderson Cancer Center,
Houston, Texas: The MD Anderson Phase I endostatin study.
J. Heymach, Children's Hospital, Boston, Massachusetts: Use
of circulating endothelial cells as a surrogate marker for
endostatin therapy in patients.
J.P. Eder, Dana-Farber Cancer Institute, Boston, Massachu-
setts: Clinical trials of endostatin.
Banbury grounds
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Genetic Enhancement of Athletic Performance
March 17-20
FUNDED BY WADA Health, Medical & Research Committee
ARRANGED BY T. Friedmann, University of California, San Diego
G.I. Wad ler, New York University School of Medicine, Manhasset
J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: T. Friedmann, University of California, San Diego
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Introduction.
T. Friedmann, University of California, San Diego: Background.
A. Ljungqvist, International Amateur Athletic Federation,
Enebyberg, Sweden: Welcome.
R. Pound, World Anti-Doping Agency, Montreal, Quebec,
Canada: Introduction.
G.I. Wad ler, New York University School of Medicine, Manhas-
set, New York: The history of the nature of doping.
J.O. Koss, WADA Health, Medical & Research Committee,
Aurora, Ontario, Canada: Athlete's perspective.
R.K. Mueller, Leipzig University, Germany: Current methods of
screening.
SESSION 2
Chairperson: G. Goldspink, Royal Free & University College Medical School, London, United Kingdom
T. Friedmann, University of California, San Diego: Principles of
gene therapy: History, current state, and directions.
H.L. Sweeney, University of Pennsylvania, Philadelphia: Target
tissues, muscle.
J. Glorioso, University of Pittsburgh, Pennsylvania: Detection
of gene transfer and genetic approaches to pain control.
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C. Evans, Brigham and Women's Hospital, Boston, Massa-
chusetts: Stem cells, injury, and tissue repair.
0. Cohen-Haguenauer, Hospital Saint-Louis, Paris, France:
Regulatory issues.
Questions and General Discussion
J.-C. Mbanya, P. Verbiest, R. Pound
SESSION 3: Genetic Targets: Metabolism, Muscle Function and
Capacity, Energy Utilization
Chairperson: G.I. Wad ler, New York University School of Medicine
C. Sundberg, Karolinska Institute, Stockholm, Sweden:
Muscle physiology.
C. Sundberg, Karolinska Institute, Stockholm, Sweden:
Metabolism of exercising muscle.
G. Goldspink, Royal Free & University College Medical School,
London, United Kingdom: IGF-1.
SESSION 4: Roundtable Discussion
Chairperson: T. Friedmann, University of California, San Diego
H.L. Sweeney, University of Pennsylvania, Philadelphia
B.J. Byrne, University of Florida School of Medicine, Gainesville
D.C. Wallace, Emory University School of Medicine, Atlanta,
Georgia
B. Saltin, The Copenhagen Muscle Research Centre, Denmark
G.I. Wad ler, New York University School of Medicine, Manhas-
set
Growth Factors, Oxygen Carrying
, Manhasset, New York
B.J. Byrne, University of Florida School of Medicine,
Gainesville: EPO.
D.C. Wallace, Emory University School of Medicine, Atlanta,
Georgia: Mitochondrial energy production and performance.
J. Glorioso, University of Pittsburgh, Pennsylvania: Metabolic
changes: Microarrays.
Legal and Ethical Aspects of Gene-based Enhancement
in Sport
Chairperson: R.R. Young, Holme Roberts & Owen LLP,
Colorado Springs, Colorado
B.-M. Knoppers, Universite de Montreal, Quebec, Canada:
Legal, medical perspective.
E.T. Juengst, Case Western Reserve University, Cleveland,
Ohio: Biomedical ethics of enhancement.
A. Schneider, The University of Western Ontario, London,
Canada: The ethics of sport.
R.R. Young, Holme Roberts & Owen LLP, Colorado Springs,
Colorado: Sport and the law.
SESSION 5: Open Discussion, WADA Statement, and Communique
Chairpersons: A. Ljungqvist, International Amateur Athletic Federation,
Enebyberg, Sweden; R. Pound, World Anti-Doping Agency, Montreal,
Quebec, Canada; G.I. Wad ler, New York University School of Medicine,
Manhasset, New York; and T. Friedmann, University of California, San Diego
B. Drinkwater, A. Schneider
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RNA Metabolism and the Fragile X Syndrome
April 7-10
FUNDED BY National Institute of Mental Health, NIH, and National Institute of Child
Health and Human Development, NIH
ARRANGED BY R.B. Darnell, The Rockefeller University, New York
S.T. Warren, HHMI, Emory University School of Medicine, Atlanta, Georgia
D.L. Nelson, Baylor College of Medicine, Houston, Texas
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R.B. Darnell, The Rockefeller University, New York
SESSION 1: FMRP and the Regulation of RNA and Protein Metabolism
Chairperson: R.B. Darnell, The Rockefeller University, New York
S. Ceman, Emory University School of Medicine, Atlanta, K. Jensen, The Rockefeller University, New York: Identifying in
Georgia: Regulation of FMRP function by posttranslational vivo RNA targets of vertebrate RNA-binding proteins.
modifications. H.T. Orr, University of Minnesota, Minneapolis: The SCA1 pro-
B. Oostra, Erasmus Universiteit Rotterdam, The Netherlands: tein, ataxin-1, and RNA processing.
Transport of FMRP in PC12 cells. D.L. Black, HHMI, University of California, Los Angeles: Neuro-
Y. Feng, Emory University, Atlanta, Georgia: FMRP in develop- nal regulation of pre-mRNA splicing.
ing neural cells. Overview and Questions
SESSION 2: FMR RNA Targets
Chairperson: S.T. Warren, HHMI, Emory University School of Medicine, Atlanta, Georgia
J. Darnell, The Rockefeller University, New York: Unique RNA RNAs containing G-quartets.
targets of the RGG box and KH domains of FMRP. L.J. Regan, Yale University, New Haven, Connecticut: Specific
W.T. Greenough, University of Illinois, Urbana: Possible pheno- RNA recognition by FMRP: The role of the KH domains.
type contributions of some FMRP-interacting mRNAs.
H. Moine, Institut de Genetique et de Biologie Moleculaire et Overview and Questions
Cellulaire, Strasbourg, France: The interaction of FMRP with
J.L. Mandel, B. Oostra, G. Bassell
SESSION 3: RNA Trafficking and Translational Control
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston,
0. Steward, University of California, Irvine: Targeting mRNA to
synaptic sites on dendrites.
G.J. Bassell, Albert Einstein College, Bronx, New York:
Regulation and function of FMRP and FMR1 mRNA traffick-
ing in developing neurons.
M.W. Hentze, European Molecular Biology Laboratory,
Heidelberg, Germany: Translational regulation by mRNA-
SESSION 4: FMR in Flies
Chairperson: W.T. Greenough, University of Illinois, Urbana
T.A. Jongens, University of Pennsylvania School of Medicine,
Philadelphia: Analysis of behavioral and germ line detects of
dfmrl mutant Drosophila.
A. Costa, Princeton University, New Jersey: dFMR-Orb inter-
actions and mRNA localization/translation.
J. Morales, Baylor College of Medicine, Houston, Texas: DFXR
regulates brain morphology and function in the CNS.
H. Matthies, University of Utah, Salt Lake City: Does Dro-
SESSION 5: FMR RNA Physiology
Chairperson: R.B. Darnell, The Rockefeller University, New York
K.M. Huber, University of Texas Southwestern Medical Center,
Dallas: Role for ERK in mGluR and protein-synthesis-depen-
dent LTD.
M.F. Bear, HHMI, Brown University, Providence, Rhode Island:
Fragile X: The LTD connection.
R. Malinow, Cold Spring Harbor Laboratory: AMPA receptor
trafficking during synaptic plasticity.
K. Zito, Cold Spring Harbor Laboratory: Identification of genes
differentially expressed in wild-type and fmrl knockout
mouse barrel cortex.
Summing Up: Current Issues, Future Plans
R.B. Darnell, The Rockefeller University, New York
D.L. Nelson, Baylor College of Medicine, Houston, Texas
S.T. Warren, HHMI, Emory University School of Medicine,
Atlanta, Georgia
Texas
binding proteins.
J. Richter, University of Massachusetts Medical School,
Worcester: CPEB-mediated translational control.
J.R. Fallon, Brown University, Providence, Rhode Island: Regu-
lation of FMR1 mRNA translation in neurons.
Overview and Questions
sophila FMRP regulate microtubule dynamics/stability?
K. Moses, Emory University School of Medicine, Atlanta,
Georgia: Genetic screen for dominant modifiers of dFMRp.
J.-L. Mandel, Institut Genetique et de Biologie Moleculaire et
Cellulaire, Illkirch, France: FMRP interactors and Drosophila
results.
Overview and Questions
Coffee break
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American Eugenics and the New Biology:
Perspectives and Parallels
April 14-16
FUNDED BY National Human Genome Research Institute
ARRANGED BY D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: History
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Introduction
G. Allen, Washington University, St. Louis, Missouri: Progressive
origins of eugenics and the Eugenics Record Office.
E. Carlson, SUNY, Stony Brook: Badseed, corrupted germ
plasm, prized pedigrees, and eugenic worth.
SESSION 2: Impacts
S. Selden, University of Maryland, College Park: Fitter Families
for Future Firesides: State fairs and the construction of merit
and race in America, 1913-1930.
P.A. Lombardo, University of Virginia, Charlottesville: Immigra-
tion and sterilization in the United States.
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SESSION 3: Resources: Dolan DNA Learning Center
D. Mick los and J.A. Witkowski, Cold Spring Harbor Laboratory:
Introduction to the Image Archive on the American Eugenics
Movement.
SESSION 4: Lessons
B. Biesecker, National Human Genome Research Institute,
Bethesda, Maryland: Use of genetic information: Reproduc-
tive choice, risk prediction, and (ultimately) behavior change.
D. Goldman, National Institutes of Health, Bethesda, Mary-
land: Genetics of alcoholism.
R. Apodaca, R Ryan, G. Allen
Sequence-based Disease Gene Hunts
April 28-May 1
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY A. Chakravarti, Johns Hopkins University School of Medicine, Baltimore, Maryland
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
A. Chakravarti, Johns Hopkins University School of Medicine, Baltimore, Maryland
SESSION 1: Concepts of Complex Disease
Chairperson: A. Chakravarti, Johns Hopkins University School of Medicine, Baltimore, Maryland
J.K. Pritchard, University of Chicago, Illinois: Allelic hetero-
geneity, haplotype blocks, and linkage disequilibrium map-
ping.
X. Estivill, The Hospital for Sick Children, Toronto, Canada:
Somatic interstitial duplications of chromosome 15 in anxiety
SESSION 2: Human Genomic Variation
Chairperson: C.H. Langley, University of California, Davis
disorders.
C.H. Langley, University of California, Davis: Association map-
ping of a model organism: Patterning of Drosophila sensory
organs.
J.L. Weber, Marshfield Medical Research Foundation, Wiscon- scale study of human haplotypes in four population sam-
sin: Diallelic insertion/deletion polymorphisms. ples.
J.C. Stephens, Genaissance Pharmaceuticals, Inc., New Haven, D. Cutler, Johns Hopkins University School of Medicine,
Connecticut: DNA variation of human genes. Baltimore, Maryland: Human genetic substructure and its
D. Altshuler, Massachusetts General Hospital, Boston: A large- implications for disease association studies..
Genome Structure
Chairperson: F.S. Collins, National Human Genome Research Institute, Bethesda, Maryland
J.D. McPherson, Washington University, St. Louis, Missouri:
Whole-genome comparative physical maps.
M. Clamp, The Sanger Institute, Cambridge, United Kingdom:
Human genome annotation in Ensembl.
SESSION 4: Genome Scanning Technology
Chairperson: D. Altshuler, Massachusetts General Hospital,
Boston
C.R. Cantor, Sequenom Inc., San Diego, California: Finding
disease genes in the healthy population.
M.S. Chee, Illumina, Inc., Cardiff, California: Automated large-
scale SNP genotyping on randomly assembled arrays.
M. Zwick, McKusick-Nathans Institute of Genetic Medicine,
Baltimore, Maryland: High-throughput genome resequenc-
ing using microarrays and the ABACUS software package.
M. Wig ler, Cold Spring Harbor Laboratory: Mapping genome
deletions using microarray methods.
SESSION 5: Discussion: Present and Future
Chairperson: A Chakravarti, Johns Hopkins University
School of Medicine, Baltimore, Maryland
Points for Discussion Arising during Meeting
F.S. Collins, National Human Genome Research Institute, Bethes-
da, Maryland: Commentary.
M. Clamp, E. Dawson
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Green Tea and Cancer: A Critical Review
May 12-15
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY C.S. Yang, Rutgers University, Piscataway, New Jersey
SESSION 1: Chemistry: Inhibition of Tumorigenesis in Animal Models
Chairpersons: A. Conney, Rutgers University, Piscataway, New Jersey, and H. Fujiki, Saitama Cancer
Center Research Institute, Japan
C.-T. Ho, Rutgers University, New Brunswick, New Jersey, and
D. Salentine, Unilever Research Vlaardingen, The Netherlands:
Chemistry and antioxidant mechanism of green tea catechins.
H. Fujiki, Saitama Cancer Center Research Institute, Japan:
Cancer prevention with green tea before cancer onset and
combination cancer prevention with green tea following
cancer treatment.
A.H. Conney, Rutgers University, Piscataway, New Jersey:
Inhibition of skin tumorigenesis by tea: What are the mech-
anisms and active constituents?
F.-L. Chung, American Health Foundation, Valhalla, New York:
Inhibition of lung carcinogenesis by tea.
SESSION 2: Studies In Vivo
Chairpersons: J. Weisburger, American Health Foundation, Valhalla, New York, and H. Mukhtar, Uni-
versity of Wisconsin, Madison
J. Weisburger, American Health Foundation, Valhalla, New
York: Inhibition of colon carcinogenesis by tea.
R. Dashwood, Oregon State University, Corvallis: Response of
Apcmin and A33DNb-cat mutant mice to treatment with tea,
sulindac, and 2-amino--I -methy1-6-phenylimidazo(4,5-b)pyri-
dine (PhIP).
Wisconsin, Madison: Green tea in
prevention of prostate cancer.
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Y. Hera, Tokyo Food Techno Co., Ltd., Japan: The fate of tea
catechins in vivo.
X. Meng, Rutgers University, Piscataway, New Jersey: Bio-
availability and biotransformation of tea polyphenols.
Public Lecture: C.S. Yang, Rutgers University, Piscataway,
New Jersey: Beneficial health effects of tea: Evidence, myth,
and perspectives.
A. Conney, L. Arab
SESSION 3: Mechanistic Studies In Vitro
Chairpersons: I.B. Weinstein, Columbia University, New York, and Z. Dong,
University of Minnesota, Austin
I.B. Weinstein, Columbia University, New York: Molecular
mechanisms of growth inhibition by EGCG.
Z. Dong, University of Minnesota, Austin: The effects of tea
polyphenols on signal transduction pathways.
Y. Cao, Karolinska Institute, Stockholm, Sweden: Suppression
of angiogenesis by green tea.
M. Egeblad, University of California, San Francisco: Green tea
as a matrix metalloproteinase inhibitor: Review of the litera-
ture.
S. Garbisa, Universita degli Studi di Padova, Italy: Green tea
inhibition of matrix proteases instrumental to invasion.
SESSION 4: Epidemiological Studies I
Chairpersons: L. Arab, University of North Carolina, Chapel Hill, and Y.-T. Gao,
Shanghai Cancer Insti -tute, China.
L. Arab, University of North Carolina at Chapel Hill: Tea and
rectal cancer, epidemiologic studies in the U.S. and Russia.
I. Hakim, University of Arizona Health Sciences Center,
Tucson: Green tea and oxidative stress among smokers:
Results from a randomized clinical trial.
Y.-T. Gao, Shanghai Cancer Institute, China: Epidemiological
studies on cancer and green tea drinking in Shanghai, China.
Y. Tsubono, Tohoku University, Sendai: A summary of Japanese
epidemiologic studies, published and unpublished.
J.-M. Yuan, University of Southern California: Urinary tea
polyphenols in relation to reduced risk of gastric and
esophageal cancers: Findings from the Shanghai cohort
study.
Z.-F. Zhang, University of California of Los Angeles School of
Public Health: Green tea drinking and reduced risk of gastric
cancer and chronic gastritis.
SESSION 5: Epidemiological Studies II
Chairperson: C.S. Yang, Rutgers University, Piscataway, New Jersey
Z.-M. Chen, Radcliffe Infirmary, Oxford, United Kingdom:
Green tea and cancer mortality: A prospective study of
220,000 male adults in China.
C.-C. Hsieh, University of Massachusetts, Worcester: Green
tea and cancer: Some thoughts on intervention studies.
SESSION 6: Final Assessment and Future Research
Discussion A: What are the mechanisms of inhibition of car-
cinogenesis by tea constituents? How do we integrate stud-
ies in vivo and in vitro?
Discussion B: Does tea consumption inhibit human carcino-
genesis? How can we reconcile the different results in epi-
demiological studies?
Discussion C: What are the key questions to be answered on
tea and cancer? How can we set about answering them?
Meier House
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Designer Molecules for Biosensor Applications
August 12-14
FUNDED BY National Science Foundation, through a grant to University of Illinois, Urbana
ARRANGED BY B. Mishra, Courant Institute of Mathematical Sciences, New York University, New York
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: B. Mishra, Courant Institute of Mathematical Sciences, New York University, New York
M. Desai, Program Officer, National Science Foundation, Arling-
ton,Virginia
J.T. Schwartz, Courant Institute of Mathematical Sciences,
New York University, New York
M. Wig ler, Cold Spring Harbor Laboratory
J. Dahlberg, University of Wisconsin, Madison
SESSION 2: Discussion Panels I
PANEL 1: Genome-based Techniques
Chairperson and Discussion Leader: F.R. Kramer, The International Center for Public Health,
Newark, New Jersey
C.R. Cantor, Sequenom, Inc., San Diego, California
J. Dahlberg, University of Wisconsin, Madison
J. Ju, Columbia Genome Center, New York
F.R. Kramer, The International Center for Public Health, Newark, New Jersey
M. Wig ler, Cold Spring Harbor Laboratory
Discussion during Coffee break
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SESSION 3: Discussion Panels II
PANEL 2: Protein-based Techniques
Chairperson and Discussion Leader: R. Brent, The Molecular Sciences Institute, Inc., Berkeley,
California
R. Brent, The Molecular Sciences Institute, Inc., Berkeley, California
R.R. Breaker, Yale University, New Haven, Connecticut
I. Burbulis, The Molecular Sciences Institute, Inc., Berkeley, California
A. Ellington, University of Texas, Austin
M. Sitharam, University of Florida, Gainesville
SESSION 4: Discussion Panels III
PANEL 3: Miscellaneous
Chairperson and Discussion Leader: N.C. Seeman, New York University, New York
N.C. Seeman, New York University, New York
H.R. Garner, University of Texas Southwestern Medical Center, Dallas
E.M. David, The Rockefeller University, New York
B. Mishra, Courant Institute of Mathematical Sciences, New York University, New York
A. Ray, University of Rochester, New York
SESSION 5: Conclusions
Chairperson: B. Mishra, Courant Institute of Mathematical Sciences, New York University, New York
R. Brent, The Molecular Sciences Institute, Inc., Berkeley California: Personal perspective.
SESSION 6: Panel Summaries and Review
SESSION 7: Key Points for Report and Recommendations
M. Desai, National Science Foundation, Arlington, Virginia
S. Katona, Department of Health and Human Services, Washington, D.C.
J.T. Schwartz, Courant Institute of Mathematical Sciences, New York University, New York
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Cell Immortalization and Transformation
September 22-25
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY G. Peters, Cancer Research UK, London, United Kingdom
J. Sedivy, Brown University, Providence, Rhode Island
Introduction:
G. Peters, Cancer Research UK, London, United Kingdom
SESSION 1: Telomeres and Mortality
Chairperson: C.J. Marshall, Institute of Cancer Research, London,
T. de Lange, The Rockefeller University, New York: Telomere-
directed senescence.
R.R. Redder, Children's Medical Research Institute, West-
mead, Australia: Coexistence of ALT and telomerase in cells
and tumors.
M.A. Blasco, National Centre of Biotechnology, Madrid, Spain:
Functional interactions at the mammalian telomere: Impli-
cations for cancer and aging.
SESSION 2: Senescence versus Stasis
Chairperson: T. de Lange, The Rockefeller University, New York
S. Lowe, Cold Spring Harbor Laboratory: Initiation and main-
tenance of cellular senescence.
J.W. Shay, University of Texas Southwestern Medical Center,
Dallas: Telomerase and human epithelial cell tumor progres-
sion.
D. Galloway, Fred Hutchinson Cancer Research Center, Seattle,
Washington: Telomere-independent pathways in senescent
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United Kingdom
W.E. Wright, University of Texas Southwestern Medical Center,
Dallas: Telomere-based replicative aging versus damage
responses in human cells.
L. Donehower, Baylor College of Medicine, Houston, Texas:
Aging-associated phenotypes in p53 mutant mice.
M. Serrano, National Center of Biotechnology, Madrid, Spain:
"Super p53" mice: Phenotype of transgenic mice containing
supernumerary p53 genes.
and immortal human cells.
T.D. Tlsty, University of California San Francisco: Loss of
genomic integrity in human mammary epithelial cells: Early
events in breast cancer.
R. Bernards, The Netherlands Cancer Institute, Amsterdam:
New tools to study immortalization and transformation.
A. Zetterberg, C. He lin, J. DeCaprio, G. Peters, N. Sharp less
SESSION 3: Cell Cycle/Myc
Chairperson: C.J. Sherr, St. Jude Children's Research Hospital,
A. Zetterberg, Karolinska Institute, Stockholm, Sweden: Cell
growth and checkpoints in G1.
K. He lin, European Institute of Oncology, Milano, Italy: Sup-
pression of the pRB- or p53-mediated G, checkpoint is
required for E2F-induced S-phase entry.
J.M. Sedivy, Brown University, Providence, Rhode Island:
Memphis, Tennessee
What does Myc do: A few new insights into the cell growth
versus proliferation conundrum.
A. Trumpp, Swiss Institute for Experimental Cancer Research,
Epalinges, Switzerland: A novel role for c-Myc in stem cell
self-renewal.
SESSION 4: INK4a/ARF
Chairperson: G. Peters, Cancer Research UK, London, United Kingdom
C.J. Sherr, St. Jude Children's Research Hospital, Memphis,
Tennessee: Ink4 genes and ARF.
N.E. Sharp less, Lineberger Comprehensive Center, Chapel
Hill, North Carolina: The relative roles of p161mK4 and p19.. in
murine cancer.
G. Peters, Cancer Research UK, London, United Kingdom:
Transformation of P161Nk4A-deficient human fibroblasts.
SESSION 5: Transformation/Tumorigenesis
Chairperson: J.M. Sedivy, Brown University, Providence, Rhode
W.C. Hahn, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: Human cell transformation: Cooperation among
telomerase, tumor suppressor proteins, and oncogenes.
C. Counter, Duke University Medical Center, Durham, North
Carolina: Distinct requirements for Ras oncogenesis in
human versus mouse cells.
M. Frame, Beatson Institute for Cancer Research, Glasgow,
J.A. DeCaprio, Dana-Farber Cancer Institute, Boston,
Massachusetts: Genetic interactions between SV40 large T
antigen and p53, Ink 4a, and Arf.
M. van Lohuizen, The Netherlands Cancer Institute, Amster-
dam: Senescence-bypass and transformation screens in
primary mouse cells.
Island
United Kingdom: Transformation and cancer behavior con-
trolled by Src kinase.
C.J. Marshall, Institute of Cancer Research, London, United
Kingdom: Interactions between GTPase signaling pathways
in cell proliferation.
Hartmut Land, University of Rochester Medical Center, New
York: Mechanisms of oncogene cooperation.
Coffee break during meeting
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A Critical Review of Melanoma: Biology and Therapy
September 29-October 2
FUNDED BY Herbert J. Siegel Fund For Cancer Pharmacogenomics
ARRANGED BY M. Herlyn, The Wistar Institute, Philadelphia, Pennsylvania
S. Lowe, Cold Spring Harbor Laboratory
Introduction:
S. Lowe, Cold Spring Harbor Laboratory
M. Herlyn, The Wistar Institute, Philadelphia, Pennsylvania
SESSION 1: The Clinical Problem
Chairperson: S. Lowe, Cold Spring Harbor Laboratory
L. Schuchter, University of Pennsylvania, Philadelphia: Over- results and mechanism of response of regional perfusion of
view of the treatment of malignant melanoma: Limitations of melanoma.
our current therapeutic options. M. Berwick, Memorial Sloan-Kettering Cancer Center, New York:
D.L. Fraker, University of Pennsylvania, Philadelphia: Clinical Gene-environment interactions in the etiology of melanoma.
SESSION 2: Biology of Melanoma
Chairperson: M. Herlyn, The Wistar Institute, Philadelphia, Pennsylvania
D.C. Bennett, St. George's Hospital Medical School, London,
United Kingdom: Melanocyte senescence, apoptosis, p16,
and melanoma progression.
C. Berking, University of Munich, Germany: Induction of
human melanoma by growth factors and UVB radiation.
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E.E. Medrano, Baylor College of Medicine, Houston, Texas:
The oncogenic protein Ski in melanoma development.
D.E. Fisher, Dana-Farber Cancer Institute, Boston, Massachu-
setts: MITF: Master transcriptional regulator in melanocytes
and melanoma.
L. Schuchter, D. Fraker, M. Berwick
SESSION 3: Genetics of Melanoma
Chairperson: J. Sambrook, Peter Mac Callum Cancer Research Institute, East Melbourne, Australia
D. Hogg, The University of Toronto, Canada: Using familial
melanoma to probe mechanisms of tumor suppression.
J.M. Trent, National Human Genome Research Institute,
Bethesda, Maryland: Using microarrays to dissect the genet-
ics of melanoma.
B. Bastian, University of California, San Francisco: Genomic
characteristics of melanocytic neoplasms.
L. Chin, Dana-Farber Cancer Institute, Boston, Massachusetts:
Genetics, genomics, and biology of malignant melanoma.
SESSION 4: Molecular Biology of Melanoma
Chairperson: A.J. Levine, Institute for Advanced Studies, Princeton, New Jersey
Z.A. Ronai, Mount Sinai School of Medicine, New York: The
transcriptional switch and melanoma resistance to apoptosis.
M.S. Soengas, University of Michigan Comprehensive Cancer
Center, Ann Arbor: Bypassing cell death deficiencies in
melanoma.
A. Ben-Ze'ev, Weizmann Institute of Science, Rehovot, Israel:
Novel target genes of ri-catenin signaling in melanoma.
M. McMahon, University of California, San Francisco:
Regulation of apoptosis by Raf protein kinases.
SESSION 5: Detection and Targeting of Melanoma
Chairperson: D.E. Fisher, Dana-Farber Cancer Institute, Boston, Massachusetts
D. Becker, University of Pittsburgh Cancer Institute, Pennsyl-
vania: Molecular and optical imaging analysis of melanoma
and nevi in the context of biological therapy.
I. Hellstrom, Pacific Northwest Research Institute, Seattle,
Washington: Therapeutic tumor vaccination of an MHC class
I and II negative mouse melanoma.
D. Herlyn, The Wistar Institute, Philadelphia, Pennsylvania: Iden-
tification of melanoma antigen p23 using antibody phage dis-
play.
S. Ferrone, Roswell Park Cancer Institute, Buffalo, New York:
HLA class I antigen abnormalities in melanoma cells: What
have we learned?
P.S. Huang, GlaxoSmithKline, King of Prussia, Pennsylvania:
Application of the IL-18 cytokine as an antimelanoma therapy.
Walking to lunch at Robertson House
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DNA Interactive Advisory Panel-Second Meeting
October 6-8
FUNDED BY Howard Hughes Medical Institute
ARRANGED BY D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Banbury Center
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory: Welcome and procedures.
D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor Laboratory: Project overview and review.
Prototype DNA Interactive Modules
VVVVVV page: C.-H. Yang
Timeline: S. Chan and E.-S. Jeong
DNA: S. Chan and C.-H. Yang
Genome: S. Chan and W.-B. Wu
WWW Site: D. Mick los and A. Arva
SESSION 2: Dolan DNA Learning Center
Session A: Design and Functionality
Customizable VVWVV site
Lesson Builder
DVD
Session B: Design and Functionality
Timeline
DNA
Genome
Session C: Content and Teacher Resources
Timeline
DNA
Genome
Session D: Content and Teacher Resources
Manipulation
Applications
Implications
Session Reports
Future Activities
Keeping Connected
Classroom Testing
Dissemination and Workshops
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Lesson Builder: D. Mick los and A. Arva
Summer Fellows: C. Gough, L. Fletcher, M. Colvard
Classroom demo of lesson builder
Teacher Guide for Anastasia
DVD and Animation Resources: M. Whitby and D. Berry
imimiummilimmai11110
Banbury Conference Center
DNA Recombination and Repair
October 20-23
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Haber, Brandeis University, Waltham, Massachusetts
S. Hawley, Stowers Institute for Medical Research, Kansas City, Missouri
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Overviews:
J. Petrini, Memorial Sloan-Kettering Cancer Center, New
York, and P. Sung, University of Texas Health Science
Center, San Antonio:
What does the MRX (MRN) complex do? Does it directly act
as an exonuclease in vivo or does it control an unknown
exonuclease (or endonuclease)? Does it bridge DNA ends or
span sister chromatids similar to other SMC proteins? Does
it play a role in end-joining other than in budding yeast?
S.C. Kowalczykowski, University of California, Davis:
How does Rad51 p assemble on to a filament and what do
other recombination proteins do during this process of stand
invasion?
SESSION 2
Overviews:
D. Bishop, University of Chicago, Illinois:
What does Dmcl do that Rad51 doesn't do? How might
Dmcl and Radi act at opposite ends of a DSB? How are
the two ends of a DSB coordinated and why doesn't BIR
occur if both ends of a DSB share homology to the donor?
F.W. Stahl, University of Oregon, Eugene, and M. Lichten,
National Cancer Institute, NIH, Bethesda, Maryland:
Are there two distinct crossover-generating pathways in
meiosis, one using only Rad51 (but also Msh4/5-indepen-
dent) and one using both Dmcl and Rad51? How many
non-crossover pathways are there and how do they relate to
crossover-generating events?
SESSION 3
Overviews:
R. Rothstein, Columbia University, New York, and R. Kanaar,
Erasmus University Rotterdam, The Netherlands:
Are there "recombination centers" where many independent
repair events occur? How do donor and recipient sequences
assemble at these places?
S. Takeda, Kyoto University Medical School, Japan, and M.
Jasin, Sloan-Kettering Institute, New York:
What distinguishes vertebrate/mammalian DSB repair from
yeast? What do the BRAG proteins do? Why is Rad52 dis-
pensable in worms and flies and not very important in verte-
brate cells, even though its overall properties appear to be
preserved?
T. Petes, F. Stahl
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SESSION 4
Overviews:
R.S. Hawley, Stowers Institute for Medical Research, Kansas
City, Missouri, and N. Kleckner, Harvard University, Cam-
bridge, Massachusetts:
What is the role of known SC components in facilitating mei-
otic exchange and/or synapsis?
B. Michel, Institut National de la Recherche Agronomique,
Jouy-en-Josas, France, and R.G. Lloyd, University of
Nottingham, United Kingdom:
How does recombination lead to replication restart? In
eukaryotes, what proteins carry out the functions assigned
to RecG and RuvABC?
SESSION 5
Overviews:
S.C. West, Clare Hall Laboratories Cancer Research UK,
Herts, N.M. Hollingsworth, SUNY, Stony Brook, and A.
Shinohara, Osaka University, Osaka, Japan:
Is Mus81/Mms4 (Eme1) THE Holliday junction resolvase, or
A HJ resolvase, or does it act predominantly to cleave other
types of branched molecules? Budding versus fission yeast.
What other HJ-resolving activities are found in eukaryotes.
J. Haber, Brandeis University, Waltham, Massachusetts, and
F. Fabre, Commissariat a l'Energie Atomique, Fontenay-
aux-Roses, France:
How many distinct roles are played by the helicases
Sgs1and Srs2? Do they act early/middle/late or after recom-
bination is complete? What is the significance that over-
expressing SGS1 suppresses srs2 but not vice versa?
Grand Summing Up
F. Fabre, N. Kleckner
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M. Lichten, L. Symington, J. Haber
Global Vaccine Shortage: The Threat to Children and
What to Do About It
October 23-25
FUNDED BY Bill & Melinda Gates Foundation, through a grant to Albert B. Sabin Vaccine Institute, Inc.
ARRANGED BY L.K. Gordon, VaxGen, Inc., Brisbane, California
H. Larson, UNICEF, New York
N.E. Tomich, U.S. Medicine Institute, Bethesda, Maryland
L. Miller, Intermedica, Darien, Connecticut
SESSION 1: Keynote Speeches
C. Bellamy, UNICEF, New York
K. Reilly, Wyeth Global Vaccines, St. Davids, Pennsylvania
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
L.K. Gordon, VaxGen, Inc., Brisbane, California
H. Larson, UNICEF, New York
N.E. Tomich, U.S. Medicine Institute, Bethesda, Maryland: Charge
to the conference.
Piers Whitehead, VaxGen Inc., Brisbane, California: 2002 Mercer
Report. The worldwide problem.
SESSION 2: Return on Investment in the Vaccine Industry
Overview:
D. Braga, Aventis, USA, Swiftwater, Pennsylvania
Discussants:
K. Reilly, Wyeth Global Vaccines, St. Davids, Pennsylvania
J. Heinrich, U.S. General Accounting Office, Washington, D.C.
S. Jarrett, UNICEF, New York
Round Table Discussions
Reports from Round Tables
SESSION 3: The Regulatory Process and Vaccines I
Chairperson: L.K. Gordon, VaxGen, Inc., Brisbane, California
Overview:
W. Vandersmissen, GlaxoSmithKline Biologicals, Rixensart,
Belgium
Discussants:
J.E. Fischer, Committee on Veterans' Affairs, Washington, D.C.
K. Midthun, FDA, NIH, Rockville, Maryland
J. Milstien, World Health Organization, Geneva, Switzerland
SESSION 4: The Regulatory Process and Vaccines II
Chairperson: L.K. Gordon, Vax Gen, Inc., Brisbane, California
Round Table Discussions
Reports from Round Tables
SESSION 5: Adequate Vaccine Capacity
Chairperson: L.K. Gordon, VaxGen, Inc., Brisbane, California
Overview:
A. Robbins, Tufts University School of Medicine, Boston,
Massachusetts
Discussants:
D. Simpson, Centers for Disease Control & Prevention, Atlanta,
Georgia
L. Tan, American Medical Association, Chicago, Illinois
Round Table Discussions
Reports from Round Tables
SESSION 6: Vaccines as a National Priority
Overview:
S. Bice, Centers for Disease Control & Prevention, Atlanta, Georgia
Discussants:
R. Chalk, National Academy of Sciences, Washington, D.C.
L.Z. Cooper, American Academy of Pediatrics, New York
J.I. Santos, National Immunization Council, Mexico City,
Mexico
Round Table Discussions
Reports from Round Tables
Review of Reports: Identifying Areas of Consensus
Next Steps: Need for Task Forces to Follow Up?
D. Simpson, J. Heinrich, M. Chafee
Psychobiology of Emotion
October 27-30
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY R.J. Dolan, Institute of Neurology, London, United Kingdom
L. Wolpert, University College London, United Kingdom
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
L. Wolpert, University College London, United Kingdom
SESSION 1: Neural Basis of Emotion I
Chairperson: R.J. Dolan, Institute of Neurology, London, United Kingdom
D.J. Anderson, HHMI, California Institute of Technology, Pasa-
dena: Neural substrates of innate fear and their regulation by
anxiety.
J.H. Bachevalier, University of Texas Health Science Center,
Houston: Neural correlates of emotion from the perspective
of primate neuropsychological studies.
A. Calder, MRC Cognition & Brain Science Unit, Cambridge,
United Kingdom: The neuropsychology of disgust and anger.
R.J. Davidson, University of Wisconsin, Madison: The neuro-
science of affective style.
W.C. Drevets, National Institutes of Health, NIMH/MIB,
Bethesda, Maryland: The neurobiology of major depression.
SESSION 2: Neural Basis of Emotion II
Chairperson: J.H. Bachevalier, University of Texas Health Science Center, Houston
R. Garcia, Universite Nice-Sophia Antipolis, Nice, France:
Neural basis of emotional perseveration.
K. Nader, McGill University, Montreal, Canada: Reconsolidation:
New opportunities for treatment of psychiatric disorders.
T Ono, Toyama Medical & Pharmaceutical University, Sugitani,
Japan: Neural representation of emotion in the prefrontal
cortex, limbic system, and nucleus accumbens.
D. Pare, Rutgers University, Newark, New Jersey: Activity-depen-
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dent synaptic plasticity in intercalated neurons of the amyg-
dala.
J.A. Parkinson, University of Cambridge, United Kingdom:
Psychological representations and neural mechanisms
underlying appetitive emotional conditioning.
P.J. Whalen, University of Wisconsin, Madison: The human
dorsal amygdaloid region in facial expression processing.
D. Dennett, J. Parkinson, J. Winston
SESSION 3: Emotion and Cognition
Chairperson: L. Wolpert, University College London, United Kingdom
A. Bechara, University of Iowa College of Medicine, Iowa City:
Is emotion beneficial or disruptive to judgment and decision-
making?
A. Dickinson, University of Cambridge, United Kingdom: The
function of affect: The interface between cognition and moti-
vation.
R.J. Dolan, Institute of Neurology, London, United Kingdom:
Emotion, cognition, and behavior.
M. Gallagher, Johns Hopkins University, Baltimore, Maryland:
Amygdala/orbitofrontal interactions for goal-directed behav-
ior.
E.A. Phelps, New York University, New York: The human
amygdala and episodic memory or interaction of cognition
and emotion.
SESSION 4: Emotion, Mood, and Personality
Chairperson: L. Wolpert, University College London, United Kingdom
D. Evans, University of Bath, United Kingdom: Emotions and Self-regulation of emotion.
physical health: A biological mechanisms for the placebo A. Holmes, National Institutes of Health, Bethesda, Maryland:
response. Analysis of emotional behavior in genetically modified mice.
J.J. Gross, Stanford University, California: Emotion regulation. A. Ohman, Karolinska Hospital, Stockholm, Sweden: The
T Heatherton, Dartmouth College, Hanover, New Hampshire: overlap of emotion activation and attention capture.
SESSION 5: Emotion, Mood, and Society
Chairperson: D. Dennett, Tufts University, Medford, Massachusetts
D. Fess ler, University of California at Los Angeles: The evolu- Maryland: Genetic variation and the response of the human
tionary psychology of human emotions. amygdala.
A. Hopfensitz, CREED, University of Amsterdam, The Nether- J.S. Winston, University College London, United Kingdom:
lands: Emotions in economics. Brain regions responding to social and emotional informa-
AR. Hariri, National Institute of Mental Health, Bethesda, tion in faces.
SESSION 6: General Discussion and Summary
Chairpersons: R.J. Dolan, Institute of Neurology, London, United Kingdom, and L. Wolpert, University
College London, United Kingdom
A. Dickerson, K. Nader, J. Bachevalier
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Sequence Diversity in Crop Plants: Results, Interpretations,
and Applications
November 3-6
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Doebley, University of Wisconsin, Madison
J. Antoni Rafalski, DuPont Agricultural Enterprise, Newark, Delaware
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Theoretical/General
Chairperson: B. Burr; Brookhaven National Laboratory, Upton, N
B.S. Weir, North Carolina State University, Raleigh, North Caro-
lina: Recent methods for characterizing population structure
and association mapping.
A. Long, University of California, Irvine: Using linkage disequi-
librium to dissect complex traits.
E. Thompson, North Carolina State University, Raleigh: The
SESSION 2: Learning from Flies and Humans
Chairperson: J. Doebley, University of Wisconsin, Madison
A.G. Clark, Cornell University, Ithaca, New York: LD patterns
and haplotypes in humans.
W. Stephan, University of Munich, Germany: Species and
recombination effects on DNA sequence variation in the
tomato genus.
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ew York
information available in the pedigree relationships among
inbred lines.
M. Nordborg, University of Southern California, Los Angeles:
A genomic-wide survey of polymorphism in Arabidopsis.
H.K. Dooner, Rutgers University, Piscataway, New Jersey: The
polymorphic organization of the bz genomic region in maize.
C.F. Aquadro, Cornell University, Ithaca, New York: Finding
novel genes based on footprints of natural selection.
C. Schlotterer, Universitat fur Veterinarmedizin, Vienna,
Austria: Local selective sweeps: What can be learned from
Drosophila?
S. Tingey, T Mitchell-Olds
SESSION 3: Sequence Diversity in Plants I
Chairperson: S. Tingey, DuPont Company, Newark, Delaware
M.D. Purugganan, North Carolina State University, Raleigh:
Selection in the Arabidopsis genome.
T. Mitchell-Olds, Max-Planck Institute for Chemical Ecology,
Jena, Germany: Functional nucleotide polymorphisms within
and between species.
K. Schmid, Max-Planck Institute for Chemical Ecology, Jena,
Germany: Population genomics in Arabidopsis Identification
and analysis of rapidly evolving genes.
P.B. Cregan, USDA, Agricultural Research Service, Beltsville,
Maryland: Nucleotide and haplotype diversity and linkage
disequilibrium in cultured and wild soybean.
M. Aquade, Universitat de Barcelona, Spain: Variation in
phenylpropanoid genes in cruciferae.
SESSION 4: Sequence Diversity in Plants II
Chairperson: J.A. Rafalski, DuPont Agricultural Enterprise, Newark, Delaware
0. Savolainen, University of Oulu, Finland: Sequence diversity
in species at different stages of domestication.
B.S. Gaut, University of California, Irvine: DNA sequence diver-
sity in maize and its wild relatives.
M. Morgante, DuPont Crop Genetics, Newark, Delaware: Se-
quence conservation in conifers.
0. Smith, Pioneer Hi-Bred International, Inc., Johnston, Iowa:
Marker diversity and preliminary LD results among lines in
elite breeding populations.
SESSION 5: Linking Phenotypes and Sequences
Chairperson: D.T. Tomes, Pioneer Hi-Bred International, Inc., Johnston, Iowa
J.A. Rafalski, DuPont Agricultural Enterprise, Newark,
Delaware: Sequence diversity selection and linkage disequi-
librium in maize elite germ plasm.
E. Buckler, North Carolina State University, Raleigh: Candidate
gene associations across diverse maize germ plasm.
J. Liu, Cornell University, Ithaca, New York: Genetic basis of
the evolution of crop plant morphology.
M. Cooper, Pioneer Hi-Bred International Inc., Johnston, Iowa:
Modeling breeding strategies for complex traits.
J. Doebley, University of Wisconsin, Madison: What micro-
satellites tell us about maize and its genome.
Back view of Banbury Conference Center
Microbial Forensics
November 10-13
FUNDED BY National Institute of Justice of the U.S. Department of Justice and
the U.S. Department of Energy (NNSA, CNBP)
ARRANGED BY S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
B. Budowle, Federal Bureau of Investigation, Washington, D.C.
R. Breeze, USDA, Agricultural Research Service, Washington, D.C.
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
SESSION 1: Issues
Chairperson: R. Breeze, USDA, Agricultural Research Service, Washington, D.C.
B. Budowle, FBI Academy, Washington, D.C.: What is the big
picture? What are FBI needs and how can they be in concert
with those of HHS, USDA, DOD, DOE, EPA, etc.? What are
the court needs?
R.P. Harmon, Alameda County Attorney's Office, Oakland,
California: Rules of evidence for the courts.
J. Smith, FBI Laboratory, Washington, D.C.: How did DNA
testing begin in U.S. Courts? What problems were encoun-
SESSION 2: High-consequence Pathogens for the FBI
Chairperson: R. Breeze, USDA, Agricultural Research
Service, Washington, D.C.
FBI's Human, Animal, and Plant Concerns:
B. Budowle, FBI, Washington, D.C., and L Collins Kelley,
USDA, Agricultural Research Service, Athens, Georgia
SESSION 3: What Is The State of the Art for "Signatures?" I
Chairperson: A.D. Steinberg, Mitretek Systems, McLean,
Virginia
General Issues and Specific Cases:
Key differences between classes of pathogens
Evidence for laboratory of origin and/or recent culture
Distinguishing from background, close neighbors, and mixed
populations
D.L. Rock, USDA, Agricultural Research Service, Greenport,
New York: Viruses.
P. Keim, Northern Arizona University, Flagstaff: Bacteria.
G.A. Payne, North Carolina State University, Raleigh: Fungi.
J. Marks, University of California, San Francisco: Botulinum tox-
ins.
P.J. Jackson, Los Alamos National Laboratory, New Mexico:
Geo-location.
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tered? How did this grow into the CODIS system? What can
be learned for microbial forensics?
R. Breeze, USDA, Agricultural Research Service, Washington,
D.C.: Developments in physical security, personnel assur-
ance, and pathogen surety for select human and agricultur-
al pathogens: How guns, guards, and gates relate to micro-
bial forensics.
P. Keim, R. Okinaka
SESSION 4: What Have We Learned About Microbial
Forensics Over the Past Year? Including What Should Have
Been in Place for Anthrax?
Chairperson: S.E. Schutzer, UMDNJ-New Jersey Medical
School, Newark
D. Beecher, FBI Academy, Quantico, Virginia: Microbiological
sampling at the scene of a covert biological release.
J.W. Ezzell, USAMRIID, Ft. Detrick, Maryland: Sample analy-
sis: Meeting a forensic standard.
P. Keim, Northern Arizona University, Flagstaff: High-resolution
DNA typing for precise identification of bacterial pathogens.
T.D. Read, The Institute for Genomic Research, Rockville,
Maryland: Genomics of Bacillus anthracis.
SESSION 5: What Is the State of the Art for "Signatures?" II
Chairperson: P. Keim, Northern Arizona University, Flagstaff
S. Salzberg, The Institute for Genomic Research, Rockville,
Maryland, and John J. Dunn, Brookhaven National
Laboratory, Upton, New York: Foreign genes: Identification,
function, origin, natural, or engineered.
W.D. Wilson, Lawrence Livermore National Laboratory,
California, and C.M. Schaldach, Lawrence Livermore
National Laboratory, California: Nongenomic signatures.
A.D. Steinberg, Mitretek Systems, McLean, Virginia: Host-
pathogen interactions.
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark:
Components of the immune response distinguishing perpe-
trator from victim.
B.J. Luft, SUNY, Stony Brook: Protective measures: Antibiotic
half-life vaccines.
D.L. Wilson, FBI, Washington, D.C., and M. Wilson, FBI,
Washington, D.C.: Matrices and trace substances.
SESSION 6: Validating Signatures I
Chairperson: D.L. Rock, USDA, Agricultural Research
Service, Greenport, New York
C.L. Cook, Defense Threat Reduction Agency, Ft. Belvoir,
Virginia, and L. Collins Kelley, USDA, Agricultural Research
Service, Athens, Georgia: The DTRA Microbial Forensics
Initiative.
SESSION 7: Validating Signatures II
Chairperson: D.L. Rock, USDA, Agricultural Research
Service, Greenport, New York
C. Carrillo, USDA, Agricultural Research Service, NASS,
Greenport, New York: Pathogen evolution: Behavior in cul-
ture vs. interspecies and intraspecies infections.
J.J. Dunn, Brookhaven National Laboratory, Upton, New
York: The unexpected signature.
SESSION 8: General Discussion: What Do These Signature
Techniques Mean?
Discussion Leaden R. Breeze, USDA, Agricultural Research
Service, Washington, D.C.
What do they not tell us?
How do we interpret them?
What do we need to do to get the degree of attribution we
require? And can we reach it?
Can the signatures be forged?
How do we get automated technologies for high through-
put?
SESSION 9: Can We Have a Systematic Approach to an
Unknown Sample?
Discussion Leader: R. Breeze, USDA, Agricultural Research
Service, Washington, D.0
E.S. Raveche, UMDNJ-New Jersey Medical School, Newark:
An algorithmic approach.
SESSION 10: Outline of a U.S. Microbial Forensics System I
Discussion Leader: R. Breeze, USDA, Agricultural Research
Service, Washington, D.0
P.J. Jackson, Los Alamos National Laboratory, New Mexico, and
P. Keim, Northern Arizona University, Flagstaff: Repositories.
N.D. Zinder, The Rockefeller University, New York: Personal
perspective: Academia and chemical and biological defense.
SESSION 11: Outline of a U.S. Microbial Forensics System II
Chairpersons: B. Budowle, Federal Bureau of Investigation,
Washington, D.C., and S.E. Schutzer, UMDNJ-New Jersey
Medical School, Newark
T. Slezak, Lawrence Livermore National Laboratory, California,
and N. Kahn, CIA/DST/ODDST/ITIC, Washington, D.C.: Data-
bases.
R.T. Okinaka, Los Alamos National Laboratory, New Mexico:
Sample issues/near neighbors.
S.A. Morse, CDC/NCID/BPRP, Atlanta, Georgia: Validation.
OA/QC Proficiency Tests
Research Needs
G. Parker, U.S. Army Medical Research and Material
Command, Fort Detrick, Maryland: For each threat class,
how can we get the capacity to obtain the information we
need and the degree of attribution we require?
Discussion and Recommendations for Action Agencies
Discussion Leaders: B. Budowle, Federal Bureau of
Investigation, Washington D.C., and S.E. Schutzer,
UMDNJ-New Jersey Medical School, Newark
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Phage Therapy: Potential and Challenges
November 13-15
FUNDED BY ICF Ventures
ARRANGED BY J. Ramachandran, GangaGen, Inc., Palo Alto, California
G.K. Schoolnik, Stanford University Medical Center, California
S. Subramani, University of California, San Diego
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J. Ramachandran, GangaGen, Inc., Palo Alto, California
SESSION 1: The New Phage Biology
Chairperson: S. Adhya, National Cancer Institute, NIH, Bethesda, Maryland
R. Young, Texas A&M University, College Station: Timing is
everything; optimizing phage lysis for any growth condition.
P. Garcia, Centro de Investigaciones Biological, Madrid,
Spain: Pneumococcal phages and their lytic enzyme.
M.J. Loessner, Technical University of Munich, Germany: The
weapons of the enemy: Viral enzymes for selective targeting
SESSION 2: Phage Therapy I
Chairperson: G.K. Schoolnik, Stanford University Medical Center,
S. Adhya, National Cancer Institute, NIH, Bethesda, Maryland:
Bacteriophage therapy of experimental bacterimia .
V.A. Fischetti, The Rockefeller University, New York: Using
phage lytic enzymes to control bacterial infections.
C.R. Merril, National Institute of Mental Health, NIH, Bethesda,
Maryland: Phage interactions with mammalian systems:
Pharmacokinetic effects and other considerations for
antibacterial phage therapy.
SESSION 3: Phage Therapy II
Chairperson: R. Young, Texas A&M University, College Station
W.C. Summers, Yale University, New Haven, Connecticut:
Historical origins of phage therapy.
R. Adamia, United Nations, New York: Tbilisi experience.
G.K. Schoolnik, Stanford University Medical Center, California:
Clinical results from Poland.
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of pathogenic bacteria.
M. Weldor, New England Medical Center, Boston, Massachu-
setts: Mechanisms controlling the horizontal and vertical
transmission of the cholera toxin genes.
D. Fitzgerald, National Cancer Institute, Bethesda, Maryland:
Pseudomonas and phage.
California
E. Kutter, Evergreen State College, Olympia, Washington:
Virulent phage infection under conditions reflecting their nat-
ural habitats.
J.A. Fralick, Texas Tech University Health Sciences Center,
Lubbock: Phage therapy: The treatment of P aeruginosa
infections of burn wounds and C. difficile associated disease
in animal model systems.
J.M. Manur, GangaGen Biotechnologies Pvt. Ltd., Bangalore,
India: Investigation of potential limitations of phage therapy.
K. Mushy, GangaGen Life Sciences Inc., Ottawa, Canada:
Regulatory issues and challenges.
Oxidases in Inflammation and Cellular Signaling
November 17-20
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY G.M. Bokoch, The Scripps Research Institute, La Jolla, California
U.G. Knaus, The Scripps Research Institute, La Jolla, California
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
G.M. Bokoch, The Scripps Research Institute, La Jolla, California
SESSION 1: Neutrophil NADPH Oxidase (Phox I)
Chairperson: A.R. Cross, The Scripps Research Institute, La Jolla, California
K. Rittinger, National Institute for Medical Research, London,
United Kingdom: NADPH oxidase assembly: A structural
perspective.
A. Jesaitis, Montana State University, Bozeman: Structural
changes induced in human neurtrophil cytochrome b by
NADPH oxidase activators.
E. Pick, Tel Aviv University Sack ler School of Medicine, Israel:
Deconstructing the oxidase.
G.M. Bokoch, The Scripps Research Institute, La Jolla,
California: Mechanism of NADPH oxidase regulation by Rac
GTPase.
M. Dinauer, Indiana University School of Medicine, Indiana-
polis: Superoxide production by phagocytes: NADPH oxi-
dase and regulation by RhoGTPase Rac2.
M.-C. Dagher, Laboratoire Biochimie at Biophysique des
Systemes Intogres, Departement Reponse et Dynamique
Cellulaire, CEA, Grenoble, France: Insights into differential
reactivity of G12V and Q61L rac mutants.
SESSION 2: Neutrophil NADPH Oxidase (Phox II)
Chairperson: E. Pick, Tel Aviv University Sack ler School of Medicine, Israel
A.R. Cross, The Scripps Research Institute, La Jolla, Califor-
nia: Electron transport in NADPH oxidase.
T.E. DeCoursey, Rush Medical Center, Chicago, Illinois:
Interactions between voltage-gated proton channels and
NADPH oxidase.
L. Henderson, University of Bristol, United Kingdom:
Expression of Nox homologues in gp91phox knockout PLB-
985 cells: An explanation for the presence of voltage-gated
proton currents.
A.W. Segal, University College London, United Kingdom: The
influence of NADPH oxidase induced K+ movement into the
phagocytic vacuole on protease activity and microbial killing.
M.T. Quinn, Montana State University, Bozeman: Transcrip-
tional regulation of p67phox gene expression.
H. Sumimoto, Kyushu University, Fukuoka, Japan: The adap-
tor protein p4Ophox as a positive regulator of the phagocyte
NADPH.
J. Jones, T. Leto
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SESSION 3: Noxel Oxidases (Nox I)
Chairperson: R. Clark, University of Texas Health Science Center, San Antonio
R. Clark, University of Texas Health Science Center, San
Antonio: Regulation and function of NADPH oxidases: NOX1
versus the phagocyte oxidase.
K.-H. Krause, Geneva University Hospital, Switzerland: Nox1
in humans and mice.
T.L. Leto, National Institute of Allergy and Infectious Diseases,
NIH, Bethesda, Maryland: The Nox/Duox family of NAD(P)H
oxidases: Potential mediators of host defense and inflamma-
tion.
SESSION 4: Novel Oxidases (Nox II)
Chairperson: W.M. Nauseef, University of Iowa, Iowa City
R. Arnold, Emory University, Atlanta, Georgia: The Nox family
of NADPH oxidases: Regulation and cancer associations.
B. Banfi, Geneva University Hospital, Switzerland: Activation of
NOX1 by two novel subunits.
W.M. Nauseef, University of Iowa, Iowa City: Biosynthesis of
NOX proteins: Work in progress.
T. Kawahara, University of Tokushima, Japan: Roles of
Nox1 in innate immune responses of the gastrointestinal
tract.
M. Geiszt, Semmelweis University, Budapest: Functional char-
acterization of NADPH oxidase: Remarkable similarities to
the phox systems.
U.G. Knaus, The Scripps Research Institute, La Jolla,
California: Regulation and functions of Nox proteins.
R. Fluhr, Weizmann Institute of Science, Rehovot, Israel:
Multifunctional ROS signaling plants.
J.D.G. Jones, John Inns Centre, Norwich, United Kingdom:
Diverse roles of plant respiratory burst oxidase homologs in
cellular signaling.
SESSION 5: ROS Signaling and Cellular Consequences
Chairperson: S.G. Rhee, National Heart, Lung & Blood Institute, NIH, Bethesda, Maryland
S.G. Rhee, National heart, Lung & Blood Institute, NIH,
Bethesda, Maryland: Intracellular messenger function of
hydrogen peroxide.
N.K. Tonks, Cold Spring Harbor Laboratory: Harnessing lig-
and-induced reversible oxidation for elucidating the signaling
function of protein tyrosine phosphatases.
E. Werner, Emory University, Atlanta, Georgia: A novel mecha-
nism for ras-dependent ROS generation.
P. Hordijk, Sanquin Research at CLB, Amsterdam, The Nether-
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lands: Role of endothelial ROS in the control of cell-cell adhe-
sion and leukocyte transmigration.
P.J. Pagano, Case Western Reserve University, Cleveland,
Ohio: Adenoviral targeting of NADPH oxidase inhibitors to
the vasculature.
S. Nemoto, National Heart, Lung & Blood Institute, NIH,
Bethesda, Maryland: Strategies to isolate novel regulators of
the intracellular redox state.
Glucocorticoid Regulatory Mechanisms and Pathophysiology
December 8-11
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY K. Yamamoto, University of California, San Francisco
D.K. Granner, Vanderbilt University School of Medicine, Nashville, Tennessee
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Overview: M. Dal !man, University of California, San Francisco
Discussants:
S. Davis, Vanderbilt University, Nashville Tennessee
D.B. De Franco, University of Pittsburgh School of Medicine, Pennsylvania
D.K. Granner, Vanderbilt University School of Medicine, Nashville,
Tennessee
G. Schutz, German Cancer Research Center, Heidelberg
What are the key actions and coupling networks for cortico-
steroids in metabolism, stress, and the HPA axis?
Overview: J. Funder, Prince Henry's Institute of Medical
Research, Clayton, Australia
Discussants
E.R. de Kloet, Gorlaeus Laboratory, Leiden, The Netherlands
What are the key actions and coupling networks for cortico-
steroids in cardiovascular and renal physiology?
SESSION 2
Overview: J.N. Miner, Ligand Pharmaceuticals,
San Diego, California
Discussants:
H. Samuels, New York University, New York
A. Shiau, Tularik, Inc., South San Francisco, California
S. Simons, National Institute of Diabetes and Digestive and
Kidney Diseases, NIH
H.E. Xu, Van Andel Research Institute, Grand Rapids, Michigan
How can we begin to move toward rational design of
selective glucocorticoid agonists?
Overview: M. Garabedian, New York University School of Medicine,
New York
Discussants:
J. Funder, Prince Henry's Institute of Medical Research, Clayton, Australia
R Herrlich, Institute of Toxicology and Genetics, Karlsruhe, Germany
D. Pearce, University of California, San Francisco
G. Schutz, German Cancer Research Center, Heidelberg
How do receptor modifications, such as phosphorylation,
methylation, sumoylation, couple receptor action to other
signaling pathways, and what cross-talk circuits are most
significant physiologically?
G. Schutz, B. Thompson
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SESSION 3
Overview: P. Herrlich, Institute of Toxicology and Genetics, Karlsruhe, Germany
Discussants:
A.C.B. Cato, Institute of Toxicology and Genetics, Karlsruhe, Germany
G. Haegeman, University of Gent, Belgium
T. Heinzel, Institute for Biomedical Research, Frankfurt, Germany
B. Thompson, University of Texas Medical Branch, Galveston
What are the key actions and coupling networks for corti-
costeroids in immune cell and inflammatory development,
physiology, and pathophysiology?
Overview: L. Freedman, Merck Research Labs, West Point, Pennsylvania
Discussants:
R. Derynck, University of California, San Francisco
M. Garabedian, New York University School of Medicine, New York
What are the key actions and coupling networks for corti-
costeroids in bone pathophysiology?
SESSION 4
Overview: K. Yamamoto, University of California, San Francisco
Discussants:
M. Brown, Dana-Farber Cancer Institute, Boston, Massachusetts
G.L. Hager, National Cancer Institute, NIH, Bethesda, Maryland
T. Heinzel, Institute for Medical Research, Frankfurt, Germany
D.K. Granner, Vanderbilt University School of Medicine, Nashville, Tennessee
H. Samuels, New York University, New York
How can we understand combinatorial assembly of tran-
scriptional regulatory complexes?
Overview: D.K. Granner, Vanderbilt University School of Medicine, Nashville, Tennessee
Discussants:
T.K. Archer, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North
Carolina
M. Brown, Dana-Farber Cancer Institute, Boston, Massachusetts
T. Heinzel, Institute for Medical Research, Frankfurt, Germany
S.S. Simons, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland
What are the activities and actions of receptor cofactors, and
how do they signal specific changes in polymerase activity?
SESSION 5
Overview: T. K. Archer, National Institute of Environmental Health
Sciences, NIH, Research Triangle Park, North Carolina
Discussants:
D.B. De Franco, University of Pittsburgh School of Medicine, Pennsylvania, and others,
What are the signals, mechanisms, and physiological signifi-
cance of receptor proteolysis?
Overview: G.L. Hager, National Cancer Institute, NIH, Bethesda, Maryland
Discussants:
D.B. De Franco, University of Pittsburgh School of Medicine, Pennsylvania
K. Yamamoto, University of California, San Francisco
What are the mechanisms and significance of receptor
dynamics and intracellular localization?
Grand Summing Up
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With the entire human DNA sequence now "in the bag," ahead lies the task of translating this trove of
information into healthier and happier lives. We still need to find the genes behind many common,
chronic diseases that stealthily sap productivity and shorten lifespan-including asthma, noninsulin-
dependent diabetes, schizophrenia, and bipolar disorder (manic depression). Each of these "complex"
disorders appears to involve multiple genes whose expression is further modified by environmental fac-
tors. Thus, we cannot expect a single "magic bullet" to treat these diseases. Rather, different patients
will require different treatments to counter the specific gene changes that are at the root of their illness.
Prescribing the right gene-based remedy may require a precision that is generally absent from med-
icine today. Everyone must have taken pause at the paradox of a physician asking us if we are allergic
to a particular drug. After all, shouldn't the doctor be the one to inform us of a potential problem?
Unfortunately, trial and error is the only way to determine a patient's response to many drugs-it takes
an allergic reaction to know you are allergic! Thus, the endgame of genetic medicine is pharmacoge-
netics-predicting drug response and tailoring treatment to each person's genetic makeup.
The term "pharmacogenetics" was first coined in 1959 by Friedrich Vogel to describe inherited drug
responses that vary between population groups. For example, some African American soldiers serving
in Italy during World War II had severe reactions to the antimalaria drug primaquine. Later work showed
that inherited defects in so-called metabolic enzymes-the cytochrome P450 monooxygenases
(CPY450s)-are responsible for many adverse drug responses. In the liver, the CPY450 enzymes con-
vert many drugs to their bioactive forms. It is estimated that mutations in CPY450 genes lead to poor
or toxic metabolism of more than half of the common drugs-including albuterol, codeine derivatives,
p-blockers, monoamine oxidase inhibitors, antihypertensives, tricyclic antidepressants, antipsychotics,
neuroleptics, and Prozac-as well as a similar proportion of anticancer drugs. Prevalence of mutations
in different CPY450 genes varies greatly, affecting as few as several percent of people in one popula-
tion or as many as 20% in another.
Affymetrix produces a Gene Chip® that can assess common mutations in all of the major CPY450
genes. However, until such assays become standard in medical care, people will continue to be guinea
pigs in experiments with increasingly powerful drugs. This is especially troubling in the case of psy-
choactive drugs, whose improper metabolism can send patients even deeper into psychosis.
Each person's unique disease susceptibilities and responses to drugs are, in large part, the balance
between our uniqueness as individuals and similarities we share with others in our historical population
groups. Written in each person's DNA is a record of our shared ancestry and our species' struggle to
populate the earth. Our ancient ancestors moved around, and eventually out of, Africa. They moved in
small groups, following river valleys and coastlines, reaching Asia and Europe. Land bridges that
appeared during recurring Ice Ages later allowed them to reach Australia and the Americas.
As these early people wandered, their DNA accumulated mutations. Some provided advantages
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that allowed these pioneers to adapt to new homes and ways of living. Others were nonessential.
Mutations are the grist of evolution, producing gene and protein variations that have allowed humans
to adapt to a variety of environments-and to become the most far-ranging mammal on the planet. The
same mutational processes that generated human diversity-point mutations, insertions/deletions,
transposition, and chromosome rearrangements-also generated disease.
It may be hard to see from our current vantage point, but the entire industrial revolution has occu-
pied only about 0.1% of our 150,000-year history as a species. The cradles of western civilization-
classical Greece and Rome-take us back into only 2% of our history. The earliest city-states of
Mesopotamia, Babylonia, Assyria, and China take us back only 4% of the way into our past. At 7%,
we reach the watershed of agriculture, which changed forever the way humans would live and work.
After language, the domestication of plants and animals is the single greatest civilizing factor in human
history. Increased production and performance of domesticated organisms made possible urbanization
and task specialization in human society. Thus, the labor of fewer and fewer farmers produced enough
food and clothing materials to satisfy the needs of growing numbers of nonfarmers-artisans, engi-
neers, scribes, and merchants-freeing them to develop other elements of culture. Reaching back the
remaining 93% of our history, to the dawn of the human species, we lived only as hunter-gatherers.
Throughout most of human history, the hunter-gatherer group was the basic population unit upon
which evolution acted. These small populations were subject to the founder effect, inbreeding, and
genetic drift (a random fluctuation of nonessential alleles). Over millennia, these effects join with selec-
tion to concentrate particular gene variations within different population groups. The fastest evolving
part of our genome, the mitochondria! control region, accumulates about one new mutation every
20,000 years. Mutations are five- to tenfold less frequent in most regions of the nuclear chromosomes.
Thus, virtually every gene in our genome is, on average, only one or two mutation events away from
our hunter-gatherer heritage. Our genomes preserve the genetic residue of a time when all human
beings lived in small, cohesive groups. Our basic anatomy, physiology, and many aspects of behavior
are essentially identical to the hunter-gatherers who ranged through the ancient landscapes of Africa,
Europe, Asia, Australia, and the Americas. These ideas can substantially broaden our understanding of
the genetic basis and treatment of human disease.
Ancient humans of the species Homo erectus left Africa 1.7 million years ago, reaching Europe and Asia (dashed lines).
Groups of Homo sapiens left Africa about 70,000 years ago (solid lines). These groups replaced any remaining ancient popu-
lations, reaching Asia and Australia about 60,000 years ago and entering Europe about 45,000 years ago.
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Enabling Students to Explore Our Shared Genetic Heritage
Over the past four years, we have developed a unique program that allows students to use their own
DNA as a starting point to investigate the related concepts of pharmacogenetics and human variation.
Using a laboratory kit developed by the DNA Learning Center (DNALC) and distributed nationwide by
the Carolina Biological Supply Company, students isolate DNA from hair roots or cheek cells. Their DNA
is mixed with freeze-dried polymerase chain reaction (PCR) reagents to amplify (clone) a highly variable
region of their mitochondrial genome. The amplified samples are then shipped to the DNALC, where
student interns perform the final DNA sequencing reactions. In addition to our national program, we
now offer DNA sequencing as a lab field trip for local school districts at both the Cold Spring Harbor
DNALC and the DNALC West in Lake Success.
During the year, our DNA Sequencing Service processed over 3400 samples submitted by 95 high
schools, 44 universities/colleges, and nine community colleges. As a testament to the growing popu-
larity of this free service, the number of samples tm
processed this year has grown over 70% from last
year. DNA sequences are uploaded to the Sequence
Server database on our BioServers VVVVVV site, where
they can be used to perform a number of analyses,
including BLAST searches and CLUSTAL sequence
alignments. The curriculum focuses on evolutionary
comparisons with other students' DNA, modern
human DNA from around the world, ancient human
DNA, and Neandertal DNA. Visits to the Bio Servers
VVVVVV site tripled from 30,332 in 2001 to 89,677 in
2002.
We are grateful to Frank Stephenson at Applied
Biosystems for allowing the DNALC to increase the size of our program while continuing to provide the
service free of charge. Applied Biosystems provides costly experimental reagents and critical technical
assistance for maintaining our ABI 377 DNA sequencing machine. Lori Grady and Jodi Barditch in Tim
Tully's lab and Ray Preston at the CSHL Cancer Genome Research Center provide technical support
for the program.
The Genes We Share
In September, we launched our tribute to the Human Genome Project, a new exhibition entitled The
Genes We Share. The 2000-square-foot exhibit takes a global look at the incredible genetic similarity
of all human beings, as well as the differences that make each person unique. Visitors are encouraged
to view the human genome as a record of our shared ancestry, an instruction manual for our bodies,
and a source of information that can foreshadow a person's future health.
In our main hall, visitors have the opportunity to look at their similarities and differences on both an
individual and a population level. An interactive area encourages visitors to compare characteristics that
make them unique-such as tongue-rolling ability, hairiness, eye color, and other physical traits. Shifting
focus even closer, microscopic footage and high-resolution animations have been used to highlight the
body structures and biological processes that we all share. DNA and personality profiles of identical
twins from Long Island, Matt and Danny, explore the relationship between nature (DNA) and nurture
(environment).
After this personal view, the focus shifts to the level of human populations and how genetic differ-
ences have evolved between them. A wall-sized, interactive world map depicts the migration paths of
our earliest ancestors and illustrates some of the environmental factors that influenced human evolu-
tion. An interactive table in the shape of a mitochondrion allows visitors to explore the use of DNA to
study human evolution and trace our ancestry. An adjacent gallery is given over to a recreation of a
Paleolithic cave in southern Europe. Here, skeletons of a chimpanzee, modern human, and Neandertal
The ABI 377
DNA sequencer
is a working
exhibit at the
DNALC.
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The Genes We Share exhibition.
encourage visitors to consider the genetic and anatomical changes that set humans apart from other
primates. Prehistoric paintings, as well as Neandertal and Cro-Magnon burials, encourage visitors to
think about the earliest evidence of unique human behaviors and self awareness.
The interpretation of the human DNA sequence is introduced by an interactive exhibit, "Stories in
Our Genes," in which Matt Ridley presents a guided tour through the human chromosomes-based
on his popular book, Genome: Autobiography of a Species in 24 Chapters. An eight-foot-tall adapta-
tion of the original metal DNA model constructed in 1953 by Francis Crick and James Watson repre-
sents the beginning of our quest to understand the "book of life." A working DNA sequencer, operat-
ing daily to sequence the DNA submitted by student classes from around the United States, illustrates
more recent advances in DNA technology. Finally, exhibits on DNA "chips" and gene therapy give the
visitor an opportunity to ponder how DNA will impact their future lives and health.
The exhibit received notable visitors in 2002, including Prince Andrew, the Duke of York, and the
actor William Hurt. In October, scientists attending the Human Origins and Disease meeting at Cold
Spring Harbor Laboratory visited the exhibit, and were particularly keen to see the Neandertal skeleton
reconstruction, the first ever displayed in any museum. Experts included Dr. Chris Stringer from the
Natural History Museum in London, and Dr. Svante Paabo, whose team isolated the first DNA from
ancient Neandertal bones. Funding for The Genes We Share was provided by the Richard Lounsbery
Foundation, The William A. Haseltine Foundation for Medical Sciences and the Arts, Tularik Inc., and
Laurie J. Landeau, V.M.D.
DNA Interactive for DNA's 50th Birthday
As part of the many activities that will mark the 50th anniversary of the discovery of the structure of DNA,
the DNALC took on the challenge of developing a VWVVV site to parallel a five-part television series,
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DNA: The Secret of Life, due to air in spring
2003. The WVVW site, DNA Interactive (DNA!), is
funded by a grant from the Howard Hughes
Medical Institute. DNAi offers visitors a unique
multimedia resource through which to learn
about the history and impact of DNA science.
Many of the 18 instructional modules in DNAi
make use of a "4-P" structure, which allows stu-
dents to "discover" key principles of DNA sci-
ence. Problem introduces the question at hand
and provides key background information.
Players uses video clips to introduce the views
and approaches of the principal scientists work-
ing on the problem. Pieces of the Puzzle uses
animations to illustrate experiments that provide
clues to solving the problem. Putting It Together
uses animations, videos, and/or interactive games to synthesize the answers to the problem.
By far the most ambitious project yet attempted by our Bio Media Group, the site incorporates over
five hours of video footage gleaned from interviews with over 70 scientists-including ten Nobel
Laureates. More than 150 animations illuminate key experiments in the history of DNA and bring to life
the molecular processes that govern DNA replication and expression. A ten-person team at the DNALC
coordinated with producers at the Walter and Eliza Hall Institute in Melbourne, Australia, and at three
companies in London (Windfall Films, RGB Post, and The Mill). The Mill won an Academy Award for visu-
al effects in Gladiator and is noted for creating much of the wizardly magic in the Harry Potter movies.
DNAi is built using Flash MX, an integrated VVVVW platform released by Macromedia in summer
2002. Flash MX gives us the flexibility to easily integrate different media types-text, animations, and
video-into a unified page design. Flash MX has the great advantage of playing its own formatted video
files, allowing for seamless integration of a video player into the web page itself. Thus, the DNAi site
requires a single plug-in, Flash 6, for both animation and video playback, without the need for an addi-
tional Real Player or Quicktime plug-in. We also developed a video window that incorporates a scrol-
lable caption-aiding the hearing-impaired, improving intelligibility of speakers, and allowing quotations
to be cut and pasted into word processing documents.
Although it employs the latest technology, the site provides a satisfying multimedia experience for
broadband and dial-up users alike. We devoted considerable effort to optimizing file size and video
compression to minimize loading time and provide improved performance compared to sites of similar
complexity. Flash formatting allowed us to achieve 100-fold compression of video files-with surpris-
ingly little loss of quality. The video player provides three viewing options, which ensures smooth oper-
ation for all users. At an average dial-up speed of 40 kbps, the largest pages and multimedia files load
in a maximum of 30 seconds, with smaller files loading in 15 seconds or less.
The site will also include a Lesson Builder that will allow teachers to build their own multimedia
"power point"-style presentation using resources from the DNAi VVWVV site. All animations, videos,
photos, and narratives will be keyword-tagged and accessioned in a database. Registered teachers
then can use keywords to search the database for items of interest. After previewing material generat-
ed by the search, a lesson is created simply by dragging the desired items into a linear "filmstrip." Each
lesson is stored under a teacher's profile, and a URL of the lesson can be shared with fellow teachers
or students in a class.
DNA-nteractive
11=11111=1111111=11M1E
Conclusion of Five Years of Macy Support
In the fall, we completed the final year of a five-year program to develop the companion VVWVV sites
DNA From the Beginning (DNAFTB, http://www.dnaftb.org) and Your Genes, Your Health (YGYH,
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www.dnaftb.org
www.ygyh.org
http://www.ygyh.org). These sites are specifically designed to provide students and families with
the basic information they need to understand the science behind genetic disorders. Visitors to
these popular sites doubled, from 804,296 in 2001 to 1.67 million in 2002.
In funding this project, the Josiah Macy, Jr. Foundation helped establish our Biomedia Group,
a multidisciplinary team of science, communication, and design professionals. The program
was among the first initiated by June Osborn, when she became Macy Foundation President
after serving as Dean of the School of Public Health at the University of Michigan. Macy chair-
man Clarence Michalis and board member David Luke were also instrumental in a 1987 grant,
which helped establish the DNALC's instructional programs.
DNAFTB was completed in November 2000 and is currently the first site listed on a search
for "DNA" using Google, the web's most popular search engine. The site is organized around 41
key concepts that span one and a half centuries, beginning with basic principles of Mendelian
genetics (1865) and ending with current techniques on targeted gene knockouts. The work of
over 90 scientists, including 32 Nobel Laureates, is highlighted in animations and interviews.
In November 2001, we produced a CD-ROM that makes DNAFTB available to a much broader
audience-allowing those who lack an Internet connection to use the work at school or at home, as
well as providing quick operation and full-motion video to those with slow Internet connections. Sales
of the CD-ROM have generated enough income to consider producing other-language DNAFTB CD-
ROMs and YGYH CD-ROMs. DNAFTB is currently being translated into three languages: German,
Traditional Chinese, and Icelandic. These translated versions will be mirrored here at the DNALC, as
well as hosted at the German, Taiwanese, and Icelandic sites.
YGYH was completed in November 2002. The site is specifically targeted at patients and families
who are looking for understandable information about a specific genetic disorder. YGYH is organized
according to questions visitors may have about the disorder: What is it? What causes it? How is it
inherited? How is it diagnosed? How is it treated? What is it like to have it? Where can I get more infor-
mation?
The site focuses on 15 disorders, which were chosen using three criteria: high incidence rate,
known genetic cause, and severity of the phenotype (symptoms). In each case, we enlisted the par-
ticipation of the genetic foundation or organization for information and access to patients and/or physi-
cians for video interviews. Each disorder comprises a number of resource pages that provide in-depth
information. The first "page" provides quick facts for casual browsing. Subsequent pages include
detailed animations to help visitors visualize the unseen world of genes and molecules and explain the
biology of the disorder. Video interviews with researchers and patients provide insiders' views on genet-
ic disorders. Links help users find support groups and additional information.
Eugenics Image Archive
The Image Archive on the American Eugenics Movement web site continues to be a popular resource
for students and faculty alike. In 2002, the Archive received 187,263 visitors, more than double the vis-
its in the previous year.
Early in the year, we set to the task of editing the 1000 new images collected in the United
E E c5 States and England since the launch of the site in February, 2000. At a May meeting, the work-
ilrel)ive ing group of Steve Selden, Gar Allen, Elof Carlson, and Paul Lombardo helped prepare the
www.eugenicsarchive.org
captions for the completed images. Pending final edits, these new images should become
available in spring 2003. Additional images were collected during a visit to the Max Planck
Society Historical Archives in Berlin, Germany-including images of Otmar Freiherr von Verschuer and
his twin studies.
The working group, along with Barbara Biesecker (National Human Genome Research Institute) and
David Goldman (National Institutes of Health), contributed their expertise by speaking in May at the sec-
ond of three Banbury meetings, American Eugenics and the New Biology: Perspectives and Parallels.
This meeting aims to familiarize "opinion leaders" about this dark saga in American science. The meet-
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ing drew 26 participants from diverse fields, including family genetics, education, ethics, journalism,
government, industry, and philanthropy. The third of the Banbury meetings will be held in 2003.
May 2, 2002 marked an important data in eugenics history: the 75th anniversary of the Supreme
Court decision that upheld the concept of eugenic sterilization for people considered genetically "unfit."
This famous court case, "Buck v. Bell," was the focus of a feature article that was included on the
Archive web site as well as on Gene Almanac. In the fall, we began production on a multimedia mod-
ule to provide an in-depth look at the Buck v. Bell case. Here, we enlisted extensive help from our friend
Paul Lombardo, a legal historian who has devoted his career to unraveling the truth behind Buck v. Bell.
With a PBS film crew, we followed Paul on a virtual "pilgrimage" of key sites in the Buck v. Bell story:
the Virginia Colony for the Epileptic and Feeble Minded, in Lynchburg, where protagonist Carrie Buck
and her mother Emma were incarcerated; the Amherst County Court House, where the case was first
heard, before going to the U.S. Supreme Court; and the Venable School, in Charlottesville, where
Carrie's child Vivian was a solid student before her early death. Dr. Lombardo's analysis of this nadir in
U.S. jurisprudence was filmed against the backdrop of the rotunda of the University of Virginia, designed
by Thomas Jefferson, and widely considered a symbol of the American dream for human rights. Clips
from the interviews will be featured at the Eugenics Archive and on the new DNA Interactive site.
Inside Cancer
tit
IInside Cancer, funded by the National Institutes of Health, Science Education " '!""'
Partnerships Award (SEPA) program, is a multimedia web site under development
that is geared toward the general public, especially teachers and students. It will Coming in 2003.
be a resource for people who want authoritative information on the workings of a cancer cell.
Animations and video interviews with cancer researchers and other experts will help people understand
the complex science and issues of cancer.
Inside Cancer will feature five modules: What Is Cancer? emphasizes cancer as a disease and
shows how cancers develop from a single cell; Causes & Prevention identifies behaviors and environ-
mental factors that increase cancer incidence; Diagnosis & Treatment shows how oncologists diagnose
cancers, the types of treatment options available, and how they work; Cancer in the Laboratory intro-
duces major cancer researchers and the importance of their discoveries; Pathways to Cancer is a
three-dimensional tour of a cell that focuses on the signaling pathway. Disruption of the pathway can
lead to irregular cell growth and cancer. Each module is subdivided into an Overview and relevant con-
tent segments. The Overview will be the "highlight reel," and will introduce visitors to more in-depth
content.
Major development effort has focused on creating high-resolution, three-dimensional animations of
a cell's signaling pathway for the Pathways to Cancer module. A pathway initiated by platelet-derived
growth factor (PDGF) was chosen because it provides an opportunity to illustrate the key points at
which cellular growth control can be lost during oncogenesis. The importance of protein products of
proto-oncogenes, c-sis, ras, c-fos, c-jun, and the role of phosphorylation in the regulation of protein
function are illustrated. Since the PDGF receptor is a target for the new Novartis drug, Gleevec", the
pharmacological action of cell-signaling inhibitors can also be stressed. We look forward to launching
Inside Cancer late in 2003.
Setting up Sister Institutions to the East, West, and North
East In July, we signed a three-year contract with the Ministry of Education (MOE) to use the DNALC
model to support expansion of life sciences education in Singapore. The project is part of a national
thrust to make biotechnology the "fourth pillar" of Singapore's future economy. With a centrally con-
trolled school system the size of metropolitan Chicago, Singapore potentially provides the first large-
scale, integrated deployment of lab-based instruction in genetics and molecular biology. Two years
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The DNA Learning Center West opened its doors
in June, 2002.
ago, there was essentially no hands-on biotechnology instruction at the precollege level in Singapore-
precisely where the United States was in 1988 when we started the DNALC.
In addition to the DNALC project, significant resources are flowing into the school system through
both MOE and the Agency for Science, Technology, and Research (A"STAR). Over the past two years,
virtually every high school has been equipped with basic equipment for DNA analysis-including PCR
machines, which have proved the stalling point for many American high schools. Recent government
studies have pointed to the need to liberalize some elements of the highly structured school system.
Teachers are being encouraged to experiment with new courses and enrichment activities. Thus, all the
factors seem right to create in Singapore a superb model for preparing students to live, work, and fruit-
fully participate in the gene age.
The project got off to a fast start, with DNALC staff conducting three weeks of training in Singapore
for middle- and high-school faculty. Twelve Singaporean teachers then participated in three-week
"attachments" in the United States, attending DNALC workshops here and in Boston. By year's end,
four teaching labs and a bioinformatics lab modeled after the DNALC were under construction at the
Singapore Science Center (SSC), which will focus on student enrichment, and the National Institute of
Education (NIE), which will focus on teacher training. Complete mirrors of the DNALC WVWV sites were
also installed at NIE (http://dnalc.nie.edu.sg) and the Singapore Bioinformatics Institute (http://dnalc.
bii.a-star.edu.sg).
West With the strong support of CSHL trustee Arthur Spiro, we collaborated with the Research
Institute of the North ShoreLong Island Jewish (NSLIJ) Health System to establish a DNA Learning
Center West in Lake Success, New York. The new center, which opened in June, includes a genet-
ic/biochemistry lab, prep lab, and office. Lab field trips at West include a tour of the adjacent Clinical
Core Laboratory. The objective of the new center is to extend DNALC services to schools in Western
Nassau County, Brooklyn, Queens, and Manhattan. Toward this end, five weeks of student workshops
were conducted during the summer, and field trips during the first half of the academic year brought
total attendance to 700 during the first year of operation.
North In October, we commenced collaboration with the Science Center of Eastern Connecticut, in
New London, to update their instructional activities with labs and multimedia experiences in molecular
genetics. This was part of a reorganization from which emerged the Science Epicenter & DNA Learning
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Center (SE DNALC). The objective here is to serve Connecticut school systems located directly across
Long Island Sound from us. Together with DNALC West, SE DNALC potentially will extend our influ-
ence in an arch around Long Island Sound, serving much of the major population center of the
Northeast. The project is of special interest to Pfizer, Inc., whose central research division is located in
nearby Groton.
Technology transfer (including the Singapore, NSLIJ, and Science EpiCenter collaborations; spon-
sored research by the Carolina Biological Supply Company; and royalties on teaching kits and CDs)
contributed about $365,000 in annual revenue, or about 15% of the 2002 operating income. We are
exploring additional licensing collaborations with Roberson Museum and Science Center in
Binghamton, New York, and the city of Leipzig, Germany.
DNA Science, 2nd Edition
By year's end, the second edition of our popular lab text, DNA Science, was in press. The 2nd edition
preserves the successful formula of the 1st edition: one part well-tested laboratories and one part
insightful, explanatory text. First circulated in mimeographed form in 1988 and formally published in
1990, this book was largely responsible for bringing DNA experiments within reach of advanced high
school and beginning college students.
The core laboratory sequence, developed by Dave Mick los and Greg Freyer in the laboratory of
CSHL Nobel Laureate Rich Roberts, introduces the basic techniques of DNA restriction, transforma-
tion, isolation, and analysis-and then applies these techniques to the construction and analysis of a
simple recombinant DNA molecule. We resisted the temptation to tinker very much with the laborato-
ries, since they are the best-tested and most widely used teaching labs available on the basic tech-
niques of gene manipulation. Two new labs focus on gene products: a colorimetric assay for the activ-
ity of (f-lactamase (the enzyme produced by the ampicillin resistance gene) and expression and purifi-
cation of green fluorescent protein.
The text portion has been entirely reorganized and updated, increasing from 200 to 300 pages. As
before, the narrative takes students behind the scenes of modern research to show them the evolution
of concepts and methods. The first three chapters cover essential principles of genetics, and DNA
structure and function. The next three chapters introduce small-
and large-scale methods for analyzing DNA, culminating in the race
to sequence the human genome and new methods for working
with hundreds of genes simultaneously. The final two chapters
focus on the applications of molecular techniques to understand
cancer, human variation, and our emergence as a species. The
human genetics chapter also contains the first substantial treat-
ment of American eugenics available in a general biology text.
Although much has changed in biology since the first edition,
the ideas and techniques in this book are still the minimum require-
ments for any degree in DNA manipulation. We hope that DNA
Science continues to provide a simple roadmap for beginning an
exploration of the molecule of life-one that will take on added
importance as more and more biology teachers around the world
realize the value of giving students the freedom to get their hands
dirty with DNA.
HHMI Bioinformatics
iy
'DNA Science
A FIRST COUR" RR,
DAVID A. MI( KL
GREG A.FREVEK
Mao DAVID rt. CROTII
The free publication of genome sequences and bioinformatics tools offers students and teachers the
unprecedented opportunity to work with important biological data at the same time and with the same
tools as researchers. With funding provided by the Howard Hughes Medical Institute (HHMI), we con-
tinued to encourage students and teachers to make use of this trove of data. Our HHMI program intro-
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duces students and faculty to genomic biology and bioinformatics using a mobile, networked computer
laboratory. Central to the program is Vector Net, a stand-alone, portable computer laboratory consist-
ing of 12 laptops and a laptop server. The server mirrors the entire DNALC Gene Almanac site, includ-
ing bioinformatics tools and Gen Bank data sets.
The student component of the HHMI project, New York City Genes, reached 1662 primarily minor-
ity students. Working in collaboration with CUNY's Gateway Institute for Pre-College Education,
Vector Net was rotated to Erasmus High School (Brooklyn), Science Skills Center High School
(Brooklyn), the High School for the Humanities (Manhattan), and John F. Kennedy High School (Bronx).
The availability of a set of networked computers in the biology classroom allowed students to move
between lab experiments and computer analysis of their own DNA polymorphisms. Vector Net saw
intensive use in Community School District 29, where students worked on our multimedia DNA foren-
sics activity, The Mystery of Anastasia.
During the year, VectorNet was used to train 355 biology educators. Of these teachers, 235 attend-
ed short-term workshops at in-services and national conventions; the remaining 122 attended one of
six-week-long Vector Bioinformatics workshops held at sites across the nation:
Contra Costa County Office of Education, Pleasant Hill, California
Foundation for Blood Research, Scarborough, Maine
National Center for Biotechnology Information, Bethesda, Maryland
Southwest Foundation for Biomedical Research, San Antonio, Texas
Stowers Institute for Medical Research, Kansas City, Missouri
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
During the workshop, participants make extensive use of computer tools to learn principles of gene
analysis, including DNA sequence annotation, gene structure and regulatory elements, gene families and
whole-gene analysis, functional genomics and DNA arrays, and gene discovery using SNPs and other
markers. Participants also amplify two DNA polymorphisms and use their own data as a starting point
to investigate DNA data sets, population genetics, human origins, and disease mechanisms. This illus-
trates the crossover between DNA experiments done in vitro (test tubes) and in sllico (computers).
At the workshop VVWW site, we continued development of lesson plans and user-friendly bioinfor-
matics tools for the analysis of DNA-such as nucleotide counters, a start/stop-codon searcher, and
a restriction site finder. The web site currently logs about 1000 visitors per month. DNALC staff also
joined CSHL's Meetings and Courses department in developing and teaching a two-day bioinformat-
ics course for research scientists. During 2002, 142 researchers from around the country participated
in The Genome Access Course (TGAC), which was conducted five times at the CSHL Woodbury
Cancer Genome Research Center.
Leadership Institute in Human and Molecular Genetics
Modeled after the intensive graduate training programs held at CSHL, the Pfizer-funded Leadership
Institute provides high-level training for a select group of high school faculty. Known also by its nick-
name, DNA Boot Camp, the 2002 program brought together 18 exemplary high school teachers from
across the United States, as well as four educators from Singapore. During the intensive three-week
workshop, participants performed laboratories from the DNALC's new module in human and plant
genomic biology, made extensive use of the computer laboratory as they investigated bioinformatics,
and worked on independent projects. They shared lodging and dining facilities with CSHL staff and vis-
iting scientists, and spent the weekends exploring Long Island and Manhattan. This eclectic group of
lead teachers represented 16 states, from the urban Northeast, to the rural South, to the Southwest
and Northwest.
New NSF Plant Initiative
Plant molecular genetic and genomic research still lag behind medically oriented research on microbes
and higher animals. As a result, relatively few lab experiences that expose students to the growing
insights into plants offered by genomic biology are available at the lower college level. So we were
Wild type (left) and mutant clf-2 (right) of the model plant Arabidopsis thaliana.
happy when, in December, the National Science Foundation (NSF) funded our proposal to develop a
laboratory- and Internet-based curriculum to bring college students up to the minute with modern plant
research. This proposal clearly struck a common chord with the six reviewers, all of whom rated it as
"excellent." This is the first time in 15 years that any proposal we have submitted has received such a
unanimous vote of confidence from NSF reviewers.
The project is based largely on data emanating from plant research at CSHL. A comprehensive set
of laboratories will be based on rapid and reproducible PCR chemistry developed under a previous NSF
grant. Using the model plant Arabidopsis and important food crops, the laboratories illustrate key con-
cepts of gene and genome analysis, including the relationship between phenotype and molecular
genotype, genetic modification of plants and detection of transgenes in foods, and linkage and bioin-
formatic methods for gene mapping. Students will also have the unique opportunity to explore func-
tional genomics by assisting CSHL researcher David Jackson with the cellular analysis of Arabidopsis
genes of unknown function. An Internet "super site" will support the laboratories with online protocols,
custom analysis tools, shared databases, and collaborative bulletin boards.
The project will be kicked off in June 2003 with a focus workshop of faculty advisors drawn from two-
and four-year colleges representing six regions of the United States. During the dissemination phase, in
2004-2005, faculty advisors will organize week-long training workshops to reach 144 instructors.
Student Instruction
In 2002, we brought our newly enlarged facility into full operation-including three teaching labs and a
computer lab. With an expanded menu of lab field trips, we provided lab experiences for more than
14,000 middle- and high-school students-an increase of 30% over 2001. We also marked an excit-
ing milestone, with 100,000 students having participated in lab experiments at the DNALC since the
opening of our first laboratory in 1988. Although our programs are targeted primarily at school groups,
we also welcomed 6000 members of the general public, who combine a visit to The Genes We Share
exhibit with Long Island Discovery, Cablevision's multimedia production that chronicles the colorful his-
tory of Long Island.
Genetics as a Model for Whole Learning (GMWL), our program of in-school instruction and lab field
trips for 5-7th graders, reached over 17,000 students in 40 school districts and private schools on
Long Island. Field trips to the DNALC combine lab work-such as extracting DNA or transforming DNA
into bacteria-with a tour of our new museum exhibit, The Genes We Share. The multimedia explo-
ration Anastasia: Dead or Alive? continues to be popular for field trips, but faculty are also using the
VWVW version in their own classrooms.
During the year, we renewed a contract with the New York City Board of Education to provide the
GMWL program to more than 1800 minority students in Community School District #29 in Queens. We
continued our ongoing partnership with CUNY's Gateway Institute for Pre-College Education, which
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provides enrichment to prepare minority high school students for success in higher education. We pro-
vided gratis lab field trips for 450 Gateway students and minority students from Central Islip High
School, Elmont Memorial High School, Theodore Roosevelt High School, Martin Van Buren High
School, and Midwood High School.
Founded in 1985, the DNALC's Curriculum Study program remains the nation's oldest and largest
coordinated effort in the country to bring molecular biology and recombinant DNA technology into the
science classroom. Our 38 member districts include both public and private schools in Suffolk, Nassau,
Queens, the Bronx, and Manhattan. In 2002, we welcomed three new members to the Curriculum
Study Program: Kings Park Central School District, Fordham Preparatory School, and North Shore
Hebrew Academy High School.
Great Moments in DNA Science, the Curriculum Study Honors Student Seminars, attracted 467
area high school students during three evenings in April. The speakers, and their topics of discussion,
were:
Peter Mombaerts, The Rockefeller University: Cloning and Embryonic Stem Cells
Vivek Mittal, Cold Spring Harbor Laboratory: Exploring Cancer with DNA Microarrays
Maureen O'Leary, Stony Brook University: The Origins of Whales: Discovering an Evolutionary
Transition from Land to Sea Using Molecules and Bones
The summer proved to be our busiest and most productive workshop season to date. We con-
ducted 29 student workshops at the DNALC and DNALC West, reaching a total of 676 students-a
34% increase over 2001 attendance. Off-site, we supported gratis workshops for 72 minority students
at Central Islip High School (Suffolk), Wyandanch High School (Suffolk), Brooklyn Technical High School
(Brooklyn), and John F. Kennedy High School (Bronx).
Staff and Interns
The DNALC bid farewell to several staff members in 2002. Maureen Cowan left her position as a mid-
dle school educator to pursue a career as a chemistry teacher at St. Mary's School in Manhasset. Our
talented multimedia designer Wen-Bin Wu returned to Hong Kong to run his family's import-export
business. Hong Zhou departed as manager of our DNA Sequencing Service.
The ranks of the instructional group were swelled by the arrival of Erin Maroney, Kimberly Kessler,
and Michael O'Brien. Erin has a degree in plant and soil science from the University of Vermont (2001).
She teaches and helps administer the middle school program. With a degree in biology from Boston
College (2002), Kimberly manages our after-school intern program, in addition to teaching middle and
high school students. Michael graduated from SUNY at Albany in May 2002 with a degree in
Biochemistry and Molecular Biology. In addition to teaching high school labs, he manages the DNA
Sequencing Service. Kimberly and Michael are both "alumni," having visited the DNALC as high school
students. Kimberly performed labs here as part of SUNY Stony Brook's Women in Science and
Engineering. Michael was a student of Fred Gil lam at Sachem High School, who was among the first
high school faculty to implement the DNA Science curriculum.
The BioMedia Group continues to thrive, and has nearly doubled in size in response to recent ambi-
tious projects, including DNA Interactive and Inside Cancer. Thus, we were delighted to welcome three
new members to our design staff: Eun-Sook Jeong, Darius Farraye, and Karwai Pun. With Master of
Art degrees from Long Island University at C.W. Post and Hong lk University in Seoul, Eun-Sook has
crossed several continents in her career as an interior designer and multimedia artist. A native of Korea,
she began her career at the DNALC as a summer intern while finishing work toward a master's degree.
Darius has a strong background in multimedia web design and received a degree in Interactive Design
from The Pratt Institute in 2002. Karwai joined us after having received degrees in art history and mul-
timedia design, and working for an Internet design firm in Norway. A native of Long Island, she also vis-
ited the DNALC with her Northport High School biology class.
Fund-raising at the DNALC got a boost in 2002 with the addition of Erin Wahlgren as Senior
Development Officer. Erin graduated from Simmons College in Boston with a double major in English and
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Art History, and went on to hold development positions at the New York Public Library and Old Westbury
Gardens. Although Erin reports to the Development Department, she is an integral part of the DNALC team.
Our high school intern program continues to offer students the opportunity to conduct independent
research projects under the direction of Scott Bronson and Jennie Aizenman. Michelle Louie and Dan
De Roulet researched techniques for tagging Arabidopsis genes with the jellyfish gene encoding green
fluorescent protein. Saroja Bangaru spent the summer with CSHL scientist David Jackson and studied
the control of morphogenesis in plants, using maize as a model system. Caroline Lau was selected as
an Intel finalist (international) for her work on striped bass population genetics. Jared Winoker and
Kunal Kudakia researched human diversity using a combination of computer tools and techniques
developed at the DNALC.
In addition to preparing reagents used in our teaching labs, interns play a critical role in our free DNA
Sequencing Service. Lara Abramowitz, Sirish Kondabolu, and Jonathan Mogen (Half Hollow Hills High
School), Eric Paniagua (Long Island School of the Gifted), Alex Hogg (Friend's Academy), Michelle Louie
(King's Park High School), and senior intern Alina Duval (Hofstra University) worked together to meet
the increasing demand for the DNALC's on-site sequencing service. Joining the intern program in 2002
were Pushpa Abraham (Kings Park High School), Lara Abraham (Half Hollow Hills High School),
Jennifer Aiello (Kings Park High School), Christina Bezas (Huntington High School), Michael Casimir
(Ward Melville High School), Daisy Choi (Cold Spring Harbor High School), Kimberly lzzo (Kings Park
High School), David Wagman (Syosset High School), and Phillip Witkin (Syosset High School).
Bringing DNALC West online required recruiting and training a new group of high school interns:
Robert Weintraub (Walt Whitman High School); Alinea Noronha (Herricks North High School); and Devin
Chu (Archbishop Molloy High School).
The BioMedia Group was delighted to welcome Felix Hu back for the summer and Christmas
breaks. Felix started his first term at Georgia Tech last year. Tracy Mak, a veteran BioMedia intern, also
started her first college term last year at Cornell. Felix's sister Regina Hu (Northport High School) and
Watson School graduate student Elizabeth Thomas continue to work for us during the year. Ariel Gitlin
(Cold Spring Harbor High School) and Ryan Chiu (Horace Mann High School) started as new BioMedia
interns. Ray Zhang (Elwood John Glenn High School) worked with us for the summer. Amelia Dorrer
(C.W. Post) joined the team as a college intern. BioMedia interns help with a number of different tasks
having to do with web site development, such as writing and editing scripts, animations, and web
pages; designing new material; beta-testing web sites; and reviewing video clips.
Several art students took short-term positions at the DNALC to work on production of The Genes
We Share exhibit, including Dana Liebowitz (Bennington College), Matt Mottola (New York Institute of
Technology), Kerry Janney (C.W. Post), and Greg Furjanic (C.W. Post). Exhibit interns performed a
range of tasks, such as drafting plans, sculpting and painting the human origins "cave," assembling
display cases, filling blood bags with theatrical blood, and hand lettering signage.
The following interns left to pursue their scientific interests in college and/or research. We congrat-
ulate Marie Mizuno and Jonathan Mogen for their acceptance into the "Partners for the Future" pro-
gram. Marie is currently working in the lab of Yuri Lazebnik researching apoptosis while Jonathan is
working with Yi Zhong investigating neurofibromatosis 1 (NF1) and presenilin genes. Eric Paniagua
(Long Island School for the Gifted) joined the lab of Jerry Yin to research molecular mechanisms
involved in long-term memory. In August, we bid farewell to the following interns as they began their
freshman year at the following institutions: Yan Liang Huang (Harborfields High School) University of
Notre Dame, Caroline Lau (Syosset High School) Princeton University, Janice Lee (Oyster Bay High
School) Boston University, Jarrett Linder (Half Hollow Hills High School) Cornell University, and Alex
Witkowski (Cold Spring Harbor High School) SUNY Albany. Daniel DeRoulet (Columbia University) and
Rebecca Yee (Wellesley College) used their summer breaks to assist with summer workshops and
advanced research projects. Additionally, Andrew Diller left the DNALC to pursue a career in the fine
arts and Wayne Chiang (Cold Spring Harbor High School) moved back to Taiwan with his family.
Dave Micklos
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2002 Workshops, Meetings, and Collaborations
January 14-15 Site visit by Lisa Darmo, Elizabeth Paine, and Lawrence Wallace, Carolina Biological
Supply Company, Burlington, North Carolina
January 17-19 DNA Interactive Advisory Board Meeting, Banbury Center and DNALC, CSHL
January 22 Site visit by Philip Batterhan, International Congress of Genetics, Melbourne, Australia
January 28 New York City Genes teacher training, York College, Queens, New York
January 28-31 The O'Reilly Bioinformatics Technology Conference, Tucson, Arizona
January 30 National Institute of Social Sciences Issues Discussion Group, Colony Club, New York,
New York
February 1 Inter-School Exchange Reception
February 8 Site visit by Richard Riley, Clemson University, Clemson, South Carolina
February 19 Site visit by James Ravanis and Steven Spofford, Rindge School of Technical Arts,
Cambridge, Massachusetts
February 19-22 Site visit by Phoon Lee Chaeng, Goh-Goh Poh Gek, Cheong Kim Fatt, and Lee Seng
Hai, Singapore Ministry of Education; Anne Dhanaraj, Singapore Science Centre; and
Lee Sing Kong, Singapore National Institute of Education
February 25 Site visit by Gail Carmack, UTeach Program, University of Texas-Austin
February 25-27 National Institutes of Health Science Education Partnership Award Meeting, Houston,
Texas
February 26 Site visit by Regan Huff, Mc Wane Center, Birmingham, Alabama
February 28 Site visit to Biogen, Cambridge, Massachusetts
March 6-8 National Institute of Standards and Technology, Best Practices Meeting, Gaithersburg,
Maryland
March 7 Site visit by Bonnie Kaiser and Robert Schill, The Rockefeller University, New York, New
York; and Catherine Rubin, EduChange
March 8 Site visit by Jennifer Chidsey and Paul Flagg, Ross School, East Hampton, New York
March 11 Exhibit development meetings with Mark Holterman, University of Illinois at Chicago; and
David Teplica
March 11-13 Howard Hughes Medical Institute Undergraduate Program Review, Chevy Chase,
Maryland
March 15-20 DNA Interactive editorial meeting, London and Cambridge, England
March 20-24 Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Contra Costa County
Office of Education, Pleasant Hill, California
March 27-30 National Science Teachers Association Annual Meeting, San Diego, California
April 3 Your Genes, Your Health interview, Dominick Sabatino, Nassau University Medical Center,
East Meadow, New York
April 4 Site visit by Carson Powers, David Tesseo, Jean Caron, Phil Maniscalo, Martha Grossel,
and Richard Hinman, Science Center of Eastern Connecticut, New London
April 9 Your Genes, Your Health interview, Anthony Cervo
April 14-16 National Institutes of Health ELSI conference, American Eugenics and the New Biology:
Perspectives and Parallels, Banbury Center, CSHL
April 15 Great Moments in DNA Science Honors Students Seminar, CSHL
April 20-21 Presentation for Genomic Revolution exhibit opening, North Carolina Museum of Natural
Sciences, Raleigh
April 23 Great Moments in DNA Science Honors Students Seminar, CSHL
Your Genes, Your Health interview, Robert Desnick, Mount Sinai School of Medicine,
New York, New York
April 24 National Institute of Social Sciences Board Meeting, Harvard Club, New York, New York
April 25 Presentation for Sayville High School Career Café Day
April 27 Presentation for Arbor Day Festival, Planting Fields Arboretum, Oyster Bay, New York
April 29 Great Moments in DNA Science Honors Students Seminar, CSHL
May 7-9 DNA Interactive filming, San Francisco, California
May 10 Site visit by Huanming Yang, Beijing Genomics Institute, China
May 13-15 National Human Genome Research Institute ELSI Project, Eugenics Image Archive,
Editorial Advisory Panel Meeting, Banbury Center, CSHL
May 17 Site visit by Eugene Mitacek and Suzanne Ettinger, New York Institute of Technology, Old
Westbury
May 21 DNA Interactive editorial meeting, DNALC
Your Genes, Your Health interview, Edwin Kolodny, New York University School of
Medicine, New York
May 22 Site visit by Don Colbert, SUNY Binghamton
May 28-June 1 Teacher training workshop, National Institute of Education, Singapore
May 29-30 Site visit by Janna Greenhalth and Pat Quinn, Science Center of Eastern Connecticut,
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June 3-14
June 11
June 13
June 17-21
June 19
June 20
June 24
June 24-28
June 25
June 27-July 3
July 8-12
July 8-26
July 9
July 12
July 15
July 15-19
July 16
July 19
July 20-23
July 22-26
July 26
July 29-August 2
August 5-9
August 12
August 12-16
August 15
August 19-23
New London
Teacher training workshops, National Institute of Education, Singapore
Your Genes, Your Health interview, Susan Fishbein, Late Onset Tay-Sachs Foundation,
Glenside, Pennsylvania
Site visit by Kevin Seeley, Pall Corporation, Port Washington, New York
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Southwest
Foundation for Biomedical Research, San Antonio, Texas
Josiah Macy, Jr., Foundation Meeting, DNALC
Your Genes, Your Health interview, Judith Willner and Randi Zinberg, Mount Sinai School
of Medicine, New York, New York
DNA Learning Center West opening and reception, Lake Success, New York
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Stowers Institute for
Medical Research, Kansas City, Missouri
Site visit by Frederick Seitz and Florence Arwade, Lounsbery Foundation
Fun With DNA Workshop, DNALC
Fun With DNA Workshop, DNALC West
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
Fun With DNA Workshop, DNALC
Fun With DNA Workshop, DNALC West
World of Enzymes Workshop, DNALC
DNA Science Minority Workshop, Central Islip High School, New York
Pfizer Leadership Institute in Human and Molecular Genetics, DNALC
Your Genes, Your Health interview, the McHale family
Site visit by Woodrow Wilson Biology Institute participants
Site visit by Gateway Institute for Pre-College Education administrators and teachers
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Minority Workshop, Wyandanch High School, New York
Your Genes, Your Health interviews, Michael Shelanski, Columbia University, New York,
New York; and Thomas Winiewski, New York University School of Medicine, New York
Site visit by Mary Miller and Rob Semper, Exploratorium Origins Project, San Francisco,
California
DNA Interactive editorial meeting, DNALC
Fun With DNA Workshop, DNALC
DNA Science Minority Workshop, John F. Kennedy High School, Bronx, New York
Genomic Biology & PCR Workshop, DNALC
Site visit by Matt Ridley, author and chairman of the International Centre for Life,
Newcastle upon Tyne, United Kingdom
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC West
DNA Science Minority Workshop, Brooklyn Technical High School, New York
Fun With DNA Workshop, DNALC
Fun With DNA Workshop, DNALC West
World of Enzymes Workshop, DNALC
Genomic Biology & PCR Workshop, DNALC
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, National Center for
Biotechnology Information, Bethesda, Maryland
Site visit by Lawrence Scherr, North Shore-Long Island Jewish Health System
Fun With DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Whitehead Institute
for Biomedical Research, Cambridge, Massachusetts
Your Genes, Your Health interview, Julie Zale
Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Workshop, Cambridge, Massachusetts
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Foundation for Blood
Research, Scarborough, Maine
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August 26-30
September 6-9
September 18
September 25
September 26-29
September 27
September 27-30
October 3
October 6-8
October 7
October 9
October 15
October 19-25
October 20
October 25
October 30-
November 2
November 5
November 7-8
November 13
November 14
November 18
November 22
November 25
December 2-6
December 19
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Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC West
DNA Science Workshop, DNALC
DNA Interactive editorial meeting, DNALC
The Genes We Share exhibit opening
Site visit by Lisa Darmo, Charles Matthews, George Ross, and Lawrence Wallace,
Carolina Biological Supply Company, Burlington, North Carolina
Site visit by Prince Andrew, Duke of York
Museums, Media and the Public Understanding of Research International Conference,
Science Museum of Minnesota, St. Paul
Presentation for Science Center of Eastern Connecticut, New London
Multimedia Educational Resource for Learning and Online Teaching (MERLOT)
International Conference, Atlanta, Georgia
Site visit by Tim Herman and Michael Patrick, Center for BioMolecular Modeling,
Milwaukee School of Engineering, Wisconsin
DNA Interactive Advisory Panel Meeting, Banbury Center, CSHL
Site visit by Barbara Delatiner, New York Times
Site visit to the Carolina Biological Supply Company, Burlington, North Carolina
National Institute of Social Sciences Board Meeting, New York, New York
Planning and web site development meeting, National Institute of Education, Singapore
Your Genes, Your Health interview, Melissa Goldman
Site visit by Judith Kirk, Westmead Hospital, Sydney, Australia; and Joe Sambrook, Peter
MacCallum Cancer Institute, Melbourne, Australia
National Association of Biology Teachers Annual Convention, Cincinnati, Ohio
DNA Interactive filming, Charlottesville, North Carolina
Site visit by Connie Barnes, Elizabeth Button, Diane Carpenter-Crews, Jim Moody, and
Mary Sokolowski, SUNY Binghamton
Site visit by Kathleen Belton and Drew Bogner, Molloy College, Rockville Center, New
York
Site visit by Cain Goddard, OSI Pharmaceuticals, and William Hurt, actor
Site visit by Daniels Gieseler, German public television
Site visit by Mary Miller, Exploratorium Origins Project, San Francisco, California
Site visit by Russ Hodge, European Molecular Biology Laboratory, Heidelberg, Germany
DNA Interactive editorial meeting, London, England
Site visits to Max Planck Institute, Berlin and Leipzig, Germany
Site visit by Julie Clayton, Nature Magazine
Sites of Major Faculty Workshops 1985-2002
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA Foothill College, Los Altos Hills 1997
University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
Canada College, Redwood City 1997
Pierce College, Los Angeles 1998
California Lutheran University, Thousand Oaks 1999
Laney College, Oakland 1999
California State University, Fullerton 2000
Salk Institute for Biological Studies, La Jolla 2001
Contra Costa County Office of Education, Pleasant Hill 2002
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992,1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
University of Miami School of Medicine 2000
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991,1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986,1987
University of Chicago 1992,1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
National Center for Biotechnology Information, Bethesda 2002
MASSACHUSETTS Beverly High School 1986
City Lab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994,1996
Whitehead Institute for Biomedical Research, Cambridge 2002
Biogen, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990,1991
MISSOURI Washington University, St. Louis 1989
Washington University, St. Louis 1997
Stowers Institute for Medical Research, Kansas City 2002
NEW HAMPSHIRE St. Paul's School, Concord 1986,1987
New Hampshire Community Technical College, Portsmouth 1999
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
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Bronx High School of Science 1987
Columbia University, New York 1993
Cold Spring Harbor High School 1985,1987
DeWitt Middle School, Ithaca 1991,1993
DNA Learning Center 1988-1995, 2001-2002
DNA Learning Center 1990,1992,1995,2000
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991,1993
Wheatley School, Old Westbury 1985
US Military Academy, West Point 1996
Stuyvesant High School, New York 1998-1999
Trudeau Institute, Lake Saranac 2001
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
Oklahoma City Community College 2000
Oklahoma Medical Research Foundation, Oklahoma City 2001
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999
Austin Community College-Rio Grande Campus 2000
Southwest Foundation for Biomedical Research, San Antonio 2002
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998,2000
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON University of Washington, Seattle 1993,1998
Fred Hutchinson Cancer Research Center, Seattle 1999,2001
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986,1987
University of Wisconsin, Madison 1988,1989
Madison Area Technical College 1999
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001-2002
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
COLD SPRING HARBOR
LABORATORY PRESS
2002 PUBLICATIONS
SERIALS
Genes and Development, Volume 16, 1-3320
Genome Research, Volume 12, 1-2003
Learning and Memory Volume 9, 1-442
Protein Science, Volume 11, 1-2980
Cold Spring Harbor Symposia on Quantitative Biology:
Volume 66: The Ribosome
LABORATORY MANUALS AND HANDBOOKS
Protein-Protein Interactions: A Molecular Cloning
Manual, Erica Golemis (ed.)
DNA Microarrays: A Molecular Cloning Manual, David
Bowtell and Joe Sambrook (eds.)
Proteins and Proteomics: A Laboratory Manual,
Richard Simpson
Manipulating the Mouse Embryo: A Laboratory Manual
(3rd ed.), Andras Nagy, Marina Gertsenstein, Kristina
Vinterstein, and Richard Behringer
Lab Ref: A Handbook of Recipes, Reagents, and Other
Reference Tools Required at the Bench, Jane Roskams
and Linda Rodgers (eds.)
TEXTBOOKS
Discovering Genomics, Proteomics, & Bioinformatics,
A. Malcolm Campbell and Laurie J. Heyer
GENERAL INTEREST AND CHILDREN'S BOOKS
Ageless Quest: One Scientists Search for Genes That
Prolong Life, Lenny Guarente
I Wish I'd Made You Angry Earlier: Essays on Science,
Scientists, and Humanity Max Perutz
Have a Nice DNA and Gene Machines Fran Balkwill
and Mic Rolph (Enjoy Your Cells series)
Staying Alive: Fighting HIV/AIDS, Fran Balkwill and
Mic Rolph
OTHER
Retroviruses CD, John M. Coffin, Stephen H. Hughes,
and Harold E. Varmus
Essentials from Cells: A Laboratory Manual CD,
David L. Spector and Robert D. Goldman
CSHL Annual Report 2001
Banbury Center Annual Report 2001
Watson School of Biological Sciences Annual Report
2001
Administrative and Financial Annual Report 2001
A selection of recently published books
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The journal publishing program
COLD SPRING HARBOR LABORATORY PRESS
After a promising start, 2002 became a financially challenging year. A substantial decline in journal
advertising sales, increased pressure for discounts from book resellers, and grant pressures on authors
that delayed completion of important books all combined to produce financial results that were below
expectation. Total income from our publishing program decreased by 7% to $9,050,700, and the net
operating excess declined by more than 30%.
Nevertheless, Cold Spring Harbor Laboratory Press continues to make an important contribution to
the Laboratory's educational mission, with an international publishing program that addresses three
distinct audiences. Through research journals, scientific monographs, and laboratory manuals, the pro-
gram assists the continuing professional education of working scientists and the training of graduate
students for advanced degrees. In addition, textbooks are published for undergraduates. And a grow-
ing number of books are published for readers who are not technically trained but interested in biolog-
ical research and its impact on medical practice and social policy. In 2002, each of these three audi-
ences found something new to interest them from Cold Spring Harbor.
Books
A complete list of the 2002 publications appears opposite. Ten new books, one expanded paperback
edition, and two CDs were published.
Professional scientists worldwide rely on the technical manuals published by the Laboratory, many
of which have originated in practical courses taught here. More than 20 manuals are now available,
including the 2001 edition of Molecular Cloning by Joe Sambrook and David Russell, the world's most
widely used manual of DNA techniques, which continued to sell strongly throughout the year. New titles
added in 2002 included the first editions of three manuals for important, emerging sets of technologies.
Proteins and Proteomics by Richard Simpson provides an authoritative, protocol-based approach to
proteomics. Protein-Protein Interactions, edited by Erica Golemis, presents methods for dissecting
intracellular machinery. And in DNA Microarrays, the expertise of many scientists in this rapidly evolv-
ing field was welded into a coherent whole by the creative editing of David Bowtell and Joe Sambrook.
Another new and important release was the third edition of the classic developmental biology manual
Manipulating the Mouse Embryo, first published in 1982 and entirely revised and rewritten for this edi-
tion by Andras Nagy, Marina Gertsenstein, Kristina Vinterstein, and Richard Behringer.
Academic books in electronic form are slowly gaining popularity, and several new approaches to this
medium were made during the year. The proteomics and microarrays manuals were published in asso-
ciation with dedicated web sites containing supplementary material and links to on-line resources such
as reference databases. Similar sites were constructed in association with popular textbooks (e.g.,
Bioinformatics and Genes & Signals), offering resources for teaching and downloadable figures that can
be turned easily into slide presentations. In addition, for the first time, two established Cold Spring
Harbor books, Retroviruses and Cells: A Laboratory Manual, were republished on compact disk, ensur-
ing that although not necessarily available in print, their contents would remain accessible to the sci-
entific community in an easily searchable form. Improved accessibility also prompted our decision to
make available on-line, free of charge, the entire text of several specialized monographs through the
Book Shelf project at the National Center for Biotechnology Information. We also licensed 13 books in
electronic form to the companies Net library and Ebrary, both of which provide academic and institu-
tional business information specialists with consolidated on-line reference material. These initiatives are
at early stages, but it is important that we explore emerging business models as scientists' reliance on
Internet-delivered information continues to grow.
Some kinds of books, however, seem destined to remain most popular in print form. These include
a new kind of manual we have pioneered in partnership with author Kathy Barker. Focused more on
the human aspects of science than the technical, her books At The Bench, advising novices on how
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to prosper in a laboratory environment, and At The Helm, on succeeding as a newly appointed princi-
pal investigator, were high on our list of best-sellers this year. Academic institutions are beginning to
pay close attention to the professional career development of their scientific staff. The print handbook
Lab Ref, by Jane Roskams and Linda Rodgers, also did well as an easy-to-use bench resource.
There were two releases in our general interest category. The 1998 collection of essays by Max
Perutz I Wish I'd Made You Angry Earlier was much admired and sold very well. Although in his 80s,
Max was prolific, and so many of his warm, insightful commentaries and book reviews appeared in sub-
sequent years that we began a dialog about the publication of a paperback edition containing some of
the newer essays. Sadly, Max died in February 2002 as the project began to take shape. So the
expanded paperback edition became his memorial, assembled with the help of his children Vivienne
and Robin, and with the addition of a wonderful tribute to Max by his friend and colleague John Meurig
Thomas.
The second title in this category was Ageless Quest, by MIT's Lenny Guarente, a book on a theme
perfectly summarized by its subtitle One Scientist's Search for Genes That Prolong Youth. The author
made appearances at bookstores on both coasts to talk about his research and sign books, and he gave
interviews to radio, television, and print journalists. His book was warmly received and was particularly
appreciated by fellow scientists for its honest description of a life in a hot area of research and the clari-
ty of his explanations of complex technicalities. Its particularly striking cover, a young woman wistfully
contemplating her image in a mirror, typified what has become a much commented on feature of all our
books, both popular and professional-their attractiveness as objects, in both design and production.
These features, and the accuracy of typesetting, reflect the skills of our very able Production Department.
The success of a book like Ageless Quest in reaching its intended popular audience is critically depen-
dent on the willingness of bookstores (including on-line booksellers) and library suppliers to stock it. After
two years of relentless persistence by our Sales Department, relationships with the major players in the
commercial marketplace have now been cemented. As a result, popular science books from Cold Spring
Harbor can now be found reliably in bookstores at Harvard, Boston, Stanford, and other prominent uni-
versities, as well as in retail stores in major cities and the most dominant on-line bookshops. A particu-
larly satisfying consequence of these new business relationships was the decision in Ann Arbor,
Michigan, to base a community reading project around Philip Reilly's 2002 paperback Abraham Lincoln's
DNA and Other Adventures in Genetics. With the assurance that the book would be readily available in
local stores, the committee of "Ann Arbor Reads" arranged a three-month program of events surround-
ing the book, beginning January 2003, that includes talks by the author, lectures in schools and colleges
on themes from the book, library reading groups, and other community-oriented activities.
Cordial relationships with retailers and wholesalers are also critical to the further development of our
textbook program, since professors recommending books to students expect them to be immediate-
ly available nearby. The textbook list expanded in 2002 with the release of an innovative book for
advanced genetics courses entitled Discovering Genomics, Bioinformatics, and Proteomics, by
Malcolm Campbell and Laurie Heyer of Davidson College. Copublished with the notable textbook pub-
lishing house Benjamin Cummings, it is an excellent introductory book that offers a less mathematical-
ly challenging approach than our market-leading textbook, David Mount's Bioinformatics: Genome and
Sequence Analysis, which continued to be widely adopted in many American universities. Another grat-
ifying commercial development was the designation of six of our books as Special Selections by the
Library of Science Book of the Month Club.
The marketing of future textbooks will be assisted by the staff of the Customer Service Department,
who, in addition to their regular duties of fulfilling book orders and journal subscriptions, adopted tele-
marketing to inform prospective buyers about the availability of newly published books. The Press web
site and the ability to broadcast e-mail messages are also invaluable additions to the techniques avail-
able for book promotion. Many thousands of scientists worldwide have elected to receive announce-
ments of new books and special offers, and the web site contains the definitive catalog of all books
currently available from the Press. Nevertheless, traditional promotional activities continued vigorously,
with attractively redesigned newsletters and catalogs, a range of book-specific brochures and adver-
tisements, and exhibits at more than a dozen major scientific conferences.
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There was further consolidation of Cold Spring Harbor Laboratory Press Europe in 2002, with dis-
tribution in Oxford and active sales representation in several European countries. The sales goal for
Europe was met, encouraging further improvement and expansion in 2003. New book distributors
were appointed in Latin America, Southeast Asia, Egypt, Turkey, and Slovakia, widening an established
distribution network in Japan, Korea, and India. International links were forged and maintained through
attendance at the London and Frankfurt Book Fairs. Negotiations for translation rights have now result-
ed in the publication of Cold Spring Harbor books in more than 10 languages.
Two more books were added to the popular Enjoy Your Cells series for children. The author, Fran
Balkwill, is now Professor of Cancer Biology at St. Bartholomew's Hospital, London, but despite the
demands of a busy research career, she is increasingly involved in science education. Gene Machines
and Have A Nice DNA once again show how good she is at describing scientific concepts in clear,
uncluttered language, and her text is perfectly complemented by Mic Ralph's colorful and entertaining
artwork.
Ten years after we began distributing their first children's books, Fran and Mic's work has become
familiar to scientists all over the world. One of them is Siamon Gordon, Professor of Experimental
Pathology at Oxford, who was born and medically trained in South Africa. At his urging, Fran, Mic, and
Cold Spring Harbor Laboratory Press began the development of a book in the characteristic style of
the Enjoy Your Cells series but dedicated to the goal of informing South African teenagers about the
biology of HIV/AIDS, their risk of infection, and ways of preventing it. The authors researched this pro-
ject during a 2001 visit to South Africa, and the book, entitled Staying Alive: Fighting HIV/AIDS, was
written with much advice from the teachers, students, and community workers they met on their trav-
els. With the help of start-up grants, we were able to print 20,000 copies of the book. In July, the
authors, Siamon Gordon and his wife Lyndall, social scientist Linzi Rabinowitz, my son Tony, and I spent
three weeks travelling in three provinces of South Africa, visiting schools, squatter camps, and orphan-
ages in urban and rural areas, to distribute these copies free of charge. In each province, we publicized
the location of distribution sites for the book. We were also able to develop a network of educators will-
ing to use the book in a variety of settings and tell us about their experience. During our visit, we were
privileged to meet teachers, social workers, doctors, politicians, patient activists, and others struggling
with the tragedy of AIDS in South Africa. They included Education Minister Dr. Kadar Asmal who, in
endorsing the book, gave us our mission statement: "Since AIDS has no cure or vaccine, education
must be the social vaccine." As the year ended, we were excited and honored by the news that our
application to the Bill and Melinda Gates Foundation for funds to further the work with Staying Alive in
2003 had been approved.
Journals
Genes & Development's circulation in 2002 reflected its continued strength in institutional subscrip-
tions. All research journals that formerly enjoyed high levels of individual subscriptions are seeing those
subscriptions decline as ever-larger numbers of institutions network the electronic edition of the jour-
nal to their entire staff. Genes & Development is no exception. Nevertheless, manuscript submission
continued to increase, up by 8%, and the journal's impact factor rose to 20.88, maintaining its position
among the top ten elite journals in experimental biology. Rudi Grosschedl (University of Munich) com-
pleted his first year as European Editor.
The circulation of Genome Research showed a 10% growth in institutional subscriptions.
Manuscript submission increased by 70%, assisted by implementation of an entirely electronic manu-
script submission and review system, and the journal's impact factor rose to 8.56.
The circulation of Learning & Memory improved by 3%. The manuscript submission rate increased
by 62% and the journal's impact factor was 3.52.
The contract to publish the Protein Society's journal Protein Science began in 2001 and for the second
year in a row, institutional subscriptions rose strongly, by 40%. Its impact factor was 3.47. Our success in
increasing the journal's visibility, the attractive redesign, and reliable production schedules were key assets
in our winning the RNA Society's competition to publish its journal RNA, starting in January 2003.
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The journal program's expansion and its tight editorial focus on high-quality gene and protein sci-
ence offer the opportunity to develop the sale of site licenses to companies and packages of on-line-
only journals to library consortia, particularly abroad. This new income stream supplements declining
revenue from traditional subscription sales. This program was very successful, resulting in ten new con-
tracts during the year with associated revenue of more than $200,000. Representation at the London
Online Conference resulted in several new leads for consortia and corporate clients abroad.
Total advertising sales in journals fell in 2002 by 30% compared with the previous year. Genome
Research was particularly affected by the economic downturn that hit genomics and bioinformatics
companies, many of which closed their doors for good; however, the gap was partly offset by improved
revenue from Protein Science, which rode a rising tide of commercial interest in proteomics. RNA sci-
ence is also in a growth phase, driven by the recent solution of the structure of the ribosome and the
discovery of RNA interference as a means of silencing genes, so there are encouraging revenue
prospects for the journal RNA in the coming year.
There is much current debate about the responsibility of publishers to make scientific information
more readily available. Centralized, free databases of published papers are important resources in this
respect. Cold Spring Harbor journal papers older than one year are already freely available at the jour-
nals' web sites, and in 2002, our Journal Production Department embarked on the unexpectedly
lengthy and technically complex process of depositing these papers in the PubMedCentral database
at the National Library of Medicine. This task is now expected to be completed early in 2003. The
Department survived an abrupt and complete change in personnel early in the year and is now man-
aged and staffed by experienced publishing professionals who have not only maintained impressive on-
time publishing schedules, but also successfully dealt with a number of innovations such as the han-
dling of digital artwork from authors, on-line manuscript submission and review, and the ability to pub-
lish papers on-line ahead of print.
Staff
The staff members of the Press (as of December 2002) are listed elsewhere in this volume. As always,
I am enormously grateful to all of them for the care, pride, and professionalism they bring to the work
they do. Publishing is the work of teams, and the achievements listed in this report are the product of
talented individuals willing to pool their skills for the benefit of the program as a whole.
Our spacious and comfortable offices on the Woodbury Campus, in which we celebrated our first
anniversary, house 40 of our staff members, with one other in our valuable office on the main campus
and another in our much used writing center, the Meier House on the Banbury Estate. Another three
staff members are in offices in San Diego, New Mexico, and Connecticut, and a further three in our
warehouse at Hauppauge.
In 2002, we welcomed seven new staff members: Debbie Banninger, Cindy Blaut, Melissa Frey,
Pauline Henick, Mary Mulligan, Linda Sussman, and Rita Wallace. We also bade farewell to Alison
Herlihy, Nora Ruth, Laurie Saukas, Michele Schoudel, and Peri Zeenkov.
Finally, I would like to emphasize the vital role that the senior staff of the Press play in this expand-
ing enterprise. Jan Argentine, Editorial Development Manager; Ingrid Benirschke, Marketing Manager;
Kathy Cirone, Circulation Manager; Kathryn Fitzpatrick, Marketing Manager; Nancy Hodson,
Operations Manager; Geraldine Jaitin, Customer Service Manager; Bill Keen, Finance Director; Guy
Keyes, Sales Manager; Marcie Siconolfi, Advertising Manager; Linda Sussman, Journal Production
Manager; Denise Weiss, Book Production Manager; the editors of our journals, Terri Grodzicker at
Genes & Development and Laurie Goodman at Genome Research; and Elizabeth Powers, Executive
Assistant. The Press and the Laboratory are fortunate to have these talented and dedicated individu-
als in key positions as a foundation for continued growth.
John R. Inglis
386
v "
FINANCE
FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2002
With comparative financial information for the year ended December 31, 2001
Assets: 2002 2001
Cash and cash equivalents $ 15,998,950 25,917,330
Accounts receivable:
Publications 1,507,910 2,070,714
Other 621,788 1,396,569
Grants receivable 5,155,499 5,194,624
Contributions receivable 4,485,178 6,681,094
Publications inventory 2,214,499 2,027,130
Prepaid expenses and other assets 1,630,366 2,436,437
Investments 174,146,179 185,947,777
Investment in employee residences 4,347,627 4,495,774
Restricted use asset 2,240,000 1,400,000
Land, buildings and equipment, net 108,416,078 108,104,940
Total assets $ 320,764,074 345,672,389
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 4,347,089 5,928,294
Notes payable 170,119 202,154
Bonds payable 45,200,000 45,200,000
Deferred revenue 3,648,453 2,615,372
Total liabilities 53,365,661 53,945,820
Net assets:
Unrestricted 154,939,682 170,584,179
Temporarily restricted 10,132,940 13,179,303
Permanently restricted 102,325,791 107,963,087
Total net assets 267,398,413 291,726,569
Total liabilities and net assets $ 320,764,074 345,672,389
CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2002
With comparative totals for the year ended December 31, 2001
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2002
Total
2001
Total
Revenue and other support:
Public support (contributions and
non-government grant awards) $ 11,374,015 10,077,203 3,605,790 25,057,008 22,251,408
Government grant awards 22,680,109 22,680,109 20,728,880
Indirect cost allowances 15,073,780 - 15,073,780 14,274,887
Program fees 2,910,787 - 2,910,787 2,677,232
Publications sales 9,050,738 9,050,738 9,940,567
Dining services 2,850,201 - 2,850,201 2,628,965
Rooms and apartments 2,222,483 2,222,483 1,890,226
Royalty and licensing fees 1,173,659 - 1,173,659 2,234,554
Investment income (interest and
dividends) 5,515,942 - 5,515,942 8,285,120
Miscellaneous 583,033 - 583,033 541,080
Total revenue 73,434,747 10,077,203 3,605,790 87,117,740 85,452,919
Net assets released from restrictions 13,123,566 (13,123,566)
Total revenue and other support 86,558,313 (3,046,363) 3,605,790 .-87,117,740 85,452,919
Expenses:
Research 42,240,020 42,240,020 39,464,156
Educational programs 12,105,086 - 12,105,086 11,490,571
Publications 9,345,581 9,345,581 9,800,811
Banbury Center conferences 1,141,308 - 1,141,308 1,026,037
Dolan DNA Learning Center programs 2,368,850 2,368,850 1,468,244
Watson School of Biological Sciences
programs 1,648,168 - - 1,648,168 1,104,729
General and administrative 10,562,264 - 10,562,264 9,739,917
Dining services 4,146,716 - - 4,146,716 3,551,730
Total expenses 83,557,993 - 83,557,993 77,646,195
Excess of revenue and other support
over expenses 3,000,320 (3,046,363) 3,605,790 3,559,747 7,806,724
Other changes in net assets:
Net (depreciation) appreciation in fair value
of investments
(18,644,817) (9,243,086) (27,887,903) (16,949,723)
(Decrease) increase in net assets (15,644,497) (3,046,363) (5,637,296) (24,328,156) (9,142,999)
Net assets at beginning of year 170,584,179 13,179,303 107,963,087 291,726,569 300,869,568
Net assets at end of year $ 154,939,682 10,132,940 102,325,791 267,398,413 291,726,569
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended December 31, 2002 and 2001
With comparative financial information for the year ended December 31, 2001
2002 2001
Cash flows from operating activities:
Decrease in net assets $ (24,328,156) (9,142,999)
Adjustments to reconcile (decrease) increase in net assets
to net cash provided by operating activities:
Depreciation and amortization 5,165,482 4,620,198
Net depreciation (appreciation) in fair value of investments 27,594,426 16,949,723
Contributions restricted for long-term investment (5,020,794) (7,504,820)
Restricted use asset (840,000) (1,400,000)
Changes in assets and liabilities:
Decrease (increase) in accounts receivable 1,337,585 (341,935)
Decrease (increase) in grants receivable 39,125 (1,542,261)
Decrease in contributions receivable 1,754,273 1,425,568
(Increase) decrease in publications inventory (187,369) 300,183
Decrease (increase) in prepaid expenses and other assets 806,071 (744,895)
Decrease in accounts payable and accrued expenses (1,581,205) (2,000,575)
Increase (decrease) in deferred revenue 1,033,081 (79,689)
Net cash provided by operating activities 5,772,519 538,498
Cash flows from investing activities:
Capital expenditures (5,476,620) (13,401,394)
Proceeds from sales and maturities of investments 185,039,464 58,387,861
Purchases of investments (200,832,291) (53,119,270)
Net change in investment in employee residences 148,147 (1,448,345)
Net cash used in investing activities (21,121,300) (9,581,148)
Cash flows from financing activities:
Permanently restricted contributions 3,605,790 1,421,839
Contributions restricted for investment in land, buildings,
and equipment 1,415,003 6,082,981
Decrease in contributions receivable 441,643 23,948
Repayment of notes payable (32,035) (25,778)
Net cash provided by financing activities 5,430,401 7,502,990
Net decrease in cash and cash equivalents (9,918,380) (1,539,660)
Cash and cash equivalents at beginning of year 25,917,330 27,456,990
Cash and cash equivalents at end of year 15,998,950 25,917,330
Supplemental disclosures
Interest paid $ 1,132,279 1,447,427
Noncash investing and financing activities:
Contributed property $ 840,000 1,400,000
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COMPARATIVE OPERATING HISTORY 1998-2002
(Dollars in Thousands)
1998 1999 2000 2001 2002
Revenue:
Main Lab:
Grants and contracts $ 24,025 27,179 30,345 34,716 37,872
Indirect cost allowances 11,054 11,207 12,718 14,134 14,987
Other 9,441 9,426 10,618 12,528 10,918
CSHL Press 6,341 6,400 8,684 9,941 9,051
Banbury Center 1,444 1,848 1,856 1,666 1,763
Dolan DNA Learning Center 1,334 1,392 1,471 1,878 2,978
Watson School of Biological Sciences - 218 682 927 1,496
Total revenue 53,639 57,670 66,374 75,790 79,065
Expenses:
Main Lab:
Research and training 24,025 27,179 30,345 34,716 37,872
Operation and maintenance of plant 5,549 5,765 6,589 7,027 8,661
General and administrative 3,378 3,844 6,162 6,492 6,395
Other 7,328 7,863 7,075 9,505 8,550
CSHL Press 6,141 6,077 8,186 9,515 8,962
Banbury Center 1,321 1,614 1,702 1,536 1,597
Dolan DNA Learning Center 1,228 1,280 1,362 1,801 2,780
Watson School of Biological Sciences 218 682 927 1,496
Total expenses, excluding depreciation
and amortization 48,970 53,840 62,103 71,519 76,313
Excess before depreciation, amortization
and designation of funds 4,669 3,830 4,271 4,271 2,752
Depreciation and amortization (3,443) (3,526) (3,974) (4,620) (5,165)
(Designation) release of funds (2) (750) (297) 349 1,848
Net operating excess (deficit) $ 476 304 (565)
(1)The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(2) Funds designated to underwrite future direct and indirect expenses of new research programs.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
DECEMBER 31, 2002
Corporate Contributions
and Grants Interest and
3.9% Miscellaneous
Auxiliary Activities 0.6% Royalty and Licensing
19.2% Fees
2.9%
Foundation and Private
--- Contributions and
Grants
20.5%
11\41111111111111141111111111
Endowments and Board
Designated Funds
12.1%
Federal Grants
40.8%
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the Federal Government and through grants, cap-
ital gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2002.
GRANTS January 1, 2002-December 31, 2002
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2002 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Dr. Lowe 04/01/02 03/31/03 393,302 *
Program Projects Dr. Herr 01/01/77 12/31/06 4,712,097 *
Dr. Stillman 08/01/87 07/31/05 3,633,903
Research Support Dr. Cline 12/06/95 11/30/04 745,769
Dr. Cline 03/01/98 03/31/06 509,098
Dr. Enikolopov 08/01/99 05/31/04 344,836
Dr. Enikolopov 09/12/94 11/30/03 409,907
Dr. Enikolopov 03/11/02 12/31/03 207,500
Dr. Grewal 03/01/00 02/28/05 268,800
Dr. Hannon 09/01/00 08/31/05 289,743
Dr. Hannon 03/01/01 02/28/03 166,000
Dr. Helfman 09/01/99 06/30/04 397,701
Dr. Hernandez 07/01/99 06/30/04 237,827
Dr. Herr 03/01/02 02/28/06 298,800 *
Dr. Hirano 07/01/01 06/30/05 351,623
Dr. Hirano 05/01/96 04/30/04 353,055
Dr. Huang 08/01/01 06/30/06 425,391
Dr. Joshua-Tor 05/01/01 03/31/06 443,500
Dr. Joshua-Tor 02/15/02 01/31/07 398,500 *
Dr. Joshua-Tor 08/01/96 11/30/04 249,216
Dr. Krainer 06/01/01 05/31/06 534,241
Dr. Lowe 07/01/99 06/30/04 334,902
Dr. Malinow 05/01/92 04/30/05 565,432
Dr. Malinow 04/01/95 02/28/03 419,634
Drs. McCombie/VVigler/Zhang 01/01/99 12/31/03 484,705
Dr. Neuwald 09/30/98 08/31/06 373,500
Dr. Skowronski 04/01/98 03/31/03 502,367
Dr. Spector 04/01/90 03/31/03 721,989
Dr. Stein 09/01/02 06/30/05 613,047 *
Dr. Stillman 07/01/91 05/31/04 536,168
Dr. Svoboda 12/01/98 11/30/03 406,883
Dr. Svoboda 12/01/02 11/30/07 326,523 *
Dr. Tonks 08/01/91 03/31/06 609,418
Dr. Tonks 05/01/97 06/30/05 348,600
Drs. Tully/Zhong 09/28/00 06/30/03 274,509
*New Grants Awarded in 2002.
'Includes Direct & Indirect Cost.
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Grantor Program/Principal Investigator Duration of Grant 2002 Funding*
Dr. Wig ler 09/30/02 07/31/04 166,000
Dr. Wig ler 05/01/99 07/31/03 996,358
Dr. Xu 08/01/01 07/31/05 303,219
Dr. Xu 01/01/98 12/31/02 311,754
Dr. Yin 09/30/02 07/31/04 166,000
Dr. Zhang 08/01/00 07/31/03 403,616
Dr. Zhang 09/30/97 08/31/03 641,728
Dr. Zhong 02/01/96 06/30/03 292,073
Fellowships E. Govek 05/01/01 04/30/03 24,766
Dr. Kuhlman 12/01/02 11/30/05 38,320 *
Dr. Lucito 06/01/02 05/31/07 114,280 "`
Dr. Ronemus 12/01/01 11/30/04 48,148
Training Support Dr. Helfman 09/01/84 12/31/03 303,114
Course Support Macromolecular Crystallography 09/01/00 08/31/05 51,223
C. elegans 08/01/98 07/31/06 63,937
Neurobiology Short-term Training 07/01/01 06/30/06 160,527
Cell and Developmental Biology of 04/01/93 03/31/04 18,974
Xenopus
Cancer Center Research Workshops 01/01/83 03/31/05 308,013
Acquiring and Analyzing Genomic 04/01/95 03/31/04 89,045
Sequence Data
In Situ Immunochemistry, In Situ 07/01/98 06/30/03 73,128
Hybridization, and Live Cell Imaging
Bioinformatics: Writing Software for 07/01/00 06/30/05 73,094
Genome Research
Making and Using DNA Microarrays 09/30/99 06/30/04 65,652
Meeting Support Zebrafish Development and Genetics 04/18/00 03/31/03 18,000
Axion Guidance and Neural Plasticity 06/01/00 05/30/05 26,468
Molecular Chaperones and the Heat 04/01/02 03/31/03 13,000 *
Shock Response
Evolution of Developmental Diversity 04/17/02 03/31/07 13,000 *
Molecular Genetics of Aging 06/01/02 05/31/03 23,241
Germ Cells 07/01/02 06/30/03 6,000 *
Mouse Molecular Genetics 07/12/02 06/30/07 17,438 *
Translational Control 07/05/02 06/30/07 8,000 *
Gene Expression and Signaling in the 04/19/02 03/31/07 2,000 *
Immune System
Cancer Genetics and Tumor Suppressor 08/07/00 07/31/05 15,000
Genes
The 67th Symposium: The Cardiovascular 05/15/01 04/30/06 5,000
System
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Cline 09/01/99 08/31/04 119,499
Dr. Helfman 02/01/99 01/31/04 115,202
Dr. Jackson 08/01/02 07/31/05 110,000 *
Dr. Jackson 10/01/01 09/30/06 131,263
Drs. Martienssen/McCombie/Stein/Lucito 09/01/01 08/31/05 490,077
Dr. Martienssen 10/01/01 09/30/06 136,489
Dr. Stein 09/01/02 08/31/04 297,412 *
Dr. Timmermans 07/01/02 06/30/05 116,471 *
New Grants Awarded in 2002.
*Includes Direct & Indirect Cost.
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Training Support Undergraduate Research Program 06/01/00 05/31/03 65,204
Course Support Advanced Bacterial Genetics 05/01/99 04/30/04 72,785
Arabidopsis Molecular Genetics 04/01/00 03/31/03 66,500
Cell and Development Biology of Xenopus 09/01/02 08/31/06 21,520 *
Meeting Support Evolution of Developmental Diversity 03/15/02 02/28/03 10,000 *
Molecular Genetics of Bacteria and 07/01/02 06/30/03 8,000 *
Phages
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/01 08/31/03 98,250
Drs. Martienssen/McCombie 09/01/01 09/30/03 250,000
Dr. Martienssen 12/01/00 11/30/03 85,000
Dr. Stein 09/01/00 08/31/04 849,094
Dr. Stein 09/15/00 09/14/04 255,264
Dr. Stein 10/01/02 09/30/04 220,000
Dr. Timmermans 09/01/01 08/31/03 65,960
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Conklin 09/30/02 09/29/05 161,216
Dr. Hannon 06/01/00 07/01/04 126,000
Dr. Hannon 04/01/02 03/31/06 801,448
Drs. Hannon/Lowe 09/01/02 08/31/05 166,000
Dr. Lazebnik 06/01/01 05/31/04 203,637
Dr. Van Aelst 09/01/01 08/31/03 167,000
Dr. Zhong 04/01/02 03/31/04 166,000
Fellowship Support M. Carmel! 05/01/02 04/30/05 22,000 *
Dr. Du 06/01/02 05/31/05 50,000
Dr. Hamaguchi 04/15/00 05/15/04 65,203
Dr. Hannon 06/01/00 05/31/04 80,858
Dr. Kannanganattu 01/01/01 12/31/03 44,622
Z. Nahle 07/01/02 06/30/05 22,000
Dr. Narita 07/01/01 06/30/04 51,247
Y. Seger 07/01/01 06/30/04 22,000
Dr. Silva 11/01/01 10/31/03 49,000
DEPARTMENT OF ENERGY
Meeting Support The 68th Symposium 09/01/02 08/31/03 15,000 *
MISCELLANEOUS GRANTS
Research Support
American Cancer Society Dr. Wig ler 01/01/96 12/31/03 10,000
American Cancer Society Dr. Wig ler 01/01/01 12/31/05 70,000
AKC Canine Health Foundation Drs. McCombie/Hannon 07/20/02 06/30/03 33,000 *
Babylon Breast Cancer Coalition Dr. Wig ler 12/01/02 12/31/03 10,000 *
*New Grants Awarded in 2002.
'Includes Direct & Indirect Cost.
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Michael Scott Barish Human Cancer Dr. Wig ler 01/01/02 12/31/02 66,010 *
Grant sponsored by the 1 in 9:
The Long Island Breast Cancer
Action Coalition
Breast Cancer Research Foundation Dr. Wig ler 10/01/00 09/30/03 1,000,000
The Charles Dana Foundation Siegel Fund for Cancer Pharmacogenomics 01/01/02 12/31/02 100,000
DARPA/NYU Consortium Agreement Drs. Wigler/Mittal 09/18/01 09/17/04 226,127
DOE/University of Arizona Consortium Drs. McCombie/Martienssen/Stein 09/15/02 09/14/03 36,742
Agreement
Ellison Medical Foundation Dr. Grewal 09/01/99 08/31/03 50,000
Forbeck Research Foundation Dr. Lowe 11/09/02 10/31/03 1,000 *
Fraxa Research Foundation Dr. Yin 05/01/02 04/30/03 50,000 *
Glen Cove CAR.E.S. Dr. Hamaguchi 04/01/02 03/31/03 25,000 *
Irving Hansen Foundation Dr. Tansey 08/01/02 07/31/03 20,000 *
Anya Hulbert/Matt Ridley Watson Archives 09/01/02 08/31/03 10,000 *
Helen Hoffritz Foundation Dr. Cline 12/01/96 01/31/03 30,000
Helicon Dr. Tully 07/01/02 06/30/03 168,000
Immuno-RX Dr. Mittal 08/01/02 07/31/04 205,903
Lehrman Trust Library Support 04/01/00 03/31/03 140,108
L.I.A.B.C. Long Islanders Against Dr. Wig ler 01/01/02 12/31/02 106,846
Breast Cancer
Long Beach Cancer Coalition Dr. Muth uswamy 09/01/02 08/31/03 2,500 *
Elizabeth McFarland Breast Cancer Dr. Wig ler 09/01/00 12/31/03 31,946
Research
McKnight Endowment Dr. Svoboda 08/01/02 07/31/04 100,000 *
Millennium Pharmaceuticals Dr. Lowe 10/02/02 10/01/03 20,000 *
Miracle Foundation Dr. Wig ler 04/01/02 03/31/03 100,000 *
Louis Morin Charitable Trust Drs. Joshua-Tor/Du bnau 01/01/00 11/30/03 151,917 *
The News Corporation Foundation Siegel Fund for Cancer Pharmacogenomics 01/01/02 12/31/02 100,000 *
NIH/Baylor College of Medicine Dr. Mills 09/01/01 08/31/06 208,113
Consortium Agreement
NIH/Cal Tech Consortium Agreement Dr. Stein 09/15/00 06/30/03 277,399
NIH/Cal Tech Consortium Agreement Dr. Stein 07/01/02 06/30/04 274,780 *
NIH/Cal Tech Consortium Agreement Dr. Stein 07/01/02 06/30/04 181,399 *
NIH/Columbia University Consortium Dr. Lowe 09/30/00 07/31/05 494,898
Agreement
NIH/Jackson Laboratory Consortium Dr. Stein 01/01/02 12/31/02 50,000
Agreement
NIH/Nanaprobes, Inc. Consortium Dr. Spector 09/01/02 02/28/03 15,770 *
Agreement
NIH/Northwestern University Dr. Spector 07/01/01 12/31/02 66,400
Consortium Agreement
NIH/SUNY-Downstate Medical School Dr. Yin 09/01/01 06/30/06 90,000
Consortium Agreement
NIH/Washington University Consortium Dr. Stein 03/01/99 10/31/03 45,348
Agreement
NIH/Washington University Consortium Dr. Stein 09/30/99 10/31/03 17,174
Agreement
NIH/UCSD Consortium Agreement Dr. Zhang 09/01/01 08/31/04 144,316
NSF/Rutgers University Consortium Drs. Spector/Martienssen 10/01/00 09/30/05 443,408
Agreement
NSF/University of Arizona Consortium Drs. McCombie/Martienssen/Stein 09/15/02 09/14/03 171,835 *
Agreement
NSF /SUNY- StonyBrook Consortium Dr. Jackson 09/01/02 08/31/04 190,004 *
Agreement
NSF/Yale University Consortium Drs. McCombie/Martienssen 09/15/01 09/14/03 49,690
Agreement
*New Grants Awarded in 2002.
*Includes Direct & Indirect Cost.
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NSF/University of Wisconsin Dr. Martienssen 09/01/00 08/31/05 239,131
Consortium Agreement
New York State Funds Library Support 07/01/02 06/30/03 4,409 *
NYSTAR/Mt. Sinai School of Medicine Dr. Svoboda 10/01/02 09/30/03 175,000 *
Consortium Agreement
NY Botanic Garden Plant Consortium Dr. McCombie 03/01/02 12/31/03 81,442
Mr. and Mrs. Edmond Nouri Dr. Tully 04/01/00 03/31/03 122,869
OSI Pharmaceuticals Dr. Hannon 10/21/02 10/20/03 1,000,000
OSI Pharmaceuticals Drs. Hannon/Mittal 10/21/02 10/20/05 450,000
The David and Lucille Packard Drs. Chklovskii/Mainen/Zador 07/01/01 06/30/04 421,496
Foundation
The Perkin Fund Women's Partnership For Science 06/01/02 05/31/04 37,500
Plainview/Oyster Bay Cancer Dr. Muthuswamy 09/01/02 08/31/03 7,000
Coalition
Rockefeller University Agreement Dr. Mills 09/01/02 08/31/03 67,413 *
SAIC-NCI Dr. Hannon 10/21/02 10/21/03 500,000 *
Ann and Herb Siegel Philanthropic Siegel Fund for Cancer Pharmacogenomics 01/01/00 11/30/03 300,000
Foundation
Starr Foundation Drs. Stillman/Hatchwell 06/01/02 05/31/03 316,393 *
Strauss Hawkins Foundation Drs. Brody/Zador 01/30/02 01/29/03 100,000 *
Sungene Plant Consortium Dr. Martienssen 07/01/00 06/30/05 135,000
Seraph Foundation Dr. Enikolopov 10/01/01 09/30/03 29,000
Tularik, Inc. Dr. Wig ler 11/01/97 10/31/03 660,000
Tularik, Inc. Dr. Wig ler 01/01/02 12/31/03 500,000
USDA/University of Arizona Drs. McCombie/Martienssen/Stein 09/15/02 09/14/03 171,830
Consortium Agreement
The V Foundation Dr. Muthuswamy 05/01/02 04/30/04 50,000 *
Westvaco Plant Consortium Dr. Martienssen 01/01/98 12/31/02 135,343
Whitehall Foundation, Inc. Dr. Huang 08/16/01 08/15/04 75,000
Zeneca Plant Consortium Dr. Martienssen 07/20/99 07/19/04 135,000
Fellowships
AACH Amgen Fellowship Dr. Wendel 07/01/02 06/30/03 30,000
American Cancer Society Dr. Hastings 01/01/00 12/31/02 34,000
Burroughs Wellcome Dr. Zito 09/01/02 08/31/03 58,000
CaP CURE Prostate Cancer Dr. Lucito 01/01/02 12/31/03 100,000
CSHL Association Funds Labwide Support 04/01/02 03/31/03 224,535
Cure Autism Now Dr. Takahashi 06/01/02 05/31/04 40,000
Deutsche Forschungsgemeinschaft Dr. Rumpel 11/01/02 10/31/04 28,176
(DFG)
Dorcas Cummings Memorial Fund Undergraduate Research Program 01/01/02 12/31/02 9,198
Epilepsy Foundation Dr. Haas 07/01/02 06/30/03 40,000
Eppley Foundation Dr. Huang 01/01/02 12/31/02 22,000
Goldring Fellowship Dr. Stillman 09/01/00 08/31/03 30,000
Helen Hay Whitney Foundation Dr. Zito 07/01/00 06/30/03 45,000
Dr. Karpova 07/01/02 06/30/03 41,000
Dr. Sheu 04/01/01 03/31/04 42,500
Howard Hughes Medical Institute Graduate Student Support 09/01/94 08/31/03 60,850
Human Frontier Science Program Dr. Ango 04/01/02 03/31/05 42,000
Organization (HFSPO) Dr. Bureau 10/01/01 09/30/03 42,000
Dr. lijima 04/26/02 04/25/04 42,000
Dr. Scheuss 09/01/02 08/31/05 42,000
Jane Coffin Childs Dr. Gillespie 07/01/02 06/30/03 40,500
Jephson Educational Trust Undergraduate Research Program 01/01/02 12/31/02 10,000
Johns Hopkins/Ellison Foundation Dr. Kass-Eisler 01/01/02 03/31/03 110,984
Consortium Agreement
*New Grants Awarded in 2002.
*Includes Direct & Indirect Cost.
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Ambassador Felix Schnyder Memorial Dr. Van Aelst 01/01/02 12/31/02 15,000 *
Fund, administered by The Lauri
Strauss Leukemia Foundation
The Leukemia & Lymphoma Society Dr. Duelli 12/31/00 12/30/03 35,000
Dr. Losada 07/01/01 06/30/04 50,000
Dr. Noma 07/01/02 06/30/05 40,000 *
Dr. Speck 07/01/01 06/30/04 40,000
The Leukemia & Lymphoma Society Dr. Tansey 07/01/01 06/30/06 100,000
Special Fellow Award
Life Science Research Foundation Dr. Samuel 01/01/02 05/31/03 58,142
Maxfield Foundation Dr. Lazebnik 12/01/00 11/30/03 5,000
NARSAD Dr. Haas 07/01/02 06/30/04 30,000
Dr. Barria-Roman 07/01/02 06/30/04 30,000
Pew Charitable Trust Dr. Huang 07/01/02 06/30/06 60,000
Rita Allen Foundation Dr. Hannon 10/01/00 09/30/03 50,000
Searle Scholars Program Dr. Mainen 07/01/01 06/30/04 80,000
SUNY-Stony Brook Training Grant Dr. L. Zhang 2001 2002 38,154
Wellcome Trust Dr. Akerman 10/01/01 09/30/03 29,513
Wellcome Trust Dr. Newey 10/01/01 09/30/03 26,306
Course Support
Eppley Foundation Stem Cell 04/01/02 12/31/02 34,870 *
Eppley Foundation Human Neurological Diseases 06/01/02 12/31/02 23,750 *
Esther A. & Joseph Klingenstein Neuro Course Support 03/01/02 02/28/05 50,000 *
Fund, Inc.
Merck & Co, Inc. Developmental Disabilities in Children 04/01/01 03/31/03 46,192
Howard Hughes Medical Institute Advanced Neurobiology Courses 01/01/91 12/31/03 330,000
Meeting Support
Alfred P. Sloan DNA Jubilee 06/01/02 03/31/03 25,000
Dana Foundation DNA Jubilee 10/01/02 09/30/03 100,000
March of Dimes Germ Cells 04/01/02 03/31/03 5,000
Alzheimer's Association Heat Shock 01/01/02 12/31/02 2,000
Merck & Co, Inc. Heat Shock 01/01/02 12/31/02 1,000
Invitrogen Life Technologies Heat Shock 01/01/02 12/31/02 2,000
Medical & Biological Laboratories, Heat Shock 01/01/02 12/31/02 1,000
Inc. Ltd.
Lalor Foundation Germ Cells 09/01/00 08/31/03 7,250
*New Grants Awarded in 2002.
'Includes Direct & Indirect Cost.
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BANBURY CENTER
Grantor Program/Principal Investigator
Duration
of Grant 2002 Funding'
FEDERAL SUPPORT
NIH-National Human Genome
Research Institute
National Institute of Justice of the
U.S. Department of Justice
NIH-National Institute of Mental
Health and National Institute
of Child Health and Human
Development (through a grant
to the University of Illinois, Urbana)
National Science Foundation
(through a grant to New York
University)
U.S. Department of Energy
(NNSA, CNBP)
NONFEDERAL SUPPORT
Meeting Support
Amyotrophic Lateral Disease
Association
Bill and Melinda Gates Foundation
(through a grant to Albert B. Sabin
Vaccine Institute, Inc.)
Howard Hughes Medical Institute
Howard Hughes Medical Institute
Huntington's Disease Society
of America
ICF Ventures
Herbert J. Siegel Fund for
Cancer Pharmacogenomics
WADA Health, Medical and
Research Committee
Yamanouchi USA Foundation
*New Grants Awarded in 2002.
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American Eugenics and the New Biology: 2002 $33,099
Perspectives and Parallels
Microbial Forensics 2002 30,000
RNA Metabolism and the Fragile X Syndrome 2002 32,752 *
Designer Molecules for Biosensor Applications
Microbial Forensics
Neurodegenerative Disease Models: From
Pathogenesis to Therapeutics
Global Vaccine Shortage: The Threat to
Children and What to do About It
2002
2002
2002
19,208
10,000
19,894
2002 28,224
DNA Interactive Advisory Panel 2002 20,921
DNA Interactive Advisory Panel, 2002 21,381
Second Meeting
Neurodegenerative Disease Models: 2002
From Pathogenesis to Therapeutics
Phage Therapy-Potential and Challenges 2002
A Critical Review of Melanoma- 2002 34,607
Biology and Therapy
Genetic Enhancement of Athletic
Performance
Glucocorticoid Regulatory 2002 41,825
Mechanisms and Pathophysiology
19,894 *
50,000 *
2002 39,619 *
DOLAN DNA LEARNING CENTER
Grantor
FEDERAL GRANTS
National Institutes of Health
ELSI Research Program
National Institutes of Health
NONFEDERAL GRANTS
Howard Hughes Medical Institute
Howard Hughes Medical Institute
Josiah Macy, Jr. Foundation
Pfizer Foundation
Program/Principal Investigator Duration of Grant 2002 Funding.'
Creation of a Digital Image Archive
on the American Eugenics Movement
Creation of Inside Cancer
Precollege Science Education Initiative
for Biomedical Research Institutions
DNA Interactive Education Program
DNA from the Beginning
Leadership Institute in Human and
Molecular Genetics
03/98-03/03
01/01-12/03
09/99-08/03
01/02-12/02
10/97-09/02
01/02-12/02
The following schools each awarded a grant for the Genetics as a Model for Whole Learning Program:
$ 183,660
274,051
149,664
951,932
215,251
69,618
Bay Shore Union Free School District $1,000 Massapequa Union Free School District 1,650
Bellmore-Merrick Central High School District 5,300 North Bellmore Union Free School District 1,000
Brooklyn District #17 1,400 Northport-East Northport Union Free School District 6,160
Buckley Country Day School 365 North Shore Hebrew Academy 700
Commack Union Free School District 425 Old Westbury School of the Holy Child 2,115
East Meadow Union Free School District 4,780 Oyster Bay-East Norwich Central School District 2,592
East Williston Union Free School District 1,680 Port Washington Union Free School District 10,275
Elmont Union Free School District 500 Progressive School of Long Island 300
Elwood Union Free School District 3,235 Queens Community School District #29 33,375
Farmingdale Union Free School District 980 Rockville Centre Union Free School District 5,210
Garden City Union Free School District 6,075 Saint Aidan School 250
Great Neck Union Free School District 7,225 Saint Anne School 350
Green Vale School 1,180 Saint Dominic Elementary School 3,500
Half Hollow Hills Central School District 4,900 Saint Edward School 2,025
Harborfields Central School District 9,595 Saint Savior School 350
Herricks Union Free School District 1,125 South Huntington Union Free School District 12,650
Holy Family Regional School 250 Syosset Central School District 21,075
Jericho Union Free School District 5,800 Three Village Central School District 750
Lawrence Union Free School District 6,480 United Nations School 500
Locust Valley Central School District 16,125 Whitby School 250
Lynbrook Union Free School District 500 Yeshiva Darchei Torah 250
Mamaroneck Central School District 2,800
The following schools each awarded a grant for Curriculum Study:
Bellmore-Merrick Central High School District 1,100 Long Beach City School District 1,100
Bethpage Union Free School District 1,100 Massapequa Union Free School District 2,200
Commack Union Free School District 1,100 North Shore Central School District 2,200
Elwood Union Free School District 1,100 North Shore Hebrew Academy High School 2,000
Fordham Preparatory School 2,000 Oceanside Union Free School District 1,100
Great Neck Union Free School District 1,100 Oyster Bay-East Norwich Central School District 2,200
Green Vale School 1,100 Plainedge Union Free School District 1,100
Harborfields Central School District 2,200 Plainview-Old Bethpage Central School District 2,200
Island Trees Union Free School District 1,100 Port ledge School 1,100
Jericho Union Free School District 1,100 Port Washington Union Free School District 1,100
Kings Park Central School District 2,000 Roslyn Union Free School District 1,100
Lawrence Union Free School District 2,200 Sachem Central School District 1,100
Levittown Union Free School District 1,100 South Huntington Union Free School District 1,100
Locust Valley Central School District 1,100
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INSTITUTIONAL ADVANCEMENT
It is a pleasure to acknowledge the philanthropy of the many thoughtful people who are increasing the
pace of biomedical discovery at Cold Spring Harbor Laboratory. With the fruits of the human genome
project in hand, the challenge to control cancer is no longer theoretical or technical, but financial. It is
private funding that makes the difference and stimulates breakthrough science.
The gifts reported here will help to control cancer, increase our understanding of neurological disor-
ders, and assure the education of the next generation of scientific leaders. Private gifts fund the inno-
vation in molecular biology that characterizes the advanced education and research at Cold Spring
Harbor Laboratory.
We deeply appreciate such commitment to the best science for a better life.
Rod Miller, Vice President for Institutional Advancement
Cold Spring Harbor Laboratory is a nonprofit research and educational institution, chartered by the
State of New York. Less than half of the Laboratory's annual revenues are derived from Federal grants
and contracts, and thus, we rely heavily on support from the private sector: foundations, corporations,
and individuals. Contributions from the private sector are tax-exempt under the provisions of Section
501(0(3) of the Internal Revenue Code. In addition, the Laboratory is designated a "public charity" and,
therefore, is enabled to receive funds resulting from the termination of "private foundations."
Foundations, corporations, and individuals can give to Cold Spring Harbor through a variety of
methods:
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker.
Appreciated securities should be given outright, which will avoid capital gains taxes on the appreci-
ated value. Securities that have decreased in value should be sold, and the proceeds donated. In this
way, a donor will receive a deduction for both the loss and the charitable contribution.
Life Insurance: You may designate the Cold Spring Harbor Laboratory as the beneficiary of an exist-
ing or new policy, or irrevocably assign ownership of the policy. There are estate tax benefits in either
case. If ownership is assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive investment and
tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such donations;
the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to extent, tim-
ing, and tax needs.
Bequests: Designating Cold Spring Harbor Laboratory as beneficiary ensures that a bequest will be
utilized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be done by cre-
ating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the private foun-
dation are accounted for as a separate fund and used for the purposes specified by the donor.
Alternatively, the private foundation can be established as a supporting organization of Cold Spring
Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or the Watson
School of Biological Sciences. Please check with your employer to augment your gift.
For additional information, please contact the Office of the Vice President for Institutional Advancement, Cold Spring
Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6858.
CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 2002-December 31, 2002
Contributions of $5,000 and above, exclusive of Annual Fund
In 2002, Cold Spring Harbor Laboratory received significant support in the form of capital, program,
and gifts-in-kind contributions from individuals, foundations, and corporations.
Rita Allen Foundation, Inc.
Arrow Electronics
Babylon Breast Cancer Coalition
The Michael Scott Barish Human Cancer Grant
sponsored by 1 in 9: The Long Island
Breast Cancer Action Coalition
Benjamin Development Co.
Mr. William Braden
The Breast Cancer Research Foundation*
Gladys Brooks Foundation
Cambrex Corporation
CaP CURE
The Charles A. Dana Foundation
Mr. and Mrs. Charles E Dolan
Ellison Medical Foundation
The Eppley Foundation for Research
Forest Laboratories, Inc.
Mr. Robert B. Gardner, Jr.
Genzyme Corporation
Glen Cove C.A.R.E.S.
The Lillian Goldman Charitable Trust
Goldring Family Foundation
Mr. and Mrs. John S. Grace
Irving A. Hansen Memorial Foundation
The William A. Haseltine Foundation
Jeff Hawkins and Janet L. Strauss
Human Genome Sciences, Inc.
Dr. Anya Huriburt and Dr. Matt Ridley
Mary Woodard Lasker Charitable Trust
The Lehrman Institute
Estate of Elisabeth Sloan Livingston
Long Islanders Against Breast Cancer
(L.I.A.B.C.)
Richard Lounsbery Foundation
Marks Family Foundation
G. Harold and Leila Y. Mathers Charitable
Foundation
The Maxfield Foundation
Breast Cancer Awareness Day in memory of
Elizabeth McFarland
The Miracle Foundation
Louis Morin Charitable Trust
The News Corporation Foundation
Mr. and Mrs. Edmond J. Nouri
David and Lucile Packard Foundation
Peninsula Community Foundation
The Perkin Fund*
Pew Charitable Trust
Plainview-Old Bethpage Breast Cancer
Coalition
William Townsend Porter Foundation
William E. and Maude S. Pritchard Charitable
Trust
Mr. and Mrs. John R. Reese
The Seraph Foundation
Ann L. and Herbert J. Siegel Philanthropic
Fund
Alfred P. Sloan Foundation
The Starr Foundation
Lauri Strauss Leukemia Foundation
The Times Mirror Foundation
Tularik, Inc.
The V Foundation*
Dr. and Mrs. James D. Watson
The Whitehall Foundation
Total $8,407,076.94
New Pledges Awarded in 2002.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
CAPITAL CAMPAIGN
January 1, 2002-December 31, 2002
Contributions and pledges, exclusive of Annual Fund
The Watson School of Biological Sciences at Cold Spring Harbor Laboratory was established in 1998
to provide graduate education in the biological sciences at the Ph.D. level. The mission of the doctor-
al program is for students to gain extensive knowledge in biology through a combined research and
education experience, with strong guidance from the faculty, and to complete the program in approx-
imately four years. This accelerated program is designed to increase the number of highly skilled biol-
ogists available to apply the wealth of data from the human genome.
In its fourth year, the Watson School matriculated 6 additional students, bringing the total number
to 26. In 2002, the Watson School received significant support from individuals, foundations, trusts,
and corporations.
Purpose Donor
Arnold and Mabel Beckman Arnold and Mabel Beckman Foundation
Graduate Studentship
Core Course Arnold and Mabel Beckman Foundation
Dean's Chair Annenberg Foundation
Lita Annenberg Hazen Foundation
Fellowships Bristol-Myers Squibb Company
The Charles A. Dana Foundation
Mr. and Mrs. Alan E. Goldberg
William Randolph Hearst Foundation
Mr. and Mrs. David H. Koch
Mr. and Mrs. Robert D. Lindsay and Family
Estate of Elisabeth Sloan Livingston
The Miller Family Foundation
Lectureships Mr. and Mrs. George Cutting
The William Stamps Farish Fund"
Florence Gould Foundation
Joy and George Rathmann/The Rathmann Family Foundation
Ziering Family Foundation
Visiting Lectureship Dr. and Mrs. Mark Ptashne
The Watson Fund for Anonymous
Innovative Graduate The William H. Donner Foundation
Education The David and Lucile Packard Foundation
The Seraph Foundation
The G. Unger Vetelsen Foundation
Mark and Karen Zoller
Total $5,766,654
*New Pledges Awarded in 2002.
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
In 2001, a significant change was made to the structure of the Corporate Sponsor Program with the
introduction of a new category, Corporate Benefactor. This category is intended for the very large phar-
maceutical companies that have, over the years, been formed by the amalgamation of companies
which were each a Corporate Sponsor. Pfizer Inc., which was about to merge with Warner Lambert,
was the founding member of this group. We are delighted that no fewer than five companies followed
Pfizer's example in 2002. These companies are Aventis Pharma AG; Bristol-Myers Squibb Company;
GlaxoSmithKline; Eli Lilly and Company; Novartis Pharma AG; and Pfizer Inc. This support from some
of the largest pharmaceutical companies made a most significant contribution to the Program.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for 16 representatives of the Corporate Benefactors and 8 representatives of
the Corporate Sponsors at our meetings. In 2002, Corporate Sponsors could select from 20 meetings
in Grace Auditorium. Of these scientists, Benefactors and Sponsors may send six and three, respec-
tively, to meetings at Banbury Center, where attendance is otherwise only by invitation. Member com-
panies receive gratis copies of Cold Spring Harbor Laboratory Press publications including the journals
Genes & Development, Learning & Memory Protein Science, and Genome Research. Our Sponsors
are acknowledged in all relevant publications, including the books of abstracts given to each of the
7000 participants who come to the meetings each year. The names of the sponsoring companies are
listed on the poster describing the meetings, and this is mailed to approximately 20,000 scientists
throughout the world. In addition, the companies are listed on Cold Spring Harbor Laboratory Web
Sites-those of the Meetings Office and Banbury Center.
The Corporate Sponsor Program continues to be critical to the vigorous meetings program held at
Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory campus or at the
Banbury Center. Only with the strong foundation provided by the program can we plan with confidence
for the year's meetings and introduce new and unusual topics. We are, then, very grateful to all of the
companies that joined us in 2002, and they are listed below.
CORPORATE BENEFACTORS
Aventis Pharma AG Glaxo SmithKline Novartis Pharma AG
Bristol-Myers Squibb Company Eli Lilly and Company Pfizer Inc.
CORPORATE SPONSORS
Abbott Laboratories Diagnostic Products Corporation New England BioLabs, Inc.
Amersham Biosciences, Inc. Forest Laboratories, Inc. OSI Pharmaceuticals, Inc.
Amgen Inc. Genentech, Inc. Pall Corporation
Applied Biosystems Hoffmann-La Roche Inc. Pharmacia Corporation
AstraZeneca Johnson & Johnson Pharmaceutical Research Res Gen, Inc.
BioVentures, Inc. & Development, L.L.C. Schering-Plough Research Institute
Chugai Pharmaceutical Co., Ltd. Kyowa Hakko Kogyo Co., Ltd. Wyeth Genetics Institute
Cogene BioTech Ventures, Ltd. Merck Research Laboratories
CORPORATE CONTRIBUTORS
Bingen, Inc. Integrated DNA Technologies, Inc. Prolinx, Inc.
Epicentre Technology Invitrogen Qbiogene
Key Gene Lexicon Genetics, Inc. ZymoGenetics, Inc.
ImmunoRx
PLANT CORPORATE ASSOCIATES
Mead Westvaco Corporation
Monsanto Company
Pioneer Hi-Bred International, Inc.
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
Total $1,036,000
CORPORATE AFFILIATES
Affymetrix, Inc
Ceptyr, Inc.
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Dolan DNALC Corporate Advisory Board Annual Fund
The Corporate Advisory Board, established in 1992, serves the Dolan DNA Learning Center as a liai-
son to the corporate community and assists in securing unrestricted support. As a means of raising
support and awareness, the Corporate Advisory Board conducts the annual Golf Tournament and the
Annual Fund.
Chairman: Edward A. Chernoff, Motors & Armatures, Inc.
Vice Chairman: Christiaan B. Reynolds, McLagan Partners
CSHL Trustee Liaison: Arthur M. Spiro
Michael Aboff, Aboff's Inc.
Brett Ashley, Cole Communications
Rocco S. Barrese, Dilworth & Barrese
Thomas J. Calabrese, Daniel Gale Agency
Richard A. Catalano, KPMG LLP
Robert E. Diller, Brinkmann Instruments, Inc./
Eppendorf AG
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business Products
Centre
Arthur D. Herman, Herman Development Corp.
ANNUAL FUND CONTRIBUTIONS
GENOME SUPPORTERS
Contributions of $10,000 or more
Mr. Edward A. Chernoff, Motors & Armatures,
Inc.
Luitpold Pharmaceuticals, Inc.
CHROMOSOME SUPPORTERS
Contributions of $5,000 or more
Laurie J. Landeau, V.M.D.
Newsday
051 Pharmaceuticals, Inc.
GENE SUPPORTERS
Contributions of $2,500 or more
Daniel Gale Agency
EXON SUPPORTERS
Contributions of $1,000 or more
Aboff's, Inc.
Mr. and Mrs. G. Morgan Browne
Harweb Foundation
Mr. Arthur D. Herman
Mr. and Mrs. George A. Roche
Mr. and Mrs. William D. Roche
The Schiff Foundation
Grace and Bruce Stillman
Mr. and Mrs. Robert Zeisel
INTRON SUPPORTERS
Contributions of $500 or more
All Pro Carpet Co., Inc.
Ms. Rosemary Bourne
Epstein, Becker & Green, P.C.
Fleet
Dr. and Mrs. Candido E. Fuentes-Felix
Landscapes by Jeffco, Inc.
Mr. and Mrs. Andrew McNeill
Reckson Operating Partnership, LP
Mrs. Wendy Vander Poel Russell
The Tilles Family Foundation
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John C. Kean III, Kean Development Company
Laurie J. Landeau, V.M.D.
Ralf A. Lange, Luitpold Pharmaceuticals, Inc.
John J. Leahy, Citibank, N.A.
Lilo Leeds, Institute for Student Achievement
James E. Mattutat, ACI Capital Co., Inc.
Patricia Petersen, Daniel Gale Agency
William D. Roche
Wendy Vander Poel Russell, CSHL Honorary
Trustee
Horst Saalbach, Ph.D., Festo Corp.
TRIPLE CODON SUPPORTERS
Contributions of $250 or more
Mr. Lawrence B. Benenson
Mr. and Mrs. Michael Boylan
D. Reis Furniture Manufacturing Corp.
Dr. and Mrs. Thomas J. Dowling, Jr.
Dunetz Marcus, LLC
The First National Bank of Long Island
Dr. and Mrs. Steven Goldberg
Huntington Hills Center for Health & Rehab
Kaufman & Moomjian, LLC
Sutton & Edwards, Inc.
NUCLEOTIDE PAIR SUPPORTERS
Contributions of $100 or more
Mr. and Mrs. Adnan Akant
Drs. John Amodio and Eileen Fontanetta
Apo Life, Inc.
Mr. Ashish Bakshi
Dr. and Mrs. Pierre R. Beaubrun
Mr. and Mm. Frank D. Bossert
Mr. and Mrs. Steven Corwin
Dr. and Mrs. Burke A. Cunha
D. & J. People's Centennial House, Inc.
Mr. Thomas Debow
Mr. Scott Feldman
Mr. and Mrs. J. Paul Gitlin
Haft, Dougherty & Connell, CPA's
Mr. and Mrs. Warren J. Herman
Dr. Magdalen Hull
Dr. Nabil idly
Mr. and Mrs. Richard Kniffn
Mr. and Mrs. Brajesh Kothari
Mr. Warren B. Lane
Candido and Irene N. Llovera
Mr. Glen Malings
Mr. and Mm. Matthew Mallgrave
Mr. Kevin McCarthy
Ms. Victoria Meagher
Meldon- Silverman Agency, Inc.
Mr. and Mrs. Rod Miller
Mojave Therapeutics
Mr. and Mrs. Donald Morrongiello
Total $132,176.75
Peter G. Schiff, Northwood Ventures LLC
Charles R. Schueler, Cablevision Systems Corp.
Dixie Scovel, Newsday
Kevin Seeley, Ph.D., Pall Corp.
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of New
York
Robert Van Nostrand, OSI Pharmaceuticals, Inc.
Frederick Volp, Ph.D., CSH Central School
District
William N. Wham, ISC Inc.
Muro Pharmaceutical, Inc.
Therese and Gary Nielsen
Mr. and Mm. Luis Paniagua
Mr. and Mrs. Ronald A. Peterson
Mr. and Mrs. John Pufahl
Mr. and Mm. Thomas Reimels
Rubin & Rothman, LLC
Mr. and Mrs. Marc Schafler
Dr. and Mrs. Haresh Shah
Mr. and Mrs. Michael J. Spahn
Mr. David E. Strahl
Mr. and Mrs. Thomas Tucker
NUCLEOTIDE SUPPORTER
Contributions of $50 or more
Mr. Carl J. Becker
Ms. Amy Braden
Mr. Paul Blanz
Mr. and Mrs. Emile Chang
Ms. May-Loo Dai
Mr. John Debellis and Ms. Christina Jackowski
Dr. Francine Falco
Dr. Michael Gaffney
Ms. Jennifer Giwa-Folkes
Mr. and Mrs. Daniel A. Golub
Mr. and Mrs. Robert H. Holthausen
Mr. Al Horowitz
Mr. and Mrs. Valdemar Jacobsen
Mr. James R. Jankowski
Dr. and Mrs. Alan S. Katz
Dr. and Mrs. Jay Kugler
Mr. Joel Lamm
Mm. Mary Lou Lysaght
Mr. and Mrs. Richard MacDougall
Mr. and Mrs. James Murphy
Mr. Charlie Prizzi
Mr. and Mrs. Jeremy B. Rawitz
Mr. and Mrs. Anthony J. Sabino
Dr. and Mrs. Robert Schortz
Ms. Dorothy Schumejda
Mr. and Mrs. Jeffrey Stern
Dr. Krishnaiyer Subramani
Mr. and Mrs. Gerald C. Wen
Mr. and Mrs. Dennis Whitley
NINTH ANNUAL GOLF TOURNAMENT SPONSORS
FOUNDING TOURNAMENT SPONSOR
J.P. Morgan Chase & Co.
MAJOR CORPORATE SPONSORS
Cablevision Systems Corp.
Fortunato Sons, Inc.
Luitpold Pharmaceuticals, Inc.
Marsh USA, Inc.
Motors & Armatures, Inc.
Quick & Reilly/Fleet Securities, Inc.
CORPORATE SPONSOR
Badge Agency, Inc.
HOLE-IN-ONE SPONSORS
Badge Agency, Inc.
Competition BMW of Smithtown
REGISTRATION TABLE SPONSOR
U.S. Trust Company of New York
PUTTING GREEN SPONSORS
Jack Berleth & Sons Inc.
Daniel Gale Agency
GOLD PACKAGE SPONSORS
Aetna U.S. Healthcare
All-Pro Carpet
Barnes & Noble College Bookstores, Inc.
Brinkmann Instruments, Inc. /Eppendorf AG
Brownstone Agency, Inc.
Ciardullo Landscapes & Designs Inc.
Citibank, N.A.
Corte' Business Systems, Inc.
Daniel Gale Agency Inc.
Davis & Gilbert LLP
Dilworth & Barrese
Arthur Herman
Huntington Business Products Centre
ISC, Incorporated
Kean Development Co., Inc.
KPMG LLP
Luitpold Pharmaceuticals, Inc.
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo
Northwood Ventures
OSI Pharmaceuticals, Inc.
Bernard F. Reynolds
Christiaan B. Reynolds
Total
Rivkin Radler LLP
Alan Seligson
U.S. Trust Company of New York
SILVER PACKAGE SPONSORS
Advantage Title
Bee, Eisman & Ready
Thomas Calabrese
The Hartford
John Passarelli
State Bank of Long Island
BRONZE PACKAGE SPONSORS
Aboff's, Inc.
Burt Building Materials
Callan, Koster, Brady & Brennan LLP
Lawrence Feldman
Lawrence Goodman
Bradley J. Marsh, DPM
Peter Marsh
Andrew Martens
James E. Mattutat
Jack Ross
TEE/GREEN SPONSORS
Electronix Systems
Candido E. Fuentes-Felix, M.D., FA.C.S.
Jostens
Long Island Power Authority
The Sheridan Press
GOLF CART SPONSORS
A Partymaker, Inc.
Corrigan Custom Carpentry
Lewisy Fuel Oil
Andrew Martone
RAFFLE AND LIVE AUCTION
SPONSORS
Aboff's
Aix en-Provence
Brett Ashley
Audio Command Systems
Barney's Restaurant
Broadway Cares/Equity Fights AIDS
Bryant & Cooper Steakhouse
Buon Appetito Gourmet Market
Edward A. Chernoff
$131,335.97
Total Dolan DNALC Annual Fund
Chez Ma Tante
Paul Czeladnicki
Danfords on the Sound
Foxwoods Resort & Casino
Candido E. Fuentes-Felix, M.D., FA.C.S.
Halesite Deli
Gordon S. Hargraves
Huntington Business Products Centre
Huntington Hilton
Lilo and Gerard Leeds
Marquis Wines & Spirits
Mr. and Mrs. James E. Mattutat
Meritage Restaurant
Mill River Inn
Monet Salon & Day Spa
New York Islanders
New York Mets
Piccolo Restaurant of Huntington
The Quick Family
Christiaan B. Reynolds
Ruvo Restaurant & Bar
Scarsella's
Sharp Electronics
St. Andrews Restaurant
Tease Restaurant
Tilles Center for the Performing Arts
Village Travel
Winebow
FAVOR BAG SUPPLIERS
Citibank
Daniel Gale Agency
Enoteca Castello
Huntington Business Products Centre
Newsday
United Healthcare
GOLF CHAIRMAN
James E, Mattutat
AUCTIONEER
Francis Wahlgren, Senior Vice President,
Christie's
THANK YOU
Howard M. Blankman
Cold Spring Harbor Laboratory volunteers
Dolan DNA Learning Center volunteers
Piping Rock Club staff
$263,512.72
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Cold Spring Harbor Laboratory Association (CSHLA)
Officers
David H. Deming, President
Trudy H. Calabrese, First Vice President
John S. Grace, Vice President
Joseph T. Donohue, Treasurer
Cathy Cyphers Soref, Secretary
Directors
David L. Banker Allen D. Jebsen Ann C. Seifert
George W. Cutting, Jr. Alan M. Kisner, M.D. Susan Sheeline
Frances N. Elder Mary Alice Kolodner Cynthia R. Stebbins
Lori Garofalo Michael S. O'Brien Bruce Stillman, Ph.D.
Robert A. Gay Gilbert R. Ott, Jr. Richard Torrenzano
William F. Gerry Lawrence Remmel Marjorie von Stade
Lynn M. Gray Henry Salzhauer James D. Watson, Ph.D.
Susan Ho llo
Honorary Directors
John P. Cleary, Esq.
Mary D. Lindsay
Anne R. Meier
Association President's Report
2002 was another active year for our Association. Community outreach went particularly well, with
close to 100 new members joining. Unrestricted funding for our most creative young researchers
remained strong despite the lackluster economy.
Thanks to our generous supporters, the Laboratory continues to provide some of the top postdoc-
toral researchers in the world with opportunities to pursue highly unique avenues of investigation, rather
than serving as assistants in established laboratories. This year, our Association members raised
$790,729.51 for our Annual Fund, ensuring that this important Cold Spring Harbor Laboratory tradition
endures.
Leadership is key to the Association. We welcomed David Banker, Lori Garofalo, and Richard
Torrenzano as new Directors. Our most sincere thanks for exceptional outreach and genuine enthusi-
asm for the Laboratory during their tenures went to retiring Directors Nicholas Bartilucci, Robin Hadley,
and Eileen Pulling.
Our February 4 Annual Meeting was followed by a delicious, heart-healthy dinner based on recipes
from our engaging featured lecturer, Dr. Walter C. Willett, Professor of Epidemiology and Nutrition and
Chairman of the Department of Nutrition at Harvard School of Public Health, and Professor of Medicine
at Harvard Medical School. Much of Dr. Willett's work focuses on dietary determinants of heart disease
and cancer, the subject of his recent book, Eat, Drink and Be Healthy: The Harvard Medical School
Guide to Healthy Eating.
The annual Jazz at the Lab fundraiser on April 13 was an even greater financial success than last
year. Featuring the classic jazz greats-Joe Bushkin on piano, Harry Allen on tenor sax, John Allred on
trombone, Bob Merrill on trumpet, and Bucky Pizzarelli on guitar-the evening will long be remembered
by guests who enjoyed a night of world-class jazz, preserved, as in 2001, on a CD. The concert was
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Mary Beth Donohue, Bill Sheeline, Mary Lindsay, Cora Michalis at Jazz at the Lab.
followed by a delicious buffet dinner and a vibrant late-set performance. Special thanks for a beautiful-
ly organized and creative evening go to Committee co-chairs Mary Beth and Joe Donohue and Lisa
and Gil Ott, and the Underwriting co-chairs, Susan and Mark Ho llo, Susan and Bill Sheeline, Ginny and
David Knott, and Cathy and Doug Soref. The evening's financial success was due primarily to the gen-
erosity of our Jazz 2002 Underwriters, listed below:
Premier Underwriters
Mr. and Mrs. David H. Deming
Mr. and Mrs. Charles F Dolan
Mr. and Mrs. Joseph T. Donohue
Mr. and Mrs. Stephen Garofalo-
Garofalo Foundation, Inc.
Lead Underwriters
Mr. and Mrs. John Barry
Mr. and Mrs. Timothy Broadbent
Mr. and Mrs. G. Morgan Browne
Mr. and Mrs. Elliot Conway
Mr. and Mrs. George W. Cutting,
Mr. and Mrs. Daniel C. de Roulet
Mr. and Mrs. Thomas Dooley
Mr. and Mrs. Jack Grace
Mr. and Mrs. Austen T. Gray, Jr.
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
Litwin Foundation
Mrs. Robin T. Hadley Mr. Harold L. Rosenberg and
Mr. and Mrs. Mark G. Ho llo Dr. Laurie Sayet Rosenberg
Mr. and Mrs. David M. Knott Mr. and Mrs. Douglas Soref
Mr. and Mrs. Eduardo Mestre Mr. and Mrs. James Stebbins
Mr. and Mrs. Clarence Michalis
Mr. and Mrs. Gonzalo M. Mocorrea
Mr. and Mrs. Barry Newburger
Mr. and Mrs. Matt O'Connell
Jr. Pall Corporation
Mr. and Mrs. Howard Phipps
Mrs. Judith R. Pournaras
Ms. Lisa Puntillo and
Mr. Robert Pascucci
Mr. and Mrs. Hollis Russell
The Salzhauer Family
Mr. and Mrs. Mr. and Mrs. Peter
Schiff-The Schiff Foundation
Mr. and Mrs. William Sheeline
Dr. and Mrs. Bruce Stillman
Mr. and Mrs. Roland Tatzel
Mr. and Mrs. Walter C. Teagle
Mr. and Mrs. Peter TillesThe
Tilles Family Foundation
Dr. and Mrs. James D. Watson
Mr. and Mrs. Fred Wilpon
Mr. and Mrs. Bernard Yatauro
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Special events expanded this year to include a new and very successful annual science fair for local
first graders from the Goose Hill School. Lots of input and organization from our own science teacher
Director, Mary Alice Kolodner, made for a day that was a real hit with the children. Our young scien-
tists, many of whom are supported by the annual fund, used the opportunity to hone their "explana-
tion" skills to show our young neighbors exactly what it is that scientists do.
The Dorcas Cummings Lecture was held on June 2, 2002. Our guest speaker, Dr. Richard Lifton of
the Yale University School of Medicine, Department of Genetics, fascinated the audience with his dis-
cussion on "Salt and Blood Pressure: New Insights from Human Genetic Studies." Thanks to the yeo-
man outreach efforts and organizational saavy of co-chairs, Lynn Gray and Cynthia Stebbins, 27 terrif-
ic dinner parties followed the lecture. A very special thank you to the friends in our community who
generously hosted these dinners, welcoming into their homes visiting scientists from around the coun-
try world, our own Lab scientists, and friends.
Mr. and Mrs. M. Farrag Ahmed
Mr. and Mrs. W. Dillaway Ayres, Jr.
Ms. Lenore Blair
Dr. and Mrs. Gerald X. Brogan, Jr.
Mr. and Mrs. Thomas J. Calabrese
Mr. and Mrs. John P. Cleary
Mr. and Mrs. Norris Darrell
Mr. and Mrs. Robert A. Gay
Mr. and Mrs. Edward H. Gerry
Mr. and Mrs. John S. Grace
Mr. and Mrs. Austen T. Gray, Jr.
Dr. and Mrs. Gordon S. Hargraves
Dr. and Mrs. Alan M. Kisner
Mr. and Mrs. Michael L Kolodner
Mr. and Mrs. David L. Luke III
Mr. and Mrs. Edmond J. Nouri
Mr. and Mrs. Robert O'Connor
Mr. and Mrs. Gilbert R. Ott, Jr.
Mr. and Mrs. Robert A. Pilkington
Mr. and Mrs. James L Pirtle
Mr. and Mrs. Henry E. Salzhauer
Mr. and Mrs. Owen T. Smith
Mr. and Mrs. Douglas Soref
Dr. and Mrs. John C. Stevenson
Mr. and Mrs. Thomas R.
Vandeventer
Dr. and Mrs. Gary I. Wad ler
Mr. and Mrs. Robert P. Walton
My wife Jamie and I enjoyed hosting the Partnership Picnic for Lab scientists and their neighbor-
hood "partners" on Sunday September 22. The balmy weather and blue skies set the tone for a relaxed
and sociable afternoon. Mary Beth and Joe Donohue graciously offered to host our Major Donor party
on October 26. We were intrigued to learn from Senthil Muthuswamy, our featured scientific speaker,
about his latest breast cancer research findings. There could be no better setting than the elegant com-
fort of the Donohue's living room to learn how our Association annual fund supports research that
seeks to understand the causes of breast cancer.
The third annual Biotechnology Luncheon on November 21 was sponsored once again by the U.S.
Trust Company at their attractive 47th Street offices. Guest speakers Dr. Emilio Emini, Senior Vice
President of Vaccine and Biologics Research, Merck Laboratories, and Dr. John Inglis, Executive
Director of the Cold Spring Harbor Laboratory Press addressed the topic, "Staying Alive: Fighting
HIV/AIDS." Dr. Emini shed some light on a Merck AIDS vaccine currently in clinical trials, and Dr. Inglis
discussed his fascinating trip to South Africa this summer where he and collaborators distributed near-
ly 20,000 copies the CSHL Press's children's book about AIDS prevention. Association Director Larry
Remmel is largely responsible for filling every seat in the house for this enlightening, information-packed
luncheon.
David H. Deming
President
Members of the Cold Spring Harbor Association
ANGELS
Contributors of $10,000 and above
Roger and Lori Bahnik
The Albert C. Bostwick Foundation
Mr. William Braden
Mr. and Mrs. Richard Cashin
Mr. and Mrs. David H. Deming
Robert B. Gardner, Jr.
Lori and Stephen Garofalo
Mr. Robert D. Goldfarb
Mrs. Oliver R. Grace
Lynn and Austen Gray
Mr. and Mrs. Charles E. Han-is
Mary D. Lindsay
Mr. and Mrs. David L. Luke III
Mrs. William L. Matheson
Dr. and Mrs. Walter a Meier
Gillian and Eduardo Mestre
Mr. and Mrs. William R. Miller
Mr. and Mrs. Douglas Morris
Mr. and Mrs. Charles Murcott
The Howard Phipps Foundation-
Mrs. and Mrs. Howard Phipps, Jr.
& Mr. and Mrs. Constantine
Sidamon-Eristoff
The Dorothy Schiff Foundation
Mrs. Helen Grace Spencer
Dr. and Mrs. James D. Watson
The Alex J. Weinstein Foundation, Inc.
BENEFACTORS
Contributions of $5,000 or more
Mr. and Mrs. W. DillaWay Ayr., Jr.
Helen M. Brooks
Mrand
Clarkson Family Foundation/ Bayard
and Virginia Clarkson
The Craigmyle Foundation
Mr. and Mrs. Norris Darrell, Jr.
Mr. and Mrs. Edward H. Gerry
Mr. and Mrs. Oliver R. Grace, Jr.
Michael Griffin and Joyce Bertoldo
Robin T Hadley
The Korein Foundation
Mr. John MacBain
Robert L. Marcus
Mr. and Mrs. James F. Stebbins
Mr. and Mrs. Philip R. von Stade
PATRONS
Contributions of $2,500 or more
Abby and George O'Neill Trust
Mr. and Mrs. Robert H.B. Baldwin
Marion S. Bannard
The Richard A. and Amelia
Bernstein Foundation, Inc.
Mr. and Mrs. Peter B. Cannell
Mr. and Mrs. John P. Cleary
George W. Cutting
The William Ewing Foundation
Mr. and Mrs. Robert W. Fagiola
Mr. and Mrs. Robert A. Gay
Mr. and Mrs. William F. Gerry
Mr. and Mrs. Barclay Jones
Mr. and Mrs. Townsend J. Knight
Mr. and Mrs. Clarence F. Michalis
Mr. and Mrs. Keith M. Moffat
Nastech Pharmaceutical
Norwood Foundation, Inc./The
Bancroft Families
Quality 1keg Dist., Inc./Ruth Nussdorf
John and Joyce Phelan
Mrs. Richardson Pratt, Jr.
Mr. and Mrs. Preston V. Pumphrey
John and Hope Reese
Nita Soref
Grace and Bruce Stillman
Till. Family Foundation
Mr. and Mrs. Douglas A. Warner III
Young President's Organization
ASSOCIATES
Contributions of $1,000 or more
Anonymous
Robert H. Arnow
David L Banker
Mr. and Mrs. Nicholas J. Bartilucci
Mr. Edmund Bartlett
Liz and Rod Berens
Pam and Gene Bernstein
Allen and Jane Boorstein
Mr. and Mrs. Hans E.R. Bosch
Dr. David Botstein and Dr. Renee Fitts
Lisa and Tim Broadbent
Mrs. Jackson Burke
Mr. and Mrs. Thomas J. Calabrese, Jr.
Mr. and Mrs. Vincent F. Carosella
Robert B. Catell
Phyllis and Leon Charash
Harry and Mary Ann Chariston
Mrs. Thomas H. Choate
Mr. and Mrs. David C. Clark
Mrs. Robert L Clarkson, Jr.
Mr. and Mrs. John H. Coleman
Mr. and Mrs. Richard T. Cunniff
Mr. and Mrs. Curtis Cushman
Peter and Comelia Dagher
Mr. and Mrs. Guy L. de Chazal
Mr. and Mrs. Daniel de Roulet
Mr. and Mrs. Donald L. Deming
Mr. and Mrs. Joseph T. Donohue
Dr. Lester Dubnick
Mr. and Mrs. William T. Dunn
Mr. and Mrs. Patrik L Edsparr
Mrs. James A. Eisenman
Mrs. Duncan Elder
Johnston and Lisa Evans
Robert and Marjorie Feeney
E.M. Geddes, Jr.
Mr. and Mrs. Edward M. Giles
Mr. and Mrs. John S. Grace
Mr. and Mrs. Frank Hanan
Mr. and Mrs. Gordon S. Hargraves
Henry U. Harris, Jr.
Mr. Richard Hazlewood
Mr. and Mrs. Landon Hilliard III
Mrs. Albert L. Hoffman
Christopher and Cathy Hogg
Frederic B. Ingraham
Frank and Elizabeth Ingrassia
Karches Foundation
Jeffrey Keller and Dolores Fredrich
Kipp-Stawski Group
Andrea B. and Peter D. Klein
Mr. and Mrs. Michael L Kolodner
Mr. and Mrs. Abraham Krasnoff
Mr. and Mrs. Gordon F. Lamb
Mr. Edward M. Lamont
Mr. and Mrs. James M. Large, Jr.
Lois A. Lenahan
Leo Model Foundation, Inc.
Eugene and Shirley Levitt
Mrs. Georgie W. Lewis
Mr. and Mrs. Robert D. Lindsay and
Family
David M. Livingston, M.D.
Luke D. Lynch, Jr.
Dr. Egon Mayer and Dr. Marcia
Kramer Mayer
The General William Mayer
Foundation-Mr. and Mrs. Gerald
M. Mayer, Jr.
Mr. and Mrs. Prakash Melwani
Mr. and Mrs. Francis W. Murray
Mr. and Mrs. William J. Nammack
Carol R. Noyes
Mr. and Mrs. Michael S. O'Brien
Howard and JoAnne Olian
Mrs. and Mrs. Gerald D. Olin
The Anthony and Claire Pace
Foundation Inc.
Dr. David B. Pall
Mr. and Mrs. Edward L. Palmer
Mr and Mrs. Nicholas B. Paumgarten
Mr. and Mrs. Robert A. Pilkington
Mr. Jay C. Plourde
Mr. and Mrs. Richard I. Purnell
Mr. and Mrs. Lawrence Remmel
Daryl and Steven Roth
Richard and Pamela Rubinstein
Mr. and Mrs. J. Wright Rumbough
Wendy Vander Poel Russell
Salzhauer Family Fund
Mr. and Mrs. Thomas L. Seifert
Mr. and Mrs. Enrique F. Senior
Herbert A. Slater
Mr. and Mrs. Owen T Smith
The Christopher D. Smithers
Foundation
Mr. and Mrs. Douglas S. Soref
Mr. Jeffrey B. Soref
Mr. and Mrs. James L. Spingarn
Robert and Cornelia Spring
Mr. and Mrs. Erwin P. Staller
Shirley Steers
Judith and Irwin Tantleff
Mr. and Mrs. Roland Tatzel
Mr. and Mrs. Pascal Franchot Tone
Mr. and Mrs. Stanley S. Trotman, Jr.
Universal Music Group
Drs. Scott Ratner and Marjorie Van
de Stouwe
Mrs. Martin Victor
Walter B. James Fund #2
Katharine B. Whipple
Mr. Gerald I. White
Alec Wildenstein
Judy and Fred Wilpon Family
Foundation
Mayer Wolf
NEIGHBORS
Contributions of $500 or more
Mr. and Mrs. Richard Aurelio
Mr. and Mrs. Frederick Baum
Rosemary Bourne
Mr. and Mrs. William J. Candee III
Mr. Christopher R. Castroviejo
Eleanor Chernick, Ed.D.
Mr. James W. Cleary
Donna and Barry Cosel-Pieper
Rosamond A. Dean
James and Sophie Donaldson
Mr. Martin Elias
Fort Hill Animal Hospital
Mr. and Mrs. Roger Fradin
Mr. and Mrs. Charles S. Gay
Elbridge T Gerry, Jr.
Helen and Monte Getler
Mr. Lawrence Graev
William and Dora Grover
Mr. and Mrs. Harold W. Hawkey
lmowitz, Koenig & Co., LLP
Miani Johnson
Mr. and Mrs. Jeffrey Keifer
Mr. and Mrs. John Klingenstein
Mr. and Mrs. Ragnar M. Knutsen
Mr. and Mrs. Robert V Lindsay
George N. Lindsay, Jr. and Nancy
Metz
Mr. Norman Liss
Mrs. Mary A. Littauer
Jane N.P. Mallinson
Mr. and Mrs. William B. Matteson
Stacey and Isidore Mayrock
Ms. Thomasina Michalik and Mr.
Joe Heynoaet
Kim Anh and Jeffrey H. Miller
Mr. and Mrs. John P. Morgan II
Matt & Libby O'Connell
Martha M. Osterhus
Mr. and Mrs. Gilbert R. Ott, Jr
Mr. and Mrs. Philip F. Palmedo
Mrs. Ellmore C. Patterson
Mm. Sterling Pile
Mr. and Mrs. Richard F. Powers III
Mr. and Mrs. Robert Rimsky
Gloria and Marvin Sharfin
Deborah K. Solbert
Mr. and Mrs. Howard Simpson
Mrs. Sherwood Waldron
Philip Bonanno and Dorothy Whalen
Mrs. T Scudder Winslow
FRIENDS
Contributions of $300 or more
Albrecht, Viggiano, Zureck & Co., P.C.
Mr. and Mrs. Edward H. Auchincloss
Henry and Erica Babcock
Ted and Rebecca Bahr
Bancker Construction Corp.
Marcia and Douglas Bateson
Mrs. George de B. Bell
John and Diane Berejka
William L. Bernhard
Mr. John C. Bierwirth
Mr. and Mrs. Peter H. Blohm
Gloria and Sed Browne
Mr. and Mrs. Ward C. Campbell
Dr. and Mrs. Walter Carpenter
Mr and Mrs. Gilbert W. Chapman, Jr
Mr. and Mrs. Miner D. Crary, Jr.
John and Elizabeth DePasquale
Nancy and Kostas Douzinas
Mayor E. R. Dro.ch
Mr. and Mrs. William Everdell
Mr. and Mrs. John Ferrari
William C. Gay, Jr.
Joseph L. Goldstein, M.D.
Mr. and Mrs. Melvin Heller
Jonathan Holtz-Holtz Family
Foundation
Arline and William Jacobs
Dm. Barbara B. Knowles and Davor
Softer
Mr. and Mrs. Thomas A. Leon
Mr. and Mrs. Mario Lipari
Mr. Barry Utes and Ms. Leigh A.
Hutchinson
Candido and Irene N. Llovera
Cynthia Johnson MacKay
Elliot Mayrock
William H. Miller
George M. Milne
George G. Montgomery, Jr.
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Mrs. Gloria S. Mooney
Lisa and Roger Mullarkey
Li li and John Noesen
Mr. and Mrs. Frank J. Olt, Jr.
Mr. and Mrs. James Pirtle
Mr. and Mrs. Richard C. Pisano, Jr.
Francis and Richard Powers
George C. Pratt
Rita and Bill Quinlan
Susan Rose & Mary Vince
Sharon and Marvin Schechter
Steven and Eileen Schlussel
Joseph Martin Schor
Sequa Corporation
John and Pat Sheehy
Dr. and Mrs. Peter W. Sherwood
Dr. and Mrs. Walter Shropshire, Jr.
Mary and Robert Sibert
Mr. and Mrs. Paul Stallings
Drs. Joan and Thomas Steitz
Dr. and Mrs. John C. Stevenson
Claire and Keshav Talwar
Elizabeth F. Wadsworth
Mr. and Mrs. Thomas J. Walsh
Heidi Wang
Winifred I. Warner
Lisa and Lewis Warren
Douglas Williams
Charles Yanofsky
BASIC
Contributions of $100 or more
Anonymous (2)
Action Remediation Co., Inc.
Bruce Alberts
Mr. and Mrs. Charles 0. Ames
Mr. and Mrs. Prescott Ammarell
Drs. H.W and S.R. Andersen
Jean E. Andersen
Carl and Mary Anderson
Mr. and Mrs. J. Bryan Anthony
Mrs. S. Reed Anthony
Richard and Donna Appell
Richard T. Azar and Diane McGaw
Ms. Diane Bachor
Marion and Jens Bakke
Mr. and Mrs. John Barry
Mr. and Mrs. Anthony B. Barton
Fred and Caroline Ba77ini
Mr. and Mrs. Robert E. Benson
Paul and Carol Bentel
Peter J. Bergen
Dr. Barbara Bergman
Marjorie M. Bhavnani
William Binnian
Bladykas Engineering P.C.
Mary Lenore Blair
Graeme B. Bolger
Maria L. Brisbane
Mr. and Mrs. Charles A. Brisbane
Dr. and Mrs. Gerard X. Brogan, Jr.
Mrs. Catherine Brown
Mr. and Dr. Douglas W. Brown
Ms. Roberta Brown, CSA
Richard and Vicki Browne
Mr. and Mrs. James L. Brundige
Anne and Jacques Busquet
Dr. Charles Buntschuh and Ms.
Joan Ca ly
Ms. Eve M. Califano
Mr. John Casa ly and Ms. Louise
Parent
W.J. Catacosinos/Laurel Hill Capital
Partners, LLC
Mrs. Jean Cattier
Michael and Maureen Chalos
Mr. and Mrs. Robert Clark
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Mr. Kevin N. Clowe
Peter B. Colgrove and Ann J. Miles
C.E. Colley
Ruth Ashby and Ernesto Colon
Maryda S. Colowick
Mr. and Mrs. Leonard J. Connolly
Dr. and Mrs. Joseph Conolly
Mr. and Mrs. Elliot S. Conway
Mr. Donald Cook
Mrs. Ann B. Copeland
Dr. John Coraor and Dr. Hanna
Nekvasil
Cord Meyer Development Company
Mr. Richard L. Cosnotti and the Rev.
Sharon C. Bledsoe
Douglas Craig
Robert L. Cummings III
Daniel Gale Agency
Drs. Michael and Carol Dannenberg
Ms. Katya Davey
Lawrence L. Davis
Mr. and Mrs. Daniel P. Davison
Mrs. Vincent de Roulet
Mr. Robert B. Deans, Jr.
Mr. and Mrs. Mark DeGennaro
Jenice Delano
Edward F. Del Foe III
Mr. and Mrs. William R. Dens low, Jr.
Alfred M. Derrow, M.D.
Suzanne V. Dillenbeck
Thomas L. Dillmann
Dr. Robert Ditkoff and Mrs. Andi
Emerson-Ditkoff
Mr. and Mrs. Charles F. Dolan
Mr. and Mrs. Thomas E. Dooley
John R. Drexel IV
Eileen and Chuck Dubroff
Julie C. Eichenberger
Stephen Ely
Dr. and Mrs. N. Dennis Eryou
Bonnie M. Ewing
Mr. and Mrs. John Falk
Mr. Sidney Farkas
Mr. and Mrs. Frank Feinberg
J. Barry Ferguson
Lucy and Pete Fetterolf
Noah and Risa Finkel
Mr. and Mrs. Paul Forchelli
Julia Fredericks
Mr. and Mrs. Elizabeth and David
Fuchs
Mr. Charles R. Gabalis
Mr. and Mrs. D. Kent Gale
Clarence E. Galston
Dr. Sam Gandy
Dr. Martin Gellert
Roger and Edith Gerber
Mr. Hugh Jay Gershon
Dr. and Mrs. Stephen Gettinger
The Reverend and Mrs. Paul E. Gilbert
Dr. Morton D. Glantz
Will and Maxine Glenn
Gondelman Foundation
Hope T. Goodwin
George Gorelick
Charles and Janet Goulding
Mr. and Mrs. Howard E. Grace
Mrs. Margaret F. Grace
Mr. and Mrs. Jack Grace
Dr. and Mrs. Raymond B. Griffiths
Hamilton, Levy, Miller & Company, Inc.
Mrs. Moss Hart
Mrs. Chester Hartenstein
Mr. Khalid and Dr. Souhad Hassan
Oliver Hazard
Huyler C. Held
Mr. and Mrs. Michael R. Held
Susy and David J. Helme
Anthony S. Hendrick
Dr. and Mrs. Stephen M. Hershowitz
Charles A. Hickmann
Mr. and Mrs. Charles R. Holcomb
Mr. and Mrs. Mark G. Hollo
Ms. Nancy H. Holmes
Mr. Jerome Holoubek
Mr. and Mrs. Mark Hopkinson
Mary Jo and George Hossfeld
George H. Howard
Shiu-Lok Hu
Charles and Elizabeth Hubbard
Ellen Hull
Philip and Gretchen Hull
Mr. and Mrs. Rudolf Hunermund
Jitka and Pavel Illner
Mr. and Mrs. Herbert S. Ingham
Mr. and Mrs. Valdemar F. Jacobsen
Stuart and Kathleen James
Mr. and Mrs. John Jennings
Ms Ruth Grace Jervis
Polly Stover Kahn
Sandra and Howard Kane
Bonnie J. Kansler
Mr. and Mrs. Morris I. Karpen
Mary and John Kean
Mr. and Mrs. Jawaid M. Khan
Dr. and Mrs. Alan M. Kisner
Mr. and Mrs. David M. Knott
Magdalene and Harry P. Koumas
Mr. and Mrs. Warren G. Kraft
Albert and Helga Kramen
Bernice and Gerald Landau
Doris and Howard Landau
Mrs. John W. Lapsley
Mrs. Leslie S. Learned
Pamela T. LeBoutillier
Mr. and Mrs. Anthony V. Leness
Charles and Beth Levinthal
Frank and Maureen Liantonio
Mr. and Mrs. Thomas Lieber
Martin and Sylvia Lipnik
The Litwin Foundation, Inc.
Dr. Fred Lobovsky
Mr. and Mrs. Alan J. Long
Mr. and Mrs. John B. LoRusso
Dr. and Mrs. Richard Losick
Mary Anne Lubanko
Mr. and Mrs. Robert Luckey
Janet I. Maclnnes
Mr. and Mrs. Patrick H. Mackay
Wilfred G. Mackey
Mr. Sayre MacLeod III
Sid Margolis
Joseph and Mary Ann Marriott
William H. Mathers
Barbara and Angus McIntyre
Mr. Randall P. McIntyre
Linda H. McLaughlin
Mary H. McLaughlin
Mr. and Mrs. Gregory McMahon
Mrs. Irving Meltzer
Mr. Todd L. Mendik
Mr. and Mrs. Wm A. Milanese
Mr. and Mrs. Rod Miller
Kunihiko Miura
Mr. and Mrs. Gonzalo M. Mocorrea
Lawrence B. Mogen, D.D.S.
Mr. and Mrs. Walter Mondschein
Mr. E Warren Moore
Valerie Wilson Morris
Charles and Jane Morton
Mrs. Harriet Moser
Gisela Mosig
Mr. and Mrs. Brent Mowery
Tess Mullarkey
Elizabeth B. Munier
Drs. Elisa and Chris Muran
Rem and Marion Myers
Mr. and Mrs. Barry P Newburger
Mrs. William Niven
Mr. and Mrs. Stanley U. North, Jr.
Mr. and Mrs. David C. Noyes
Mr. and Mrs. Robert O'Connor
Mr. and Mrs. Francis E. O'Connor
Ms. Sandy Oringer
Innis O'Rourke, Jr.
Barry M. Osborn
Mr. and Mrs. Robert C. Palermo
Pall Corporation
Mr. Robert Pascucci and Ms. Lisa
Puntillo
Mr. and Mrs. Howard Phipps III
Sarah Plimpton
David P. Pearson
Dr. and Mrs. Nathaniel Peirce
Mr. and Mrs. Peter J. Pell
Cecily and Paul Pennoyer
Mr. and Mrs. John R. Pflug
Kathy and Peter Picoli
Mr. and Mrs. Stuyvesant Pierrepont
Judge and Mrs. Thomas C. Platt
Mr. Graham L. Platt
Barbara S. Powers
LouRae and Cap Powers
M. Wynona Powers
Katie Raftery
Ms. Judith R. Rand
Mr. and Mrs. Daren A. Rathkopf
Gerry Redmond
Frances Stevens Reese
Cornelius J. Reid, Jr.
Elizabeth Reilley
Mr. and Mrs. Charles J. Reina
Bernard J. Reverdin
The Richard Foundation/
Mr. and Mrs. Harold B. Richard
Francis and Patricia Roberts
Doug and Kathy Robinson
Mr. and Mrs. Samuel B. Rogers
Mr. Harold L. Rosenberg and Dr.
Laurie Sayet Rosenberg
Mr. and Mrs. Ron Rosman
Stanley and Harriet Roth
Mr. and Mrs. Michael Campbell
Rowland
Dr. and Mrs. Emanuel J. Rubin
Mr. and Mrs. Hollis F Russell
Mr. Edward S. Ruthazer and Ms.
Shiho Kanamaru
Murray and Gloria Safran
Dr. Marilyn Moffat Salant
Patricia P. Sands
Phyllis Satz
Ms. Carol Scal
Julia C. Schieffelin
The Schiff Foundation
Mrs. Charles J. Schuster
Mr. and Mrs. John E. Schwartzberg
Ann Scolnick and Bernard Musso
Jane Seymour
Dr. and Mrs. George J. Sheehan
Mr. and Mrs. William E. Sheeline
Dr. and Mrs. Edward M. Shepard
Col. and Mrs. Robert E. Sheridan
Mr. Irwin Sicherman, O.D.
Mr. John D. Simpson
Mrs. William C. Simpson
Maxine Singer
Mr. and Mrs. C. Arthur Smith, Jr.
Mr. and Mrs. John C. Smith
Mr. and Mrs. Stan Smith
Mr. and Mrs. Theodore B. Smith, Jr.
Mrs. Adele Smithers-Fornaci
James and Joan Sommermeyer
Norman and Alice Sorenson
Jackie and Hal Spielman Joan R Tilney Mr. and Mrs. Colton R Wagner Wellington, Jr.
Mr. and Mrs. Dennis A. Spink Stanford W. Ting Dr. and Mrs. Peter F.R. Walker Mr. and Mrs. John E. Welsh III
Mr. and Mrs. James Stewart Mr. and Mrs. Godfrey G. Truslow Margo Geer Walker Mr. and Mrs. Robert L. Wendt
Mr. William M. Stiger Alan and Ann Tucker Mr. and Mrs. Robert R Walton Westminster Publications, Inc.
Janice and Hyman Strell Cornelius and Barbara Ulman Mr. Thomas J. Ward Mr. and Mrs. Peter White
Mr. and Mrs. Brian E. Swiggett Jourdan B. Urbach Charles W.B. Wardell, Jr. Mary Louise Whitmarsh
Jim and Kathleen Szymanski Mrs. Luis E. Uribe Mr. and Mrs. Warren T Wasp Mrs. John C. Wilmerding
John W. Taylor Mrs. Beverly S. VanderPoel Stephen H. Wafters Catherine Bostwick Wilson
Mrs. David S. Taylor Dr. and Mrs. Thornton Vandersall Richard and Janina Weghorn Eckard Wimmer
Dudley B. Tenney Dr. and Mrs. E. Verlander Mr. and Mrs. L.B. Wehle, Jr. Mr. and Mrs. Frederick C. Witsell, Jr.
Anne M. Thomas N. & I. Vetsch Mr. and Mrs. David Weinstein Mrs. Gordon R. Wright
Mr. and Mrs. Edward M. Thomas Mr. and Mrs. Joseph C. Viviani Ms. Judy Weiss and Mr. Jack Keith R. Yamamoto
Ms. Adaire M. Thompson Arthur and Hattie Vogel Zucker Mr. and Mrs. Bernard Yatauro
Three Harbors Garden Club Mr. and Mrs. Donald Vogel Mr. and Mm. W. Perry Welch Mr. Clarence K. Yutkowitz
Mr. and Mrs. George H. Tilghman Gary and Nancy Wad ler Mr. and Mrs. Herbert G. Joan C. Zulch
CSHLA CORPORATE AND FOUNDATION MATCHING CONTRIBUTORS
Bristol-Myers Squibb Foundation, Inc.
General Electric Fund
Green Point Financial
iStar Financial, Inc.
CSHLA Annual Fund
Merrill Lynch Co. Foundation, Inc.
Oppenheimer Funds, Inc.
Pfizer Matching Gift Center
CSHLA Membership and Other Support
The J.P. Morgan Chase Foundation
Union Pacific Corporation
United Way of Long Island
Angels, Benefactors, Patrons, Associates $ 646,556.37
Friends, Basic $ 110,592.97
Other (Jazz, Nonmember Gifts, Honor/Memorial) $ 33,580.17
Total $790,729.51
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Mr. Esteban Araya Ms. Ginger Hahn Ms. Mary Anne Lubanko Mr. Joseph F. Sartori
Mr. and Mrs. Richard A. Baker Mrs. Roberta A. Harned Mrs. William E. Mahoney Dr. Abraham L. Schaffer
Ms. Barbara P. Ball Mr. and Mrs. Thomas M. Hearn Mr. and Mrs. John A. Mangano Edward M. Selfe
Mr. Mark Bloomfield, Esq. Dr. and Mrs. Stephen M. Mr. and Mrs. Robert M. McLane Mrs. William Shelton
Mr. and Mrs. Thomas L. Britt Hershowitz Mr. and Mrs. Innis O'Rourke, Jr. Mr. and Mrs. Herbert L. Smith III
Ms. Hope Flaherty Cooper Ms. Sara L. Heskins Ms. Judith A. Paul Mr. Edward C. Steele
Mr. and Mrs. Donato M. Diorio Ms. Virginia L. Hlavac John G. Peterkin Ms. Judith Steers
Mr. and Mrs. John F Ducey, Jr. Mr. and Mrs. George J. Hossfeld Mrs. Corinne Richards Mr. and Mrs. C. Champe Taliaferro
Mrs. Christopher Elkus Mr. and Mrs. Waldo Hutchins III Mr. and Mrs. Alan S. Rosenberg Mr. and Mrs. Thomas E. Uhl
Mr. Charles Eschmann, Jr. Mr. and Mrs. Albert Kalimian Mrs. Miriam K. Rothenberg Mrs. Cathie B. Wardell
Mr. Arthur K. Feldman, Esq. Mr. and Mrs. Andrew S. Kanrich Mr. and Mrs. J. Wright Rumbough Mr. and Mrs. Mark Watkins
Ms. Karin M. Fiore Mr. and Mrs. Mark Katz Mrs. Wendy Vander Poel Russell Mr. Jason Weinger
Mr. and Mrs. Irwin Frish Mr. Stephen E. Kaufman, Esq. Mr. and Mrs. Edward S. Sacks Mr. and Mm. Frederick C. Witsell, Jr.
Mr. Robert B. Gardner, Jr. Lackey Realty Ms. Frances Sall Donald H. Wolmer, M.D.
Ms. Barbara Greenhut-Rosen M.J. LaViano & Sons, Inc. Sam-Jon Corp.
IN MEMORY OF
Eva Amder
Naomi Antonoff
Jules W. Aubry
Jack De Gaetano
James Eisenman
Elisa Fiore
Robert P Fisher
Lucy Franke
Oscar Hasse
Alton Ara Hovnanian
Jake Jagoda
Katherine Koury
Diane Krouse
Annie Krumholtz
Brother Peter Lawrence
Robley Logan
William Matheson
Elizabeth McFarland
Mr. and Mrs. DeWitt Peterkin, Jr.
Jack Richards
Elizabeth Rouss
Nora Schmidt
Ralph C. Scudder
Bill and Gene Senglaub
Donald J. Sutherland
IN HONOR OF
Karen Berger
Joan Berman
Dr. and Mrs. Clinton G. Bush III
John and Rita Cleary
Eric and Michelle Frank
John and Lola Grace
Wendy VanderPoel Russell
Mr. And Mrs. Henry Shatkin
James Spingarn
Len Taubenblatt
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President's Council
The President's Council was formed nine years ago to bring together leaders from business, research,
and biotechnology who share an interest in science and Cold Spring Harbor Laboratory's research.
President's Council members contribute $25,000 or more annually to support the Laboratory's Cold
Spring Harbor Fellows-exceptional young Ph.D.s and M.D.s who are making great strides toward
independent and important research. The 2001 meeting took place on May 17 and 18 and explored
the topic Human Instincts and Evolutionary Psychology. Our presenting scientists were engaging
speakers and leaders in their field: famed science writer Dr. Matt Ridley, Dr. Richard Wrangham from
Harvard University, Dr. Patricia Wright from Stony Brook University, and Dr. Randolph Nesse from the
University of Michigan. The following were members of the 2002 President's Council:
Mr. and Mrs. Abraham Appel
Mr. and Mrs. Donald Everett Minn
Mr. and Mrs. Roderick H. Cushman
Mr. Michel David-Weill
Mr. and Mrs. John H. Friedman
Dr. and Mrs. Leo A. Guthart
Mr. and Mrs. Charles E. Harris
Total
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. Thomas J. McGrath
Mr. Donald A. Pels
Mr. and Mrs. James H. Simons
Dr. and Mrs. Charles L. Stone, Jr.
Dr. and Mrs. James M. Stone
$255,835.30
Jane Friedman, Susan Harris, Bram Appel
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James Stone, Rod and Verena Cushman, Jim Watson
The Harbor Society
The Harbor Society recognizes the distinguished group of men and women who include Cold Spring
Harbor Laboratory in a charitable gift plan. A planned gift through a bequest in a will, trust, or other
asset transfer advances the educational and research programs, sustaining the best science for the
control of cancer and neurological disorders.
In 2002, the Laboratory recorded with deep appreciation generous support from the Estate of
Elisabeth Sloan Livingston, a charitable remainder trust from Mrs. Samuel D. Parkinson, the commit-
ment of a trust by Florence Strelkowski, and from another close supporter, a bequest in a will for the
benefit of the Laboratory.
Undergraduate Research Program
The Undergraduate Research Program introduces college students to the skills they need to become
research scientists. Twenty-five participants, 11 men and 14 women, from eight countries conducted
research under the guidance of staff scientists for ten weeks this summer on projects of mutual inter-
est.
CONTRIBUTORS ENDOWMENTS
Dorcas Cummings
Reverend Linda P. Hancock
Jephson Educational Trust
National Science Foundation
Mrs. Pamela P. Post
Mrs. Joan P. Tilney
Emanuel Ax Fund
Burroughs Wellcome Fund
Garfield Fellowship
H. Bentley. Glass Fellowship
Libby Fellowship
Robert H.P. Memorial Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
Total $240,032
Total Private Contributions $16,759,840.47
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LABORATORY STAFF
Bruce W. Stillman, Director and Chief Executive Officer
James D. Watson, President
Winship Herr, Dean, Watson School of Biological Sciences
Hollis Cline, Associate Director for Research
W. Dil laway Ayres Jr., Chief Operating Officer
G. Morgan Browne, Chief Financial Officer
Lari Russo, Comptroller
John Maroney, Director, Office of Technology Transfer/ In-
House Council
FACULTY
Professors
Gregory Hannon
David Helfman
Noun's Hernandez*
Adrian Krainer
Scott Lowe
Roberto Malinow
Robert Martienssen
W. Richard McCombie
Bhubaneswar Mishra
David Spector
Nicholas Tonks
Timothy Tully
Michael Wig ler
Michael Zhang
Associate Professors
Grigori Enikolopov
Shivinder Grewal
Tatsuya Hirano
David Jackson
Leemor Joshua-Tor
Yuri Lazebnik
Andrew Neuwald
Jacek Skowronski
Lincoln Stein
Arne Stenlund
Karel Svoboda*
William Tansey
Linda Van Aelst
Rui-Ming Xu
Jerry Yin
Yi Zhong
Assistant Professors
Carlos Brody
Dmitri Chklovskii
Masaaki Hamaguchi
Z. Josh Huang
Robert Lucito
Zachary Mainen
Alea Mills
Vivek Mittal
Senthil Muthuswamy
Michael Myers
Marja Timmermans
Anthony Zador
Investigator
Eli Hatchwell
Senior Computer
Scientist
Andrew Reiner
Computer Scientists
John Healy
Ravi Sachidanandam
CSHL Fellows
Gilbert Henry
Terence Strick
Research Investigators
Douglas Conklin
Nei lay Dedhia
Erik Enemark
Natalia Peunova
Mona Spector
Adjunct Associate
Professor
Scott Powers
Adjunct Assistant
Professor
Craig Ogata*
Senior Visiting Professor
Scott Powers
*Employee of Howard Hughes Medical Institute
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Terri I. Grodzicker, Assistant Director for Academic
Affairs
Jan A. Witkowski, Executive Director of Banbury Center
David A. Mick los, Executive Director of Dolan DNA
Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Executive Director of Meetings and
Courses
Visiting Scientists
Vladimir Bourtchouladze
Antonius Holtmaat
Tao Hu
John Jenco
Boris Kuzin
Mirjana Maletic-Savatic
Tatyana Michurina
Takao Ono
Vladimir Scheinker
Senior Fellow
Luca Cartegni
Postdoctoral Fellows
Carlos Aizenman
Colin Akerman
Eric Allemand
Jannik Andersen
Jean-Raymond Ango
Anindya Bagchi
Andres Barria-Roman
Carine Became!
Jennifer Bestman
Jannic Boehm
Benjamin Boettner
Katherine Braun
Anka Bric
Athanasios Bubulya
Paula Bubulya
Deirdre Buckley
Ingrid Bureau
Mary Byrne
Nansheng Chen
Maoyen Chi
Olivier Cuvier
Elisa De Stanchina
Robert Del Vecchio
Wim Karel Paul Deleu
Laurence Denis
Michael Deweese
Graziella Di Cristo
Eric Drier
Jian Du
Joshua Dubnau
Dominik Duelli
James Egan
Veronica Egger
Ingrid Ehrlich
Viola Ellison
Yuda Fang
Kim Farina Graham
Toshiyuki Fukada
Supriya Gangadharan
Peter Gillespie
Francois Grenier
No Grosse
Hui-Fu Guo
Kurt Haas
Frances Hannan
Todd Harris
Michelle Hastings
Naoya Hata
Michael Hamann
Andreas Herbst
Shanta Hinton
Maarten Hoek
Hao-Chi Hsu
Ping Hu
Ying Huang
Kanae lijima
Koichi lijima
Susan Janicki
Eric Julien
Natarajan Kannan
Prasanth Kumar
Kannanganattu
Sibel Kantarci
Guy Karger
Rotem Karni
Alla Karpova*
Alyson Kass-Eisler
Adam Kepecs
William Keyes
Catherine Kidner
Jae-Yean Kim
Sandra Kuhlman
Prakash Kumar
Rajeev Kumar
Patrice Lassos
Jidong Liu Michael Wehr Kendall Jensen Marcella Tello-Ruiz
Yingfang Liu Hans Guido Wendel Michelle Juarez Leonid Teytelman
Ana Losada Caizhi Wu Manpreet Katari Gudmundur Thorisson
Christian Machens Shouzhen Xia Edward Kim Doreen Ware
Carla Margulies Bin Xiang Charles Kopec Charles Youens-Clark
Bruce May Zhenyu Xuan Jonathan Kui Wei Zhao
Shanmugam Mayilvahanan* Canzhu Yang Michael Kwofie
Juan Mendez Ryohei Yasuda Arlinda Lee Research Associates
Tzu-Ching Meng Maria Yuneva Sungwoo Lee
Jinrong Min Lifang Zhang Shih-Chieh Lin Carmelita Bautista
Amitabh Mohanty Qing-Shuo Zhang Zachary Lippman Lisa Manche
Marta Moita Zhiguo Zhang Alexandra Lucs Mila McCurrach
Masashi Narita Zuo Zhang Asra Malikzay Linda Rodgers
Esther Nimchinsky Fang Zhao Marco Mangone Simone Saighetti
Sarah Newey Xinyang Zhao* Anagha Matapurkar Patricia Wendel
Kenichi Noma Xuemei Zhao John Mignone
Thomas Oertner Ahmad Zia* Marissa Moore Lab Facility Managers
Pol O'Fearghail Jack Zilfou Masafumi Muratani Diane EspositoGonzalo Hugo Otazu-Aldana Karen Zito Elizabeth Murchison Stephen Hearn
Helena Palka-Hamblin Zaher Nahle Sang Yong Kim
Lance Palmer Graduate Students Sabrina Nunez Kimberly La VineXiaokang Pan Hazeem Okunola Pamela McCloskeyGeraldine Pawlak Anitra Auster Togay Oztaskin Timothy Mulligan
Amandine Penel Nilanjana Banerjee Patrick Paddison Spencer Teplin
Tara Phelps-Durr Emily Bernstein Thomas Pologruto Ming Wang
Antonella Piccini Allison Blum Sachin Ranade Regina Whitaker
Michael Quirk Darren Burgess Emiliano Rial Verde
Pablo Rabinowicz Alyssa Carlberg Ashish Saxena Laboratory ManagerMichael Regulski Michelle Carmell Yvette Seger
Francesc Roca Amy Gaudy Stephanie Shaw Martha Daddario
Michael Ronemus Anna Lena Chabes Hang Shi
Simon Rumpel Santanu Chakraborty Khalid Siddiqui Scientific Administrators
Edward Ruthazer Kenneth Chang Ji-Joon Song Dianne AckerinaKalpana Samudre* Bidisha Chattopadhyaya Lung-Hao Tai Sadie AranaNamiko Satoh Sihem Cheloufi Dougal Tervo Patricia BirdVolker Scheuss Beth Chen Elizabeth Thomas Natalie HodgeLaura Schramm* Brian Chen Niraj Tolia Idee MallardiJonathan Sebat Hsu Hain Chen Andriy Tovkach Carol MarcincukKenneth Seidenman Yi-Chun Chen Thomas Tubon Anita MatthesAndrey Shabes Carmine Chiariello Kathryn Tworkowski Barbara MatusikGordon Shepherd* Shu-Ling Chiu Quan Wen Jane ReaderYi-Jun Sheu Michelle Cilia Joseph West Carol Sekunda*Ryushi Shudo Laureen Connell Joanna Wysocka Lyzette WilliamsJose Silva Catherine Cormier Min Yu Madeline WisnewskiPhilip Smith Ahmet Den li Chih-Chi Yuan
Sen Song
Christian Speck
Elena Ejkova
Farida Emran
Hatim Zariwala
Ming Ming Zhao Laboratory Technicians
Armen Stepanyants Rebecca Ewald Joan Alexander
Tomasz Swigut Claudia Feierstein Research Programmers Esteban ArayaTakuya Takahashi Elvin Garcia Juana Arroyo
Vatsala Thirumalai Eve-Ellen Govek Shulamit Avraham Shola Aruleba
Joshua Trachtenberg Hilde Grasmo-Wendler Scott Cain Deborah Aufiero
Mitsuko Uchida Ira Hall Gengxin Chen Vivekanand Balija
Naoshige Uchida Jill Hemish Fiona Cunigham Jody Barditch
Anne Vaahtokari Brian Hill Sujit Dike Amy Brady
Matthew Vaughn Shun Ho Jeremiah Faith Kimberly Bronson
Erik Vollbrecht Ikuko Hotta Geeta Joshi-Tope Barry Burbach*
Thomas Volpe Tomas Hromadka Gupreet Katari Christopher Catapano
Jinhua Wang Helen Hsieh Kato Mamoru Nancy Dawkins-Pisani
Qun Wang Ajit Janardhan Liya Ren Melissa de la Bastide
Yalin Wang Ashkan Javaherian Steven Schmidt Margaret Falkowski
*Employee of Howard Hughes Medical Institute
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Eugenia Friedman
Lori Grady
Teresa Haire
Inessa Hakker
Michiko Hirano
Frederick Katzenberger
Tatsuhiko Kawaguchi
Gayle Lark
Tsai-Ling Lee
Zhi Zhong Li
Stacy Lopez
Beicong Ma*
Jennifer Meth
Beth Miller
Barbara Mish
Ophelia Morris
Stephanie Muller
Masako Narita
Lidia Nascimento
Aigoul Nourjanova
Ximena Opitz-Araya
Andrew O'Shaughnessy
Ronnie Packer
Timothy Pal
Raymond Preston
Sagarika Ray
Michael Riggs
Dongyon Roh
Christine Rosenthal
Lise Lotte Schmidt
Stephen Schuck
Joseph Simorowski
Stephanie Smith
Lori Spiegel
Izabela Sujka
Yu ling Sun*
Julie Thomas
Jennifer Troge
Rachel von Roeschlaub
Jing Wang
Jeanne Wiggins
Priscilla Wu
Ying Wu
Guoping Xiao
Mianjia Ye
Lewis Yesner
Xiaoqun Zhang*
Hui Zhou
Ying-hua Zhu
Theresa Zutavern
Media Makers/Laboratory
Aides
Maria Andrade
June Blanchford
Patricia Brady
Marjorie Brand
Florinda Chaves
Terrance Chisum
Janice Douglas
So-Young Eom
Salvador Henriquez
Marcela Lara
Vincent Meschan
Hong Jie Shen
Rulan Shen
Jinghong Tang-Qiu
Ramu Umamaheswari
Margaret Wallace
Xiu-Xia Zhang
Research Administration
Maureen Bell
Denise Roberts
Watson School of
Biological Sciences
Winship Herr, Dean
Lilian Gann
Mark Beavers
Janet Duffy
DEPARTMENTS
Comptrollers Office and
Accounting
Lari Russo, Comptroller
Sharon Bense
Karine Boyce
Damian Desiderio
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